The residue at position 12 to 19 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 30 to 37 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 to 162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 to 30 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 265 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 265 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 427 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 156 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 268 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 108 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 110 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 38 to 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 68 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 101 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 123 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 159 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 86 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 92 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 95 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 169 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 273 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 302 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 307 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 323 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 350 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 370 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 108 to 131 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 183 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 216 to 239 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 462 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 52 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 95 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 29 to 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 19 to 23 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 30 to 34 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 121 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 123 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 124 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 246 to 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 134 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 211 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 252 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 12 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 41 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 124 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 15 to 22 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 367 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 395 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 293 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 65 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 83 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 99 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 124 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 8 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 9 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 39 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 91 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 414 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 527 to 535 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 551 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 4 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 20 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 43 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 143 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 60 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 535 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 537 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 539 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 894 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 977 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 984 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 987 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 127 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 13 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 114 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 116 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 196 to 203 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 to 246 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 30 to 33 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 415 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 495 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 390 to 396 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 55 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 84 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 105 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 112 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 394 to 401 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1032 to 1039 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 42 to 50 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 189 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 230 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 353 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 414 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 417 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 79 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 238 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 242 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 7 to 12 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 141 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 256 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 282 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 22 to 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 27 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 84 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 151 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 166 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 181 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 239 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 344 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 362 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 377 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 388 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 391 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 397 to 398 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 416 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 434 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 9 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 18 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 73 to 82 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 to 192 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 36 to 43 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 426 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 196 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 511 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 318 to 326 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 344 to 349 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 569 to 577 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 590 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 51 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 92 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 141 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 156 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 189 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 258 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 272 to 276 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 279 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 279 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 295 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 295 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 364 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 895 to 902 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 to 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 220 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 161 to 169 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 247 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 249 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 255 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 13 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 14 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 15 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 16 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 40 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 122 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 123 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 177 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 206 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 213 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 95 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 140 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 383 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 82 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 279 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 286 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 356 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 146 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 159 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 110 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 126 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 129 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 63 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 303 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 241 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 243 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 97 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 156 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 51 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 59 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 62 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 159 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 174 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 164 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 200 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 193 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 9 to 16 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 211 to 218 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 258 to 262 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 323 to 326 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 19 to 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 668 to 675 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 15 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 37 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 122 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 97 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 102 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 105 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 117 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 190 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 193 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 196 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 200 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 205 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 247 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 253 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 257 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 180 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 181 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 250 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 666 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 826 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 827 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 72 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 73 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 137 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 167 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 47 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 49 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 64 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 64 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 166 to 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 191 to 195 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 283 to 286 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 16 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 129 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 132 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 268 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 375 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 377 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 380 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 12 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 28 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 30 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 32 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 39 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 11 to 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 165 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 23 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 13 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 15 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 47 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 81 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 90 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 153 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 186 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 251 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 251 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 254 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 325 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 325 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 327 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 329 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 330 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 190 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 242 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 262 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 279 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 68 to 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 221 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 250 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 315 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 to 379 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 415 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 419 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 442 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 483 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 563 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 566 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 571 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 281 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 284 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 14 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 62 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 78 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 103 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 150 to 155 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 238 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 118 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 124 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 27 to 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 to 273 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 306 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 to 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 6 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 326 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 380 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 196 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 449 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 451 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 453 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 818 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 892 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 899 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 902 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 76 to 83 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 43 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 238 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 242 forms a bond with O2, indicating a strong binding affinity.
The residue at position 288 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 289 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 366 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 367 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 374 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 376 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 20 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 85 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 136 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 268 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 281 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 53 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 166 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mg of chlorophyll a ChlzD2, indicating a strong binding affinity.
The residue at position 130 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 143 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mg of chlorophyll a PD2, indicating a strong binding affinity.
The residue at position 215 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 262 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 29 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 214 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 239 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 243 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 120 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 143 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 39 to 46 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 46 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 442 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 223 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 6 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 36 to 39 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 64 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 122 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 397 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 400 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 8 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 291 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 397 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 14 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 89 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 154 to 158 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 2 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 73 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 76 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 243 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 328 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 to 34 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 246 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 287 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 287 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 339 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 366 to 369 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 390 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 to 17 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 186 to 193 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 233 to 237 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 30 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with nilotinib, indicating a strong binding affinity.
The residue at position 48 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 141 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 228 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 319 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 324 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 116 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 137 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 8 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 99 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 102 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 181 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 289 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 318 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 339 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 367 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 388 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 333 to 340 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 to 40 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 639 to 646 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 77 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 129 to 137 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 198 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 284 to 290 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 297 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 385 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 511 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 81 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 123 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 124 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 195 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 491 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 37 to 44 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 19 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 14 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 39 to 42 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 144 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 225 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 240 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 300 to 306 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 304 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 306 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 414 to 416 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 to 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 222 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 286 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 315 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 378 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 386 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 248 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 250 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 256 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 33 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 437 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 80 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 152 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 213 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 283 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 201 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 86 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 72 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 64 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 85 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 129 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 23 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 140 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 293 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 467 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 469 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 471 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 531 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 533 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 535 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 539 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 594 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 598 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 602 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 191 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 249 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 285 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 389 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 412 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 453 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 535 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 538 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 543 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 177 to 182 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 223 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 30 to 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 12 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 to 119 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 134 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 24 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 27 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 43 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 80 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 116 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 187 to 190 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 401 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 408 to 410 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 408 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 235 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 293 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 329 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 349 to 351 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 390 to 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 429 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 433 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 456 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 497 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 577 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 580 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 585 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 61 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 65 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 68 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 136 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 196 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 268 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 234 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 16 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 47 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 86 to 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 74 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 145 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 205 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 277 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 10 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 19 to 28 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 252 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 362 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 7 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 11 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 22 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 180 to 183 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 183 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 191 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 282 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 203 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 204 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 225 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 226 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 275 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 313 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 314 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 315 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 316 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 317 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 129 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 131 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 139 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 214 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 283 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 322 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 152 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 153 to 160 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 88 to 92 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 63 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 196 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 371 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 126 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 170 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 189 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 215 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 332 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 333 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 342 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 344 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 47 to 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 to 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 182 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 266 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 355 to 358 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 390 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 24 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 127 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 251 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 278 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 306 to 330 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 3 to 10 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 161 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 138 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 109 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 116 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 349 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 351 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 414 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with ascopyrone M 1, indicating a strong binding affinity.
The residue at position 627 forms a bond with 1,5-anhydro-D-fructose, indicating a strong binding affinity.
The residue at position 627 forms a bond with ascopyrone M 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with 1,5-anhydro-D-fructose, indicating a strong binding affinity.
The residue at position 630 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 632 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 639 forms a bond with ascopyrone M 2, indicating a strong binding affinity.
The residue at position 639 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 641 forms a bond with 1,5-anhydro-D-fructose, indicating a strong binding affinity.
The residue at position 641 forms a bond with ascopyrone M 2, indicating a strong binding affinity.
The residue at position 709 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 726 forms a bond with 1,5-anhydro-D-fructose, indicating a strong binding affinity.
The residue at position 726 forms a bond with ascopyrone M 2, indicating a strong binding affinity.
The residue at position 9 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 132 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 116 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 119 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 189 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 294 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 36 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 92 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 167 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 156 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 465 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 490 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 517 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 522 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 538 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 539 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 540 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 540 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 627 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 628 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 673 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 198 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 39 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 104 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 133 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 101 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 317 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 339 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 73 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 139 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 627 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 74 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 22 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 64 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 168 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 201 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 203 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 29 to 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 494 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 to 11 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 22 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 149 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 164 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 221 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 221 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 308 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 325 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 350 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 378 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 396 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 413 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 30 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 106 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 129 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 398 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 411 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 416 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 228 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 125 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 125 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 126 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 129 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 186 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 274 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 479 to 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 402 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 178 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 55 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 39 to 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 501 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 503 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 867 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 943 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 950 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 953 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 177 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 203 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 204 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 295 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 379 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 209 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 133 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 190 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 202 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 92 to 97 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 368 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 130 to 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 300 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 326 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 326 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 351 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 378 to 381 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 to 93 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 194 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 309 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 311 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 314 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 340 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 65 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 172 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 172 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 217 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 245 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 268 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 297 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 92 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 305 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 327 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 48 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 50 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 70 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 232 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 373 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 15 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 6 to 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 124 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 18 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 128 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 142 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 223 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 238 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 298 to 304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 302 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 304 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 330 to 332 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 412 to 414 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 221 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 47 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 286 to 296 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 328 forms a bond with heme, indicating a strong binding affinity.
The residue at position 468 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 4 to 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 296 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 311 to 315 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 337 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 22 to 46 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 39 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 40 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 46 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 52 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 114 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 179 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 386 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 419 to 423 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 226 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 128 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 172 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 191 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 217 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 217 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 274 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 334 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 335 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 133 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 18 to 25 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 87 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 507 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 887 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 889 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 898 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 899 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 332 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 662 to 670 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 685 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 20 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 27 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 472 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 541 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 20 to 28 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 38 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 179 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 183 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 to 179 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 9 to 13 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 32 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 133 to 138 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 11 to 14 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 25 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 78 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 142 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 156 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 171 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 229 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 335 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 353 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 368 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 379 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 382 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 388 to 389 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 407 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 425 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 442 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 9 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 42 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 64 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 269 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 261 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 281 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 290 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 26 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 62 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 109 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 111 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 128 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 135 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 317 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 328 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 182 to 189 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 212 to 217 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 305 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 446 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 12 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 409 to 413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 777 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 851 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 858 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 861 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 139 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 154 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 227 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 332 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 365 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 376 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 422 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 439 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 24 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 35 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 107 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 108 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 123 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 154 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 152 to 156 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 244 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 22 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 240 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 359 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 174 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 450 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 490 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 535 to 538 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 123 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 148 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 152 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 57 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 60 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 511 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 891 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 893 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 902 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 903 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 35 to 42 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 170 to 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 195 to 199 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 264 to 267 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 319 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 33 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 280 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 349 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 21 to 28 forms a bond with heme, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 23 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 51 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 89 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 107 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 144 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 28 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 318 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 54 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 143 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 169 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 177 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 292 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 111 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 2155 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2158 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2184 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2187 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2218 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2221 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2233 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2235 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 51 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 53 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 208 to 213 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 329 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 379 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 170 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 310 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 404 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 407 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 422 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 427 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 22 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 484 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 287 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 13 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 16 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 88 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 137 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 224 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 330 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 348 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 363 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 374 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 377 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 402 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 420 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 437 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 9 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 55 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 63 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 66 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 247 forms a bond with baclofen, indicating a strong binding affinity.
The residue at position 247 forms a bond with phaclofen, indicating a strong binding affinity.
The residue at position 270 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 270 forms a bond with baclofen, indicating a strong binding affinity.
The residue at position 270 forms a bond with phaclofen, indicating a strong binding affinity.
The residue at position 287 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 287 forms a bond with baclofen, indicating a strong binding affinity.
The residue at position 287 forms a bond with phaclofen, indicating a strong binding affinity.
The residue at position 367 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 367 forms a bond with baclofen, indicating a strong binding affinity.
The residue at position 466 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 466 forms a bond with baclofen, indicating a strong binding affinity.
The residue at position 466 forms a bond with phaclofen, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 183 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 186 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 55 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 85 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 152 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 177 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 181 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 374 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 378 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 484 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 510 to 511 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 533 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 560 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 720 to 729 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 796 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 804 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 821 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 111 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 115 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 118 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 195 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 296 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 443 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 175 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 177 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 180 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 183 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 249 to 269 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 283 to 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 434 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 146 to 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 108 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 127 to 132 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 175 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 124 to 132 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 128 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 156 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 21 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 148 to 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 45 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 92 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 12 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 82 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 104 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 122 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 184 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 194 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 918 to 925 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 75 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 122 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 33 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 34 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 126 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 21 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 98 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 171 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 177 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 179 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 372 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 446 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 450 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 175 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 116 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 123 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 169 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 512 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 895 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 897 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 906 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 907 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 13 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 36 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 44 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 66 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 67 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 122 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 126 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 198 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 202 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 231 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 276 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 304 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 86 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 138 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 161 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 122 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 122 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 123 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 126 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 174 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 183 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 271 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 331 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 342 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 342 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 342 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 424 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 424 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 431 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 451 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 451 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 475 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 151 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 363 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 366 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 379 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 383 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 151 to 156 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 239 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 69 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 178 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 183 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 243 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 269 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 298 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 40 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 204 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 96 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 309 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 331 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 15 to 21 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 144 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 183 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 273 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 179 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 190 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 193 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 470 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 182 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 196 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 90 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 109 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 150 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 49 to 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 24 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 31 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 160 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 194 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 257 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 260 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 274 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with heme, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 62 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 287 to 290 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 5 to 19 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 163 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 308 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 312 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 545 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 551 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 172 to 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 260 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 262 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 79 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 131 to 139 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 200 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 18 to 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 227 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 251 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 129 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 10 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 26 to 33 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 766 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1056 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1059 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1065 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 333 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 384 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 510 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 5 to 6 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 93 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 122 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 153 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 214 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 87 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 88 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 110 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 136 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 190 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 200 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 301 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 301 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 305 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 305 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 444 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 448 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 452 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 11 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 71 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 489 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 493 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 369 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 16 to 20 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 116 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 124 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 128 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 170 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 215 to 224 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 142 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 to 253 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 348 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 384 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 521 to 526 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 246 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 251 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 405 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 408 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 411 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 415 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 423 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 435 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 446 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 57 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 96 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 140 to 146 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 163 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 212 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 487 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 53 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 181 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 203 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 248 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 213 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 347 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 397 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 553 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 581 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 139 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 75 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with N(2)-succinyl-L-ornithine, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with N(2)-succinyl-L-ornithine, indicating a strong binding affinity.
The residue at position 236 forms a bond with N(2)-succinyl-L-ornithine, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 278 forms a bond with N(2)-succinyl-L-ornithine, indicating a strong binding affinity.
The residue at position 302 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 to 209 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 315 to 319 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 319 to 322 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 to 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 6 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 7 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 98 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 235 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 213 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 6 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 8 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 8 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 14 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 16 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 16 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 20 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 22 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 25 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 25 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 27 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 34 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 35 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 35 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 37 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 38 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 38 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 42 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 45 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 45 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 49 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 51 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 51 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 59 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 61 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 62 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 62 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 158 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 204 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 15 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 14 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 72 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 75 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 395 to 402 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 549 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 22 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 565 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 569 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 667 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 671 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 443 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 457 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 546 to 553 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 28 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 to 213 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 265 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 571 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 897 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 902 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 913 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 916 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 921 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 924 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 930 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 932 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 255 to 283 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 to 191 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 to 316 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 to 386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 676 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 677 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 716 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 720 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 884 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 886 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 263 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 167 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 169 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 76 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 177 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 366 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 34 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 47 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 75 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 91 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 163 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 238 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 163 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 167 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 10 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 76 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 267 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 300 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 339 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 365 to 369 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 32 to 40 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 33 to 40 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 87 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 92 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 123 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 124 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 127 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 185 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 126 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 66 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 120 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 208 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 37 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 169 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 126 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 140 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 220 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 235 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 295 to 301 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 299 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 301 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 327 to 329 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 405 to 407 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 109 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 187 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 261 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 213 to 218 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 306 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 447 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 491 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 78 to 83 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 133 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 209 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 234 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 66 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 96 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 308 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 310 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 313 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 339 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 317 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 369 to 372 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 241 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 143 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 209 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 67 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 79 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 107 to 115 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 118 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 104 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 124 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 127 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 200 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 299 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 48 to 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 212 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 364 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 14 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 21 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 25 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 64 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 95 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 119 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 250 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 253 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 267 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 170 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 233 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 234 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 236 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 363 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 263 to 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 493 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 508 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 599 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 402 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 409 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 409 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 261 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 288 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 448 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 454 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 51 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 169 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 177 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 42 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 357 to 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 311 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 335 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 387 to 389 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 to 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 515 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 523 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 526 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 584 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 35 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 66 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 90 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 110 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 167 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 114 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 488 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 525 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 526 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 622 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 520 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 88 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 460 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 462 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 464 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 819 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 893 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 900 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 903 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 8 to 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 132 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 613 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 624 to 625 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 to 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 364 to 373 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 368 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 375 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 398 to 401 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 450 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 452 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 458 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 95 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 122 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 161 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 189 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 243 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 262 to 267 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 288 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 46 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 to 30 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 21 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 78 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 118 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 224 to 229 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 224 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 243 to 249 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 243 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 245 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 248 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 452 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 35 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 15 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 30 to 34 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 53 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 57 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 76 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 71 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 288 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 329 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 27 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 67 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 101 to 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 147 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 186 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 302 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 326 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 431 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 434 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 455 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 461 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 419 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 116 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 136 to 141 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 321 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 368 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 to 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 32 to 35 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 to 27 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 152 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 230 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 245 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 305 to 311 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 309 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 311 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 419 to 421 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 43 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 117 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 480 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 483 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 485 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 543 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 544 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 545 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 549 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 21 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 90 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 97 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 204 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 314 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 525 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 187 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 215 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 220 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 236 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 204 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 to 44 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 332 to 339 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 11 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 13 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 38 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 59 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 7 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 724 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 220 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 431 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 270 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 299 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 42 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 45 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 60 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 27 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 124 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 197 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 336 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 340 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 344 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 386 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 411 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 33 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 86 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 120 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 286 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 327 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 102 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 to 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 45 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 84 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 112 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 29 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 33 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 36 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 71 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 224 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 226 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 256 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 31 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 166 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 349 to 357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 492 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 574 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 578 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 650 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 130 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 153 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 307 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 331 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 425 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 428 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 443 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 449 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 66 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 387 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 148 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 175 to 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 221 to 225 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 289 to 292 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 348 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 183 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 238 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 285 to 294 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 300 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 324 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 343 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 407 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 429 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 453 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 500 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 660 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 86 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 49 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 54 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 100 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 61 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 153 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 46 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 143 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 151 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 187 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 213 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 to 261 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 302 to 303 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 314 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 456 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 463 to 465 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 463 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 158 to 166 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 277 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 173 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 177 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 264 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 53 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 104 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 221 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 101 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 32 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 69 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 116 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 232 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 232 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 53 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 56 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 366 to 370 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 417 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 252 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 271 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 274 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 283 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 858 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 858 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 864 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 919 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 919 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 921 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 921 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 926 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 998 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 998 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1004 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1058 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1058 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1060 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1060 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 68 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 99 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 163 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 224 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 208 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 to 297 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 293 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 158 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 66 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 91 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 106 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 232 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 253 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 47 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 50 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 23 to 30 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 159 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 206 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 233 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 12 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 14 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 450 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 452 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 454 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 12 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 261 to 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 336 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 403 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 407 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 444 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 462 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 391 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 155 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 166 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 7 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 90 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 261 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 273 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 37 to 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 174 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 21 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 39 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 42 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 14 to 25 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 194 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 307 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 329 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 9 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 20 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 47 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 41 to 67 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 183 to 187 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 218 to 222 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 207 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 257 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 278 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 307 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 334 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 181 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 189 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 235 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 282 to 291 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 297 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 31 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 506 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 511 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 530 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 550 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 555 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 568 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 574 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 905 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 910 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 923 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 929 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 954 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 959 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 972 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 978 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1007 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1012 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1025 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1031 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 219 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 251 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 341 to 344 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 348 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 670 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 671 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 116 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 166 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 10 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 66 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 124 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 393 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 167 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1850 to 1852 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1892 to 1895 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1918 to 1919 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1963 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1969 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 152 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 to 175 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 254 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 176 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 177 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 377 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 387 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 416 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 419 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 422 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 426 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 149 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 88 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 95 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 100 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 217 to 223 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 241 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 247 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 247 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 306 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 306 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 344 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 362 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 366 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 391 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 391 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 391 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 393 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 72 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 121 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 497 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 to 205 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 595 to 602 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 122 to 128 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 91 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 219 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 247 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 119 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 440 to 442 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 440 to 442 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 493 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 493 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 524 to 525 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 570 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 608 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 608 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 614 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 652 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 674 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 735 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 23 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 107 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 291 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 to 25 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 202 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 117 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 120 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 162 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 182 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 196 to 203 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 246 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 to 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 273 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 537 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 538 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 540 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 342 to 369 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 428 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 431 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 461 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 464 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 91 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 247 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 45 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 203 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 19 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 148 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 189 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 351 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 57 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 451 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 17 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 21 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 33 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 128 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 515 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 8 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 10 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 297 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 232 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 268 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 268 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 339 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 51 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 53 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 36 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 10 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 249 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 428 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 429 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 477 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 478 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 18 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 165 to 172 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 190 to 194 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 192 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 139 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 148 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 181 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 501 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 841 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 843 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 852 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 853 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 11 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 61 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 259 to 262 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 333 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 401 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 405 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 442 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 443 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 161 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 410 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 25 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 34 to 40 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 35 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 169 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 248 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 323 to 329 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 329 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 437 to 440 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 263 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 73 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 74 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 111 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 168 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 785 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 788 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 796 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 799 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 814 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 817 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 822 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 830 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 77 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 146 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 134 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 60 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 298 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 301 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 34 to 41 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 46 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 49 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 53 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 81 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 150 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 175 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 179 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 212 to 219 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 372 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 376 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 482 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 508 to 509 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 531 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 558 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 718 to 727 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 794 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 802 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 819 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 21 to 25 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 243 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 249 to 252 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 196 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 225 to 230 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 248 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 360 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 25 to 32 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 50 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 561 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 663 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 45 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 33 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 34 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 106 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 167 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 201 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 265 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 282 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 5 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 31 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 15 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 40 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 61 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 103 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 119 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 507 to 514 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 to 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1317 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1396 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1399 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1704 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1809 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1812 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 228 to 231 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 251 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 384 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 454 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 58 to 67 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 49 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 138 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 168 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 to 296 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 298 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 301 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 381 to 385 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 412 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 466 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 467 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 468 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 463 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 11 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 142 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 143 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 144 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 204 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 226 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 19 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 428 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 429 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 435 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 437 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 112 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 127 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 28 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 127 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 341 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 345 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 349 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 391 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 416 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 56 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 61 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 167 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 176 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 749 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 753 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 277 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 109 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 302 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 343 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 423 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 426 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 431 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 480 to 482 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 496 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 202 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 379 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 3 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 298 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 358 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 361 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 24 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 20 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 152 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 199 to 204 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 199 to 204 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 235 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 235 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 366 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 394 to 397 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 416 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 477 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 185 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 100 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 62 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 236 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 318 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 409 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 33 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 36 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 52 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 55 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 532 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 538 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 172 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 175 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 349 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 349 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 38 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 58 to 65 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 176 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 269 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 366 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 201 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 274 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 112 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 114 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 116 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 121 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 148 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 152 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 157 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 67 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 106 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 163 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 87 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 465 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 467 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 812 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 887 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 897 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 60 to 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 135 to 142 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 305 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 351 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 353 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 353 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 489 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 514 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 559 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 625 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 626 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 677 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 683 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 702 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 705 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 767 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 770 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 795 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 798 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 799 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 799 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 907 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 246 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 247 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 270 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 419 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 31 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 62 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 86 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 106 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 162 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 6 to 11 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 56 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 69 to 72 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 40 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 17 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 519 to 526 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 255 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 281 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 140 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 143 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 228 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 327 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 154 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 588 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 590 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 592 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 415 to 417 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 144 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 218 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 45 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 30 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 178 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 186 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 380 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 403 to 406 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 453 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 457 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 23 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 129 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 167 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 193 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 53 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 118 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 112 to 120 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 82 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 140 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 140 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 167 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 227 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 227 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 230 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 303 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 305 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 306 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 87 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 89 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 93 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 97 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 162 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 167 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 173 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 177 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 228 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 482 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 520 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 251 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 349 to 350 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 69 to 76 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 154 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 211 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 280 to 284 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 395 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 399 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 46 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 301 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 316 to 320 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 342 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 28 to 31 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 304 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 29 to 36 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 60 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 240 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 244 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 336 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 507 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 522 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 84 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 151 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 153 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 230 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 232 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 157 to 164 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 176 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 18 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 124 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 285 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 326 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 36 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 13 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 117 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 to 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 286 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 301 to 305 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 327 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 76 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 77 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 168 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 11 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 61 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 64 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 70 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 337 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 678 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 682 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 772 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 776 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 328 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 16 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 34 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 50 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 108 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 123 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 131 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 137 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 139 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 270 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 273 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 305 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 312 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 126 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 262 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 502 to 509 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 210 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 427 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 472 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 472 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 548 to 551 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 608 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 612 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 615 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 615 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1016 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 330 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 424 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 442 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 448 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 131 forms a bond with heme, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 383 to 390 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 429 to 433 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 483 to 486 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 65 to 72 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 110 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 194 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 221 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 234 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 239 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 273 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 276 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 293 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 296 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 301 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 304 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 312 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 319 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 108 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 281 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 246 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 45 to 52 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 220 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 280 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 302 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 322 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 355 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 372 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 396 to 398 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 403 to 404 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 447 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 448 to 449 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 474 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 476 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 478 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 550 to 552 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 200 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 9 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 181 to 188 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 293 to 296 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 101 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 105 to 110 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 105 to 110 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 133 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 133 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 161 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 167 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 96 to 110 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 677 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 677 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 681 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 681 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 684 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 684 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 685 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 685 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with hexadecanoyl-CoA, indicating a strong binding affinity.
The residue at position 175 forms a bond with hexadecanoyl-CoA, indicating a strong binding affinity.
The residue at position 240 forms a bond with hexadecanoyl-CoA, indicating a strong binding affinity.
The residue at position 253 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 283 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 286 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1404 to 1411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 195 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 196 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 198 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 131 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 61 to 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 124 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 96 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 160 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 171 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 86 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 5 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 146 to 184 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 112 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 62 to 70 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 174 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 203 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 370 to 377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 109 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 221 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 455 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 503 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 548 to 551 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 455 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 600 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 636 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 668 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 796 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 934 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 997 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 146 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 175 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 258 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 127 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 317 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 397 to 399 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 421 to 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 528 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 536 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 539 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 550 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 552 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 555 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 77 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 132 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 181 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 182 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 95 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 100 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 103 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 115 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 188 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 191 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 194 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 198 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 203 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 245 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 251 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 255 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 111 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 128 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 556 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 560 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 657 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 661 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 222 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 330 to 332 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 232 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 219 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 227 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 313 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 61 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 29 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 116 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 185 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 191 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 193 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 390 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 414 to 417 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 465 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 469 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 178 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 to 31 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 602 to 609 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 211 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 299 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 91 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 156 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 7 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 18 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 166 to 172 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 190 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 647 to 654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 26 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 to 31 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 194 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 to 99 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 121 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 144 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 forms a bond with heme, indicating a strong binding affinity.
The residue at position 60 forms a bond with heme, indicating a strong binding affinity.
The residue at position 48 to 55 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 77 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 87 to 94 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 91 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 173 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 82 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 32 to 39 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 61 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 154 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 164 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 165 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 136 to 141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 34 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 40 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 105 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 107 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 109 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 155 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 71 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 96 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 123 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 211 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 26 to 29 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 49 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 206 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 319 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 76 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 95 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 435 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 99 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 141 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 338 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 344 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 246 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 339 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 384 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 57 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 32 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 57 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 149 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 78 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 130 to 138 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 199 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 31 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 33 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 36 to 41 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 168 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 426 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 129 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 143 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 306 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 337 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 70 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 142 to 148 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 173 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 297 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 304 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 307 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 604 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 608 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 708 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 712 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 78 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 120 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 313 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 203 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 286 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 328 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 387 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 126 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 341 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 101 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 304 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 347 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 21 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 132 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 141 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 346 to 353 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 392 to 396 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 446 to 449 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 423 to 430 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 485 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 715 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 719 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 87 to 96 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 199 to 247 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 379 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 382 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 385 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 425 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 75 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 77 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 92 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 112 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 to 210 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 43 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 75 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 to 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 29 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 to 47 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 290 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 388 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 179 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 197 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 206 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 328 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 332 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 363 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 9 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 9 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 234 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 263 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 213 to 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 349 to 352 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 391 to 393 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 38 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 75 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 279 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 349 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 54 to 61 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 565 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 568 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 582 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 585 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 590 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 593 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 611 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 614 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 145 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 179 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 206 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 228 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 714 to 771 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 838 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 850 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 850 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 852 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 451 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 676 to 683 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 113 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 438 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 457 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 to 487 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 494 to 496 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 237 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 324 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 to 84 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 248 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 322 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 325 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 339 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 342 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 356 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 359 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 327 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 392 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 419 to 420 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 435 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 444 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 40 to 43 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 176 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 191 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 249 to 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 253 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 255 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 130 to 136 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 251 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 252 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 55 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 178 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 199 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 203 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 124 to 129 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 104 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 372 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 273 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 83 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 920 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 935 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 938 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 939 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 11 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 14 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 21 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 51 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 401 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 458 to 465 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 493 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1215 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1240 to 1247 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 421 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 610 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 638 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with pyridine, indicating a strong binding affinity.
The residue at position 123 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 342 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 346 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 390 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 367 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 135 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 188 to 194 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 110 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 550 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 575 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 579 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 514 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 517 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 602 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 10 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 687 to 694 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 158 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 4 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 309 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 374 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 to 76 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 224 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 76 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 140 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 169 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 333 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 351 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 366 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 380 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 386 to 387 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 405 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 423 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 440 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 113 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 202 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 301 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 62 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 138 to 145 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 223 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 239 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 34 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 168 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 440 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 479 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 483 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 483 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 29 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 290 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 331 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 224 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 302 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 7 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 27 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 28 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 119 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 55 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 498 to 505 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 144 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 90 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 91 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 92 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 115 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 117 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 203 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 204 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 230 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 255 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 278 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 291 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 62 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 21 to 25 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 139 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 187 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 11 to 17 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 272 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 86 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 116 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 33 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 121 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 166 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 296 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 328 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 333 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 336 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 165 to 174 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 277 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 284 to 287 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 323 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 380 to 384 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 to 408 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 25 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 120 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 339 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 343 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 385 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 50 to 57 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 50 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 312 to 315 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 312 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 314 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 315 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 14 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 16 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 18 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 25 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 89 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 91 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 98 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 125 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 127 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 129 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 131 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 136 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 159 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 83 to 87 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 613 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 628 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 628 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 632 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 632 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 772 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 776 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 780 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 21 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 32 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 96 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 130 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 132 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 134 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 141 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 15 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 18 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 41 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 52 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 240 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 312 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 334 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 46 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 141 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 564 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 568 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 666 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 670 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 164 to 171 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 171 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 276 to 279 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1254 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1257 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1269 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1271 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1274 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1277 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1288 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1291 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 23 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 89 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 183 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 187 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 392 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 477 to 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 302 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 362 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 365 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 216 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 219 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 70 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 86 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 158 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 233 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 189 to 194 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 251 to 257 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 275 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 320 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 165 to 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 293 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 329 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 330 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 341 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 561 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 605 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 919 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 922 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 32 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 113 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 20 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 91 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 22 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 47 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 107 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 254 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 342 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 348 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 378 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 450 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 478 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 481 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 19 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 114 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 205 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 513 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 215 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 230 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 260 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 313 to 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 4 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 7 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 39 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 19 to 27 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 345 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 428 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 433 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 191 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 50 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 22 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 133 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 233 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 323 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 326 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 348 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 285 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 312 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 312 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 337 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 364 to 367 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 388 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 137 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 249 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 71 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 71 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 75 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 75 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 100 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 100 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 129 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 129 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 134 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 134 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 150 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 150 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 151 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 152 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 152 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 244 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 244 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 245 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 293 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 293 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 67 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 62 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 187 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 to 41 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 279 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 279 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 11 to 18 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 24 to 25 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 470 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 474 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 477 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 94 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 141 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 268 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 284 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 34 to 41 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 345 to 352 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 376 to 383 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 322 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 492 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 86 to 91 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 129 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 83 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 283 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 284 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 77 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 268 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 301 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 366 to 370 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 108 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 140 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 225 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 227 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 305 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 375 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 468 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 411 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 348 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 409 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 437 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 470 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 557 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 168 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 128 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 188 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 260 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 562 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 566 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 665 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 669 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 266 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 350 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 414 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 418 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 77 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 224 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 57 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 66 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 157 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 162 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 166 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 191 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 282 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 292 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 328 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 360 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 366 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 367 to 369 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 140 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 34 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 157 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 162 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 167 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 194 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 197 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 212 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 215 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 220 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 223 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 235 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 241 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 78 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 106 to 114 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 14 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 17 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 19 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 310 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 450 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 458 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 81 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 120 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 149 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 178 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 141 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 151 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 233 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 235 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 275 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 331 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 13 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 347 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 530 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 26 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 32 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 112 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 157 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 15 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 28 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 191 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 256 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 259 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 273 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 99 to 108 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 358 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 388 to 391 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 472 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 528 to 529 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 534 to 538 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 603 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 32 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 59 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 313 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 335 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 144 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 179 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 254 to 260 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 277 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 303 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 322 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 212 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 338 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 352 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 352 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 354 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 768 to 846 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 913 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 925 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 925 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 927 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 24 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 129 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 281 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 160 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 406 to 408 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 413 to 419 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 17 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 43 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 56 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 617 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 to 110 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 52 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 91 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 121 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 24 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 26 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 51 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 123 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 160 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 200 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 298 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 569 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 928 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 931 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 948 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 951 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 9 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 198 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 204 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 311 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 338 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 343 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 350 to 351 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 390 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 394 to 398 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 405 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 8 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 258 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 284 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 82 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 87 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 237 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 78 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 232 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 233 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 235 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 316 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 319 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 320 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 335 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 349 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 352 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 353 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 434 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 94 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 417 to 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 440 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 45 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 240 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 244 forms a bond with O2, indicating a strong binding affinity.
The residue at position 290 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 291 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 369 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 376 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 378 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 441 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 35 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 36 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 109 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 162 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 240 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 to 265 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 31 to 32 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 178 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 454 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 466 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 469 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 471 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 528 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 529 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 530 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 534 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 36 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 56 forms a bond with heme, indicating a strong binding affinity.
The residue at position 59 forms a bond with heme, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 44 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 108 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 139 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 103 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 184 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 220 to 223 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 259 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 276 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 171 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 313 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 346 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 to 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 to 27 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 53 to 57 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 311 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 313 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 317 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 112 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 473 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 473 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 550 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 588 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 588 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 594 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 630 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 632 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 654 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 715 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 567 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 571 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 673 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 189 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 3 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 11 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 14 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 87 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 241 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 492 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 495 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 341 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 347 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 271 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 274 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 306 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 313 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 104 to 111 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 186 to 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 244 to 247 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 315 to 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 289 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 298 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 382 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 287 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 351 to 354 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 387 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 170 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 205 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 335 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 189 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 200 to 205 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 260 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 227 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 255 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 277 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 306 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 217 to 224 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 329 to 332 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 131 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 195 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 236 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 68 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 93 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 104 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 152 to 157 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 210 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 212 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 233 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 19 to 21 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 19 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 21 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 279 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 259 to 263 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 488 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 270 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 60 forms a bond with urate, indicating a strong binding affinity.
The residue at position 61 forms a bond with urate, indicating a strong binding affinity.
The residue at position 162 forms a bond with urate, indicating a strong binding affinity.
The residue at position 179 forms a bond with urate, indicating a strong binding affinity.
The residue at position 234 forms a bond with urate, indicating a strong binding affinity.
The residue at position 235 forms a bond with urate, indicating a strong binding affinity.
The residue at position 261 forms a bond with urate, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 60 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 76 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 100 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 148 to 153 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 209 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 211 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 2 to 4 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 to 44 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 349 to 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 360 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 31 to 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 66 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 120 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 320 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 325 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 202 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 358 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 456 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 471 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 476 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 176 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 187 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 58 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 50 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 12 forms a bond with a tetrapyrrole, indicating a strong binding affinity.
The residue at position 18 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 137 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 146 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 320 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 322 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 337 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 341 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 342 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 345 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 360 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 361 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 362 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 135 to 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 to 204 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 8 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 10 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 10 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 12 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 12 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 14 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 24 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 228 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 27 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 82 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 164 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 168 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 68 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 101 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 5 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 21 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 88 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 114 to 122 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 146 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 17 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 67 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 85 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 37 to 44 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 855 to 863 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 878 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 12 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 120 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 283 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 69 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 108 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 166 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 102 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 126 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 192 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 196 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 311 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 258 to 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 40 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 159 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 298 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 298 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 697 to 754 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 820 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 832 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 832 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 834 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 89 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 85 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 168 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 63 to 70 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 to 340 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 308 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 587 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 591 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 691 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 695 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 3 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 150 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 184 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 256 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 272 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 168 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 219 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 247 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 55 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 57 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 59 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 76 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 21 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 62 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 407 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 410 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 59 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 129 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 131 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 171 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 210 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 213 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 215 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 253 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 255 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 261 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 290 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 328 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 330 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 331 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 336 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 363 to 370 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 409 to 413 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 463 to 466 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 214 to 221 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 330 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 721 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 722 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 761 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 765 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 934 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 936 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 279 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 326 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 348 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 349 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 349 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 353 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 438 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 453 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 455 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 459 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 461 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 462 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 78 to 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 96 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 253 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 289 to 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 666 to 673 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 47 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 176 to 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 182 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 270 to 273 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 326 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 88 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 124 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 128 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 257 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 269 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 118 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 276 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 313 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 340 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 432 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 432 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 457 to 460 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 541 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 101 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 360 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 363 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 311 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 343 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 448 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 114 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 149 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 262 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 216 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 301 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 14 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 400 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 441 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 121 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 191 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 442 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 87 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 218 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 67 to 72 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 278 to 283 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 354 to 357 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 392 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 153 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 134 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 187 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 379 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 53 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 120 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 122 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 67 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 126 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 161 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 222 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 3 to 7 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 30 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 54 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 247 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 3 to 17 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 9 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 88 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 211 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 27 to 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 114 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 forms a bond with arginine, indicating a strong binding affinity.
The residue at position 305 forms a bond with arginine, indicating a strong binding affinity.
The residue at position 322 forms a bond with arginine, indicating a strong binding affinity.
The residue at position 354 forms a bond with arginine, indicating a strong binding affinity.
The residue at position 355 forms a bond with arginine, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 152 to 159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 393 to 400 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 439 to 443 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 493 to 496 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 329 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 66 to 72 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 218 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 188 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 213 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 218 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 63 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 66 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 259 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 346 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 411 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 18 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 154 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 204 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 9 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 12 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 235 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 424 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 426 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 435 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 460 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 462 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 471 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 496 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 498 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 500 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 507 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 531 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 533 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 535 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 537 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 542 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 425 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 123 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 125 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 55 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 81 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 100 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 129 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 268 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 549 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 550 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 552 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 306 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 328 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 293 to 298 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 322 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 129 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 457 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 462 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 113 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 242 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 520 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 521 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 549 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 550 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 553 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 20 to 27 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 40 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 68 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 107 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 169 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 25 to 30 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 240 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 11 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 45 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 19 to 21 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 223 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 225 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 246 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 106 to 113 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 182 to 186 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 51 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 101 to 109 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 232 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 240 to 247 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 248 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 346 to 352 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 380 to 382 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 386 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 411 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 472 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 66 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 150 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 253 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 280 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 300 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 347 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 113 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 145 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 134 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 138 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 141 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 124 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 352 to 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 111 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 32 to 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 207 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 93 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 95 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 102 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 133 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 138 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 405 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 451 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 476 to 479 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 507 to 510 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 13 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 13 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 54 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 188 to 193 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 188 to 193 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 224 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 224 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 355 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 383 to 386 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 406 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 463 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 230 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 273 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 289 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 157 to 162 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 181 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 to 87 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 to 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 26 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 246 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 387 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 460 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 31 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 199 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 212 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 296 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 135 to 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 to 209 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 106 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 255 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 386 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 78 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 40 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 174 to 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 199 to 203 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 325 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 348 to 351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 385 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 42 to 49 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 to 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 226 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 284 to 296 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 186 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 261 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 383 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 436 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 460 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 468 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 519 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 129 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 128 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 8 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 167 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 358 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 392 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 37 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 84 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 87 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 189 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 239 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 606 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 610 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 724 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 728 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 56 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 112 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with heme, indicating a strong binding affinity.
The residue at position 110 forms a bond with heme, indicating a strong binding affinity.
The residue at position 302 forms a bond with heme, indicating a strong binding affinity.
The residue at position 358 forms a bond with heme, indicating a strong binding affinity.
The residue at position 318 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 343 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 165 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 233 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 251 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 21 to 28 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 476 to 478 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 221 to 225 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 to 334 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 334 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 337 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 498 to 500 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 498 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 500 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 386 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 417 to 420 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 426 to 429 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 427 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 429 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 490 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 513 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 221 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 127 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 182 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 276 to 290 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 373 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 124 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 261 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 355 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 404 to 407 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 411 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 430 to 433 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 506 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 83 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 83 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 107 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 107 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 92 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 235 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 412 to 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 479 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 121 to 130 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 266 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 277 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 334 to 338 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 184 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 264 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 138 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 139 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 67 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 68 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 178 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 270 to 284 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 367 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 19 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 20 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 21 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 22 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 45 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 47 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 130 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 131 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 156 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 182 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 223 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 224 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 to 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 222 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 222 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 351 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 379 to 382 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 402 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 469 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 311 to 315 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 424 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 475 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 to 506 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 240 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 8 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 197 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 273 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 285 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 349 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 355 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 364 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 385 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 385 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 418 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 435 to 436 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 83 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 303 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 318 to 322 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 344 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 171 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 178 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 326 to 328 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 157 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 292 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 311 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 316 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 113 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 240 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 241 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 308 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 386 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 388 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 461 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 34 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 289 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 to 32 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 43 to 47 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 69 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 88 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 233 to 238 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 to 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 145 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 789 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 791 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 793 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 795 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 800 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 320 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 328 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 603 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 647 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 370 to 372 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 557 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 88 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 108 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 386 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 to 87 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 207 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 206 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 140 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 176 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 180 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 54 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 148 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 448 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 482 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 489 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 534 to 537 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 113 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 354 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 382 to 385 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 405 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 255 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 307 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 326 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 126 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 to 8 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 88 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 98 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 to 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 409 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 433 to 436 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 483 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 487 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 6 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 104 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 228 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 166 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 170 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 30 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 36 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 54 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 162 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 166 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 204 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 250 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 49 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 814 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 888 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 895 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 898 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 79 to 86 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 455 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 84 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 84 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 88 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 88 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 186 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 186 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 209 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 211 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 274 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 276 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 276 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 55 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 254 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 273 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 351 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 351 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 286 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 313 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 365 to 368 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 389 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 299 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 303 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 443 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 447 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 451 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 29 to 33 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 322 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 143 to 150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 261 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 124 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 165 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 193 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 294 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 100 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 14 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 171 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 222 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 270 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 365 to 370 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 386 to 395 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 173 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 559 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 568 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 654 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 662 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 670 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 671 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 591 to 599 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 614 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 364 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 269 to 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 199 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 199 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 201 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 203 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 210 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 76 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 185 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 100 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 145 to 149 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 158 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 186 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 463 to 470 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 701 to 708 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 308 to 314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 312 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 314 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 340 to 342 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 422 to 424 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 154 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 244 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 267 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 415 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 238 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 82 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 232 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 24 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 50 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 63 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 106 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 21 to 27 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 207 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 7 to 13 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 80 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 219 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 240 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 to 164 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 244 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 177 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 178 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 180 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 253 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 309 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 309 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 309 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 312 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 313 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 315 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 315 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 176 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 217 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 221 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 225 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 271 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 274 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 236 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 259 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 404 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 449 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 449 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 to 155 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 60 to 67 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 466 to 473 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 461 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 805 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 879 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 886 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 889 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 277 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 277 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 507 to 508 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 214 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 340 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 614 to 621 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 72 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 50 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 52 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 81 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 106 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 145 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 175 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 115 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 134 to 139 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 155 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 158 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 199 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 286 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 287 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 307 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 315 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 338 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 389 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 9 to 16 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 183 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 283 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 92 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 50 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 52 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 67 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 to 189 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 111 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 15 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 528 to 531 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 538 to 539 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 579 to 582 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 10 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 11 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 12 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 36 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 37 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 38 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 125 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 151 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 228 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 399 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 417 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 133 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 216 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 219 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 149 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 208 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 278 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 76 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 79 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 281 to 295 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 288 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 469 to 477 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 490 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 13 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 210 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 19 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 498 to 500 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 498 to 500 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 551 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 551 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 556 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 579 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 582 to 583 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 628 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 666 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 666 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 710 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 732 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 793 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 159 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 191 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 259 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 259 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 262 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 328 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 361 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 361 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 420 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 420 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 69 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 72 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 84 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 177 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 28 to 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 54 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 81 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 27 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 31 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 35 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 351 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 402 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 532 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 118 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 223 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 227 to 231 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 27 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 225 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 381 to 383 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 383 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 414 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 508 to 511 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 375 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 375 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 527 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 204 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 207 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 257 to 262 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 361 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 411 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 to 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 458 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 813 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 164 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 445 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 91 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 429 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 129 to 134 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 300 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 311 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 345 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 368 to 375 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 394 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 397 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 425 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 425 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 127 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 304 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 347 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 310 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 346 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 347 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 358 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 88 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 608 to 615 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme d1, indicating a strong binding affinity.
The residue at position 57 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 94 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 97 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 108 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 122 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 138 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 203 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 229 forms a bond with Fe of heme d1, indicating a strong binding affinity.
The residue at position 232 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 245 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 272 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 292 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 420 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 536 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 583 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 31 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 103 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 103 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 118 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 218 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 236 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 5 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 8 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 38 to 42 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 70 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 109 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 14 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 291 to 301 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 76 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 82 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 57 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 471 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 118 to 123 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 197 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 269 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 345 to 347 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 386 to 389 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 425 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 452 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 493 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 573 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 576 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 581 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 310 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 312 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 315 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 69 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 69 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 88 to 96 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 92 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 92 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 135 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 135 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 139 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 515 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 518 to 520 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 518 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 545 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 546 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 577 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 600 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 647 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 653 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 757 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 764 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 775 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 792 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 352 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 354 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 369 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 372 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 373 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 374 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 377 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 392 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 393 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 394 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 414 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 33 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 66 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 416 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 416 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 183 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 235 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 253 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 499 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 388 to 512 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 273 to 287 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 370 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 315 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 337 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 236 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 316 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 to 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 480 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 84 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 88 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 100 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 145 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 147 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 168 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 170 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 231 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 234 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 297 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 415 to 417 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 557 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 160 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 287 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 316 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 377 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 385 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 418 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 44 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 46 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 312 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 13 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 97 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 195 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 258 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 263 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 328 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 508 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 511 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 550 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 42 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 46 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 91 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 167 to 174 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 192 to 196 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 to 17 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 16 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 93 to 97 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 432 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 464 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 58 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 457 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 484 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 208 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 24 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 81 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 120 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 226 to 231 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 226 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 230 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 245 to 251 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 247 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 250 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 251 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 335 to 338 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 456 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 479 to 487 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 506 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 701 to 758 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 825 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 837 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 837 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 839 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 181 to 186 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 240 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 763 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 826 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 76 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 18 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 710 to 718 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 731 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 154 to 157 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 234 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 321 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 254 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 265 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 9 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 78 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 236 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 295 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 305 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 307 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 331 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 80 to 85 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 112 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 119 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 353 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 402 to 405 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 409 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 428 to 431 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 504 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 64 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 326 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 329 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 57 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 12 to 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 209 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 559 to 566 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 121 forms a bond with heme, indicating a strong binding affinity.
The residue at position 141 forms a bond with heme, indicating a strong binding affinity.
The residue at position 166 forms a bond with heme, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 202 forms a bond with heme, indicating a strong binding affinity.
The residue at position 34 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 61 to 70 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 13 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 14 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 498 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 571 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 571 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 573 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 24 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 4 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 6 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 12 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 14 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 18 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 20 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 25 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 32 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 33 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 33 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 36 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 36 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 40 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 43 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 43 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 47 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 49 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 49 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 54 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 58 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 59 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 18 to 27 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 340 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 328 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 145 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 39 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 70 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 74 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 95 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 100 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 103 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 163 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 166 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 109 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 231 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 261 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 21 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 125 to 133 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 157 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 35 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 272 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 274 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 277 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 321 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 356 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 361 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 640 to 647 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 47 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 250 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 347 to 350 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 113 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 219 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 366 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 75 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 80 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 226 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 384 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 413 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 365 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 373 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 339 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 551 to 563 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 585 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 587 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 598 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 317 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 80 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 125 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 190 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 99 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 170 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 176 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 367 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 391 to 394 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 440 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 444 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 28 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 166 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 to 125 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 149 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 5 to 16 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 302 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 445 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 289 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 316 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 341 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 368 to 371 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 350 to 353 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 433 to 435 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 433 to 435 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 486 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 486 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 517 to 518 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 563 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 601 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 601 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 607 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 643 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 645 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 323 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 136 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 29 to 32 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 212 to 217 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 125 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 126 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 153 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 215 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 52 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 125 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 197 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 448 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 174 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 314 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 314 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 202 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 350 to 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 456 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 554 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 578 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 650 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 788 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 356 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 366 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 366 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 514 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 246 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 77 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 113 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 198 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 283 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 5 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 7 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 7 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 13 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 15 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 15 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 19 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 21 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 26 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 29 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 34 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 37 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 41 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 44 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 44 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 48 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 50 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 50 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 57 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 60 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 60 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 779 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 781 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 790 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 348 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 148 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 149 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 203 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 27 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 31 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 145 to 149 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 485 to 492 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 531 to 535 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 585 to 588 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 208 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 167 to 175 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 297 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 198 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 109 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 111 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 127 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 43 to 47 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 75 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 95 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 170 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 14 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 48 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 36 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 39 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 131 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 164 to 172 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 258 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 95 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 355 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 to 93 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 230 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 288 to 300 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 418 to 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 167 to 173 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 198 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 579 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 41 to 44 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 124 to 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 5 to 7 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 84 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 434 to 441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 92 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 199 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 215 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 261 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 517 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 551 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 131 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 291 to 301 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 to 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 162 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 164 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 296 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 366 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 373 to 374 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 to 204 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 416 to 423 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 463 to 467 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 517 to 520 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 231 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 31 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 222 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 301 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 389 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 18 to 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 18 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 to 49 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 319 to 326 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 484 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 578 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 483 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 7 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 106 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 113 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 114 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 432 to 437 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 464 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 482 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 489 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 516 to 521 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 27 to 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 67 to 72 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 111 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 191 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 201 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 155 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 170 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 330 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 672 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 676 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 766 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 304 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 326 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 140 to 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 62 forms a bond with heme, indicating a strong binding affinity.
The residue at position 65 forms a bond with heme, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 449 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 558 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 572 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 572 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 141 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 225 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 311 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 132 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 167 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 222 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 438 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 441 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 426 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 554 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 598 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 886 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 909 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 262 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 265 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 297 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 304 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 106 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 90 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 116 to 117 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 55 to 62 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 422 to 424 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 428 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 468 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 492 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 497 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 267 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 629 to 637 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 652 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 260 to 263 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 461 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 63 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 99 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 135 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 137 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 51 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 253 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 381 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 899 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 911 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 482 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 488 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 41 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 64 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 165 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 351 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 418 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 467 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 474 to 475 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 483 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 22 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 121 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 126 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 137 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 214 to 217 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 284 to 287 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 421 to 424 forms a bond with a phosphatidylglycerol phosphate, indicating a strong binding affinity.
The residue at position 516 forms a bond with a phosphatidylglycerol phosphate, indicating a strong binding affinity.
The residue at position 520 forms a bond with a phosphatidylglycerol phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 102 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 245 to 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 420 to 423 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 102 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 193 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 498 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 888 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 195 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 291 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 697 to 755 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 822 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 834 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 836 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 280 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 310 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 136 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 231 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 123 forms a bond with 2,3-dihydroxypropane-1-sulfonate, indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with 2,3-dihydroxypropane-1-sulfonate, indicating a strong binding affinity.
The residue at position 169 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 385 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 to 75 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 187 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 201 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 293 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 353 to 359 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 357 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 359 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 385 to 387 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 468 to 470 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 385 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 117 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 264 to 271 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 354 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 411 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 801 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1042 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1198 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 132 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 507 to 514 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 553 to 557 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 607 to 610 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 26 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 224 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 232 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 317 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 454 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 76 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 139 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 153 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 159 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 168 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 172 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 212 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 215 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 227 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 230 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 236 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 239 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 244 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 248 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 126 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 182 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 221 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 225 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 228 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 143 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 323 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 493 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 214 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 127 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 191 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 264 to 269 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 104 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 185 to 192 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 232 to 236 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 61 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 61 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 20 to 27 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 to 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 240 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 641 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 345 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 125 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 109 to 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 109 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 231 to 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 17 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 33 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 34 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 45 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 99 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 101 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 7 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 9 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 101 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 212 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 to 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 114 to 120 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 135 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 244 to 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 312 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 70 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 169 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 236 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 279 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 327 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 540 to 542 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 547 to 553 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 578 to 581 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 19 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 to 43 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 80 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 119 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 176 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 381 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 47 to 51 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 304 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 328 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 440 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 446 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 289 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 370 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 374 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 378 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 409 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 409 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 415 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 417 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 417 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 419 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 422 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 422 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 425 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 426 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 429 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 432 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 129 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 164 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 221 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 89 to 94 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 21 to 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 47 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 212 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 259 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 166 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 287 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 386 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 418 to 419 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 107 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 502 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 890 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 892 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 901 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 356 to 363 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 to 167 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 258 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 290 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 334 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 488 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 491 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 499 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 502 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 508 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 512 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 520 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 351 to 353 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 391 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 393 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 417 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 33 to 40 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 294 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 94 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 349 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 408 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 411 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 283 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 324 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 172 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 172 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 180 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 422 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 446 to 449 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 496 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 500 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 27 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 29 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 31 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 121 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 149 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 217 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 278 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 298 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 370 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 584 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 650 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 653 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 654 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 693 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 190 to 195 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 291 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 327 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 339 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 18 to 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 37 to 43 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 to 18 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 86 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 466 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 810 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 884 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 891 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 13 to 20 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 80 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 80 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 454 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 51 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 178 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 96 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 14 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 14 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 187 to 192 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 187 to 192 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 223 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 223 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 352 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 380 to 383 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 470 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 329 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 596 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 600 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 700 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 704 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 107 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 to 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 318 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 323 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 18 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 50 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 54 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 61 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 82 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 84 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 85 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 129 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 144 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 149 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 154 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 95 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 356 to 358 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 506 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 526 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 558 to 560 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 560 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 573 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 177 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 221 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 165 to 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 56 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 104 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 to 415 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 to 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 49 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 102 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 301 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 244 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 258 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 73 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 109 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 110 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 292 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 428 to 433 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 478 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 485 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 512 to 517 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 149 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 303 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 385 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 42 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 133 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 251 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 266 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 277 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 358 to 360 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 365 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 338 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 362 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 529 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 197 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 324 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 85 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 94 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 157 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 157 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 190 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 258 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 329 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 331 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 333 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 334 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 197 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 28 to 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 to 133 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 579 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 581 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 651 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 71 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 280 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 287 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 78 to 83 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 110 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 178 to 183 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 223 to 227 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 843 to 850 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 147 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 170 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 262 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 294 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 296 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 to 232 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 279 to 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 142 to 148 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 31 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 312 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 406 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 409 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 436 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 301 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 324 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 328 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 347 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 398 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 417 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 76 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 82 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 199 to 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 415 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 97 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 31 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 128 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 257 to 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 344 to 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 421 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 444 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 353 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 404 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 461 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 23 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 160 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 11 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 73 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 134 to 141 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 71 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 78 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 150 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 211 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 281 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 125 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 178 to 184 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 to 259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 15 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 445 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 59 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 23 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 187 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 197 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 209 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 225 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 226 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 229 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 232 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 244 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 245 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 251 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 260 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 262 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 37 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 190 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 364 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 368 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 431 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 446 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 465 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 488 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 499 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 660 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 696 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 697 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 697 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 808 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 72 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 150 to 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 277 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 348 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 6 to 7 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 251 to 259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 37 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 171 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 42 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 55 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 136 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 150 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 153 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 41 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 152 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 79 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 198 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 251 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 100 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 411 to 418 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 71 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 109 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 126 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 623 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 408 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 446 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 464 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 159 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 159 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 266 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 269 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 164 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 41 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 79 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 276 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 408 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 413 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 113 to 119 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 119 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 622 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 626 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 682 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 470 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 518 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 113 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 181 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 323 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 327 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 371 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 395 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 137 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 204 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 138 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 145 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 19 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 57 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 85 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 111 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 136 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 172 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 304 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 363 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 398 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 267 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 351 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 351 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 127 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 233 to 238 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 233 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 254 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 459 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 to 329 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 329 to 332 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 678 to 685 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1327 to 1334 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 270 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 16 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 to 11 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 83 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 105 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 191 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 213 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 222 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 374 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 397 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 123 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 208 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 212 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 534 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 387 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 437 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 268 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 350 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 354 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 172 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 271 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 17 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 17 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 190 to 195 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 190 to 195 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 227 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 227 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 356 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 384 to 387 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 407 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 475 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 253 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 343 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 348 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 381 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 558 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 567 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 653 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 661 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 669 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 670 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 33 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 165 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 125 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 9 to 12 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 228 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 109 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 12 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 518 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 555 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 556 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 558 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 110 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 114 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 144 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 153 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 163 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 175 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 27 forms a bond with folate, indicating a strong binding affinity.
The residue at position 189 forms a bond with folate, indicating a strong binding affinity.
The residue at position 140 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 529 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 317 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 329 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 14 to 21 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 227 to 233 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 258 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 267 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 46 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 397 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 437 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 540 to 546 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 317 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 273 to 278 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 387 to 389 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 389 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 420 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 514 to 517 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 50 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 116 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 28 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 9 forms a bond with dTDP-4-amino-4,6-dideoxy-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with dTDP-4-amino-4,6-dideoxy-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with dTDP-4-amino-4,6-dideoxy-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 112 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 116 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 175 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 209 forms a bond with dTDP-4-amino-4,6-dideoxy-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 182 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 378 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 380 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 465 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 597 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 597 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 601 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 601 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 741 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 745 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 749 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 458 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 215 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 235 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 318 to 320 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 to 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 to 27 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 167 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 225 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 379 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 404 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 135 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 143 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 34 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 66 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 122 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 303 to 304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 303 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 332 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 626 to 633 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 536 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 221 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 246 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 7 to 14 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 60 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 82 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 149 to 154 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 676 to 684 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 699 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 143 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 159 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 27 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 50 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 13 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 133 to 140 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 22 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 84 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 123 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 229 to 234 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 229 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 248 to 254 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 253 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 273 to 276 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 455 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 379 to 386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 358 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 358 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 359 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 555 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 218 to 225 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 265 to 269 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 330 to 333 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 33 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 155 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 159 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 162 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 28 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 68 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 69 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 137 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 225 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 306 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 383 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 412 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 29 to 40 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 152 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 346 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 406 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 409 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 437 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 458 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 525 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 567 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 573 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 579 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 697 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 770 to 774 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 773 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 818 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 822 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 874 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 962 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1160 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1215 to 1216 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 68 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 156 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 193 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 198 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 219 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 226 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 182 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 450 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1870 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1904 to 1910 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1948 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 158 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 6 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 17 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 49 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 91 to 95 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 251 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 110 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 187 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 381 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 458 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 462 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 56 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 to 113 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 to 226 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 10 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 198 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 95 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 127 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 130 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 191 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 267 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 279 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 439 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 478 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 482 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 482 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 519 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 904 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 913 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 914 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 334 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 700 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 348 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 412 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 408 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 410 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 411 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 505 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 538 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 585 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 834 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 891 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 914 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 916 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 917 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1011 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1044 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1091 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1340 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1397 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1420 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1422 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1423 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1517 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1550 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 284 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 62 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 34 to 42 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 114 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 to 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 46 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 112 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 117 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 70 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 464 to 471 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 510 to 514 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 564 to 567 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 80 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 196 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 244 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 504 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 511 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 513 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 552 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 4 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 370 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 213 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 263 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 308 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 68 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 221 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 389 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 393 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 819 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 821 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 830 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 831 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 118 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 41 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 105 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 107 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 231 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 28 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 56 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 184 to 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 232 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 320 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 104 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 118 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 240 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 93 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 129 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 130 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 133 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 446 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 302 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 456 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 460 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 323 to 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 376 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 20 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 96 to 100 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 40 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 241 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 245 forms a bond with O2, indicating a strong binding affinity.
The residue at position 316 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 319 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 369 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 198 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 289 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 39 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 375 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 178 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 408 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 415 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 415 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 195 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 417 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 421 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 495 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 265 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 322 to 323 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 358 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 447 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 488 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 533 to 536 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 243 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 247 forms a bond with O2, indicating a strong binding affinity.
The residue at position 292 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 293 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 371 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 378 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 380 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 443 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 509 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 88 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 189 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 377 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 69 to 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 95 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 206 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 123 to 131 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 155 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 56 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 147 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 242 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 262 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 291 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 205 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 205 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 249 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 266 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 268 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 269 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 366 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 111 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 113 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 142 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 458 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 to 463 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 468 to 474 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 499 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 506 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 366 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1642 to 1649 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 28 to 33 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 284 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 481 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 60 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 327 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 to 62 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 74 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 274 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 192 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 108 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 308 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 321 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 91 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 96 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 283 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 298 to 302 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 324 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 131 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 136 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 140 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 472 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 816 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 890 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 11 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 23 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 91 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 140 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 34 to 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 72 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 99 to 107 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 569 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 154 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 165 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 169 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 320 to 321 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 182 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 190 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 455 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 459 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 72 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 151 to 159 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 222 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 90 to 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 32 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 197 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 199 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 397 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 421 to 424 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 472 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 476 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 315 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 367 to 370 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 391 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 34 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 37 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 38 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 39 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 118 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 186 to 190 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 209 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 278 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 81 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 247 to 252 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 210 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 45 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 496 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 541 to 544 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 235 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 237 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 238 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 239 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 243 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 246 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 247 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 273 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 402 to 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 137 to 142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 25 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 107 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 130 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 156 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 165 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 231 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 253 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 255 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 258 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 286 to 290 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 309 to 310 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 183 to 188 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 242 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 93 to 101 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 97 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 97 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 140 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 140 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 17 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 18 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 910 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 12 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 46 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 144 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 219 to 226 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 155 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 212 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 292 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 333 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 341 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 369 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 372 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 382 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 436 to 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 278 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 319 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 92 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 166 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 168 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 175 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 201 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 205 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 212 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 244 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 246 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 248 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 253 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 278 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 280 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 282 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 289 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 583 to 585 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 614 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 660 to 661 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 89 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 896 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 906 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 155 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 164 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 198 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 332 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 4 to 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 to 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 177 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 179 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 299 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 358 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 367 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 388 to 390 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 419 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 421 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 423 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 427 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 468 to 472 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 501 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 508 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 508 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 512 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 8 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 19 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 4 to 6 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 159 to 164 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 383 to 387 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 409 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 353 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 362 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 383 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 383 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 91 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 119 to 127 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 122 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 162 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 166 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 168 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 286 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 460 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 466 to 469 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 643 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 700 to 704 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 738 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 745 to 747 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 805 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 831 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 837 to 840 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 929 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 415 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 419 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 135 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 67 to 75 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 116 to 125 forms a bond with monodehydro-L-ascorbate radical, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 319 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 489 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 to 168 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 292 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 171 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 355 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 392 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 355 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 10 to 17 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 205 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 327 to 331 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 381 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 77 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 368 to 372 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 394 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 430 to 437 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 287 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 423 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 283 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 577 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 621 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 926 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 929 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 171 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 250 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 265 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 325 to 331 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 329 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 331 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 439 to 442 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 444 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 101 to 105 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 to 186 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 104 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 249 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 358 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 359 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 363 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 368 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 448 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 449 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 462 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 477 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 651 to 682 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 795 to 806 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 937 to 947 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1012 to 1030 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1110 to 1125 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 71 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 77 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 112 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 605 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 609 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 723 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 727 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 31 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 9 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 52 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 132 to 139 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 213 to 219 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 46 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 410 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 449 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 484 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 491 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 536 to 539 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 182 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 210 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 216 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 313 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 352 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 321 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 324 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 353 to 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 389 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 129 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 77 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 86 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 175 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 97 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 82 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 315 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 316 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 65 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 418 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 16 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 104 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 5 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 8 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 17 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 237 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 261 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 305 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 397 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 425 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 450 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 485 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 487 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 46 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 259 to 266 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 339 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 to 353 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 406 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 424 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 770 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 801 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 805 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 883 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 915 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 917 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1013 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1082 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 98 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 113 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 44 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 47 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 15 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 25 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 166 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 174 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 180 forms a bond with 11-cis-retinal, indicating a strong binding affinity.
The residue at position 202 forms a bond with 11-cis-retinal, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 150 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 85 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 89 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 212 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 360 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 419 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 125 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 154 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 182 to 187 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 407 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 416 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 417 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 391 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 521 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 130 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1280 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1282 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1283 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1285 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1288 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 135 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 16 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 17 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 108 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 to 194 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 to 308 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 108 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 156 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 122 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 13 to 20 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 116 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 499 to 504 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 539 to 546 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 544 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 47 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 145 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 369 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 to 292 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 104 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 109 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 51 to 55 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 116 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 95 to 103 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 99 to 103 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 99 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 99 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 142 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 142 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 509 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 482 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 484 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 545 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 614 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 153 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 165 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 183 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 220 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 256 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 263 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 113 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 19 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 241 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 295 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 345 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 390 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 115 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 119 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 209 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 212 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 213 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 258 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 260 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 279 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 282 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 314 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 390 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 164 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 26 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 352 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 367 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 378 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 381 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 387 to 388 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 406 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 424 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 441 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 49 to 56 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 104 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 185 to 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 239 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 254 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 97 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 128 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 132 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 8 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 175 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 301 to 307 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 426 to 433 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 445 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 128 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 247 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 150 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 183 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 228 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 256 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 308 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 287 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 311 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 405 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 408 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 423 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 211 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 358 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 133 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 269 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 324 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 330 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 342 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 347 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 362 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 364 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 37 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 134 to 142 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 166 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 336 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 649 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 720 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 723 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 83 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 164 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 187 to 191 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 27 to 28 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 87 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 291 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 361 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 368 to 369 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 to 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 435 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 554 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 558 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 823 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 825 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 834 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 835 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 358 to 361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 393 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 133 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 401 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 90 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 169 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 496 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 567 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 569 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 573 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 650 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 222 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 193 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 95 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 246 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 254 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 5 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 to 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 55 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 81 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 101 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 163 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 124 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 47 forms a bond with heme, indicating a strong binding affinity.
The residue at position 50 forms a bond with heme, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 95 to 100 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 72 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 403 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 19 to 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 11 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 272 to 275 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 183 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 195 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 385 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 414 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 289 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 292 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 67 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 92 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 107 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 227 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 250 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 203 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 to 127 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 161 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 217 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 198 to 208 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 to 195 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 91 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 98 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 134 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 167 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 226 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 296 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 238 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 212 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 227 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 287 to 293 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 291 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 293 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 318 to 320 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 439 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 50 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 90 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 466 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 468 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 470 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 99 to 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 140 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 to 183 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 100 to 106 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 46 to 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 274 to 277 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 343 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 346 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 367 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 395 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 398 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 149 to 156 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 266 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 290 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 334 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 453 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 478 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 513 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 515 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 285 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 77 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 88 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 148 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 320 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 372 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 390 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 392 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 394 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 400 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 534 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 909 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 985 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 992 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 995 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 276 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 278 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 307 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 7 to 12 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 71 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 73 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 116 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 115 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 435 to 437 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 435 to 437 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 488 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 488 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 519 to 520 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 565 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 603 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 603 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 609 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 647 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 730 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 26 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 135 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 192 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 698 to 755 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 821 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 833 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 833 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 835 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 323 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 335 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 341 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 353 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 519 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 543 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 627 to 634 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 119 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 to 187 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 275 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 3 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 6 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 18 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 25 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 252 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 276 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 320 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 408 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 436 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 461 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 495 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 497 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 93 to 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 49 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 646 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 648 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 650 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 652 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 657 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 94 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 323 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 292 to 296 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 318 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 to 69 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 257 to 261 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 316 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 486 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 141 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 253 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 367 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 506 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 868 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 870 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 879 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 880 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 100 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 166 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 269 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 128 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 143 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 330 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 418 to 422 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 438 to 447 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 448 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 52 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 49 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 287 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 44 forms a bond with beta-L-fucose 6, indicating a strong binding affinity.
The residue at position 73 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 138 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with beta-L-fucose 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with beta-L-fucose 4, indicating a strong binding affinity.
The residue at position 198 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 230 forms a bond with beta-L-fucose 5, indicating a strong binding affinity.
The residue at position 242 forms a bond with beta-L-fucose 5, indicating a strong binding affinity.
The residue at position 277 forms a bond with beta-L-fucose 6, indicating a strong binding affinity.
The residue at position 291 forms a bond with beta-L-fucose 6, indicating a strong binding affinity.
The residue at position 71 to 80 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 196 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 418 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 496 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 53 to 61 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 43 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 15 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 16 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 16 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 76 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 82 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 63 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 244 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 431 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 455 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 317 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 7 to 14 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 233 to 240 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 280 to 284 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 97 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 297 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 302 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 284 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 82 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 166 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 319 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 340 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 195 to 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 284 to 287 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 121 to 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 to 188 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 294 to 298 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 362 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 363 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 399 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 450 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 453 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 11 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 16 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 124 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 240 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 126 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 239 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 69 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 832 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 833 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 156 to 160 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 281 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 295 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 295 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 354 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 34 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 95 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 98 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 101 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 109 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 112 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 118 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 188 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 189 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 193 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 194 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 194 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 194 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 195 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 225 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 368 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 385 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 389 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 401 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 401 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 402 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 402 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 528 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 528 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 529 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 559 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 569 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 569 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 572 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 572 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 574 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 575 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 122 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 196 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 253 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 377 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 407 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 204 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 to 219 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 259 to 263 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 324 to 327 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 67 to 72 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 144 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 207 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 241 to 246 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 167 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 221 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 273 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 166 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 300 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 217 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 269 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 528 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 562 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 492 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 503 to 504 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 152 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 155 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 243 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 52 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 69 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 157 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 255 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 190 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 88 to 93 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 174 to 183 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 453 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 483 to 486 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 515 to 518 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 554 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 607 to 608 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 613 to 617 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 688 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 198 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 337 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 345 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 387 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 412 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 91 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 11 to 35 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 424 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 115 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 195 to 202 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 to 245 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 295 to 298 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 110 to 115 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 128 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 171 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 178 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 182 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 36 to 43 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 322 to 329 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 333 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 350 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 450 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 110 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 291 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 30 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 106 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 128 to 136 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 160 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 1562 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1566 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1586 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 75 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 250 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 37 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 123 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 153 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 189 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 249 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 9 to 12 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 84 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 265 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 269 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 314 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 315 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 398 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 146 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 204 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 39 to 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 41 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 72 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 43 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 to 330 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 350 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 427 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 433 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 394 to 396 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 401 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 58 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 297 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 91 to 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 87 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 172 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 181 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 207 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 209 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 211 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 213 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 218 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 252 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 259 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 290 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 295 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 173 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 290 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 314 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with 5-hydroxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 546 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 547 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 579 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 581 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 142 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 220 to 223 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 277 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 278 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 149 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 637 to 645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 663 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 490 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 589 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 593 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 75 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 75 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 102 to 110 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 167 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 390 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 416 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 21 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 119 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 174 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 361 to 369 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 372 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 372 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 376 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 376 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 278 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 170 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 194 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 166 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 253 to 257 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 198 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 266 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 348 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 350 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 350 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 69 to 76 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 62 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 92 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 249 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 266 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 827 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 836 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 837 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 216 to 224 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 159 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 265 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 9 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 287 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 324 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 335 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 314 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 319 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 575 to 583 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 603 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 117 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 168 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 205 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 307 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 342 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 197 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 115 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 85 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 103 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 105 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 131 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 135 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 136 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 118 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 184 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 318 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 415 to 422 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 to 77 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 94 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 197 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 25 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 151 to 155 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 233 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 37 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 76 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 487 to 490 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 500 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 502 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 574 to 575 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 619 to 628 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 632 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 661 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 99 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 315 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 142 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 321 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 136 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 72 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 363 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 477 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 38 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 95 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 174 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 to 210 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 250 to 254 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 333 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 455 to 456 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 456 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 466 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 344 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 377 to 384 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 395 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 522 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 3 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 37 to 42 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 40 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 95 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 128 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 251 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 340 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 28 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 66 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 108 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 31 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 407 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 490 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 517 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 543 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 631 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 59 to 66 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 115 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 124 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 211 to 215 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 to 290 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 221 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 99 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 222 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 236 to 243 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 264 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 264 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 220 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 236 to 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 322 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 594 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 92 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 111 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 190 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 179 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with 1D-myo-inositol 1,3,4,5-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with 1D-myo-inositol 1,3,4,5-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 53 forms a bond with 1D-myo-inositol 1,3,4,5-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with 1D-myo-inositol 1,3,4,5-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 156 to 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 439 to 441 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 439 to 441 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 492 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 492 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 523 to 524 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 569 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 607 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 607 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 613 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 649 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 651 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 734 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 489 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 289 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 304 to 308 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 330 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 428 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 119 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 225 to 230 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 225 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 244 to 250 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 244 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 246 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 249 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 453 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 225 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 351 to 353 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 399 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 384 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 318 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 149 to 156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 73 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 264 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 369 to 372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 184 to 191 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 352 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 21 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 82 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 213 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 232 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 236 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 121 to 126 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 to 30 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 187 forms a bond with folate, indicating a strong binding affinity.
The residue at position 517 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 273 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 334 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 164 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 185 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 207 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 249 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 494 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 159 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 189 to 194 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 196 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 196 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 200 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 200 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 204 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 253 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 154 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 24 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 80 to 87 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 583 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 241 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 261 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 262 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 275 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 151 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 294 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 294 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 422 to 429 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 468 to 472 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 522 to 525 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 68 to 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 95 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 332 to 339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 464 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 451 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 492 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 537 to 540 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 to 8 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 50 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 560 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 569 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 655 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 663 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 671 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 672 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 226 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 40 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 42 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 69 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 71 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 124 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 125 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 126 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 153 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 240 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 246 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 128 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 182 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 184 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 194 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 203 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 232 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 335 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 337 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 383 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 385 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 434 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 180 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 202 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 211 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 362 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 366 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 389 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 784 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1112 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1115 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1121 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 72 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 167 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 204 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 305 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 324 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 329 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 290 to 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 330 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 349 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 44 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 76 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 201 to 209 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 471 to 478 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 517 to 521 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 571 to 574 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 326 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 402 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 426 to 431 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 517 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 532 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 540 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 543 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 603 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 215 to 224 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 to 281 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 424 to 431 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 470 to 474 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 524 to 527 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 107 to 111 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 78 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 79 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 85 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 87 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 324 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 324 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 324 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 366 to 368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 368 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 368 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 975 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1062 to 1064 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1069 to 1073 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 120 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 241 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 330 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 84 to 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 91 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 151 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 56 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 131 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 263 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 268 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 269 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 392 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 499 to 500 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 510 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 514 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 560 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 563 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 572 to 581 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 19 to 24 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 278 to 292 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 294 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 134 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 80 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 108 to 116 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 39 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 43 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 45 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 78 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 169 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 170 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 257 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 293 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 299 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 300 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 342 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 356 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 7 to 10 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 81 to 87 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 46 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 375 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 16 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 115 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 55 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1 to 3 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 4 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 98 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 116 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 274 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 83 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 146 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 146 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 179 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 244 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 247 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 319 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 321 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 323 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 324 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 166 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 338 to 345 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 385 to 389 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 403 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 329 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 355 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1102 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1105 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1111 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 239 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with (2E,6E)-farnesyl diphosphate 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with (2E,6E)-farnesyl diphosphate 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with (2E,6E)-farnesyl diphosphate 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with (2E,6E)-farnesyl diphosphate 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with (2E,6E)-farnesyl diphosphate 2, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with (2E,6E)-farnesyl diphosphate 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with (2E,6E)-farnesyl diphosphate 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 341 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 341 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 54 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 172 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 180 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 266 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 300 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 35 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 111 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 143 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 145 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 147 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 294 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 130 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 221 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 31 to 38 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 154 to 157 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 154 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 319 to 321 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 504 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 541 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 544 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 582 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 159 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 381 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 466 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 484 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 to 128 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 269 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1597 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1693 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1696 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 554 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 558 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 656 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 171 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 268 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 122 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 147 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 148 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 214 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 163 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 476 to 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 191 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 103 to 108 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 236 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 485 to 493 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 181 to 186 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 to 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 251 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 304 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 125 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 205 to 211 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 368 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 355 to 358 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 365 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 275 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 342 to 344 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 359 to 367 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 45 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 754 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 757 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 773 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 777 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 781 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 784 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 800 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 804 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 76 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 323 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 863 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 865 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 972 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1025 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 7 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 22 to 29 forms a bond with heme, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 49 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 208 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 7 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 18 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 45 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 50 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 149 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 106 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 170 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 174 to 180 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 203 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 206 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 84 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 156 to 161 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 94 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 415 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 417 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 465 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 479 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 568 to 575 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 368 to 375 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 359 to 362 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 179 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 271 to 285 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 58 to 77 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 293 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 207 to 214 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 254 to 258 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 319 to 322 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 to 14 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 98 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 205 to 211 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 530 to 532 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 537 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 703 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 747 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 73 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 623 to 631 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 646 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 43 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 82 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 41 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 46 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 377 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 379 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 442 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 123 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 229 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 235 to 243 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 232 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 420 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 429 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 172 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 344 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 527 to 529 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 534 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 700 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 744 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 382 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 191 to 198 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 238 to 242 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 303 to 306 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 467 to 472 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 393 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 444 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 628 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 655 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 759 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 761 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 785 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 814 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 815 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 816 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 535 to 542 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 162 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 266 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 297 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 298 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 300 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 339 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 168 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 714 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 7 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 167 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 112 to 117 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 157 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 181 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 93 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 141 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 29 to 37 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 48 to 54 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 77 to 81 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 48 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 134 to 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 203 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 211 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 405 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 106 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 95 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 211 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 35 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 285 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 309 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 39 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 145 to 150 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 58 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 273 to 278 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 394 to 397 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 839 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 850 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 851 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 178 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 311 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 363 to 366 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 387 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 to 52 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 94 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 132 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 411 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 266 to 271 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 292 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with octadecanoate, indicating a strong binding affinity.
The residue at position 1963 to 1970 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 344 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 365 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 365 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 321 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 345 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 489 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 21 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 21 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 10 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 16 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 16 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 226 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 474 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 172 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 550 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 554 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 554 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 694 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 702 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 506 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 512 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 199 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 390 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 582 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 597 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 472 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 410 to 414 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 13 to 19 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 29 to 34 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 to 125 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 35 forms a bond with beta-D-galacturonate, indicating a strong binding affinity.
The residue at position 35 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 73 forms a bond with beta-D-galacturonate, indicating a strong binding affinity.
The residue at position 73 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 89 forms a bond with beta-D-galacturonate, indicating a strong binding affinity.
The residue at position 89 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 149 forms a bond with beta-D-galacturonate, indicating a strong binding affinity.
The residue at position 149 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 209 forms a bond with beta-D-galacturonate, indicating a strong binding affinity.
The residue at position 209 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 236 forms a bond with beta-D-galacturonate, indicating a strong binding affinity.
The residue at position 236 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 24 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 41 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 129 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 173 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 216 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 259 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 218 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 233 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 291 to 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 295 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 297 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 406 to 408 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 61 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 38 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 302 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 306 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 51 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 46 to 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 to 294 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 14 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 18 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 18 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 23 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 25 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 29 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 31 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 35 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 44 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 46 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 50 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 52 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 52 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 56 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 56 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 64 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 68 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 52 to 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 78 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 135 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 203 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 214 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 259 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 458 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 463 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 221 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 236 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 296 to 302 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 302 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 328 to 330 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 410 to 412 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 145 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 328 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 204 to 208 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 330 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 379 to 382 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 386 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 481 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 297 to 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 301 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 303 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 411 to 413 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 886 to 893 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 752 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 826 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 717 to 725 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 739 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 75 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 308 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 309 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 159 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 75 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 136 to 143 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 35 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 38 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 67 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 74 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 206 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 223 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 184 to 188 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 515 to 518 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 to 52 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 to 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 213 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 101 to 107 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 369 to 376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 128 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 129 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 155 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 226 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 199 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 72 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 127 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 147 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 187 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 249 to 252 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 249 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 313 to 317 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 339 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 11 to 15 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 101 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 209 to 215 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 284 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 296 to 297 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 388 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 17 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 to 24 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 156 to 163 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 92 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 177 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 185 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 244 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 275 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 290 to 294 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 316 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 705 to 762 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 830 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 847 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 847 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 849 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 335 to 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 279 to 289 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 595 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 599 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 602 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 290 to 304 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 908 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 911 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 191 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 395 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 400 to 405 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 466 to 469 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 557 to 558 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 643 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 701 to 705 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 739 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 746 to 748 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 806 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 832 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 838 to 841 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 918 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 209 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 to 217 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 255 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 297 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 205 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 186 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 454 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 455 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 596 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 619 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 732 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 733 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 734 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 867 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 873 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 893 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 896 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 897 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 897 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 184 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 805 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1129 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1132 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1138 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 19 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 42 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 81 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 142 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 188 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 230 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 578 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 14 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 145 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 199 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 245 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 333 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 4 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 6 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 29 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 38 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 41 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 53 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 57 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 63 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 478 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 479 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 to 256 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 288 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 160 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 254 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 to 386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 109 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 259 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 356 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 357 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 445 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 69 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 29 to 53 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 596 to 604 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 370 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 374 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 410 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 168 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 169 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 119 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 130 to 135 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 454 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 495 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 540 to 543 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 to 170 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 11 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 202 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 213 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 213 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 283 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 309 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 340 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 340 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 325 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 495 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 7 to 9 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 73 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 241 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 244 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 23 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 109 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 949 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 960 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 961 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 377 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 to 42 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 277 to 286 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 205 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 308 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 408 to 413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 520 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 523 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 581 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 374 to 493 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 415 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 439 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 233 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 396 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 577 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 592 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 720 to 728 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 742 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 127 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 172 to 179 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 851 to 858 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 38 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 115 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 206 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 29 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 76 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 210 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 242 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 563 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 599 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 600 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 600 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 720 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 401 to 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 177 to 185 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 495 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 630 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 47 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 338 to 345 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 221 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 293 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 44 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 47 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 168 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 685 to 689 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 724 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 815 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 527 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 581 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 602 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 603 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 621 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 623 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 240 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 410 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 242 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 259 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 335 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 278 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 106 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 133 to 141 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 296 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 50 to 57 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 312 to 316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 253 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 319 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 338 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 340 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 581 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 585 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 693 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 319 to 325 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 349 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 260 to 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 16 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 110 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 329 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 41 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 46 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 422 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 111 to 116 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 156 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 170 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 180 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 155 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 24 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 25 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 48 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 51 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 154 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 313 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 167 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 170 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 173 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 504 to 512 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 4 to 5 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 212 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 276 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 186 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 117 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 to 360 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 113 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 137 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 156 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 102 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 141 to 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 320 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 104 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 to 189 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 26 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 59 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 61 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 93 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 191 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1084 to 1092 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 399 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 473 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 475 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 481 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 483 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 491 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 561 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 82 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 54 forms a bond with heme, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 276 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 362 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 382 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 393 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 394 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 396 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 396 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 401 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 401 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 404 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 411 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 116 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 319 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 330 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 47 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 61 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 61 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 66 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 82 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 86 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 93 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 94 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 96 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 110 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 111 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 281 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 283 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 305 to 311 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 305 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 472 to 478 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 407 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 77 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 287 to 298 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 221 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 530 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 535 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 619 to 620 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 654 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 40 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 69 to 72 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 613 to 620 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 310 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 362 to 365 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 386 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 404 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 409 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 307 to 315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 284 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 412 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 to 389 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 355 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 to 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 64 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 139 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 214 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 342 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 86 to 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 92 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 196 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 32 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 167 to 171 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 296 to 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 357 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 80 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 158 to 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 354 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 79 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 289 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 13 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 159 to 164 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 24 to 28 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 251 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 260 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 611 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 612 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 612 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 722 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 775 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 10 to 19 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 211 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 187 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1728 to 1730 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1728 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1729 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1730 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1754 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1764 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1773 to 1783 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1797 to 1800 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1827 to 1829 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1828 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1829 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 3 to 32 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 208 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 616 to 623 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 415 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 478 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 587 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 588 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 592 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 677 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 678 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 691 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 706 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 881 to 912 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1027 to 1038 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1170 to 1180 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1245 to 1263 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1343 to 1358 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 327 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 389 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 390 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 496 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 499 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 332 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 967 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 974 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 122 to 129 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 342 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 416 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 455 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 455 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 103 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 418 to 420 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 418 to 420 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 471 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 471 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 502 to 503 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 548 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 586 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 586 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 592 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 628 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 713 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 60 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 166 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 248 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 268 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 295 to 298 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 295 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 4 to 33 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 32 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 4 to 22 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 8 to 12 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 44 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 189 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 194 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 222 to 226 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 47 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 263 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1560 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1562 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1689 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 400 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 111 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 171 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 285 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 7 to 10 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 21 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 347 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 373 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 376 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 419 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 436 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 462 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 498 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 597 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 620 to 621 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 621 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 631 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 79 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 103 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 303 to 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 427 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 617 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 643 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 647 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 650 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 222 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 369 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 423 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 428 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 29 to 36 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 276 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 276 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 173 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 349 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 349 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 489 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 493 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 497 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 105 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 133 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 638 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 646 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 647 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 304 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 368 to 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 404 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 90 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 307 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 310 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 100 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 318 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 36 to 40 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 145 to 153 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 216 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 244 to 248 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 355 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 356 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 387 to 389 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 406 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 158 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 178 to 184 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 234 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 431 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 110 to 115 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 283 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 344 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 119 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 130 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 146 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 162 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 250 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 271 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 287 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 356 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 872 to 879 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 to 121 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 to 154 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 to 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 415 to 423 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 434 to 441 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 309 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 114 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 463 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 472 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 503 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 505 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 514 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 539 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 544 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 230 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 to 118 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 133 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 277 to 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 125 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 261 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 263 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 285 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 70 to 77 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 612 to 620 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 634 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 341 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 466 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 469 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 470 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 473 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 476 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 602 to 610 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 531 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 188 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 662 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 270 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 310 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 397 to 405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 418 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 188 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 252 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 102 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 278 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 to 84 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 95 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 124 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 138 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 294 to 300 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 307 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 166 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 394 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 345 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 405 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 126 to 132 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 462 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 466 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 539 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 128 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 250 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 76 to 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 280 to 292 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 309 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 12 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 83 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 229 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 4 to 70 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 256 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 378 to 381 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 385 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 388 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 340 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 328 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 164 to 179 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 190 to 222 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 to 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 26 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 27 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 28 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 53 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 136 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 137 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 163 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 229 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 448 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 255 to 259 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 273 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 276 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 320 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 355 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 360 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 105 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 382 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 411 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 70 to 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 377 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 68 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 156 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 243 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 449 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 237 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 268 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 46 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 353 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 to 13 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 77 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 12 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 306 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 333 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 474 to 598 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 545 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 359 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 525 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 117 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 190 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 294 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 412 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 430 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 435 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 139 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 216 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 128 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 277 to 291 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 374 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 236 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 to 390 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 401 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 524 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 528 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 301 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 365 to 368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 400 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 302 to 303 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 173 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 250 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 380 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 25 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 116 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 41 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 248 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 396 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 432 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 270 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 325 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 433 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 433 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 439 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 486 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 486 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 494 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 589 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 589 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 595 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 641 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 641 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 643 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 643 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 649 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 350 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 353 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 374 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 402 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with trans-zeatin 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with trans-zeatin 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with trans-zeatin 3, indicating a strong binding affinity.
The residue at position 81 forms a bond with trans-zeatin 3, indicating a strong binding affinity.
The residue at position 83 forms a bond with trans-zeatin 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 341 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 441 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 447 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 487 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 491 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 491 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 44 to 51 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 78 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 to 191 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 256 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 to 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 160 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 195 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 195 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 82 to 88 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 288 to 294 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 194 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 243 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 243 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 347 forms a bond with 3,3',5-triiodo-L-thyronine 1, indicating a strong binding affinity.
The residue at position 347 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 25 to 33 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 900 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 273 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 57 to 60 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 657 to 664 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 474 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 474 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 26 to 33 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 57 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 180 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 615 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 16 to 23 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 2101 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2104 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2136 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2139 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2170 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2173 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2185 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2187 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 433 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 22 to 26 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 55 to 60 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 186 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 286 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 224 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 253 to 258 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 377 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 51 forms a bond with heme, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 139 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 355 to 376 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 to 426 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 577 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 579 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 54 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 66 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 61 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 238 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 241 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 264 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 287 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 304 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 77 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 105 to 113 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 75 forms a bond with heme, indicating a strong binding affinity.
The residue at position 82 forms a bond with heme, indicating a strong binding affinity.
The residue at position 166 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 365 to 367 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 367 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 466 to 471 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 466 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 431 to 432 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 61 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 261 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 454 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 158 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 164 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 166 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 211 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 266 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 49 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 357 to 364 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 239 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 299 to 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 303 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 305 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 413 to 415 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 459 to 462 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 557 to 558 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 591 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 14 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 687 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 689 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 772 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 21 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 19 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 26 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 138 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 142 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 24 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 245 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 407 to 414 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 455 to 459 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 509 to 512 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 20 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 165 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 6 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 9 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 166 to 174 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 78 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 79 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 170 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 113 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 142 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 163 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 53 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 65 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 97 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 196 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 199 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 202 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 206 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 273 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 277 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 305 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 51 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 55 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 64 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 75 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 251 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 263 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 265 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 634 to 642 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 660 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 210 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 212 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 187 to 190 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 278 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 29 to 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mg of chlorophyll a ChlzD2, indicating a strong binding affinity.
The residue at position 128 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 141 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mg of chlorophyll a PD2, indicating a strong binding affinity.
The residue at position 213 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 260 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 80 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 139 to 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 to 258 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 311 to 315 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 379 to 384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 49 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 53 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 287 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 302 to 306 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 696 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 699 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 702 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 706 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 752 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 755 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 758 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 762 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 826 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 829 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 854 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1089 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 434 to 435 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 118 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 142 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 167 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 175 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 182 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 36 to 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 158 to 165 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 294 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 301 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 5 to 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 656 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 658 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 708 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 6 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 581 to 589 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 109 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 65 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 544 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 583 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 608 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 608 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 610 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 645 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 645 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 646 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 647 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 678 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 680 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1017 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1035 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1051 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1087 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1090 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1144 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 4 to 9 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 to 282 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 to 118 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 158 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 172 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 49 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 344 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 432 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 452 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 466 to 468 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 468 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 481 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 132 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 246 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 67 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 180 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 180 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 235 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 to 380 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 679 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 718 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 885 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 887 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 91 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 264 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 514 to 521 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 550 to 554 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 620 to 623 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 384 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 99 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 101 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 108 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 135 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 137 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 139 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 297 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 73 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 77 to 81 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 229 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 257 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 98 to 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 573 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 675 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 44 to 52 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 26 to 31 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 29 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 112 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 271 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 338 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 358 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 364 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 132 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 298 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 143 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 232 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 235 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 153 to 162 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 322 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 386 to 389 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 404 to 406 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 410 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 419 to 422 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 519 to 520 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 525 to 529 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 561 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 599 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 102 to 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 305 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 15 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 124 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 153 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 341 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 390 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 438 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 440 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 522 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 549 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 651 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 653 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 677 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 706 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 707 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 708 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 654 to 661 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 236 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 288 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 332 to 336 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 11 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 25 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 30 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 63 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 73 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 55 to 58 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 20 to 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 148 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 229 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 244 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 304 to 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 308 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 310 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 171 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 182 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 570 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 668 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 672 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 217 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 260 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 274 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 69 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 65 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 488 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 364 to 379 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 391 to 423 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 40 to 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with urate, indicating a strong binding affinity.
The residue at position 68 forms a bond with urate, indicating a strong binding affinity.
The residue at position 163 forms a bond with urate, indicating a strong binding affinity.
The residue at position 180 forms a bond with urate, indicating a strong binding affinity.
The residue at position 223 forms a bond with urate, indicating a strong binding affinity.
The residue at position 249 forms a bond with urate, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 587 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 589 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 659 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 451 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 3 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 239 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 349 to 351 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 564 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 608 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 923 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 418 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 422 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 18 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 73 to 80 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 24 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 166 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 154 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 553 to 558 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 29 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 58 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 70 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 63 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 238 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 84 to 88 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 73 to 78 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 265 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 632 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 636 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 63 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 13 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 308 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 368 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 371 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 37 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 121 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 57 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 215 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 20 to 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 to 221 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 270 to 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 97 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 116 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 176 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 566 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 602 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 603 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 603 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 723 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 269 to 275 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 294 to 298 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 363 to 366 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 419 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 74 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 30 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 111 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 157 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 160 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 163 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 246 to 251 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 238 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 18 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 18 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 18 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 151 to 158 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 328 to 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 83 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 410 to 418 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 450 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 25 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 39 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 44 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 63 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 250 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 144 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 53 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 253 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 54 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 118 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 120 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 35 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 132 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 207 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 357 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 398 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 423 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 216 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 120 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 244 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 223 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 166 to 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 to 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 916 to 918 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 993 to 995 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 470 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 502 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 567 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 570 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 160 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 302 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 129 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 157 to 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 314 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 317 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 42 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 45 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 920 to 927 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 196 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 190 to 197 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 237 to 241 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 302 to 305 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 148 to 152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 80 to 86 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 314 forms a bond with heme, indicating a strong binding affinity.
The residue at position 452 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 104 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 114 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 153 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 183 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 147 to 154 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 135 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 213 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 228 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 288 to 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 292 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 294 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 393 to 395 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 323 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 366 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 373 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 580 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 131 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 152 to 160 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 245 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 253 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 377 to 379 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 374 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 64 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 188 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 59 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 72 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 50 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 58 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 81 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 312 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 429 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 429 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 454 to 457 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 538 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 154 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 541 to 548 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1360 to 1367 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 350 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 351 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 134 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 408 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 256 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 409 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 448 to 450 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 156 to 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 401 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 408 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 48 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 133 to 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 336 to 337 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 to 89 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 303 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 754 to 761 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 406 to 414 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 429 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 240 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 169 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 199 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 347 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 351 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 394 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 419 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 466 to 473 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 688 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 692 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 764 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 249 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 273 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 317 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 405 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 433 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 458 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 492 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 494 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 92 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 171 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 561 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 597 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 598 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 598 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 718 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 202 to 207 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 156 to 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 273 to 276 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 370 to 374 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 399 to 401 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 195 to 200 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 204 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 265 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 289 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 299 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 38 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 122 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 294 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 302 to 303 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 166 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 169 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 39 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 132 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 144 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 130 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 383 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 449 to 452 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 589 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 101 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 513 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 400 to 403 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 439 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 587 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 590 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 595 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 144 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 174 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 21 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 24 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 25 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 159 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 354 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 356 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 359 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 64 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 173 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 225 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 335 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 355 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 357 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 360 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 375 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 376 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 23 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 240 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 820 to 828 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 843 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 915 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 917 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 927 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 57 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 84 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 89 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 110 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 161 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 163 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 217 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 279 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 297 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 299 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 334 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 335 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 371 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 404 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 48 to 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 576 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 620 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 918 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 935 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 938 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 114 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 347 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 368 to 369 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 393 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 398 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 432 to 433 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 460 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 492 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 526 to 535 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 613 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 97 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 192 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 427 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 520 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 648 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 351 to 355 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 317 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 6 to 8 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 7 to 8 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 81 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 360 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 367 to 368 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 93 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 211 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 202 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 204 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 206 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 243 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 245 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 279 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 281 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 283 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 285 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 97 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 335 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 337 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 433 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 435 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 559 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 586 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 687 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 689 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 713 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 742 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 743 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 744 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 6 to 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 563 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 558 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 204 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 364 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 493 to 495 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 500 to 506 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 439 to 561 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 498 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 513 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 6 to 10 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 463 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 439 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 441 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 443 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 445 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 468 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 470 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 525 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 628 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 666 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 687 to 689 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 794 to 797 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 24 to 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 108 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 138 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 138 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 139 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 142 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 144 to 149 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 21 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 92 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 356 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 358 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 378 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 381 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 396 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 397 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 398 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 281 to 287 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 503 to 508 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 284 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 56 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 452 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 219 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 547 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 551 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 213 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 333 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 333 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 309 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 386 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 415 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 285 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 152 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 191 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 193 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 268 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 133 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 254 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 312 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 313 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 324 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 340 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 307 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 331 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 383 to 385 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 407 to 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 519 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 522 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 580 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 613 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 613 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 617 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 617 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 757 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 761 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 765 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 154 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 220 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 322 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 414 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 36 to 43 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 161 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 33 to 36 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 155 to 164 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 361 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 391 to 394 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 424 to 427 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 524 to 525 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 530 to 534 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 566 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 604 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 146 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 147 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 605 to 612 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 209 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 643 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 5 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 99 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 118 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 119 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 127 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 132 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 155 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 130 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 103 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 171 to 176 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 216 to 220 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 618 to 625 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 778 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 780 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 65 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 29 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 199 to 204 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 106 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 136 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 63 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 88 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 28 to 33 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 54 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 110 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 189 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 27 to 28 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 387 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 311 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 348 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 397 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 617 to 624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 326 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 562 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 606 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 924 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 303 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 186 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 280 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 363 to 371 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 385 to 388 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 264 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 359 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 396 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 535 to 536 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 402 to 404 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 409 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 431 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 455 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 502 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 146 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 496 to 498 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 550 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 623 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 653 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 704 to 706 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 728 to 729 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 309 to 316 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 40 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 46 forms a bond with tunicamycin A1, indicating a strong binding affinity.
The residue at position 56 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 119 forms a bond with tunicamycin A1, indicating a strong binding affinity.
The residue at position 125 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 178 to 186 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with tunicamycin A1, indicating a strong binding affinity.
The residue at position 252 forms a bond with tunicamycin A1, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 303 forms a bond with tunicamycin A1, indicating a strong binding affinity.
The residue at position 405 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 503 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 674 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 677 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 680 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 684 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2055 to 2063 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2094 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with heme, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 136 forms a bond with heme, indicating a strong binding affinity.
The residue at position 153 to 159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 314 to 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 536 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 540 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 109 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 158 to 163 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 249 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 88 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 74 to 81 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 314 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 467 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 183 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 222 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 229 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 107 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 228 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 235 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 246 to 252 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 277 to 282 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 263 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 355 to 362 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 714 to 721 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 593 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 13 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 367 to 375 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 389 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 501 to 508 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 699 to 707 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 727 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1063 to 1071 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1084 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 154 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 296 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 48 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 110 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 141 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 144 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 185 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 188 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 225 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 228 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 229 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 303 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 306 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 307 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 382 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 385 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 386 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 430 forms a bond with heme c 9, indicating a strong binding affinity.
The residue at position 433 forms a bond with heme c 9, indicating a strong binding affinity.
The residue at position 434 forms a bond with Fe of heme c 9, indicating a strong binding affinity.
The residue at position 480 forms a bond with heme c 10, indicating a strong binding affinity.
The residue at position 483 forms a bond with heme c 10, indicating a strong binding affinity.
The residue at position 484 forms a bond with Fe of heme c 10, indicating a strong binding affinity.
The residue at position 555 forms a bond with heme c 11, indicating a strong binding affinity.
The residue at position 558 forms a bond with heme c 11, indicating a strong binding affinity.
The residue at position 559 forms a bond with Fe of heme c 11, indicating a strong binding affinity.
The residue at position 587 forms a bond with heme c 12, indicating a strong binding affinity.
The residue at position 590 forms a bond with heme c 12, indicating a strong binding affinity.
The residue at position 591 forms a bond with Fe of heme c 12, indicating a strong binding affinity.
The residue at position 525 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 530 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 535 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 538 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 645 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 648 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 700 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 703 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 900 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 902 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1009 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1062 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 94 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 121 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 107 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 23 to 27 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 189 to 194 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 189 to 194 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 225 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 225 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 209 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 119 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 154 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 219 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 322 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 324 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 194 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 228 to 233 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 28 to 29 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 33 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 129 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 353 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 405 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 74 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 138 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 349 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 364 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 375 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 384 to 385 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 403 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 421 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 438 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 516 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 74 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 174 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 250 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 293 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 61 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 86 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 111 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 113 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 239 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 286 to 298 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 to 60 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 485 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 10 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 277 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 263 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 266 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 271 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 274 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 279 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 284 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 311 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 314 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 329 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 332 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 337 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 340 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 347 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 354 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 475 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 544 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 84 to 88 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 308 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 120 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 480 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 487 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 532 to 535 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 495 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 495 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 526 to 527 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 572 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 610 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 610 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 616 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 676 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 737 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 7 to 10 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 191 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 232 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 281 to 284 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 277 to 282 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 335 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 356 to 358 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 403 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 302 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 342 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 363 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 48 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 197 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 292 to 297 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 394 to 397 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 492 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 111 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 609 to 616 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 54 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 144 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 285 to 313 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 48 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 109 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 159 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 225 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 226 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 29 to 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 187 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 50 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 235 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 365 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 183 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 292 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 52 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 548 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 552 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 655 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 435 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 508 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 508 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 510 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 424 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 498 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 500 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 414 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 417 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 479 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 481 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 266 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 328 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 340 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 360 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 39 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 62 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 79 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 to 52 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 15 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 322 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 727 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 731 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 793 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 796 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 821 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 824 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 825 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 825 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 960 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 321 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 404 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 433 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 545 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 594 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 598 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 702 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 706 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 17 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 5 to 12 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 432 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 434 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 553 to 556 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 617 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 620 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 620 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1041 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 365 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 183 to 190 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 230 to 234 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 295 to 298 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 241 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 264 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 410 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 213 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 307 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 207 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 228 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 258 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 38 to 42 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 107 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 111 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 243 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 289 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 313 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 313 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 465 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 338 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 388 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 413 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 506 to 513 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 95 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 15 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 193 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 255 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 15 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 373 to 375 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 413 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 415 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 439 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 222 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 310 to 311 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 297 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 324 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 719 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1035 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1038 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1044 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 88 to 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 168 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 271 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 348 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 369 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 129 forms a bond with heme, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 210 to 215 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 519 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 498 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 543 to 546 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 509 to 516 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1194 to 1201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 881 to 889 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 908 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 145 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 178 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 243 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 246 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 320 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 322 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 323 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 40 to 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 452 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 452 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 510 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 510 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 512 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 512 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 518 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 248 to 254 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 32 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 115 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 198 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 201 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 271 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 274 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 303 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 306 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 307 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 382 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 9 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 12 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 87 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 104 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 341 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 113 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 247 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 296 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 309 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 335 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 340 to 344 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 274 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 335 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 681 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 685 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 285 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 389 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 429 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 104 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 462 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 462 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 493 to 494 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 539 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 577 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 577 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 583 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 618 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 620 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 642 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1 to 94 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 104 to 217 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 303 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 81 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 510 to 514 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 536 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 190 to 194 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 162 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 189 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 12 to 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 160 to 289 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 238 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 292 to 411 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 359 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 30 to 33 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 152 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 112 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 120 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 245 to 251 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 187 to 194 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 234 to 238 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 299 to 302 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 to 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 9 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 11 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 162 to 166 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 386 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 110 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 361 to 365 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 370 to 376 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 400 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 410 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 65 to 70 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 399 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 forms a bond with cis,cis-muconate, indicating a strong binding affinity.
The residue at position 128 forms a bond with cis,cis-muconate, indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 426 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 426 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 143 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 152 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 212 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 186 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 267 to 274 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 406 to 409 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 449 to 450 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 446 to 451 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 159 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 163 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 251 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 430 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 260 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 175 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 382 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 385 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 390 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 18 to 29 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 214 to 222 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 98 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with heme, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 132 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 213 to 218 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 339 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 13 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 319 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 348 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 411 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 419 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 481 to 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 258 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 270 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 445 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 130 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 264 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 370 to 371 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 394 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 396 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 398 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 402 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 443 to 447 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 476 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 483 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 483 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 355 to 363 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 56 to 61 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 449 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 31 to 36 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 331 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 10 to 14 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 165 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 311 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 369 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 486 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 263 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 265 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 398 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 406 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 120 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 189 to 195 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 218 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 221 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 to 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1015 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1017 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1026 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1027 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 229 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 273 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 424 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 431 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 472 to 475 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 276 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 398 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 412 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 452 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 350 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 91 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 to 315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 109 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 109 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 113 to 118 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 66 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 422 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 427 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 to 296 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 335 to 338 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 522 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 525 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 530 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 213 to 219 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 29 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 171 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 173 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 178 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 204 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 206 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 210 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 215 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 258 to 263 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 209 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 232 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 253 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 267 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 410 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 420 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 486 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 280 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1329 to 1336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 493 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 531 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 1013 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1020 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1020 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 219 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 295 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 132 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 304 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 316 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 336 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 338 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 330 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 331 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 354 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 499 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 686 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 162 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 394 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 237 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 396 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 424 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 535 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 797 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 835 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 994 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 998 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1096 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1100 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1133 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 48 to 53 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 178 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 232 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 to 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 37 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 221 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 388 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 53 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 3 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 354 to 357 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 316 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 227 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 325 forms a bond with heme, indicating a strong binding affinity.
The residue at position 63 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 81 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 88 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 90 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 92 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 117 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 120 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 142 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 198 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 200 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 209 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 210 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 210 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 247 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 286 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 288 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 336 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 373 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 376 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 612 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 613 forms a bond with Co of cob(II)alamin, indicating a strong binding affinity.
The residue at position 614 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 615 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 658 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 660 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 689 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 712 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 85 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 124 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 230 to 235 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 230 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 234 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 249 to 255 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 251 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 458 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 507 to 510 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 250 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 316 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 316 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 340 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 340 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 376 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 423 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 447 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 455 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 506 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 138 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 457 to 464 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 509 to 510 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 462 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 507 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 552 to 555 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 525 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 87 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 337 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 361 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 528 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 70 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 202 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 225 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 168 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 77 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 421 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 424 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 426 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 483 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 484 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 485 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 489 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 328 to 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 308 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 81 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 208 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 214 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 259 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 267 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 299 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 8 to 15 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 33 to 37 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with GTP 3, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 to 120 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 508 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 263 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 266 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 233 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 444 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 25 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 76 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 82 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 33 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 124 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 145 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 147 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 361 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 366 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 377 to 379 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 177 to 184 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 960 to 967 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 115 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 119 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 169 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 253 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 434 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 458 to 465 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1220 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1245 to 1252 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1245 to 1252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 357 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 423 to 427 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 423 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 510 to 516 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 522 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 570 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 570 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 410 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 388 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 487 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 717 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 721 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 639 to 646 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 575 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 366 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 373 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 313 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 316 to 324 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 116 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 274 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 311 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 338 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 430 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 430 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 455 to 458 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 539 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 462 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 79 to 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 285 to 297 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 326 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 328 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 331 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 387 to 388 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 411 to 415 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 500 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 501 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 502 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 259 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 261 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 371 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 576 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 24 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 157 to 163 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 353 to 355 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 394 to 397 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 501 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 584 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 589 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 910 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 913 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 926 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 929 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 934 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 937 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 956 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 959 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 677 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 222 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 283 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 467 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 491 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 499 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 91 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 105 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 130 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 200 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 315 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 25 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 215 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 342 to 344 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 347 to 348 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 352 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 432 to 435 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 721 to 724 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 809 to 811 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 883 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 887 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 50 forms a bond with phycourobilin, indicating a strong binding affinity.
The residue at position 61 forms a bond with phycourobilin, indicating a strong binding affinity.
The residue at position 280 to 294 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 12 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 116 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 203 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 21 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 22 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 117 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 8 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 255 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 269 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 159 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 187 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 63 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 91 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 60 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 274 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 264 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 330 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 331 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 351 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 359 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 382 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 433 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 620 to 624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 644 to 648 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 934 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 988 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1007 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1018 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 to 29 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 61 to 70 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 to 224 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 356 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 359 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 71 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 110 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 430 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 287 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 292 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 292 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 325 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 386 to 394 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 390 to 394 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 36 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 68 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 122 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 142 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 57 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 115 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 124 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 145 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 148 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 151 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 155 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 177 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 233 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 505 to 512 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 292 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 297 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 229 to 236 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 218 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 67 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 141 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 179 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 450 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 345 to 353 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 348 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 467 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 719 to 728 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 795 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 803 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 820 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 125 to 131 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 291 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 341 to 346 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 359 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 240 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 244 to 248 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 93 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 392 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 422 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 609 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 265 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 287 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 498 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 506 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 544 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 198 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 325 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 146 to 150 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 210 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 196 to 207 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 to 366 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 381 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 to 196 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 225 to 228 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 200 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 136 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 224 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 68 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 214 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 218 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 394 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 603 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 97 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 235 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 249 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 131 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 to 42 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 to 36 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 205 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 260 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 253 to 256 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 389 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 393 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 431 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 449 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 469 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 520 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 523 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 169 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 213 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 359 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 359 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 362 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 362 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 366 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 407 to 410 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 163 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 175 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 662 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 665 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 667 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 672 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 705 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 707 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 709 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 711 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 716 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 735 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 737 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 739 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 741 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 746 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 800 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 802 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 804 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 806 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 582 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 675 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 683 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 691 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 692 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 163 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 19 to 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 35 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 148 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 147 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 256 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 15 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 146 to 153 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 212 to 216 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 497 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 498 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 504 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 33 to 41 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 352 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 515 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 515 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 145 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 200 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 119 to 125 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 140 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 138 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 to 44 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 140 to 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 265 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 310 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 410 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 430 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 444 to 446 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 446 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 29 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 115 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 235 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 436 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 258 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 261 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 281 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 305 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 41 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 126 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 199 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 74 to 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 76 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 107 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 108 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 151 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 491 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 141 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 529 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 529 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 533 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 533 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 677 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 685 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 668 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 668 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 672 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 672 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 848 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 852 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 856 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 302 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 21 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 165 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 305 to 310 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 423 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 454 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 548 to 551 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 55 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 293 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 308 to 312 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 335 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 8 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 12 forms a bond with O2, indicating a strong binding affinity.
The residue at position 58 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 59 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 206 to 213 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 605 to 612 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 187 to 192 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 94 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 74 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 75 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 99 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 119 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 168 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 236 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 98 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 190 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 194 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 216 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 151 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 172 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 245 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 296 to 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 342 to 344 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 74 to 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 to 172 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 192 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 443 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 23 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 147 to 151 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 147 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 107 to 112 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 152 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 166 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 176 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 29 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 627 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 421 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 444 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 474 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 481 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 526 to 529 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 45 to 50 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 48 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 103 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 272 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 342 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 343 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 345 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 355 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 163 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 54 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 57 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 169 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 291 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 217 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 254 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 442 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 316 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 166 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 192 to 197 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 201 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 286 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 57 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 90 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 172 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 823 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 904 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 907 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 127 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 266 to 271 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 345 to 347 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 390 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 355 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 219 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 179 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 207 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 338 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 371 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 394 to 395 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 395 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 500 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 506 to 507 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 35 to 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 77 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 287 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 483 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 512 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 524 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 35 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 294 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 656 to 663 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 41 to 46 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 77 to 81 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 546 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 548 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 237 to 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 534 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 921 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 136 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 418 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 7 to 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 62 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 167 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 176 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 508 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 308 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 456 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 471 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 475 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 227 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 151 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 440 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 79 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 168 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 337 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 355 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 366 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 392 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 392 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 396 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 247 to 254 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 222 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 230 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 241 to 247 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 299 to 304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 304 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 347 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 182 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 190 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 276 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 425 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 499 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 501 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 507 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 509 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 517 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 302 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 366 to 369 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 418 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 512 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 54 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 97 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 244 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 331 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 344 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 408 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 430 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 454 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 501 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 171 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 236 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 803 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 885 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 74 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 forms a bond with U0126, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with K-252a, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with K-252a, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with U0126, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 177 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 156 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 50 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 56 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 36 to 41 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 67 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 880 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 883 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 903 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 907 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 920 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 43 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 57 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 124 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 140 to 145 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 109 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 459 to 464 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 257 to 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 373 to 375 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 375 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 406 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 499 to 502 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 70 to 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 66 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 117 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 166 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 216 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 254 to 257 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 77 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 350 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 371 to 372 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 396 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 401 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 435 to 436 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 463 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 494 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 528 to 537 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 615 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 78 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 89 to 96 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 129 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 140 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 43 to 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 333 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 205 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 15 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 197 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 341 to 344 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 586 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 679 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 687 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 695 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 696 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 68 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 85 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 92 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 93 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 94 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 272 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 to 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 to 175 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 43 to 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 82 to 86 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 154 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 132 to 137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 83 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 118 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 460 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 462 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 466 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 495 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 497 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 499 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 501 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 506 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 63 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 186 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 132 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 133 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 136 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 194 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 30 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 13 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 87 to 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 to 27 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 60 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 104 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 199 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 434 to 437 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 451 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 477 to 478 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 515 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 66 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 67 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 182 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 188 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 239 to 242 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 55 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 82 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 84 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 101 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 491 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 532 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 124 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 259 to 262 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 364 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 146 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 194 to 201 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 241 to 245 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 306 to 309 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 92 to 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 69 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 39 to 46 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 328 to 335 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 9 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 108 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 509 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 621 to 628 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 61 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 154 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 221 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 253 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 274 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 325 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 347 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 352 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 430 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 451 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 453 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 454 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 226 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 236 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 18 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 109 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 541 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 116 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 201 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 207 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 339 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 91 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 91 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 254 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 242 to 247 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 165 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 142 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 175 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 248 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 271 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 300 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 280 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 11 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 46 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 336 to 342 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1132 to 1139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 542 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 545 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 547 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 590 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 591 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 592 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 596 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 601 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 155 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 245 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 269 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 269 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 301 to 318 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 401 to 408 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 447 to 451 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 501 to 504 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 420 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 608 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 635 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 639 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 642 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 306 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 407 to 411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 32 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 35 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 116 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 159 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 162 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 165 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 168 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 209 to 216 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 242 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 243 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 353 to 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 17 to 23 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 137 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 151 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 247 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 326 to 332 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 330 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 332 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 440 to 442 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 181 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 186 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 228 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 234 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 238 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 145 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 113 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 114 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 138 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 158 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 208 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 277 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 160 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 254 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 598 to 605 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 215 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 53 to 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 308 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 to 172 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 113 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 16 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 62 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 273 to 278 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 328 to 332 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 399 to 404 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 340 to 342 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 172 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 230 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 336 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 354 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 369 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 380 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 383 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 408 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 426 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 443 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 392 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 89 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 317 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 87 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 89 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 262 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 274 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 282 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 36 to 44 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 215 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 440 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 564 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 649 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 658 to 661 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 811 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 442 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 467 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 471 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 473 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 538 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 606 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 72 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 89 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 92 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 126 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 118 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 120 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 309 to 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 473 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 476 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 182 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 82 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 493 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 425 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 428 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 480 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 481 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 482 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 205 to 228 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 453 to 457 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 70 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 71 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 537 to 539 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 544 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 709 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 753 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 815 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 141 to 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 366 to 372 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1553 to 1560 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 273 to 276 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 559 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 213 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 6 to 9 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 20 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 223 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 401 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 291 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 143 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 268 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 459 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 500 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 545 to 548 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 12 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 50 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 105 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 248 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 166 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 679 to 686 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 347 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 420 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 464 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 201 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 215 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 317 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 459 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 459 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 514 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 514 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 516 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 516 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 521 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 211 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 73 to 76 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 306 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 283 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 463 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 465 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 481 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 484 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 400 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 116 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 122 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 152 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 197 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 137 to 145 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 208 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 279 to 291 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 239 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 241 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 61 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 63 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 206 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 306 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 16 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 102 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 279 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 41 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 201 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 398 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 439 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 86 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 125 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 231 to 236 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 231 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 250 to 256 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 255 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 308 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 344 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 345 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 356 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 340 to 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 363 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 379 to 380 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 285 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 346 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 346 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 499 to 506 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 545 to 549 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 599 to 602 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 336 to 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 483 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 483 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 514 to 515 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 560 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 598 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 598 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 604 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 640 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 664 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 725 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 9 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 444 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 183 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 121 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 725 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 151 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 178 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 314 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 328 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 338 to 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 607 to 614 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 100 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 179 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 49 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 235 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 236 to 240 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 253 to 260 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 337 to 341 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 220 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 225 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 228 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 244 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 319 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 332 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 351 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 373 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 228 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 to 157 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 339 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 360 to 367 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 106 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 188 to 191 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 434 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 264 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 288 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 684 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 686 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 688 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1046 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1239 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1246 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1249 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 367 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 510 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 221 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 277 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 359 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 396 to 398 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 398 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 97 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 135 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 230 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 259 to 264 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 383 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 143 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 434 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 461 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 488 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 515 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 539 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 547 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 598 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 534 to 541 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 159 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 162 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 586 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 128 to 134 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 229 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 201 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 227 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 348 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 352 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 67 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 100 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 182 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 247 forms a bond with heme, indicating a strong binding affinity.
The residue at position 267 forms a bond with heme, indicating a strong binding affinity.
The residue at position 301 forms a bond with heme, indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 337 forms a bond with heme, indicating a strong binding affinity.
The residue at position 36 to 62 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 211 to 217 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 345 to 372 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 158 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 178 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 192 to 199 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 219 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 173 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 224 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 297 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 498 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 212 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 136 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 4 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 704 to 761 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 828 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 840 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 840 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 842 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 10 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 42 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 46 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 65 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 68 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 71 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 75 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 123 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 75 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 138 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 138 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 171 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 239 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 311 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 313 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 315 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 316 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 52 to 59 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 356 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 111 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 188 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 384 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 408 to 411 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 463 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 160 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 194 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 294 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 297 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 100 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 179 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 283 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 312 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 333 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 360 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 381 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 205 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 450 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 92 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 235 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 432 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 511 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 281 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 353 to 355 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 36 to 39 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 336 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 342 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 372 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 29 to 36 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 146 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 215 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 260 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 139 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 31 to 34 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 76 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 82 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 81 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 149 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 214 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 214 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 226 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 230 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 232 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 277 to 282 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 117 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 332 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 125 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 169 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 188 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 214 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 331 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 341 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 343 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 180 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 32 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 424 to 431 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 270 to 275 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 384 to 386 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 386 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 417 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 512 to 515 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 532 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 10 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 356 to 364 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 378 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 to 222 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 205 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 211 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 233 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 782 to 789 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 96 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 101 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 437 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 438 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 439 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 494 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 495 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 556 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 559 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 125 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 90 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 74 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 7 to 19 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 121 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 121 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 64 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 78 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 124 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 232 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 318 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 444 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 346 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 349 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 350 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 273 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 321 to 326 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 326 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 369 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 399 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 436 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 147 to 170 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 246 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 250 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 254 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 301 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 580 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 583 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 586 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 590 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 609 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 612 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 615 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 619 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 251 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 339 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 345 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 375 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 447 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 475 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 122 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 259 to 263 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 383 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 432 to 435 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 439 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 458 to 461 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 534 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 93 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 245 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 352 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 367 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 379 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 383 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 157 to 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 274 to 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 371 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 245 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 171 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 231 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 149 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 243 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 257 to 261 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 264 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 280 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 351 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 865 to 872 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 171 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 5 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 9 forms a bond with O2, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 56 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 75 to 80 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 305 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 306 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 561 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 592 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 15 to 23 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 657 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 152 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 254 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 289 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 465 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 660 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 688 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 692 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 695 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 30 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 9 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 17 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 50 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 95 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 38 to 43 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 145 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 226 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 241 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 301 to 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 307 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 333 to 335 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 113 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 116 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 263 to 270 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 353 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 801 to 802 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1083 to 1086 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1263 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 166 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 169 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 204 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 81 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 109 to 117 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 84 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 440 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 517 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 517 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 519 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 356 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 8 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 306 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 332 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 341 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 454 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 17 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 289 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 330 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 514 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 22 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 30 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 71 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 148 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 174 to 180 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 204 to 208 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 96 to 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 87 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 145 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 154 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 346 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 348 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 363 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 366 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 367 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 368 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 371 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 386 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 387 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 388 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 240 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 134 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 83 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 122 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 228 to 233 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 247 to 253 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 to 275 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 444 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 400 to 407 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 446 to 450 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 500 to 503 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 111 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 156 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 326 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 510 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 894 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 126 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 232 to 237 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 232 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 251 to 257 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 256 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 460 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 589 to 591 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 596 to 602 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 629 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 636 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 237 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 379 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 260 to 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 339 to 341 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 219 to 224 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 364 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 368 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 399 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 521 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 122 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 289 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 105 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 354 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 355 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 443 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 178 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 210 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 311 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 107 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 109 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 239 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 527 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 630 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 689 to 691 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 796 to 799 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 492 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 162 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 369 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 66 forms a bond with heme, indicating a strong binding affinity.
The residue at position 69 forms a bond with heme, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 186 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 331 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 404 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 520 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 659 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 720 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 234 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 305 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 433 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 8 to 15 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 25 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 67 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 93 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 159 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 283 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 451 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 151 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 184 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 194 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 303 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 305 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 358 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 107 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 230 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 314 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 407 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 303 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 418 to 430 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 456 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 559 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 76 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 164 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 164 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 239 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 116 to 124 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 119 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 148 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 162 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 174 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 365 to 366 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 392 to 393 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 591 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 172 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 146 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 352 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 369 to 371 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 481 to 485 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 941 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 943 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 952 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 953 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 159 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 35 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 182 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 208 to 214 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 793 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1118 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1124 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 185 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 195 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 275 to 278 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 to 181 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 261 to 264 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 16 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 27 to 32 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 30 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 85 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 302 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 324 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 175 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 365 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 10 to 14 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 28 to 29 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 259 to 263 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 280 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 365 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 308 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 723 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 887 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 889 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 484 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 484 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 492 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 539 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 581 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 581 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 587 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 641 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 641 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 642 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 643 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 643 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 649 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 109 to 114 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 136 to 142 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 161 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 73 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 184 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 247 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 263 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 to 320 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 370 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 194 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 308 to 316 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 281 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 318 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 345 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 437 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 462 to 465 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 546 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 24 to 25 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 29 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 350 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 354 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 57 to 60 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 174 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 to 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 403 to 409 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 47 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 50 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 133 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 152 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 161 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 175 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 170 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 239 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 to 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 221 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 398 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 405 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 405 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 129 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 149 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 158 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 868 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 944 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 951 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 954 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 253 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 255 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 384 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 387 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 99 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 187 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 272 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 315 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 248 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 449 to 450 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 216 to 223 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 329 to 332 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 353 to 355 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 51 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 448 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 451 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 474 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 607 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 670 to 671 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 386 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 144 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 51 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 181 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 338 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 24 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 77 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 143 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 318 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 365 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 371 to 372 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 390 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 23 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 25 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 183 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 378 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 402 to 405 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 144 to 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 414 to 422 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 437 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 89 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 137 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 269 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 375 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 53 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 84 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 242 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 266 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 402 to 407 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 452 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 459 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 484 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 675 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 681 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 700 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 703 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 765 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 768 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 796 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 797 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 797 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 905 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 254 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 270 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 462 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 535 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 535 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 537 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 373 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 378 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 457 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 461 to 465 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 72 to 77 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 49 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 202 to 207 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 366 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 51 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 84 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 164 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 131 to 136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 634 to 641 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 113 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 68 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 68 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 154 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 413 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 324 to 332 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 488 to 495 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 232 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 269 to 272 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 56 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 56 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 473 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 546 to 554 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 75 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 615 to 622 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2381 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2385 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2385 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2405 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2407 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2408 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2414 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2414 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2415 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2415 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2428 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2429 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 135 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 531 to 538 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 581 to 585 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 635 to 638 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 288 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 164 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 721 to 778 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 845 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 857 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 857 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 859 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 406 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 413 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 413 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 to 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 to 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 332 to 338 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 116 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 9 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 73 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 124 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 273 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 81 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 313 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 344 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 477 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 to 149 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 184 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 272 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 164 to 169 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 733 to 741 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 756 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 814 to 819 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1042 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 to 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 124 forms a bond with heme, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 480 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 500 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 505 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 578 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 581 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 602 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 607 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 51 to 55 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 59 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 63 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 64 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 170 to 174 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 178 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 63 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 408 to 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 780 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1092 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1095 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1101 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 326 to 328 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 545 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 546 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 548 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 268 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 to 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 251 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 to 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 71 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 190 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 266 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 278 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 132 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 158 to 165 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 168 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 184 to 192 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 209 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 210 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 232 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 282 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 325 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 326 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 350 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 467 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 468 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 498 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 510 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 515 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 517 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 547 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 587 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 588 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 610 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 692 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 693 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 715 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 96 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 110 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 419 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 423 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 485 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 494 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 244 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 275 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 278 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 279 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 294 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 311 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 314 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 332 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 359 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 364 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 376 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 380 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 606 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 714 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 968 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 103 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 427 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 431 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 438 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1755 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1761 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1766 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 24 to 30 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 317 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 247 to 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 268 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 448 to 449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 142 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 355 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 661 to 669 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 689 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 471 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 506 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 726 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 121 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 138 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 305 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 119 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 443 to 448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 508 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 381 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 420 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 420 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 205 to 212 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 120 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 111 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 114 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 344 to 349 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 356 to 361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 29 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 249 to 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 to 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 170 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 52 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 67 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 7 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 658 to 666 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1029 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1031 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 215 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 132 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 141 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 345 to 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 76 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 287 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 to 11 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 234 to 262 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 288 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 293 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 293 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 326 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 387 to 395 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 391 to 395 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 425 to 426 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 411 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 414 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 431 to 433 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 431 to 433 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 484 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 484 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 515 to 516 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 561 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 599 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 599 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 605 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 641 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 726 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 398 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 11 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 11 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 111 forms a bond with heme, indicating a strong binding affinity.
The residue at position 111 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 114 forms a bond with heme, indicating a strong binding affinity.
The residue at position 114 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 45 forms a bond with heme, indicating a strong binding affinity.
The residue at position 151 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 81 to 86 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 102 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 103 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 125 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 225 to 228 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 446 to 453 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 318 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 367 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 389 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 394 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 492 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 496 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 498 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 499 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 224 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 73 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 249 to 253 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 270 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 313 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 348 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 353 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 122 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 880 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 238 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 298 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 25 to 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 549 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 878 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 881 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 25 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 55 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 411 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 555 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 1102 to 1110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 181 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 189 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 143 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 57 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 118 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 122 to 128 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 151 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 154 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 679 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 228 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 445 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 22 to 29 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 37 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 350 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 352 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 353 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 355 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 388 to 390 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 411 to 412 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 473 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 528 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 12 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 68 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 380 to 387 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 426 to 430 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 480 to 483 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 361 to 368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 107 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 148 to 156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 558 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 597 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 622 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 622 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 624 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 665 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 665 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 666 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 667 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 698 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 698 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1040 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1058 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1074 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1109 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1112 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1162 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1169 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1170 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 354 to 361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 326 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 343 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 442 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 108 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 153 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 156 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 161 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 589 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 633 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 932 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 104 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 294 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 299 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 299 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 332 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 393 to 401 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 397 to 401 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 59 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 254 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 295 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 358 to 366 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 380 to 383 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 318 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 15 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 to 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 70 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 137 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 244 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 223 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 366 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 147 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 172 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 176 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 209 to 216 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 417 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 421 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 527 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 552 to 553 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 575 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 602 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 814 to 823 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 890 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 898 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 915 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 58 forms a bond with urate, indicating a strong binding affinity.
The residue at position 59 forms a bond with urate, indicating a strong binding affinity.
The residue at position 160 forms a bond with urate, indicating a strong binding affinity.
The residue at position 177 forms a bond with urate, indicating a strong binding affinity.
The residue at position 219 forms a bond with urate, indicating a strong binding affinity.
The residue at position 220 forms a bond with urate, indicating a strong binding affinity.
The residue at position 246 forms a bond with urate, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 252 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 161 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 235 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 240 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 299 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 321 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 335 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 142 to 149 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 373 to 374 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 355 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 51 to 58 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 187 to 195 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 131 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 133 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 159 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 168 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 312 to 316 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 219 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 244 to 251 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 321 to 325 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 383 to 386 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 201 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 280 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 27 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 81 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 167 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 512 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 191 to 198 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 888 to 895 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 104 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 246 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 239 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 to 114 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 163 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 264 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 276 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 250 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 302 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 304 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 307 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 340 to 342 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 387 to 391 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 417 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 471 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 472 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 473 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 439 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 459 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 473 to 475 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 475 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 122 to 130 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 189 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 277 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 108 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 254 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 199 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 to 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 to 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 245 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 62 to 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 355 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 261 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 374 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 257 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 273 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 422 to 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 158 to 162 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mg of bacteriochlorophyll a 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mg of bacteriochlorophyll a 6, indicating a strong binding affinity.
The residue at position 290 forms a bond with Mg of bacteriochlorophyll a 4, indicating a strong binding affinity.
The residue at position 297 forms a bond with Mg of bacteriochlorophyll a 7, indicating a strong binding affinity.
The residue at position 298 forms a bond with Mg of bacteriochlorophyll a 3, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 340 to 350 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 12 forms a bond with pyridoxal, indicating a strong binding affinity.
The residue at position 47 forms a bond with pyridoxal, indicating a strong binding affinity.
The residue at position 47 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 148 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 186 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 293 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 419 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 112 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 333 to 335 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 350 to 358 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 115 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 117 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 144 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 232 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 299 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 306 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 311 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 252 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 266 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 194 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 85 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 115 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 47 forms a bond with O2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 202 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 563 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 319 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 535 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 75 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 338 to 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 442 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 467 to 470 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 551 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 12 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 112 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 399 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 13 to 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 221 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 242 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 260 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 352 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 360 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 365 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 368 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 377 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 418 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 421 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 436 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 441 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 446 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 449 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 457 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 461 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 356 to 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 445 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 522 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 607 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 81 to 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 464 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 468 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 270 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 249 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 258 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 358 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 24 to 25 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 95 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 314 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 139 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 150 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 702 to 762 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 829 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 841 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 841 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 843 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 73 to 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mg of chlorophyll a ChlzD2, indicating a strong binding affinity.
The residue at position 129 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 142 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg of chlorophyll a PD2, indicating a strong binding affinity.
The residue at position 214 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 261 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 547 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 550 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 347 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 388 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 389 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 389 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 394 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 397 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 398 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 404 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 180 to 183 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 346 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 350 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 393 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 406 to 527 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 222 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 351 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 209 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 285 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 73 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 190 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 192 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 221 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 275 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 306 to 310 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 332 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 257 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 641 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 644 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 659 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 661 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 669 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 672 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 693 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 696 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 719 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 721 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 723 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 730 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 751 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 753 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 762 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 348 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 243 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 300 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 306 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 335 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 108 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 142 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 82 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 790 to 797 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 205 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 349 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 358 to 361 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 368 to 369 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 403 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 444 to 452 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 468 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 300 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 14 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 17 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 633 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 637 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 638 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 641 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 649 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 to 320 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 401 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 430 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 362 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 440 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 836 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 849 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 30 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 41 to 46 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 99 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 325 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 328 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 346 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 352 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 45 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 56 to 61 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 59 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 114 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 382 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 752 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 758 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 777 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 780 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 871 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 875 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 875 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 963 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 25 to 49 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 272 to 276 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 380 to 387 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 434 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 458 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 458 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 243 to 254 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 25 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 105 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 115 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 118 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 123 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 134 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 120 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 294 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 337 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 342 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 651 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 694 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 699 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 704 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 989 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 992 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 994 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1035 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1036 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 294 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 357 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 158 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 162 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 101 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 130 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 131 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 212 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 223 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 276 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 287 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 390 to 397 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 463 to 470 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 509 to 513 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 563 to 566 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 to 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 342 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 473 to 478 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 39 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 586 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 166 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 12 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 41 to 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 15 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 70 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 167 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 127 to 135 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 125 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 213 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 523 to 530 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 67 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 69 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 71 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 6 to 20 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 166 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 178 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 341 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 368 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 389 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 225 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 259 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 262 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 415 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 423 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 426 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 443 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 507 to 508 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 524 to 526 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 542 to 543 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 542 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 543 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 689 to 690 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 132 to 140 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 159 to 164 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 66 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 237 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 33 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 239 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 243 forms a bond with O2, indicating a strong binding affinity.
The residue at position 375 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 377 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 9 to 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 412 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 74 to 77 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 151 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 420 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 655 to 663 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 678 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 380 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 285 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 640 to 646 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 663 to 665 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 756 to 757 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 759 to 760 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 825 to 826 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 14 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 268 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 280 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 108 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 385 to 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 415 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 548 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with alpha-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with N-acetyl-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with alpha-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with N-acetyl-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with alpha-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with N-acetyl-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with alpha-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with N-acetyl-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with alpha-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with N-acetyl-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with alpha-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with N-acetyl-D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 227 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 469 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 507 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 91 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 613 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1012 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 80 to 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 130 to 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 543 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 544 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 548 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 580 to 581 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 585 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 596 to 598 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 645 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 7 to 10 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 to 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 to 382 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 152 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 217 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 222 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 227 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1187 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1189 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1190 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1192 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1195 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 88 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 428 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 431 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 484 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 486 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 490 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 123 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 126 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 131 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 78 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 131 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 135 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 156 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 159 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 162 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 166 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 189 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 199 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 207 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 242 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 277 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 100 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 215 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 526 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 865 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 314 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 311 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 314 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 317 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 321 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 367 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 371 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 460 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 230 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 249 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 250 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 156 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 207 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 211 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 214 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 245 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 247 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 258 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 318 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 319 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 404 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 337 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 103 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 453 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 478 to 481 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 473 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 992 to 999 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 201 to 207 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 24 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 565 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 292 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 429 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 435 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 478 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 28 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 276 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 347 to 348 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 365 to 373 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 387 to 390 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 452 to 459 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 545 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 585 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 588 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 1740 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1746 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1751 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with N-glycoloyl-alpha-neuraminate, indicating a strong binding affinity.
The residue at position 59 forms a bond with N-glycoloyl-alpha-neuraminate, indicating a strong binding affinity.
The residue at position 101 forms a bond with N-glycoloyl-alpha-neuraminate, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 to 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 278 to 290 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 356 to 358 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 18 to 22 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 136 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 885 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 896 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 411 to 418 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 458 to 462 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 270 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 326 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 332 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 344 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 36 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 87 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 118 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 277 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 221 to 226 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 276 to 283 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 326 to 329 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 374 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 222 to 226 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 349 to 356 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 437 to 441 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 498 to 501 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 to 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 273 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 477 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 492 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 566 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 496 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 498 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 230 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 721 to 728 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 364 to 367 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 244 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 264 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 283 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 115 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 533 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 208 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 39 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 76 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 112 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 235 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 235 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 238 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 241 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 241 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 247 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 247 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 315 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 187 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 475 to 480 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 525 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 532 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 559 to 564 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 241 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 341 to 349 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 473 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 53 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 79 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 94 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 275 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 396 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 450 to 453 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 482 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 533 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 28 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 327 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 345 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 407 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 437 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 520 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 292 to 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 488 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 566 to 569 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 196 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 3 to 9 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 4 to 7 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 120 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 215 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 538 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 539 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 290 to 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 598 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 638 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 670 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 809 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 239 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 372 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 387 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 392 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 38 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 124 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 398 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 451 to 452 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 477 to 482 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 483 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 121 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 204 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 208 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 501 to 505 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 671 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 708 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 839 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 to 109 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 359 to 372 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 169 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 253 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 277 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 278 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 122 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 to 94 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 613 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 634 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 637 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 100 to 105 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 132 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 170 to 174 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 198 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 132 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 146 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 278 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 137 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 62 to 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 280 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 329 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 329 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 22 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 25 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 26 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 220 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 290 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 134 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 438 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 204 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 238 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 311 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 354 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 376 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 29 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 247 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 311 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 384 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 392 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 437 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 503 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 506 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 536 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 699 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 779 to 780 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 178 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 327 to 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 396 to 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 458 to 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 215 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 502 to 504 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 509 to 515 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 129 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 to 133 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 156 to 165 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 177 to 181 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 209 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 248 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 277 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 304 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 33 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 191 to 196 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 407 to 414 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1041 to 1048 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 422 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 426 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 532 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 580 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 607 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 827 to 836 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 903 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 911 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 928 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 121 forms a bond with bergaptol, indicating a strong binding affinity.
The residue at position 174 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 198 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 221 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 255 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 259 forms a bond with bergaptol, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 107 to 137 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 146 to 181 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 201 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 349 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 384 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 421 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 560 to 561 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 236 to 241 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 255 to 261 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 260 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 464 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 505 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 223 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 235 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 359 to 362 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 to 36 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 221 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 112 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 215 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 401 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 472 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 487 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 212 to 220 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 to 135 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 141 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 360 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 204 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1 to 25 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 304 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 305 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 560 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 684 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 703 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 706 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 768 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 771 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 800 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 800 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 908 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 to 24 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 618 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 330 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 335 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 222 to 233 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 72 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 85 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 88 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 98 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 118 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 125 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 171 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 173 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 173 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 273 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 172 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 61 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 235 to 240 forms a bond with strychnine, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 234 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 249 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 15 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 15 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 56 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 357 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 385 to 388 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 408 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 465 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 84 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 95 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 134 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 240 to 245 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 259 to 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 473 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 76 to 81 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 320 to 321 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 320 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 346 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 6 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 to 155 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 167 to 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 100 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 535 to 543 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 556 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1131 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1261 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1264 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 17 to 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mg of bacteriochlorophyll a 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mg of bacteriochlorophyll a 6, indicating a strong binding affinity.
The residue at position 23 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 195 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 14 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 278 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 319 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 354 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 259 to 265 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 23 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 24 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 554 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 557 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 562 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 206 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 212 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 232 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 237 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 240 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 245 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 250 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 277 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 280 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 295 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 297 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 302 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 305 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 313 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 323 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 173 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 251 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 110 to 115 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 203 to 212 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 327 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 487 to 490 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 505 to 507 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 521 to 524 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 568 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 629 to 630 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 635 to 639 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 671 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 709 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 285 to 299 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 204 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 360 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 808 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 882 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 7 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 56 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 167 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 186 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 190 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 326 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 368 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 50 to 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 261 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 822 to 830 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 845 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 575 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 677 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 685 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 693 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 694 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 152 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 187 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 220 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 246 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 270 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 273 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 325 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 85 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 148 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 181 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 242 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 245 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 317 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 319 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 322 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 44 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 44 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 628 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 to 247 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 250 to 371 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 330 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 363 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 395 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 258 to 261 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 399 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 388 to 395 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 434 to 438 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 488 to 491 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1029 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1029 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 427 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 163 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 285 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 428 to 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 500 to 502 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 183 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 225 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 397 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1780 to 1783 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1803 to 1806 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1831 to 1832 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1904 to 1905 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 304 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 134 to 141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 236 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 236 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 239 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 242 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 242 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 248 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 248 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 316 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 281 to 284 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1516 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1548 to 1554 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1592 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 325 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 336 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 44 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 132 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 222 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 145 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 319 to 321 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 to 137 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 115 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 459 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 493 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 502 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 212 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 221 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 329 to 333 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 58 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 161 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 355 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 427 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 477 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 484 to 485 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 493 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 330 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 734 to 738 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 737 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 782 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 838 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 945 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1138 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1192 to 1193 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 192 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 731 to 739 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 754 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 357 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 520 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 163 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 232 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 348 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 365 to 367 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 174 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 305 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 209 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 218 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 154 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with beta-L-fucose 6, indicating a strong binding affinity.
The residue at position 111 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 201 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with beta-L-fucose 4, indicating a strong binding affinity.
The residue at position 283 forms a bond with beta-L-fucose 5, indicating a strong binding affinity.
The residue at position 333 forms a bond with beta-L-fucose 6, indicating a strong binding affinity.
The residue at position 347 forms a bond with beta-L-fucose 6, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 7 to 9 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 to 38 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 to 151 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 122 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 126 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 154 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 808 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 454 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 531 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 100 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 122 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 78 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 500 to 502 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 507 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 676 to 677 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 727 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 22 to 26 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 432 to 433 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 80 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 109 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 80 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 137 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 205 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 216 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 603 to 610 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 221 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 213 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 258 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 308 to 312 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 400 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 468 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 327 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 43 forms a bond with O2, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 47 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 404 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 521 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 218 to 224 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 19 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 148 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 11 to 15 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 39 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 147 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 335 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 206 to 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 49 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 91 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 157 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 191 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 192 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 197 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 207 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 357 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 43 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 164 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 315 to 319 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 341 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 308 to 319 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 395 to 400 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 453 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 455 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 462 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 464 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 607 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 608 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 618 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 253 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 276 to 281 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 398 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 429 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 58 to 66 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 181 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 184 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 186 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 209 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 220 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 223 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 133 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 131 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 234 to 239 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 234 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 238 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 253 to 259 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 258 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 278 to 281 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 443 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 395 to 403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 905 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 916 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 39 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 170 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 173 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 188 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 432 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 441 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 701 to 709 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 723 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 459 to 466 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 289 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 308 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 881 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 234 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 147 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 169 to 173 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 358 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 90 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 113 to 121 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 145 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 421 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 424 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 294 to 303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 451 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 290 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 490 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 592 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 144 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 276 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 328 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 329 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 346 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 350 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 351 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 354 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 369 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 201 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 202 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 258 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 253 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 277 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 300 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 329 to 345 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 441 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 100 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 130 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 266 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 179 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 195 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 211 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 216 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 213 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 275 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 283 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 321 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 356 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 388 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 470 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 527 to 531 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 565 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 572 to 574 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 628 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 654 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 660 to 663 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 734 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 391 to 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 393 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 424 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 519 to 522 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 179 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 250 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 276 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 305 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 6 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 461 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 502 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 547 to 550 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 65 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 96 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1049 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1067 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1070 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1079 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1082 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1087 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1094 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1098 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1104 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1117 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1120 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 145 to 149 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 26 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 73 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 74 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 75 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 163 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 164 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 198 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 199 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 222 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 225 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 253 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 284 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 408 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 73 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 67 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 525 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 391 to 398 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 491 to 494 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 444 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 to 283 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 26 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 119 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 342 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 383 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 265 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 266 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 347 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 425 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 427 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 500 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 493 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 76 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 213 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 281 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 240 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 146 to 153 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 370 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 141 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 298 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 335 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 362 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 453 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 478 to 481 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 562 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 27 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 117 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 208 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 310 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 286 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 327 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 473 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 377 to 384 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 423 to 427 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 477 to 480 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 160 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 229 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 22 to 27 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 502 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 566 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 567 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 990 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1050 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 16 to 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 389 to 391 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 to 418 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 527 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 530 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 541 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 546 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 126 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 237 to 242 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 237 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 256 to 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 310 to 314 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 336 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 352 to 359 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 398 to 402 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 452 to 455 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 507 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 193 to 199 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 446 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 501 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 341 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 356 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 377 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 377 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 296 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 144 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 158 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 173 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 366 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 409 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 219 to 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 16 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 179 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 250 to 255 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 136 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 248 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 313 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 20 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 77 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 117 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 223 to 228 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 242 to 248 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 267 to 270 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 428 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 51 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 187 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 216 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 264 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 269 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 563 to 570 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 498 to 503 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 306 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 406 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 496 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 203 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 66 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 10 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 44 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 207 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 263 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 348 to 351 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 31 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 392 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 20 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 138 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 141 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 142 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 398 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 497 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 498 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 500 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 315 to 319 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 378 to 381 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 428 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 505 to 516 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 349 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 187 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 230 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 233 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 430 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 450 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 461 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 461 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 555 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 555 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 569 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 569 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 293 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 118 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 73 to 77 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 79 to 87 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 432 to 440 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 132 to 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 372 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 210 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 215 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 184 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 194 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 199 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 241 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 251 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 222 to 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 353 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 426 to 430 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 426 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 117 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 9 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 68 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 73 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 416 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 440 to 441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 705 to 712 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1346 to 1353 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 207 to 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 287 to 290 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 291 to 292 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 409 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 411 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 413 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 443 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 447 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 487 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 489 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 491 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 362 to 365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 378 to 380 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 475 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 46 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 346 to 353 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 28 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 283 to 288 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 129 forms a bond with a tetrapyrrole 1, indicating a strong binding affinity.
The residue at position 1022 forms a bond with a tetrapyrrole 2, indicating a strong binding affinity.
The residue at position 334 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 to 207 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 284 to 289 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 416 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 504 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 86 to 114 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 to 108 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 93 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 185 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 304 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 513 to 517 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 722 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 853 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 365 to 371 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 135 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 167 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 260 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 281 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 297 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 366 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 901 to 908 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 492 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with beta-D-galactofuranose, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with beta-D-galactofuranose, indicating a strong binding affinity.
The residue at position 167 forms a bond with beta-D-galactofuranose, indicating a strong binding affinity.
The residue at position 220 forms a bond with beta-D-galactofuranose, indicating a strong binding affinity.
The residue at position 248 forms a bond with beta-D-galactofuranose, indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 111 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 151 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 18 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 18 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 59 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 229 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 229 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 363 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 391 to 394 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 414 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 105 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 244 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 246 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 251 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 285 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 287 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 289 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 296 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 321 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 323 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 325 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 327 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 332 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 477 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 45 to 53 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 422 to 430 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 340 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 346 to 347 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 405 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 433 to 434 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 449 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 458 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 300 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 350 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 356 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 188 to 194 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 354 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 374 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 374 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 415 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 561 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 141 to 147 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 45 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 54 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 150 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 149 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 362 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 342 to 349 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 737 to 856 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 894 to 1014 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 233 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 137 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 to 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 to 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 503 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 to 191 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 314 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 359 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 157 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 489 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 576 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 630 to 632 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 849 to 852 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 428 to 429 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1 to 5 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 145 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 235 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 248 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 254 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 317 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 138 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 109 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 111 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 54 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 372 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 462 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 206 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 103 forms a bond with folate, indicating a strong binding affinity.
The residue at position 107 forms a bond with folate, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with folate, indicating a strong binding affinity.
The residue at position 157 to 162 forms a bond with folate, indicating a strong binding affinity.
The residue at position 196 forms a bond with folate, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 305 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 67 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 114 to 120 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 114 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 351 to 352 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 23 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 115 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 21 to 29 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 6 to 7 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 151 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 209 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 215 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 237 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 243 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 649 to 656 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1276 to 1283 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 15 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 119 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 31 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 112 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 155 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 187 to 194 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 233 to 237 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 146 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 164 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 337 to 344 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 300 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 41 to 49 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 27 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 73 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 147 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 180 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 210 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 292 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 293 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 372 to 374 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 177 to 180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 58 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 224 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 280 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 144 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 322 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 326 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 350 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 1078 to 1085 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 212 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 352 to 353 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 to 111 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 165 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 171 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 181 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 631 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 633 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 648 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 703 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 576 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 601 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 6 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 116 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 120 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 174 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 242 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 332 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 333 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 358 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 384 to 385 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 404 to 407 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 408 to 412 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 45 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 109 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 111 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 551 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 595 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 884 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 110 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 113 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 118 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 122 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 142 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 191 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 198 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 6 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 19 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 21 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 72 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 75 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 79 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 80 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 182 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 492 to 495 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 515 to 517 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 548 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 147 to 151 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 169 to 175 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 228 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 236 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 353 to 357 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 22 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 24 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 137 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 170 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 199 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 139 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 52 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 74 to 81 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 221 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 63 to 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 163 to 171 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 514 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 365 to 372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 123 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 123 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 133 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 146 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 146 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 147 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 352 to 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 219 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 273 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 93 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 176 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 177 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 189 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 266 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 272 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 294 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 300 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 150 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1594 to 1601 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 to 32 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 195 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 44 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 128 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 446 to 453 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 496 to 500 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 550 to 553 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 502 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 31 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 112 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 792 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 75 to 82 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 89 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 96 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 98 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 99 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 897 to 904 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 20 to 24 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 338 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 340 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 364 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 385 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 454 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 562 to 566 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 652 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 598 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 120 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 86 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 149 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 223 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 234 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 72 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 to 236 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 318 to 326 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 196 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 280 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 616 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 75 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 418 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 93 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 441 to 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 208 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 291 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 374 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 281 to 284 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 172 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 381 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 279 to 293 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 438 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 81 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1159 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1189 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1192 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 287 to 291 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 352 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 179 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 188 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 1 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 178 to 183 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 315 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 352 to 355 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 283 to 295 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 81 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 153 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 to 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 33 to 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 325 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 329 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 332 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 478 to 480 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 282 forms a bond with a protein, indicating a strong binding affinity.
The residue at position 339 forms a bond with a protein, indicating a strong binding affinity.
The residue at position 624 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 626 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 572 to 579 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 forms a bond with heme, indicating a strong binding affinity.
The residue at position 236 forms a bond with heme, indicating a strong binding affinity.
The residue at position 270 forms a bond with heme, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 306 forms a bond with heme, indicating a strong binding affinity.
The residue at position 210 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 110 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 204 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 279 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 453 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 80 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 141 to 148 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 253 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 372 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 658 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 258 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 324 to 331 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 77 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 605 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 607 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 609 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 611 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 616 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 60 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 394 to 401 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 440 to 444 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 494 to 497 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 to 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 483 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 486 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 545 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 546 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 547 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 551 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 556 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 73 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 262 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 166 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 194 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 254 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 275 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 291 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 360 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 879 to 886 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 678 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 690 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 13 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 669 to 676 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 to 297 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 340 to 341 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 374 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 393 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 525 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 525 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 529 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 564 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 564 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 674 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 726 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 726 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 393 to 395 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 417 to 422 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 533 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 218 to 225 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 278 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 413 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 124 to 137 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 160 to 169 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 194 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 724 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 728 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 154 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 265 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 267 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 358 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 264 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 441 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 444 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 486 to 493 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 437 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 264 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 271 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 304 to 305 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 419 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 453 to 455 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 455 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 468 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 280 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 41 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 179 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 378 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 382 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 395 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 317 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 567 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 611 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 912 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 549 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 552 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 151 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 739 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 741 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 743 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1112 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1194 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1201 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 664 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 667 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 678 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 681 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 727 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 730 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 741 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 744 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 795 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 798 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 809 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 812 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 852 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 855 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 866 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 869 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 206 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 210 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 133 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 162 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 471 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 489 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 492 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 166 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 176 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 209 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 211 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 213 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 220 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 241 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 243 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 245 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 285 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 230 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 251 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 639 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 257 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 176 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 649 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 713 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 738 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 742 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 195 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 291 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 168 to 172 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 250 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 350 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 380 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 401 to 402 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 99 to 107 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 188 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 to 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 23 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 480 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 116 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 443 to 450 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 180 to 183 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 13 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 327 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 385 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 385 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 459 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 519 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 521 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 141 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 177 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 205 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 258 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 303 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 576 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 374 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 672 to 679 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1014 to 1021 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 498 to 504 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 700 to 758 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 326 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 328 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 330 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 331 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 266 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 269 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 222 forms a bond with heme, indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 468 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 470 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 500 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 502 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 504 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 511 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 536 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 538 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 540 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 542 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 547 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 570 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 572 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 574 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 576 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 225 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 to 340 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 461 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 217 to 225 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 to 331 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 397 to 402 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 132 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 137 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 274 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 243 to 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 444 to 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 450 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 310 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 76 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 197 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 286 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with N-acetyl-L-glutamine, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with N-acetyl-L-glutamine, indicating a strong binding affinity.
The residue at position 269 forms a bond with N-acetyl-L-glutamine, indicating a strong binding affinity.
The residue at position 299 forms a bond with N-acetyl-L-glutamine, indicating a strong binding affinity.
The residue at position 14 to 18 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 286 to 289 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 398 to 405 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 444 to 448 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 107 to 111 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 136 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 234 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 285 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 991 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 263 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 285 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 313 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 314 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 343 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 119 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 188 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 192 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 475 to 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 682 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 813 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 190 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 196 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 304 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 387 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 526 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 249 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 53 to 77 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 255 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 384 to 388 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 49 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 79 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 262 to 285 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 309 to 328 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 341 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 348 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 350 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 355 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 357 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 363 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 364 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 365 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 366 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 368 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 368 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 372 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 373 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 382 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 383 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 395 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 402 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 77 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 428 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 466 to 467 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 495 to 496 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 530 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 12 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 15 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 20 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 532 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 601 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 703 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 724 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 725 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 726 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 727 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 499 to 507 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 40 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 15 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 30 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 46 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 48 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 58 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 58 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 64 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 66 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 199 to 206 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 299 to 302 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 649 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 649 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 653 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 653 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 824 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 311 to 315 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 329 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 367 to 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 36 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 124 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 210 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 254 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 64 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 172 to 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 530 to 538 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 552 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 310 to 317 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 356 to 360 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 217 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 230 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 243 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 94 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 177 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 93 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 206 to 210 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 100 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 165 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 59 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 344 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 350 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 380 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 452 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 480 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 483 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 516 to 524 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 490 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 215 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 540 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 214 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 387 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 36 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 31 to 34 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 159 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 162 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 250 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 254 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 299 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 300 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 385 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 387 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 36 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with heme, indicating a strong binding affinity.
The residue at position 614 to 621 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1260 to 1267 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 19 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 163 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 189 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 250 to 254 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 92 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 234 to 239 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 259 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 137 to 144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 to 284 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 349 to 350 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 154 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 120 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 188 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 199 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 to 211 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 78 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 217 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 270 to 291 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 313 to 332 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 62 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 166 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 305 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 308 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 133 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 186 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 to 246 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 48 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 51 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 88 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 98 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 143 to 148 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 213 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 131 to 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 440 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 442 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 473 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 475 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 509 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 511 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 513 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 520 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 547 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 549 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 551 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 558 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 388 to 391 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 578 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 583 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 56 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 114 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 157 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 161 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 171 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 11 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 131 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 221 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 252 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 24 to 31 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 38 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 116 to 124 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 135 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 286 to 289 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 517 to 519 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 27 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 89 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 128 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 462 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 228 to 235 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 1983 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1987 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1987 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2007 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2009 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2010 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2016 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2016 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2017 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2017 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2030 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2031 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 83 to 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 519 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 521 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 114 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 134 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 141 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 371 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 157 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 73 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 280 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 284 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 329 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 330 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 415 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 417 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 565 to 572 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 408 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 415 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 469 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 483 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 467 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 86 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 512 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 514 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 21 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 20 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with a 1-acyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 38 forms a bond with a 1-acyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 55 to 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 264 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 5 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 24 to 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 268 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 2072 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2075 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2094 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2097 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2128 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2131 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2143 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2145 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 42 to 46 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 404 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 583 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 122 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 724 to 732 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 762 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 365 to 368 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 372 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 375 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 285 to 292 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 362 to 366 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 424 to 427 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 364 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 163 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 279 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 300 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 165 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 564 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 566 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 112 to 119 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 138 to 146 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 538 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 539 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 562 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 643 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 644 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 666 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 32 to 52 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 441 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 36 to 42 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 154 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 168 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 246 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 261 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 321 to 327 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 327 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 436 to 438 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 8 to 33 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 151 to 166 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 267 to 277 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 419 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 104 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 109 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 147 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 292 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 361 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 80 to 88 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 390 to 395 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 573 to 575 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 669 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 676 to 678 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 737 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 8 to 15 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 85 to 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 362 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 369 to 370 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 319 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 514 to 522 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 212 to 218 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 335 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 441 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 442 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 527 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 5 to 9 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 196 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 511 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 513 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 515 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 517 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 522 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 556 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 558 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 560 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 562 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 567 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 111 to 124 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 820 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 54 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 206 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 249 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 251 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 868 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 870 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 977 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1036 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 215 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 64 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 81 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 88 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 91 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 9 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 12 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 15 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 19 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 217 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 300 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 302 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 68 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 443 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 449 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 492 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 173 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 347 to 463 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 220 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 300 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 305 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 385 to 389 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 415 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 469 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 470 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 472 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 493 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 530 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 579 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 324 to 327 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 415 to 416 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 217 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 254 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 254 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 109 to 114 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 154 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 168 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 355 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 384 to 386 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 488 to 489 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 569 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 592 to 593 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 109 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 112 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 116 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 146 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 155 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 165 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 177 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 to 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 419 to 421 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 431 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 31 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 58 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 69 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 144 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 170 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 218 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 222 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 283 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 322 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 65 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 82 to 93 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 295 to 306 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 384 to 391 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 51 to 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 360 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 540 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 544 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 662 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 12 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 31 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 196 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 235 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 304 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 333 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 398 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 400 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 405 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 19 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 209 to 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 114 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 72 to 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 853 to 861 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 481 to 488 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 527 to 531 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 581 to 584 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 107 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 363 to 366 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 1629 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1636 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1639 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1645 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 253 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 383 to 386 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 326 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 807 to 814 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 808 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 812 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 381 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 115 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 142 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 151 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 197 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 270 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 276 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 330 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 332 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 11 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 264 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 375 to 382 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 419 to 422 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 210 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 357 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 336 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 341 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 277 to 287 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 128 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 214 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 244 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 267 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 134 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 134 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 402 to 409 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 448 to 452 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 502 to 505 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 302 to 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 192 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 384 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 447 to 454 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1197 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1224 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 836 to 844 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 864 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 786 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1108 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1114 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 70 to 84 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 304 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 28 to 29 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 286 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 261 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 313 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 333 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 365 to 366 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 113 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 79 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 123 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 488 to 496 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 241 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 293 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 462 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 464 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 533 to 540 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 582 to 586 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 636 to 639 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 6 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 10 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 57 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 59 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 336 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 340 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 340 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 483 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 487 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 491 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 117 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 46 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 60 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 123 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 37 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 75 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 303 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 18 to 27 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 to 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 5 to 17 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 525 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 to 300 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 364 to 367 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 542 to 546 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 734 to 739 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 749 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 191 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 75 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 138 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 257 forms a bond with [8Fe-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 423 forms a bond with [8Fe-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 417 to 419 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 342 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 346 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 355 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 127 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 141 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 232 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 324 to 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 328 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 330 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 356 to 358 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 441 to 443 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 309 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 535 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 91 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 132 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 134 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 210 to 330 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 473 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 476 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 478 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 569 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 570 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 571 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 575 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 580 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 53 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 274 to 277 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 516 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 125 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 211 to 216 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 275 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 3 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 93 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 to 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 262 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 337 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 467 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 469 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 517 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 522 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 182 to 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 374 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 116 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 641 to 648 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 to 18 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 50 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 247 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 261 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 290 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 490 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 570 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 29 to 35 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 64 to 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 207 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 217 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 139 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 281 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 282 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 10 to 17 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 471 to 478 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 745 to 752 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 211 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 356 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 356 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 359 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 363 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 404 to 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 21 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 230 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 230 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 360 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 388 to 391 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 411 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 479 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 14 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 776 to 784 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 799 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 83 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 204 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 to 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 to 110 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 31 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 109 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 180 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 194 to 201 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 221 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 31 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 159 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 195 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 392 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 416 to 419 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 467 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 471 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 82 to 92 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 563 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 607 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 to 17 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 9 to 12 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 156 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 275 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 162 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 382 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 384 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 386 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 471 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 179 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 235 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 235 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 6 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 315 to 321 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 319 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 134 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 351 to 372 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 403 to 422 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 575 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 95 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 100 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 104 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 125 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 128 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 131 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 135 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 172 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 174 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 203 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 99 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 132 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 132 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 163 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 188 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 243 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 542 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 543 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 544 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 548 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 553 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 67 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 72 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 197 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 208 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 265 to 268 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 189 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 273 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 249 to 254 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 32 to 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 248 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 272 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 316 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 403 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 431 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 456 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 490 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 105 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 168 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 168 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 201 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 268 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 340 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 342 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 344 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 345 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 160 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 164 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 211 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 217 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 179 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 194 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 256 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 258 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 347 to 354 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 393 to 397 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 447 to 450 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 227 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 55 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 182 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 191 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 425 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 430 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 431 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 439 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 259 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 262 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 311 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 719 to 776 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 843 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 855 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 855 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 22 to 28 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 231 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 306 to 312 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 310 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 312 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 424 to 426 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 379 to 386 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 425 to 429 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 479 to 482 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 320 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 324 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 328 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 375 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 466 to 473 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 706 to 713 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 93 to 97 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 141 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 148 to 152 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 480 to 487 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 526 to 530 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 580 to 583 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 97 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 440 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 26 to 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 420 to 424 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 604 to 608 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 354 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 93 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 509 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 29 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 110 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 153 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 156 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 1794 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1797 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1811 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1814 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1819 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1822 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1840 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1843 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 63 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 116 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 513 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 272 to 276 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 343 to 346 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 353 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 532 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 532 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 669 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 672 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 672 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 676 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 680 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 63 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 131 to 137 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 161 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 64 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 90 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 156 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 282 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 75 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 113 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 27 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 57 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 295 to 302 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 467 to 470 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 50 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 41 to 48 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 394 to 401 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 437 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 440 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 443 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 447 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 483 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 490 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 526 to 531 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 643 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 691 to 692 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 59 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 32 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 375 to 379 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 520 to 524 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 19 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 364 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 365 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 384 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 385 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 386 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 to 259 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 38 to 45 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 354 to 361 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 164 to 168 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 38 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 166 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 125 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 396 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 431 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 462 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 464 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 465 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 526 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 594 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 159 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 474 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 530 to 534 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 575 to 577 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 632 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 658 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 664 to 667 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 251 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 37 to 44 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 213 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 239 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 406 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 878 to 885 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 631 to 639 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 303 to 304 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 445 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 305 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 308 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 338 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 13 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 61 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 123 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 499 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 499 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 530 to 531 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 576 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 614 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 614 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 620 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 658 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 680 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 741 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 52 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 268 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 288 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 268 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 446 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 375 to 382 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 250 to 254 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 315 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 350 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 219 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 132 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 244 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 150 to 157 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 135 to 140 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 385 to 392 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 306 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 336 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 340 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 363 to 370 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 389 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 392 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 527 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 542 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 248 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 362 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 434 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 to 246 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 258 to 265 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 136 to 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 157 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 699 to 756 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 to 202 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 75 to 82 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 104 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 113 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 178 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 204 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 344 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 136 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 164 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 167 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 124 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 10 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 to 22 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 31 to 36 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 to 124 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 278 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 360 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 566 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 to 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 320 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 492 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 494 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 348 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 259 to 264 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 374 to 376 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 407 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 443 to 447 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 511 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 545 to 546 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 582 to 584 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 624 to 625 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 629 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 210 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 430 to 437 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 469 to 473 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 523 to 526 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 450 to 458 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 473 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 584 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 482 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 562 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 562 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 564 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 219 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 247 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 379 to 380 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 460 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 482 to 483 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 754 to 762 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 775 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 60 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 107 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 217 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 277 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 432 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 438 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 438 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 445 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 447 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 473 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 473 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 477 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 483 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 504 to 506 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 540 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 542 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 592 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 595 to 596 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 598 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 657 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 659 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 664 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 196 to 203 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with D-galactose 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with D-galactose 1, indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with D-galactose 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with D-galactose 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with D-galactose 2, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with D-galactose 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with D-galactose 3, indicating a strong binding affinity.
The residue at position 111 forms a bond with D-galactose 3, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with D-galactose 3, indicating a strong binding affinity.
The residue at position 33 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 621 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 to 340 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 252 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 304 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 517 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 255 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 1 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 140 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1294 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1391 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1394 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1451 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1478 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1519 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1521 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 305 to 313 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 323 to 331 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 636 to 644 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 203 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 287 to 294 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 336 to 339 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 109 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 242 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 65 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 296 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 296 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 428 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 256 to 261 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 to 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 189 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 220 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 274 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 18 to 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 to 120 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 to 221 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 326 to 329 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 18 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 242 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 347 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 356 to 359 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 415 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 459 to 467 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 436 to 559 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 507 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 114 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 744 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 414 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 425 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 425 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 523 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 537 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 537 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 213 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 442 to 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 978 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 980 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1087 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1139 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 146 to 151 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 207 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 235 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 463 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 504 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 549 to 552 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 to 302 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 91 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 110 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 226 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 279 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 214 to 220 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 272 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 45 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 233 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 332 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 158 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 182 to 186 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 70 to 78 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 to 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 to 46 forms a bond with phosphatidylinositol bisphosphate, indicating a strong binding affinity.
The residue at position 99 to 105 forms a bond with phosphatidylinositol bisphosphate, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with phosphatidylinositol bisphosphate, indicating a strong binding affinity.
The residue at position 824 to 832 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 851 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 544 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 115 to 121 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 266 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 125 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 182 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 208 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 210 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 353 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 457 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 188 to 191 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 191 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 199 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 285 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 135 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 228 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 189 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 246 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 441 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 467 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 188 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 280 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 258 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 449 to 457 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 214 to 219 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 307 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 33 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 37 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 391 to 394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 29 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 156 to 160 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 341 to 345 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 400 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 54 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 76 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 77 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 92 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 36 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 67 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 91 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 111 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 146 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 179 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 186 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 23 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 23 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 160 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 40 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 186 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 231 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 201 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 449 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 23 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 10 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 206 to 229 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 70 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 170 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 170 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 602 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 604 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 606 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 172 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 55 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 122 to 128 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 61 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 385 to 387 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 549 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 549 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 551 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 213 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 262 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 270 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 10 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 3 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 18 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 150 to 164 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 690 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 694 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 131 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 272 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 226 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 469 to 470 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 598 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 642 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 925 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 942 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 945 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 215 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 185 to 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 578 to 585 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 257 to 260 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 280 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 699 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 702 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 727 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 731 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 731 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 47 to 54 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 411 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 414 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 416 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 472 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 474 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 297 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 14 to 18 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 17 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 358 to 360 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 375 to 383 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 635 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 662 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 259 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 376 to 383 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 422 to 426 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 481 to 484 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 418 to 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 122 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 810 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 842 to 848 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 886 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 59 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 199 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 235 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 367 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 432 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 471 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 475 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 462 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 463 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 481 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 483 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 485 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 487 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 492 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 96 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 410 to 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 594 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 597 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 600 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 606 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 625 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 628 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 631 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 635 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 254 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with (2S)-3-sulfopropanediol, indicating a strong binding affinity.
The residue at position 187 forms a bond with (2S)-3-sulfopropanediol, indicating a strong binding affinity.
The residue at position 462 forms a bond with (2S)-3-sulfopropanediol, indicating a strong binding affinity.
The residue at position 464 forms a bond with (2S)-3-sulfopropanediol, indicating a strong binding affinity.
The residue at position 672 forms a bond with (2S)-3-sulfopropanediol, indicating a strong binding affinity.
The residue at position 7 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 13 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 38 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 42 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 412 to 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 215 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 524 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 940 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 48 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 98 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 126 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 171 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 46 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 394 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 414 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 412 to 415 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 685 to 688 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 769 to 771 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 840 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 350 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 406 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 410 to 417 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 439 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 441 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 452 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 360 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 459 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 233 to 236 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 407 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 511 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 514 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 528 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 533 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 116 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 175 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 181 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 204 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 210 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 625 to 632 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 to 187 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 21 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 to 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 276 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1 to 10 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 367 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 415 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 572 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 436 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 559 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 29 to 34 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 114 to 123 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 458 to 461 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 500 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 568 to 569 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 574 to 578 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 654 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 2 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 59 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 99 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 207 to 212 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 226 to 232 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 419 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 162 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 252 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 299 to 300 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 42 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 158 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 138 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 423 to 424 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 448 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 187 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 190 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 401 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 411 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 372 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 155 to 162 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 to 206 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 230 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 234 to 238 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 9 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 212 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 382 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 476 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 480 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 139 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 155 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 158 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 200 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 245 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 250 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 2 to 9 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 4 to 9 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 351 to 352 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 64 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 127 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 190 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 396 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 120 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 263 to 270 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 342 to 346 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 400 to 403 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 36 to 44 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 214 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 25 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 252 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 348 to 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 to 296 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 296 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 280 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 379 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 151 to 156 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 145 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 7 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 246 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 227 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 301 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 177 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 72 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with queuosine 5'-phosphate, indicating a strong binding affinity.
The residue at position 526 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 271 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 273 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 275 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 277 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 282 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 249 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 280 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 205 to 212 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 252 to 256 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 68 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 418 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 421 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 421 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 143 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 88 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 22 to 27 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 375 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 269 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 346 to 354 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 368 to 371 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 147 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 8 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 676 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 684 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 692 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 693 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 421 to 428 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 175 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 222 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 48 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 342 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 381 to 383 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 422 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 424 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 447 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 61 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 495 to 502 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 6 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 9 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 352 to 355 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 306 to 308 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 507 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 510 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 545 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 784 to 785 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 144 to 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1236 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1236 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1242 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1288 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1288 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1290 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1290 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1307 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 167 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 209 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 to 404 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 414 to 420 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 to 301 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 340 to 344 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 394 to 397 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 366 to 373 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 445 to 452 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1075 to 1082 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 to 317 forms a bond with heme, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 173 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 600 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 600 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 601 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 602 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 765 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 767 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 770 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 788 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 822 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 823 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 902 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 903 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 904 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1009 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1015 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1035 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1038 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1039 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1298 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 129 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 153 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 197 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 283 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 311 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 336 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 370 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 372 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 347 to 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 619 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 631 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 650 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 730 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 871 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 891 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 894 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 895 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 895 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 142 to 147 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 386 to 391 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 407 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 433 to 435 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 462 to 465 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 469 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 500 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 506 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 517 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 545 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 252 to 259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 328 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 442 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 510 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 520 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 372 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 415 to 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 352 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 361 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 382 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 142 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 to 301 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 456 to 585 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 574 to 701 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 127 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 176 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 271 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 380 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 431 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 492 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 581 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 616 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 616 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 618 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 620 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 620 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 624 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 627 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 222 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 82 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 135 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 241 to 246 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 260 to 266 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 262 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 265 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 482 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 8 to 15 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 121 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 271 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 280 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 314 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 414 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 416 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 687 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 688 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 798 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 804 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 825 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 828 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 829 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 829 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 95 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 120 to 128 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 152 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 75 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 170 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 239 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 240 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 77 to 84 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 311 to 316 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 135 to 143 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 167 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 219 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 377 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 400 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 402 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 516 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 519 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 532 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 537 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 631 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 634 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 647 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 652 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 767 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 770 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 783 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 788 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1031 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1052 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 526 to 534 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 548 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 457 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 163 to 170 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 188 to 192 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 82 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 427 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 25 to 30 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 34 to 39 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 133 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 265 to 271 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 136 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 163 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 167 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 188 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 697 to 704 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 566 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 589 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 699 to 702 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 716 to 720 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 721 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 728 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 733 to 735 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 786 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 640 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 356 to 359 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 366 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 169 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 715 to 772 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 839 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 851 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 851 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 853 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 207 to 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 348 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 348 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 109 to 114 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 143 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 26 to 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 forms a bond with beta-D-fructose, indicating a strong binding affinity.
The residue at position 41 forms a bond with beta-D-fructose, indicating a strong binding affinity.
The residue at position 42 forms a bond with beta-D-fructose, indicating a strong binding affinity.
The residue at position 45 forms a bond with beta-D-fructose, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with beta-D-fructose, indicating a strong binding affinity.
The residue at position 200 to 207 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 247 to 251 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 312 to 315 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 470 to 473 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 513 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 529 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 544 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 548 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 141 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 195 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 387 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 476 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 384 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 415 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 516 to 519 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 15 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 296 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1940 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1957 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2007 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2009 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 593 to 708 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 290 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 319 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 395 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 176 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 352 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 422 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 452 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 484 to 486 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 507 to 508 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 21 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 210 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 318 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 380 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 296 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 332 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 454 to 455 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 465 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 129 to 144 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 155 to 187 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 390 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 408 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 415 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 45 to 52 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 147 to 154 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 4 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 145 to 173 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 29 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 718 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 637 to 644 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 435 to 438 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 102 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 16 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 396 to 403 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 442 to 446 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 496 to 499 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 63 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 133 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 22 to 31 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 227 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 228 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 517 to 519 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 524 to 530 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 557 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 564 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 366 to 368 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 170 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 379 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 189 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 9 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 to 46 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 288 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 290 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 294 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 179 to 185 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 45 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 46 forms a bond with ethanolamine 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 265 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 406 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 9 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 51 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 62 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 146 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 172 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 208 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 212 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 221 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 870 to 877 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 542 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 584 to 587 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1 to 4 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 309 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 225 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 152 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 252 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 372 to 379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 390 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 513 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 517 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 44 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 31 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 15 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 17 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 473 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 122 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 155 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 to 338 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 121 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 129 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 184 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 218 to 223 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with GTP 3, indicating a strong binding affinity.
The residue at position 562 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 163 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 231 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 274 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 321 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 117 to 130 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 323 to 335 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 311 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 283 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 205 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 210 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 262 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 299 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 265 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 551 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 557 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 604 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 605 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 606 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 183 to 189 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 347 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 397 to 402 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 415 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 583 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 937 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 957 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 489 to 494 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 690 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 765 to 768 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 452 to 464 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 486 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 488 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 499 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 to 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 218 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 422 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 126 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 216 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 217 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 220 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 265 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 267 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 286 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 289 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 321 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 322 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 397 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 172 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 24 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 115 to 123 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 147 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 7 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 8 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 9 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 31 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 32 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 33 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 113 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 114 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 69 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 126 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 161 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 133 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 161 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 285 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2108 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2111 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2130 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2133 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2164 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2167 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2179 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2181 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 56 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 56 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 518 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 518 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 194 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 4 to 8 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 564 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 592 to 599 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 667 to 673 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 792 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 793 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 806 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 381 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 381 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 385 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 385 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 525 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 533 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 77 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 187 to 194 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 883 to 890 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 627 to 635 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 653 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 228 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 244 to 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 445 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 451 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 122 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 162 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 164 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 166 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 168 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 212 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 258 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 260 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 265 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 94 to 102 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 98 to 102 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 98 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 98 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 141 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 141 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 236 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 368 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 543 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 587 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 869 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 872 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 314 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 387 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 472 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 148 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 359 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 385 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 388 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 394 to 395 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 431 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 160 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 161 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 212 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 216 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 219 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 250 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 252 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 263 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 330 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 331 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 338 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 416 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 846 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1172 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1175 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1191 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1194 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 511 to 513 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 280 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 303 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 332 to 348 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 444 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 47 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 80 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 149 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 78 to 83 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 414 to 416 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 420 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 529 to 530 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 535 to 539 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 571 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 609 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 646 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 646 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 648 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 662 to 669 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 652 to 659 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 505 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 to 479 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 518 to 522 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 572 to 575 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 293 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 420 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 463 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 539 to 542 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 599 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 603 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 606 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 606 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1004 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 296 to 303 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 373 to 377 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 435 to 438 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 143 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 310 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 368 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 419 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 476 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1264 to 1271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 292 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 333 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 21 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 21 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 386 to 394 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 253 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 323 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 329 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 385 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 105 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 161 to 169 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 365 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 396 to 400 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 450 to 453 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 745 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 482 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 508 to 510 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 525 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 390 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 394 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 18 forms a bond with Fe of heme b b595, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe of heme b b558, indicating a strong binding affinity.
The residue at position 334 forms a bond with Fe of heme b b558, indicating a strong binding affinity.
The residue at position 1032 to 1039 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 441 to 448 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 487 to 491 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 541 to 544 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 168 to 172 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 766 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 770 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 777 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 802 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 804 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 808 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 166 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 210 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 352 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 355 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 355 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 400 to 403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 396 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 57 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 374 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 378 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 526 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 310 to 319 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 329 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 281 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 216 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 218 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 392 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 414 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 432 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 549 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 53 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 242 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 429 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 309 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 472 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 38 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 189 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 117 forms a bond with heme, indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 384 to 387 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 473 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 529 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 537 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 592 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 596 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 600 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 12 to 16 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 48 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 193 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 108 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 forms a bond with [7Fe-V-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 423 forms a bond with [7Fe-V-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 237 to 243 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 8 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 631 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 246 to 251 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 358 to 365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 415 to 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 325 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 425 to 430 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 425 to 430 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 516 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 531 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 539 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 542 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 612 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 355 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 556 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 236 to 240 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 135 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 131 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 100 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 204 to 208 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 256 to 259 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with bergaptol, indicating a strong binding affinity.
The residue at position 179 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 203 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 226 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 246 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 260 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 264 forms a bond with bergaptol, indicating a strong binding affinity.
The residue at position 381 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 238 to 242 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 414 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 417 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 446 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 453 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 457 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 462 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 463 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 540 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 541 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 580 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 587 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 597 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 607 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 310 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 24 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 399 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 164 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 27 to 28 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 589 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 172 to 178 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 227 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 237 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 605 to 609 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 703 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 824 to 828 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 496 to 503 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 484 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 529 to 532 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 276 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 484 to 485 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 to 49 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 76 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 189 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 494 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 496 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 498 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 503 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 259 to 264 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 33 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 83 to 88 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 218 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 231 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 242 to 248 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 274 to 279 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 90 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 129 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 106 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 148 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 472 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 603 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 605 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 608 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 850 to 858 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 15 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 347 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 848 to 855 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 73 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 75 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 103 to 111 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 165 to 171 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 281 to 293 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 162 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 62 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 47 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 30 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 130 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 204 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 33 to 39 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 450 to 457 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 192 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 225 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 169 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 314 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 31 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 199 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 255 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 143 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 47 to 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 169 to 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 393 to 397 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 393 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 397 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 294 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 117 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 118 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 130 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 182 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 188 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 212 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 218 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 241 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 61 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 66 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 122 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 190 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 176 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 543 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 258 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 287 to 303 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 400 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 203 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 239 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 443 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 476 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 528 to 531 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 449 to 454 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 552 to 555 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 585 to 586 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 188 forms a bond with 5-methoxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 728 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 768 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 779 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 807 to 810 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 815 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 897 to 898 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 898 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 329 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 185 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 226 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 314 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 320 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 422 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 453 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 263 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 275 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 138 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 349 to 357 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 3 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 16 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 117 to 123 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 261 to 267 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1340 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1344 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 312 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 376 to 379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 84 to 108 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 419 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 484 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 484 to 491 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 530 to 534 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 584 to 587 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 82 to 88 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 113 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 159 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 146 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 148 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 216 to 220 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 265 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 362 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 367 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 378 to 380 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 514 to 521 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1333 to 1340 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 283 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 114 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 490 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 490 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 567 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 605 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 605 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 611 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 512 to 519 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 90 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 1035 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 263 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 292 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 295 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 276 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 180 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 84 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 147 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 180 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 248 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 320 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 324 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 325 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 347 to 354 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 216 to 222 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 246 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 323 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 57 to 60 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 65 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 89 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 16 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 201 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 260 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 455 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 458 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 503 to 506 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 155 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 30 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 35 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 35 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 43 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 43 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 95 to 101 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 128 to 137 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 227 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 230 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 276 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 278 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 297 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 300 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 328 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 331 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 332 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 407 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 193 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 216 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 236 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 237 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 249 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 250 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 65 to 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 277 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 352 to 357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 432 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 246 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 269 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 286 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 366 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 465 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 142 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with heme, indicating a strong binding affinity.
The residue at position 457 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 106 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 239 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 336 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 to 377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 448 to 452 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 483 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 57 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 97 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 134 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 152 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 155 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 158 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 169 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 198 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 220 forms a bond with tRNA anticodon stem loop of tRNA, indicating a strong binding affinity.
The residue at position 222 forms a bond with tRNA anticodon stem loop of tRNA, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 247 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with tRNA anticodon stem loop of tRNA, indicating a strong binding affinity.
The residue at position 281 forms a bond with tRNA anticodon stem loop of tRNA, indicating a strong binding affinity.
The residue at position 295 forms a bond with tRNA anticodon stem loop of tRNA, indicating a strong binding affinity.
The residue at position 297 forms a bond with tRNA anticodon stem loop of tRNA, indicating a strong binding affinity.
The residue at position 298 forms a bond with tRNA anticodon stem loop of tRNA, indicating a strong binding affinity.
The residue at position 624 to 631 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 82 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 110 to 118 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 122 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 407 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 148 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 166 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 166 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 174 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 177 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 273 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 304 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 304 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 310 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 364 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 366 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 372 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 490 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 214 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 275 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 367 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 456 to 463 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 110 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 236 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 238 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 192 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 476 to 480 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 530 to 533 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 331 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 335 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 43 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 140 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 328 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 391 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 446 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 462 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 415 to 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 285 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 324 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 342 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 494 to 495 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 497 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 550 to 553 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 206 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 174 to 183 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 387 to 391 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1308 to 1315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 to 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 forms a bond with heme, indicating a strong binding affinity.
The residue at position 285 forms a bond with heme, indicating a strong binding affinity.
The residue at position 353 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 39 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 244 to 249 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 to 269 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 463 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 121 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 to 303 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 456 to 586 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 575 to 702 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 380 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 116 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 142 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 216 to 222 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 15 to 21 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 41 to 44 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 344 to 351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 74 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 209 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 207 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 464 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 121 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 525 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 535 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 143 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 713 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 741 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 946 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 228 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 210 to 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 567 to 574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 177 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 210 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 231 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 261 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 275 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 54 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 270 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 225 to 228 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 282 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 283 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 241 to 295 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 172 to 178 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 337 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 339 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 483 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 613 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 202 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 33 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 82 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 116 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 162 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 61 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 291 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 351 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 528 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 553 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 87 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 150 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 150 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 183 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 250 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 322 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 326 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 327 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 386 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 390 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 435 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 75 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 88 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 241 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 to 53 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 348 to 471 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 558 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 920 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 732 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 185 to 188 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 321 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 77 to 90 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 117 to 126 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 74 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 152 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 351 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 53 to 60 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 146 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 400 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 88 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 61 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 62 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 205 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 209 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 526 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 125 to 133 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 152 to 157 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 210 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 236 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 241 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 244 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 249 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 254 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 281 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 284 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 299 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 306 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 309 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 317 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 327 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 525 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 393 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 163 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 349 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 353 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 193 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 195 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 287 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 43 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 70 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 72 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 236 to 265 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 47 to 55 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 47 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 176 to 184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 294 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 308 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 318 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 875 to 881 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 936 to 938 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 963 to 971 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1030 to 1032 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1174 to 1175 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1179 to 1180 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 88 to 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 370 to 374 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 363 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 262 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 428 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 120 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 181 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 13 to 20 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 356 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 358 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 464 to 471 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 506 to 510 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 574 to 577 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 304 to 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 441 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 682 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 686 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 689 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 244 to 251 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 641 to 648 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1010 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1019 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1020 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with heme, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 to 62 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 109 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 121 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 171 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 206 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 281 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 63 to 70 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 to 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 230 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 351 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 68 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 189 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 121 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with benzamidine, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with benzamidine, indicating a strong binding affinity.
The residue at position 225 forms a bond with benzamidine, indicating a strong binding affinity.
The residue at position 57 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 164 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 164 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 175 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 182 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 219 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 246 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 255 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 262 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 110 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1178 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1309 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1312 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 397 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 416 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 227 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 309 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 401 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 23 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 23 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 239 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 239 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 371 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 399 to 402 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 422 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 482 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 397 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 184 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 192 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 2 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 50 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 55 to 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 209 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 128 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 173 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 188 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 191 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 277 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 279 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 315 to 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 439 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1823 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2127 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2129 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 97 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 235 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 215 to 221 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 507 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 221 to 225 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 56 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 75 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 76 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 106 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 107 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 131 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 151 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 201 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 270 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 334 to 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 216 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 219 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 242 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 265 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 277 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 19 to 23 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 454 to 577 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 521 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 536 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 114 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 16 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 34 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 34 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 106 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 231 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 235 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 263 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 155 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 173 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 348 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 270 to 273 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 410 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 451 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 470 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 404 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 441 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 113 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 315 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 463 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 31 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 37 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 61 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 87 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 93 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 104 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 154 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 186 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 187 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 187 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 218 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 382 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 394 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 394 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 395 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 395 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 521 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 521 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 522 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 551 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 561 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 561 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 564 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 564 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 566 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 567 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 362 to 370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 6 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 183 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 253 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 145 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 202 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 531 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 539 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 48 to 55 forms a bond with beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(9Z)-octadecenoyl]-sphing-4-enine, indicating a strong binding affinity.
The residue at position 140 forms a bond with beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(9Z)-octadecenoyl]-sphing-4-enine, indicating a strong binding affinity.
The residue at position 207 forms a bond with beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(9Z)-octadecenoyl]-sphing-4-enine, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 132 to 137 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 247 to 252 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 265 to 272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 409 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 568 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 to 340 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 422 to 423 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 10 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 226 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 375 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 405 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 564 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 390 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 393 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 241 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 241 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 521 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 649 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 375 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 46 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 59 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 104 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 42 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 121 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 173 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 224 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 249 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 269 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 28 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 224 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 298 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 436 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 662 forms a bond with Mg of divinyl chlorophyll a B1, indicating a strong binding affinity.
The residue at position 670 forms a bond with Mg of divinyl chlorophyll a B3, indicating a strong binding affinity.
The residue at position 678 forms a bond with divinyl chlorophyll a B3, indicating a strong binding affinity.
The residue at position 679 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 477 to 484 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 523 to 527 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 577 to 580 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 683 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 381 to 389 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 815 to 823 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 903 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 904 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 937 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1003 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 329 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 329 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 333 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 481 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 116 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 184 to 190 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 213 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 463 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 556 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 560 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 560 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 701 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 705 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 709 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 3 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 414 to 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 388 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 16 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 27 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 101 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 125 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 178 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 190 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 110 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 277 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 351 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 353 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 355 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 400 to 404 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 433 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 440 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 440 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 444 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 264 to 267 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 397 to 398 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 438 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 458 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 477 to 479 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 479 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 930 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 170 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 571 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 594 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 695 to 698 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 712 to 716 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 726 to 728 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 776 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 779 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 863 to 872 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 53 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 77 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 120 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 301 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 255 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 272 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 349 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 396 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 400 to 404 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 411 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 238 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 527 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 478 to 485 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 524 to 528 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 578 to 581 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 338 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 398 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 401 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 27 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 114 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 289 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 321 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 326 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 329 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 81 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 84 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 241 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 822 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 824 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 843 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 845 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 894 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 410 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 13 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 609 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 613 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 345 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 420 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 424 to 428 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 435 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 217 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 788 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 790 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 809 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 811 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 860 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 337 to 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 310 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 21 to 45 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 110 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 406 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 427 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 169 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 249 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 304 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 343 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 286 to 289 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 26 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 336 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 110 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 152 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 321 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 400 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 437 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 139 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 153 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 234 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 317 to 323 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 321 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 323 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 349 to 351 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 431 to 433 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 339 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 434 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 459 to 462 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 543 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 300 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 197 to 205 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 285 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 334 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 263 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 438 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 442 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 466 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 345 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 347 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 348 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 383 to 385 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 430 to 434 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 460 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 514 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 516 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 248 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 130 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 151 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 122 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 389 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 91 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 398 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 402 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 434 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 436 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 470 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 472 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 474 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 481 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 505 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 507 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 509 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 511 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 516 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 302 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 306 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 328 to 330 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 371 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 397 to 398 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 465 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 467 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 472 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 651 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 655 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 54 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 50 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 39 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 255 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 270 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 330 to 336 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 336 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 362 to 364 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 444 to 447 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 600 to 607 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 180 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 938 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 939 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 945 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1003 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1003 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1011 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 175 to 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 200 to 204 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 726 to 734 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 753 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 223 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 320 to 321 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 344 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 351 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 364 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 396 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 423 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 433 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 460 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 87 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 107 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 138 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 139 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 221 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 222 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 68 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 195 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 201 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 294 to 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 298 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 300 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 23 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 349 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 350 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 379 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 520 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 521 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 545 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 146 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 253 to 257 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 346 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 351 to 354 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 to 377 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 438 to 444 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 290 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 8 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 to 18 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 328 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 425 to 432 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 462 to 466 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 527 to 530 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 23 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 26 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 3 to 8 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 45 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 46 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 47 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 237 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 286 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 288 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 447 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 455 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 461 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 364 to 368 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 390 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 135 to 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 353 to 359 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 377 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 404 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 421 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 544 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 901 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 198 to 203 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 198 to 203 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 234 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 234 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 364 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 392 to 395 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 415 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 472 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 6 to 13 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 128 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 228 to 233 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 633 to 638 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 658 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 705 to 711 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 755 to 756 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 844 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 867 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1136 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1141 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1162 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1164 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 288 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 291 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 388 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 391 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 491 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 494 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 567 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 570 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 1073 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1293 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1297 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 269 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 9 to 13 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 190 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 58 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 278 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 366 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 914 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 994 to 996 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1001 to 1005 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1041 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 438 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 408 to 415 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 321 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 408 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 28 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 76 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 306 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 362 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 426 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 434 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 442 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 54 to 63 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 166 to 213 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 390 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 70 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 498 to 506 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 529 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 283 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 335 to 351 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 447 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 to 81 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 193 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 207 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 287 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 362 to 368 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 366 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 368 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 394 to 396 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 477 to 479 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 504 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 to 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 to 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 109 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 127 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 127 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 135 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 138 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 144 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 181 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 217 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 224 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 196 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 198 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 222 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 271 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 196 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 221 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 232 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 238 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 238 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 240 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 223 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with corrinoid, indicating a strong binding affinity.
The residue at position 207 forms a bond with corrinoid, indicating a strong binding affinity.
The residue at position 309 to 314 forms a bond with corrinoid, indicating a strong binding affinity.
The residue at position 329 to 332 forms a bond with corrinoid, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with corrinoid, indicating a strong binding affinity.
The residue at position 366 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 372 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 376 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 394 to 401 forms a bond with corrinoid, indicating a strong binding affinity.
The residue at position 409 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 419 forms a bond with corrinoid, indicating a strong binding affinity.
The residue at position 420 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 423 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 427 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 60 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 61 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 62 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 295 to 303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 89 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 152 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 185 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 250 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 253 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 163 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 323 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 355 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 402 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 406 to 410 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 417 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 8 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 16 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 49 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 224 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 to 200 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 831 to 839 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 856 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 to 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 497 to 498 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 284 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 299 to 303 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 326 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 324 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 147 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 176 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 200 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 219 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 350 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 352 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 258 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 107 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 439 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 577 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Zn(2+) 201, indicating a strong binding affinity.
The residue at position 17 forms a bond with Zn(2+) 201, indicating a strong binding affinity.
The residue at position 74 forms a bond with Zn(2+) 201, indicating a strong binding affinity.
The residue at position 77 forms a bond with Zn(2+) 201, indicating a strong binding affinity.
The residue at position 386 to 388 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 388 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 510 to 513 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 441 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 515 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 515 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 to 380 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 561 to 565 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 to 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 254 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 285 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 287 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 532 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 536 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 563 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 565 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 625 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 627 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 40 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 408 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 347 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 349 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 365 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 366 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 411 to 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 512 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 234 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 271 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 513 to 520 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 237 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 239 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 295 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 12 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 55 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 29 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 436 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 356 to 358 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 36 to 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 forms a bond with heme, indicating a strong binding affinity.
The residue at position 36 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 236 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 252 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 263 to 269 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 295 to 300 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 114 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 287 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 1850 to 1852 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 1940 to 1941 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 1957 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1959 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1993 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 276 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 384 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 284 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 523 to 530 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 573 to 577 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 627 to 630 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 30 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 34 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 336 to 343 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 383 to 387 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 195 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 200 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 242 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 248 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 252 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 51 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 405 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 502 to 507 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 549 to 552 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 583 to 585 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 591 to 593 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 465 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 468 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 471 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 510 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 513 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 516 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 520 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 229 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 235 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 284 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 630 to 638 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 656 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 to 246 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 392 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 219 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 271 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 271 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 303 to 304 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 343 to 347 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 104 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 412 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 416 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 27 to 30 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 88 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 149 to 156 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 76 to 89 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 116 to 125 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 344 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 forms a bond with (E)-ferulate, indicating a strong binding affinity.
The residue at position 212 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 235 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 256 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 269 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 270 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 275 forms a bond with (E)-5-hydroxyferulate, indicating a strong binding affinity.
The residue at position 475 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 535 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 11 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 436 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 148 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 265 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 190 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 275 to 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 463 to 467 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 528 to 531 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 7 to 11 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 299 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 378 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 684 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 53 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 142 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 160 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 171 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 177 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 214 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 250 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 257 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 119 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 169 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 216 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 600 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 616 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 674 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 185 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 187 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 232 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 78 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 80 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 96 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 159 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 259 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 270 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 270 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 339 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 372 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 467 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 467 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 436 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 22 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 173 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 204 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 60 to 90 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 223 to 259 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 394 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 396 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 398 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 403 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 148 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 152 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 538 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 32 to 40 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 228 to 234 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 259 to 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 182 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 276 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 67 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 68 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 53 to 58 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 882 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 26 to 32 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 156 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 429 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 14 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 296 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 396 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 28 to 35 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 171 to 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 448 to 450 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 454 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 521 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 526 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 534 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 157 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 159 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 163 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 180 to 187 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 227 to 231 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 162 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 77 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 173 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 241 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 317 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 318 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 354 to 358 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1280 to 1284 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1316 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1320 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1339 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 641 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 643 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 645 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 647 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 652 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 671 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 673 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 675 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 677 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 682 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 318 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 324 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 328 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 216 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 702 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 to 81 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 120 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 723 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 748 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 774 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 779 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 795 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 796 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 797 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 797 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 885 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 886 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 929 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 66 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 163 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 50 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 309 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 755 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 757 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1107 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1295 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1302 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1305 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 94 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 279 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 310 to 315 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 328 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 277 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 298 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 301 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 471 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 296 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 68 to 73 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 151 to 160 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 402 to 404 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 417 to 420 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 517 to 518 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 523 to 527 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 559 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 597 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 269 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 465 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 472 to 477 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 472 to 473 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 440 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 514 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 523 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 549 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 563 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 563 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 15 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 15 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 15 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 143 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 143 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 143 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 307 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 277 to 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 418 to 419 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 458 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 119 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 261 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 263 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 6 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 12 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 687 to 744 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 811 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 823 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 823 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 825 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 128 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 14 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 147 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 172 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 222 to 226 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 253 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 18 to 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 to 41 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 forms a bond with benzoate 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with benzoate 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with benzoate 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with benzoate 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with benzoate 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with cis,cis-muconate, indicating a strong binding affinity.
The residue at position 293 forms a bond with benzoate 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 257 to 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 344 to 350 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 357 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 400 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 72 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 10 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 210 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 214 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 217 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 225 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 256 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 257 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 259 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 265 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 324 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 343 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 112 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with a (3R)-3-[(carboxymethyl)amino]fatty acid, indicating a strong binding affinity.
The residue at position 70 forms a bond with a (3R)-3-[(carboxymethyl)amino]fatty acid, indicating a strong binding affinity.
The residue at position 93 forms a bond with a (3R)-3-[(carboxymethyl)amino]fatty acid, indicating a strong binding affinity.
The residue at position 100 forms a bond with a (3R)-3-[(carboxymethyl)amino]fatty acid, indicating a strong binding affinity.
The residue at position 158 forms a bond with a (3R)-3-[(carboxymethyl)amino]fatty acid, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 275 forms a bond with a (3R)-3-[(carboxymethyl)amino]fatty acid, indicating a strong binding affinity.
The residue at position 184 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 204 to 215 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 473 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 543 to 545 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 543 to 545 forms a bond with L-cysteine, indicating a strong binding affinity.
The residue at position 543 to 545 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 543 to 545 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 550 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 550 forms a bond with L-cysteine, indicating a strong binding affinity.
The residue at position 550 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 550 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 702 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 702 forms a bond with L-cysteine, indicating a strong binding affinity.
The residue at position 702 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 702 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 746 to 749 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 746 to 749 forms a bond with L-cysteine, indicating a strong binding affinity.
The residue at position 746 to 749 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 746 to 749 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 95 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mg(2+) 6, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg(2+) 6, indicating a strong binding affinity.
The residue at position 304 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mg(2+) 6, indicating a strong binding affinity.
The residue at position 428 forms a bond with Mg(2+) 7, indicating a strong binding affinity.
The residue at position 432 forms a bond with Mg(2+) 7, indicating a strong binding affinity.
The residue at position 237 to 241 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 646 to 648 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 787 to 788 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 135 to 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 forms a bond with pyridone 6, indicating a strong binding affinity.
The residue at position 96 forms a bond with pyridone 6, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 185 to 191 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 82 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 143 to 150 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 317 to 321 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 108 to 115 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 141 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 9 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 226 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 246 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 249 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 256 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 328 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 331 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 335 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 372 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 376 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 394 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 404 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 124 forms a bond with 3-dehydroshikimate, indicating a strong binding affinity.
The residue at position 126 forms a bond with 3-dehydroshikimate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 3-dehydroshikimate, indicating a strong binding affinity.
The residue at position 241 forms a bond with 3-dehydroshikimate, indicating a strong binding affinity.
The residue at position 279 forms a bond with 3-dehydroshikimate, indicating a strong binding affinity.
The residue at position 300 forms a bond with 3-dehydroshikimate, indicating a strong binding affinity.
The residue at position 304 forms a bond with 3-dehydroshikimate, indicating a strong binding affinity.
The residue at position 336 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 338 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 381 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 385 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 406 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 423 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 461 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 464 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 483 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 485 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 488 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 525 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 548 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 550 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 578 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 582 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 207 to 214 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 83 to 87 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 128 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 235 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 52 to 60 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 239 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 273 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 316 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 340 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 345 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 353 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 204 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 206 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 18 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 74 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 936 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 939 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 514 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 115 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 161 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 589 to 596 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 337 to 340 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 430 to 431 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 524 to 527 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 572 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 225 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 286 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 1365 to 1367 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1389 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1409 to 1418 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 219 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 241 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 246 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 251 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 259 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 264 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 321 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 324 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 329 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 332 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 83 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 83 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 111 to 119 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 207 to 230 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 318 to 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 227 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 238 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 281 to 286 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 87 to 94 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 260 to 267 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 164 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 294 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 108 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 637 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 362 to 364 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 403 to 406 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 593 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 598 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 137 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 482 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 485 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 546 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 547 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 548 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 552 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 1051 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1083 to 1089 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 286 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 500 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 59 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 377 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 381 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 384 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 37 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 49 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 63 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 64 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 99 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 246 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 358 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 362 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 406 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 147 to 156 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 257 to 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 357 to 361 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 386 to 388 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 404 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 62 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 166 to 170 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 338 to 342 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 349 to 350 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 398 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 590 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 10 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 77 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 132 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 64 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 67 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 194 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 197 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 200 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 52 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 85 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 168 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 431 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 431 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 92 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 111 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 198 to 202 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 183 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 187 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 168 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 164 to 168 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 105 to 110 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 123 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 177 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 66 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 67 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 51 to 55 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 378 to 385 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 963 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 970 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 973 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 183 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 254 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 301 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 317 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 141 to 146 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 367 to 374 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 399 to 400 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with CO, indicating a strong binding affinity.
The residue at position 249 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 277 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 322 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 416 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 419 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 422 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 426 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 454 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 457 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 460 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 464 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 522 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 551 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 586 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1065 to 1073 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1091 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1138 to 1141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 438 to 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 50 to 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 302 to 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 368 to 375 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 414 to 418 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 468 to 471 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 317 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 28 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 133 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 625 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 118 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 119 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 145 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 170 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 206 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 120 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 157 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 266 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 52 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 54 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 144 forms a bond with (2R)-2,3-bisphosphoglycerate, indicating a strong binding affinity.
The residue at position 144 forms a bond with dATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with adenosine 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with dATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with P(1),P(4)-bis(5'-adenosyl) tetraphosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 206 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 215 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 249 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 250 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 292 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 362 forms a bond with (2R)-2,3-bisphosphoglycerate, indicating a strong binding affinity.
The residue at position 362 forms a bond with P(1),P(4)-bis(5'-adenosyl) tetraphosphate, indicating a strong binding affinity.
The residue at position 436 forms a bond with adenosine 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with adenosine 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with dATP, indicating a strong binding affinity.
The residue at position 453 forms a bond with P(1),P(4)-bis(5'-adenosyl) tetraphosphate, indicating a strong binding affinity.
The residue at position 456 forms a bond with dATP, indicating a strong binding affinity.
The residue at position 457 forms a bond with (2R)-2,3-bisphosphoglycerate, indicating a strong binding affinity.
The residue at position 457 forms a bond with P(1),P(4)-bis(5'-adenosyl) tetraphosphate, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 196 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 525 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 527 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 532 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 532 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 537 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 539 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 546 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 546 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 549 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 551 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 554 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 599 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 599 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 601 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 606 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 606 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 611 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 613 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 620 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 620 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 624 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 626 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 629 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 117 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 357 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 37 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 39 to 43 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 275 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 277 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 99 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 99 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 103 to 108 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 103 to 108 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 332 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 435 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 354 to 361 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 400 to 404 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 454 to 457 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 65 to 70 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 89 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 97 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 336 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 7 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 7 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 125 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 89 to 94 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 190 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 229 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 243 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 286 to 291 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 841 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1176 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1179 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1185 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 53 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 42 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 99 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 966 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 969 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 367 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 369 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 426 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 267 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 33 to 39 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 37 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 77 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 168 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 169 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 204 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 242 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 270 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 311 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 472 to 480 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 355 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 88 to 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 477 to 482 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 519 to 521 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 521 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 565 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1201 to 1203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1208 to 1212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 544 to 551 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 590 to 594 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 644 to 647 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 100 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 486 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 486 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 18 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 308 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 310 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 176 to 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 to 296 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 629 to 631 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 636 to 642 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 725 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 23 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 124 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 462 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 465 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 467 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 526 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 527 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 528 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 532 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 537 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 42 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 198 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 27 to 29 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 72 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 79 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 85 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 194 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 483 to 491 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 244 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 268 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 313 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 577 to 578 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 459 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 203 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 to 326 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 326 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 215 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 217 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 221 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 226 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 157 forms a bond with 3',2'-cGAMP, indicating a strong binding affinity.
The residue at position 232 forms a bond with 3',2'-cGAMP, indicating a strong binding affinity.
The residue at position 235 forms a bond with 3',2'-cGAMP, indicating a strong binding affinity.
The residue at position 255 forms a bond with 3',2'-cGAMP, indicating a strong binding affinity.
The residue at position 258 forms a bond with 3',2'-cGAMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with 3',2'-cGAMP, indicating a strong binding affinity.
The residue at position 285 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 462 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 622 to 624 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 629 to 635 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 723 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 229 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 407 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 214 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 250 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 274 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 318 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 406 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 434 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 100 to 106 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 387 to 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 391 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 502 to 504 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 86 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 353 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 279 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 283 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 414 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 416 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 108 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 363 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 367 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 395 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 402 to 403 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 470 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 474 to 478 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 96 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 173 to 179 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 175 to 179 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 262 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 321 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 350 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 352 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 320 to 321 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 406 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 722 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 725 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 738 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 742 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 750 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 753 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 766 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 778 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 781 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 794 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 798 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 806 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 809 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 822 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 826 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 61 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 129 to 135 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 158 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 161 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 12 to 16 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 83 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 379 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 825 to 833 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 847 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 55 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 89 to 93 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 269 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 401 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 429 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 454 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 488 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 178 to 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 328 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 143 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 146 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 107 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 188 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 250 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 252 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 288 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 289 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 295 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 339 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 704 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 707 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 829 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 351 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 72 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 523 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 225 to 228 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 244 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 69 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 132 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 214 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 333 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 358 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 393 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 67 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 346 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 397 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 64 to 69 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 170 to 200 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 829 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 840 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 179 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 107 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 152 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 471 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 474 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 476 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 523 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 524 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 525 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 877 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 261 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 349 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 355 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 385 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 457 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 485 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 488 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 206 to 213 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 253 to 257 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 318 to 321 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 160 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 194 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 196 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 589 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 589 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 593 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 593 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 733 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 737 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 752 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 756 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 836 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 837 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 837 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 837 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 950 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 950 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 1001 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 709 to 717 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 293 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 forms a bond with heme, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 281 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 318 to 321 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 433 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 457 to 464 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 492 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 325 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 222 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 to 121 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 25 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 261 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 171 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 801 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1130 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 583 to 590 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 50 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 54 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 63 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 70 to 76 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 68 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 146 to 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 237 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 280 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 488 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 263 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 320 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 357 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 112 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 343 to 344 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 300 to 307 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1067 to 1075 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1089 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 30 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 67 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 242 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 303 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 679 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 174 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 327 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 119 to 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 330 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 371 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 371 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 509 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 512 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 512 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 520 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 56 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 272 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 292 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 148 to 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 216 to 220 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 205 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 332 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 727 to 728 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 727 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 749 to 752 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 762 to 764 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 788 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 809 to 810 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 811 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 812 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 833 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 893 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 906 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 906 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 908 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 924 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 13 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 21 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 160 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 179 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 66 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 99 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 238 to 243 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 240 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 242 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 656 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 659 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 662 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 667 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 670 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 673 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 689 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 694 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1149 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1153 to 1154 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1171 to 1172 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1193 to 1194 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1582 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 343 to 350 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 252 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 261 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 334 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 336 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 369 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 371 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 64 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 65 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 65 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 129 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 192 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 221 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 252 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 394 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 211 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 132 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 96 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 219 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 329 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 391 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 79 to 93 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 to 308 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 503 to 510 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 390 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 392 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 609 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 609 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 753 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 166 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 98 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 110 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 359 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 366 to 368 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 366 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 365 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 51 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 64 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 66 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 90 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 95 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 104 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 514 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 514 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 141 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 224 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 256 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 258 to 261 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 289 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 301 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 74 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1288 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1397 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1400 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1457 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1489 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1530 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1532 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 583 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 55 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 57 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 486 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 506 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 517 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 517 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 580 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 580 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 589 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 614 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 614 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 628 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 628 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 232 to 236 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 509 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 520 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 520 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 604 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 618 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 618 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 151 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 276 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 278 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 351 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 421 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 396 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 444 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 444 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 446 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 446 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1142 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1148 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1206 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1556 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1562 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1611 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1613 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1878 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1881 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1884 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 438 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 438 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 375 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 435 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 52 to 62 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 414 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 2 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 5 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 7 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 201 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 234 to 244 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 326 to 334 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 359 to 364 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 521 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 835 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 315 to 322 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 223 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 452 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 494 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 539 to 542 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 565 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 567 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 569 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 571 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 5 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 249 to 256 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 836 to 843 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 484 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 484 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 131 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 326 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 330 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 478 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 372 to 374 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 412 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 438 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 48 forms a bond with O2, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 436 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 126 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 156 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 158 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 165 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with heme, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 267 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 8 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 18 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 37 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 280 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 46 forms a bond with sulfur of a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 130 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 186 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 211 forms a bond with sulfur of a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 244 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 212 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 36 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 32 to 56 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 137 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 266 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 330 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 332 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 334 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 335 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 62 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 454 to 461 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 790 to 795 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 to 75 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 277 to 283 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 670 to 789 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 837 to 957 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 670 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 696 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 700 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 390 to 397 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 436 to 440 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 490 to 493 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 267 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 313 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 94 to 109 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 443 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 459 to 460 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 393 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 409 to 410 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 294 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 299 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1902 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1934 to 1940 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1978 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 437 to 444 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1094 to 1101 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 28 to 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 59 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 400 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 410 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 444 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 448 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 455 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 476 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 10 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 349 to 350 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 367 to 375 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 421 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 7 to 11 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 192 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 210 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 105 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 493 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 496 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 525 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 532 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 532 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 542 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 614 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 615 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 652 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 659 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 669 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 390 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 392 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 462 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 276 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 386 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 75 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 504 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 527 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 659 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 739 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 232 to 236 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 62 to 82 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 238 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 292 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 56 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 60 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 192 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 196 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 243 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 249 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 155 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 557 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 187 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 139 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 359 to 364 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 to 471 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 501 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 532 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 540 to 542 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 204 to 211 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 251 to 255 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 212 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 28 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 85 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 92 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 193 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 94 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 121 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 147 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 67 to 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 194 to 203 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 484 to 487 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 502 to 504 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 518 to 521 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 565 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 626 to 627 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 632 to 636 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 668 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 706 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 309 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 110 forms a bond with tacrine, indicating a strong binding affinity.
The residue at position 466 forms a bond with tacrine, indicating a strong binding affinity.
The residue at position 448 to 453 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 343 to 347 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 594 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 518 to 522 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 396 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 537 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 538 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 562 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 56 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 170 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 174 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 217 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 502 to 510 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 42 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 54 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 86 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 96 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 111 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 163 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 165 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 165 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 251 to 255 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 263 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 710 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 770 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 805 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 843 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 982 to 983 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 15 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 148 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 208 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 545 to 552 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 13 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 69 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 70 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 68 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 69 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 70 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 90 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 171 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 173 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 219 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 369 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 247 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 268 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 284 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 353 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 863 to 870 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 230 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 259 to 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 343 to 346 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 426 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 120 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 309 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 57 to 65 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with Fe of heme b b595, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe of heme b b558, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe of heme b b558, indicating a strong binding affinity.
The residue at position 571 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 599 to 606 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 674 to 680 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 800 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 813 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 783 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 786 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 802 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 806 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 226 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 230 to 234 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 97 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 27 to 30 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 139 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 148 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 304 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 383 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 397 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 295 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 298 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 321 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 862 to 864 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 871 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 878 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 904 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 453 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 131 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 354 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 358 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 403 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 114 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 214 to 217 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 217 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 225 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 322 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 34 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 117 to 123 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 155 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 182 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 186 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 24 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 296 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 360 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 379 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 392 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 48 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 53 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 109 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 177 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 33 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 36 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 81 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 144 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 144 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 177 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 111 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 238 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 12 to 19 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 453 to 460 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 489 to 493 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 558 to 561 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 273 to 277 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 242 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 244 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 308 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 356 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 449 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 641 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 778 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 778 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 780 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 132 to 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 500 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 503 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 14 to 21 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 6 to 11 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 157 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 198 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 200 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 236 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 240 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 244 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 248 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 274 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 83 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 233 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 237 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 489 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 547 to 551 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 585 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 592 to 594 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 647 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 673 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 679 to 682 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 753 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 366 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 372 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 461 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 534 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 534 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 151 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 217 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 444 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 46 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 116 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 402 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 284 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 511 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 515 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 46 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 104 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 145 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 21 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 100 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 124 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 258 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 300 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 42 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 183 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 197 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 516 to 518 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 523 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 689 to 690 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 738 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 91 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 375 to 383 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 186 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 933 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 965 to 970 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1009 to 1011 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1026 to 1027 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1042 to 1049 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1068 to 1069 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 555 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 632 to 639 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 127 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 213 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 473 to 475 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 297 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 524 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 229 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 368 to 373 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 360 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 398 to 405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 511 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 546 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 565 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 637 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 677 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 712 to 714 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 127 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 226 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 310 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 351 to 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 182 to 191 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 185 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 423 to 433 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1470 to 1478 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1493 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 377 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 378 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 465 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 468 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 56 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 60 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 66 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 89 to 96 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 to 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 858 to 865 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 448 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 467 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 398 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 764 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 767 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 791 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 794 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 817 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 205 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 332 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 347 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 17 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 125 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 122 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 130 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 174 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 193 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 219 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 336 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 337 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 346 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 348 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 57 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 96 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 103 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 104 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 136 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 199 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 293 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 416 to 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 19 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 23 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 214 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 223 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 376 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 380 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 403 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 219 forms a bond with an aliphatic aldoxime, indicating a strong binding affinity.
The residue at position 299 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 320 forms a bond with an aliphatic aldoxime, indicating a strong binding affinity.
The residue at position 390 to 393 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 423 to 426 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 523 to 524 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 529 to 533 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 158 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 51 to 59 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 276 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 516 to 518 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 523 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 688 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 732 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 130 forms a bond with heme, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 225 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 354 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 600 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 118 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 55 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 109 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 399 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 436 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 336 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 338 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 339 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 341 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 374 to 376 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 397 to 398 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 458 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 458 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 511 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 512 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 513 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 103 to 109 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 76 to 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 10 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 84 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 300 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 317 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 149 to 154 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 242 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 284 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 408 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 387 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 416 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 249 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 111 to 118 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 121 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 137 to 145 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 235 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 278 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 279 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 303 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 420 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 421 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 451 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 463 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 468 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 470 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 500 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 540 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 541 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 563 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 645 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 646 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 668 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 131 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 269 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 10 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 31 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 73 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 76 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 122 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 239 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 384 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 388 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 417 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 513 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 296 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 87 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 180 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 213 to 220 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 373 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 377 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 483 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 509 to 510 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 559 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 94 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 102 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 237 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 584 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 651 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 784 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 739 to 743 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 743 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 743 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 805 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 808 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 889 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 995 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 213 to 221 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 87 to 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 227 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 421 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 208 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 480 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 590 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 397 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 94 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 237 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 293 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 56 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 134 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 279 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 262 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 325 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 328 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 394 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 400 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 454 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 456 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 30 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 33 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 34 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 291 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 373 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 206 to 212 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 138 to 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 172 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 378 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 242 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 54 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 393 forms a bond with a gentamycin, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 386 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 387 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 388 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 489 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 514 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 604 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 53 to 63 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 152 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 17 to 27 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 190 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 212 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 223 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 329 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 331 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 435 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 436 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 459 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 393 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 411 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 413 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 293 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 297 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 348 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 85 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 85 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 213 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 268 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 173 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 182 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 211 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 4 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 305 to 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 622 to 629 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 579 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 582 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 603 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 608 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 187 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 243 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group of a glycoprotein, indicating a strong binding affinity.
The residue at position 251 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group of a glycoprotein, indicating a strong binding affinity.
The residue at position 254 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group of a glycoprotein, indicating a strong binding affinity.
The residue at position 320 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group of a glycoprotein, indicating a strong binding affinity.
The residue at position 341 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group of a glycoprotein, indicating a strong binding affinity.
The residue at position 358 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group of a glycoprotein, indicating a strong binding affinity.
The residue at position 400 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 365 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 256 to 262 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 194 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 235 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 274 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 278 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 338 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 127 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with folate, indicating a strong binding affinity.
The residue at position 191 forms a bond with folate, indicating a strong binding affinity.
The residue at position 386 to 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 137 to 144 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 52 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 343 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 346 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 347 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 124 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 to 232 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 227 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 246 to 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 to 56 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 54 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine, indicating a strong binding affinity.
The residue at position 46 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine, indicating a strong binding affinity.
The residue at position 690 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 693 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 700 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 744 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 747 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 750 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 754 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 810 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 813 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 838 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1075 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 91 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 671 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 736 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1346 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1427 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1428 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1610 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1652 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1685 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 360 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 332 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 193 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 140 to 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 291 to 295 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 580 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 584 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 25 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 478 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 538 to 541 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 598 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 602 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 605 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 605 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1000 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 483 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 752 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 754 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 756 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 758 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 760 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 415 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 417 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 507 to 515 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 to 274 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 153 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 308 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 166 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 265 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 277 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 588 to 596 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 215 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 438 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 479 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 751 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 797 to 799 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 843 to 848 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 31 to 34 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 148 to 157 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 102 forms a bond with heme, indicating a strong binding affinity.
The residue at position 151 forms a bond with heme, indicating a strong binding affinity.
The residue at position 344 forms a bond with heme, indicating a strong binding affinity.
The residue at position 355 forms a bond with heme, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 260 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 to 332 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1579 to 1586 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 154 to 163 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 163 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 212 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 274 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 277 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 345 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 347 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 397 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 398 to 401 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 480 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 831 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 31 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 122 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 136 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 121 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe cation B, indicating a strong binding affinity.
The residue at position 258 forms a bond with Fe cation B, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe cation B, indicating a strong binding affinity.
The residue at position 347 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 349 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 70 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 152 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 205 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 62 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 262 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 284 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 416 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 219 forms a bond with octopamine, indicating a strong binding affinity.
The residue at position 267 forms a bond with octopamine, indicating a strong binding affinity.
The residue at position 115 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 145 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 148 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 151 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 336 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 735 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 828 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 829 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 829 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 961 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 650 to 657 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 673 to 680 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 159 to 167 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 175 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 190 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 325 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 343 to 344 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 328 to 332 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 56 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 125 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 316 to 323 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 to 411 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 464 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 833 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 864 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 868 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 946 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 978 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 980 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1147 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 468 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 14 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 68 to 73 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 7 to 12 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 289 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 265 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 321 to 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 349 to 354 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 121 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 271 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 291 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 593 to 601 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 615 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 to 67 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 119 to 124 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 509 to 511 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 511 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 516 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 687 to 688 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 729 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 387 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 391 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 458 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 466 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 470 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 530 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 540 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 542 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 546 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 699 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 704 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 812 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 825 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 853 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 878 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 912 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 915 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 13 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 13 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 113 forms a bond with heme, indicating a strong binding affinity.
The residue at position 113 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 116 forms a bond with heme, indicating a strong binding affinity.
The residue at position 116 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 210 to 215 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 to 269 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 24 to 28 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 173 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 591 to 598 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 97 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 352 to 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 602 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 609 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 342 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 258 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 278 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 343 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 54 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 168 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 409 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 336 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 338 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 355 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 261 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 496 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 500 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 500 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 727 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 187 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 196 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 205 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 427 to 428 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 698 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 781 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 287 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 88 forms a bond with heme, indicating a strong binding affinity.
The residue at position 92 forms a bond with heme, indicating a strong binding affinity.
The residue at position 298 forms a bond with heme, indicating a strong binding affinity.
The residue at position 351 forms a bond with heme, indicating a strong binding affinity.
The residue at position 354 forms a bond with heme, indicating a strong binding affinity.
The residue at position 39 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 340 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 230 to 251 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 377 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 386 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 295 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 391 to 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 875 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 878 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 573 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 575 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 580 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 582 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 584 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 373 to 380 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 392 to 399 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 438 to 442 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 492 to 495 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 115 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 320 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 321 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 437 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 438 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 31 to 37 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 474 to 477 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 497 to 499 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 530 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 89 to 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 693 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 355 to 363 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 481 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 540 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 541 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 542 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 346 to 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 506 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 753 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 756 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 759 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 763 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 825 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 828 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 853 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1085 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 163 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 220 to 226 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 574 to 581 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 116 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 166 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 203 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 153 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 286 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 289 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 272 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 426 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 461 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 463 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 468 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 487 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 489 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 491 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 493 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 498 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 655 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 663 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 671 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 672 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with heme, indicating a strong binding affinity.
The residue at position 280 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 289 forms a bond with heme, indicating a strong binding affinity.
The residue at position 1635 to 1642 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 329 to 334 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 449 to 450 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 503 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 503 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 505 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 203 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 721 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 462 to 584 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 360 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 388 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 420 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 421 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 508 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 to 33 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 156 to 161 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 27 forms a bond with D-galactose 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with D-galactose 3, indicating a strong binding affinity.
The residue at position 119 forms a bond with D-galactose 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 188 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 227 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 338 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 325 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 622 to 630 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 471 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 141 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 338 to 344 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 346 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 484 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 487 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 495 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 91 to 95 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 15 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1772 to 1774 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1772 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1773 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1774 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1798 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1808 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1817 to 1827 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1841 to 1844 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1871 to 1873 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1872 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1873 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 861 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 862 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 421 to 424 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 467 to 468 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 523 to 524 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 585 to 587 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 45 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 84 to 92 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 122 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 173 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 121 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 148 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 169 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 186 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 169 to 175 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 237 to 243 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 to 255 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 to 307 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 188 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 137 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 418 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 421 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 425 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 433 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 445 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 456 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 129 to 136 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 29 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 169 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 540 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 981 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 11 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 153 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 102 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 171 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 201 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 222 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 270 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 331 to 341 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 178 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 206 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 308 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 343 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 8 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 109 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 310 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 343 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 408 to 412 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 106 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 353 to 361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 359 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 187 to 192 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 529 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 578 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 582 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 701 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 347 to 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 352 to 353 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 586 to 588 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 71 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 565 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 588 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 590 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 723 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 731 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 233 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 484 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 to 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 128 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 12 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 253 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 424 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 428 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 661 to 663 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 330 to 333 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 245 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with histamine, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with histamine, indicating a strong binding affinity.
The residue at position 239 forms a bond with histamine, indicating a strong binding affinity.
The residue at position 99 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 103 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 111 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 193 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 197 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 269 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 286 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 117 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 664 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 672 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 680 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 681 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 267 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 268 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 303 to 304 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 330 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 976 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1063 to 1065 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1070 to 1074 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 269 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 167 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 20 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 212 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 34 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 169 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 209 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 213 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 234 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 51 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 560 to 562 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 112 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 247 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 461 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 468 to 469 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 336 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 349 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 398 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 400 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 402 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 403 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with heme, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 95 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 188 to 192 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 278 to 281 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 328 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 320 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 420 to 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 541 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 544 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 155 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 158 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 185 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 467 to 474 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 807 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 28 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 485 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 488 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 128 forms a bond with heme, indicating a strong binding affinity.
The residue at position 267 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 to 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 80 to 87 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 76 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 145 to 150 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 108 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 202 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 272 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 537 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1088 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1142 to 1149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 271 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2118 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2121 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2156 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2159 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2190 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2193 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2205 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2207 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 to 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 365 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 427 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 470 to 472 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 475 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 73 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 357 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 361 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 18 to 139 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 295 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 98 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 405 to 407 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 222 to 229 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 152 to 161 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 285 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 439 to 442 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 476 to 479 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 543 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 610 to 611 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 617 to 621 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 646 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 691 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 225 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 85 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 187 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 309 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 409 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 282 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 352 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 116 to 121 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 149 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 496 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 551 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 553 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 555 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 559 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 613 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 615 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 617 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 621 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 246 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 399 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 404 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 466 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 498 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 532 to 541 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 619 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 597 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 224 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 490 to 498 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 497 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 661 to 669 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 669 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 774 to 777 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 292 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 95 to 103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 64 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 116 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 219 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 243 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 257 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 234 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 462 to 469 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 263 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 89 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 175 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 178 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 79 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 248 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 279 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 79 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 82 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 149 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 202 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 204 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 207 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 694 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 705 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with heme, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 71 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 75 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 101 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 173 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 287 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 291 forms a bond with Fe(II)-heme o, indicating a strong binding affinity.
The residue at position 336 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 337 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 414 forms a bond with Fe(II)-heme o, indicating a strong binding affinity.
The residue at position 422 forms a bond with Fe of Fe(II)-heme o, indicating a strong binding affinity.
The residue at position 424 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 484 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 485 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 30 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 363 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 439 to 441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 463 to 468 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 567 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 575 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 636 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 483 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 328 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 354 to 362 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1133 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1135 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1262 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 71 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 74 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 531 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 52 forms a bond with heme, indicating a strong binding affinity.
The residue at position 55 forms a bond with heme, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 139 to 144 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 596 to 603 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 191 to 196 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 191 to 196 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 425 to 427 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 624 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 94 to 99 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 343 to 344 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 369 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 424 to 432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 230 to 236 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 268 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 88 to 92 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 161 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 188 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 889 to 896 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 185 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 203 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 379 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 439 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 459 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 12 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 125 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 129 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 227 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 288 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 290 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 295 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 40 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 291 to 300 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1275 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1373 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1376 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1433 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1460 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1501 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1503 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 339 to 346 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1085 to 1093 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 133 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 164 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 164 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 383 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 383 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 71 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 86 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 456 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 465 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 626 to 628 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 633 to 639 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 727 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 179 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 277 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 481 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 553 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 303 to 306 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 564 to 571 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 397 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 to 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 to 313 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 489 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 491 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 493 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 500 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 426 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 429 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 149 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 150 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 177 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 185 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 188 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 191 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 192 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 245 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 248 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 249 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 437 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 444 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 470 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 264 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 273 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 317 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 368 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 438 to 440 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 439 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 720 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 722 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 754 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 754 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 786 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 839 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 918 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 680 to 688 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 873 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 875 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 982 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1071 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 627 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 182 to 188 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 343 to 348 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 553 to 560 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 226 to 231 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 249 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 352 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 309 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 595 to 603 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 618 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 236 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 636 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 749 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 753 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 154 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 171 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 208 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 235 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 244 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 251 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 57 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 118 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 130 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 150 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 157 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 181 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 181 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 217 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 277 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 792 to 798 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 55 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 169 to 173 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 264 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 296 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 340 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 471 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 24 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 129 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 164 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 230 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 254 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 257 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 285 to 289 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 22 to 27 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 69 to 72 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 107 to 116 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 400 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 430 to 433 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 474 to 477 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 514 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 574 to 575 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 580 to 584 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 657 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 432 to 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 348 to 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 to 122 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 255 to 291 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 290 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 271 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 318 to 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 391 to 394 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 427 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 423 to 430 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1066 to 1073 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 456 to 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 247 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 164 to 169 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 283 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 366 to 374 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 388 to 391 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 417 to 419 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 423 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 433 to 434 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 463 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 487 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 670 to 677 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1328 to 1335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 22 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 119 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 122 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 244 to 249 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 281 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 31 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 79 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 323 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 356 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 370 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 376 to 377 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 395 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 430 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 175 to 302 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 515 to 644 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 633 to 760 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 to 23 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 74 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 154 to 159 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 210 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 309 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 432 to 435 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 10 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 133 to 141 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 499 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 501 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 548 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 553 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 300 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 746 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 915 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 917 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 283 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 383 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 384 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 109 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 27 to 29 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 88 to 93 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 224 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 234 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 245 to 251 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 287 to 292 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 429 to 433 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 492 to 495 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 542 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 617 to 628 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 759 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 761 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 763 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 765 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 770 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 61 to 67 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 461 to 468 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 498 to 502 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 567 to 570 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1065 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1097 to 1103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 176 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 205 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 233 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 314 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 125 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 252 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 263 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 267 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 129 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 220 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 251 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 113 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 207 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 121 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 378 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 119 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 127 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 171 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 190 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 216 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 345 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 30 to 33 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 295 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 327 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 350 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 446 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 466 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 491 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 496 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 538 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 517 to 524 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 94 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 152 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 187 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 49 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1611 to 1618 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 718 to 724 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 779 to 781 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 806 to 814 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 875 to 877 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1017 to 1018 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1022 to 1023 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 235 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 425 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 427 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 266 to 271 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 290 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 379 to 381 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 412 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 506 to 509 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 7 to 21 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 75 to 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 to 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 403 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 579 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 581 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 583 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 590 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 619 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 621 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 623 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 625 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 128 to 134 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 277 to 283 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 154 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 260 to 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 to 285 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 281 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 284 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 480 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 184 to 192 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 253 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 321 to 325 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 347 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 190 forms a bond with folate, indicating a strong binding affinity.
The residue at position 193 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 214 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 48 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 151 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 340 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 412 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 469 to 470 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 478 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 79 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 117 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 175 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 543 to 550 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 69 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 157 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 97 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 176 to 182 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 40 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 129 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 65 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 445 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 447 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 451 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 456 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 482 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 484 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 621 to 623 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 670 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 279 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 36 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 185 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 376 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 254 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 334 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 334 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 482 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 191 to 196 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 375 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 420 to 427 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 467 to 471 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 521 to 524 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 forms a bond with Ni of coenzyme F430, indicating a strong binding affinity.
The residue at position 229 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 274 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 336 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 447 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 260 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 136 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 143 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 373 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 21 to 27 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 165 to 169 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 202 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 214 to 217 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 272 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 332 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 406 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 522 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 661 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 722 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 242 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 289 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 309 to 310 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 324 to 330 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 343 to 344 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 435 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 560 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 604 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 261 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 340 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 55 to 58 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 143 to 150 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 to 206 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 190 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 418 forms a bond with heme, indicating a strong binding affinity.
The residue at position 602 forms a bond with heme, indicating a strong binding affinity.
The residue at position 482 to 484 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 85 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 230 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 479 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 537 to 541 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 575 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 582 to 584 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 638 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 664 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 670 to 673 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 745 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 244 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 247 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 41 to 47 forms a bond with phosphatidylinositol bisphosphate, indicating a strong binding affinity.
The residue at position 100 to 106 forms a bond with phosphatidylinositol bisphosphate, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with phosphatidylinositol bisphosphate, indicating a strong binding affinity.
The residue at position 107 to 112 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1644 to 1651 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 203 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 209 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 354 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 456 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 471 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 475 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 485 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 490 to 493 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 501 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 635 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 661 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 644 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 655 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 90 to 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 495 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 498 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 511 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 515 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 523 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 526 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 544 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 113 to 118 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 453 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 491 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ni of coenzyme F430, indicating a strong binding affinity.
The residue at position 228 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 273 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 335 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 446 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 9 to 15 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 196 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 78 to 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 to 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 630 to 637 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 132 to 140 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 58 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 84 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 110 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 117 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 55 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 55 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 194 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 369 to 377 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 391 to 394 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 274 to 279 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 to 297 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 331 forms a bond with (S)-2-amino-6-oxohexanoate, indicating a strong binding affinity.
The residue at position 427 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 489 forms a bond with (S)-2-amino-6-oxohexanoate, indicating a strong binding affinity.
The residue at position 490 forms a bond with (S)-2-amino-6-oxohexanoate, indicating a strong binding affinity.
The residue at position 286 to 293 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 557 to 564 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 331 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 350 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 353 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 264 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 268 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 313 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 397 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 399 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 119 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 127 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 129 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 190 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 22 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 61 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 66 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 70 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 89 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 92 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 95 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 99 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 130 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 658 to 665 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 148 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 219 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 394 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 357 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 73 to 77 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 459 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 535 to 538 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 595 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 599 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 602 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 995 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 208 to 212 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 241 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 415 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 700 to 707 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1409 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1412 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1427 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1429 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1432 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1435 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1454 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1459 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1499 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1505 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1520 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1523 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1528 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1531 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1537 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1542 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1575 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1578 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1593 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1596 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1601 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1604 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1612 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1618 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 35 to 40 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 to 228 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 367 to 374 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 411 to 415 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 20 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 to 298 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 10 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 114 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 27 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 94 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 146 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 97 to 104 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 to 167 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 90 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 315 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 89 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 730 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 732 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 736 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 736 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 742 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 782 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 782 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 786 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 788 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 793 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 814 to 816 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 852 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 854 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1133 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1136 to 1137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1139 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1192 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1194 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1199 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 7 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 128 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 402 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 660 to 668 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 250 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 449 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 449 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 476 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 476 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 482 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 529 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 571 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 571 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 577 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 631 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 631 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 632 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 633 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 633 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 639 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 255 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 120 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 150 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 159 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 169 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 181 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 103 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 44 to 79 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 193 to 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 639 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 645 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 679 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 683 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 683 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 116 to 124 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 148 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 192 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 220 to 224 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 320 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 89 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 103 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 108 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 128 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 194 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 198 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 313 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 549 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 134 to 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 250 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 322 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 219 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 270 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 283 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 314 to 318 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 102 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 31 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 401 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 153 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 387 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 461 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 346 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 347 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 349 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 405 to 406 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 472 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 531 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 532 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 251 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 196 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 202 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 108 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 555 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 559 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 71 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 71 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 to 292 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2 to 10 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 43 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 83 to 87 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 194 to 204 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 286 to 294 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 219 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 513 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 516 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 709 to 710 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 886 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 888 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 672 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 726 to 733 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 760 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 766 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 786 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 789 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 790 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 790 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1080 to 1087 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 to 254 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 311 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 739 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 741 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 743 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 745 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 747 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 13 to 21 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 24 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 26 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 43 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 293 to 305 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 255 to 258 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 734 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 770 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 771 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 771 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 881 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 539 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 543 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 543 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 684 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 692 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 97 to 102 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 428 to 435 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 482 to 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 to 88 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 310 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 386 to 388 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 410 to 415 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 522 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 583 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 15 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 347 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 370 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 385 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 242 to 265 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 299 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 365 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 38 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 41 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 192 to 197 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 192 to 197 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 228 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 228 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 361 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 412 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 392 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 407 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 469 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 471 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 483 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 484 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 508 to 515 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 125 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 83 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 95 to 99 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 119 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 211 to 216 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 633 to 640 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1280 to 1287 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 106 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 170 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 242 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 312 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 445 to 447 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 445 to 447 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 498 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 498 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 529 to 530 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 575 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 613 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 613 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 619 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 740 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 272 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 601 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 363 to 370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 76 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 84 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 484 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 486 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 195 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 82 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 141 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 467 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 253 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 254 to 380 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 527 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 529 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 531 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 905 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 988 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 371 to 381 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 458 to 463 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 510 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 512 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 519 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 520 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 521 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 568 to 575 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 653 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 656 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 658 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 664 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 675 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 8 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 160 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 161 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 156 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 329 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 417 to 421 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 437 to 446 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 447 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 17 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 135 to 141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 30 to 34 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 92 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 to 219 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1031 to 1039 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1059 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 363 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 692 to 749 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 816 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 828 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 830 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 521 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 299 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 305 to 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 779 to 786 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 62 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 187 to 193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 427 to 434 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 473 to 477 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 527 to 530 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 346 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 123 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 223 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 226 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 252 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 18 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 259 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 285 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 147 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 329 to 336 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 668 to 676 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 698 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 350 to 357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 53 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 62 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 69 to 72 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 35 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 37 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 61 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 74 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 485 to 487 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 644 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 710 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 824 to 828 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 824 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 474 to 481 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 520 to 524 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 574 to 577 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 367 to 376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 463 to 464 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 91 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 151 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 155 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 306 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 161 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 236 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 252 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 554 to 561 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 310 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 489 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 491 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 99 forms a bond with dimethylallyl diphosphate 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with dimethylallyl diphosphate 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with dimethylallyl diphosphate 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with dimethylallyl diphosphate 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with dimethylallyl diphosphate 1, indicating a strong binding affinity.
The residue at position 241 forms a bond with dimethylallyl diphosphate 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with dimethylallyl diphosphate 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with dimethylallyl diphosphate 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with dimethylallyl diphosphate 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with dimethylallyl diphosphate 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 103 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 180 to 186 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 209 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 108 to 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 963 to 970 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1054 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1971 to 1979 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2072 to 2073 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 to 140 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 275 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe of heme b bD, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme b bP, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe of heme b bD, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme b bP, indicating a strong binding affinity.
The residue at position 574 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 3 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 90 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 92 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 154 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 400 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 401 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 292 to 298 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 249 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 201 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 261 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 287 to 288 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 311 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 10 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 33 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 36 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 194 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 169 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 451 to 458 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 497 to 501 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 551 to 554 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 818 to 820 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 871 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 896 to 899 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 913 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 947 to 951 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 977 to 980 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 454 to 461 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 320 to 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 547 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 547 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 551 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 691 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 699 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 330 to 332 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 352 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 418 to 421 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 453 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 223 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 310 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 332 to 342 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 429 to 430 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 307 forms a bond with heme, indicating a strong binding affinity.
The residue at position 177 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 78 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 183 to 187 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 142 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 151 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 138 to 143 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1006 to 1014 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1034 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 89 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 53 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 249 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 230 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 55 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 173 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 181 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 421 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 441 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 455 to 457 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 457 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 518 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 2 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 232 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 154 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 161 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 159 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 194 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 194 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 202 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 205 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 96 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 129 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 147 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 149 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 175 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 179 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 180 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 225 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 19 to 21 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 9 forms a bond with UMP residue of RNA, indicating a strong binding affinity.
The residue at position 34 forms a bond with UMP residue of RNA, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with UMP residue of RNA, indicating a strong binding affinity.
The residue at position 75 forms a bond with UMP residue of RNA, indicating a strong binding affinity.
The residue at position 81 forms a bond with UMP residue of RNA, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with UMP residue of RNA, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with UMP residue of RNA, indicating a strong binding affinity.
The residue at position 985 to 993 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1013 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 to 57 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 91 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 161 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 197 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 409 to 412 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 511 to 515 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 553 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 327 to 333 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 230 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 787 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1106 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1109 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 175 to 181 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 570 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 572 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 574 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 576 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 87 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 88 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 180 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 203 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 172 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 236 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 123 to 136 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 159 to 168 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 34 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 84 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 407 to 414 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 570 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 419 to 539 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 220 to 223 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 223 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 231 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 446 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 490 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 490 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 484 to 490 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 562 to 564 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 919 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 921 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1028 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1081 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 31 to 35 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 157 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 303 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 230 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 281 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 335 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 298 to 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 86 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 307 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 81 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 84 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 607 to 615 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 314 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 342 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 496 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 498 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 507 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 364 to 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 166 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 500 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 537 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 537 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 647 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 153 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 135 to 141 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 164 to 170 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 357 to 365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 134 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 to 112 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 266 to 274 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 244 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 275 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 209 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 216 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 455 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 460 to 463 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 480 to 484 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 559 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 572 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 176 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 180 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 136 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 142 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 79 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 142 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 142 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 174 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 237 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 308 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 43 to 72 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 55 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 139 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 147 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 148 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 196 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 273 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 337 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 392 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 443 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 479 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 504 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 593 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 628 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 628 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 630 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 632 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 632 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 636 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 639 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 13 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 76 forms a bond with devancoaminyl-vancomycin, indicating a strong binding affinity.
The residue at position 80 forms a bond with devancoaminyl-vancomycin, indicating a strong binding affinity.
The residue at position 103 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 246 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 293 to 296 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 309 to 314 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 668 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 672 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 697 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 728 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 744 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 745 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 746 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 746 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 832 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 833 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 876 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 90 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 351 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 389 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 412 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 499 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 423 to 431 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 204 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 350 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 354 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 390 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 357 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 360 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 384 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 469 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 474 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 520 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 523 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 538 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 541 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 546 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 549 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 556 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 566 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 204 to 209 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 374 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 140 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 380 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 382 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 400 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 401 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 402 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 27 to 29 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 54 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 176 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 198 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 418 to 425 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 464 to 468 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 518 to 521 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 262 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 279 to 283 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 398 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 522 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 713 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 717 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 861 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 forms a bond with a 2,3-saturated acyl-CoA, indicating a strong binding affinity.
The residue at position 171 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 198 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with a 2,3-saturated acyl-CoA, indicating a strong binding affinity.
The residue at position 301 forms a bond with a 2,3-saturated acyl-CoA, indicating a strong binding affinity.
The residue at position 338 forms a bond with a 2,3-saturated acyl-CoA, indicating a strong binding affinity.
The residue at position 420 to 424 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 447 forms a bond with a 2,3-saturated acyl-CoA, indicating a strong binding affinity.
The residue at position 449 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 456 forms a bond with a 2,3-saturated acyl-CoA, indicating a strong binding affinity.
The residue at position 460 to 461 forms a bond with a 2,3-saturated acyl-CoA, indicating a strong binding affinity.
The residue at position 654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 520 to 528 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 511 to 518 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 561 to 565 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 615 to 618 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 14 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 16 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 32 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 36 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 47 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 49 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 52 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 54 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 639 to 647 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 665 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 186 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 forms a bond with substrate 1, indicating a strong binding affinity.
The residue at position 417 to 418 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 451 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 21 to 28 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 112 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 320 to 341 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 363 to 382 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 533 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 274 to 277 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 28 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 389 to 396 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 435 to 439 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 489 to 492 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 229 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 228 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 162 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 54 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 87 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 107 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 133 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 137 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 138 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 45 to 50 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 174 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 507 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 507 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 509 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 36 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 394 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 418 to 421 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 480 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 408 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 412 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 195 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 595 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 600 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 642 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 644 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 737 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 909 to 911 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 958 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 964 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 983 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 986 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1049 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1079 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1083 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1083 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1208 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 131 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 329 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 353 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 355 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 210 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 261 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 343 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 4 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 7 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 773 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 779 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 784 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 809 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 811 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 533 to 538 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 533 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 533 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 549 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 555 to 557 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 555 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 555 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 557 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 648 to 651 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 717 to 718 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 458 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 536 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 561 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 609 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 676 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 680 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 969 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1026 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1042 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1147 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1219 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1222 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 644 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 272 to 276 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 299 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 99 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 73 to 76 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 117 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 154 to 189 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 296 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 455 to 463 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 343 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 11 to 78 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 179 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 323 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 791 to 799 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 115 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 136 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 864 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 866 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 875 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 876 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 40 to 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 390 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 441 to 448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 289 to 300 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 319 to 321 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 165 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 214 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 218 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 255 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 116 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 119 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 143 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 219 to 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 309 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 333 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 365 to 382 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 472 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 9 to 16 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 to 59 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 805 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 931 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 931 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 946 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 947 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 297 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 371 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 406 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 421 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 482 to 486 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 683 to 687 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 707 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 794 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 800 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 821 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 824 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 825 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 52 to 57 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 125 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 475 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 536 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 604 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 361 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 364 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 370 to 371 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 389 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 695 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 401 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 401 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 341 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 365 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 459 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 832 to 839 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 612 to 619 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 267 to 272 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 564 to 566 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 115 to 124 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 71 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 114 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 30 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 236 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 154 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 163 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 295 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 322 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 214 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 276 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 322 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 244 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 833 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 836 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 850 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 853 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 859 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 863 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 871 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 128 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 133 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 200 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 5 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 to 102 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 to 272 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 245 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 112 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 317 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 321 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 325 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 366 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 235 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 246 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 251 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 296 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 30 to 36 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 123 to 130 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 351 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 452 to 459 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 488 to 492 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 557 to 560 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 244 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 90 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 122 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 301 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 437 to 438 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 157 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 410 to 417 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 456 to 460 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 306 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 476 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 501 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 307 to 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 276 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 394 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 281 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 555 to 567 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 589 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 602 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 244 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 285 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 285 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 289 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 289 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 293 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 214 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 369 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 30 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 33 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 622 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 626 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 28 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 115 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 390 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 413 to 415 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 445 to 446 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 471 to 476 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 477 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 136 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 874 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 958 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 961 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with heme, indicating a strong binding affinity.
The residue at position 189 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 298 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 4 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 280 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 295 to 299 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 293 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 315 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 358 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 389 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 403 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 407 to 409 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 475 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 558 to 566 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1 to 6 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 14 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 619 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 620 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 657 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 664 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 674 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 563 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 52 to 81 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 300 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 501 to 505 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 527 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 19 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 310 to 316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 316 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 342 to 344 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 37 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 40 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 182 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 881 to 888 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 55 to 62 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 to 164 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 380 to 383 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 116 to 123 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 to 202 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 256 to 259 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 293 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 329 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 to 306 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 991 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 993 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1002 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1003 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 349 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 130 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 139 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 305 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 423 to 426 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 278 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 121 to 128 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 68 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 152 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 171 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 175 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 116 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 436 to 438 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 436 to 438 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 489 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 489 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 520 to 521 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 566 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 604 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 604 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 610 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 646 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 648 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 731 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 3 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 6 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 35 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 58 forms a bond with heme, indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 142 to 150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1647 to 1654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 549 to 556 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1007 to 1012 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 342 to 350 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 364 to 367 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 579 to 581 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 579 to 581 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 586 to 592 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 586 to 592 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 617 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 617 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 251 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 325 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 328 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 356 to 363 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 319 forms a bond with heme, indicating a strong binding affinity.
The residue at position 455 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 281 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 236 to 243 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 282 to 286 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 12 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 12 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 400 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 400 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 400 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 404 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 404 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 415 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 415 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 457 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 490 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 490 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 490 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 166 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 43 to 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 121 to 128 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 to 171 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 461 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 57 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 85 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 94 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 257 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 261 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 286 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 133 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 429 to 436 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 475 to 479 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 529 to 532 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 275 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 690 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 691 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 801 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 828 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 831 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 832 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 832 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 to 413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 496 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 576 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 576 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 578 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 235 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 140 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 156 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 800 to 808 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 512 to 518 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 324 forms a bond with suvorexant, indicating a strong binding affinity.
The residue at position 25 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 300 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 53 to 62 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 165 to 212 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 388 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 181 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 285 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 257 to 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 forms a bond with heme, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 to 281 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 246 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 6 to 30 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 355 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 166 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 376 to 384 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 to 389 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 277 to 282 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 286 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 394 to 398 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 419 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 423 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 437 to 438 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 93 to 124 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 451 to 454 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 624 to 626 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 659 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 697 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 110 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 117 to 123 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 694 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1112 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1121 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1122 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 36 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 343 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 345 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 376 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 231 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 479 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 517 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 669 to 677 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 223 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 314 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 337 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 345 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 350 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 404 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 407 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 422 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 425 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 430 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 433 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 445 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 453 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 120 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 169 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 186 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 201 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 11 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 777 to 785 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 272 to 275 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 to 181 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 41 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 61 forms a bond with heme, indicating a strong binding affinity.
The residue at position 98 forms a bond with toluene-4-sulfonate, indicating a strong binding affinity.
The residue at position 100 forms a bond with toluene-4-sulfonate, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 99 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 100 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 186 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 465 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 473 to 480 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 454 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 269 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 272 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 392 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 422 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 457 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 461 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 476 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 to 86 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 177 to 180 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 851 to 859 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 879 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 169 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 63 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 87 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 107 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 290 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 433 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 461 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 467 to 470 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 644 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 702 to 706 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 747 to 749 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 833 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 839 to 842 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 920 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 15 to 22 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 183 to 187 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 111 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 261 to 280 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 440 to 442 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 465 to 467 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 482 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 29 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 98 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 550 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 553 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 197 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 456 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 532 to 535 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 592 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 596 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 599 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1006 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 556 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 281 to 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 324 to 343 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 281 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 226 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 289 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 330 forms a bond with 3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-seryl residue of a glycoprotein, indicating a strong binding affinity.
The residue at position 330 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 359 forms a bond with 3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-seryl residue of a glycoprotein, indicating a strong binding affinity.
The residue at position 382 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 384 forms a bond with 3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-seryl residue of a glycoprotein, indicating a strong binding affinity.
The residue at position 929 to 936 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 563 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 283 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 461 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 463 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 204 to 212 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 647 to 655 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 674 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 982 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 988 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 61 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 85 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 87 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 110 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 136 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 137 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 157 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 399 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 540 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 541 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 565 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 703 to 710 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 170 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 423 to 427 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 261 to 264 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 136 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 432 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 445 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 305 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 386 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 389 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 392 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 396 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 268 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 114 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 347 to 350 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 112 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 228 to 234 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 404 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 178 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 266 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 155 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 169 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 179 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 177 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 957 to 965 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 979 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 118 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 64 forms a bond with urate, indicating a strong binding affinity.
The residue at position 65 forms a bond with urate, indicating a strong binding affinity.
The residue at position 166 forms a bond with urate, indicating a strong binding affinity.
The residue at position 183 forms a bond with urate, indicating a strong binding affinity.
The residue at position 238 forms a bond with urate, indicating a strong binding affinity.
The residue at position 239 forms a bond with urate, indicating a strong binding affinity.
The residue at position 265 forms a bond with urate, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 120 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 465 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 830 to 838 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 855 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 259 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 295 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 350 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 72 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 160 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 77 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 221 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 228 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 251 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 255 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 42 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 262 to 268 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 294 to 299 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 174 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 352 to 356 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 505 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 582 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 582 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 584 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 542 to 545 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 616 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 619 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 634 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 636 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 639 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 642 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 666 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 704 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 728 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 733 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 736 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 741 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 746 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 782 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 785 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 800 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 803 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 808 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 811 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 819 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 828 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 331 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 310 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 312 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 313 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 315 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 349 to 351 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 396 to 400 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 477 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 536 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 537 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 570 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 890 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 895 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 914 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 917 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 923 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 925 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 258 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 413 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 328 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 375 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 73 to 77 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 113 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 117 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 60 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 281 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 619 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 718 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 160 to 167 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 to 211 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 62 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 190 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 229 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 233 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 172 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 192 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 206 to 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 233 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 221 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 68 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 441 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 449 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 470 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 537 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 585 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 591 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 709 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 782 to 786 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 785 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 830 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 834 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 886 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 974 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1172 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1227 to 1228 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 to 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 799 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 233 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 357 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 372 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 383 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 386 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 392 to 393 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 429 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 446 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 437 to 441 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 623 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 625 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 397 to 401 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 599 to 603 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 58 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 238 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 237 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 239 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 321 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 326 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 193 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 350 to 357 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 83 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 72 to 79 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 250 to 253 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 169 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 660 to 667 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1252 to 1259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 152 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 167 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 274 to 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 84 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 525 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 933 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 311 to 315 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 316 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 37 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 310 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 313 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 824 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 359 to 367 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 to 77 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 452 to 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 to 213 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 80 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 11 to 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 228 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 261 to 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with urate, indicating a strong binding affinity.
The residue at position 170 forms a bond with urate, indicating a strong binding affinity.
The residue at position 187 forms a bond with urate, indicating a strong binding affinity.
The residue at position 236 forms a bond with urate, indicating a strong binding affinity.
The residue at position 262 forms a bond with urate, indicating a strong binding affinity.
The residue at position 4 to 8 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 40 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 198 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 10 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 392 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 628 to 633 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 700 to 706 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 750 to 751 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 298 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 334 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 433 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 456 to 457 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 467 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 166 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 71 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 96 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 83 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 101 to 105 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 173 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 276 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 320 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 326 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 330 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 348 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 12 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 12 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 73 to 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 78 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 480 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 239 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 368 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 433 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 507 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 509 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 515 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 525 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 595 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 347 to 350 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 534 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 537 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 542 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 420 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 467 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 481 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 30 to 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 to 148 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 209 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 657 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 665 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 673 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 674 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 25 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 582 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 956 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 959 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1293 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1371 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1374 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1676 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1781 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1784 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 10 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 28 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 709 to 716 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 5 to 6 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 217 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 243 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 256 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 427 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 431 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 604 to 607 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 823 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 852 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 131 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 586 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 712 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 712 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 714 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 62 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 161 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 292 to 298 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 296 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 298 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 408 to 410 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 557 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 139 to 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 451 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 489 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 494 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 519 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 521 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 523 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 525 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 530 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 553 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 555 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 557 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 559 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 564 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 523 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 119 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 119 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 41 forms a bond with iodide, indicating a strong binding affinity.
The residue at position 107 forms a bond with iodide, indicating a strong binding affinity.
The residue at position 171 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 175 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 201 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 285 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 301 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 364 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 36 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 166 to 173 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 320 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 466 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 484 to 488 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 496 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 526 to 528 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 99 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 119 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 to 388 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 572 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 5 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 56 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 979 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1086 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1138 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 479 to 486 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 834 to 839 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1031 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1119 to 1124 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 1293 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 1310 to 1311 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 41 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 1366 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1368 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1370 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1372 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1377 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 44 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 101 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 75 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 85 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 95 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 95 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 289 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 221 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 100 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 139 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 67 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 89 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 116 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 117 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 186 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 56 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 296 to 301 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 413 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 169 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 352 to 359 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 214 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 401 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 472 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 518 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 525 to 526 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 534 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 15 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 56 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 295 to 298 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 138 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 451 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 556 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 625 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 463 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 176 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 983 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 101 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 463 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 466 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 468 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 519 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 520 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 521 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 525 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 50 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 361 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 449 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 469 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 483 to 485 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 485 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 337 to 340 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 182 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 257 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 271 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 282 to 288 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 314 to 319 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 444 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 390 to 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 39 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 72 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 93 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 430 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 504 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 506 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 512 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 514 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 522 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 592 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 210 to 215 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 146 to 160 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 172 to 209 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 954 to 962 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 403 to 407 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 414 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 982 to 989 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 67 to 72 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 382 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 88 to 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 526 to 529 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 55 to 64 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 101 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 120 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 403 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 274 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 106 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 166 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 175 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 59 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 62 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 82 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 835 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 837 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 839 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 846 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 344 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 183 to 189 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 208 to 212 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 346 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 152 to 156 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 66 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 68 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 123 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 180 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 297 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 326 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 330 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 334 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 9 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 39 to 42 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 123 to 134 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 11 to 15 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 20 to 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 186 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 129 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 433 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 434 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 440 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 442 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 340 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 252 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 256 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 260 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 667 to 674 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 427 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 464 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 465 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 483 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 501 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 503 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 505 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 507 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 546 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 548 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 550 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 552 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 557 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 73 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 241 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 289 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 290 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 122 to 131 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 239 to 242 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 335 to 339 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 229 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 381 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 15 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 213 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 to 22 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 16 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 723 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 305 to 313 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 828 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 838 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 187 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 36 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 325 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 381 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 400 to 403 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 476 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 72 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 78 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 157 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 216 to 223 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 328 to 331 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 493 to 498 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 177 to 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 235 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 638 to 645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1255 to 1262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 398 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 398 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 398 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 404 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 404 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 404 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 445 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 445 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 445 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 573 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 573 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 573 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 104 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 270 to 277 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 316 to 320 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 455 to 462 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1154 to 1161 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 325 to 331 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 475 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 482 to 487 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 482 to 483 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 333 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 369 to 371 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 392 to 393 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 416 to 420 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 450 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 509 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 510 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 91 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 73 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 336 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 336 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 337 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 434 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 436 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 448 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 298 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 483 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 487 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 619 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 375 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 379 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 485 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 511 to 512 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 534 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 561 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 721 to 730 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 797 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 805 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 822 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 568 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 638 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 279 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 582 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 497 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 501 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 503 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 541 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 256 to 261 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 316 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 112 to 165 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 25 to 31 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 9 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 130 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 319 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 321 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 336 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 344 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 10 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 21 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 48 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 53 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 15 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 17 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 167 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 182 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 183 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 184 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 199 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 197 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 224 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 124 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 194 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 675 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 677 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 679 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 681 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 311 to 321 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 203 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 267 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 284 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 360 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 378 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 128 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 329 forms a bond with heme, indicating a strong binding affinity.
The residue at position 467 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 102 to 108 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 189 to 196 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 88 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 163 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 397 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 209 to 214 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 444 to 446 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 444 to 446 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 497 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 497 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 528 to 529 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 574 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 612 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 612 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 618 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 172 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 636 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 738 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 759 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 760 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 761 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 762 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 762 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 278 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 14 to 20 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 273 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 302 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 452 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 456 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 459 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 5 to 9 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 437 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 132 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 206 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 207 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 412 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 565 to 573 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 588 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 274 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 279 to 284 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 273 to 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 125 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 375 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 70 to 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 180 to 190 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 241 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 288 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 1800 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2104 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2106 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 312 to 315 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 890 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 145 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 145 to 160 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 to 208 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 22 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 25 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 29 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 18 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 194 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 546 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 562 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 565 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 570 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 573 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 590 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 593 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 705 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 861 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 862 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 356 to 475 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 291 to 292 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 358 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 303 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 304 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 333 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 474 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 293 to 299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 297 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 299 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 407 to 409 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 493 to 499 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 255 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 to 32 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 742 to 749 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1426 to 1433 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 to 375 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 397 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 517 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 626 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 57 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 1093 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1095 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1104 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1105 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 363 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 368 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 400 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 408 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 485 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 486 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 487 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 547 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 553 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 1300 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1302 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1303 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1305 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1308 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 66 to 73 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 235 to 246 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 18 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 198 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 361 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 364 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 364 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 409 to 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 610 to 617 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 373 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 747 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 783 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 784 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 784 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 894 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 31 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 465 to 469 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 570 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 595 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 620 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 625 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 641 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 642 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 643 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 643 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 727 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 771 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 13 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 82 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 61 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 160 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 271 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 318 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 116 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 159 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 177 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 188 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 194 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 226 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 231 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 267 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 274 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 605 to 613 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 266 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 290 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 572 to 580 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 to 32 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 192 to 197 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 356 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 9 to 13 forms a bond with a cardiolipin, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 349 to 351 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 224 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 37 to 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 133 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 133 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 103 to 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 74 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 103 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 149 to 157 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 569 to 570 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 599 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 12 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 148 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 208 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 230 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 614 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 617 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 717 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 776 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 408 to 410 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 412 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 429 to 430 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 434 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 449 to 450 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 472 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 496 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 498 to 500 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 516 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 172 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 300 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 367 to 370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 402 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 179 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 187 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 273 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 214 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 208 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 277 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 23 to 27 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 165 to 170 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 238 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 288 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 323 to 329 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 279 to 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 172 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 171 to 177 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 359 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 51 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 44 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 66 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 33 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 283 to 292 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 233 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 307 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 443 to 446 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 341 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 345 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 354 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 339 to 341 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with a carboxymycobactin, indicating a strong binding affinity.
The residue at position 128 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 147 forms a bond with a carboxymycobactin, indicating a strong binding affinity.
The residue at position 156 forms a bond with a carboxymycobactin, indicating a strong binding affinity.
The residue at position 156 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 160 forms a bond with a carboxymycobactin, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 131 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 453 to 455 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 453 to 455 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 506 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 506 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 537 to 538 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 621 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 621 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 627 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 748 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 663 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 68 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 83 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 137 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 344 to 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 456 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 206 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 38 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 156 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 322 to 325 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 410 to 412 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 430 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 306 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 541 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 568 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 743 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 773 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 776 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 230 forms a bond with octopamine, indicating a strong binding affinity.
The residue at position 278 forms a bond with octopamine, indicating a strong binding affinity.
The residue at position 149 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 290 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 366 to 370 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with 5-(2-hydroxyethyl)-4-methylthiazole, indicating a strong binding affinity.
The residue at position 462 forms a bond with 5-(2-hydroxyethyl)-4-methylthiazole, indicating a strong binding affinity.
The residue at position 43 to 49 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 214 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 311 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 315 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 319 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 417 to 418 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 510 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 5 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 10 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 12 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 17 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 23 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 31 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 46 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 50 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 50 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 54 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 56 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 57 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 57 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 150 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 162 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 15 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 289 to 299 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 88 forms a bond with 5-hydroxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 382 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 153 to 168 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 179 to 211 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 122 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 106 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 to 342 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 52 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 280 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 759 to 766 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 88 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 92 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 222 to 229 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 209 to 217 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 37 to 65 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 226 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 497 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 624 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 627 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 418 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 421 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 473 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 474 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 475 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 415 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 418 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 420 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 405 to 412 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 187 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1091 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1102 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1103 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 43 to 51 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 350 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 355 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 360 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 361 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 397 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 402 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 403 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 90 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 197 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 336 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with 4-nitrobenzoate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 4-nitrobenzoate, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 339 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 82 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 36 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 62 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 369 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 492 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 532 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 532 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 353 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 373 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 150 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 509 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 549 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 21 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 416 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 439 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 448 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 451 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 354 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 384 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 456 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 484 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 487 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 60 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 85 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 144 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 208 to 215 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 606 to 613 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 148 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 688 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 696 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 704 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 705 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 669 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 673 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 587 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 689 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 710 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 711 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 712 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 713 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 82 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 102 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 104 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 104 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 104 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 112 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 112 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 177 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 232 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 260 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 331 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 414 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 430 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 430 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 188 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 334 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 135 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 74 to 79 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 157 to 166 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 392 to 395 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 410 to 412 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 416 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 425 to 428 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 525 to 526 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 531 to 535 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 606 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 720 to 727 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 to 153 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 159 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 195 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 242 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 267 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 299 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 583 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 585 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 615 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 647 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 209 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 317 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 310 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 367 to 371 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 394 to 395 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 396 to 398 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 119 to 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 419 forms a bond with heme, indicating a strong binding affinity.
The residue at position 603 forms a bond with heme, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 114 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 60 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 73 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 84 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 226 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 121 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 232 forms a bond with 17alpha-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 232 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 364 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 425 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 427 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 303 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 41 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 171 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 105 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 404 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 451 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 451 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 453 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 532 to 654 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 591 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 606 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 6 forms a bond with prephenate, indicating a strong binding affinity.
The residue at position 89 forms a bond with prephenate, indicating a strong binding affinity.
The residue at position 107 forms a bond with prephenate, indicating a strong binding affinity.
The residue at position 339 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 402 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 126 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 130 to 136 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 162 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 132 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 12 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 305 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 309 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 313 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 112 to 117 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 455 to 462 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 129 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 178 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 326 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 382 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 454 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 494 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 583 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 618 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 622 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 622 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 626 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 629 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 443 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 476 to 480 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 526 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 433 to 437 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 501 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 303 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 322 to 330 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 334 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 380 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 146 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 394 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 431 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 60 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 41 to 47 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 307 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 391 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 464 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 314 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 1840 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1844 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1860 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1863 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 383 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 385 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 470 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 602 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 602 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 606 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 606 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 746 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 750 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 754 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1123 to 1129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 69 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 414 to 421 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 320 to 323 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 407 to 413 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1115 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1118 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1131 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1134 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1139 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1142 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1161 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1164 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 154 to 162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 508 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 513 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 546 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 553 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 578 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 580 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 118 to 131 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 154 to 163 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 11 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 295 to 299 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 46 forms a bond with O2, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 142 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 298 to 302 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 362 to 365 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 807 to 815 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 160 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 264 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 335 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 337 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 374 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 704 to 712 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 481 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 203 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 211 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 297 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 7 to 13 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 99 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 388 to 390 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 390 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 421 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 333 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 6 to 8 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 67 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 201 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 241 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 242 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 251 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 138 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 154 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 157 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 174 to 221 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 332 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 492 to 495 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 510 to 512 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 526 to 529 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 573 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 634 to 635 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 640 to 644 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 676 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 714 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 31 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 396 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 400 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 70 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 107 to 112 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 134 to 140 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 156 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 124 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 128 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 149 forms a bond with an alpha-D-galactoside, indicating a strong binding affinity.
The residue at position 292 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 161 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 100 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 214 to 345 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 304 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 348 to 472 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 417 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 167 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 586 to 594 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 217 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 228 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 223 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 451 forms a bond with aclacinomycin Y, indicating a strong binding affinity.
The residue at position 493 forms a bond with aclacinomycin Y, indicating a strong binding affinity.
The residue at position 22 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 30 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 135 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 207 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 227 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 228 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 240 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 204 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 204 to 209 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 to 169 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 349 to 353 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 878 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 671 to 678 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 25 to 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 610 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 416 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 419 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 421 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 472 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 473 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 715 to 723 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 788 to 790 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 834 to 839 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 509 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 509 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 595 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 595 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 596 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 596 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 597 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 597 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 27 to 33 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 23 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 46 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 262 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 604 to 611 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 84 to 88 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 413 to 415 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 425 to 426 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 449 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 532 to 537 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 532 to 536 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 603 to 604 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 620 to 621 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 656 to 657 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 657 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 680 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 680 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 682 to 683 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 708 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 739 to 742 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 747 to 748 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 784 to 788 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 861 to 863 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 863 to 867 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 897 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 283 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 450 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 597 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 635 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 641 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 665 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 673 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 753 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 767 to 769 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 829 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 888 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 963 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 99 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 221 to 232 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 503 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 591 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1187 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1191 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 93 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 50 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 242 to 246 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 404 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 432 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 457 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 542 to 549 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 214 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 380 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 115 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 18 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 551 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 555 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 674 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 278 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 107 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 242 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 244 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 314 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 520 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 587 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 706 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 787 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 555 to 562 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 431 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 459 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 276 to 282 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 325 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 194 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 402 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 402 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 120 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 183 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 183 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 219 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 279 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 42 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 224 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 225 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 373 to 381 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 175 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 256 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 to 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 184 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 502 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 548 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 552 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 321 to 325 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 164 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 312 to 316 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 402 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 362 to 364 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 393 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 395 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 397 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 401 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 442 to 446 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 475 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 482 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 482 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 486 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 25 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 116 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 130 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 175 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 91 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 120 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 233 forms a bond with 17alpha-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 233 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 365 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 426 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 428 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 331 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 41 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 90 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 245 to 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 5 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 6 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 133 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 547 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 199 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 275 to 278 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 493 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 496 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 500 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 512 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 85 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 190 to 198 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 8 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 425 to 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 136 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 137 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 185 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 381 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 432 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 493 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 582 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 617 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 617 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 619 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 621 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 621 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 625 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 6 to 13 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 to 57 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 337 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 349 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 408 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 281 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1057 to 1064 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with thebaine, indicating a strong binding affinity.
The residue at position 105 forms a bond with thebaine, indicating a strong binding affinity.
The residue at position 785 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 789 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 494 to 502 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 4 to 10 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 165 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 392 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 89 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 155 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 64 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 185 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 293 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 338 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 359 to 366 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 to 216 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 439 to 443 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 443 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 to 284 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 164 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 204 to 210 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 206 to 210 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 533 to 540 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 769 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 773 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 849 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 22 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 725 to 732 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 783 to 791 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 809 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 91 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 487 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 489 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 557 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 to 292 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 80 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 396 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 403 to 405 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 493 to 496 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 670 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 727 to 731 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 765 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 772 to 774 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 858 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 864 to 867 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 963 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 365 to 369 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 297 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 334 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 475 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 478 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 478 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 486 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 395 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 104 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 714 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 216 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 216 to 220 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 105 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 162 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 383 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 385 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 400 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 402 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1102 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1104 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1116 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1119 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1124 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1127 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1139 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1142 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 544 to 552 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 358 to 361 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 490 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 119 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 256 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 277 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 324 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 346 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 351 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 449 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 453 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 455 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 38 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 194 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 202 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 287 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 145 to 276 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 277 to 398 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 145 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 175 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 232 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 382 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 385 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 410 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 428 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 445 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 93 to 101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 to 321 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 385 to 388 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 709 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 711 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 713 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 268 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 362 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 456 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 174 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 251 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 252 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 271 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 367 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 327 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 366 to 368 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 406 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 430 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 216 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 48 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 141 forms a bond with W of W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 296 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 300 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 422 to 423 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 460 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 465 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 602 to 613 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 606 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 676 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 699 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 720 forms a bond with W-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 292 to 296 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 249 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 350 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 177 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 212 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 218 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 274 to 279 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 238 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 242 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 308 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 330 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 331 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 335 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 343 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 436 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 440 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 443 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 67 to 75 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 334 to 343 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 59 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 206 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 482 to 487 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 112 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 to 180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 205 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 367 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 394 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 381 to 388 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 420 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 420 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 333 to 335 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 64 forms a bond with tetracycline, indicating a strong binding affinity.
The residue at position 82 forms a bond with tetracycline, indicating a strong binding affinity.
The residue at position 41 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 168 to 175 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 935 to 942 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 71 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 78 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 193 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 428 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 295 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 420 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 372 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 401 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 558 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 257 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 to 345 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 132 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 268 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 363 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 139 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 143 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 146 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 363 to 367 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 466 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 679 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 to 345 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 61 to 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 228 to 264 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1136 to 1142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 351 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 439 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 327 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 417 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 467 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 467 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 167 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 345 to 352 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 391 to 395 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 445 to 448 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 474 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 339 to 347 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 to 248 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 forms a bond with GDP-alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 217 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 274 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 1 to 7 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 275 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 277 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 319 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 401 to 402 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 488 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 513 to 516 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 564 to 567 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 684 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 to 108 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 303 to 306 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 134 to 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 64 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 80 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 190 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 362 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 368 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 399 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 470 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 498 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 501 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 223 to 228 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 10 to 24 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 526 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 131 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 356 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 360 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 404 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 217 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 481 to 488 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 120 to 126 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 145 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 870 to 1003 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 282 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 123 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 278 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 304 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 494 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 502 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 351 to 356 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 181 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 892 to 899 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 163 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 180 to 183 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 253 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 267 to 271 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 274 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 290 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 359 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 864 to 871 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 145 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 105 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 113 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 833 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 914 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 917 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 112 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 202 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 356 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 166 to 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 79 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 463 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 158 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 285 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 314 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 947 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 958 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 249 to 255 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1363 to 1370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2070 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 2073 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 2088 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 2090 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 2093 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 2096 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 2115 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 2120 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 2160 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 2166 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 2181 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 2184 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 2189 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 2192 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 2198 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 2203 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 2236 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 2239 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 2254 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 2257 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 2262 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 2265 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 2273 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 2279 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 850 to 857 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 433 to 436 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 449 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 88 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 163 to 172 forms a bond with folate, indicating a strong binding affinity.
The residue at position 153 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 399 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 385 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 767 to 774 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 133 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 206 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 302 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 441 to 444 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 486 to 487 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 526 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 281 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 286 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 299 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 303 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 311 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 316 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 329 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 341 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 344 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 357 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 361 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 315 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 495 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 186 to 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 473 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 165 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 645 to 652 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 467 to 475 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 530 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 531 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 256 forms a bond with heme, indicating a strong binding affinity.
The residue at position 258 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 292 forms a bond with heme, indicating a strong binding affinity.
The residue at position 471 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 472 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 4 to 18 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 329 to 333 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 238 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 240 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 272 to 279 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 474 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 478 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 609 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 394 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 599 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 601 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 603 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 605 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 610 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 629 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 631 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 633 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 635 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 640 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 287 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1576 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1672 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1675 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 263 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1 to 8 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 149 to 164 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 175 to 209 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 281 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 216 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 221 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 70 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 95 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 234 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 141 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 253 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 288 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 320 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 802 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1043 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1199 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 44 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 180 to 186 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 to 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 481 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 481 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 701 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 789 forms a bond with PAM RNA of RNA, indicating a strong binding affinity.
The residue at position 81 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 146 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 151 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 155 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 644 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 646 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 650 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 670 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 674 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 691 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 694 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 694 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 696 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 696 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 697 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 706 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 706 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 706 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 718 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 718 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 719 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 719 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 166 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 442 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 445 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 446 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 225 to 232 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 364 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 248 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 269 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 285 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 354 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 866 to 873 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 434 to 436 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 434 to 436 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 487 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 487 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 518 to 519 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 564 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 602 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 602 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 608 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 729 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 522 to 529 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 192 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 401 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 425 to 428 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 245 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 208 to 215 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with phycourobilin 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with phycourobilin 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 297 forms a bond with phycourobilin 3, indicating a strong binding affinity.
The residue at position 103 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 108 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 112 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 133 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 136 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 139 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 179 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 620 to 627 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 to 397 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 30 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 283 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 293 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 305 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 200 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 206 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 106 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 131 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 201 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 316 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 61 to 68 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 19 to 21 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 131 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 201 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 274 to 279 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 248 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 251 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 256 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 269 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 296 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 317 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 322 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 325 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 339 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 911 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 997 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 74 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 78 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 345 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 486 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 489 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 346 to 348 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 387 to 390 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 574 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 34 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 35 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 112 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 139 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 167 to 173 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 227 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 233 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 282 forms a bond with an N-(acyl)-sphingosylphosphocholine, indicating a strong binding affinity.
The residue at position 189 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 373 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 409 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 440 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 588 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 718 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 47 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 254 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 286 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 390 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 393 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 1108 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1111 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1133 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 200 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 277 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 425 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 452 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 492 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 494 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 532 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 83 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 114 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 239 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 631 to 638 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 to 212 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 294 to 296 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 224 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 556 to 671 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 154 to 159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 243 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 305 to 306 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 315 to 319 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 344 to 345 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 384 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 469 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 349 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 581 to 588 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 305 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 309 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 310 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 317 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 500 to 501 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 403 to 410 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 323 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 345 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 350 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 448 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 452 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 240 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 448 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 448 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 231 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 467 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 467 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 543 to 546 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 603 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 607 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 610 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 610 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1005 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 460 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 546 to 549 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 526 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 587 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 87 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 353 to 357 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 432 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 780 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 811 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 815 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 893 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 925 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 927 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1092 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 400 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 402 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 46 to 50 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 352 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 356 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 58 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 58 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 552 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 502 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 265 to 268 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 380 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 486 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 535 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 562 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 722 to 731 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 798 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 806 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 823 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 41 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 41 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 179 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 221 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 227 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 264 to 285 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 to 326 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 161 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 298 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 248 to 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 to 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 855 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 862 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 865 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 110 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 21 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 231 forms a bond with 17alpha-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 231 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 363 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 424 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 426 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 246 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 257 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 240 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 264 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 308 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 395 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 423 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 448 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 482 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 484 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 732 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 749 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 807 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1159 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1241 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1243 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 153 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 435 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 452 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 465 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 522 to 523 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 620 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 552 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 554 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 558 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 287 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 411 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 413 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 418 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 421 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 422 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 428 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 254 to 257 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 199 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 440 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 195 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 336 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 448 to 450 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 506 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 514 to 516 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 106 forms a bond with phenol, indicating a strong binding affinity.
The residue at position 134 forms a bond with phenol, indicating a strong binding affinity.
The residue at position 336 to 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 588 to 595 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 to 129 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 260 to 296 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 266 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 316 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 317 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 404 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 406 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 95 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 231 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 80 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 276 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 310 to 311 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 75 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 144 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 536 to 538 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 877 to 879 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 954 to 956 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 964 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1075 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1088 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 397 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 479 to 483 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 479 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 483 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 18 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 to 157 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 238 to 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 201 to 209 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 388 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 139 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 177 to 185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 136 to 143 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 to 187 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 96 to 100 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 314 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 7 to 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 21 to 30 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 67 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 86 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 164 to 168 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 26 to 31 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 28 forms a bond with pyruvate 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with pyruvate 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with pyruvate 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with pyruvate 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with pyruvate 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 33 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 28 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 325 to 329 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 87 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 121 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 173 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 192 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 218 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 63 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 232 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 288 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 21 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 143 to 148 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 to 180 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 165 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 167 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 186 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 193 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 426 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 437 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 158 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with folate, indicating a strong binding affinity.
The residue at position 182 forms a bond with folate, indicating a strong binding affinity.
The residue at position 883 to 890 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 466 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 487 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 524 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 572 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 230 to 235 forms a bond with strychnine, indicating a strong binding affinity.
The residue at position 168 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 161 to 165 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 331 to 334 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 338 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 355 to 358 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 431 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 500 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 43 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 170 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 1120 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1122 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1249 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 959 to 966 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 396 to 403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 122 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 165 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 119 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 152 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 298 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 382 to 386 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 402 to 411 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 412 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 198 to 203 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 324 to 330 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 354 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 363 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 432 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 174 to 180 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 50 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 319 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 198 to 205 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 280 to 284 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 629 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 285 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 55 to 58 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 1650 to 1657 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 to 479 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 273 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 310 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 337 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 584 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 592 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 594 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 596 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 598 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 40 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 109 to 113 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 515 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 516 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 499 to 504 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 546 to 549 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 580 to 582 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 588 to 590 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 65 to 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 794 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 52 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 100 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 189 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 19 to 25 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 214 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 311 to 314 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 132 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 248 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 71 to 99 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 672 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 674 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 676 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 678 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 683 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 192 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 327 to 329 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 455 to 458 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 513 to 514 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 581 to 582 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 783 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 to 53 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 130 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 138 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 227 to 232 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 331 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 447 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 235 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 311 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 312 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 316 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 521 to 529 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 512 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 631 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 631 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 633 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 203 to 206 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 to 293 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 315 to 334 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 719 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 761 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 768 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 152 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 452 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 395 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 649 to 656 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 134 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 208 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 243 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 210 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 284 to 290 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 288 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 290 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 388 to 390 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 46 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 185 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 339 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 420 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 483 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 593 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 597 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 682 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 683 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 696 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 711 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 886 to 917 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1032 to 1043 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1175 to 1185 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1250 to 1268 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1348 to 1363 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 821 to 828 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1023 to 1030 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 244 to 247 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 234 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 549 to 556 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 596 to 600 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 650 to 653 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 816 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 818 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 271 to 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 to 500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 575 to 578 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 to 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 187 to 190 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 396 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 462 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 279 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 353 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 385 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 470 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 474 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 64 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 142 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 50 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 55 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 111 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 218 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 497 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 60 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 84 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 544 to 546 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 544 to 546 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 551 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 703 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 743 to 746 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 743 to 746 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 748 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 82 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 100 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 102 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 128 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 167 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 353 to 360 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 399 to 403 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 453 to 456 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 104 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 33 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 46 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 89 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 227 to 232 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 331 to 334 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 354 to 363 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 416 to 417 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 109 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 361 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 406 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 422 to 424 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 455 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 344 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 383 to 385 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 424 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 426 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 449 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 65 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 90 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 154 to 159 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 116 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 121 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 189 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 25 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 134 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 183 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2066 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2069 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2090 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2093 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2124 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2127 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2139 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2141 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 to 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 387 to 388 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 172 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 280 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 289 to 292 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 60 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 93 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 175 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 1811 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1843 to 1849 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1887 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 938 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 941 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 944 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 948 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 595 to 602 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1226 to 1233 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1227 to 1234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 237 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 391 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 67 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 67 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 151 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 124 to 130 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 186 to 194 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 318 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 656 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 656 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 660 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 660 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 862 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 866 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 870 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 139 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 342 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 154 to 163 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 406 to 408 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 421 to 424 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 521 to 522 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 527 to 531 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 563 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 601 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 196 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 to 267 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 340 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 345 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 195 to 202 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 898 to 905 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 419 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 446 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 455 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 458 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 481 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1061 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1064 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1079 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1082 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1076 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1078 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1079 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1081 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1084 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 854 to 861 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 to 335 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 300 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 324 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 327 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1068 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1100 to 1106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 207 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 8 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 228 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 493 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 538 to 541 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 78 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 79 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 82 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 83 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 101 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 183 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 185 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 231 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 432 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 495 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 497 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 502 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 90 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 104 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 109 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 129 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 195 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 199 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 314 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 306 to 312 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 335 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 347 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 401 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 424 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 428 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 559 to 560 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 582 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 609 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 826 to 835 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 902 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 910 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 927 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 361 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 367 to 368 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 559 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 564 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 751 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 755 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 899 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 298 to 302 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 482 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 336 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 1084 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1091 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1091 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 518 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 529 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 539 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 547 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 551 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 471 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 528 to 532 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 566 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 573 to 575 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 629 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 655 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 661 to 664 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 735 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 400 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 32 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 281 to 290 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 660 to 663 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 670 to 671 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 711 to 714 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 87 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 352 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 414 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 501 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 118 forms a bond with (E)-ferulate, indicating a strong binding affinity.
The residue at position 195 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 238 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 251 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 257 forms a bond with (E)-5-hydroxyferulate, indicating a strong binding affinity.
The residue at position 360 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 531 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 359 to 363 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 368 to 374 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 398 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 326 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 53 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 348 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 477 to 478 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 813 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 891 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 893 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 895 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 897 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1057 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 49 to 73 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 358 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 465 to 466 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 491 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 530 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 563 to 565 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 701 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 703 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 708 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 56 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 116 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 210 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1 to 6 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 6 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 45 to 51 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 126 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 9 to 28 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 239 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 242 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 314 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 316 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 318 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 319 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 11 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 327 to 334 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 388 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 389 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 389 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 427 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 519 to 520 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 521 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 536 to 538 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 554 to 555 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 554 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 701 to 702 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 111 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 118 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 to 348 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 447 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 475 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 481 to 484 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 658 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 716 to 720 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 754 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 761 to 763 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 847 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 853 to 856 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 935 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 149 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 334 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 339 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 246 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 250 forms a bond with O2, indicating a strong binding affinity.
The residue at position 296 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 374 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 382 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 384 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 447 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 to 247 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 371 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 211 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 384 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 388 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 412 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 140 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 198 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 237 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 321 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 327 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 389 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 98 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 427 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 430 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 432 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1111 to 1118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 314 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 48 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 51 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 634 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 638 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 247 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 251 forms a bond with O2, indicating a strong binding affinity.
The residue at position 297 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 298 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 383 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 385 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 267 to 270 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 58 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 78 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 139 to 146 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 228 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 100 to 128 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 177 to 182 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 20 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 45 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 143 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 252 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 340 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 346 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 376 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 448 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 476 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 479 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 97 to 105 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 78 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 141 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 141 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 96 to 124 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 115 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 612 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 675 to 676 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 257 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 313 to 318 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 331 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 179 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 223 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 274 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 318 to 322 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 480 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 371 to 378 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 132 to 138 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 143 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 34 to 39 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 166 to 172 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 260 to 263 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 317 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 284 to 292 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 97 to 106 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 382 to 385 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 416 to 419 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 460 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 515 to 516 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 521 to 525 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 558 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 596 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 102 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 106 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 234 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 490 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 528 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 117 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 12 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 12 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 69 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 69 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 152 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 152 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 158 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 158 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 188 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 188 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 211 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 211 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 217 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 217 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 246 forms a bond with D-allulose, indicating a strong binding affinity.
The residue at position 246 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 146 to 153 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 129 to 142 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 165 to 174 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 249 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 261 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 299 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 304 to 309 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 96 to 100 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 126 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 126 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 153 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 153 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 157 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 157 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 178 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 178 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 206 to 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 18 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 174 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 398 to 399 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 440 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 115 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 621 to 629 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 490 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 490 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 492 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 122 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 128 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 203 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 343 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 359 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 150 to 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 536 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 586 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 704 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 60 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 79 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 167 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 282 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 211 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 228 to 231 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 320 to 325 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 450 to 453 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 234 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 371 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 255 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 294 to 296 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 351 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 204 to 227 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 387 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 14 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 29 to 33 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 51 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 55 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 74 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 57 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 210 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 279 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 12 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 94 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 105 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 705 to 713 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1458 to 1465 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 125 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 366 to 368 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 291 to 295 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 317 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 61 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 189 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 87 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 116 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 125 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 659 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 373 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 375 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 12 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 16 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 269 to 277 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 281 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 292 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 302 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 351 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 882 to 889 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 32 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 385 to 387 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 387 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 418 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 172 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 317 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 183 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 494 to 501 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 540 to 544 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 594 to 597 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 189 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 328 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 341 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 341 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 205 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 272 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 590 to 591 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 96 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 126 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 747 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 751 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1078 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1270 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1277 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1280 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 481 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 564 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 49 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 405 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 530 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 567 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 368 to 369 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 378 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 363 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 369 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 470 to 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 282 to 296 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 87 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 91 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 91 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 189 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 189 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 212 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 214 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 214 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 279 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 279 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 588 to 589 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 329 to 337 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 351 to 354 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 139 to 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 282 to 286 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 351 to 352 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 192 to 196 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 324 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 160 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 281 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 296 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 214 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 to 302 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 198 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 63 to 68 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 29 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 210 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 217 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 222 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 38 to 42 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 249 to 256 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 295 to 299 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 46 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 48 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 81 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 171 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 172 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 254 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 289 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 295 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 296 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 339 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 353 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 32 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 to 166 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 to 31 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 26 to 29 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 307 to 313 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 311 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 425 to 427 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 135 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 46 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 292 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 395 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 580 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 603 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 712 to 715 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 729 to 733 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 734 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 741 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 746 to 748 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 799 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 to 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 154 to 161 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 152 forms a bond with heme, indicating a strong binding affinity.
The residue at position 185 forms a bond with heme, indicating a strong binding affinity.
The residue at position 210 forms a bond with heme, indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 246 forms a bond with heme, indicating a strong binding affinity.
The residue at position 55 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 157 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 81 to 88 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 170 to 176 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 69 to 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 388 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 455 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 460 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 485 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 496 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 273 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 175 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 to 32 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 36 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 355 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 359 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 401 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 211 to 218 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 612 to 619 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 349 to 353 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with GTP 3, indicating a strong binding affinity.
The residue at position 319 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 360 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 497 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 500 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 508 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 163 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 619 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 238 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 303 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 365 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 365 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 371 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 423 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 612 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 429 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 567 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 64 to 71 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 9 to 17 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 277 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 353 to 361 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 314 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 316 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 319 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 322 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 375 to 376 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 454 to 457 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 401 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 432 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 486 to 488 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 510 to 511 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 795 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 869 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 876 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with keto-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with beta-D-fructose 1-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with beta-D-fructose 1-phosphate, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with keto-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with beta-D-fructose 1-phosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with beta-D-fructose 1-phosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with keto-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 513 forms a bond with beta-D-fructose 1-phosphate, indicating a strong binding affinity.
The residue at position 513 forms a bond with keto-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 52 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 94 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 551 to 554 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 467 to 468 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 473 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 48 to 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 145 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 149 to 155 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 181 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 184 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 186 to 313 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 502 to 624 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 620 to 740 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 295 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 82 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 84 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 119 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 128 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 711 to 719 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 15 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 170 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 220 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 348 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 256 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 258 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 423 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 118 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 42 to 46 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 77 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 346 to 347 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 275 to 303 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 459 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 221 to 225 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 18 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 438 to 440 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 438 to 440 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 491 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 491 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 496 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 519 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 522 to 523 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 568 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 606 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 606 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 648 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 650 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 734 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 52 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 234 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 84 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 157 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 232 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 2107 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2138 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2153 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2155 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 102 to 110 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 106 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 106 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 149 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 149 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 759 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 788 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1128 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1131 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1137 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 387 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 391 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 426 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 430 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 541 to 543 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 217 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 260 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 278 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 282 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 414 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 110 forms a bond with eticlopride, indicating a strong binding affinity.
The residue at position 345 forms a bond with eticlopride, indicating a strong binding affinity.
The residue at position 349 forms a bond with eticlopride, indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 481 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 481 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 558 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 596 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 596 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 602 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 638 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 129 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 335 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 317 to 321 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 343 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 450 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 474 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 474 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 273 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 569 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 597 to 604 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 672 to 678 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 799 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 451 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 627 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 734 to 735 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 202 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 220 to 223 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 215 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 224 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 377 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 381 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 404 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 2 to 20 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 545 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 545 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 689 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 697 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 98 to 106 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 102 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 102 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 145 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 145 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 152 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 149 to 156 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 288 to 296 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 345 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 189 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 326 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 330 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 283 to 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 362 to 364 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 456 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 451 to 459 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 611 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 172 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 222 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 224 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 226 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 392 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 489 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 493 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 680 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 688 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 696 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 697 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 121 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 124 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 244 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 403 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 406 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 411 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 203 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 298 to 303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 401 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 503 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 88 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 497 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 500 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 502 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 549 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 550 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 551 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 555 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 330 to 332 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 332 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 335 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 337 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 370 to 372 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 393 to 394 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 417 to 421 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 451 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 272 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 533 to 541 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 303 to 306 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 310 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1877 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1879 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1919 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 366 to 374 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 144 to 151 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 613 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 453 to 465 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 487 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 489 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 500 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 190 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 335 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 408 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 524 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 663 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 724 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 116 to 123 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 771 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 908 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 474 to 482 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 589 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 593 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 60 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 147 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 177 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 828 to 836 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 403 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 407 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 413 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 478 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 523 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 620 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 397 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 358 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 535 forms a bond with a phosphatidylglycerol phosphate, indicating a strong binding affinity.
The residue at position 539 forms a bond with a phosphatidylglycerol phosphate, indicating a strong binding affinity.
The residue at position 548 to 606 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 728 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 728 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 747 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 747 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 747 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 747 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 749 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 749 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 223 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 255 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 260 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 287 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 290 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 305 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 308 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 316 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 330 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 28 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 160 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 54 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 59 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 99 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 46 to 50 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 83 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 122 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 63 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with 4-[(2-hydroxyethoxy)carbonyl]benzoate, indicating a strong binding affinity.
The residue at position 226 forms a bond with 4-[(2-hydroxyethoxy)carbonyl]benzoate, indicating a strong binding affinity.
The residue at position 313 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 411 forms a bond with 4-[(2-hydroxyethoxy)carbonyl]benzoate, indicating a strong binding affinity.
The residue at position 416 forms a bond with 4-[(2-hydroxyethoxy)carbonyl]benzoate, indicating a strong binding affinity.
The residue at position 528 forms a bond with 4-[(2-hydroxyethoxy)carbonyl]benzoate, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 233 to 248 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 460 to 464 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 631 to 635 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 49 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 216 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 226 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 460 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 210 to 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 507 to 512 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 to 380 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 419 to 423 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 473 to 476 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 151 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 433 to 440 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 500 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 392 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 533 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 534 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 558 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 149 to 154 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 75 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 309 to 315 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 29 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 96 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 148 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 299 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 33 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 374 to 382 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 87 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 279 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 279 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 284 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 284 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 317 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 378 to 386 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 382 to 386 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 170 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 222 to 230 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 291 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 512 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 516 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 554 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 576 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 577 to 578 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 577 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 603 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 604 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 604 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 605 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 703 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 724 to 726 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 to 27 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 224 to 231 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 336 to 339 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 34 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 276 to 279 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 478 to 485 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 96 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 172 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 329 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 361 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 422 to 425 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 432 to 433 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 22 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 24 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 152 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 385 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 409 to 412 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 460 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 464 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 379 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 403 to 410 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1062 to 1069 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 517 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 534 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 542 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 176 to 180 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 382 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 37 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 126 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 130 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 168 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 680 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 687 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 142 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 426 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 284 to 291 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 379 to 383 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 455 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 793 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 824 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 828 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 906 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 938 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1107 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 855 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 857 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 887 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 890 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 906 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 912 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 925 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 928 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 21 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 28 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 62 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 63 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 65 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 66 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 67 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 181 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 218 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 666 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 668 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 718 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 615 to 735 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 731 to 870 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with 2-oxo-dATP, indicating a strong binding affinity.
The residue at position 8 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 23 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 33 forms a bond with 2-oxo-dATP, indicating a strong binding affinity.
The residue at position 33 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with 2-oxo-dATP, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 56 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 100 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with 2-oxo-dATP, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 24 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 261 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 225 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 276 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 568 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 648 to 649 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 to 85 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 51 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 196 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 199 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 623 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 624 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 659 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 105 to 110 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 343 to 346 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 421 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 448 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 531 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 to 91 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 175 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 78 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 85 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 255 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 276 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 288 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 289 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 387 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 421 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 432 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 435 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 437 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 438 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 18 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 19 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 406 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 473 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 641 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 698 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 827 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 848 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 849 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 850 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 851 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 851 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 to 216 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 240 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 247 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 278 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 223 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 235 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 239 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 29 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 131 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 142 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 240 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 297 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 303 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 315 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 334 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 149 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 797 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 80 to 85 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 167 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 231 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 646 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 648 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 635 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 71 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 322 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 706 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 745 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 908 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 910 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 320 to 323 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 174 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 23 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 221 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 229 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 315 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 172 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 205 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 433 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 419 to 430 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 502 to 507 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 555 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 557 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 710 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 711 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 721 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 127 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 580 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 583 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 597 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 600 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 608 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 616 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 705 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 711 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 757 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 757 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 759 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 759 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 578 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 143 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 235 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 238 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 309 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 239 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 267 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 400 to 401 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 481 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 504 to 505 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 130 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 265 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 294 to 296 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 399 to 400 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 480 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 506 to 507 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 255 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 300 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 329 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1025 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1027 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1038 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1048 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1049 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1067 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1070 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1080 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1085 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1094 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1097 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1108 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1109 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1112 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1115 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1127 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1128 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1131 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1134 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1142 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1144 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 128 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 432 to 439 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 468 to 472 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 538 to 541 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 583 to 589 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 630 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 to 142 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 166 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 194 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 175 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 198 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 441 to 449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 to 157 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 221 to 228 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 174 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 217 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 138 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 273 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 277 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 278 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 1390 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1392 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1470 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1575 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1578 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1602 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1605 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 82 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 346 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 367 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 365 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 370 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 395 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 397 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 431 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 437 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 442 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 466 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 468 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 472 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 477 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 228 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with folate, indicating a strong binding affinity.
The residue at position 678 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 686 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 694 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 695 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 112 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}, indicating a strong binding affinity.
The residue at position 77 forms a bond with cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}, indicating a strong binding affinity.
The residue at position 100 forms a bond with cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with cytidine 5'-{[hydroxy(2-hydroxyethyl)phosphonoyl]phosphate}, indicating a strong binding affinity.
The residue at position 258 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 362 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 368 to 369 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 387 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 221 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 216 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 216 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 218 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 224 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 707 to 773 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 854 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 95 to 100 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 272 to 275 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 387 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 374 to 381 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 475 to 478 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 321 to 328 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 365 to 369 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 126 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 758 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 760 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 784 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 813 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 380 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 93 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 195 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 197 to 204 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 273 to 277 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 299 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 142 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 571 to 573 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 597 to 600 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 630 to 635 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 650 to 651 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 673 to 674 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 757 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 804 to 806 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 333 to 336 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 233 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 746 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 749 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 756 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 820 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 823 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 848 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1079 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 324 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 380 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 399 to 402 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 475 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 131 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 91 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 781 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 782 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 12 to 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 231 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 to 247 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 394 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 62 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 65 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 16 to 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 to 46 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 410 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 452 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 482 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 19 to 27 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 321 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 448 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 257 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 262 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 338 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 350 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 353 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 356 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 372 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 377 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 585 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 962 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1175 to 1232 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1228 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1234 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1239 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 82 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 162 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 178 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 608 to 615 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 570 to 575 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 553 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1004 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1006 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1016 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 169 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 172 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 240 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 551 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 558 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 84 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 172 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 259 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 72 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 161 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 750 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 786 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 787 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 787 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 897 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 89 to 94 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 to 375 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 449 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 479 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 482 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 1 to 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 141 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 500 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 175 to 180 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 293 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 311 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 372 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 372 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 86 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 343 to 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 452 to 454 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 484 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 513 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 521 to 523 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 56 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 336 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 365 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 474 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 164 to 173 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 199 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 468 to 470 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 527 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 586 to 587 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 592 to 596 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 666 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 230 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 15 to 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 277 to 283 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 400 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 123 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 1197 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1200 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1213 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1216 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1221 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1224 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1242 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1245 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 561 to 569 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 to 236 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 883 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 885 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 992 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1045 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 169 to 178 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 204 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 469 to 471 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 486 to 489 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 552 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 614 to 615 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 620 to 624 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 656 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 694 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 to 241 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 579 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 584 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 676 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 684 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 81 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 384 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 395 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 458 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 85 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 91 to 97 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 157 to 165 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 21 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 84 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 141 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 159 to 168 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 420 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 142 forms a bond with beta-L-arabinofuranose, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with beta-L-arabinofuranose, indicating a strong binding affinity.
The residue at position 270 forms a bond with beta-L-arabinofuranose, indicating a strong binding affinity.
The residue at position 322 forms a bond with beta-L-arabinofuranose, indicating a strong binding affinity.
The residue at position 322 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 122 to 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 to 309 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 601 to 609 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 409 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 447 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 171 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 174 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 162 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 181 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 519 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 522 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 533 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 535 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 545 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 552 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 339 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 401 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 277 to 282 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 669 to 676 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1332 to 1339 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 124 to 139 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 150 to 182 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1227 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1230 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1235 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1238 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 842 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 386 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 451 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 215 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 266 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 310 to 314 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 516 to 517 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 522 to 526 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 171 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 551 to 558 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 to 25 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 63 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 208 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 148 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 177 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 201 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 220 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 351 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 353 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 801 to 809 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 820 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 263 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 352 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 53 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 64 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 224 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 228 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 256 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 607 to 614 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 68 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 94 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 466 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 501 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 360 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 161 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 40 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 137 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 359 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 363 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 139 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 183 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 185 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 211 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 235 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 411 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 349 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 351 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 353 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 370 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 407 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 410 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 518 to 526 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 577 to 585 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 643 to 645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 690 to 693 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 711 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 430 to 434 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 464 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 276 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 290 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 293 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 322 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 359 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 503 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 503 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 507 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 511 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 624 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 541 to 548 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 591 to 595 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 645 to 648 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 276 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 14 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 744 to 861 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 177 to 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 229 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 75 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 79 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 97 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 221 to 226 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 240 to 246 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 240 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 441 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 90 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 533 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 538 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 323 to 327 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 349 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 401 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 80 to 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 728 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 731 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 742 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 745 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 799 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 802 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 813 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 816 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 857 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 860 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 871 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 874 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1301 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1304 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1306 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1309 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 316 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 664 to 671 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 214 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with heme, indicating a strong binding affinity.
The residue at position 29 forms a bond with heme, indicating a strong binding affinity.
The residue at position 312 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 435 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 458 to 459 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 469 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 393 to 400 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1097 to 1154 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1150 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1156 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1161 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 287 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 450 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 470 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 484 to 486 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 486 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 227 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 365 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 373 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 403 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 to 84 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 253 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 418 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 434 to 435 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 211 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 480 to 484 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 534 to 537 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 1311 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1314 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 100 to 105 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 116 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 159 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 494 to 496 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 348 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1015 to 1018 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1025 to 1028 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1026 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1028 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1098 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1120 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1138 to 1142 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1254 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 305 to 306 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 103 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 215 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 216 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 451 to 458 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 544 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 584 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 587 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 1737 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1743 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1748 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 240 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 199 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 200 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 655 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 595 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 599 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 99 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 259 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 348 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 267 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 39 to 44 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 250 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 320 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 378 to 379 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 402 to 406 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 430 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 489 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 490 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 491 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 25 to 27 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 72 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 97 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 113 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with N(6)-dimethylallyladenine, indicating a strong binding affinity.
The residue at position 169 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 381 forms a bond with N(6)-dimethylallyladenine, indicating a strong binding affinity.
The residue at position 381 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 456 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 527 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 530 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 249 to 254 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 261 to 266 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 199 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 20 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 to 63 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 171 to 181 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 93 to 101 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 to 108 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 45 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 381 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 274 to 279 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 151 to 156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 459 to 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 326 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 328 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 931 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1010 to 1012 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1017 to 1021 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1057 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 271 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 370 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 373 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 499 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 502 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 575 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 578 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 1267 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1271 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 2 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 33 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 113 to 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 394 to 513 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 265 to 268 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 340 to 341 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 39 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 81 to 88 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 24 to 35 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 167 to 173 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 328 to 331 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 to 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 389 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 413 to 416 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 466 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 927 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1007 to 1009 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1014 to 1018 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 311 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 682 to 690 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 704 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 209 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 235 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 158 to 165 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 290 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 312 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 355 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 386 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 400 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 404 to 406 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 472 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 1943 to 1951 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1972 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 120 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 263 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 487 to 489 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 816 to 820 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 816 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 188 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 188 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 213 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 215 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 280 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 280 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 192 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 198 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 158 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 164 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 145 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 146 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 194 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 197 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 340 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 392 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 595 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 630 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 634 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 634 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 638 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 641 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 203 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 472 to 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1139 to 1146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 515 to 521 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 550 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 to 199 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 278 to 282 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 299 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 398 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 8 to 14 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 47 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 68 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 13 forms a bond with biliverdin IXalpha, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1648 to 1655 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 to 503 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 11 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 338 to 344 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 127 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 23 to 31 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 267 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 316 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 339 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 431 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 451 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 452 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 541 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 546 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 565 to 566 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 588 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 333 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 15 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 181 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 218 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 245 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 254 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 261 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 283 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 117 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 395 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 316 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 316 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 327 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 327 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 116 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 144 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 195 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 432 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 142 to 147 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 22 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 309 to 319 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 198 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 207 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 607 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 754 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 807 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 423 to 430 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 586 to 589 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 328 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 329 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 392 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 292 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 382 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 53 to 59 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 352 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 581 to 584 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 591 to 592 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 632 to 635 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 500 to 504 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 554 to 557 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 328 to 337 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 390 to 391 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 771 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1089 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1098 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 729 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 729 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 731 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 735 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 735 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 741 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 743 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 781 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 785 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 787 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 792 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 813 to 815 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 851 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 853 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1220 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1223 to 1224 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1226 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1279 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1281 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1286 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 33 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 221 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 331 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 393 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 170 to 179 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 289 to 292 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 to 389 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 412 to 413 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 195 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 217 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 222 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 420 to 421 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 1079 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1121 to 1127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1165 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 594 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 928 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1002 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1009 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1012 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1027 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1029 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1033 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1033 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1038 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1074 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1076 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1101 to 1103 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1165 to 1166 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1168 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1221 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1223 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1228 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 343 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 382 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 382 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 18 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 188 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 321 to 325 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 138 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 375 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 253 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 411 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 415 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 430 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 432 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 433 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 588 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 592 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 594 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 618 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 620 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 624 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 774 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 778 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 222 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 319 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 318 to 324 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 467 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 467 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 475 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1178 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1184 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1240 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1242 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1604 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1610 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1659 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1661 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1924 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1927 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1930 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 167 to 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 367 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 987 to 995 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1010 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 295 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 297 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 337 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1322 to 1329 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 395 to 396 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 45 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 410 to 421 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 493 to 498 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 546 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 548 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 555 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 701 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 712 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 190 to 194 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 659 to 666 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1318 to 1325 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 496 to 504 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 682 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 726 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1050 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1053 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1070 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1073 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 357 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 51 to 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 228 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 277 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 73 to 78 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 100 to 106 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 125 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 132 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 136 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 157 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 420 to 428 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 427 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 427 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 245 to 255 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 787 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 791 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 492 to 495 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 502 to 503 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 543 to 546 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 151 to 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 290 to 298 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 363 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 216 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 343 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 394 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 451 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 18 to 22 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 54 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 82 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 285 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 528 to 535 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 694 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 756 to 760 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 759 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 804 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 808 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 860 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 946 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1134 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1189 to 1190 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 244 to 249 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 93 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 238 to 243 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 257 to 263 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 200 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 30 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 54 to 61 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 299 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 50 to 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 520 to 522 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 414 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 46 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 149 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 338 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 409 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 456 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 463 to 464 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 368 to 370 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 409 to 412 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 516 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 596 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 599 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 604 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 146 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 494 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 514 to 515 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 520 to 522 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 529 to 535 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 548 to 549 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 107 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 442 to 445 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 109 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 121 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 124 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 138 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 140 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 105 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 132 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 239 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 263 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 307 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 393 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 421 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 446 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 480 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 226 to 233 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 to 276 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 116 to 122 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 95 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 114 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 143 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 56 to 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 56 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 168 to 175 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 100 to 105 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 77 to 84 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 218 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 363 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 614 to 622 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 133 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 138 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 156 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 764 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 833 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 913 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 915 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1027 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1033 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1053 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1056 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1057 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 277 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 455 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 458 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 462 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 466 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 84 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 393 to 394 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 45 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 55 forms a bond with a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid, indicating a strong binding affinity.
The residue at position 297 forms a bond with a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 340 forms a bond with a 2,3-bis-O-phytanyl-sn-glycerol 1-phospholipid, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 864 to 866 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 873 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 880 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 906 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 258 to 264 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 13 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 275 to 278 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 283 to 286 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 337 to 341 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 297 to 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 24 to 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 to 152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 749 to 756 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 344 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 385 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 513 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 603 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 77 to 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with heme, indicating a strong binding affinity.
The residue at position 42 forms a bond with heme, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 229 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 809 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 129 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 145 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 161 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 249 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 270 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 286 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 355 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 222 to 227 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 181 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 204 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 to 450 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 450 to 453 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 442 to 449 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 489 to 493 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 543 to 546 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 181 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 to 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 404 to 407 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 443 to 445 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 261 to 266 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 340 to 342 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 388 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 26 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 180 to 187 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 33 to 42 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 167 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 19 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 160 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 101 to 109 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 199 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 196 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 242 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 39 to 43 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 30 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 61 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 85 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 105 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 355 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 375 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 138 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 229 to 235 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 426 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 349 to 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with heme, indicating a strong binding affinity.
The residue at position 28 forms a bond with heme, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 160 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 256 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 338 to 346 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 380 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 573 to 581 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 296 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 352 to 355 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 359 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 348 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 376 to 379 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 399 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 454 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 263 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 218 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 219 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 92 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 491 to 608 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 365 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 417 to 424 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 413 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 833 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 836 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 837 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 255 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 796 to 803 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 47 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 135 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 385 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 84 to 91 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 388 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 396 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 409 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 442 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 492 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 494 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 249 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 289 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 17 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 80 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 199 forms a bond with [7Fe-V-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 98 to 102 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 37 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 196 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 200 to 206 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 238 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 395 to 396 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 418 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 436 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 440 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 444 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 499 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 505 to 507 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 509 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 72 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 72 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 168 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 395 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 455 to 456 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 49 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 150 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 336 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 408 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 455 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 462 to 463 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 471 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 547 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 618 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 200 to 235 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 106 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 114 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 114 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 157 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 276 to 279 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 166 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 200 to 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 227 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 443 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 31 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 391 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 to 217 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 294 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 370 to 374 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 399 to 400 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 438 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 193 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 432 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 451 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 466 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 486 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 622 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 179 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 207 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 310 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 349 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 199 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 254 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 92 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 136 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 345 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 279 to 284 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 305 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 399 to 401 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 401 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 432 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 523 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 423 to 425 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 408 to 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 210 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 214 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 218 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 254 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 371 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 466 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 87 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 42 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 553 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 676 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 746 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 43 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 547 to 554 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 736 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 787 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 868 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 869 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1051 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1093 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1126 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 34 to 42 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 601 to 608 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 to 129 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 192 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 195 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 199 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 311 to 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 321 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 161 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 166 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 208 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 214 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1469 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1472 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1484 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1487 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1493 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1496 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1506 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1510 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 43 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 268 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 343 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 302 to 308 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 306 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 308 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 227 to 232 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 138 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 153 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 182 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 185 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 188 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 192 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 256 to 261 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 320 to 324 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 390 to 395 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 239 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 463 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 454 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 487 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 547 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 616 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 426 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 417 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 420 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 470 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 472 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 476 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 133 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 177 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 252 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 272 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 344 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 547 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 613 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 616 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 617 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 655 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 97 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 175 to 179 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 187 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 191 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 256 to 259 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 263 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 320 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 230 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 80 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 769 to 847 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 914 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 926 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 926 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 928 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 207 to 214 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 232 to 236 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 320 to 323 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 876 to 884 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 329 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 330 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 431 to 438 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 481 to 485 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 535 to 538 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 to 281 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 57 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 272 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 436 to 442 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 401 to 405 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 429 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 488 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 363 to 366 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 413 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 489 to 500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 93 to 97 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 210 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 391 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 483 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 485 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 489 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 494 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 517 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 519 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 523 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 528 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 359 to 365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 440 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 131 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 273 to 278 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 to 278 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 240 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 209 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 313 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 327 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 327 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 625 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 627 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 632 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 115 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 211 to 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 205 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 76 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 157 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 160 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 158 to 164 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 228 to 234 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 291 to 297 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 210 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 248 to 256 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 387 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 157 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 161 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 188 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 217 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 223 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 441 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 469 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 517 to 520 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 521 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 581 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 603 to 604 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 631 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 220 to 226 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 513 to 521 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 65 to 72 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 167 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 288 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 387 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 419 to 420 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 364 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 527 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 184 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 81 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 195 to 202 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 242 to 246 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 130 to 138 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 7 to 13 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 220 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 231 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 294 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 301 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 327 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 358 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 358 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 187 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 5 to 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 to 268 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1098 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 17 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 17 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 62 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 281 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 304 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 443 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 24 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 412 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 129 to 134 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 245 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 457 to 462 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 490 to 501 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 751 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 754 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 125 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 351 to 353 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 6 to 8 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 95 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 144 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 147 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 250 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 250 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 331 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 350 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 385 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 422 to 425 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 422 to 425 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 422 to 425 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 449 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 449 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 449 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 494 to 497 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 222 to 231 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 278 to 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 236 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 251 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 334 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 710 to 766 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 849 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 551 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 552 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 628 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 630 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 632 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 726 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 729 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 730 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 132 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 185 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 113 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 116 to 117 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 70 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 95 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 153 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 188 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 105 to 112 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 187 to 191 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 262 to 268 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 362 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 66 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 66 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 150 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 432 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 433 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 439 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 502 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 591 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 591 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 597 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 651 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 652 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 653 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 659 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 170 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 284 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 929 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 975 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 998 to 999 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1001 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1036 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1049 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1054 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 398 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 913 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 916 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 919 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 921 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 497 to 504 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 95 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 191 to 219 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 523 to 531 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 356 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 59 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 107 to 113 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 133 to 145 forms a bond with streptomycin, indicating a strong binding affinity.
The residue at position 742 to 842 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 357 to 360 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 364 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 426 to 433 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 521 to 525 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 589 to 592 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 296 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 375 to 376 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 222 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 595 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 604 to 605 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 607 to 612 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 248 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 629 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 635 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 681 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 681 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 683 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 683 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 700 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 64 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 108 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 289 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 52 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 256 to 277 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 294 to 313 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 to 237 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 187 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 259 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 274 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 300 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 323 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 349 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 362 to 365 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 395 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 664 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 729 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 748 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 121 forms a bond with 6-aminopenicillanate, indicating a strong binding affinity.
The residue at position 310 forms a bond with 6-aminopenicillanate, indicating a strong binding affinity.
The residue at position 336 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 33 to 38 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 to 183 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 325 to 329 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 328 to 330 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 330 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 333 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 335 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 368 to 370 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 415 to 419 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 449 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 508 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 135 to 148 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 172 to 181 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 505 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 36 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 531 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 721 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 866 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 19 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 78 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 131 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 135 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 318 to 321 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 279 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 522 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 79 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 140 to 147 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 303 to 310 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 337 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 443 to 451 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 499 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 514 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 499 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 544 to 547 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 809 to 817 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 403 to 410 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 634 to 638 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 691 to 694 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1362 to 1370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1383 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 266 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 288 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 385 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 385 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 444 to 446 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 444 to 446 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 485 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1491 to 1551 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 304 to 310 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 465 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 476 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 292 to 304 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 to 242 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 461 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 505 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 545 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 566 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 568 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 489 to 497 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with an N-(acyl)-sphingosylphosphocholine 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with N-acetyl-D-glucosamine 6-sulfate, indicating a strong binding affinity.
The residue at position 53 forms a bond with an N-(acyl)-sphingosylphosphocholine 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with N-acetyl-D-glucosamine 6-sulfate, indicating a strong binding affinity.
The residue at position 54 forms a bond with an N-(acyl)-sphingosylphosphocholine 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with an N-(acyl)-sphingosylphosphocholine 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with an N-(acyl)-sphingosylphosphocholine 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with an N-(acyl)-sphingosylphosphocholine 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with an N-(acyl)-sphingosylphosphocholine 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with an N-(acyl)-sphingosylphosphocholine 5, indicating a strong binding affinity.
The residue at position 116 forms a bond with an N-(acyl)-sphingosylphosphocholine 3, indicating a strong binding affinity.
The residue at position 133 forms a bond with an N-(acyl)-sphingosylphosphocholine 4, indicating a strong binding affinity.
The residue at position 137 forms a bond with an N-(acyl)-sphingosylphosphocholine 3, indicating a strong binding affinity.
The residue at position 138 forms a bond with an N-(acyl)-sphingosylphosphocholine 4, indicating a strong binding affinity.
The residue at position 138 forms a bond with N-acetyl-D-glucosamine 6-sulfate, indicating a strong binding affinity.
The residue at position 144 forms a bond with an N-(acyl)-sphingosylphosphocholine 5, indicating a strong binding affinity.
The residue at position 168 forms a bond with an N-(acyl)-sphingosylphosphocholine 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 101 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 200 forms a bond with heme, indicating a strong binding affinity.
The residue at position 220 forms a bond with heme, indicating a strong binding affinity.
The residue at position 253 forms a bond with heme, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 498 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 218 to 226 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 112 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 115 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 86 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 98 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 243 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 438 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 289 to 296 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 367 to 371 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 426 to 429 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 to 76 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 399 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 423 to 426 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 475 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 479 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 29 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 83 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 183 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 128 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 304 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 347 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 352 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 656 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 709 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 1000 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1003 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1046 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1051 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1056 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 81 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 to 311 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 690 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 690 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 694 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 694 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 221 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 342 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 393 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 90 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 116 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 211 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 711 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 415 to 422 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 461 to 465 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 245 to 256 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 287 to 288 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 333 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 238 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 155 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 160 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 294 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 298 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 314 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 387 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 134 forms a bond with heme, indicating a strong binding affinity.
The residue at position 165 forms a bond with heme, indicating a strong binding affinity.
The residue at position 190 forms a bond with heme, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 226 forms a bond with heme, indicating a strong binding affinity.
The residue at position 353 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 451 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 280 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 662 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 737 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 743 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 513 to 516 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 139 to 147 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 172 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 175 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 841 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 921 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 924 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 244 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 198 to 319 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 310 to 428 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 1089 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1096 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1096 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 103 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 107 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 149 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 194 to 203 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 291 to 298 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 337 to 341 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 391 to 394 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 to 129 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 to 213 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 116 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 195 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 335 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 395 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 293 to 296 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 133 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 136 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 137 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 393 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 492 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 493 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 495 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 104 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 106 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 194 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 195 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 229 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 230 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 253 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 256 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 441 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 249 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 71 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 125 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 437 to 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 to 347 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 26 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 27 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 96 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 97 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 202 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 205 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 293 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 357 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 651 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 658 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 33 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 561 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 106 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 415 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 55 to 81 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 198 to 202 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 246 to 257 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 448 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 656 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 685 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 688 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 to 27 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 385 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 422 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 563 to 564 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 567 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 654 to 656 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 656 to 658 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 50 to 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 133 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 644 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 682 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 683 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 683 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 799 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 388 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 41 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 46 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 54 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 56 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 59 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 66 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 69 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 75 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 79 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 87 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 89 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 103 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 296 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 164 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 241 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 299 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 302 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 305 to 312 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 445 to 453 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 501 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 516 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 133 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 239 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 243 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 127 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 157 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 192 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 196 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 275 to 278 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 372 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 57 to 60 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 257 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 454 to 456 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 600 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 692 forms a bond with Mg of divinylchlorophyll a' A1, indicating a strong binding affinity.
The residue at position 700 forms a bond with Mg of divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 708 forms a bond with divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 709 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 497 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 236 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 260 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 304 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 398 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 426 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 451 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 486 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 392 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 470 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 487 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 490 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 506 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 509 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 521 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 524 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 592 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 597 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 609 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 612 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 642 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 647 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 659 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 662 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 701 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 706 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 718 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 721 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 747 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 752 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 764 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 767 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 8 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 35 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 177 to 181 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 223 to 338 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 297 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 341 to 457 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 407 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 416 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 8 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 27 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 28 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 165 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 708 to 765 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 844 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 844 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 846 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 140 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 378 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 292 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 329 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 356 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 447 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 472 to 475 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 556 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 118 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 138 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 145 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 375 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 10 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 12 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 14 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 44 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 95 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 96 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 97 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 99 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 183 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 212 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 218 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 666 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 674 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 682 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 683 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 359 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 374 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 251 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 333 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 189 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 211 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 220 forms a bond with Zn(2+) A, indicating a strong binding affinity.
The residue at position 369 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 396 forms a bond with Zn(2+) B, indicating a strong binding affinity.
The residue at position 271 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 448 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 451 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 797 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 840 to 847 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 495 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 495 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 497 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 552 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 555 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 570 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 572 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 604 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 607 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 80 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 82 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 89 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 230 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 232 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 234 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 242 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 37 to 44 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 107 to 117 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 151 to 161 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 201 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 245 to 250 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 273 to 284 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 288 forms a bond with echinenone, indicating a strong binding affinity.
The residue at position 380 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 484 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 93 to 97 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 198 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 115 to 121 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 475 to 480 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 374 to 381 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 348 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 547 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 739 to 743 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 742 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 787 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 845 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 940 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1135 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 147 to 151 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 285 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 370 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 146 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 160 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 167 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 353 to 358 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 999 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1001 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1117 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 586 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 140 to 148 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 172 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 392 to 399 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1087 to 1094 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 281 to 288 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 328 to 332 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 184 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 355 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 435 to 443 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with O2, indicating a strong binding affinity.
The residue at position 346 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 23 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 389 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 390 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 391 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 409 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 410 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 411 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 3 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 135 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 135 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 139 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 139 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 538 to 545 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 261 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 269 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 258 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 327 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 4 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 231 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 235 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 67 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 292 to 299 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 232 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 18 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 82 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 141 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 114 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 118 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 533 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 419 to 426 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 465 to 469 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 72 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 73 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 97 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 117 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 166 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 234 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 267 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 170 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 176 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 180 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 216 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 277 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 216 to 220 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 380 to 382 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 450 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 61 to 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 to 135 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 232 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 285 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 700 to 757 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 278 to 287 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 81 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 130 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 131 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 200 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 469 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 236 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 143 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 86 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 267 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 361 to 369 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 365 to 369 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 221 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 to 309 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 63 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 63 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 31 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 to 259 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 337 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 165 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 305 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 307 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 313 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 328 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 355 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 360 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 372 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 600 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 708 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 962 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 566 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 593 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 4 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 253 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 277 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 321 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 1124 to 1127 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1147 to 1150 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1176 to 1177 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1226 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1248 to 1249 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 399 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 227 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 52 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 53 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 158 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 182 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 182 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 411 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 489 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 543 to 552 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 569 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 588 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 48 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 81 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 161 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 262 to 269 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 312 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 848 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 859 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 860 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 101 to 129 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 220 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 292 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 360 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 43 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 569 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 40 to 47 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 207 to 211 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 364 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 373 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 401 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 495 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 517 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 520 to 527 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1331 to 1338 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 23 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 26 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 4 to 6 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 157 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 147 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 321 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 505 to 510 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 508 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 580 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 137 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 275 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 122 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 250 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 252 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 258 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 260 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 261 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 262 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 106 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 158 to 164 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 218 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 258 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 262 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 307 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 308 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 190 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 331 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 335 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 377 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 300 to 307 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 382 to 386 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 175 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 197 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 312 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 330 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 357 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 362 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 374 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 378 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 602 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 710 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 964 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 464 to 476 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 498 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 511 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 514 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 643 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 710 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 383 to 390 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1019 to 1026 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 216 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 to 344 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 266 to 287 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 308 to 327 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 243 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 336 to 342 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 336 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 109 to 116 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 239 to 242 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 84 to 91 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 602 to 603 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 619 to 620 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 655 to 656 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 656 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 679 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 679 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 681 to 682 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 707 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 741 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 746 to 747 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 783 to 787 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 860 to 862 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 862 to 866 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 896 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 209 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 257 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 261 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 21 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with adenine group of DNA, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with 8-oxoguanine group of DNA, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with 8-oxoguanine group of DNA, indicating a strong binding affinity.
The residue at position 126 forms a bond with adenine group of DNA, indicating a strong binding affinity.
The residue at position 188 forms a bond with adenine group of DNA, indicating a strong binding affinity.
The residue at position 308 forms a bond with 8-oxoguanine group of DNA, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 72 to 79 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 308 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 467 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 125 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 175 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 190 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 549 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 551 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 556 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 589 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 591 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 593 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 595 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 600 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 619 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 623 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 625 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 630 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 229 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 376 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 279 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 289 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 326 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 340 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 344 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 54 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 310 to 316 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 419 to 427 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 12 to 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 361 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 498 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 506 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 8 to 20 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 115 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 77 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 198 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 348 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 385 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 526 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 529 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 529 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 537 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 278 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 183 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 201 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 290 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 358 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 86 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 217 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 240 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 243 to 248 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 397 to 399 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 469 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 521 to 524 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 148 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 173 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 210 to 217 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 241 to 245 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 381 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 385 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 491 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 517 to 518 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 540 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 567 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 727 to 736 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 803 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 811 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 828 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 347 to 348 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 176 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 314 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 317 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 838 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 912 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 919 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 922 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 32 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 259 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 417 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 472 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 655 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 402 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 470 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 472 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 537 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 605 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 197 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 731 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 732 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 767 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 293 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 782 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 801 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 805 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 828 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 832 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 501 to 509 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with urate, indicating a strong binding affinity.
The residue at position 229 forms a bond with urate, indicating a strong binding affinity.
The residue at position 230 forms a bond with urate, indicating a strong binding affinity.
The residue at position 256 forms a bond with urate, indicating a strong binding affinity.
The residue at position 253 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 383 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 415 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 416 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 503 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 36 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 812 to 819 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 to 287 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 305 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 408 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 444 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 566 to 567 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 567 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 577 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 167 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 210 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 187 to 221 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 121 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 154 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 126 to 134 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 513 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 516 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 540 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 554 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 196 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 212 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 280 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 502 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 502 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 571 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 683 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 258 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 292 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 28 to 29 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 348 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 254 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 177 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 453 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 222 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 237 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 133 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 1388 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1391 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1407 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1433 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1436 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1445 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1350 to 1357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 314 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 127 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 130 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 134 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 171 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 71 to 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 354 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 264 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 111 to 116 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 138 to 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 400 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 474 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 482 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 484 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 492 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 562 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 212 to 217 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 337 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 599 to 654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 731 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 744 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 744 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 746 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 174 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 180 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 208 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 376 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 384 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 784 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 218 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 39 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 70 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 72 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 123 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 151 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 211 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 237 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 243 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 149 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 89 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 105 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 55 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 63 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 122 to 130 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 179 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 366 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 43 to 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 187 to 192 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 87 to 115 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 365 to 378 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 13 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 14 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 43 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 81 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 83 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 86 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 103 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 104 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 104 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 133 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 163 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 175 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 176 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 176 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 189 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 193 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 335 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 142 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 321 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 155 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 208 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 248 to 252 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 9 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 142 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 342 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 531 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 541 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 292 to 299 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 338 to 342 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 392 to 395 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 61 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 78 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 156 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 353 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 21 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 23 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 25 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 590 to 598 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 394 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 119 to 124 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 77 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 491 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 440 to 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 to 126 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2 to 5 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 to 125 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 251 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 477 to 482 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 615 to 616 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 220 to 228 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 619 to 626 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 424 to 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 445 to 450 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 623 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 250 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 299 to 308 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 232 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 600 to 601 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 617 to 618 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 653 to 654 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 654 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 677 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 677 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 679 to 680 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 705 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 739 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 744 to 745 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 781 to 785 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 858 to 860 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 860 to 864 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 894 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 235 to 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 403 to 408 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 424 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 459 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 480 to 482 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 527 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 336 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 156 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 303 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 135 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 173 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 204 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 324 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 328 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 106 to 114 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 441 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 443 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 136 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 757 to 764 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 171 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 389 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 408 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 411 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 76 to 84 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 190 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 245 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 275 to 279 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 364 to 372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 350 to 358 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 118 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 129 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 479 to 486 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 525 to 529 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 579 to 582 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 270 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 311 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 3 to 8 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 297 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 299 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 61 to 69 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 205 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 280 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 432 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 436 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 478 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 503 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 78 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 196 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 132 to 147 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 158 to 195 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 397 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 359 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 286 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 344 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 580 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 732 to 789 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 867 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 867 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 869 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 425 to 427 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 425 to 427 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 478 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 478 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 555 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 593 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 593 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 599 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 527 to 534 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 482 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 304 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 381 to 382 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 2 to 3 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 365 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 444 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 469 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 414 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 421 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 621 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 641 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 665 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 710 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 1046 to 1052 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 147 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 438 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 440 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 459 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 462 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 490 to 491 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 62 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 112 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 119 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 61 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1188 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1282 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1285 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 536 to 544 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 386 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 to 77 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 53 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 251 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 260 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 333 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 338 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with dipyrromethane, indicating a strong binding affinity.
The residue at position 82 forms a bond with dipyrromethane, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with dipyrromethane, indicating a strong binding affinity.
The residue at position 200 to 206 forms a bond with dipyrromethane, indicating a strong binding affinity.
The residue at position 223 to 229 forms a bond with dipyrromethane, indicating a strong binding affinity.
The residue at position 118 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 123 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 190 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 398 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 471 to 478 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 to 99 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 38 to 44 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 157 to 164 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 254 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 401 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 433 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 463 to 465 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 363 to 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 428 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 296 to 303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 77 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 664 to 672 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 888 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 892 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 64 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 180 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 53 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 129 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 169 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 39 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 379 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 387 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 420 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 31 to 38 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with pyridine, indicating a strong binding affinity.
The residue at position 51 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 154 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 344 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 417 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 220 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 441 to 443 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 441 to 443 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 494 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 494 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 525 to 526 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 571 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 609 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 609 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 615 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 13 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 294 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 313 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 130 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 197 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 50 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 71 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 159 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 246 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 837 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 963 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 963 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 978 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 979 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 to 312 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 284 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 450 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 582 to 590 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 498 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 531 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 535 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 537 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 795 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 823 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 864 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 890 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 892 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 892 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 894 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 913 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 918 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 918 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 920 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 921 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 921 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1009 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1011 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1011 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1013 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1014 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1032 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1037 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1037 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 13 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 to 168 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 435 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 510 to 515 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 533 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 563 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 243 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 303 to 309 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 307 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 309 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 418 to 420 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 219 to 226 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 331 to 334 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 392 to 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 549 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 550 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 626 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 727 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 728 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 47 to 54 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 321 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 324 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 70 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 462 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 477 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 478 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 207 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 to 292 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 to 335 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 335 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 531 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 533 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 537 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 614 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 1634 to 1641 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 66 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 46 to 50 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 94 to 108 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 131 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 207 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 261 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 209 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 806 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 826 to 831 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 847 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 858 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 175 to 179 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 485 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 313 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 491 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 988 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 990 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1001 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1003 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1007 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1043 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1146 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1147 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1433 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1435 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1446 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1448 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1450 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1452 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1470 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1472 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1490 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1595 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 458 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 481 to 488 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 503 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 506 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 139 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 514 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 409 to 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 to 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 861 to 863 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 870 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 877 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 903 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 55 to 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 182 to 188 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 330 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 413 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 416 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 481 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 483 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 487 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 52 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 79 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 86 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 144 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 146 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 184 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 142 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 409 to 414 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 521 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 582 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 8 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mg of chlorophyll a 8, indicating a strong binding affinity.
The residue at position 113 forms a bond with Mg of chlorophyll a 11, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 156 forms a bond with Mg of chlorophyll a 10, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg of chlorophyll a 14, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg of chlorophyll a 9, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg of chlorophyll a 13, indicating a strong binding affinity.
The residue at position 454 forms a bond with Mg of chlorophyll a 7, indicating a strong binding affinity.
The residue at position 465 forms a bond with Mg of chlorophyll a 16, indicating a strong binding affinity.
The residue at position 468 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 400 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 424 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 438 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 1181 to 1189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 658 to 669 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 788 to 798 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 30 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 51 to 55 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 93 to 97 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mg of bacteriochlorophyll a 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mg of bacteriochlorophyll a 6, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mg of bacteriochlorophyll a 4, indicating a strong binding affinity.
The residue at position 285 forms a bond with Mg of bacteriochlorophyll a 7, indicating a strong binding affinity.
The residue at position 286 forms a bond with Mg of bacteriochlorophyll a 3, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 314 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 98 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 201 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 15 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 16 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 55 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 57 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 92 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 95 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 171 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 213 to 228 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 355 to 369 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 476 to 486 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 238 to 245 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 320 to 324 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 382 to 385 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 285 to 289 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 to 12 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 113 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 206 to 213 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 208 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 447 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 451 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 349 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 468 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 509 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 554 to 557 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 to 308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 109 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 491 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 14 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 16 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 954 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 957 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1010 to 1013 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1016 to 1019 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1034 to 1036 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1040 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 278 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 294 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 363 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 899 to 906 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 272 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 388 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 60 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 63 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 13 to 17 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 49 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 194 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 30 to 55 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 505 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 428 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 4 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 481 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 203 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 261 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 280 to 285 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 235 to 240 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 235 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 254 to 260 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 264 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 319 to 333 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 306 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 326 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 408 to 409 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 483 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 553 to 555 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 to 116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 115 to 126 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 240 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 501 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 545 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 545 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 35 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 236 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 239 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 243 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 271 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 14 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 136 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 142 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 144 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 322 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 385 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 441 to 445 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 269 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 482 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 482 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 513 to 514 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 559 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 597 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 597 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 603 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 639 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 68 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 91 to 106 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 456 to 457 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 389 to 391 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 22 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 95 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 98 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 416 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 250 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 8 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 59 to 66 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 618 to 623 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 807 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 822 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 150 to 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1494 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1498 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1518 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 385 to 395 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 472 to 477 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 525 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 527 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 534 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 579 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 676 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 682 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 682 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 693 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 208 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 209 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 260 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 786 to 794 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 936 to 943 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 943 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 962 to 966 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1031 to 1034 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1105 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 628 to 635 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 342 to 349 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 389 to 393 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 443 to 446 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 129 to 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 116 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 174 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 636 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 661 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 442 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 461 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 483 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 512 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 538 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 543 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 100 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 203 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 278 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 430 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 434 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 476 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 501 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 400 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 401 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 529 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 532 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 639 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 672 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 682 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 700 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 667 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 732 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1361 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1442 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1443 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1625 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1667 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1700 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 213 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 274 to 277 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 30 to 35 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 871 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 17 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 40 to 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 58 to 65 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 29 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 96 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 340 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 423 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 425 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 448 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 36 to 40 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 62 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 81 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 1614 to 1621 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 248 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 272 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 273 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 328 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 421 to 428 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 511 to 519 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 to 34 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 286 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 501 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 647 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 651 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 655 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 137 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 150 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 182 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 209 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 357 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 159 to 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 328 to 331 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 to 199 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 34 to 41 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 231 to 238 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 278 to 282 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 343 to 346 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 281 to 284 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 to 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 to 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 204 to 211 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1637 to 1644 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 292 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 299 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 542 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 545 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 552 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 585 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 587 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 591 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 596 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 615 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 617 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 619 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 621 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 626 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 658 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 661 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 278 to 288 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 11 to 14 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 301 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 381 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 470 to 477 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 171 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 217 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 573 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 to 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 372 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 23 to 47 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 220 forms a bond with octopamine, indicating a strong binding affinity.
The residue at position 268 forms a bond with octopamine, indicating a strong binding affinity.
The residue at position 387 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 389 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 449 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 82 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 619 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 82 to 87 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 729 to 737 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 810 to 815 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1036 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 to 92 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 376 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 335 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 352 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 355 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 524 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 569 to 572 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 348 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 375 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 392 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 396 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 633 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 743 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 997 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 362 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 48 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 382 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 403 to 404 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 406 to 408 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 433 to 435 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 460 to 466 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 52 to 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 168 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 351 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 49 to 57 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 165 to 170 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 167 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 333 to 336 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 73 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 487 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 227 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 387 to 394 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 433 to 437 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 487 to 490 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 to 121 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 228 to 231 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 70 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 73 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 77 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 80 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 82 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 84 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 109 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 112 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 190 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 192 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 201 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 202 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 202 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 239 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 278 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 280 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 328 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 365 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 368 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 599 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 600 forms a bond with Co of cob(II)alamin, indicating a strong binding affinity.
The residue at position 601 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 602 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 645 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 647 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 676 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 699 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 339 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 340 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 342 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 796 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 821 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 149 to 155 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 300 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 41 to 47 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 227 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 101 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 500 to 507 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 873 to 880 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1175 to 1182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 56 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 166 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 206 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 69 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 404 to 411 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 450 to 454 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 504 to 507 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 280 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 359 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 363 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 4 to 5 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 208 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 239 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 6 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 178 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 384 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 116 to 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 to 63 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 212 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1040 to 1057 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1229 to 1244 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 798 to 805 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 36 to 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 442 to 449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 91 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 18 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 468 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 569 to 570 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 538 to 546 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 641 to 647 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 701 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 206 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 640 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 642 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 402 to 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 155 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 164 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 620 to 628 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 531 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 60 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 445 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 448 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 506 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 507 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 508 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 512 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 517 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 174 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 191 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 206 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 207 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 223 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 54 to 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 118 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 39 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 168 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 218 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 243 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 263 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 274 to 279 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 206 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 209 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 193 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 264 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 267 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 271 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 299 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 299 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 387 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 553 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 582 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 598 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 60 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 115 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 135 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 194 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 25 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 80 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 54 to 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 17 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 69 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 73 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 73 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 94 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 110 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 203 to 206 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 258 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 258 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 255 to 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 189 forms a bond with sulfur of a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 271 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 321 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 370 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 386 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 390 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 394 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 429 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 642 to 649 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 197 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 205 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 289 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 131 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 138 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 225 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 239 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 243 to 248 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 302 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 302 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 745 to 862 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 60 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 158 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 333 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 419 to 423 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 439 to 448 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 449 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 33 to 39 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 166 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 185 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 192 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 425 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 436 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 104 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 221 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 254 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 86 to 91 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 173 to 182 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 298 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 454 to 457 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 472 to 474 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 478 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 488 to 491 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 535 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 596 to 597 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 602 to 606 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 639 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 677 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 282 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 361 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 226 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 117 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 371 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 372 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 376 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 475 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 490 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 622 to 653 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 766 to 777 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 902 to 912 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 977 to 995 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1075 to 1090 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 335 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 446 to 450 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 394 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 436 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 37 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 37 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 114 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 114 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 175 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 175 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 177 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 177 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 181 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 181 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 234 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 234 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 259 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 259 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 279 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 279 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 1091 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 10 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 59 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 180 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 163 to 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 531 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 to 105 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 40 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 56 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 59 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 573 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 232 to 239 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 565 to 572 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 13 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 196 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 462 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 463 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 463 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 576 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 81 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 142 to 149 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 92 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 194 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 383 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 504 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 511 to 512 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 520 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 596 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 134 to 139 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 125 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 137 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 194 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 200 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 223 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 229 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 8 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 11 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 128 to 136 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 558 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 559 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 173 forms a bond with a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 209 forms a bond with a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 209 forms a bond with a 1-acyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 290 to 297 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 336 to 340 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 390 to 393 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 88 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 192 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 376 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 447 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 494 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 501 to 502 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 510 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 79 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 594 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 578 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 601 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 714 to 717 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 731 to 735 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 736 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 743 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 748 to 750 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 801 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 434 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 472 to 473 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 500 to 501 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 523 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 to 77 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 to 241 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 381 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 460 to 464 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 49 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 594 to 597 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 331 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 938 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1018 to 1020 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1025 to 1029 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1065 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 29 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 43 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 87 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 98 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 93 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 156 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 189 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 254 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 257 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 328 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 333 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 491 to 494 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 501 to 502 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 542 to 545 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 203 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 519 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 299 to 305 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 329 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 423 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 116 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 149 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 156 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 498 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 536 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 218 to 223 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 398 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 520 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 75 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 194 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 34 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 258 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 313 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 184 to 190 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 537 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 547 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 214 to 223 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 461 to 463 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 464 to 466 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 562 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 126 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 35 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 548 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 550 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 557 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 620 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 620 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 653 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 716 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 716 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 719 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 791 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 791 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 793 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 795 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 796 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 160 to 167 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 186 to 194 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 212 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 328 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 352 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 469 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 470 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 512 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 519 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 549 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 589 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 590 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 612 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 694 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 695 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 717 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 799 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1120 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1123 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 56 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 130 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 17 to 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 845 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 190 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 500 to 503 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 523 to 525 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 176 to 182 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 250 to 258 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 830 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 247 forms a bond with hyperforin, indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with hyperforin, indicating a strong binding affinity.
The residue at position 407 forms a bond with hyperforin, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 346 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 99 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 35 to 40 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 95 to 99 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 611 to 618 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 166 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 283 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 287 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 184 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 219 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 227 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 230 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 36 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 38 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 62 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 75 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 282 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 56 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 91 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 173 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 409 to 410 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 382 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 383 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 50 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 89 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 11 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 14 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 14 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 583 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 587 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 198 to 204 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 258 to 266 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 40 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 146 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 864 to 872 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 892 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 305 to 306 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 138 to 143 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 202 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 424 to 429 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 442 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 457 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 467 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 488 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 159 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 164 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 212 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 301 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 907 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 907 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 926 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 927 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 179 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 171 to 176 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 473 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 268 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 320 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 339 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 369 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 396 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 437 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 735 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 822 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 888 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 916 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 920 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 400 to 401 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 256 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 275 to 280 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 370 to 372 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 377 to 383 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 332 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 85 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 85 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 89 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 89 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 181 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 181 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 187 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 187 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 210 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 266 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 277 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 277 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 89 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 48 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 74 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 147 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 265 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 431 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 73 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 610 to 617 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 484 to 489 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 138 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 369 to 377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 208 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 36 to 62 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 57 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 13 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 295 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 to 196 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 to 60 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 440 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 21 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 185 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 254 to 259 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 224 to 229 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 149 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 205 to 212 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 349 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 448 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 317 to 324 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 351 to 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 253 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 110 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 239 to 243 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 377 to 379 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 409 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 588 to 594 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 632 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1300 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1306 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1345 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1349 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1349 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 181 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 269 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 42 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 111 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 473 to 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 29 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 to 248 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 447 to 454 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1193 to 1200 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 141 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 655 to 657 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 673 to 674 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 689 to 746 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 813 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 827 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 455 to 462 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 501 to 505 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 555 to 558 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 295 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 527 to 534 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1347 to 1354 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 329 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 404 to 406 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 428 to 433 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 542 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 391 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 446 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 602 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 610 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 618 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 619 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 90 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 240 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 236 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 146 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 305 to 309 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 331 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 176 to 208 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 420 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 202 to 209 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 249 to 253 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 208 forms a bond with Se-Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with Se-Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 332 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 410 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 412 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 435 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 59 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 61 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 86 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 90 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 97 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 195 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 233 to 238 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 34 to 39 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 151 to 157 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 256 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 273 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 276 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 374 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 403 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 239 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 291 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 361 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 570 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 199 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 1025 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 504 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 686 to 687 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 496 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 375 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 378 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 428 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 429 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 430 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 439 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 344 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 209 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 487 to 491 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 433 to 441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 289 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 41 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 111 to 117 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 35 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 74 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 222 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 224 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 226 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 397 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 268 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 237 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 238 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 393 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 466 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 33 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 440 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1130 to 1137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 19 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 249 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 228 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 118 to 125 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 365 to 366 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 461 to 464 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 492 to 495 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 351 to 353 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 392 to 395 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 579 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 10 to 12 forms a bond with dTDP-beta-L-4-epi-vancosamine, indicating a strong binding affinity.
The residue at position 127 forms a bond with devancoaminyl-vancomycin, indicating a strong binding affinity.
The residue at position 133 forms a bond with devancoaminyl-vancomycin, indicating a strong binding affinity.
The residue at position 141 forms a bond with devancoaminyl-vancomycin, indicating a strong binding affinity.
The residue at position 169 forms a bond with devancoaminyl-vancomycin, indicating a strong binding affinity.
The residue at position 207 forms a bond with dTDP-beta-L-4-epi-vancosamine, indicating a strong binding affinity.
The residue at position 230 forms a bond with dTDP-beta-L-4-epi-vancosamine, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with dTDP-beta-L-4-epi-vancosamine, indicating a strong binding affinity.
The residue at position 293 to 298 forms a bond with dTDP-beta-L-4-epi-vancosamine, indicating a strong binding affinity.
The residue at position 447 to 448 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 163 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 422 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 367 to 369 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 408 to 411 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 603 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 16 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 291 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 271 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 286 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 289 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 312 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 335 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 364 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 349 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 400 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 457 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 to 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 to 387 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 518 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 520 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 612 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 620 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 262 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 286 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 330 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 449 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 474 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 509 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 511 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 349 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 370 to 371 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 395 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 400 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 434 to 435 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 462 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 493 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 527 to 536 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 614 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 445 to 452 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 38 to 45 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 357 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 366 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 393 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 487 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 503 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 509 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 130 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 319 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 289 to 296 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 259 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 285 to 291 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 28 to 35 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 445 to 452 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 482 to 486 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 549 to 552 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 325 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 328 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 412 to 413 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 408 to 415 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 454 to 458 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 147 forms a bond with Ni of coenzyme F430, indicating a strong binding affinity.
The residue at position 225 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 270 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 333 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 444 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 310 to 311 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 256 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 316 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 522 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 964 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 511 to 518 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 357 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 642 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 86 to 93 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 418 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 163 to 172 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 240 to 245 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with 4-aminobutanal, indicating a strong binding affinity.
The residue at position 262 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 296 forms a bond with 4-aminobutanal, indicating a strong binding affinity.
The residue at position 455 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 461 forms a bond with 4-aminobutanal, indicating a strong binding affinity.
The residue at position 125 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 146 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 157 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 305 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 281 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 296 to 300 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 322 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 934 to 940 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 979 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 to 43 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 337 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 132 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 70 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 412 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 512 to 516 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 560 to 563 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 591 to 623 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 890 to 897 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 617 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 117 to 122 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 296 to 300 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 359 to 362 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 409 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 485 to 496 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 326 to 329 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 154 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 354 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 44 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 33 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 286 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 1591 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1593 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1595 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1601 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1666 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 470 to 475 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 to 103 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 110 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 144 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 521 to 522 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 688 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 691 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 720 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 727 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 727 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 731 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 731 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 736 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 737 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 814 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 815 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 848 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 855 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 865 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 875 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 490 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 419 to 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1502 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1502 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1508 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1557 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1557 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1558 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1559 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1559 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1559 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1562 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1565 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1565 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1824 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1827 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1830 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 330 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 661 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 26 to 31 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 195 to 200 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 19 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 145 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 162 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 177 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 178 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 199 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 410 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 486 to 497 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 455 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 493 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 495 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 497 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 502 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 373 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 373 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 373 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 377 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 377 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 515 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 518 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 518 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 16 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 390 to 391 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 419 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 496 to 501 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 519 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 549 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 376 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 300 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 333 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 354 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 132 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 332 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 336 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 360 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 554 to 558 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 471 to 472 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 341 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 341 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 436 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 436 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 440 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 440 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 44 forms a bond with cyanopindolol, indicating a strong binding affinity.
The residue at position 279 to 283 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 to 313 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 160 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 202 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 83 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 417 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 29 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 40 to 129 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 122 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 411 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 432 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 222 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 163 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 202 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 209 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 295 to 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 240 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 251 to 257 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 676 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 299 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 964 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 193 to 200 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 to 122 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 135 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 184 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 188 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 643 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 647 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 188 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 43 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 404 to 407 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 456 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with L-glutamyl-tRNA(Glu), indicating a strong binding affinity.
The residue at position 127 forms a bond with L-glutamyl-tRNA(Glu), indicating a strong binding affinity.
The residue at position 132 forms a bond with L-glutamyl-tRNA(Glu), indicating a strong binding affinity.
The residue at position 138 forms a bond with L-glutamyl-tRNA(Glu), indicating a strong binding affinity.
The residue at position 206 to 211 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 to 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 79 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 277 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 281 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 335 to 339 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 84 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 336 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 353 to 355 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 435 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 144 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 331 to 340 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 393 to 394 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 326 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 824 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 440 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 561 to 568 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 614 to 618 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 668 to 671 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 336 to 337 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 76 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 267 to 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 346 to 348 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 186 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 69 to 75 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 18 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 810 to 817 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 66 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 144 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 452 to 459 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 498 to 502 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 214 to 224 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 305 to 311 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 25 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 27 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 29 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 56 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 58 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 111 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 112 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 113 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 140 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 227 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 774 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 776 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 862 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 882 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 885 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 30 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 41 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 63 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 47 to 51 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 72 to 77 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 95 to 109 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 208 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 262 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 429 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 431 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 510 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 699 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 700 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 729 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 757 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 808 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 810 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 831 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 856 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 857 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 858 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 110 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 110 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 153 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 153 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 117 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 376 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 652 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 416 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 810 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 812 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 915 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 448 to 455 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 76 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with 5-hydroxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 110 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 820 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 20 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 206 to 211 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 106 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 181 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 184 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 32 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 137 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 140 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 924 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 199 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 322 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 200 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 204 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 207 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 222 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 243 to 249 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 to 38 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 168 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 412 to 416 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 432 to 441 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 442 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 183 to 202 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 470 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 15 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 52 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 357 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 383 to 385 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 405 to 407 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 409 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 568 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 228 to 235 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 275 to 279 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 157 to 162 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 224 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 245 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 325 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 375 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 386 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 471 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 471 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 215 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 215 forms a bond with phenylglyoxylate, indicating a strong binding affinity.
The residue at position 267 to 270 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 322 forms a bond with phenylglyoxylate, indicating a strong binding affinity.
The residue at position 451 forms a bond with phenylglyoxylate, indicating a strong binding affinity.
The residue at position 454 forms a bond with phenylglyoxylate, indicating a strong binding affinity.
The residue at position 485 to 489 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 508 to 509 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1265 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1265 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1271 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1320 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1320 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1322 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1322 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1328 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1596 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1599 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1602 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 to 52 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 586 to 588 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 107 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 243 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 307 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 184 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 186 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 192 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 381 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 439 to 442 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 460 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 476 to 477 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 554 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 137 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 562 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 576 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 576 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 63 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 89 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 155 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 278 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 445 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 968 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 975 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 978 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 715 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 457 to 464 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 503 to 507 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 557 to 560 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 70 to 77 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 352 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 429 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 455 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 528 to 535 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 3 to 21 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 68 to 76 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 176 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 205 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 301 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 119 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 230 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 476 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 483 to 488 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 483 to 484 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 682 to 809 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 846 to 966 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 210 to 229 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 445 to 447 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 188 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 207 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 211 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 232 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 345 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 456 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 372 to 380 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 394 to 397 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 166 to 170 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 339 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 413 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 460 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 467 to 468 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 476 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 102 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 189 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 232 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 235 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 335 to 342 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 253 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 89 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 163 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 585 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 596 to 597 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 388 to 395 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 601 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 811 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 141 to 156 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 167 to 204 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 137 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 151 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 119 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 413 to 416 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 447 to 449 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 497 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 500 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1955 to 1963 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1976 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1628 to 1635 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 135 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 326 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 504 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 507 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 515 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 202 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 107 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 348 forms a bond with beta-D-fructose 1-phosphate, indicating a strong binding affinity.
The residue at position 514 forms a bond with beta-D-fructose 1-phosphate, indicating a strong binding affinity.
The residue at position 514 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 662 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 670 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 678 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 104 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 226 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 11 to 25 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 93 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 426 to 433 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1070 to 1077 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 300 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 338 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 403 to 407 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 64 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 70 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 70 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 113 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 52 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 164 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 178 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 271 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 331 to 337 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 445 to 447 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 21 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 38 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 126 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 213 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 13 to 42 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 440 to 447 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 490 to 494 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 544 to 547 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 318 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 to 241 forms a bond with strychnine, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 42 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 537 to 540 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 601 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 604 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 604 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1002 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1023 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1047 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1094 to 1100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1153 to 1154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 to 198 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 to 226 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 364 to 365 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 371 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 480 to 489 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 481 to 487 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 574 to 575 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 609 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 668 to 670 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 709 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 736 to 737 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 767 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 793 to 795 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 816 to 817 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 953 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 956 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 959 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 963 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 986 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 989 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 992 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 996 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 182 to 187 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 263 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 404 to 415 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 415 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 511 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 511 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 513 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 513 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 517 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 782 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1104 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1107 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1113 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 286 to 291 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1003 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 222 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 237 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 240 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 263 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 303 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 619 to 626 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 157 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 346 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 468 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 475 to 476 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 484 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 35 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 181 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 449 to 579 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 520 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 9 to 14 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 228 to 233 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 7 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 47 to 51 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 to 112 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 436 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 457 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 460 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 488 to 489 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 509 to 510 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 164 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 148 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 551 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 570 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 581 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 581 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 640 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 644 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 653 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 676 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 690 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 690 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 117 to 124 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 188 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 272 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 55 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 67 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 81 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 69 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 348 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 413 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 416 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 38 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 455 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 426 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 321 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 327 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 339 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 270 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 159 to 164 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 555 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 447 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 24 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 250 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 171 to 179 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 416 to 421 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 435 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 405 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 70 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 70 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 218 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 218 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 236 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 236 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 257 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 141 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 395 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 280 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 223 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 184 to 189 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 109 to 114 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 432 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 169 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with heme, indicating a strong binding affinity.
The residue at position 203 forms a bond with heme, indicating a strong binding affinity.
The residue at position 238 forms a bond with heme, indicating a strong binding affinity.
The residue at position 240 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 274 forms a bond with heme, indicating a strong binding affinity.
The residue at position 239 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 250 to 256 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 284 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 289 to 294 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 381 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 408 to 410 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 435 to 439 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 489 to 495 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 489 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 422 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 8 to 28 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 762 to 770 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 784 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 56 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 208 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 179 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 501 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 504 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 576 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 577 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 578 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 582 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 53 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 153 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 164 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 241 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 558 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 337 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 233 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 303 to 304 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 306 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 103 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 169 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 199 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 253 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 256 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 257 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 263 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 266 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 283 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 286 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 287 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 334 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 337 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 338 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 347 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 384 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 387 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 388 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 483 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 291 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 394 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 287 to 288 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 33 to 40 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 172 to 176 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 205 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 386 to 387 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 390 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 488 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 701 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 707 to 709 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 788 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 804 to 805 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 250 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with folate, indicating a strong binding affinity.
The residue at position 696 forms a bond with dopamine, indicating a strong binding affinity.
The residue at position 696 forms a bond with histamine, indicating a strong binding affinity.
The residue at position 825 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 827 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 16 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 69 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 284 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 286 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 70 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 357 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 417 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 579 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 552 to 557 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 to 278 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 to 180 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 110 to 118 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 188 to 194 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 328 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 135 to 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 22 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 222 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 244 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 291 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 294 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 309 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 320 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 334 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 396 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 441 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 495 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 110 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 115 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 143 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 181 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 23 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 110 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 184 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 278 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 293 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 609 to 616 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 592 to 596 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 686 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 803 to 807 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 403 to 523 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 174 to 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 to 224 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 112 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 218 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 298 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 429 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 303 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 309 to 310 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 396 to 397 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 412 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 421 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 119 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 691 to 746 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 230 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 230 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 233 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 311 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 283 to 289 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 246 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 348 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 444 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 444 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 33 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 495 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 518 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 521 to 522 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 647 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 649 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 658 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 662 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 671 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 733 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 513 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 65 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 223 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 225 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 274 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 164 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 257 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 20 to 26 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 295 to 300 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 375 to 381 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 297 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 224 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 143 to 149 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 295 to 299 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 346 to 347 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 434 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 550 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 574 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 22 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 94 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 328 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 393 to 397 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 476 to 484 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 118 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 328 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 343 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 371 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 291 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 240 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 249 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 294 to 413 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 480 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 482 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 548 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 550 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 554 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 74 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 178 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 648 to 655 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1246 to 1253 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 451 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 463 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 465 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 378 to 380 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 301 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 546 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 230 to 234 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 130 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 165 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 168 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 51 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 96 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 527 to 534 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 428 to 436 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 43 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 362 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 299 to 306 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 304 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 307 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 603 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 699 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 702 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 722 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 725 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 802 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 825 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 828 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 836 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 841 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 890 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 893 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 898 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 901 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 916 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 925 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 27 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 142 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 291 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 291 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 343 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 344 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 361 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 365 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 366 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 369 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 364 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 281 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 291 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 325 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 339 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 343 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 268 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 396 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 462 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 69 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 417 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 539 to 540 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 573 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 595 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 121 to 126 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 154 to 185 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 495 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 525 to 533 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 291 to 296 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1147 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1147 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1149 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1154 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1154 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1159 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1182 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1203 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1203 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1207 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1209 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1213 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1234 to 1236 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1277 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1313 to 1314 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1316 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1355 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1370 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1372 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1377 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 113 forms a bond with (S)-carazolol, indicating a strong binding affinity.
The residue at position 113 forms a bond with (S)-timolol, indicating a strong binding affinity.
The residue at position 118 forms a bond with (S)-timolol, indicating a strong binding affinity.
The residue at position 203 forms a bond with (S)-carazolol, indicating a strong binding affinity.
The residue at position 293 forms a bond with (S)-timolol, indicating a strong binding affinity.
The residue at position 312 forms a bond with (S)-carazolol, indicating a strong binding affinity.
The residue at position 312 forms a bond with (S)-timolol, indicating a strong binding affinity.
The residue at position 316 forms a bond with (S)-timolol, indicating a strong binding affinity.
The residue at position 205 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 249 to 252 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 366 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 463 to 471 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 44 forms a bond with O2, indicating a strong binding affinity.
The residue at position 435 to 442 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 485 to 489 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 539 to 542 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 to 175 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 158 to 163 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 199 to 204 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 104 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 149 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 172 to 176 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 204 to 210 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 225 to 248 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 381 to 383 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 13 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 266 to 267 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 to 103 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 630 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 695 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 25 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 796 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1436 to 1443 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 6 to 9 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 134 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 169 to 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 194 to 198 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 155 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 179 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 202 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 78 to 85 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 440 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 549 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 565 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 566 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 567 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 567 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 653 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 654 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 701 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 396 to 402 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 442 to 443 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 552 to 554 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 443 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 398 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 473 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 10 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 176 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 200 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 215 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 76 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 544 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 544 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 603 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 683 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 742 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 9 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 41 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 68 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 94 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 38 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 96 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 122 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 134 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 193 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 264 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 253 to 257 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 274 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 354 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 43 to 50 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 357 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 33 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 68 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 69 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 277 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 389 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 389 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 393 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 393 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 430 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 430 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 547 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 547 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 598 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 598 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 601 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 601 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 146 to 154 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 178 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 to 269 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 8 to 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 170 to 297 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 499 to 585 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 613 to 718 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 170 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 96 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 160 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 199 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 202 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 207 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 638 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 676 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 255 to 260 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 104 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 162 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 162 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 252 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 255 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 139 to 144 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 962 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 972 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 168 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 170 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 455 to 461 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 468 to 475 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 514 to 518 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 568 to 571 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 198 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 223 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 629 to 636 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 315 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 541 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 545 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 663 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1180 to 1182 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 1235 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1260 to 1263 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1277 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1311 to 1315 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1341 to 1344 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 380 to 388 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 296 to 297 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 564 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 580 to 581 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 442 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 78 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 351 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 454 to 458 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 475 to 484 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 485 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 539 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 120 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 393 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 417 to 420 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 468 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 1440 to 1485 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 467 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 506 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 317 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 287 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 to 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 1377 to 1384 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 141 to 149 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 242 to 249 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 248 to 255 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 57 forms a bond with bilirubin IXalpha, indicating a strong binding affinity.
The residue at position 61 forms a bond with bilirubin IXalpha, indicating a strong binding affinity.
The residue at position 80 forms a bond with bilirubin IXalpha, indicating a strong binding affinity.
The residue at position 112 forms a bond with bilirubin IXalpha, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with bilirubin IXalpha, indicating a strong binding affinity.
The residue at position 31 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 31 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 46 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 46 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 65 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 65 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 116 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 116 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 174 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 174 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 175 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 175 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 151 to 155 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 502 to 632 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 573 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 635 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 241 to 248 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 507 to 514 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 250 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 297 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 332 to 338 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 351 to 352 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 387 to 394 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 5 to 8 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 19 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 219 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 337 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 343 to 344 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 397 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1191 to 1199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 138 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 121 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 73 to 77 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 144 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 148 to 154 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 177 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 170 to 177 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 257 to 285 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 593 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 188 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 214 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 238 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 512 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 48 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 232 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 277 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 295 to 323 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 70 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 516 to 574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 696 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 696 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 717 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 717 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 717 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 717 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 719 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 719 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 216 to 222 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 to 51 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 542 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 342 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 354 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 3 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 5 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 5 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 9 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 18 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 33 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 40 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 40 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 44 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 44 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 50 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 52 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 56 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 58 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 58 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 311 to 314 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 335 to 344 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 361 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 546 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 856 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 873 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 45 to 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 to 164 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 129 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 137 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 164 to 172 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 235 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 134 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 185 to 188 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 188 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 196 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 282 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 357 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 364 to 365 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 162 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 167 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 167 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 238 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 609 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 611 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 624 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 627 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 632 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 635 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 650 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 653 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme, indicating a strong binding affinity.
The residue at position 1211 to 1268 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1264 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1270 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1275 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1995 to 2009 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 339 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 699 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 709 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 108 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 159 to 164 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 96 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 460 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 279 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 520 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 474 to 478 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 675 to 679 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 241 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 296 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 261 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 351 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 136 to 166 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 175 to 210 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 318 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 355 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 366 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 186 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 243 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 269 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 288 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 255 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 107 forms a bond with (5Z,8Z,11Z,14Z)-eicosatetraenoate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with (5Z,8Z,11Z,14Z)-eicosatetraenoate, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 653 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 656 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 33 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 376 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 756 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 758 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 760 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1130 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1211 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1218 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1221 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 213 to 220 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 481 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 507 to 508 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 530 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 557 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 717 to 726 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 793 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 801 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 818 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 969 to 974 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 213 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 to 222 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 287 to 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 331 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 512 to 523 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 251 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 286 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 443 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 449 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 907 to 914 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 to 347 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 255 to 261 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 114 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 226 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 260 to 263 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 303 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 110 to 115 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 335 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 519 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 546 to 550 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 610 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 619 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 653 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 657 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 723 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 737 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 242 to 246 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 136 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 325 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 397 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 454 to 455 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 463 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 1 to 2 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 59 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 253 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 441 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 563 to 564 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 574 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 412 to 414 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 83 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 114 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 120 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 129 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 480 to 483 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 599 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 675 to 677 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 699 to 704 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 796 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 811 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 819 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 835 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 838 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 34 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 329 to 350 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 372 to 391 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 38 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 110 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 223 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 450 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 275 to 279 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 481 to 605 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 552 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 72 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 224 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 391 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 80 forms a bond with (S)-warfarin, indicating a strong binding affinity.
The residue at position 135 forms a bond with phylloquinone, indicating a strong binding affinity.
The residue at position 139 forms a bond with (S)-warfarin, indicating a strong binding affinity.
The residue at position 139 forms a bond with phylloquinone, indicating a strong binding affinity.
The residue at position 312 to 318 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 161 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 291 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 169 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 477 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 481 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 28 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 128 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 188 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 305 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 366 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 366 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 50 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 53 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 19 to 28 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 39 to 43 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 65 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 84 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 34 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 444 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 488 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 36 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 221 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 210 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 22 to 29 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 259 to 269 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 50 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 146 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 273 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 504 to 514 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 538 to 540 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 629 to 632 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 727 to 731 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 727 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 755 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 756 to 758 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 479 to 486 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 35 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 314 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 345 to 352 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 379 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 578 to 582 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 745 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 779 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 19 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 580 to 585 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 580 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 580 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 581 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 622 to 624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 624 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 624 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1440 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1517 to 1519 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1524 to 1528 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1564 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 825 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 523 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 528 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 714 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 862 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 530 to 537 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1378 to 1385 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 226 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 275 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 276 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 277 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 278 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 279 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 576 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 495 to 501 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 646 to 654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 to 333 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 417 to 423 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 324 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 338 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 342 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 791 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 820 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 667 to 668 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 208 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 146 to 152 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 176 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 179 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 463 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 517 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 272 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 273 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 299 to 303 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 124 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 186 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 248 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 79 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 431 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 83 to 90 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 501 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 512 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 515 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 521 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1347 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1429 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1611 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1653 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1686 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 173 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 134 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 362 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 364 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 541 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 5 to 10 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 3 to 4 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 118 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 12 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 15 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 414 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 417 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 420 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 424 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 452 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 455 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 458 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 462 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 520 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 549 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 584 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 511 to 513 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 518 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 730 to 731 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 474 to 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 to 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 291 to 303 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 357 to 363 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 240 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 to 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 74 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 78 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 84 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 20 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 43 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 479 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 458 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 460 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 462 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 159 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 32 to 36 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 64 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 103 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 60 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 60 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 92 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 272 to 278 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 10 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 72 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 135 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 135 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 233 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 236 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 310 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 312 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 313 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 98 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 170 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 284 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 288 forms a bond with Fe(II)-heme o, indicating a strong binding affinity.
The residue at position 333 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 334 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe(II)-heme o, indicating a strong binding affinity.
The residue at position 419 forms a bond with Fe of Fe(II)-heme o, indicating a strong binding affinity.
The residue at position 421 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 481 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 482 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 321 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 416 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 452 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 590 to 591 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 604 to 611 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 510 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 512 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 629 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 707 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with 2'-deoxycoformycin, indicating a strong binding affinity.
The residue at position 141 forms a bond with 2'-deoxycoformycin, indicating a strong binding affinity.
The residue at position 170 forms a bond with 2'-deoxycoformycin, indicating a strong binding affinity.
The residue at position 200 forms a bond with 2'-deoxycoformycin, indicating a strong binding affinity.
The residue at position 221 forms a bond with 2'-deoxycoformycin, indicating a strong binding affinity.
The residue at position 278 forms a bond with 2'-deoxycoformycin, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 324 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 86 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 149 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 149 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 182 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 704 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 708 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 653 to 700 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 343 to 347 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 641 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 156 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 75 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 386 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 388 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 410 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 440 to 441 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 101 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 131 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 36 to 39 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 260 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 320 to 326 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 324 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 435 to 437 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 113 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 806 to 807 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1088 to 1091 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1203 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1268 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 621 to 628 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1247 to 1254 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 326 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 402 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 407 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 246 to 254 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 447 to 448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 310 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 417 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 981 to 984 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1004 to 1013 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1031 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1068 to 1069 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 108 forms a bond with bortezomib, indicating a strong binding affinity.
The residue at position 398 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 791 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 240 to 247 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 286 to 290 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 to 83 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 35 to 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 219 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 115 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 232 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 243 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 136 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 176 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 68 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 75 to 104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 forms a bond with a 1-acyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 126 to 131 forms a bond with a 1-acyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with a 1-acyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 436 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 679 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 431 to 436 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 433 to 438 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 633 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 707 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 708 to 711 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 389 to 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 534 to 538 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 491 to 498 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 94 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 133 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 190 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 383 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 45 to 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 204 to 210 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 25 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 183 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 654 to 662 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 849 to 856 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 453 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 12 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 72 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 92 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 135 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 166 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 30 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 199 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 207 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 293 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 1031 to 1038 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 414 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 459 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 466 to 467 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 475 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 333 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 335 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 362 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 373 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 374 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 374 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 738 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 133 to 139 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 162 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 115 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 295 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 338 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 343 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 650 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 693 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 698 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 703 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 977 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 980 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 982 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1028 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1033 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 158 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 340 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 105 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 137 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1018 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1025 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1025 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 120 to 125 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 159 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 85 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 803 to 947 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 943 to 1074 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 16 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 439 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 486 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 220 to 226 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 289 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 302 to 305 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 354 to 360 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 855 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 857 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 178 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 267 to 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 237 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 248 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 120 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 300 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 308 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 38 to 44 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 94 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 321 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 226 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 227 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 11 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 27 to 32 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 361 to 365 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 241 to 248 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 288 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 174 to 181 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 360 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 506 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 524 to 528 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 536 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 566 to 568 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 1083 to 1135 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1136 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1142 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1147 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 275 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 232 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 232 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 247 to 252 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 247 to 252 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 247 to 252 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 292 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 292 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 292 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 313 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 314 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 363 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 368 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 461 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 477 to 480 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 336 to 344 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 642 to 645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 443 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 185 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 327 to 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 415 to 417 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 677 to 681 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 149 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 58 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 127 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 180 to 188 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 327 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 428 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 484 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 126 to 134 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 225 to 253 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 191 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 276 forms a bond with hypoxanthine, indicating a strong binding affinity.
The residue at position 193 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 326 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 339 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 304 to 310 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 350 to 351 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 360 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 50 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 780 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 192 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 214 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 330 to 332 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 384 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 454 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 484 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 515 to 517 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 539 to 540 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 465 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 264 to 272 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 290 to 295 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 201 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 349 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 353 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 397 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 422 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 133 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 153 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 645 to 653 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 673 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 556 to 559 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 579 to 588 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 605 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 642 to 643 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 332 forms a bond with CO2, indicating a strong binding affinity.
The residue at position 276 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 534 to 542 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 720 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 87 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 221 to 257 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 395 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 397 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 402 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1052 to 1059 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 342 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 353 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 353 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 419 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 426 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 452 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 483 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 122 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 445 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 74 to 98 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 964 to 968 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 164 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 282 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 232 to 239 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 82 to 86 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 311 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 72 to 80 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 134 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 201 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 215 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 221 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 252 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 302 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 312 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 63 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 163 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 353 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 423 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 464 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 480 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 27 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 27 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 42 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 42 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 61 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 61 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 112 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 112 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 170 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 170 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 171 forms a bond with 5-(2-oxoethylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 171 forms a bond with 5-(2-oxopropylideneamino)-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 60 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 84 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 104 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 184 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 1214 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 333 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 789 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 482 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 514 to 517 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 527 to 529 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 571 to 572 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 662 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 662 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 664 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 181 to 187 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 137 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 326 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 398 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 450 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 457 to 458 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 466 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 313 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 417 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 39 to 43 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 298 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 376 to 384 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 398 to 401 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 206 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 366 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 461 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 483 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 511 to 512 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 532 to 533 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 7 to 12 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 to 19 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 170 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 187 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 163 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 655 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 708 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 999 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1002 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 1004 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1044 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1046 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1050 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 91 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 470 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 473 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 532 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 533 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 534 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 538 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 341 to 348 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 59 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 to 161 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 198 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 208 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 81 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 114 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 256 to 261 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 260 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 145 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 220 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 646 to 653 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 553 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 553 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 557 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 557 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 698 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 706 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 321 to 326 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 117 to 122 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 314 forms a bond with 20-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 314 forms a bond with 25-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 314 forms a bond with 7beta-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 314 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 314 forms a bond with ergosterol, indicating a strong binding affinity.
The residue at position 493 to 496 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 522 to 523 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 102 to 106 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 141 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 260 to 263 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 353 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 408 to 409 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 440 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 165 to 168 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 333 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 55 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 234 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1057 to 1063 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 577 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1233 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1235 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1281 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1284 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1411 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 822 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 825 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 859 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 862 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 185 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 230 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 250 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 685 to 693 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 118 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 115 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 148 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 192 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 221 to 229 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 328 to 332 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 348 to 353 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 302 to 306 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 13 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 339 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 380 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 380 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 521 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 521 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 285 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 301 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 829 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 841 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 841 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 843 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 976 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 48 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 78 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 79 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 103 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 123 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 173 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 242 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 195 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 324 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 407 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 432 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 117 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 585 to 592 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 165 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 202 to 206 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 231 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 232 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 220 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 62 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 755 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 755 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 761 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 761 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 769 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 807 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 807 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 818 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 839 to 841 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 877 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 879 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1198 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1201 to 1202 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1257 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1259 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1264 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 209 to 214 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 360 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 406 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 276 forms a bond with mycophenolate, indicating a strong binding affinity.
The residue at position 326 forms a bond with mycophenolate, indicating a strong binding affinity.
The residue at position 333 forms a bond with mycophenolate, indicating a strong binding affinity.
The residue at position 225 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 213 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 215 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 220 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 252 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1019 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1025 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1085 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 193 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 272 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 534 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 557 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 580 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 588 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 210 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 662 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 730 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 755 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 758 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 867 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 351 to 358 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 33 to 39 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 48 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 53 forms a bond with alpha,alpha-trehalose, indicating a strong binding affinity.
The residue at position 369 to 370 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 610 to 611 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 305 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 382 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 502 to 506 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 556 to 559 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 780 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 324 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 459 to 465 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 55 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 89 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 88 to 95 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 139 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 368 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 370 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 410 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 462 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 494 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 685 to 686 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 424 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 447 to 450 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 496 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 562 to 565 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 707 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 114 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 322 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 326 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 367 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 11 to 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 304 to 314 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 40 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 392 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 428 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 21 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 245 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 247 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 247 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 332 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1776 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2080 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2082 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1693 to 1700 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe(III)-coprogen, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe(III)-coprogen, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe(III)-coprogen, indicating a strong binding affinity.
The residue at position 357 forms a bond with Fe(III)-coprogen, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe(III)-coprogen, indicating a strong binding affinity.
The residue at position 416 forms a bond with Fe(III)-coprogen, indicating a strong binding affinity.
The residue at position 160 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 702 to 756 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 259 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 310 to 314 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 391 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 111 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 651 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 671 to 673 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 718 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 14 forms a bond with O2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 270 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 536 to 537 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 118 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 740 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 858 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 246 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 517 to 518 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 248 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 309 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 364 to 365 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 403 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 173 to 179 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 372 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 375 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 123 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 141 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 143 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 176 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 177 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 1137 to 1144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 186 forms a bond with adenine, indicating a strong binding affinity.
The residue at position 212 forms a bond with adenine, indicating a strong binding affinity.
The residue at position 371 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 321 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 18 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 31 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 221 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 343 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 347 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 57 to 63 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 693 to 701 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 717 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 90 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 209 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 434 to 438 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 27 to 28 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 32 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 22 to 138 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 425 to 429 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 343 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 346 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 386 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 386 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 304 to 305 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 137 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 22 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 421 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 54 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 80 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 162 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 22 to 27 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 forms a bond with heme, indicating a strong binding affinity.
The residue at position 174 forms a bond with heme, indicating a strong binding affinity.
The residue at position 199 forms a bond with heme, indicating a strong binding affinity.
The residue at position 201 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 235 forms a bond with heme, indicating a strong binding affinity.
The residue at position 168 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 534 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 535 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 539 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 571 to 572 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 576 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 587 to 589 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 636 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 692 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 310 to 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 30 to 35 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 to 112 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 312 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 47 to 55 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 366 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 96 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 35 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 82 to 88 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 554 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 556 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 637 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 241 forms a bond with NH4(+), indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 38 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 256 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 287 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 120 to 126 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 to 170 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 322 to 328 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 392 to 399 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 438 to 443 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 570 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 35 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 372 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 469 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 227 to 234 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 273 to 277 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 327 to 330 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 forms a bond with 2'-hydroxybiphenyl-2-sulfinate, indicating a strong binding affinity.
The residue at position 60 forms a bond with 2'-hydroxybiphenyl-2-sulfinate, indicating a strong binding affinity.
The residue at position 70 forms a bond with 2'-hydroxybiphenyl-2-sulfinate, indicating a strong binding affinity.
The residue at position 407 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 435 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 460 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 496 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 32 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 34 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 36 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 63 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 65 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 118 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 119 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 120 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 147 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 234 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 238 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 238 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 238 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 238 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 272 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 277 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 277 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 277 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 322 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 322 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 322 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 322 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 358 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 358 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 358 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 358 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 358 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 362 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 406 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 406 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 406 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 406 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 406 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 514 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 517 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 517 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 517 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 517 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 783 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 785 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 653 to 660 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 347 to 348 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 358 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 271 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 332 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 441 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 489 to 490 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 497 to 499 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 550 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 877 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 40 to 46 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 75 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 77 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 94 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 97 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 416 to 419 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 606 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 611 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 289 to 303 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 213 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 237 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 93 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 705 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1101 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 931 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 48 to 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 70 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 73 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 95 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 102 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 126 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 270 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 270 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 109 to 113 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 58 to 59 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 97 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 34 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 116 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 127 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 43 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 377 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 388 to 394 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 78 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 56 to 82 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 199 to 203 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 131 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 23 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 816 to 823 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 307 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 407 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 206 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 206 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 272 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 272 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 303 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 29 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 431 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 435 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 473 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 48 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 485 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 489 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 489 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 9 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 11 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 16 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 30 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 39 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 49 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 53 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 55 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 56 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 164 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 422 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 432 to 433 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 462 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 486 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 491 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 169 to 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 to 51 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 346 to 353 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 212 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 220 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 306 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 171 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 200 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 229 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 256 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 396 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 71 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 149 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 133 to 140 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 534 to 541 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 169 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 424 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 487 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 183 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 183 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 386 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 458 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 500 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 557 to 559 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 581 to 582 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1394 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1410 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1437 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1440 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 1449 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 149 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 567 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 569 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 29 to 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 765 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 814 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 817 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 496 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 517 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 564 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 849 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 852 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 906 to 908 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 911 to 914 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 930 to 932 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 935 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 58 to 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 to 125 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 501 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 91 to 98 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 378 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 40 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 99 to 107 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 248 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 336 to 340 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 509 to 514 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 to 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 to 342 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 381 to 385 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 137 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 188 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 440 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 186 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 307 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 33 to 41 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 123 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 435 to 444 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 to 474 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 533 to 534 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 366 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 369 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 379 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 383 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 386 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 397 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 400 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 403 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 410 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 411 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 414 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 417 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 422 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 424 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 408 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 416 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 445 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 457 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 470 to 471 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 404 to 411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 396 to 398 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 431 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 479 to 480 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 504 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 464 to 471 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 5 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 31 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 213 forms a bond with [7Fe-V-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 306 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 309 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 342 to 344 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 365 to 366 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 389 to 393 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 418 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 474 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 280 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 372 to 374 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 to 137 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 350 to 351 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 368 to 376 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 390 to 393 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 49 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 141 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 163 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 166 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 47 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 307 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 100 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 171 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 195 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 658 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 666 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 674 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 675 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 712 to 769 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 955 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 958 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 961 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 963 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 341 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 410 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 31 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 55 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 102 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 244 to 248 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 55 to 60 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 64 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 64 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 144 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 57 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 295 to 298 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 260 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 100 to 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 to 43 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 13 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 456 to 463 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 446 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 446 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 346 to 348 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 43 forms a bond with 1-eicosanoylglycerol, indicating a strong binding affinity.
The residue at position 56 forms a bond with 1-eicosanoylglycerol, indicating a strong binding affinity.
The residue at position 109 forms a bond with 1-eicosanoylglycerol, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with (9Z,12Z)-octadecadienoate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with 1-eicosanoylglycerol, indicating a strong binding affinity.
The residue at position 131 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 131 forms a bond with N-eicosanoyl ethanolamine, indicating a strong binding affinity.
The residue at position 88 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 155 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 184 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 217 to 224 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 248 to 252 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 382 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 514 to 515 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 537 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 564 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 724 to 733 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 800 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 808 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 825 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 409 to 415 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1121 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1124 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1137 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1140 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1145 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1148 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1167 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1170 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 341 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 196 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 172 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1134 to 1141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 to 308 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 132 to 138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 92 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 97 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 106 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 81 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 111 to 118 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 156 to 161 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 212 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 92 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 93 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 823 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1149 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1152 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1158 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 33 to 57 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 525 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 530 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 716 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 720 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 870 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 187 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 to 122 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 to 166 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 367 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 562 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 707 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 130 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 92 to 100 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 332 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 159 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 186 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 546 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 549 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 352 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 94 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 177 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 161 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 110 to 116 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 405 to 406 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 141 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 145 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 166 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 172 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 176 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 212 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 105 to 110 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 267 to 271 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 379 to 383 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 400 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 445 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 480 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 485 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 459 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 525 to 533 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 197 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 238 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 292 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 295 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 338 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 338 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 365 to 380 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 392 to 424 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 726 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 730 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 664 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 672 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 680 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 681 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 1643 to 1650 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 750 to 754 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 753 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 798 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 856 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 954 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1203 to 1204 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 225 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 352 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 463 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 196 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 205 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 327 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 331 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 361 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 97 to 102 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 316 forms a bond with heme, indicating a strong binding affinity.
The residue at position 44 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 277 to 281 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 392 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 396 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with ganglioside GT1b (d18:1(4E)), indicating a strong binding affinity.
The residue at position 118 forms a bond with ganglioside GT1b (d18:1(4E)), indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with ganglioside GT1b (d18:1(4E)), indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 392 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 319 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 341 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 363 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 495 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 284 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 325 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 460 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 467 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 471 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 237 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 22 to 23 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 135 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 22 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 103 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 108 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 174 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 639 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 648 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 371 to 379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 418 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 421 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 960 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 217 to 225 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 260 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 370 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 436 to 438 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 478 to 486 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 479 to 484 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 548 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 572 to 573 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 666 to 668 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 707 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 765 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 791 to 793 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 814 to 815 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 941 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 944 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 947 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 951 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 974 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 977 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 980 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 984 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 38 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 142 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 334 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1736 to 1744 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1760 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 44 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 58 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 60 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 435 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 445 to 446 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 475 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 499 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 504 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 86 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 1254 to 1261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 27 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 104 to 109 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 316 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 60 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 85 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 89 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 96 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 194 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 250 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 408 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 312 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 751 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 365 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 367 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 332 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 341 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 362 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 457 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 457 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 497 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 498 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 498 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 498 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 615 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 615 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 618 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 666 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 666 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 669 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 669 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 276 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 202 to 207 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 202 to 207 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 238 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 238 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 369 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 480 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 131 to 146 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 157 to 189 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 363 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 181 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 394 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 428 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 592 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 227 to 231 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 235 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 292 to 296 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 312 to 316 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 364 to 365 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 to 140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 429 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 34 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 305 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 6 forms a bond with pantetheine 4'-phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with pantetheine 4'-phosphate, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 468 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 470 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 556 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 14 to 30 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 151 to 155 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 202 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 241 to 245 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 94 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 164 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 179 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 267 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 272 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 350 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 457 to 580 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 528 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 979 to 981 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 998 to 999 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1054 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1180 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1183 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1195 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1198 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1207 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1220 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1228 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1300 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1303 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1315 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1318 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1324 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1327 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1335 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1337 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 237 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 265 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 773 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 846 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 856 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 90 to 98 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 182 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 190 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 320 to 321 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 36 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 45 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 47 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 365 to 373 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 to 98 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 33 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 61 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 146 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 173 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 191 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 181 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 305 to 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 593 to 594 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 329 to 336 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 375 to 379 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 310 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 315 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 333 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 338 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 341 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 346 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 351 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 405 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 408 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 423 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 426 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 431 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 434 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 454 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 80 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 420 to 423 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 398 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 135 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 233 to 238 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 325 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 325 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 329 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 329 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 339 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 339 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 383 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 421 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 421 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 117 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 138 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 178 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 181 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 202 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 205 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 244 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 247 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe of heme c 10, indicating a strong binding affinity.
The residue at position 308 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 311 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe of heme c 9, indicating a strong binding affinity.
The residue at position 319 forms a bond with heme c 9, indicating a strong binding affinity.
The residue at position 322 forms a bond with heme c 9, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe of heme c 9, indicating a strong binding affinity.
The residue at position 341 forms a bond with Fe of heme c 12, indicating a strong binding affinity.
The residue at position 349 forms a bond with heme c 10, indicating a strong binding affinity.
The residue at position 352 forms a bond with heme c 10, indicating a strong binding affinity.
The residue at position 353 forms a bond with Fe of heme c 10, indicating a strong binding affinity.
The residue at position 362 forms a bond with heme c 11, indicating a strong binding affinity.
The residue at position 365 forms a bond with heme c 11, indicating a strong binding affinity.
The residue at position 366 forms a bond with Fe of heme c 11, indicating a strong binding affinity.
The residue at position 378 forms a bond with heme c 12, indicating a strong binding affinity.
The residue at position 381 forms a bond with heme c 12, indicating a strong binding affinity.
The residue at position 382 forms a bond with Fe of heme c 12, indicating a strong binding affinity.
The residue at position 449 forms a bond with Fe of heme c 13, indicating a strong binding affinity.
The residue at position 470 forms a bond with Fe of heme c 11, indicating a strong binding affinity.
The residue at position 477 forms a bond with heme c 13, indicating a strong binding affinity.
The residue at position 480 forms a bond with heme c 13, indicating a strong binding affinity.
The residue at position 481 forms a bond with Fe of heme c 13, indicating a strong binding affinity.
The residue at position 482 forms a bond with Fe of heme c 14, indicating a strong binding affinity.
The residue at position 493 forms a bond with heme c 14, indicating a strong binding affinity.
The residue at position 496 forms a bond with heme c 14, indicating a strong binding affinity.
The residue at position 497 forms a bond with Fe of heme c 14, indicating a strong binding affinity.
The residue at position 516 forms a bond with Fe of heme c 16, indicating a strong binding affinity.
The residue at position 519 forms a bond with heme c 15, indicating a strong binding affinity.
The residue at position 522 forms a bond with heme c 15, indicating a strong binding affinity.
The residue at position 523 forms a bond with Fe of heme c 15, indicating a strong binding affinity.
The residue at position 536 forms a bond with heme c 16, indicating a strong binding affinity.
The residue at position 539 forms a bond with heme c 16, indicating a strong binding affinity.
The residue at position 540 forms a bond with Fe of heme c 16, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 213 to 217 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 30 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 117 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 119 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 148 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 237 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 146 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 388 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 100 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 52 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 155 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 423 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 509 to 510 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 433 to 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 103 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 133 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 239 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 to 86 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 320 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 349 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 412 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 420 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 67 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 82 to 89 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 28 to 31 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 61 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 168 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 323 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 244 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 329 to 332 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 440 to 446 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 257 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 336 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 366 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 37 to 61 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 20 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 23 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 369 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 606 to 608 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 96 to 103 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 111 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 129 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 246 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 247 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 75 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 600 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 603 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 162 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 188 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 342 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 350 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 605 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 608 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 623 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 628 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 633 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 636 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 643 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 648 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 675 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 678 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 693 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 695 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 700 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 703 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 716 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 724 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 451 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 598 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 636 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 642 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 666 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 674 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 754 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 768 to 770 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 830 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 889 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 965 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 47 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 346 to 347 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 348 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 125 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 320 to 324 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 346 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 235 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 48 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 64 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 70 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 494 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 63 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 380 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 383 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 53 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 81 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 566 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 570 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 713 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 717 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 721 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 180 to 187 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 262 to 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 504 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 576 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 578 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 582 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 660 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1484 to 1491 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 421 to 422 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 314 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 574 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 576 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 578 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 580 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 585 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 604 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 606 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 608 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 610 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 615 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 99 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 128 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 163 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 164 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 178 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 1286 to 1331 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 26 to 33 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 190 to 200 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 to 109 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 346 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 364 to 368 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 376 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 406 to 408 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 34 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 38 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 148 to 152 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 281 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 155 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 473 to 474 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 482 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 47 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 291 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 208 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 61 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 96 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 89 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 262 to 272 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 288 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 295 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 340 to 342 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 381 to 383 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 267 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 361 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 391 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 463 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 491 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 494 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 45 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 153 to 157 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 386 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 450 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 454 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 797 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 798 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 811 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 79 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 104 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 207 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 210 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 26 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 266 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 450 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 764 to 766 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 1058 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 61 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 191 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 35 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 488 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 286 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 485 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 569 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 806 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 78 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 178 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 193 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 262 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 370 forms a bond with 2-methylbutanoate, indicating a strong binding affinity.
The residue at position 623 to 626 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 298 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 66 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 304 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 367 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 383 to 385 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 388 to 389 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 421 to 424 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 322 to 323 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 361 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 293 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 240 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 261 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 259 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 to 116 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 204 to 213 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 237 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 316 to 320 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 122 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 55 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 72 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 258 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 230 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 79 to 85 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 179 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 125 to 132 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 257 to 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 33 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 160 to 164 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 107 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 556 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 579 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 696 to 699 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 713 to 717 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 718 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 725 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 730 to 732 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 783 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 56 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 186 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 229 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 232 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 338 to 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 436 to 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 246 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 295 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 401 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 154 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 245 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 521 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 712 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 860 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 55 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 161 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 196 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 304 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 332 to 336 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 692 to 699 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 520 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 524 to 525 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 532 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 594 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 826 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 539 to 597 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 719 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 719 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 738 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 738 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 738 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 738 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 740 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 740 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 169 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 298 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 558 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 68 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 560 to 567 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 744 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 228 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 260 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 305 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 85 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 176 to 181 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 324 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 336 to 340 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 349 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 354 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 360 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 409 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 449 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 548 to 551 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 565 to 569 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 496 to 626 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 565 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 122 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 129 to 136 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 343 to 346 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 389 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 610 to 614 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 708 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 813 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 829 to 833 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 381 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 383 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 446 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 15 to 22 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 6 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 241 to 245 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 648 to 655 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 676 to 677 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 213 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 24 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 38 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 82 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 93 forms a bond with alpha-L-arabinopyanose, indicating a strong binding affinity.
The residue at position 764 to 772 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 785 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 103 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 117 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 554 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 677 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 63 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 115 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 146 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 112 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 152 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 146 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 452 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 455 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 517 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 518 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 519 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 523 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 592 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 595 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 598 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 603 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 606 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 625 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 141 to 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 284 to 288 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 550 to 668 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 202 to 208 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 369 to 370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 333 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 107 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 417 to 421 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 761 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 to 120 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 249 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 355 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 389 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 389 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 214 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 217 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 162 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 273 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 368 to 376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1117 to 1124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 506 to 511 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 554 to 557 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 588 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 596 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 382 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 7 to 11 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 76 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 100 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 131 forms a bond with (R)-glycerate, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with (R)-glycerate, indicating a strong binding affinity.
The residue at position 163 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 192 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 220 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 299 to 302 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 580 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 645 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 318 to 337 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 400 to 403 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 527 to 529 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 552 to 554 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 569 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 500 to 508 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 845 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 849 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 54 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 369 to 375 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 to 163 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 435 to 436 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 289 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 252 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 257 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 273 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 275 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 280 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 283 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 320 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 323 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 343 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 348 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 351 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 358 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 365 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 505 to 512 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 223 to 229 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 140 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 258 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 263 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 246 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 312 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 334 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 339 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 444 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 446 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 447 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 479 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 617 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 132 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 455 to 457 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 455 to 457 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 508 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 508 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 539 to 540 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 585 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 623 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 623 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 629 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 750 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 441 to 443 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 175 to 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 327 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 331 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 373 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 402 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 406 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 454 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 477 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 479 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 483 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 618 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 619 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 621 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 712 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 714 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 716 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 717 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 718 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 723 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 748 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 748 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 749 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 750 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 752 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 754 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 754 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 759 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 759 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 487 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 615 to 621 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 593 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 161 to 166 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 64 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 106 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 106 forms a bond with 3',3'-cGAMP, indicating a strong binding affinity.
The residue at position 106 forms a bond with 3',3'-cUAMP, indicating a strong binding affinity.
The residue at position 617 forms a bond with 3',3'-cGAMP, indicating a strong binding affinity.
The residue at position 617 forms a bond with 3',3'-cUAMP, indicating a strong binding affinity.
The residue at position 224 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 121 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 180 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 237 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 370 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 373 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 379 to 380 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 433 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 49 to 55 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 220 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 168 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 283 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 84 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 84 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 158 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 236 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 259 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 319 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 368 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 175 to 179 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 229 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 119 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 179 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 183 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 224 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 11 to 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 772 to 779 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 338 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 353 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 376 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 322 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 95 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 186 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 328 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 331 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 406 to 410 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 69 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 122 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 179 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 296 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 325 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 329 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 333 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 394 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 397 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 371 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 846 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 356 to 363 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 403 to 407 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 457 to 460 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 to 258 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 292 to 299 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 326 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 418 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 398 to 401 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 588 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 393 to 396 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 118 to 124 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 707 to 714 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 282 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 to 477 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1291 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1388 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1448 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1475 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1516 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 538 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 561 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 655 to 658 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 672 to 676 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 687 to 689 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 737 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 740 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 829 to 838 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 705 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 440 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 444 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 472 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 476 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 482 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 434 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 444 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 476 to 482 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 73 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 80 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 149 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 281 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 281 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 233 to 241 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 325 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 333 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 463 to 464 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 152 to 273 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 274 to 416 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 457 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 533 to 536 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 597 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 600 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 114 to 119 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with 1D-myo-inositol 1,4,5-trisphosphate, indicating a strong binding affinity.
The residue at position 507 to 510 forms a bond with 1D-myo-inositol 1,4,5-trisphosphate, indicating a strong binding affinity.
The residue at position 567 to 569 forms a bond with 1D-myo-inositol 1,4,5-trisphosphate, indicating a strong binding affinity.
The residue at position 31 to 32 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 to 204 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 386 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 414 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 474 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 475 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 562 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 240 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 514 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 97 to 102 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 359 to 365 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 370 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 485 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 486 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 541 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 600 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 706 to 762 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 to 423 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 432 to 434 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 432 to 434 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 485 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 485 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 516 to 517 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 562 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 600 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 600 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 606 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 180 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 238 to 244 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 265 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 270 to 275 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 40 to 50 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 69 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1104 to 1110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1163 to 1164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1184 to 1241 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1237 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1243 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1248 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 62 to 73 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 34 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 43 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 45 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 14 to 17 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 28 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 214 to 218 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 419 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 491 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 532 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 615 to 616 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 239 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 515 to 573 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 695 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 695 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 716 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 716 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 716 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 716 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 718 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 158 to 163 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 34 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 35 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 183 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 85 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 104 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 101 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 48 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 109 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 149 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 180 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 216 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 276 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 62 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 88 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 271 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 489 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 212 to 217 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 360 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 391 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 516 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 126 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 133 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 315 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 1168 to 1175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 563 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 565 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 571 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 627 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 629 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 635 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 185 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 158 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 184 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 2 to 7 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 477 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with glycyl-L-leucine, indicating a strong binding affinity.
The residue at position 383 to 385 forms a bond with glycyl-L-leucine, indicating a strong binding affinity.
The residue at position 433 to 436 forms a bond with glycyl-L-leucine, indicating a strong binding affinity.
The residue at position 56 to 61 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 427 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 499 to 506 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 521 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 634 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 413 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 165 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 231 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 302 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 304 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 306 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 307 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 394 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 611 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 611 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 615 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 615 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 755 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 759 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 763 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 112 to 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 374 to 382 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 to 144 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 207 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 43 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 12 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 153 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 243 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 259 to 263 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 168 to 172 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 211 to 216 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 270 to 276 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 296 to 300 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 365 to 368 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 898 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 to 147 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 238 to 244 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 255 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 278 to 282 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 299 to 300 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 322 to 323 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 556 to 563 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 776 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 857 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 860 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 82 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 75 forms a bond with alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 75 forms a bond with alpha-D-taluronate, indicating a strong binding affinity.
The residue at position 97 forms a bond with alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 97 forms a bond with alpha-D-taluronate, indicating a strong binding affinity.
The residue at position 153 forms a bond with alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 153 forms a bond with alpha-D-taluronate, indicating a strong binding affinity.
The residue at position 173 forms a bond with alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 173 forms a bond with alpha-D-taluronate, indicating a strong binding affinity.
The residue at position 196 forms a bond with alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 196 forms a bond with alpha-D-taluronate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with alpha-D-taluronate, indicating a strong binding affinity.
The residue at position 240 forms a bond with alpha-D-mannuronate, indicating a strong binding affinity.
The residue at position 240 forms a bond with alpha-D-taluronate, indicating a strong binding affinity.
The residue at position 379 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 1080 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 217 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 245 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 458 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 480 to 481 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 1161 to 1168 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 298 to 305 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 620 to 627 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 221 to 227 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1081 to 1088 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 356 to 359 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 283 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 444 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 492 to 493 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 642 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 648 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 653 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 684 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 686 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 693 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 621 to 626 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 306 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 308 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 310 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 314 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 352 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 394 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 401 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 405 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 249 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 253 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 384 forms a bond with Fe of Fe(II)-heme o, indicating a strong binding affinity.
The residue at position 384 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 386 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 209 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 506 to 510 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 844 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 481 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 538 to 542 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 576 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 583 to 585 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 639 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 665 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 671 to 674 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 744 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 1286 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1290 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1016 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1018 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1026 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1032 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1041 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1052 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1075 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1115 to 1118 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1141 to 1142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1144 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1186 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1191 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1192 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1193 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1198 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 66 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 67 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 142 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 207 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 209 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 32 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 64 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 29 to 32 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 80 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 109 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 125 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 223 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 209 to 232 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 625 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 668 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 679 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 688 to 690 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 725 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 735 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 to 249 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 304 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 735 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 772 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 772 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 882 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 265 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 32 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 235 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 210 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 249 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 278 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 305 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 297 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 298 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 109 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 53 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 77 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 78 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 79 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 26 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 213 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 230 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 371 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 290 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 251 to 256 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 356 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 407 to 408 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 311 to 318 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 357 to 361 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 411 to 414 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 536 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 537 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 561 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 311 to 316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 184 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 342 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 420 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 484 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 487 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 338 to 342 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 482 to 484 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 514 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 100 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 109 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 128 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 163 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 167 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 171 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 246 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 56 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 115 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 145 to 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 351 to 354 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 401 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 476 to 487 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 384 to 387 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 428 to 429 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 17 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 36 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 40 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 238 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 242 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 560 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 562 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 755 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 835 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 928 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 954 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 957 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 958 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1149 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1219 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1223 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1224 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1235 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1236 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 207 to 222 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 347 to 361 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 467 to 477 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 198 to 204 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 455 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 613 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 399 to 400 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 497 to 499 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 to 87 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 153 to 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 155 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 306 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 337 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 411 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 587 to 594 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 633 to 637 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 687 to 690 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 488 to 495 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 538 to 542 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 592 to 595 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 to 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 to 185 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 413 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 590 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 31 to 35 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 197 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 377 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 604 to 608 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 702 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 823 to 827 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 15 to 22 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 142 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 80 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 175 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 268 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 330 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 347 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 351 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 352 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 355 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 135 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 140 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 209 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 375 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 418 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 435 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1660 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1663 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1666 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 964 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 964 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 965 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 301 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 131 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 222 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 230 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 424 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 448 to 451 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 502 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 506 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 281 to 291 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 147 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 349 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 427 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 478 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 679 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 681 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 705 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 734 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 735 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 736 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 624 to 630 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 685 to 687 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 712 to 720 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 781 to 783 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 923 to 924 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 928 to 929 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 329 to 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 821 to 824 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 834 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 422 to 429 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 208 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 15 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 73 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 221 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 497 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 520 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 522 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 526 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 470 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 495 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 544 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 617 to 620 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 695 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 757 to 761 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 760 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 805 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 809 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 861 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 948 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1191 to 1192 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 154 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 281 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 470 to 471 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 404 to 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 505 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 770 to 777 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 467 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 504 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 553 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 526 to 533 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 108 to 120 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 128 to 135 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 8 to 25 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 201 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 460 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 536 to 539 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 596 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 603 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1012 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 to 189 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 26 to 31 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 181 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 333 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 337 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 367 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 481 to 486 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2178 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2181 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2211 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2214 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2245 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2248 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2260 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2262 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 19 to 25 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 338 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 366 to 368 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 132 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 198 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 241 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 to 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 319 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 350 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 559 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 560 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 348 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 507 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 540 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 641 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 291 to 292 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 233 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 217 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 228 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 284 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 196 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 210 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 214 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 242 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 139 to 145 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 56 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 59 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 395 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 149 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 252 to 257 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 387 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 408 to 409 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1171 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1262 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1265 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 438 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 47 forms a bond with malonate, indicating a strong binding affinity.
The residue at position 100 forms a bond with malonate, indicating a strong binding affinity.
The residue at position 175 forms a bond with malonate, indicating a strong binding affinity.
The residue at position 197 forms a bond with malonate, indicating a strong binding affinity.
The residue at position 214 to 218 forms a bond with malonate, indicating a strong binding affinity.
The residue at position 244 forms a bond with malonate, indicating a strong binding affinity.
The residue at position 383 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 422 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 430 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 433 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 420 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 423 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 424 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 427 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 430 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1030 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1030 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 446 to 454 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 562 to 567 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 605 to 610 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 262 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 345 to 349 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 772 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 803 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 807 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 885 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 917 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 919 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1084 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 395 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 419 to 422 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 355 to 359 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 60 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 256 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 62 to 66 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 185 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 258 to 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 295 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 540 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 960 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 76 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 101 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 194 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 119 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 5 to 13 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 188 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 to 79 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 305 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 618 to 621 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 633 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 111 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 151 to 156 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 185 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1198 to 1255 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1251 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1257 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1262 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1974 to 1988 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 883 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 191 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 47 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 147 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 406 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 448 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 465 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 159 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 95 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 145 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 189 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 350 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 523 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 587 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 126 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 137 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 34 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 94 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 239 to 244 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 258 to 264 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 399 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 428 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 538 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 57 to 64 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 123 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 264 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 107 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 52 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 537 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 624 to 625 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 511 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 576 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 579 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 445 to 452 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1075 to 1082 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 128 to 134 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 157 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 160 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 542 to 611 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 677 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 677 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 689 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 689 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 689 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 689 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 691 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 691 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 358 to 362 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with dodecanoate, indicating a strong binding affinity.
The residue at position 116 forms a bond with dodecanoate, indicating a strong binding affinity.
The residue at position 183 forms a bond with dodecanoate, indicating a strong binding affinity.
The residue at position 351 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 372 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 15 to 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 212 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 to 489 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 442 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 39 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 113 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 114 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 161 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 179 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 332 to 340 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 6 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 forms a bond with Mg of chlorophyll a ChlzD2, indicating a strong binding affinity.
The residue at position 131 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 144 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mg of chlorophyll a PD2, indicating a strong binding affinity.
The residue at position 216 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 263 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 326 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 501 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 509 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 320 to 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 to 290 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 431 to 438 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 467 to 471 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 537 to 540 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 585 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 615 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 681 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 107 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 214 to 220 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 206 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 215 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 323 to 327 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 189 to 196 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 236 to 240 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 399 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 408 to 409 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 427 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 462 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 264 forms a bond with bilirubin IXalpha, indicating a strong binding affinity.
The residue at position 617 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 619 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 621 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 715 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 718 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 719 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 227 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 416 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 444 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 273 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 249 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 494 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 183 to 189 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 212 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 215 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 830 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 845 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 848 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 860 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 870 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 51 to 57 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 792 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1119 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1137 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1140 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 362 to 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 112 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 223 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 249 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 262 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 433 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 437 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 610 to 613 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 48 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 244 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 590 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 601 to 602 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 367 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 371 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 372 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 375 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 390 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 44 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 70 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 89 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 254 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 256 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 258 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 330 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 340 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 342 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 379 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 383 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 707 to 763 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 842 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 364 to 372 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 386 to 389 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 76 to 84 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 217 to 222 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 565 to 567 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 610 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 637 to 638 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 to 118 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 991 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 991 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 997 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1053 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1053 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1061 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1504 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1504 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1510 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1559 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1561 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1561 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1567 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1832 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1835 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1838 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 194 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 220 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 251 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 378 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 59 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 83 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 294 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 363 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 370 to 371 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 163 to 171 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 189 to 194 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 693 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 444 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 16 to 22 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 11 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 93 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 208 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 278 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 386 forms a bond with 2-methylbutanoate, indicating a strong binding affinity.
The residue at position 264 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 73 to 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 to 65 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 974 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 976 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1060 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1062 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1102 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1112 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1114 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1130 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1139 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1199 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1215 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1223 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1225 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1257 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1794 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1809 to 1811 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 297 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 389 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 438 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 130 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 134 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 168 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 164 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 483 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 558 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 591 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 476 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 479 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 508 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 515 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 519 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 519 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 524 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 602 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 603 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 638 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 645 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 655 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 665 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 619 to 624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 624 to 628 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 744 to 745 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 855 to 859 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 859 to 862 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 205 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 566 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 568 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 818 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 838 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1035 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1167 to 1174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1229 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 325 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 358 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 69 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 133 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 137 to 143 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 166 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 169 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 450 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 452 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 492 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 321 to 326 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 to 139 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1 to 7 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 349 to 356 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 900 to 907 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 557 to 558 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 818 to 827 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 894 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 902 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 919 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 26 to 29 forms a bond with GDP-4-dehydro-alpha-D-rhamnose, indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 219 forms a bond with GDP-4-dehydro-alpha-D-rhamnose, indicating a strong binding affinity.
The residue at position 250 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 329 forms a bond with GDP-4-dehydro-alpha-D-rhamnose, indicating a strong binding affinity.
The residue at position 26 forms a bond with 1D-myo-inositol 1,3,4,5-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with 1D-myo-inositol 1,3,4,5-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with 1D-myo-inositol 1,3,4,5-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 408 to 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 474 to 477 forms a bond with clofedanol, indicating a strong binding affinity.
The residue at position 474 to 477 forms a bond with dasatinib, indicating a strong binding affinity.
The residue at position 542 forms a bond with clofedanol, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 197 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 967 to 975 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 988 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 50 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 81 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 84 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 95 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 98 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 572 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 616 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 423 to 430 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 454 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 465 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 504 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 555 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 395 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 478 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 522 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 525 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 613 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 639 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 315 forms a bond with dodecanoyl-AMP, indicating a strong binding affinity.
The residue at position 316 forms a bond with dodecanoyl-AMP, indicating a strong binding affinity.
The residue at position 408 forms a bond with dodecanoyl-AMP, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 101 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 111 to 116 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 522 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 524 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 528 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 283 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 320 to 323 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 532 to 539 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 144 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 116 to 117 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 488 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 309 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 226 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 591 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 594 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 597 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 619 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 624 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1422 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1424 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1482 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1508 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1510 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1551 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1561 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1563 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1579 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1588 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1648 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1664 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1670 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1672 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1674 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1677 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1706 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 2028 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 2043 to 2045 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 2049 to 2051 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2059 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 18 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 122 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 138 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 150 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 158 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 200 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 206 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 242 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 249 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 11 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 170 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 123 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 199 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 257 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 389 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 55 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 58 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 351 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 352 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 354 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 387 to 389 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 410 to 411 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 434 to 438 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 470 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 524 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 525 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 526 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 331 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 334 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 340 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 344 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 622 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 258 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 274 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1028 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1031 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1046 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1050 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1058 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1062 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 282 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 972 to 977 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 872 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 416 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 424 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 342 to 350 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 108 to 114 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 136 to 142 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 328 to 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 to 98 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 379 to 385 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 383 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 385 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 494 to 496 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 21 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 27 to 28 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 35 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 90 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 274 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 330 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 853 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 856 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 879 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 170 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 913 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 945 to 951 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 990 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 230 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 233 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 256 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 279 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 210 to 217 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 525 to 532 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 327 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1015 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 245 to 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 to 81 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 215 to 251 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 385 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 482 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 325 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 331 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 343 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 351 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 354 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 369 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 18 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 322 to 325 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 973 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 975 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 984 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 985 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 533 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 534 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 534 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 594 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 595 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 621 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 638 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 638 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1638 to 1645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 461 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 481 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 495 to 497 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 497 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 238 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 294 to 296 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 177 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 362 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 416 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 419 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 565 to 570 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 26 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 383 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 407 to 410 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 133 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 376 to 381 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 134 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 206 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 252 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 523 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 568 to 571 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 73 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 101 to 109 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 1177 to 1184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 508 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1457 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1460 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1475 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1478 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 288 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 348 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 383 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 419 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 557 to 558 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 315 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 319 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 436 to 440 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 370 to 377 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 416 to 420 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 470 to 473 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 289 to 299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 to 126 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 76 to 83 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 392 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 465 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 151 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 408 to 412 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 428 to 437 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 438 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 1079 to 1087 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 to 192 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 291 to 292 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 575 to 578 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 424 to 431 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1067 to 1074 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 612 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 698 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 706 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 714 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 715 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 390 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 395 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 395 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 402 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 410 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 412 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 415 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 415 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 475 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 475 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 477 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 170 to 174 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 241 to 251 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 317 to 325 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 716 to 723 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 157 to 162 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 415 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg of a bacteriochlorophyll c, indicating a strong binding affinity.
The residue at position 198 to 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 268 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 424 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 72 to 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 14 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1086 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 651 to 658 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 to 306 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 376 to 380 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 438 to 441 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 126 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 134 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 223 to 228 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 251 to 255 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 425 to 432 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 143 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 251 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 254 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 273 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 370 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 477 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 327 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 212 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 385 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 389 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 413 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 180 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 226 forms a bond with serotonin, indicating a strong binding affinity.
The residue at position 707 to 764 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 831 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 845 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 315 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 501 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 514 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 519 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 690 to 691 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 732 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 392 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 68 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 464 to 586 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 523 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 538 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 157 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 169 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 315 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 96 forms a bond with CO, indicating a strong binding affinity.
The residue at position 229 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 257 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 309 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 403 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 406 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 409 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 413 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 441 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 444 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 447 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 451 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 509 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 538 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 573 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 132 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 548 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 577 to 579 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 356 to 370 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 477 to 487 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 253 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 285 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 392 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 351 to 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 464 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 444 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 469 to 472 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 553 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 853 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 377 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 382 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 553 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 55 to 58 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1059 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1107 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1107 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1109 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1109 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1115 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 191 to 197 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 251 to 259 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 33 to 62 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 433 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 60 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 79 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 38 to 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 369 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1000 to 1008 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1028 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 290 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 171 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 190 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 267 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 23 to 52 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 200 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 435 to 438 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 452 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 519 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 98 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 40 to 43 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 477 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 219 to 286 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with paraoxon, indicating a strong binding affinity.
The residue at position 36 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 155 to 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 366 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 366 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 494 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 502 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 384 to 385 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 332 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 487 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 326 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 54 forms a bond with Li(+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Li(+), indicating a strong binding affinity.
The residue at position 156 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 311 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 141 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 347 to 353 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 738 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 170 to 176 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 200 to 204 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 260 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 230 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 136 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 538 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 539 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 114 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 125 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 125 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 189 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 189 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 236 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 318 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 318 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 190 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 190 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 239 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 239 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 343 forms a bond with 3,3',5-triiodo-L-thyronine 1, indicating a strong binding affinity.
The residue at position 343 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 123 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 282 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 209 to 215 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 112 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 456 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 526 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 528 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 530 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 532 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 35 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 39 to 42 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 51 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 70 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 345 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 366 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 192 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 237 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 302 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 307 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1014 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1064 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1064 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1069 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1072 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1072 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 24 to 34 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 487 to 492 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 97 to 102 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 12 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 19 to 23 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with flaviolin 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with flaviolin 1, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with flaviolin 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 248 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 373 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 45 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 48 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 339 to 346 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 386 to 390 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 440 to 443 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 313 to 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 776 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 778 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 780 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 787 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1462 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1464 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1466 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1473 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 758 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 762 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 71 to 78 forms a bond with 3,4-dihydroxybenzoate, indicating a strong binding affinity.
The residue at position 71 to 78 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 71 forms a bond with benzoate, indicating a strong binding affinity.
The residue at position 71 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 75 forms a bond with benzoate, indicating a strong binding affinity.
The residue at position 75 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 135 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 135 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 142 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 158 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 169 forms a bond with 3,4-dihydroxybenzoate, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 573 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 576 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 183 to 191 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 413 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 481 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 483 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 544 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 613 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 374 to 376 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 414 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 440 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 105 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 to 19 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 355 to 358 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 442 to 448 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 348 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 352 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 1967 to 1975 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1996 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 598 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 790 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 794 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 941 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 559 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 587 to 594 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 662 to 668 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 781 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 795 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 592 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 203 to 209 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 274 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 to 474 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 567 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 584 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 587 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 692 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 692 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 698 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 744 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 744 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 746 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 746 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 763 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with tRNA variable arm of tRNA, indicating a strong binding affinity.
The residue at position 398 forms a bond with tRNA discriminator base of tRNA, indicating a strong binding affinity.
The residue at position 463 forms a bond with tRNA acceptor arm of tRNA, indicating a strong binding affinity.
The residue at position 395 to 402 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 441 to 445 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 495 to 498 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 284 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 845 to 847 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 854 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 861 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 887 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 127 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 219 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 225 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1640 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1643 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1646 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 286 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 590 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 590 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 63 to 70 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 697 to 705 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 285 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 321 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 148 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 348 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 865 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 307 to 313 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 122 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 165 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 170 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 104 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 168 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 147 to 153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 913 to 914 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1297 to 1299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1471 to 1475 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 391 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 447 to 449 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 482 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 530 to 531 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 555 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 188 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 192 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 271 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 10 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 30 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 134 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 260 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 430 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 569 to 576 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 339 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 353 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 368 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 394 to 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 394 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 398 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 25 to 30 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 112 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 121 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 90 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 156 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 281 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 175 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 566 to 574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 to 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 137 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 270 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 125 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 288 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 305 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 126 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 194 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 26 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 91 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 230 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 417 to 420 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 80 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 168 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 172 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 160 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 965 to 968 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 978 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 980 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 663 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 809 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 828 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 831 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 832 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 839 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 842 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 882 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 886 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 896 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 969 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 989 to 991 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 992 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 311 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 319 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 322 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 224 forms a bond with heme, indicating a strong binding affinity.
The residue at position 244 forms a bond with heme, indicating a strong binding affinity.
The residue at position 278 forms a bond with heme, indicating a strong binding affinity.
The residue at position 1113 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1133 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1136 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1145 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1148 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1153 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1160 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1164 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1170 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1186 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 531 to 533 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 538 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 704 to 705 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 753 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 128 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 130 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 178 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 181 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 178 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 49 forms a bond with O2, indicating a strong binding affinity.
The residue at position 555 to 565 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 589 to 591 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 776 to 780 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 119 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 139 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 223 to 227 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 219 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 204 to 211 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 193 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 476 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 480 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 484 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 278 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 327 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 356 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 369 to 372 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 259 to 265 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 191 to 195 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 185 to 196 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 353 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 382 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 584 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 683 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 685 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 709 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 738 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 739 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 740 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 74 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 75 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 134 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 136 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 136 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 137 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 168 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 389 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 486 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 413 forms a bond with heme, indicating a strong binding affinity.
The residue at position 433 forms a bond with heme, indicating a strong binding affinity.
The residue at position 467 forms a bond with heme, indicating a strong binding affinity.
The residue at position 503 forms a bond with heme, indicating a strong binding affinity.
The residue at position 332 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 418 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 259 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 49 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 62 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 105 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 312 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 405 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 729 forms a bond with Val-boroPro, indicating a strong binding affinity.
The residue at position 338 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 154 forms a bond with red chlorophyll catabolite, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with red chlorophyll catabolite, indicating a strong binding affinity.
The residue at position 291 forms a bond with red chlorophyll catabolite, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 266 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 1121 to 1128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 82 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 121 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 1639 to 1646 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 32 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 1126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1200 to 1202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1207 to 1211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 234 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 to 170 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 238 to 243 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with 4-aminobutanal, indicating a strong binding affinity.
The residue at position 260 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 294 forms a bond with 4-aminobutanal, indicating a strong binding affinity.
The residue at position 453 forms a bond with betaine aldehyde, indicating a strong binding affinity.
The residue at position 459 forms a bond with 4-aminobutanal, indicating a strong binding affinity.
The residue at position 209 to 219 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 503 to 504 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 680 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 365 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 376 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 390 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 281 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 419 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 421 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 89 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 180 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 161 to 168 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1004 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1007 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 151 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 65 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1478 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1478 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1480 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1482 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1512 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1563 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1563 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1597 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1620 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1621 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1644 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1668 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1693 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1693 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1697 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 34 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 302 to 303 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 153 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 69 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 75 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 134 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 347 to 351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 392 to 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 402 to 406 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 435 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 460 to 463 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 544 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 739 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 753 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 756 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 287 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 253 to 256 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 279 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 124 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 396 to 400 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 590 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 56 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 36 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 40 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 118 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 339 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 292 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 1432 to 1434 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1432 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1480 to 1490 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1504 to 1506 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1532 to 1534 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1533 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 305 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 156 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 288 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 362 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 363 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 376 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 456 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 457 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 604 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 40 to 48 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 105 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 136 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 137 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 140 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 198 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 286 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 224 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 270 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 313 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 193 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 98 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 104 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 487 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 319 to 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 541 to 599 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 721 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 721 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 41 to 46 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 56 to 57 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 62 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 7 to 14 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 151 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 177 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 159 to 163 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 218 to 225 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 258 to 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 274 to 277 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 681 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 689 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 697 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 698 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 141 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 227 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 119 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 171 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 379 to 384 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 45 to 50 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 608 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 701 forms a bond with Mg of divinylchlorophyll a' A1, indicating a strong binding affinity.
The residue at position 709 forms a bond with Mg of divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 717 forms a bond with divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 718 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 20 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 338 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 339 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 362 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 391 to 407 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 503 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 184 to 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 335 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 182 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 184 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 189 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 217 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 224 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 251 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 256 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 241 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 57 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 390 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 105 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 261 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 839 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 842 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 896 to 898 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 901 to 904 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 920 to 922 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 925 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 330 to 332 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 488 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 491 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 493 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 550 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 552 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 561 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 95 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 125 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 834 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 960 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 960 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 975 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 976 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 367 to 372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 355 to 362 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 401 to 405 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 455 to 458 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 527 to 671 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 587 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 599 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 25 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 44 forms a bond with alpha-L-fucose 6, indicating a strong binding affinity.
The residue at position 73 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with alpha-L-fucose 3, indicating a strong binding affinity.
The residue at position 138 forms a bond with alpha-L-fucose 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with alpha-L-fucose 3, indicating a strong binding affinity.
The residue at position 177 forms a bond with alpha-L-fucose 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with alpha-L-fucose 4, indicating a strong binding affinity.
The residue at position 198 forms a bond with alpha-L-fucose 3, indicating a strong binding affinity.
The residue at position 230 forms a bond with alpha-L-fucose 5, indicating a strong binding affinity.
The residue at position 242 forms a bond with alpha-L-fucose 5, indicating a strong binding affinity.
The residue at position 282 forms a bond with alpha-L-fucose 6, indicating a strong binding affinity.
The residue at position 296 forms a bond with alpha-L-fucose 6, indicating a strong binding affinity.
The residue at position 41 to 46 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 407 to 408 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 412 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 497 to 500 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 506 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 606 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 777 to 780 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 804 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 814 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 844 to 845 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 870 to 872 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 910 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 946 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 950 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 73 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 87 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 180 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 293 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 195 to 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 451 to 452 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 536 to 537 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 558 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 257 to 260 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 239 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 325 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 130 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 134 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 185 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 471 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 544 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 546 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 328 to 335 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 650 to 657 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 243 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 272 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 275 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 449 to 456 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 495 to 499 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 549 to 552 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 527 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 513 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 704 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 853 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 83 to 98 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 448 to 449 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 174 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 178 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 211 to 218 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 419 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 423 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 529 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 554 to 555 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 577 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 604 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 816 to 825 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 892 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 900 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 917 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 85 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 241 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 5 to 10 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 211 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 249 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 429 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 458 to 459 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 477 to 478 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 505 to 507 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 528 to 529 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 223 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 98 to 105 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 300 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 323 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 51 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 77 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 144 to 152 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 176 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 204 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 247 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 349 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 391 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 393 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 490 to 495 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 40 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 99 to 103 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 82 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 84 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 145 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 146 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 177 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 185 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 207 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 208 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 209 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 210 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 211 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 212 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 241 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 243 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 250 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 314 to 318 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 329 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 576 to 577 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 to 245 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 702 to 759 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 826 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 838 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 472 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 671 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 697 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 701 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 704 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 179 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 320 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 430 to 431 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 385 to 388 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 392 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 395 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 174 to 179 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 to 131 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 43 to 48 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 120 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 217 to 222 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 204 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 235 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 374 to 379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 337 to 358 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 380 to 399 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 647 to 648 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 671 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 773 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 1671 to 1688 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 1886 to 1901 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 216 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 685 to 804 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 56 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 211 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 222 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 319 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 34 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 83 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 103 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 184 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 177 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 181 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 195 to 202 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 92 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 119 to 127 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 301 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 22 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 3 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 5 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 5 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 8 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 8 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 10 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 to 221 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 110 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 793 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 582 to 589 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 192 to 202 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 438 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 121 to 127 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1043 to 1051 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1066 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 to 77 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 254 to 258 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 183 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 306 to 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 392 to 399 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 86 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 295 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 375 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 350 to 353 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 747 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 362 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 364 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 366 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 371 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 414 to 421 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 566 to 569 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 53 forms a bond with heme, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 597 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 278 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 293 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 94 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 101 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 103 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 105 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 130 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 133 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 211 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 213 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 223 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 223 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 260 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 299 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 301 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 349 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 386 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 389 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 628 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 629 forms a bond with Co of cob(II)alamin, indicating a strong binding affinity.
The residue at position 630 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 631 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 674 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 705 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 728 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 188 to 192 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 12 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 168 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 197 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 225 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 40 to 66 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 154 to 157 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with alpha-L-rhamnose 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with alpha-L-rhamnose 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with alpha-L-rhamnose 1, indicating a strong binding affinity.
The residue at position 634 to 636 forms a bond with alpha-L-rhamnose 1, indicating a strong binding affinity.
The residue at position 643 forms a bond with alpha-L-rhamnose 1, indicating a strong binding affinity.
The residue at position 695 forms a bond with alpha-L-rhamnose 1, indicating a strong binding affinity.
The residue at position 916 forms a bond with alpha-L-rhamnose 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 153 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 186 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 237 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 303 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 305 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 349 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 350 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 356 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 402 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 786 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 915 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1197 to 1204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 234 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 291 to 295 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 to 70 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 54 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 359 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 413 to 416 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 77 to 81 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 203 to 206 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 30 to 40 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 151 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 180 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 183 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 7 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 737 to 744 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 to 234 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 405 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 399 to 402 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 433 to 436 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 475 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 541 to 542 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 547 to 551 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 583 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 243 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 38 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 40 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 275 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 774 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 210 to 217 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 261 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 124 to 129 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 9 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 456 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 458 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 460 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 462 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 427 to 431 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 623 to 630 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 281 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 387 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 396 to 397 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 897 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 899 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1006 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1059 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 81 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 296 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 432 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 5 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 176 to 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 222 to 226 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 142 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 to 315 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 415 to 417 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 367 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 370 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 374 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 415 to 418 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 54 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 59 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 63 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 82 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 85 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 88 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 204 to 208 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 258 to 261 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 to 269 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 389 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 204 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 7 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 428 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 453 to 456 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 537 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 384 to 387 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 316 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 350 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 367 to 369 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 68 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 68 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 79 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 107 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 120 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 219 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 266 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 269 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 244 forms a bond with hyperforin, indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with hyperforin, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 212 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 141 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 219 to 224 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 48 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 423 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 443 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 524 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 585 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 4 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 10 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 14 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 22 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 22 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 33 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 40 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 113 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 120 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 456 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 458 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 500 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 92 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 101 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 321 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 360 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 43 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 898 to 905 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 96 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 364 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 234 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 238 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 94 to 102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 74 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 8 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 45 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 556 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 172 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 227 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 235 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 321 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 170 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 211 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 279 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 687 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 586 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 586 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 690 to 694 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 691 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 722 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 816 to 817 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 816 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 865 to 868 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 872 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 891 to 894 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 967 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 44 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 320 to 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 565 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 379 to 380 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 301 to 308 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 314 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 351 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 354 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 355 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 360 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 372 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 375 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 376 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 411 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 423 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 430 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 433 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 434 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 437 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 474 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 477 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 478 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 491 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 496 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 499 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 500 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 507 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 528 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 574 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 590 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 591 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 675 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 192 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 265 to 269 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 494 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 146 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 167 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 173 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 177 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 213 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme b b558, indicating a strong binding affinity.
The residue at position 119 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 501 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 510 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 645 forms a bond with SQ109, indicating a strong binding affinity.
The residue at position 200 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 66 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 485 to 487 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 485 to 487 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 538 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 538 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 543 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 569 to 570 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 653 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 653 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 695 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 697 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 706 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 710 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 719 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 781 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 329 to 343 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 421 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 564 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 411 to 413 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 138 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 332 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 503 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 448 to 453 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 581 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 to 102 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 89 to 93 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 to 165 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 to 224 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 261 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 362 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 443 to 446 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 716 to 719 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 875 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 879 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 257 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 300 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 324 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 329 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 337 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 174 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 283 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 309 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 392 to 394 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 414 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 513 to 515 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 538 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 643 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 359 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1133 to 1140 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 75 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 243 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 299 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 82 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 320 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 323 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 52 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 125 to 140 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 151 to 183 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 509 to 517 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 143 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 168 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 208 to 212 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 340 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 344 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 450 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 475 to 477 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 647 to 656 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 648 to 653 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 721 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 729 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 746 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 to 210 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 422 to 426 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 426 to 429 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 146 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 109 to 116 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 135 to 143 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 519 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 542 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 659 to 662 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 676 to 680 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 693 to 695 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 746 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 322 to 329 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 366 to 370 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 256 to 263 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1040 to 1048 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1063 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 916 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1029 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1058 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1059 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 168 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 214 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 10 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 828 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 831 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 865 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 868 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 98 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 4 to 28 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 189 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 192 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 278 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 280 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 to 389 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 384 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1031 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1105 to 1107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1112 to 1116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 874 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 876 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 983 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1042 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 96 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 292 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 158 to 167 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 167 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 216 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 278 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 281 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 306 to 308 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 351 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 374 to 378 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 401 forms a bond with octanoyl-CoA, indicating a strong binding affinity.
The residue at position 402 to 405 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 522 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 554 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 556 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 312 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 188 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 387 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 146 to 150 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 345 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 373 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 333 to 340 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 131 to 138 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 725 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 726 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 755 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 794 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 814 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 815 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 842 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 844 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 884 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 908 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 910 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 910 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 912 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 913 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 931 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 937 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 937 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 938 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 939 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 939 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 131 forms a bond with (E)-ferulate, indicating a strong binding affinity.
The residue at position 208 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 231 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 264 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 265 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 270 forms a bond with (E)-5-hydroxyferulate, indicating a strong binding affinity.
The residue at position 211 to 219 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 167 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 186 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 194 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 1176 to 1233 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1229 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1235 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1240 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 64 forms a bond with oteseconazole, indicating a strong binding affinity.
The residue at position 118 forms a bond with itraconazole, indicating a strong binding affinity.
The residue at position 307 forms a bond with posaconazole, indicating a strong binding affinity.
The residue at position 377 forms a bond with oteseconazole, indicating a strong binding affinity.
The residue at position 370 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 480 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 506 to 507 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 556 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 716 to 725 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 792 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 800 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 817 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 153 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 381 to 389 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 403 to 406 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 125 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 681 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 728 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 853 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 188 to 191 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 492 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 343 to 348 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 118 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 50 forms a bond with O2, indicating a strong binding affinity.
The residue at position 134 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 179 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 234 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 378 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 382 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 382 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 34 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 926 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 251 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 254 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 656 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 659 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 666 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 699 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 701 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 703 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 710 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 729 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 731 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 733 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 740 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 794 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 796 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 798 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 323 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 475 to 482 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 126 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 183 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 342 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 229 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 525 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 526 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 527 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 531 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 536 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 360 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 363 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 396 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 160 to 164 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 472 to 476 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 165 to 175 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 725 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 729 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 791 to 798 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 90 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 118 to 126 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 115 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 290 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 322 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 327 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 330 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 565 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 259 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 347 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 353 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 383 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 455 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 486 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 95 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 114 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 134 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 204 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 319 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 67 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 155 to 159 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 351 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 367 to 369 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 133 to 138 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1221 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 370 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 389 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 405 to 407 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 407 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 394 to 402 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 361 to 369 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 383 to 386 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 225 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 307 to 312 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 317 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 405 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 49 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 137 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 138 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 240 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 139 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 236 to 242 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 258 to 263 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 33 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 139 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 177 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 412 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 95 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 332 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 118 forms a bond with heme, indicating a strong binding affinity.
The residue at position 122 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 416 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 419 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 448 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 455 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 464 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 465 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 542 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 543 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 418 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 445 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 437 to 444 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 483 to 487 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 537 to 540 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 to 254 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 448 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 482 to 484 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 484 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 336 to 346 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 332 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 348 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 163 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 294 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 141 to 149 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 173 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 201 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 32 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 1401 to 1408 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 155 to 190 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 203 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 333 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 335 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 218 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 264 to 269 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 to 251 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 13 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 50 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 54 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 73 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 10 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 43 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 158 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 162 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 200 to 205 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 200 to 205 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 236 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 236 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 367 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 417 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 478 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 135 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 293 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 142 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 369 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 370 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 374 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 460 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 473 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 488 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 620 to 651 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 764 to 775 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 900 to 910 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 975 to 993 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1073 to 1088 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 to 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 304 to 315 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 311 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 125 to 131 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 154 to 160 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 289 to 297 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 347 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 398 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 320 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 346 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 360 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 38 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 419 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 422 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 71 to 85 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 252 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 314 to 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 394 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 894 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1024 to 1031 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 2088 to 2095 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 247 to 253 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 416 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 317 to 328 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 to 407 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 465 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 613 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 614 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 624 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1320 to 1327 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 123 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 230 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 633 to 640 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 563 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 586 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 694 to 697 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 711 to 715 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 716 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 723 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 728 to 730 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 781 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 186 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 395 to 399 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 449 to 452 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 24 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 32 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 61 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 914 to 921 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 244 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 275 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 6 to 9 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 160 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 to 178 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 550 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 206 to 214 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 258 to 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 304 to 308 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 358 to 361 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 333 to 338 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 131 to 136 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 83 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 127 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 133 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 281 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 202 to 209 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 248 to 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 302 to 305 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 57 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 61 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 296 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 503 to 505 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 117 forms a bond with CO, indicating a strong binding affinity.
The residue at position 251 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 279 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 318 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 408 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 411 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 418 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 446 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 449 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 456 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 514 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 543 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 578 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1337 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1380 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 88 to 95 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 79 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 239 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 466 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 51 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 295 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 296 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 301 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 332 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 410 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 276 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 180 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 614 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 618 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 620 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 240 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 416 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 170 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 176 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 232 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 232 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 234 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 234 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 240 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 380 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 547 to 550 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 518 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 543 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 496 to 502 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1004 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1007 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1020 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1028 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1031 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 772 to 780 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 795 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 423 to 424 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 516 to 517 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 310 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 311 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 311 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 314 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 443 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 445 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 39 forms a bond with a 1-acyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 124 to 129 forms a bond with a 1-acyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with a 1-acyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 122 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 703 to 760 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 827 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 272 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 277 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 210 to 264 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 269 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 403 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 407 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 467 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 471 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 848 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 852 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 792 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 189 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 286 to 290 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 to 236 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 301 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 332 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 65 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 140 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1208 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1347 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 243 to 248 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 323 to 329 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 319 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 376 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 380 to 383 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 435 to 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 441 to 444 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 92 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 126 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 128 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 14 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 750 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1120 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1208 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 6 to 11 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 71 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 415 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 292 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 304 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 354 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 601 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 709 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 963 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 467 to 474 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 707 to 714 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 258 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 265 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 292 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 294 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 296 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 709 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 230 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 73 to 77 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 287 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 331 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 339 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 505 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 89 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 122 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 140 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 142 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 168 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 172 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 173 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 49 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 65 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 71 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 147 to 151 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 626 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 659 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 147 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 519 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 521 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 523 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 530 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 665 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 679 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 755 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 768 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 849 to 855 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 120 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 299 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 350 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 457 to 458 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 576 to 578 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 221 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 362 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 364 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 366 to 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 884 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 902 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 112 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 106 to 111 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 98 to 105 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 386 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 393 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 21 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 67 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 421 to 429 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 131 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 620 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 620 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 764 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 768 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 271 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 367 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 397 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 468 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 496 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 499 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 26 to 50 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 forms a bond with caffeine, indicating a strong binding affinity.
The residue at position 137 forms a bond with caffeine, indicating a strong binding affinity.
The residue at position 245 forms a bond with caffeine, indicating a strong binding affinity.
The residue at position 251 forms a bond with caffeine, indicating a strong binding affinity.
The residue at position 384 forms a bond with caffeine, indicating a strong binding affinity.
The residue at position 449 to 454 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 to 466 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 571 to 578 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 215 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 365 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 431 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 164 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 621 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 664 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 675 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 684 to 686 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 731 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 415 to 418 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 424 to 427 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 425 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 488 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 511 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 25 to 31 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 90 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 413 to 421 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 2 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 3 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 4 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 14 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 38 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 44 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 360 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 364 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 117 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 211 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 568 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 571 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 574 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 580 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 597 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 600 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 603 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 607 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 3 to 5 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 6 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 38 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 45 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 236 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 285 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 857 to 865 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 97 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 45 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 94 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 101 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 108 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 167 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 170 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 179 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 180 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 183 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 195 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 43 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 53 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 49 forms a bond with heme, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 383 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 to 12 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 163 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 86 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 147 to 154 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 1373 to 1380 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 213 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 213 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 231 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 231 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 487 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 489 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 548 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 557 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 203 to 211 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 109 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 524 to 535 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 419 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 35 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 140 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 226 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 417 to 424 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 131 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 134 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 78 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 172 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 226 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 232 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 467 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 520 to 527 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 to 186 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 11 to 15 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 47 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 191 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 127 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 379 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 408 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 411 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 414 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 172 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 300 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 315 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 339 to 343 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 362 to 364 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 445 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 400 to 401 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 399 to 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 2087 to 2094 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 866 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 870 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 162 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 274 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 395 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 469 to 476 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 515 to 519 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 569 to 572 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 946 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 170 to 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 328 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 24 to 30 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 161 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 313 to 319 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 317 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 345 to 347 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 427 to 429 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 88 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 91 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 113 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 408 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 30 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 240 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 166 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 179 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 183 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 263 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 143 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 222 to 232 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 266 to 273 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 300 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 392 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 160 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 272 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 333 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 379 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 626 to 634 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2345 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2375 to 2381 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2419 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 223 forms a bond with a 1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol, indicating a strong binding affinity.
The residue at position 246 forms a bond with a 1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol, indicating a strong binding affinity.
The residue at position 294 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 296 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 163 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 410 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 163 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 223 to 227 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 3 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 151 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 216 to 225 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 282 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 44 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 81 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 117 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 348 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 388 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 389 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 390 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 392 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 43 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 339 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 415 to 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 439 to 444 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 551 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 570 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 71 to 78 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 181 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 7 to 9 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 258 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 305 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 340 to 346 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 758 to 765 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 479 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 156 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 160 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 270 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 280 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 349 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 350 to 355 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 351 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1951 to 1959 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1980 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 962 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1073 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1086 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 138 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 362 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 301 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 142 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 197 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 118 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 392 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 395 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 398 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 402 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 410 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 14 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 195 to 199 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 304 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 435 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 438 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 438 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 442 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 446 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 70 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 75 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 190 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 193 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 196 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 264 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 268 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 305 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 321 forms a bond with muraymycin D2, indicating a strong binding affinity.
The residue at position 251 to 272 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 108 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 492 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 495 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 495 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 497 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 566 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 567 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 568 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 572 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 539 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 564 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 402 to 406 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 456 to 459 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 427 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 27 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 106 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 35 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 260 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 346 to 347 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 2, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with dTDP-4-dehydro-6-deoxy-alpha-D-glucose 1, indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 56 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 64 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 87 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 90 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 93 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 97 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 227 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 230 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 236 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 240 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 435 to 556 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 506 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 281 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 5 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 46 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 46 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 209 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 213 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 217 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 253 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 426 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 430 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 608 to 611 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 221 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 258 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1287 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1290 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1314 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1317 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1348 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1353 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1367 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1372 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 31 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 38 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 283 to 288 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 345 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 360 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 381 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 381 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 233 to 243 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 300 to 308 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 523 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 524 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with heme, indicating a strong binding affinity.
The residue at position 97 forms a bond with heme, indicating a strong binding affinity.
The residue at position 345 forms a bond with heme, indicating a strong binding affinity.
The residue at position 423 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 463 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 465 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 466 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 467 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 568 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 593 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 687 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 231 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 53 to 60 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 449 to 456 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 21 to 25 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 584 to 592 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 484 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 to 186 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 101 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 91 to 97 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 403 to 406 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 176 to 181 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 36 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 347 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 420 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 469 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 476 to 477 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 485 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 546 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 177 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 327 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 327 to 339 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 298 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 299 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 318 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 778 to 783 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 256 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 22 to 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 40 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 146 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 181 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 265 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 268 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 515 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 519 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 519 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 48 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 52 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 140 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 207 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 77 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 500 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 18 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 115 to 123 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 544 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 545 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 36 to 60 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 565 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 471 to 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 561 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 148 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 154 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 166 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 435 to 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 to 25 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 77 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 216 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 126 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 128 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 657 to 665 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 178 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 265 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 84 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 96 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 127 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 184 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 144 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 248 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 252 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 255 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 274 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 356 to 358 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 373 to 381 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 374 to 376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 253 to 260 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 508 to 638 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 579 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 2378 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2408 to 2414 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2452 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 394 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 127 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 316 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 319 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with (E)-ferulate, indicating a strong binding affinity.
The residue at position 210 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 233 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 254 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 272 forms a bond with (E)-5-hydroxyferulate, indicating a strong binding affinity.
The residue at position 576 to 584 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 164 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 313 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 316 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 317 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 262 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 309 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 344 to 350 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 326 to 334 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 62 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 429 to 436 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 466 to 468 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 530 to 533 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 235 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 245 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 564 to 569 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 13 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 117 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 108 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 112 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 256 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 409 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 176 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 514 to 515 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 567 to 569 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 387 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 9 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 75 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 172 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 213 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 439 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 134 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 245 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 487 to 488 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 516 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 527 to 528 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 714 to 722 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 736 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 507 to 509 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 42 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 57 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 60 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 101 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 134 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 152 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 154 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 184 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 685 to 692 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 792 to 797 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 260 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 309 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 310 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 397 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 102 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 71 to 77 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 189 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 203 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 283 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 358 to 364 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 362 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 364 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 473 to 475 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 139 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 48 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 258 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 509 to 515 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 294 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 401 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 411 to 412 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 441 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 465 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 470 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 136 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 138 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 175 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 296 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 109 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 188 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 118 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 61 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 122 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 192 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 192 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 666 to 667 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 424 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 668 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 704 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 705 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 705 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 816 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 307 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 250 to 255 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 53 to 58 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 137 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 145 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 201 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 235 to 240 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 345 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 139 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 466 to 474 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 313 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 400 to 408 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 392 to 400 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 401 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 405 forms a bond with O2, indicating a strong binding affinity.
The residue at position 450 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 451 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 536 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 538 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 77 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 319 to 322 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1009 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1085 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1092 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 6 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 10 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 452 to 455 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 611 to 612 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 626 to 628 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 661 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 699 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 80 to 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 300 to 312 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 14 to 22 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 112 to 121 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 277 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 312 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 198 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 320 to 327 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 372 to 376 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 531 to 538 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 681 to 687 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 31 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 162 forms a bond with melatonin, indicating a strong binding affinity.
The residue at position 181 forms a bond with melatonin, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 440 to 443 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 204 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 1868 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1903 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1918 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1920 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1925 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 272 to 275 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 48 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 141 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 170 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 173 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 329 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 332 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 333 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 797 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 495 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 542 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 667 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 432 to 436 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1120 to 1122 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1151 to 1153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1151 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1162 to 1163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1236 to 1239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1241 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1447 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1452 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1496 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 689 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 692 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 695 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 699 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 745 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 748 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 751 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 755 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 819 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 822 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 847 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1071 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 2 to 6 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 259 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 264 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 326 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 358 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 392 to 401 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 479 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 428 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 540 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 32 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 77 to 81 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 237 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 284 to 293 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 299 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 368 to 371 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 329 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 360 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 215 to 221 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 236 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 394 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 266 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 273 to 285 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 12 to 20 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 487 to 494 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 718 to 726 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 790 to 791 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 138 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 142 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 143 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 144 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 226 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 174 to 182 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 23 to 27 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 59 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 202 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 220 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 117 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 391 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 394 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 397 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 401 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 409 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 432 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 685 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 55 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 314 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 411 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 249 to 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 369 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 120 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 219 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 283 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 381 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 387 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 35 to 64 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 863 to 870 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 133 to 140 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 to 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 233 to 236 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 957 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 959 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1017 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1043 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1085 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1095 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1113 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1122 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1182 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1198 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1206 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1208 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1240 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1780 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1795 to 1797 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 11 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 13 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 180 to 215 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 30 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 57 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 451 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 664 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 667 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 140 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 340 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 379 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 602 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 605 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 622 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 638 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 644 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 654 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 657 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 768 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 768 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 768 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 774 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 774 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 774 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 815 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 815 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 815 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 943 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 943 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 943 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 148 to 205 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 426 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 469 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 493 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 498 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 506 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 270 to 275 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 230 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 787 to 844 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 912 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 64 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with beta-L-fucose, indicating a strong binding affinity.
The residue at position 140 forms a bond with beta-L-fucose, indicating a strong binding affinity.
The residue at position 141 forms a bond with beta-L-fucose, indicating a strong binding affinity.
The residue at position 147 forms a bond with beta-L-fucose, indicating a strong binding affinity.
The residue at position 153 forms a bond with beta-L-fucose, indicating a strong binding affinity.
The residue at position 184 forms a bond with beta-L-fucose, indicating a strong binding affinity.
The residue at position 185 forms a bond with beta-L-fucose, indicating a strong binding affinity.
The residue at position 178 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 382 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 152 to 156 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 161 to 165 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 248 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 295 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 330 to 336 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 289 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 292 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 172 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 115 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 183 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 324 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 127 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 156 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 344 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 125 forms a bond with heme, indicating a strong binding affinity.
The residue at position 445 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 486 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 531 to 534 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 to 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 164 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 693 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 696 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1051 to 1058 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 103 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 124 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 250 to 255 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 3 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 44 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 226 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 227 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 1786 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1810 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1882 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1915 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1931 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1939 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1956 to 1962 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1972 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1974 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1978 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1276 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1278 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1279 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1281 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1284 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1271 to 1278 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 456 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 485 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 492 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 496 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 501 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 502 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 579 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 622 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 632 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 642 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 25 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 46 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 47 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 131 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 222 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 163 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 249 to 252 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 441 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 278 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 382 to 387 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1102 to 1104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1109 to 1113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 to 342 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 to 10 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 195 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 8 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 779 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 854 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1189 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1288 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1290 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1294 to 1296 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 1310 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 1360 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 500 to 504 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 341 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 368 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 30 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 31 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 64 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 427 to 431 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 459 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 560 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 602 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 812 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 815 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 817 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 840 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 840 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 962 to 965 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 963 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 983 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 985 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 991 to 996 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 991 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 993 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1056 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1059 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1061 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1063 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 64 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 395 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 398 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 452 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 453 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 454 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 10 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 669 forms a bond with Mg of divinyl chlorophyll a B1, indicating a strong binding affinity.
The residue at position 677 forms a bond with Mg of divinyl chlorophyll a B3, indicating a strong binding affinity.
The residue at position 685 forms a bond with divinyl chlorophyll a B3, indicating a strong binding affinity.
The residue at position 686 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 231 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 250 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 to 62 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with Ni(II)-pyridinium-3,5-bisthiocarboxylate mononucleotide, indicating a strong binding affinity.
The residue at position 184 forms a bond with Ni(II)-pyridinium-3,5-bisthiocarboxylate mononucleotide, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ni of Ni(II)-pyridinium-3,5-bisthiocarboxylate mononucleotide, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 to 181 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 561 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 566 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 84 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 400 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 402 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 487 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 623 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 623 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 767 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 771 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 265 to 273 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 291 to 296 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 398 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 132 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1062 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1062 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1064 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1068 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1068 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1073 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1075 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1105 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1105 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1109 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1111 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1115 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1136 to 1138 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1173 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1200 to 1201 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1203 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1256 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1257 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1258 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1263 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 259 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 492 to 499 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 539 to 543 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 593 to 596 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 230 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 231 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 232 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 192 to 199 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 239 to 243 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 134 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 152 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 163 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 to 339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 181 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 129 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 194 to 202 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 226 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 253 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 410 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 506 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 401 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 124 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 635 to 642 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 464 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 507 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 192 to 197 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 279 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 523 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 252 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 318 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 341 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 446 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 450 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 452 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 380 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 174 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 61 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 156 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 179 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 185 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 215 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 221 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 248 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 257 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 264 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 54 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 87 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 314 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 316 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 440 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 446 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 560 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 575 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 186 to 192 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 492 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 276 to 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 5 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 347 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 423 to 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 to 452 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 628 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 321 to 332 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 405 to 410 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 464 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 473 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 602 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 603 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 613 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 210 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 213 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 219 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 223 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 145 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 180 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 232 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 686 to 805 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 453 to 460 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 499 to 503 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 553 to 556 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 111 to 118 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 144 to 149 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 474 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 502 to 503 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 381 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 384 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 390 to 391 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 288 to 299 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 91 to 95 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 149 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 150 to 155 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 301 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 194 to 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 16 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 18 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 24 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 25 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 40 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 71 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 73 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 17 to 25 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 501 to 511 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 509 to 511 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 535 to 537 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 626 to 629 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 724 to 728 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 724 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 752 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 753 to 755 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 755 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 22 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 352 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 358 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 388 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 460 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 306 to 308 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 336 to 337 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 417 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 792 to 802 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 828 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 943 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1013 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1044 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 815 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 515 to 522 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 89 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 190 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 249 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 to 233 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 13 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 91 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 842 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 702 to 709 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1343 to 1350 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 186 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 209 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 334 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 366 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 209 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 690 to 747 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 814 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 829 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 831 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 229 to 236 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 254 to 258 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 368 to 370 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 310 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 240 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 243 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 320 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 14 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 25 to 30 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 83 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 332 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 143 to 150 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 541 to 548 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 287 to 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 326 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 328 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 366 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 217 to 221 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 306 to 309 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 342 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 135 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 to 112 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 1291 to 1298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 163 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 365 to 366 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2 to 10 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 770 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 774 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 919 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 23 to 27 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 214 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 43 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 225 to 232 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 6 to 17 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 760 to 768 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 782 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 577 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 355 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 153 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 342 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 415 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 472 to 473 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 481 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 292 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 306 to 310 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 265 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 286 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 337 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 359 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 360 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 364 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 462 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 466 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 469 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 91 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 154 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 154 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 187 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 327 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 332 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 394 to 398 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 596 to 600 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 281 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 115 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 116 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 369 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 244 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 300 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 2112 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2115 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2134 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2137 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2168 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2171 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2183 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 169 to 174 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 425 to 430 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 443 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 468 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 489 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 583 to 591 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 2 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 350 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 494 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 497 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 259 to 266 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 305 to 309 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 359 to 362 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 659 to 662 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 669 to 670 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 130 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 12 forms a bond with pseudouridine, indicating a strong binding affinity.
The residue at position 26 forms a bond with pseudouridine, indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with pseudouridine, indicating a strong binding affinity.
The residue at position 38 forms a bond with pseudouridine, indicating a strong binding affinity.
The residue at position 137 forms a bond with pseudouridine, indicating a strong binding affinity.
The residue at position 166 forms a bond with pseudouridine, indicating a strong binding affinity.
The residue at position 311 forms a bond with pseudouridine, indicating a strong binding affinity.
The residue at position 177 to 186 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 287 to 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1420 to 1427 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 201 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 227 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 244 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 2341 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2343 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2345 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2347 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2352 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2384 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2386 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2388 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2390 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2395 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 497 to 505 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 to 237 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 327 to 416 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 450 to 509 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 340 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 310 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 564 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 567 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 671 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 249 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 939 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1052 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1065 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 137 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 178 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 227 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 239 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 65 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 206 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 541 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 153 to 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 531 to 661 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 600 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 246 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 29 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 51 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 53 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 77 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 103 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 104 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 122 forms a bond with N(6)-methyl-L-lysine residue of a protein, indicating a strong binding affinity.
The residue at position 122 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 242 to 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1293 to 1300 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 97 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 93 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 136 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 136 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 243 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 253 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 258 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 263 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 293 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 317 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 424 to 425 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 450 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 522 to 524 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 660 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 120 to 127 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 166 to 170 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 to 223 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1623 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1625 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1626 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1628 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1631 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 204 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 237 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 243 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 261 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 182 to 189 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 145 to 150 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 23 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 96 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 97 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 101 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 205 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 293 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 860 to 867 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 32 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 34 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 94 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 150 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 381 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 345 to 347 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 733 to 735 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 93 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 96 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 126 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 262 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 392 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 487 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 496 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 522 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 57 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 319 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 328 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 464 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 504 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 824 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 845 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 846 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 847 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 248 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 to 247 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 151 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 4 to 6 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 712 to 720 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 754 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 758 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 760 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 765 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 793 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 397 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 399 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 231 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 to 364 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 346 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 245 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 292 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 to 320 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 327 to 333 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 539 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 540 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 541 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 545 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 132 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 154 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 256 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 277 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 293 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 362 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 890 to 1026 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 510 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 510 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 512 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 581 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 583 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 587 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 61 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 75 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 80 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 100 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 169 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 186 to 193 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 894 to 901 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 400 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 426 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 59 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 62 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 68 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 to 63 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 100 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 119 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 191 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 808 to 865 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 933 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 946 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 946 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 948 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 507 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 518 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 528 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 739 to 839 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 28 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 268 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 319 to 327 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 427 to 429 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 185 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 200 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 389 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 35 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 38 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 81 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 161 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 177 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with S-adenosyl-L-methionine 3, indicating a strong binding affinity.
The residue at position 181 forms a bond with S-adenosyl-L-methionine 4, indicating a strong binding affinity.
The residue at position 187 forms a bond with S-adenosyl-L-methionine 3, indicating a strong binding affinity.
The residue at position 335 to 339 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 472 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 362 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 389 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 452 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with (S)-warfarin, indicating a strong binding affinity.
The residue at position 142 forms a bond with phylloquinone, indicating a strong binding affinity.
The residue at position 146 forms a bond with (S)-warfarin, indicating a strong binding affinity.
The residue at position 146 forms a bond with phylloquinone, indicating a strong binding affinity.
The residue at position 44 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 283 to 297 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 380 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 211 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 259 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 268 to 275 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 279 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 290 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 300 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 118 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 119 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 120 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 247 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 248 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 249 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 256 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 259 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 215 to 220 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 313 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 22 to 26 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 219 to 224 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 273 to 283 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 986 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 989 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 992 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 994 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 237 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 284 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 248 to 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 330 to 333 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 458 to 460 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 483 to 485 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 500 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 33 to 39 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 146 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 176 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 15 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 56 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 114 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 151 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 153 to 157 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 119 to 126 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 404 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 524 to 532 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 to 320 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 373 to 374 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 95 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 275 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 276 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 393 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 569 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 571 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 573 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 580 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 609 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 611 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 613 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 615 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 239 to 247 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 532 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 534 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 538 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 590 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 339 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 343 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 352 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 277 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 158 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 474 to 601 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 590 to 717 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 2063 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 2105 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 249 to 255 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1126 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1129 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1134 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1137 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1156 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1159 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 162 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 288 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 455 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 258 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 382 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 454 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 482 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 3 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 24 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 24 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 65 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 232 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 232 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 362 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 390 to 393 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 413 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 441 to 442 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 to 229 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 to 371 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 478 to 488 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 56 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 67 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 632 forms a bond with tRNA(Ile), indicating a strong binding affinity.
The residue at position 640 forms a bond with tRNA(Ile), indicating a strong binding affinity.
The residue at position 178 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 354 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 696 to 704 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 718 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 477 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 504 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 510 to 513 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 686 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 743 to 747 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 781 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 788 to 790 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 848 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 874 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 880 to 883 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 958 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 1133 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1256 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1259 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 17 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 542 to 550 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1222 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 293 to 296 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 438 to 445 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 312 forms a bond with 20-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 312 forms a bond with 25-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 312 forms a bond with 7beta-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 312 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 312 forms a bond with ergosterol, indicating a strong binding affinity.
The residue at position 491 to 494 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 520 to 521 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 79 to 86 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 220 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 296 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 322 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 303 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 513 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 547 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 172 to 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 542 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 581 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 606 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 606 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 649 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 650 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 651 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 682 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1024 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1042 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1093 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1096 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1146 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1153 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1154 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 461 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 463 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 520 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 521 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 522 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 312 to 317 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 488 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 491 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 531 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 578 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 581 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 584 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 588 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 608 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 611 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 614 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 618 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 18 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 283 to 293 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 28 to 33 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 830 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 832 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 834 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 839 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 866 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 868 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 432 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 45 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 384 to 394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 468 to 473 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 520 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 522 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 529 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 530 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 572 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 638 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 641 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 663 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 665 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 667 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 673 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 674 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 684 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 119 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 198 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 256 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 382 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 175 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 334 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 379 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 403 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 404 forms a bond with D-ribulose 1,5-bisphosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 164 to 174 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 to 473 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 511 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 518 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 368 to 369 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 28 forms a bond with N-acetyl-beta-D-glucosamine, indicating a strong binding affinity.
The residue at position 53 forms a bond with N-acetyl-beta-D-glucosamine, indicating a strong binding affinity.
The residue at position 69 forms a bond with N-acetyl-beta-D-glucosamine, indicating a strong binding affinity.
The residue at position 102 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 399 to 406 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 445 to 449 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 65 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 97 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 253 forms a bond with O2, indicating a strong binding affinity.
The residue at position 380 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 382 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 388 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 401 to 405 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 325 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 215 to 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 235 to 242 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 234 to 238 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 231 to 237 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 279 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 442 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 462 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 463 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 554 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 559 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 601 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 508 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 359 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 387 to 390 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 410 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 511 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 512 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 613 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 638 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 727 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 730 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 378 to 385 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 424 to 428 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 478 to 481 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 343 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 153 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 198 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 202 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 174 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 774 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 775 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1201 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1262 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 181 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 356 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 361 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 364 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 379 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 382 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 40 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 178 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 182 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 480 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 642 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 668 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 674 to 677 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 749 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 243 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 257 to 261 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 278 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 358 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 76 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 115 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 1298 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1410 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1413 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1470 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1557 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1559 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 42 to 60 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 352 to 353 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 to 392 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 410 to 414 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 432 to 435 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 528 to 530 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 286 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 387 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 125 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 337 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 384 to 393 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 448 to 449 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 749 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 770 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 771 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 772 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 773 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 773 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 487 to 494 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 533 to 537 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 587 to 590 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 447 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 305 to 309 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 420 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 424 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 90 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 93 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 154 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 1049 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1052 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1062 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1067 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 888 to 895 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 1665 to 1682 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 1765 to 1780 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 578 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 419 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 422 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 424 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 491 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 493 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 502 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 175 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 178 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 217 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 220 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 223 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 227 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 246 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 249 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 252 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 256 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 279 forms a bond with [4Fe-4S] cluster 6, indicating a strong binding affinity.
The residue at position 282 forms a bond with [4Fe-4S] cluster 6, indicating a strong binding affinity.
The residue at position 285 forms a bond with [4Fe-4S] cluster 6, indicating a strong binding affinity.
The residue at position 289 forms a bond with [4Fe-4S] cluster 6, indicating a strong binding affinity.
The residue at position 310 forms a bond with [4Fe-4S] cluster 7, indicating a strong binding affinity.
The residue at position 313 forms a bond with [4Fe-4S] cluster 7, indicating a strong binding affinity.
The residue at position 316 forms a bond with [4Fe-4S] cluster 7, indicating a strong binding affinity.
The residue at position 320 forms a bond with [4Fe-4S] cluster 7, indicating a strong binding affinity.
The residue at position 119 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 208 to 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 to 437 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 115 to 130 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 319 to 335 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 19 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 30 to 35 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 88 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 60 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 177 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 54 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 93 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 90 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 893 to 900 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 260 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 53 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 94 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 105 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 40 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 219 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 274 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 13 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 to 91 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 to 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 444 to 449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 399 to 401 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 487 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 489 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 489 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 491 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 360 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 430 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 437 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 338 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 426 to 430 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 446 to 455 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 456 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 272 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 335 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 347 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 368 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 294 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 189 to 195 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 192 to 227 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 415 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 31 to 32 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 355 to 360 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 258 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 44 to 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 353 to 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 76 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 139 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 139 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 172 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 240 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 126 to 134 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 154 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 199 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 276 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 171 to 175 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1825 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1839 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1842 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1847 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1850 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1868 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1871 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 811 to 818 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 to 122 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 to 264 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 264 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 358 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 209 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 409 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 185 to 191 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 261 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 310 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 332 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 333 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 438 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 442 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 444 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 445 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 403 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 448 to 450 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 495 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 583 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 583 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 585 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 625 to 633 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 651 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 186 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 189 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 222 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 225 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 229 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 256 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 78 to 89 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 205 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 136 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 163 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 229 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 637 to 641 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 660 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 682 to 684 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 887 to 889 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 2215 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2219 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2219 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2239 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2241 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2242 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2248 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2248 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2249 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2249 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2262 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2263 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 154 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 386 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 410 to 413 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 461 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 1898 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1930 to 1936 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1974 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 forms a bond with heme, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 1624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1648 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1720 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1753 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1769 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1777 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1794 to 1800 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1810 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1812 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1816 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 111 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 114 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 155 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 158 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 188 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1476 to 1483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 409 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 518 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 218 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 48 to 56 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 154 to 158 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 884 to 885 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1143 to 1144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 291 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 444 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 476 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 533 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 601 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 352 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 353 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 356 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 357 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 415 to 420 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 415 to 420 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 479 to 482 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 482 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 537 to 538 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 563 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 723 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 727 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 731 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 322 to 323 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 450 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 376 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 380 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 663 to 670 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 363 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 25 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 42 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 130 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 218 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 614 to 621 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 741 to 858 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 47 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 27 to 32 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 193 to 201 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 249 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 176 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 178 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 280 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 284 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 336 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 394 to 395 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 418 to 422 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 455 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 515 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 313 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 373 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 375 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 158 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 to 83 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1659 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1662 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1665 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 39 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 to 11 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 268 to 279 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 445 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 121 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 169 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 173 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 113 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 443 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 446 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 448 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 499 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 501 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 505 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 590 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 604 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 720 to 726 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 781 to 783 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 808 to 816 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 877 to 879 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1021 to 1022 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 276 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 302 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 447 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 495 to 496 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 503 to 505 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 to 304 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 328 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 422 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 444 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 451 to 456 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 210 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 319 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 366 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 471 to 473 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 476 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 645 to 649 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 654 to 660 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 684 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 95 to 101 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 123 to 125 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 322 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 382 to 388 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 386 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 497 to 499 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 247 to 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 461 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 964 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 160 to 164 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 272 to 282 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 298 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 305 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 391 to 393 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 263 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 459 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 466 to 471 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 466 to 467 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 to 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 8 to 14 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 8 to 13 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 107 forms a bond with (E)-ferulate, indicating a strong binding affinity.
The residue at position 246 forms a bond with (E)-5-hydroxyferulate, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 to 155 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 462 to 469 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 702 to 709 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 317 forms a bond with heme, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 54 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 142 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 228 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 238 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 246 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 278 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 300 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 308 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 315 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 318 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 151 to 159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 to 261 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 395 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 319 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 387 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 482 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 184 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 45 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 35 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 35 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 393 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 398 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 124 to 131 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 40 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 605 to 608 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1103 to 1105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1110 to 1114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 163 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 329 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 328 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 438 to 441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 to 213 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 288 to 296 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1028 to 1035 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 883 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 167 to 172 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 252 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 260 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 348 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 147 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 191 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 501 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 82 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 348 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 19 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 208 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 113 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 156 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 161 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 to 318 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 499 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 531 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 538 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 538 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 547 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 548 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 625 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 626 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 662 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 679 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 689 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 386 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 64 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 174 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 269 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 55 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 201 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 477 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 481 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 103 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 417 to 419 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 432 to 435 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 532 to 533 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 538 to 542 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 574 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 612 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 17 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 76 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 130 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 134 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 340 to 344 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 272 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 294 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 302 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 373 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 311 to 322 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 475 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 477 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 533 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 535 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 539 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 500 to 506 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 74 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 786 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 196 to 199 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 391 to 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 529 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 44 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 159 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 to 35 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 61 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 86 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 105 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 200 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 28 to 36 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 66 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 405 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 407 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 769 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 773 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 777 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 304 to 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 to 240 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 257 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 96 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 97 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 281 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 279 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 279 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 281 to 291 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 287 to 291 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 806 to 813 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 265 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 541 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 583 to 586 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 414 to 418 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 713 to 721 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 786 to 788 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 832 to 837 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 336 to 340 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 345 to 351 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 191 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 265 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 to 34 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 92 to 99 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 911 to 918 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 363 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 393 to 396 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 426 to 429 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 526 to 527 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 532 to 536 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 255 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 259 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 263 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 37 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 67 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 185 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 193 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 95 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 244 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 13 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 16 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 516 to 523 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 531 to 539 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 144 to 152 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 447 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 449 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 475 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 479 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 481 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 484 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 505 to 507 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 541 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 593 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 596 to 597 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 658 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 660 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 665 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 77 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 277 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 194 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 240 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 224 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 536 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 537 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 226 to 233 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 676 to 683 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1308 to 1315 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 517 to 544 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 527 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 145 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 403 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 38 to 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 374 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 477 to 485 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 555 to 557 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 160 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 158 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 189 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 364 to 365 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 368 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 476 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 500 to 501 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 523 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 553 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 685 to 686 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 691 to 693 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 779 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 796 to 797 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 152 to 159 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 432 to 436 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 679 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 687 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 690 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 711 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 714 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 392 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 400 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 320 to 326 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 442 to 450 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 56 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 170 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 224 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 230 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 272 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 386 to 389 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 398 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 463 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 24 forms a bond with folate, indicating a strong binding affinity.
The residue at position 185 forms a bond with folate, indicating a strong binding affinity.
The residue at position 43 to 67 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 145 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 163 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 171 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 174 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 180 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 217 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 253 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 260 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 200 to 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 349 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 350 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1049 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1073 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1074 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1077 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with 4-coumaroyl-CoA, indicating a strong binding affinity.
The residue at position 284 to 290 forms a bond with 4-coumaroyl-CoA, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with 4-coumaroyl-CoA, indicating a strong binding affinity.
The residue at position 219 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 129 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 142 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 195 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 201 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 221 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 227 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 460 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1106 to 1108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1113 to 1117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 231 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 441 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 388 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 412 to 415 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 155 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 342 to 346 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 399 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 771 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 802 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 55 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 58 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 613 to 621 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 to 206 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 181 to 187 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 179 to 306 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 492 to 614 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 610 to 730 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 553 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 566 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 571 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 689 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 692 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 705 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 710 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 856 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 859 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 872 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 877 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1121 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1124 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1137 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 417 to 419 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 472 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 570 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 1378 to 1386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1399 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 288 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 533 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 550 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 551 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 551 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 637 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 638 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 685 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 6 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 219 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 222 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 468 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 484 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 284 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 341 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 60 to 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 368 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 480 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 28 to 30 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 217 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 395 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 534 to 535 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 71 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 106 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 107 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 156 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 183 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 185 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 219 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 236 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 240 forms a bond with alpha-D-galactose, indicating a strong binding affinity.
The residue at position 783 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 279 forms a bond with D-xylobiose, indicating a strong binding affinity.
The residue at position 279 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 336 forms a bond with D-xylobiose, indicating a strong binding affinity.
The residue at position 336 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with D-xylobiose, indicating a strong binding affinity.
The residue at position 363 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 556 forms a bond with D-xylotriose 2, indicating a strong binding affinity.
The residue at position 613 forms a bond with D-xylotriose 2, indicating a strong binding affinity.
The residue at position 640 forms a bond with D-xylotriose 2, indicating a strong binding affinity.
The residue at position 642 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 208 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 212 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 364 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 368 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 404 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 228 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 394 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 569 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 573 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 576 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 723 to 731 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1092 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1135 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1135 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 110 to 220 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 125 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 156 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 89 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 166 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 281 to 288 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 376 to 380 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 805 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 836 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 840 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 918 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 950 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 952 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1048 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1117 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 657 to 664 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1302 to 1309 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 331 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 331 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 435 forms a bond with 3,3',5-triiodo-L-thyronine 1, indicating a strong binding affinity.
The residue at position 435 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 529 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 447 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 368 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 428 to 429 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 461 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 562 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 591 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 624 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 625 to 626 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 708 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 235 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 24 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 218 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 226 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 312 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 5 to 11 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 941 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 941 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 943 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 947 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 947 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 953 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 955 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 993 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 993 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 999 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1003 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1024 to 1026 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1062 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1064 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1183 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1186 to 1187 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1189 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1242 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1244 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1249 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 125 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 353 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 460 to 468 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 516 to 644 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 640 to 763 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 1081 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1084 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1089 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 95 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 143 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 156 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 209 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 112 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 712 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 607 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 393 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 20 to 26 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 35 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 265 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 409 to 413 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 452 to 453 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 463 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 43 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 447 to 454 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 493 to 497 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 547 to 550 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 97 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 160 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 189 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 358 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 132 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 340 to 361 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 383 to 402 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 65 to 95 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 227 to 263 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 398 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1050 to 1058 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1077 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 to 195 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 185 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 96 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 138 to 143 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 355 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 508 to 514 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 520 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 568 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 568 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 569 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 244 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 337 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 522 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 610 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 685 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 691 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 30 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 194 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 203 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 324 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 248 to 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 633 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 53 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 111 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 137 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 149 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 21 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 97 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 13 to 17 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 346 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 441 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 466 to 469 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 550 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 119 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1030 to 1037 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 643 to 650 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 460 to 467 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 276 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 457 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 1086 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 331 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 406 to 413 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 356 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 787 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 814 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 446 to 449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 122 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 145 to 154 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 265 to 268 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 399 to 400 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 475 to 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 34 to 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 712 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 284 to 293 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 621 to 623 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 628 to 634 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 730 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 536 to 538 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 543 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 714 to 715 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 756 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 152 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 306 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 360 to 368 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 382 to 385 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 95 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 435 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 438 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 467 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 474 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 478 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 483 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 484 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 561 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 562 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 609 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 629 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 62 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 447 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 492 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 263 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 351 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 357 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 387 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 459 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 490 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 963 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 623 to 634 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 528 to 532 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 582 to 585 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 347 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 368 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 258 to 263 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 1103 to 1110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 506 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 215 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 467 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 940 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 947 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 68 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 161 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 276 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 31 to 36 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 266 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 to 274 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 518 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 133 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 248 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 252 forms a bond with O2, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 254 to 257 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 207 to 213 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 11 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 186 to 212 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 462 to 470 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 490 to 492 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 637 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 644 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 791 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 42 to 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 871 to 878 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 339 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 259 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 336 to 340 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 207 to 212 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 152 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 264 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 267 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 325 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 328 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 287 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 289 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1140 to 1146 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1184 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 192 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 196 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 239 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 382 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 425 to 433 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 495 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 91 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 182 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 129 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 317 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 402 to 406 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 421 to 430 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 431 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 1901 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1933 to 1939 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1977 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 429 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 981 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 119 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 419 to 421 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 452 to 453 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 478 to 483 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 484 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 121 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 162 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 169 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 408 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 413 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 588 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 711 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 to 99 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 189 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 381 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 198 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 440 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 463 to 464 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 326 to 330 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 335 to 341 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 33 to 37 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with cholate 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with cholate 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with cholate 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with cholate 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with cholate 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 155 forms a bond with heme, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 263 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 307 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 127 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 127 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 154 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 154 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 158 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 158 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 179 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 179 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 673 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 681 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 689 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 690 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 122 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 165 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 58 forms a bond with glutathionylspermidine, indicating a strong binding affinity.
The residue at position 64 forms a bond with glutathionylspermidine, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with glutathionylspermidine, indicating a strong binding affinity.
The residue at position 149 forms a bond with glutathionylspermidine, indicating a strong binding affinity.
The residue at position 316 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 335 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 391 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 392 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 446 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 539 to 540 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 603 to 605 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 610 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 96 forms a bond with 20-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 96 forms a bond with 25-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 96 forms a bond with 7beta-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 96 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 96 forms a bond with ergosterol, indicating a strong binding affinity.
The residue at position 100 forms a bond with 7beta-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 336 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 340 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 344 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 538 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 682 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 690 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 96 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 118 to 133 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 322 to 338 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 17 to 21 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 to 269 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 12 to 21 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 461 to 468 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 554 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 559 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 559 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 595 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 595 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 599 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 601 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 605 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 626 to 628 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 662 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 664 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 714 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 717 to 718 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 720 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 778 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 780 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 785 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 431 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 456 to 459 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 540 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 120 forms a bond with substrate 1, indicating a strong binding affinity.
The residue at position 430 to 431 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 464 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 490 to 498 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 606 to 611 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 649 to 654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 477 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 615 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 300 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 22 to 24 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1338 to 1346 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 402 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 104 to 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 414 to 415 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 619 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 699 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 701 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 829 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 876 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1207 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1209 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1210 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1304 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1337 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 361 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 507 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 188 to 242 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 156 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 161 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 205 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 164 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 311 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 65 to 70 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 140 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 203 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 237 to 242 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 840 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 to 279 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 275 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 563 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 566 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 574 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 575 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 581 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 585 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 594 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 598 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 212 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 288 to 297 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 144 to 150 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 194 to 205 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 377 to 385 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 393 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 407 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 480 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 606 to 610 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 629 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 651 to 653 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 856 to 858 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 387 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 604 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 604 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 608 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 748 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 752 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 756 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 47 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 58 to 63 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 61 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 149 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 529 to 537 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 136 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 184 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 327 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 585 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 624 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 631 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 1565 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1569 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1589 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 118 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 143 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 157 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 333 to 341 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 235 to 242 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 626 to 633 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 519 to 527 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 149 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 187 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 187 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 189 to 195 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 191 to 195 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 56 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 305 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 375 to 379 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 394 to 403 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 404 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 to 451 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 451 to 454 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 612 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 733 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 258 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 260 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 265 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 192 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 198 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 262 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 536 to 543 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1330 to 1337 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 303 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 364 to 365 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 388 to 392 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 421 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 475 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 476 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 477 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 406 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 65 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 341 to 348 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 388 to 392 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 442 to 445 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 463 to 470 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 106 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 322 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 244 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 248 forms a bond with O2, indicating a strong binding affinity.
The residue at position 294 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 379 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 381 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 168 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 70 to 82 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 1638 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1670 to 1676 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1714 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 393 to 397 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 595 to 599 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 53 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 135 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 490 to 497 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 36 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 43 to 54 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 152 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 215 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 515 to 522 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1321 to 1328 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 126 to 132 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 137 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 155 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 158 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 145 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 176 to 223 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 321 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 285 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 178 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 835 to 955 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 1275 to 1282 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 141 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 633 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with lanosterol, indicating a strong binding affinity.
The residue at position 124 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 317 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 341 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 360 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 403 to 404 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 33 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 250 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 463 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 118 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 168 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 290 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 379 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 597 to 605 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 763 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 744 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 757 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 760 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 765 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 768 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 788 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 2 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 166 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 687 to 699 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 730 to 733 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 750 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 795 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 472 to 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 3 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 29 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 216 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 229 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 538 to 545 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 584 to 588 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 638 to 641 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 540 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 269 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 272 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 647 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 680 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 792 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 824 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 965 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1035 to 1042 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 19 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 83 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 177 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 29 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 232 to 262 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 365 to 367 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 448 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 525 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 525 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 527 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 11 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 222 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 54 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 84 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 85 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 109 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 129 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 179 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 248 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 249 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 7 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 334 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 106 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 135 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 166 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 181 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 326 to 329 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 137 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 319 to 320 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 251 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1383 to 1391 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1052 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1052 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 39 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 122 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 341 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 64 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 189 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 283 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 945 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 988 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 107 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 433 to 434 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 436 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 154 to 159 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 131 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 321 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 324 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 326 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 443 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 7 to 10 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 29 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 722 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 758 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 759 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 759 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 869 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 37 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 570 to 578 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 195 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 341 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 398 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 452 to 453 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 482 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 492 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 582 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 427 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 24 to 29 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 284 to 298 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 420 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 421 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 459 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 58 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 88 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 89 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 113 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 133 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 183 to 186 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 183 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 252 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 497 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 69 to 97 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 611 to 618 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 6 to 10 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 894 to 902 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 714 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 727 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 733 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 758 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 771 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 777 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 801 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 806 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 819 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 825 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 854 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 859 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 872 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 878 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 26 to 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 127 to 133 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 189 to 197 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 238 to 242 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 35 to 43 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 269 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 271 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 316 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 334 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 339 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 344 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 361 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 260 to 265 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 120 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 164 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 480 to 486 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 558 to 560 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 70 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 79 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 99 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 102 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 105 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 38 to 46 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 205 to 211 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 636 to 643 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 956 to 963 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 378 to 379 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 407 to 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 545 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 609 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 263 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 339 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 340 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 221 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 79 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 193 to 223 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 635 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 641 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 675 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 679 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 63 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 479 to 601 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 538 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 553 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 133 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 223 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 292 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 295 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 296 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 311 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 327 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 328 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 25 forms a bond with a penicillin, indicating a strong binding affinity.
The residue at position 405 forms a bond with a penicillin, indicating a strong binding affinity.
The residue at position 11 to 25 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 354 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 354 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 390 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 390 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 395 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 395 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 500 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 500 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 506 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 11 to 17 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 49 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 242 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 247 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 16 to 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 303 to 313 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 212 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 251 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 307 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 145 to 148 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 149 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 161 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 297 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 363 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 271 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 143 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 to 424 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 594 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 141 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 338 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 137 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 490 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 494 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 246 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 315 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 438 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 268 to 275 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 312 to 315 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 83 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 18 to 22 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 46 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 141 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 259 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 304 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 432 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 423 to 430 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 459 to 463 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 524 to 527 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 13 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 to 23 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 193 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 197 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 211 to 218 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 238 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 26 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 340 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 381 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 767 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 788 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 54 to 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 691 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 860 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 15 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 269 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 441 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 623 to 625 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 405 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 363 to 367 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 553 to 557 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 359 to 362 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 369 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 154 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 to 223 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 256 to 269 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 765 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 769 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 769 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 986 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 365 to 372 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 412 to 416 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 466 to 469 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 367 to 382 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 394 to 426 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 79 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 310 to 314 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 45 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 223 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 375 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 186 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 215 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 246 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 388 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 119 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 192 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 576 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 599 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 708 to 711 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 725 to 729 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 730 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 742 to 744 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 792 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 795 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 264 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 704 to 711 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1379 to 1386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 to 177 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 245 to 253 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 448 to 449 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 545 to 547 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 339 to 341 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 400 to 411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 to 538 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 377 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 83 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 139 to 144 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 to 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 245 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 380 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 383 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 638 to 642 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 639 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 670 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 764 to 765 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 764 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 813 to 816 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 820 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 839 to 842 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 915 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 26 to 46 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 603 to 610 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 322 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 309 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 312 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 313 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 17 forms a bond with a tetrapyrrole, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 384 to 385 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 421 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 582 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 611 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 645 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 646 to 647 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 756 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 438 to 441 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 733 to 790 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 869 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 871 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 51 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 261 to 282 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 304 to 323 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 218 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 483 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 516 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 214 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 659 to 667 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 497 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 516 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 517 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 618 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 643 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 732 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 735 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 519 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 522 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 536 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 541 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 1126 to 1134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 70 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 119 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 1007 to 1011 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 56 to 61 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 202 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 236 to 241 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 1249 to 1256 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 505 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 633 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 636 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 647 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1142 to 1143 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1160 to 1161 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1182 to 1183 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1569 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1571 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 155 to 162 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 253 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 396 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 416 to 420 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 428 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 458 to 460 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 314 to 321 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 20 to 24 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 216 to 224 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 270 to 280 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 250 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 383 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 122 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 41 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 225 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 to 408 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 847 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 856 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 440 to 449 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 450 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 358 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 386 to 389 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 409 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 69 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 277 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 347 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 307 to 326 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 326 to 328 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 331 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 366 to 368 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 506 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 218 to 225 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 318 to 321 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 102 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 247 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 356 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 361 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 366 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 446 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 447 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 475 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 649 to 680 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 793 to 804 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 935 to 945 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1010 to 1028 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1108 to 1123 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 236 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 240 forms a bond with O2, indicating a strong binding affinity.
The residue at position 285 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 371 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 1056 to 1063 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 333 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 342 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 44 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 75 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 99 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 119 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 176 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 199 to 206 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 311 to 314 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 928 to 935 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 36 to 41 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 to 174 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 564 to 571 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 611 to 615 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 665 to 668 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 179 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 304 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 336 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 14 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 58 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 222 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 226 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 462 to 468 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 859 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 344 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 842 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 854 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 175 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 219 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 309 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 346 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 348 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 348 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 352 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 355 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 896 to 903 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 421 to 422 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 490 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 494 to 498 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 505 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 62 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 74 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 83 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 91 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 288 forms a bond with flaviolin 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with flaviolin 2, indicating a strong binding affinity.
The residue at position 293 forms a bond with flaviolin 1, indicating a strong binding affinity.
The residue at position 455 to 456 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 668 to 672 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 468 to 470 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 511 to 512 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 615 to 621 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 625 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 688 to 691 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 155 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 93 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 24 to 32 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 277 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 354 to 358 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 442 to 445 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 465 to 474 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 491 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 528 to 529 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 224 to 230 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 313 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 367 to 368 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 367 to 368 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 373 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 400 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 58 to 63 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 90 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 158 to 163 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 190 to 196 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 866 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 68 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 355 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 358 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 301 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 346 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 74 to 79 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 106 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 174 to 179 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 4 to 18 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 250 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 328 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 391 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 500 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 501 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 505 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 510 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 591 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 604 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 619 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 814 to 845 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 957 to 968 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1100 to 1110 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1175 to 1193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1273 to 1287 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 74 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 466 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 243 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 245 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 288 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 295 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 320 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 322 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 324 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 326 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 331 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 224 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 188 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 18 to 21 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 431 to 435 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 485 to 488 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 24 to 25 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 84 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 288 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 343 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 378 to 380 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 401 to 402 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 425 to 429 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 529 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 530 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 164 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 81 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 259 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 272 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 369 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 395 to 399 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 395 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 399 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 384 to 392 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 177 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 167 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 708 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 90 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 91 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 94 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 97 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 101 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 248 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 333 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 398 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 402 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 428 to 435 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 908 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 977 to 978 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 980 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1028 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1033 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 648 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 738 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 742 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 836 to 843 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 to 228 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 661 to 668 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 446 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 627 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 629 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 631 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 594 to 602 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 425 to 432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 765 to 772 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 273 to 281 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 285 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 296 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 306 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with paraoxon, indicating a strong binding affinity.
The residue at position 169 forms a bond with paraoxon, indicating a strong binding affinity.
The residue at position 170 forms a bond with paraoxon, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 59 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 104 to 109 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 122 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 86 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 180 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 256 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 30 to 35 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 265 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 289 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 301 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 436 to 439 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 63 to 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1652 to 1659 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 486 to 487 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 515 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 526 to 527 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 161 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 252 to 256 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 312 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 421 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 451 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 317 to 324 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 131 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 163 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 319 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 320 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 811 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 299 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 474 to 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 66 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 104 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 160 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 111 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 112 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 220 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 435 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 436 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 548 to 555 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 751 to 758 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 874 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 49 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 158 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 245 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 348 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 89 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 193 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 381 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 454 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 174 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 163 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 61 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 67 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 116 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 231 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 233 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 295 forms a bond with ADP-D-glycero-beta-D-manno-heptose, indicating a strong binding affinity.
The residue at position 10 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 186 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 204 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 227 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 233 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 215 to 272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1740 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2041 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2043 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 142 to 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 367 to 373 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 292 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 920 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 952 to 958 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 996 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 113 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 217 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 407 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 479 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 529 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 536 to 537 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 545 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 111 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 205 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 54 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 466 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 316 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 392 to 394 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 681 to 689 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 351 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 354 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 358 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 399 to 402 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 to 194 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 190 to 194 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 336 to 337 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 829 to 836 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1107 to 1114 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 223 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 214 to 223 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 836 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 108 to 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 295 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 182 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 338 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 380 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 511 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 552 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 552 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 135 to 144 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 293 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 350 to 354 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 379 to 381 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 to 224 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 55 to 385 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 92 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 496 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 499 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 499 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 501 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 570 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 571 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 572 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 576 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 168 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 221 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 227 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 254 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 47 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 422 to 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 forms a bond with heme, indicating a strong binding affinity.
The residue at position 326 forms a bond with heme, indicating a strong binding affinity.
The residue at position 383 forms a bond with heme, indicating a strong binding affinity.
The residue at position 385 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 11 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 95 to 102 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 157 to 161 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 484 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 318 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 7 to 11 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 106 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 141 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 83 to 87 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 95 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 85 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 348 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 386 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 409 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 496 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 561 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 617 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 752 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 774 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 775 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 776 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 360 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 367 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 408 to 411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 709 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 857 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 213 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 85 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 114 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 457 to 460 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 1227 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1256 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1258 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1350 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 46 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 409 to 414 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 685 to 688 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 338 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 5 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 12 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 109 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 118 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 274 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 125 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 132 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 314 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 33 forms a bond with N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 72 forms a bond with N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 90 forms a bond with N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 150 forms a bond with N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 170 forms a bond with N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 210 forms a bond with N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 174 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 190 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 194 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 208 to 215 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 235 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 944 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 392 to 394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 264 to 270 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 158 forms a bond with heme, indicating a strong binding affinity.
The residue at position 188 forms a bond with heme, indicating a strong binding affinity.
The residue at position 213 forms a bond with heme, indicating a strong binding affinity.
The residue at position 249 forms a bond with heme, indicating a strong binding affinity.
The residue at position 1047 to 1050 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1057 to 1060 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1058 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1060 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1130 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1152 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1170 to 1174 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1286 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 212 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 402 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 280 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 287 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 394 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 467 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 78 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 78 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 221 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 221 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 239 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 239 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 700 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 708 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 407 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 406 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 409 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 449 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 454 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 455 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 532 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 533 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 568 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 575 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 583 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 593 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 377 to 384 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 403 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 75 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 228 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 729 to 736 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1415 to 1422 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 39 to 42 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 131 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 171 to 180 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 209 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 480 to 487 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 341 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 471 to 472 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 299 to 310 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 382 to 387 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 436 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 438 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 584 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 595 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 174 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 233 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 307 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 1357 to 1364 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 21 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 390 to 394 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 117 to 122 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with (1R)-(2-amino-1-hydroxyethyl)phosphonate, indicating a strong binding affinity.
The residue at position 34 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with (1R)-(2-amino-1-hydroxyethyl)phosphonate, indicating a strong binding affinity.
The residue at position 108 forms a bond with (1R)-(2-amino-1-hydroxyethyl)phosphonate, indicating a strong binding affinity.
The residue at position 126 to 133 forms a bond with (1R)-(2-amino-1-hydroxyethyl)phosphonate, indicating a strong binding affinity.
The residue at position 158 forms a bond with (1R)-(2-amino-1-hydroxyethyl)phosphonate, indicating a strong binding affinity.
The residue at position 66 forms a bond with urate, indicating a strong binding affinity.
The residue at position 194 forms a bond with urate, indicating a strong binding affinity.
The residue at position 242 forms a bond with urate, indicating a strong binding affinity.
The residue at position 243 forms a bond with urate, indicating a strong binding affinity.
The residue at position 269 forms a bond with urate, indicating a strong binding affinity.
The residue at position 568 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 571 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 573 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 665 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 673 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 427 to 434 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1239 to 1246 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 323 to 326 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 333 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 384 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 454 to 456 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 455 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 378 to 380 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 146 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 175 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 178 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 574 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 578 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 585 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 610 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 612 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 614 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 6 to 7 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 14 to 19 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 27 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 32 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 58 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 98 to 103 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 428 to 431 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 478 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 482 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 399 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 476 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 134 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 172 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 181 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 133 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 490 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 673 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 198 to 203 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 215 to 220 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 359 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 394 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 155 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 188 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 256 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 102 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 166 to 170 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 328 to 331 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 331 to 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 531 to 535 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 248 to 253 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 to 386 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 72 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 135 to 141 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 164 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 167 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 136 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 150 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 905 to 912 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 394 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 395 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 398 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 33 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 72 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 113 to 121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 355 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 86 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 87 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 111 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 181 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 250 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 244 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 20 to 29 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 144 to 172 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 342 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 47 to 51 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 118 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 96 to 105 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 47 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 51 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 73 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 77 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 164 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 193 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 199 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 1293 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1322 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1355 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1360 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1378 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1381 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 394 to 401 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 130 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 104 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 116 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 127 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 127 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 191 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 191 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 238 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 320 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 320 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 249 to 257 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 71 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 1025 forms a bond with ganglioside GT1b (d18:1(4E)), indicating a strong binding affinity.
The residue at position 1189 to 1190 forms a bond with ganglioside GT1b (d18:1(4E)), indicating a strong binding affinity.
The residue at position 1240 to 1241 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 372 to 492 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 152 to 159 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 178 to 186 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 276 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 320 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 344 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 461 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 462 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 492 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 504 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 509 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 511 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 541 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 581 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 582 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 604 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 686 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 687 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 709 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 524 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 524 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 526 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 25 to 27 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 454 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 495 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 670 to 678 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 540 to 548 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 940 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 941 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 941 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 947 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1007 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1007 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1013 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 148 to 157 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 415 to 418 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 557 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 339 to 341 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 356 to 364 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 378 to 381 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 721 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 757 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 758 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 868 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 284 to 312 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1450 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1453 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1467 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1470 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1475 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1497 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1500 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 478 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 564 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 568 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 571 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 586 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 959 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 961 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1068 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1119 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 91 to 95 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 89 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 468 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 510 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 759 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 423 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 688 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 691 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 709 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 712 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 715 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 718 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 738 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 455 to 462 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 491 to 495 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 560 to 563 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 89 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 77 to 82 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 108 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 510 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 227 to 233 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 80 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 188 to 191 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 344 to 348 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 855 to 862 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 257 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 47 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 104 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 183 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 12 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 461 to 464 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 185 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 188 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 211 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 214 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 232 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 290 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 386 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 416 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 515 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 518 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 427 to 428 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 447 to 448 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 467 to 468 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 494 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 514 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 465 to 470 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 115 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 116 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 117 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 19 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 21 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 40 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 487 to 495 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 forms a bond with urate, indicating a strong binding affinity.
The residue at position 192 forms a bond with urate, indicating a strong binding affinity.
The residue at position 240 forms a bond with urate, indicating a strong binding affinity.
The residue at position 241 forms a bond with urate, indicating a strong binding affinity.
The residue at position 267 forms a bond with urate, indicating a strong binding affinity.
The residue at position 285 to 290 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 492 to 496 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 546 to 549 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 219 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 253 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1 to 2 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 568 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 573 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 613 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 672 to 674 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 779 to 782 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 164 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 179 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 182 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 183 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 184 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 187 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 202 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 203 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 204 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 573 to 574 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 380 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 688 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 735 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 860 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 485 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 530 to 533 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 178 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 636 to 642 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 659 to 661 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 752 to 753 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 755 to 756 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 821 to 822 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 270 to 273 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 298 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 377 to 381 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 495 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 16 to 23 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 to 72 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 80 to 81 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 87 to 95 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 397 to 402 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 580 to 582 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 676 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 683 to 685 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 744 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 132 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 140 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 93 to 100 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 179 to 186 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 346 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 348 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 365 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 446 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 450 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 453 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 458 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 163 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 381 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 392 to 398 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 284 to 291 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 148 to 153 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 179 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 269 to 272 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 338 to 344 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 254 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 280 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 435 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 439 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 876 to 883 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1178 to 1185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 544 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 207 to 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 250 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 433 to 436 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 450 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 476 to 477 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 514 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 74 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 575 to 582 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 154 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 184 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 182 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 253 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 311 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 344 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 381 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 384 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 388 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 645 to 649 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 649 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 685 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 686 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 686 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 686 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 803 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 803 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 854 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 178 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 482 to 605 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 549 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 564 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 260 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 760 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 846 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 986 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 622 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 645 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 746 to 749 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 763 to 767 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 768 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 780 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 784 to 786 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 841 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 844 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 952 to 961 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 95 to 99 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 167 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 194 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 394 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 419 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 112 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 139 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 143 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 164 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 651 to 659 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 719 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 231 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 903 to 911 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 930 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 408 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 421 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 427 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 797 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 815 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 821 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 841 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 846 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 865 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 890 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 895 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 908 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 914 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 943 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 948 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 961 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 967 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 49 forms a bond with phycourobilin, indicating a strong binding affinity.
The residue at position 274 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 15 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 46 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 101 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 128 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 215 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 221 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 430 to 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 278 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 323 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 423 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 427 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 461 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 465 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 523 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 552 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 587 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 107 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 184 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 452 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 42 to 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 90 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 109 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 616 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 616 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 622 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 668 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 668 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 670 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 687 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 381 to 382 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 41 forms a bond with all-trans-retinol, indicating a strong binding affinity.
The residue at position 63 forms a bond with all-trans-retinol, indicating a strong binding affinity.
The residue at position 109 forms a bond with all-trans-retinol, indicating a strong binding affinity.
The residue at position 1560 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1572 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 212 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 353 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 356 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 625 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 640 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 764 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 767 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 413 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 210 to 216 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 589 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 591 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 593 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 627 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 636 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 310 to 315 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 689 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 690 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 719 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 803 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 805 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 826 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 851 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 852 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 55 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 29 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 112 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 424 to 428 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 556 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 598 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 686 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 696 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 742 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 752 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 809 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 814 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 837 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 837 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 967 to 969 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 967 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 995 to 1000 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 995 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 997 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1000 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 202 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 286 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 393 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 23 to 29 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 262 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 356 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 458 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 489 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 151 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 295 to 299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 227 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 22 to 28 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 295 to 298 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 49 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 82 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 97 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 337 to 344 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 101 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 193 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 362 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 107 to 111 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 421 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 278 to 282 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 259 to 262 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 602 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 659 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 670 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 672 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 679 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 722 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 732 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 638 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 665 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 686 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 663 to 670 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1299 to 1306 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with trans-zeatin 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 67 forms a bond with trans-zeatin 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with trans-zeatin 1, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with trans-zeatin 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 431 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 575 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 577 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 647 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 335 forms a bond with CO2, indicating a strong binding affinity.
The residue at position 20 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 23 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 to 29 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 88 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 209 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 430 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 486 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 491 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 143 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 155 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 241 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 247 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 270 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 276 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 2157 to 2164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanine, indicating a strong binding affinity.
The residue at position 113 to 119 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanine, indicating a strong binding affinity.
The residue at position 316 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 347 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 450 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 501 to 503 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 144 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 179 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 6 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 7 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 9 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 11 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 12 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 109 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 146 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 173 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 147 to 151 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 272 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 353 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 82 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 175 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 290 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 192 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 192 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 7 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 74 to 77 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 145 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 144 to 150 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 202 to 210 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 237 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 299 to 318 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 102 to 109 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 228 forms a bond with 17alpha-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 228 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 357 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 418 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1491 to 1498 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 135 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 561 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 562 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 209 to 218 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 413 to 417 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 234 to 242 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 forms a bond with Mo of Mo-molybdopterin guanine dinucleotide, indicating a strong binding affinity.
The residue at position 360 forms a bond with Mo of Mo-molybdopterin guanine dinucleotide, indicating a strong binding affinity.
The residue at position 522 forms a bond with Mo of Mo-molybdopterin guanine dinucleotide, indicating a strong binding affinity.
The residue at position 288 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 138 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 169 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 194 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 249 forms a bond with oxaloacetate, indicating a strong binding affinity.
The residue at position 339 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 528 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 667 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 250 to 254 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 to 275 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 142 to 147 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 198 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 388 forms a bond with tRNA discriminator base of tRNA, indicating a strong binding affinity.
The residue at position 298 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 27 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 104 to 109 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 47 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 262 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 297 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 335 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 448 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 478 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 528 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 5 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1004 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1191 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 476 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 280 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 148 to 153 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 207 to 213 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 168 to 174 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 574 to 582 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 610 to 618 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 758 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 774 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 778 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 801 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 126 to 133 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 162 to 169 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with urate, indicating a strong binding affinity.
The residue at position 165 forms a bond with urate, indicating a strong binding affinity.
The residue at position 182 forms a bond with urate, indicating a strong binding affinity.
The residue at position 237 forms a bond with urate, indicating a strong binding affinity.
The residue at position 257 forms a bond with urate, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 878 to 885 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 972 to 979 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 193 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 281 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 667 forms a bond with Mg of divinyl chlorophyll a B1, indicating a strong binding affinity.
The residue at position 675 forms a bond with Mg of divinyl chlorophyll a B3, indicating a strong binding affinity.
The residue at position 683 forms a bond with divinyl chlorophyll a B3, indicating a strong binding affinity.
The residue at position 684 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 134 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 329 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 437 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 478 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 523 to 526 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 to 180 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 53 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 64 to 69 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 67 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 122 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 279 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 340 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 956 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1067 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1080 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1081 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 124 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 166 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 306 to 308 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 33 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 100 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 101 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 83 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 158 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 178 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 181 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 34 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 9 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 26 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 40 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 45 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 47 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 51 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 51 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 57 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 59 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 65 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 65 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 326 to 330 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 382 to 386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with cholate, indicating a strong binding affinity.
The residue at position 99 forms a bond with cholate, indicating a strong binding affinity.
The residue at position 101 forms a bond with cholate, indicating a strong binding affinity.
The residue at position 534 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 574 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 577 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 1734 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1745 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 823 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 826 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 850 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 853 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 863 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 150 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 552 to 559 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 351 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 355 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 771 to 778 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 478 to 600 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 537 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 552 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 12 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 to 304 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 255 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 21 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 407 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 407 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 347 to 351 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 877 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 6 to 128 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 668 to 669 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 293 to 296 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 482 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1771 to 1773 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1771 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1797 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1807 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1816 to 1826 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1840 to 1843 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1870 to 1872 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1871 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe of heme b b595, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe of heme b b558, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of heme b b558, indicating a strong binding affinity.
The residue at position 114 forms a bond with substrate 1, indicating a strong binding affinity.
The residue at position 465 to 466 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 494 to 495 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 182 to 188 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 633 to 641 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 to 463 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 463 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1109 to 1111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1116 to 1120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1156 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 56 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 58 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 78 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 81 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 162 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 426 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 157 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 400 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 416 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 417 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 561 to 563 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 146 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 336 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 340 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 130 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 325 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 464 to 471 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 650 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 652 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 676 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 705 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 267 to 281 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 102 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 392 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 540 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 53 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 4 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 112 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 139 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 146 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 233 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 247 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 251 to 256 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 254 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 310 forms a bond with D-ornithine, indicating a strong binding affinity.
The residue at position 310 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 74 to 77 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 45 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 190 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 196 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 130 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 128 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 686 to 693 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1319 to 1326 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 600 to 601 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 436 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 442 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 481 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 485 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 242 to 246 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 392 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 52 to 60 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 185 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 233 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 735 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1144 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 28 to 30 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 173 to 178 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 372 to 376 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 404 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 443 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 469 to 471 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 472 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 499 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 522 to 523 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 486 to 491 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 486 to 487 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 96 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 203 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2 to 6 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 104 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 794 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1124 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1139 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1142 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 261 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 70 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 292 to 300 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 520 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 234 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 258 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 302 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 389 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 417 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 442 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 476 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 384 to 391 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 430 to 434 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 484 to 487 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 258 to 270 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 499 to 501 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 729 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 770 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 815 to 818 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 442 to 457 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 213 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 221 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 307 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 381 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 67 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 78 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 116 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 132 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 144 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 41 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 78 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 79 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 105 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 140 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 1 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 7 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 7 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 16 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 18 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 21 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 27 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 28 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 31 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 31 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 37 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 41 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 48 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 49 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 51 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 66 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 244 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 138 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 747 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 830 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 466 to 473 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 512 to 516 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 216 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 304 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 137 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 329 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 336 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 51 to 57 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 88 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 379 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 134 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 854 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 868 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 938 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 997 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1000 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1019 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 134 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 134 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 198 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 198 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 250 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 327 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 327 forms a bond with gibberellin A4, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 175 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 266 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 280 to 284 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 303 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 372 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 84 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 98 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 369 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 404 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 135 to 252 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 193 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 312 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 311 to 322 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 310 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 324 to 328 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with folate, indicating a strong binding affinity.
The residue at position 264 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 212 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 319 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 147 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 216 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 368 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 411 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 350 to 351 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 425 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 463 to 464 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 491 to 492 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 514 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 48 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 76 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 179 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 197 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 304 to 308 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 313 to 319 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 343 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 432 to 433 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 459 to 460 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 603 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 21 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 64 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 395 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 723 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 905 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 949 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 330 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 333 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 399 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 315 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 408 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 507 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 519 to 522 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 528 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 629 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 801 to 804 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 828 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 838 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 868 to 869 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 894 to 896 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 934 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 970 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 974 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 997 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 239 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 181 to 188 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 93 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 108 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 143 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 590 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 665 to 668 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 33 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1489 to 1496 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1542 to 1545 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1619 to 1622 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 362 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 364 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 380 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 310 to 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 680 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 681 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 890 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 284 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 116 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 155 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 161 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 198 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 234 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 241 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 91 to 95 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 74 to 79 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 173 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 233 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 95 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 115 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 174 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 203 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 94 to 99 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 358 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 360 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 364 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 360 to 365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 to 472 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 502 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 541 to 543 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 100 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 192 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 192 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 253 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 72 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 76 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 101 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 130 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 135 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 153 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 245 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 281 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 69 to 78 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 to 229 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 22 to 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 570 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 593 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 692 to 695 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 709 to 713 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 723 to 725 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 773 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 304 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 98 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 332 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 361 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 369 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 404 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 407 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 450 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 454 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 486 to 610 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 557 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 279 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 223 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 396 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 442 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 445 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 8 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 68 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 128 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 133 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 276 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 280 to 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 581 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 584 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 503 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 506 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 508 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 565 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 566 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 567 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with heme, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mg of chlorophyll a 8, indicating a strong binding affinity.
The residue at position 106 forms a bond with Mg of chlorophyll a 10, indicating a strong binding affinity.
The residue at position 138 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mg of chlorophyll a 9, indicating a strong binding affinity.
The residue at position 225 forms a bond with Mg of chlorophyll a 12, indicating a strong binding affinity.
The residue at position 404 forms a bond with Mg of chlorophyll a 7, indicating a strong binding affinity.
The residue at position 415 forms a bond with Mg of chlorophyll a 13, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 153 to 159 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 57 to 85 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 730 forms a bond with Val-boroPro, indicating a strong binding affinity.
The residue at position 96 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 109 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe of heme d1, indicating a strong binding affinity.
The residue at position 250 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 251 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 270 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 397 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 508 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 707 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 711 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1361 to 1368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 to 97 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 16 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 276 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 304 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 307 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 312 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 317 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 347 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 362 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 367 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 375 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 382 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 389 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 960 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 962 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 964 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 148 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 464 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 467 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 469 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 562 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 563 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 564 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 568 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 573 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 7 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 124 to 131 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 170 to 174 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 599 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 402 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 435 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 459 to 466 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 494 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1229 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1254 to 1261 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 248 to 252 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 421 to 424 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 428 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 447 to 450 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 523 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 257 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 294 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 to 82 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 276 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 276 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 217 to 227 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 665 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 673 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 681 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 682 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 173 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 188 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 253 to 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 337 to 340 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 432 to 434 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 474 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 309 forms a bond with AMP 3'-end residue of tRNA(Thr), indicating a strong binding affinity.
The residue at position 313 to 317 forms a bond with tRNA 3'-terminal nucleotidyl-cytidyl-cytidyl-adenosine residue of tRNA, indicating a strong binding affinity.
The residue at position 325 forms a bond with tRNA(Thr), indicating a strong binding affinity.
The residue at position 342 to 349 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with tRNA(Thr), indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 363 forms a bond with tRNA 3'-terminal nucleotidyl-cytidyl-cytidyl-adenosine residue of tRNA, indicating a strong binding affinity.
The residue at position 375 forms a bond with tRNA 3'-terminal nucleotidyl-cytidyl-cytidyl-adenosine residue of tRNA, indicating a strong binding affinity.
The residue at position 376 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 379 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 381 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 462 forms a bond with tRNA 3'-terminal nucleotidyl-cytidyl-cytidyl-adenosine residue of tRNA, indicating a strong binding affinity.
The residue at position 479 to 480 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 484 forms a bond with tRNA 3'-terminal nucleotidyl-cytidyl-cytidyl-adenosine residue of tRNA, indicating a strong binding affinity.
The residue at position 489 to 503 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 520 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 547 to 549 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 547 to 549 forms a bond with anticodon region of tRNA, indicating a strong binding affinity.
The residue at position 575 to 586 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 575 to 583 forms a bond with anticodon region of tRNA, indicating a strong binding affinity.
The residue at position 589 forms a bond with anticodon region of tRNA, indicating a strong binding affinity.
The residue at position 595 to 600 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 595 to 600 forms a bond with anticodon region of tRNA, indicating a strong binding affinity.
The residue at position 609 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 609 forms a bond with anticodon region of tRNA, indicating a strong binding affinity.
The residue at position 615 forms a bond with operator of mRNA, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 87 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 390 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 399 to 400 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 381 to 388 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1016 to 1023 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1482 to 1490 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1503 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 to 33 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1398 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1401 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1414 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1417 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1446 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1449 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1468 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1473 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 467 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 572 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 575 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 591 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 596 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 599 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 618 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 621 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 244 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 357 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 452 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 362 to 364 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 378 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 429 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 477 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 169 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 178 to 185 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 98 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1202 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1228 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1251 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 225 forms a bond with a 1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol, indicating a strong binding affinity.
The residue at position 248 forms a bond with a 1,2-diacyl-3-O-(beta-D-galactosyl)-sn-glycerol, indicating a strong binding affinity.
The residue at position 298 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 158 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 201 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 348 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 352 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 393 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 44 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 67 to 72 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 133 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 380 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 393 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 394 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 397 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 410 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 411 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 414 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 417 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 424 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 425 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 428 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 431 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 436 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 438 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 304 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 18 to 24 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 230 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 268 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 268 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 311 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 661 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 669 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 677 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 678 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 1017 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 309 to 310 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 424 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 444 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 458 to 460 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 460 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 152 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 170 to 179 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 485 to 488 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 529 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 589 to 590 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 595 to 599 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 632 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 670 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 35 to 40 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 142 to 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 303 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 885 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 952 to 953 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 955 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1013 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 357 to 364 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 192 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 195 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 207 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 47 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 508 to 514 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 to 229 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 26 to 30 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 62 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 1126 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1135 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 70 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 87 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 174 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 353 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 28 to 30 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 257 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 468 to 470 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 678 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 40 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 41 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 128 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 156 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 792 to 799 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 479 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 602 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 620 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 203 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 262 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 348 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 45 to 50 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 587 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 577 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 370 to 372 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 496 to 500 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 287 to 296 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 274 to 279 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 28 to 34 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 148 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 206 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 267 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 269 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 271 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 314 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 318 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 1005 to 1013 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1082 to 1089 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 to 216 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 259 to 264 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 297 to 303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 609 to 610 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 586 to 590 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 587 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 755 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 785 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 787 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 1219 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1244 to 1251 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 678 to 686 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 252 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 162 to 169 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 188 to 196 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 471 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 472 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 502 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 514 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 521 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 551 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 591 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 592 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 614 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 696 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 697 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 719 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 225 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 240 to 245 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 240 to 245 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 240 to 245 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 285 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 285 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 285 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 307 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 355 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 360 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 381 to 382 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 469 to 472 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 89 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 221 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 50 to 57 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 214 to 218 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 379 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 406 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 414 to 416 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 434 to 436 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 500 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 516 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 522 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 194 to 198 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 379 to 382 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 510 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 556 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 579 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with poly-gamma-D-glutamate, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with poly-gamma-D-glutamate, indicating a strong binding affinity.
The residue at position 520 forms a bond with poly-gamma-D-glutamate, indicating a strong binding affinity.
The residue at position 388 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 520 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 529 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 100 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 112 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 138 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 140 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 165 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 191 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 249 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 283 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 330 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 75 to 103 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 195 to 203 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 118 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 846 to 847 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 876 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 to 110 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 134 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 163 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 196 forms a bond with rifampicin, indicating a strong binding affinity.
The residue at position 213 forms a bond with rifampicin, indicating a strong binding affinity.
The residue at position 49 to 55 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 149 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 60 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 87 to 93 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 115 to 118 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 216 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 468 to 474 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 474 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 603 to 605 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 241 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 243 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 6 to 7 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with cholate, indicating a strong binding affinity.
The residue at position 158 forms a bond with cholate, indicating a strong binding affinity.
The residue at position 451 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 460 to 463 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 598 to 599 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 46 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 97 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 372 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 169 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 310 to 317 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 218 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 180 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 185 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with sphing-4-enine 1-phosphate, indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with sphing-4-enine 1-phosphate, indicating a strong binding affinity.
The residue at position 54 to 62 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 934 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 285 to 292 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 514 to 521 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 874 to 881 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 714 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1106 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1117 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1118 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 702 to 710 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 480 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 513 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 515 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 517 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 192 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 109 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 237 to 241 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 408 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 34 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 65 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 166 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 86 to 115 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 50 to 56 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 58 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 293 to 300 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 383 to 387 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 804 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 835 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 949 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 951 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1047 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1116 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 58 forms a bond with 5-hydroxyisourate, indicating a strong binding affinity.
The residue at position 58 forms a bond with O2, indicating a strong binding affinity.
The residue at position 59 forms a bond with 5-hydroxyisourate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 5-hydroxyisourate, indicating a strong binding affinity.
The residue at position 177 forms a bond with 5-hydroxyisourate, indicating a strong binding affinity.
The residue at position 228 forms a bond with 5-hydroxyisourate, indicating a strong binding affinity.
The residue at position 228 forms a bond with urate, indicating a strong binding affinity.
The residue at position 229 forms a bond with 5-hydroxyisourate, indicating a strong binding affinity.
The residue at position 255 forms a bond with 5-hydroxyisourate, indicating a strong binding affinity.
The residue at position 255 forms a bond with O2, indicating a strong binding affinity.
The residue at position 255 forms a bond with urate, indicating a strong binding affinity.
The residue at position 126 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 334 to 355 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 377 to 396 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 65 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 89 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 571 to 688 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 2225 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2228 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2285 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2288 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2319 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2322 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2334 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2337 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 87 to 92 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 473 to 476 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 537 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 599 to 600 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 606 to 610 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 642 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 680 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 89 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 171 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 461 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 464 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 466 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 494 to 501 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 133 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 421 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 197 to 207 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 802 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 811 to 812 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 493 to 500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 289 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 461 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 143 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 147 to 154 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 180 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 34 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 448 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 20 to 24 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 358 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 363 to 365 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 380 to 388 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 402 to 405 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 163 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 473 to 476 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 496 to 498 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 529 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 370 to 378 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 55 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 109 forms a bond with JQ1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 77 to 82 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 to 297 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 34 to 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 182 to 191 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 26 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 234 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 445 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 470 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 342 to 344 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 488 to 615 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 604 to 731 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 101 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1708 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1710 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1713 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1716 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 212 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 377 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 85 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 411 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 419 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 425 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 426 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 454 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 458 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 464 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 486 to 488 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 529 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 558 to 559 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 561 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 621 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 623 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 628 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 436 to 438 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 22 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 757 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 863 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 866 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 867 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with O2, indicating a strong binding affinity.
The residue at position 171 to 178 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 835 to 842 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 382 to 385 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 7 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 23 to 27 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 504 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 15 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 107 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 179 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 358 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 54 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 58 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 486 to 490 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 227 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 257 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 263 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 268 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 297 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 299 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 304 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 599 to 607 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 449 to 453 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 503 to 506 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 218 to 230 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 121 to 128 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 469 to 470 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 47 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 155 to 159 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 198 to 207 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 462 to 464 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 502 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 147 forms a bond with E64, indicating a strong binding affinity.
The residue at position 227 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 297 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 357 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 362 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 365 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 275 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 349 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 555 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 591 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 592 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 592 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 119 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 359 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 380 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 391 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 to 340 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 512 to 516 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 670 to 674 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 674 to 681 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 411 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 195 to 200 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 140 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 479 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 137 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 170 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 177 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 123 to 132 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 574 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 597 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 706 to 709 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 723 to 727 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 735 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 740 to 742 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 112 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 195 to 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 12 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 476 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 482 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 69 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 94 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 433 to 440 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 479 to 483 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 533 to 536 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1340 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1421 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1422 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1604 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1646 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1679 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 45 to 51 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 191 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 412 to 415 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 607 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 31 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 125 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 140 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 199 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 230 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 231 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 232 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 233 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 233 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 234 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 249 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 264 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 266 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 266 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 270 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 305 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 338 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 341 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 341 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 414 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 414 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 427 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 445 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 446 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 447 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+) 13, indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+) 14, indicating a strong binding affinity.
The residue at position 479 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 481 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 481 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 485 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 522 forms a bond with Ca(2+) 13, indicating a strong binding affinity.
The residue at position 524 forms a bond with Ca(2+) 13, indicating a strong binding affinity.
The residue at position 524 forms a bond with Ca(2+) 14, indicating a strong binding affinity.
The residue at position 537 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 555 forms a bond with Ca(2+) 14, indicating a strong binding affinity.
The residue at position 556 forms a bond with Ca(2+) 14, indicating a strong binding affinity.
The residue at position 557 forms a bond with Ca(2+) 15, indicating a strong binding affinity.
The residue at position 558 forms a bond with Ca(2+) 13, indicating a strong binding affinity.
The residue at position 558 forms a bond with Ca(2+) 14, indicating a strong binding affinity.
The residue at position 559 forms a bond with Ca(2+) 13, indicating a strong binding affinity.
The residue at position 559 forms a bond with Ca(2+) 15, indicating a strong binding affinity.
The residue at position 594 forms a bond with Ca(2+) 15, indicating a strong binding affinity.
The residue at position 596 forms a bond with Ca(2+) 14, indicating a strong binding affinity.
The residue at position 596 forms a bond with Ca(2+) 15, indicating a strong binding affinity.
The residue at position 600 forms a bond with Ca(2+) 15, indicating a strong binding affinity.
The residue at position 646 forms a bond with Ca(2+) 15, indicating a strong binding affinity.
The residue at position 389 to 391 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 391 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 422 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 436 to 444 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 206 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 411 to 418 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1064 to 1071 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 3 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 24 to 25 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 250 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 251 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 307 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 310 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 311 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 75 to 84 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 324 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 160 to 291 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 292 to 405 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 83 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 176 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 291 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 204 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 348 to 353 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 390 to 394 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 425 to 432 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 451 to 452 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1015 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1019 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 152 to 187 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 96 to 102 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 22 to 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 434 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 506 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 407 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 56 to 63 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 409 to 416 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 390 to 391 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 462 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 466 to 470 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 477 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 to 100 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 112 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 141 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 364 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 425 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 265 to 272 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 346 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 413 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 804 to 805 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1086 to 1089 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1201 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1265 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 131 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 202 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 208 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 228 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 234 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 200 to 208 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 165 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 251 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 279 to 283 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 197 to 204 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 905 to 912 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1953 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1970 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2020 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2022 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 115 to 229 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 67 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 67 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 229 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 137 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 512 to 520 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 to 134 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 538 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 546 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 548 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 312 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 234 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 391 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 439 to 440 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 to 449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 68 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 69 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 200 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 201 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 202 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 203 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 209 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 211 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 212 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 213 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 618 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with 1D-myo-inositol 1,4,5-trisphosphate, indicating a strong binding affinity.
The residue at position 493 to 496 forms a bond with 1D-myo-inositol 1,4,5-trisphosphate, indicating a strong binding affinity.
The residue at position 552 to 554 forms a bond with 1D-myo-inositol 1,4,5-trisphosphate, indicating a strong binding affinity.
The residue at position 187 to 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 7 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 10 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 to 298 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 619 to 750 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 746 to 871 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 111 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 52 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 129 to 135 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 191 to 199 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 100 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 334 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 399 to 403 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 400 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 196 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 282 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 284 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 598 to 606 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 148 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 175 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 183 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 186 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 189 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 190 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 243 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 246 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 247 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 187 to 193 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 216 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 299 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 738 to 745 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 52 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 217 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 172 to 177 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1298 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1377 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1380 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1648 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1753 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1756 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 239 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 313 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 393 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 460 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 183 to 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 265 to 269 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 267 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 327 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 329 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 365 to 367 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 388 to 389 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 412 to 416 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 442 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 503 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 184 to 190 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 15 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 59 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 160 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 80 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 110 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 135 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 155 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 205 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 274 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 57 to 62 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 548 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 548 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 550 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 560 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 569 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 577 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 622 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 622 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 624 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 629 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 634 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 636 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 643 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 643 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 649 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 652 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 458 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 500 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 23 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 87 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 144 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 316 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 395 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 420 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 514 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 515 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 516 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 265 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 443 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 454 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 105 to 220 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 304 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 310 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 410 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 50 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 82 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 179 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 219 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 725 to 729 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 500 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 504 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 506 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 540 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 542 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 547 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 572 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 583 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 612 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 617 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 302 to 306 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 344 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 384 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 392 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 394 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 396 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 441 to 445 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 474 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 481 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 485 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 456 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 461 to 464 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 481 to 485 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 560 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 278 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 303 to 308 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 393 to 394 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 434 to 438 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 727 to 734 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 119 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 121 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 123 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1479 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1481 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 358 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 457 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 458 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 33 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 882 to 890 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 107 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 214 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 226 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 284 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 307 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 167 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 206 to 214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 741 to 749 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 673 to 676 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 686 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 341 to 344 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 390 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 555 to 559 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 580 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 584 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 598 to 599 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 226 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 617 to 626 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 33 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 334 to 339 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 380 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 476 to 479 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 766 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 801 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 907 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1040 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1271 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 148 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 229 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 232 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 83 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 152 to 157 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 108 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 122 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 282 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 436 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 440 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 381 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 44 to 52 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 138 to 145 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 107 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 16 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 94 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 122 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 206 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 290 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 210 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 127 to 134 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 430 to 433 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 573 to 582 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 196 to 205 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 307 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 337 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 31 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1251 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 1353 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 1392 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 362 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 788 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 805 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1199 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1216 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1298 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1300 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 280 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 333 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 350 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 354 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 358 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 395 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 397 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 444 to 448 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 477 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 484 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 736 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 740 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 122 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 111 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 310 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 314 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 318 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 155 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 182 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 111 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 164 to 170 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 244 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 68 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 93 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 96 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 109 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 110 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 113 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 116 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 126 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 127 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 130 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 133 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 142 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 144 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 413 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 517 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 520 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 534 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 539 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 to 142 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 635 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 636 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 636 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 761 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 151 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 479 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 603 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 457 to 465 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 172 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 229 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 253 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 310 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 335 to 340 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 457 to 458 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 270 to 388 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1168 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1174 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1230 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1232 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1594 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1600 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1649 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1651 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1914 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1917 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1920 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 82 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 87 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 132 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 138 to 146 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 231 to 239 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 275 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 31 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 32 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 69 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 71 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 73 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 118 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 144 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 149 forms a bond with 3-(methylsulfanyl)acryloyl-CoA, indicating a strong binding affinity.
The residue at position 83 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 86 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 31 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 36 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 36 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 44 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 44 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 96 to 102 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 129 to 138 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1328 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1330 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1332 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 68 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 256 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 356 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 418 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 431 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 451 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 465 to 467 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 467 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 394 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 815 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 819 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 819 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 228 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 482 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 470 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 435 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 546 to 553 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with protoporphyrin IX, indicating a strong binding affinity.
The residue at position 296 forms a bond with protoporphyrin IX, indicating a strong binding affinity.
The residue at position 255 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 343 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 379 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 451 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 910 to 917 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 5 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 11 to 12 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 74 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 64 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 119 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 167 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 176 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 289 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 318 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 322 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 305 to 309 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 439 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 512 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 761 to 768 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 to 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 94 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 97 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 548 to 555 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 598 to 602 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 652 to 655 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 196 to 201 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 300 to 303 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 489 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 489 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 495 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 502 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 530 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 536 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 540 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 561 to 563 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 635 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 638 to 639 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 641 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 692 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 694 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 699 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 176 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 224 to 231 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 368 to 371 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 to 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 729 to 786 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 854 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 871 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 873 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 964 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1061 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1061 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1083 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1084 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1085 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1086 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 201 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 419 to 428 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 455 to 458 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 517 to 518 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 472 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 324 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 371 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 421 to 422 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 26 to 30 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 to 172 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 440 to 442 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 76 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 81 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 344 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 416 to 417 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 450 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 544 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 546 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 659 to 666 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 205 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 206 to 214 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 56 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 218 to 223 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 272 to 282 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 272 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 109 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 94 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 102 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 106 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 174 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 8 to 22 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 202 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 209 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 140 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 226 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 275 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 206 to 216 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 14 to 21 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 103 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 169 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 290 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 454 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 377 to 382 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 to 16 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 47 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 81 to 87 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 266 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 270 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 286 to 292 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 213 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 43 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 102 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 221 to 225 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 479 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 482 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 497 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 505 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 588 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 591 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 596 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 644 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 665 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 335 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 409 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 411 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 416 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 529 to 534 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 forms a bond with heme, indicating a strong binding affinity.
The residue at position 80 forms a bond with heme, indicating a strong binding affinity.
The residue at position 257 forms a bond with heme, indicating a strong binding affinity.
The residue at position 259 forms a bond with heme, indicating a strong binding affinity.
The residue at position 317 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 94 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 123 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 147 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 138 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 327 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 599 to 601 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 469 to 473 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 492 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 514 to 516 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 719 to 721 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 87 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 117 to 122 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 144 to 150 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 166 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 833 to 841 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 861 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 287 to 291 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 305 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 311 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 358 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 398 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 101 to 107 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1060 to 1068 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1083 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 86 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 460 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 680 to 681 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 126 to 135 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 185 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 28 to 31 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 43 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 672 to 679 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 718 to 722 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 772 to 775 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 53 to 57 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 371 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 388 to 389 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 50 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 22 forms a bond with pyridoxal, indicating a strong binding affinity.
The residue at position 57 forms a bond with pyridoxal, indicating a strong binding affinity.
The residue at position 57 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 771 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 918 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 919 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 920 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 993 to 1000 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 140 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 154 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 311 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 374 to 382 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 390 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 404 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 477 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 333 to 338 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 445 to 446 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 133 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 205 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 45 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 330 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 333 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 334 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 374 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 429 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 434 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 437 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 461 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 464 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 695 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 698 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 710 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 713 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 740 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 743 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 838 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 841 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 853 forms a bond with Zn(2+) 9, indicating a strong binding affinity.
The residue at position 856 forms a bond with Zn(2+) 9, indicating a strong binding affinity.
The residue at position 861 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 864 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 882 forms a bond with Zn(2+) 9, indicating a strong binding affinity.
The residue at position 885 forms a bond with Zn(2+) 9, indicating a strong binding affinity.
The residue at position 24 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 481 to 482 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 29 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 31 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 437 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 438 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 439 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 134 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 195 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 385 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 387 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 472 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 476 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with melatonin, indicating a strong binding affinity.
The residue at position 358 to 363 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 217 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 220 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 243 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 90 to 99 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 114 to 119 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 493 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 309 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 176 to 181 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 393 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 481 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 482 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 78 to 83 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 522 to 524 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 47 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 628 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1082 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1085 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 99 to 106 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 19 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1053 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1085 to 1091 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 77 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 101 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 1975 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1979 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1979 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1999 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2001 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2002 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2008 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2008 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2009 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2009 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2022 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2023 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with kanamycin A, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 272 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 318 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 405 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 41 to 46 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 413 to 420 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 459 to 463 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 219 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 355 to 360 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 306 to 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 71 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 151 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 178 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 196 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 471 to 475 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 525 to 528 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 105 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 173 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 332 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 372 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 378 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 391 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 394 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 429 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 441 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 448 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 451 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 452 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 455 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 475 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 478 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 479 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 492 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 497 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 500 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 501 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 508 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 529 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 575 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 591 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 592 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 676 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 47 to 51 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 386 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 391 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 423 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 426 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 441 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 444 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 449 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 474 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 196 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 614 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 632 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 637 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 123 to 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 612 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 615 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 616 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 216 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 281 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 281 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 165 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1181 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1183 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1184 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1186 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 634 to 641 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1289 to 1296 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 194 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 91 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 311 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 269 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 271 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 360 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 319 to 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 404 to 409 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 460 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 616 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 627 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 767 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 770 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 873 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 943 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 946 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 17 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 51 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 55 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 61 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 593 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 778 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 782 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 932 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 583 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 586 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 91 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 367 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 373 to 374 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 392 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 167 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 176 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 337 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 262 forms a bond with O2, indicating a strong binding affinity.
The residue at position 394 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 396 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 382 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 78 to 85 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 252 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 182 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 73 to 80 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with (9Z)-octadecenoate 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with (9Z)-octadecenoate 2, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with (9Z)-octadecenoate 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with (9Z)-octadecenoate 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 232 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 253 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 385 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 820 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1492 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1499 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1502 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1508 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 46 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 83 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 137 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 342 forms a bond with heme, indicating a strong binding affinity.
The residue at position 167 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 260 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 2 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 652 to 653 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 660 to 662 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 567 forms a bond with heme, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1069 to 1077 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1092 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 71 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 104 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 243 to 248 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 247 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 23 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 86 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 403 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 463 to 464 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 262 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 152 to 156 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 273 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 278 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 265 to 267 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 22 to 27 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 259 to 262 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 281 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 182 to 188 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 215 to 220 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 174 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 436 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 439 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 441 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 494 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 496 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 123 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 150 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 380 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 130 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 to 252 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 260 to 265 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 365 to 372 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 9 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 202 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 270 to 275 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 914 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 103 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 218 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 225 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 147 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 12 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 18 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 57 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 542 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 547 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 733 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 886 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 84 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 557 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 749 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 753 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 400 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 428 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 473 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 81 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 371 to 375 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1020 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1033 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1044 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1050 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1065 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1075 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1089 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1092 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1103 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1104 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1107 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1122 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1123 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1126 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1129 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1137 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1139 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 142 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 160 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 180 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 183 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 395 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 399 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 613 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 630 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 646 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 651 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 121 to 126 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 210 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 300 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 304 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 6 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 333 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 337 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 473 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 476 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 131 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 324 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 404 to 408 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 432 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 492 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 314 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 164 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 184 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 338 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 336 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 350 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 354 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 347 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 411 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 415 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 457 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 617 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 628 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 672 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 678 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 166 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 168 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 170 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 187 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 188 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 218 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 386 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 556 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 583 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 56 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 226 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 234 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 320 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 508 to 516 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 344 to 345 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 396 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 258 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 464 to 467 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 to 289 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 578 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 580 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 685 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 713 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 716 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 202 to 208 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 242 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 261 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 72 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 150 to 155 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 206 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 585 to 593 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 371 to 379 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 393 to 396 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 617 to 623 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 forms a bond with E64, indicating a strong binding affinity.
The residue at position 659 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 339 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 342 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 352 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 371 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 171 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 179 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 324 to 331 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 370 to 374 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 66 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 125 to 133 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 157 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 185 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 738 to 742 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 762 to 766 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1051 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1123 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1131 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1134 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1313 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 416 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 420 forms a bond with gamma-L-glutamyl-L-cysteine, indicating a strong binding affinity.
The residue at position 323 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 251 to 258 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 351 to 354 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 193 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 589 to 597 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 312 to 317 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 330 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 51 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 90 to 98 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 94 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 94 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 137 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 137 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 243 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 258 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 376 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 391 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 394 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 399 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 406 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 447 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 450 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 465 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 468 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 257 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 317 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 317 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 317 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 338 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 339 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 387 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 392 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 413 to 414 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 501 to 504 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 1164 to 1166 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 1219 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1244 to 1247 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1261 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1295 to 1299 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1325 to 1328 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 133 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 178 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 643 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 658 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 663 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 668 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 378 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 445 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 220 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 158 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 240 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 317 to 323 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 329 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 378 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 191 to 195 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 137 to 254 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 255 to 381 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 128 to 136 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 17 to 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 503 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 506 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 596 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 621 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 624 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 663 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 666 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 681 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 683 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 688 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 691 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 704 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 712 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 697 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 557 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 479 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1383 to 1390 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1132 to 1189 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1185 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1191 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1196 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1928 to 1942 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 411 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 426 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 445 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 468 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 479 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 1121 to 1123 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1152 to 1154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1152 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1237 to 1240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1242 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1453 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1495 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1497 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 249 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 252 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 329 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 50 to 55 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 330 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 541 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 642 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 642 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 648 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 694 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 694 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 696 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 696 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 702 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 420 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 451 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 444 to 446 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 237 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 to 386 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 490 to 493 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 506 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 510 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 53 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 131 to 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 477 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 485 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 269 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 125 to 130 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 244 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 313 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 409 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 414 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 454 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 323 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 414 to 416 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 431 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 440 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 148 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 458 to 465 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 508 to 512 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 562 to 565 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 164 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 200 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 398 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 422 to 425 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 75 to 105 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 242 to 278 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 543 to 551 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1278 to 1285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 363 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 595 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 338 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 529 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 668 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 220 to 228 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 291 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 631 to 638 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1273 to 1280 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 455 to 456 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 59 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 66 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 71 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 to 159 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 368 to 372 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 489 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 643 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 803 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 431 to 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 217 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 302 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 595 to 599 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 649 to 652 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 273 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 25 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 177 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 206 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 83 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 272 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 340 to 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 143 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 24 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 510 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 785 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 378 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 381 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 395 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 398 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 408 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 409 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 412 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 415 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 423 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 426 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 135 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 148 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 34 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 44 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 439 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 464 to 467 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 575 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 577 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 116 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 136 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 205 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 209 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 324 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 164 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 185 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 214 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 221 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 223 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 238 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 241 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 242 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 243 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 246 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 261 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 70 forms a bond with (2R,3S)-catechin, indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 521 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 524 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 207 to 242 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 355 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 355 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 357 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 136 to 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 361 to 367 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 499 to 501 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 675 to 676 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 62 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 501 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 45 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 152 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 802 to 803 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1084 to 1087 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 366 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 436 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 575 to 578 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 726 to 727 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 394 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 422 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 447 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 481 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 483 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 810 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 813 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 291 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 588 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 339 to 341 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 386 to 390 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 414 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 97 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 171 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 315 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 319 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 573 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 158 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 168 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 185 to 188 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 716 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 6 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 217 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 256 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 312 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 71 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 76 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 245 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 276 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 378 to 379 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 526 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 186 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 384 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 675 to 683 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 134 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 54 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 412 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 433 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 447 to 449 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 147 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 234 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 873 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 211 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 260 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 60 to 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 172 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 231 to 238 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 332 to 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 403 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 622 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 622 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 626 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 626 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 390 to 406 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 502 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 175 to 180 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 558 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 745 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 770 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 314 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 934 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 937 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 327 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 468 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 471 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 530 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 532 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 908 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 982 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 989 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 117 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 324 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 1 to 4 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 4 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 129 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 31 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 461 to 464 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 591 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 591 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 595 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 735 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 739 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 743 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 181 to 187 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 72 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 585 to 700 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 491 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 997 to 999 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1004 to 1008 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1044 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 264 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 861 to 868 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 332 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1272 to 1280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1016 to 1021 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 308 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 408 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 802 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 123 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 491 to 616 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 617 to 758 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 493 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 534 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 255 to 265 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 146 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 103 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 385 to 389 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 404 to 413 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 414 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 238 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 431 to 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 503 to 509 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 15 to 20 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 55 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 88 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 470 to 478 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 173 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 377 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 25 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 194 to 198 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 109 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 233 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 234 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 257 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 260 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 317 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 442 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 13 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 273 to 277 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 145 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 237 to 244 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 640 to 647 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 408 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 155 to 159 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 462 to 466 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 2 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 2 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 20 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 21 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 21 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 23 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 24 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 24 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 28 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 31 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 37 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 45 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 47 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 48 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 48 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 730 to 732 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 743 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 793 to 800 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 817 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 900 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 forms a bond with E7820, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with E7820, indicating a strong binding affinity.
The residue at position 682 to 687 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 525 to 527 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 532 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 698 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 742 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 224 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 506 to 514 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 295 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 297 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 302 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 336 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 338 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 152 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 293 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 100 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 163 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 257 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 260 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 331 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 335 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 336 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 221 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 forms a bond with substrate 1, indicating a strong binding affinity.
The residue at position 289 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 293 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 408 to 411 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 435 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 381 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 383 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 389 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 710 to 713 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 6 to 9 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 74 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 79 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 130 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 42 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 42 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 217 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 219 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 220 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 249 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 423 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 458 to 460 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 428 to 432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 851 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 854 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 875 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 878 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with a ribonucleoside 3'-phosphate, indicating a strong binding affinity.
The residue at position 561 to 567 forms a bond with a ribonucleoside 3'-phosphate, indicating a strong binding affinity.
The residue at position 676 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 678 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 708 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 708 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 740 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 872 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 895 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 897 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 1047 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 1127 to 1133 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 19 to 52 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 261 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 111 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 114 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 155 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 156 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 219 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 514 to 515 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 575 to 581 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 90 to 97 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe of heme d1, indicating a strong binding affinity.
The residue at position 167 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 169 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 182 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 182 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 207 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 208 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 341 forms a bond with Fe of heme d1, indicating a strong binding affinity.
The residue at position 390 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 435 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 92 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 63 to 72 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 330 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 339 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 82 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 128 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 767 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 798 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 907 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 319 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 325 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 427 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 108 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 132 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 683 to 686 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 689 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 542 to 544 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 549 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 715 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 759 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 316 to 322 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 387 to 390 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 9 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 496 to 599 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 610 to 715 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 7 to 21 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1789 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1792 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1803 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1806 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1835 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1838 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1851 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1856 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 9 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 11 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 160 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 217 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 92 to 98 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 29 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 157 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 669 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 385 to 390 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 36 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 265 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 462 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 493 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 260 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 909 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 912 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 923 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 926 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1015 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1018 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1029 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1032 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1074 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1077 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1088 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1091 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 404 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 407 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 204 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 306 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 341 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 194 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 230 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 399 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 319 to 321 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1319 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1352 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1357 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1375 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 493 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 204 forms a bond with heme, indicating a strong binding affinity.
The residue at position 262 forms a bond with heme, indicating a strong binding affinity.
The residue at position 287 forms a bond with heme, indicating a strong binding affinity.
The residue at position 289 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 323 forms a bond with heme, indicating a strong binding affinity.
The residue at position 245 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 245 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 247 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 249 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 249 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 253 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 256 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 283 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 415 to 416 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 498 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 522 to 523 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 181 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 184 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 193 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 220 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 224 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 384 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 421 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 429 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1435 to 1437 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1447 to 1448 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1494 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1499 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1503 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1708 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1711 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1721 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1724 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1730 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1733 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1739 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1741 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 225 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 821 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 853 to 859 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 897 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 132 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 117 to 124 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 335 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 304 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 333 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 396 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 404 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 165 to 174 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 456 to 459 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 474 to 476 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 480 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 495 to 498 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 577 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 648 to 649 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 659 to 663 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 117 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 296 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 320 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 322 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 412 to 424 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 450 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 191 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 237 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 680 to 687 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 349 to 352 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 to 225 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 239 to 245 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 438 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 1163 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1166 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1182 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1185 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 334 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 815 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 840 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 845 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 137 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 141 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 143 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 144 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 408 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 561 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 793 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 518 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 518 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 520 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1280 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1283 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1307 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1312 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1345 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1350 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1368 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1371 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1358 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1361 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1374 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1377 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1382 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1385 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1402 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1405 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 44 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 16 to 20 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 52 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 603 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 606 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 620 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 623 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 643 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 656 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 764 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 764 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 764 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 770 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 770 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 770 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 811 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 811 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 811 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 939 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 939 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 939 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 372 to 387 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 399 to 431 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 275 to 279 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 75 forms a bond with phycourobilin 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with phycourobilin 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with phycourobilin 3, indicating a strong binding affinity.
The residue at position 253 to 259 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 to 219 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 574 to 580 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 135 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 151 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 113 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 312 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 388 to 392 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 407 to 416 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 417 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 36 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 14 to 15 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 192 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 192 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 391 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 21 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 27 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 62 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 358 to 361 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 410 to 413 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 86 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 167 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 170 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 466 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 398 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 507 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 521 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 99 to 103 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 171 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 198 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 387 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 213 to 217 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 287 to 292 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 403 to 405 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 405 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 436 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 349 to 355 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 362 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 401 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 13 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 102 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 155 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 196 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 240 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 269 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 55 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 162 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 162 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 173 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 179 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 216 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 243 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 252 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 259 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 188 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 218 to 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 274 to 284 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 265 to 279 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 362 to 368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 571 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1061 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1065 to 1066 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1083 to 1084 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1105 to 1106 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1106 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1492 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1494 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 251 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 915 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 790 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 792 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 53 to 62 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 73 to 77 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 99 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 118 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 42 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 257 forms a bond with beta-D-fructose, indicating a strong binding affinity.
The residue at position 371 to 378 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 23 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 210 to 215 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 347 to 350 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 719 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 763 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 812 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 964 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1085 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 330 to 337 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 377 to 381 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 431 to 434 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1 to 3 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 3 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 11 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 96 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 160 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 206 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 720 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 722 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 723 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 59 to 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 194 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 218 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 267 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 229 to 239 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 166 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 229 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 232 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 307 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 308 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 163 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 382 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 384 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 395 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 513 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 536 to 539 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 549 to 550 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 270 to 273 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 834 to 840 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 895 to 897 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 922 to 930 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 991 to 993 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1133 to 1134 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1138 to 1139 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 683 to 691 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 709 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 to 60 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 to 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 717 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 723 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 757 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 761 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 761 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 981 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 983 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 1058 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 1061 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 338 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 349 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 350 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 120 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 262 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 86 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 116 to 121 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 143 to 149 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 171 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 171 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 173 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 212 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 222 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 445 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 465 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 479 to 481 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 61 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 206 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 201 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 209 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 295 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 46 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 242 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 272 to 278 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 71 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 488 to 493 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 498 to 500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 750 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 883 to 887 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 883 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 39 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 to 172 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 345 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 491 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 509 to 513 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 521 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 551 to 553 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 216 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 222 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 1 to 6 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 46 to 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 959 to 967 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 983 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 166 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 250 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 274 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 275 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 26 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 to 188 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 423 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 205 to 210 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 392 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 395 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 396 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 438 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 442 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 509 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 543 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 302 to 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ni of coenzyme F430, indicating a strong binding affinity.
The residue at position 239 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 284 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 346 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 464 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 49 to 51 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 3 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 7 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 15 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 15 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 23 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 26 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 32 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 64 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 81 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 105 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 112 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 9 to 13 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 388 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 429 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 442 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 477 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 478 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 549 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 556 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 227 to 231 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 403 to 406 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 410 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 256 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 to 189 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 93 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 224 to 228 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 1 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 2 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 6 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 11 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 92 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 286 to 292 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 290 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 114 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 556 to 558 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 183 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 375 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 516 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 153 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 88 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 138 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 303 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 305 to 310 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 323 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 422 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 812 to 822 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 815 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1146 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1148 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1226 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1331 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1334 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1358 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1361 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 329 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 499 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 717 to 774 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 858 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 858 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 860 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 117 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 179 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 286 to 293 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 369 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 398 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 510 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 630 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 592 to 600 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 386 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 203 to 206 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 138 forms a bond with (R)-acetoin, indicating a strong binding affinity.
The residue at position 138 forms a bond with (S)-acetoin, indicating a strong binding affinity.
The residue at position 140 forms a bond with (R)-acetoin, indicating a strong binding affinity.
The residue at position 151 forms a bond with (R)-acetoin, indicating a strong binding affinity.
The residue at position 151 forms a bond with (S)-acetoin, indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 189 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 136 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 296 to 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 107 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 150 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 120 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 137 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 144 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 327 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 303 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 444 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 567 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 188 forms a bond with alpha-L-fucose 4, indicating a strong binding affinity.
The residue at position 197 forms a bond with alpha-L-fucose 3, indicating a strong binding affinity.
The residue at position 229 forms a bond with alpha-L-fucose 5, indicating a strong binding affinity.
The residue at position 241 forms a bond with alpha-L-fucose 5, indicating a strong binding affinity.
The residue at position 281 forms a bond with alpha-L-fucose 6, indicating a strong binding affinity.
The residue at position 295 forms a bond with alpha-L-fucose 6, indicating a strong binding affinity.
The residue at position 65 to 70 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 97 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 165 to 170 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 350 to 470 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with CO, indicating a strong binding affinity.
The residue at position 243 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 271 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 310 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 405 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 415 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 450 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 454 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 512 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 541 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 576 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 219 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 51 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 689 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 723 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 754 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 796 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 19 to 29 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 644 to 648 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 653 to 659 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 683 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 417 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 489 to 496 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 328 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with (2S,3S)-3-methyl-L-aspartate, indicating a strong binding affinity.
The residue at position 249 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 146 to 152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 213 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 330 to 334 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 736 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 251 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 53 to 57 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 109 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 532 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 88 to 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 543 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 545 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 550 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 581 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 583 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 585 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 590 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 55 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 65 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 363 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 101 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 273 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 275 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 442 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 446 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 56 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 59 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 656 to 664 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 310 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 343 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 415 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 538 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 538 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 139 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 to 121 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 296 to 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 431 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 433 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 592 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 443 to 444 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 124 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 164 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 255 to 256 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 650 to 657 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1269 to 1276 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 430 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 430 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 277 to 284 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 442 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 788 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 819 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 901 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 933 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 935 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1031 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1100 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 574 to 576 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 581 to 587 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 612 to 615 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 109 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with folate, indicating a strong binding affinity.
The residue at position 99 forms a bond with folate, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with folate, indicating a strong binding affinity.
The residue at position 149 to 154 forms a bond with folate, indicating a strong binding affinity.
The residue at position 188 forms a bond with folate, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 118 to 123 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 150 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 229 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 392 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 462 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 492 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 525 to 527 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 550 to 551 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 268 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 697 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 744 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 869 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 43 forms a bond with N-eicosanoyl ethanolamine, indicating a strong binding affinity.
The residue at position 109 forms a bond with N-eicosanoyl ethanolamine, indicating a strong binding affinity.
The residue at position 156 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 290 to 296 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 130 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 142 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 58 to 64 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 332 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 336 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1012 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1019 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1019 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 308 to 313 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 399 to 400 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 399 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 401 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 518 to 524 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 518 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 323 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 439 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 440 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 374 to 380 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 556 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 440 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 560 to 677 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 625 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 19 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 274 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 516 to 518 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1197 to 1199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1204 to 1208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 503 to 513 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 537 to 539 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 539 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 628 to 631 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 656 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 726 to 730 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 726 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 754 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 755 to 757 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 757 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 158 to 193 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 143 to 258 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 261 to 375 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 328 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 337 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 111 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 459 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 488 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 495 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 499 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 504 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 505 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 581 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 582 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 617 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 140 to 147 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 214 to 218 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1245 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1250 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1263 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1268 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1273 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1286 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1290 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1298 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1316 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1320 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1328 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1333 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1346 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1352 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 31 to 34 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 79 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 117 to 121 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 347 to 354 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 81 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 97 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 107 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 126 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 133 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 196 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 198 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 198 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 301 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 255 to 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1071 to 1078 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 322 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 443 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 555 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 96 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 133 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 166 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 118 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 527 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 532 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 506 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 508 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 510 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 512 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 191 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 191 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 218 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 218 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 283 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 283 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 48 to 51 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 89 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 93 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 99 forms a bond with a CDP-1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 233 to 238 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 511 to 516 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 529 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 544 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 554 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 575 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 226 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 238 to 242 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 374 to 376 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 406 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 373 to 377 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 927 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 930 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 933 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 935 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 145 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 334 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 405 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 461 to 462 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 470 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 97 to 104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 376 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 197 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 200 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 207 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 231 to 238 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 139 to 146 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 539 to 546 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 342 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1104 to 1111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 to 188 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 509 to 512 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 259 to 267 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 285 to 290 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 399 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 399 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 443 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 443 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1185 to 1187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1192 to 1196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 144 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 177 to 180 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 244 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 258 to 262 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 265 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 352 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 875 to 882 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 81 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 90 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 282 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 56 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 144 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 230 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 532 to 540 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 242 to 247 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 to 267 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 354 to 357 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 374 to 376 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 471 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 449 to 452 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 307 to 314 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 978 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 981 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1002 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 234 to 240 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 303 to 309 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 368 to 374 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 49 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 371 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 375 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 398 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 406 to 408 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 492 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 508 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 514 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 207 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 236 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 240 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 61 to 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 232 to 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 299 to 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 344 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 521 to 522 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 840 to 847 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 888 to 892 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 946 to 949 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 15 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 193 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 403 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 427 to 430 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 42 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 201 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 156 to 159 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 138 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 363 to 369 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 448 to 449 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 244 to 250 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 381 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 518 to 523 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 701 to 708 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 140 to 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 128 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 153 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 357 to 360 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 189 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 169 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 252 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 269 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 607 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 606 to 613 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 75 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 75 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 326 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 339 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 829 to 838 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 961 to 969 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 73 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 460 to 462 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 460 to 462 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 513 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 513 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 590 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 628 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 628 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 634 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 755 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 459 to 466 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 569 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 592 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 715 to 718 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 732 to 736 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 744 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 749 to 751 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 194 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 334 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 598 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 47 to 79 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 35 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 42 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 46 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 48 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 63 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 64 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 143 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 161 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 587 to 588 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 527 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 595 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 397 to 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 to 269 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 287 to 292 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 374 to 376 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 417 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 53 to 61 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 480 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 483 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 569 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 571 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 72 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 96 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 106 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 294 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 338 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 435 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 344 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 233 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 47 to 52 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 226 to 231 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 306 to 310 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 369 to 372 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 419 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 1155 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1161 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1217 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1219 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1569 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1575 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1624 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1626 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1891 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1894 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1897 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 208 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 302 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 1445 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1448 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1464 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1476 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1488 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 378 to 379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 381 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 471 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 12 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 389 to 391 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 578 to 585 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 53 to 79 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 930 to 932 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 936 to 939 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 980 to 985 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 998 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 950 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 725 to 733 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 4 to 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 229 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 38 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 65 to 70 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 131 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 58 to 63 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 102 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 331 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 392 to 400 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 396 to 400 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 301 to 306 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 803 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 to 295 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 301 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 320 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 494 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 529 to 531 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 267 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 330 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 337 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 340 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 341 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 356 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 372 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 448 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 324 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 362 to 366 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 402 to 408 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 414 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 467 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 468 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 794 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 794 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 796 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 441 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 167 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 85 to 92 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 145 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 439 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 22 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 240 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 274 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 388 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 124 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 377 to 385 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 445 to 451 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 245 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 248 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 216 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 378 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 1049 to 1101 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1102 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1108 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1113 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 28 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 368 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 139 to 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 42 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 72 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 80 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 41 forms a bond with O2, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 87 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 474 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 270 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 261 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 281 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 338 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 267 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 692 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 700 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 708 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 655 to 662 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 19 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 714 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1113 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1144 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 41 to 51 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 62 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 69 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 85 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 27 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 27 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 103 to 111 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 844 to 851 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 356 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 190 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 271 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 67 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 91 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 165 to 173 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 311 to 328 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 378 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 235 to 253 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 28 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 33 to 37 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1041 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 384 to 386 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 20 to 23 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 503 to 514 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 to 30 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 122 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 166 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 185 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 211 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 328 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 329 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 338 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 340 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 16 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 488 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 405 to 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 147 to 149 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 166 to 172 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 to 386 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 213 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 234 to 235 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 42 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 179 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 372 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 168 to 173 forms a bond with phenylglyoxylate, indicating a strong binding affinity.
The residue at position 577 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 577 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 581 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 729 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 51 to 57 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 205 to 213 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 686 to 694 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 443 to 445 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 443 to 445 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 496 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 496 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 527 to 528 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 573 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 611 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 611 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 617 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 364 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 743 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1113 to 1121 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 100 to 108 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 270 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 339 to 341 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 493 to 495 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 381 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 569 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 440 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 465 to 468 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 549 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 570 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 753 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 777 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 968 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 969 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 471 to 473 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 507 to 513 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 534 to 541 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 524 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 177 to 186 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 302 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 476 to 478 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 597 to 598 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 603 to 607 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 640 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 678 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 87 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 161 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 185 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 531 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 577 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 579 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 579 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 585 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 397 to 400 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 530 to 531 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 536 to 540 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 572 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 610 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 103 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 50 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 253 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 259 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 241 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 364 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 365 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 429 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 439 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 133 to 140 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 133 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 138 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 593 to 600 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 573 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 739 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 784 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 342 to 346 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 421 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 440 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 667 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 780 to 787 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1627 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1630 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1633 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 90 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 101 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 102 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 105 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 108 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 118 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 119 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 122 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 125 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 134 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 136 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 179 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 185 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 286 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 136 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 113 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 174 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 713 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 325 to 332 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with adenine group of DNA, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with 8-oxoguanine group of DNA, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with 8-oxoguanine group of DNA, indicating a strong binding affinity.
The residue at position 129 forms a bond with adenine group of DNA, indicating a strong binding affinity.
The residue at position 313 forms a bond with 8-oxoguanine group of DNA, indicating a strong binding affinity.
The residue at position 130 to 261 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 262 to 383 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 329 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 591 to 593 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 624 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 626 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 676 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 679 to 680 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 745 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 396 to 517 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 266 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 294 to 300 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 319 to 323 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 388 to 391 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 444 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 514 to 638 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 585 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1014 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 280 to 285 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 143 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 132 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with N-acetyl-alpha-D-glucosamine 1-phosphate, indicating a strong binding affinity.
The residue at position 74 to 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 437 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 16 to 25 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 343 to 351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 495 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 287 to 288 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 422 to 424 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with dopamine, indicating a strong binding affinity.
The residue at position 140 forms a bond with (4-hydroxyphenyl)acetaldehyde, indicating a strong binding affinity.
The residue at position 1420 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1442 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 196 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 300 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 491 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 211 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 217 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 26 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 240 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 275 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 414 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 471 to 477 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 538 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 145 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 249 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 253 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 254 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 249 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 958 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 960 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1038 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1143 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1146 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1170 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1173 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 396 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 276 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 537 to 544 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1171 to 1178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 6 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 to 178 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1344 to 1351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 69 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 151 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 204 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 276 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 854 to 862 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 876 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 287 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 291 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 295 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 174 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 186 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 189 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 217 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 306 to 311 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 377 to 379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 33 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 62 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 64 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 117 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 233 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 239 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 106 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 38 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 113 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 130 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 56 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 99 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 138 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 535 to 540 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 96 to 99 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 228 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 255 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 265 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 304 to 306 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 627 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 55 to 61 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 167 to 171 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 320 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 337 to 340 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 407 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 131 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 185 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 425 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 437 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 581 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 582 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 583 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 583 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 669 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 670 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 713 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 253 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 283 to 289 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 310 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 315 to 320 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 522 to 525 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 433 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 568 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 to 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 362 to 366 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 474 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 477 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 485 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 124 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 711 to 712 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 467 to 474 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 314 to 328 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 151 to 159 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 76 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 404 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 451 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 458 to 459 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 247 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 279 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 385 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 211 to 215 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 304 to 337 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 251 to 257 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 486 to 493 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 536 to 540 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 590 to 593 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 264 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 70 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 225 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 296 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 361 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 549 to 553 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 603 to 606 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 330 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 to 267 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 374 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 78 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 88 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 248 to 254 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 460 to 461 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 592 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 106 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 120 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 130 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 7 to 31 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 90 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 538 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 463 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 28 to 29 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 535 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 684 to 741 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 808 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 820 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 822 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 797 to 805 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 947 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 11 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 43 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 195 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 30 to 36 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 31 to 34 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 316 to 322 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 389 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 7 to 11 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 796 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1336 to 1343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 to 211 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 54 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 145 to 272 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 458 to 563 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 591 to 696 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 148 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 310 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 313 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 319 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 341 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 248 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 to 253 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 33 to 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 to 100 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 164 to 176 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 288 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 428 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 23 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 241 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 455 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 381 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 104 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 272 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 279 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 282 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 296 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 447 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 452 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1458 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1476 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1500 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1515 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1518 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1540 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1555 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1558 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 117 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 134 to 140 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 149 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 172 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 349 to 354 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 137 to 150 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 to 275 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 404 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 405 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 420 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 514 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 263 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 563 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 610 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 93 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 148 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 153 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 158 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 48 to 53 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 624 to 628 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 678 to 681 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 792 to 793 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 857 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 281 to 286 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 478 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 310 to 315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 923 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1000 to 1002 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1007 to 1011 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 665 to 672 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 40 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 124 to 131 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 252 to 257 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 249 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 337 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 373 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 445 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 473 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 209 to 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 750 to 756 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 811 to 813 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 838 to 846 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 906 to 908 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1048 to 1049 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1053 to 1054 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 123 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 125 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 83 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 171 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 212 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 215 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 218 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 321 to 326 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 650 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 654 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 720 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 728 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 261 to 267 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 293 to 296 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 64 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 405 to 409 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 123 to 129 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 293 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 848 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 859 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 868 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 872 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 238 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 19 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 502 to 504 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 241 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 198 to 203 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 28 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 119 forms a bond with 8-oxo-dGTP, indicating a strong binding affinity.
The residue at position 245 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 275 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 299 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 319 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 289 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 669 to 793 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 830 to 950 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 104 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 204 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 215 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 279 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 297 forms a bond with angiotensin II, indicating a strong binding affinity.
The residue at position 640 to 648 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 170 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 191 to 195 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 168 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 344 to 345 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 476 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 480 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 273 to 277 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 121 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 108 to 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 114 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 576 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 579 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 604 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 612 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 707 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 753 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 285 to 289 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 499 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 503 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 326 to 333 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 465 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 468 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 527 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 529 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 501 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 262 to 268 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 188 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 218 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 341 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 345 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 375 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 38 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 311 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 231 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 117 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 137 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 203 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 207 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 322 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 168 to 177 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 401 to 404 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 419 to 421 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 425 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 434 to 437 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 534 to 535 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 540 to 544 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 614 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 308 to 314 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 804 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with GTP 4, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with GTP 5, indicating a strong binding affinity.
The residue at position 387 to 388 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 505 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 563 to 567 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 601 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 608 to 610 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 690 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 696 to 699 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 771 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 9 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 286 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 309 to 314 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 424 to 426 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 426 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 457 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 407 to 409 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 422 to 425 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 522 to 523 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 528 to 532 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 564 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 602 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 74 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 82 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 498 to 509 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 514 to 519 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 561 to 564 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 604 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 47 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 313 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 390 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 614 to 616 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 615 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 664 to 669 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 700 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 720 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 189 to 242 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 33 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 487 to 489 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 408 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 462 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 255 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 386 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 525 to 526 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 923 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 926 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 929 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 931 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 138 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 241 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 227 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 418 to 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 616 to 624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 forms a bond with 11-cis-retinal, indicating a strong binding affinity.
The residue at position 201 forms a bond with 11-cis-retinal, indicating a strong binding affinity.
The residue at position 516 to 523 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 563 to 567 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 617 to 620 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 979 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 986 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 974 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 973 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 975 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 979 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 979 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 985 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1030 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1030 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1036 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1041 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1062 to 1064 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1098 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1100 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1231 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1234 to 1235 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1237 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1290 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1292 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1297 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 260 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 319 to 321 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 336 to 344 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 358 to 361 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with tyramine, indicating a strong binding affinity.
The residue at position 293 to 314 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 336 to 355 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 577 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 600 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 143 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 229 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 1316 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1317 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1322 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 447 to 455 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 18 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 68 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 196 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 256 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 282 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 673 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 29 to 49 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 344 to 345 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 349 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 423 to 426 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 700 to 703 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 783 to 785 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 858 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 862 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 256 to 265 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 562 to 564 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 569 to 575 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 602 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 13 to 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 616 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 255 to 267 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 368 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 1658 to 1665 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 151 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 1631 to 1638 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 73 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 81 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 97 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 166 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 579 to 582 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 619 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 32 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 11 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 71 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 75 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 132 to 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 239 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg(2+) 6, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mg(2+) 6, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 434 forms a bond with Mg(2+) 7, indicating a strong binding affinity.
The residue at position 36 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 384 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 409 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 423 to 425 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 425 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 461 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 465 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 982 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 9 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 57 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 6 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 911 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 927 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 935 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 938 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 957 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 155 to 163 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 79 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 82 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 596 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 474 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 152 to 161 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 365 to 369 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 394 to 396 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 400 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 435 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 444 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 447 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 450 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 366 to 376 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 453 to 458 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 505 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 507 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 563 to 570 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 648 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 651 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 670 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 244 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 274 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 298 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 318 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 352 to 353 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 109 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 399 to 406 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 320 to 324 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 329 to 335 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 359 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 66 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 465 to 472 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 691 to 699 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 121 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 263 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 385 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 757 forms a bond with Mo of Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 31 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 20 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 261 to 268 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 141 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 91 to 100 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 153 to 157 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 436 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 521 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 139 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 378 to 384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 458 to 460 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 528 to 533 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 341 to 344 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 408 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 75 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1382 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 8 to 22 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 299 to 304 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 465 to 473 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 to 59 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 94 to 103 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 404 to 407 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 438 to 441 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 479 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 617 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 133 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 519 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 524 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 715 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 859 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 366 to 370 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 33 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 84 to 87 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 149 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 103 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 195 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 364 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 43 to 63 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 302 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 112 to 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 407 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 to 156 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 294 to 298 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 178 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 475 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 13 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 213 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 277 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 942 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 944 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1051 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1102 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 586 to 593 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with S-adenosyl-L-methionine 3, indicating a strong binding affinity.
The residue at position 172 forms a bond with S-adenosyl-L-methionine 4, indicating a strong binding affinity.
The residue at position 178 forms a bond with S-adenosyl-L-methionine 3, indicating a strong binding affinity.
The residue at position 326 to 330 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 464 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 512 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 603 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 89 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 106 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 332 to 335 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 392 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 428 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 96 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 159 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 192 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 332 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 336 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 337 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 485 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1072 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 394 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 61 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 70 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 74 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 232 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 437 to 438 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 203 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 247 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 404 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 445 to 448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 273 forms a bond with heme, indicating a strong binding affinity.
The residue at position 293 forms a bond with heme, indicating a strong binding affinity.
The residue at position 362 forms a bond with heme, indicating a strong binding affinity.
The residue at position 121 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 150 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 219 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 32 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 161 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 139 to 147 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 675 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 702 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 137 to 145 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 333 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 370 to 375 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 376 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 377 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 451 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 523 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 565 to 572 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 615 to 619 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 669 to 672 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 3 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 597 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 642 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 647 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 705 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 889 to 897 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 911 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 957 to 959 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 963 to 966 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1009 to 1014 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 392 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 394 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 418 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 431 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 28 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 59 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 102 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 149 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 602 to 609 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1208 to 1215 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 74 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 88 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 108 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 109 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 184 forms a bond with a glycoprotein, indicating a strong binding affinity.
The residue at position 699 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 702 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 824 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 286 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 328 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 950 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1029 to 1031 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1036 to 1040 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1076 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 448 to 456 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 148 to 180 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 377 to 496 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 32 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 97 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 377 to 379 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 175 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 210 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 212 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 214 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 214 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 119 to 125 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 148 to 154 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 73 to 76 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 239 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1244 to 1252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 238 to 241 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 675 to 682 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 139 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 38 to 45 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 155 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 161 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 194 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 265 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 336 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 338 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 347 to 350 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 791 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 883 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 909 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 912 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 913 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1103 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1173 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1177 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1178 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1189 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1190 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 69 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 79 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 82 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 87 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 98 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 404 to 408 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 431 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 371 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 438 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 158 to 181 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 591 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 594 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 597 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 601 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 620 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 623 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 626 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 630 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 309 to 316 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 355 to 359 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 409 to 412 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 472 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 514 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 571 to 573 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 595 to 596 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 166 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 to 169 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 470 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 418 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 422 to 429 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 451 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 453 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 464 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 553 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 31 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 457 to 461 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 511 to 514 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 734 to 742 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 815 to 820 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 794 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 822 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 826 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 826 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 957 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 271 to 292 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 314 to 333 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 402 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 143 to 152 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 355 to 359 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 384 to 386 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 110 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 128 to 136 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 324 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 349 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 361 to 366 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 367 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 368 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 442 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 446 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 515 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 77 to 83 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 195 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 209 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 289 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 364 to 370 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 368 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 396 to 398 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 479 to 481 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 275 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 210 to 217 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 257 to 261 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 322 to 325 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 101 to 103 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 120 to 126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 335 to 340 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 to 284 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 233 to 261 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 31 to 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 377 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 431 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 478 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 78 to 84 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 196 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 365 to 371 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 369 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 371 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 397 to 399 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 480 to 482 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 339 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 262 to 269 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 800 to 801 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1041 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1082 to 1085 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1197 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1262 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 302 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 86 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 132 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 108 to 121 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 144 to 153 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 68 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 689 to 820 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 816 to 965 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 269 to 274 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 186 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 616 to 623 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 67 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 68 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 92 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 112 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 161 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 229 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 158 to 162 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 425 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 534 to 536 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 552 to 553 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 699 to 700 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 233 to 238 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 192 to 196 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 453 to 461 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 651 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 654 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 694 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 696 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 698 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 724 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 726 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 728 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 730 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 789 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 791 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 793 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 795 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 366 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 431 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 435 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 493 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 367 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 62 to 68 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 430 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 136 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 400 to 404 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 420 to 429 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 430 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 206 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 76 to 104 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 684 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 125 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 150 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 224 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 228 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 343 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 287 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 123 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 173 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 256 forms a bond with glycerol, indicating a strong binding affinity.
The residue at position 219 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 232 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 233 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 283 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 284 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 285 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 287 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 583 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 101 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 171 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 207 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 419 to 422 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 521 to 525 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 563 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 588 to 591 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 312 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 380 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 458 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 460 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 533 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 132 to 139 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 to 279 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 719 to 720 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 733 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 747 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 788 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 862 to 867 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 127 to 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 122 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 701 to 708 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1342 to 1349 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 447 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 709 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1384 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1465 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1466 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1648 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1690 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1723 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 84 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 123 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 182 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 32 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 28 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 216 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 310 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 567 to 571 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 568 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 736 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 766 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 768 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 25 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 31 to 32 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 36 to 41 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 94 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 412 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 473 to 603 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 544 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 439 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 443 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 516 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 to 82 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 5 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 8 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 20 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 27 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 251 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 275 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 319 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 54 forms a bond with phycourobilin, indicating a strong binding affinity.
The residue at position 72 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with phycourobilin, indicating a strong binding affinity.
The residue at position 574 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 577 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 612 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 623 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 188 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 192 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 467 to 469 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 677 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 95 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 744 to 751 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 to 339 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 389 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 838 to 845 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1841 to 1848 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 80 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 81 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 107 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 495 to 503 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 499 to 510 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 to 148 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 614 to 618 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 712 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 833 to 837 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 282 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 310 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 311 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 59 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 68 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 72 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 1499 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1501 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1516 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1516 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1520 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1529 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1533 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1539 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1560 to 1562 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1603 to 1605 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1628 to 1629 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1631 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1676 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1678 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1679 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1680 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1685 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 48 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 290 to 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 179 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 198 to 201 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 535 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 797 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 800 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 53 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 254 to 259 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1130 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1132 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1259 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 105 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 192 to 199 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 690 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 694 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 839 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 157 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 247 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 311 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 386 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 254 to 266 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 44 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 187 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 277 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 146 to 151 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 147 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 347 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 366 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 141 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 10 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 149 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 383 to 387 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 351 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 358 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 362 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 367 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 385 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 389 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 398 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 415 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 461 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 463 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 467 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 469 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 106 to 115 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 410 to 413 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 442 to 445 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 535 to 536 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 620 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 43 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 225 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 162 forms a bond with Mg of a chlorophyll, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg of a chlorophyll, indicating a strong binding affinity.
The residue at position 237 to 248 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 409 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 481 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 523 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 604 to 605 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 505 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 735 to 741 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 796 to 798 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 823 to 831 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 892 to 894 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1034 to 1035 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1039 to 1040 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 522 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 525 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 581 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 82 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 428 to 431 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 223 to 229 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 286 to 290 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1630 to 1637 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 489 to 492 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 507 to 509 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 523 to 526 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 570 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 631 to 632 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 637 to 641 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 673 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 711 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1632 to 1639 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with Mo of Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 371 forms a bond with Mo of Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 548 forms a bond with Mo of Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 434 to 437 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 535 to 542 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 585 to 589 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 639 to 642 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 to 72 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 259 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 521 to 523 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 13 to 27 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 368 to 372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 477 to 481 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 531 to 534 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 362 to 369 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 to 133 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 423 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 747 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 750 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 763 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 767 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 775 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 791 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 795 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 823 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 831 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 834 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 847 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 215 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 219 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 245 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 372 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 408 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 611 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 614 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1246 to 1253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 to 56 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 241 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 86 to 91 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 226 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 515 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 560 to 563 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 85 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 86 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 87 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 88 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 251 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 287 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 224 to 231 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 635 to 642 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 976 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 976 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1038 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1038 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1046 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1508 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1508 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1514 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1563 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1563 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1565 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1571 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1836 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1839 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1842 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 54 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 56 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 58 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 91 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 181 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 182 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 264 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 305 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 349 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 363 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 488 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 492 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 492 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1041 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1041 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1105 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1105 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1107 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1107 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1113 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1113 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 304 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 316 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 373 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 412 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 344 to 348 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 97 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 56 to 62 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 170 to 180 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 238 to 239 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 202 to 209 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 317 to 326 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 468 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 473 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 173 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 231 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 29 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 30 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 54 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 55 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 56 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 142 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 144 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 169 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 390 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 237 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 248 to 254 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 249 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 261 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 275 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 280 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 356 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 359 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 368 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 374 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 390 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 395 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1742 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1748 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1753 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 15 to 17 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 349 to 469 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 64 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with lanosterol, indicating a strong binding affinity.
The residue at position 300 forms a bond with itraconazole, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 161 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 113 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 268 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 272 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 276 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 309 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 393 to 395 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 to 268 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 330 to 338 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 766 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 770 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 147 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 205 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 211 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 1223 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1248 to 1255 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 11 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 121 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 766 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 145 forms a bond with taurochenodeoxycholate, indicating a strong binding affinity.
The residue at position 158 forms a bond with taurochenodeoxycholate, indicating a strong binding affinity.
The residue at position 246 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 274 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 313 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 443 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 453 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 511 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 540 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 575 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 140 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 463 to 465 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 463 to 465 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 516 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 516 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 547 to 548 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 593 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 631 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 631 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 637 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 184 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 230 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 304 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 307 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 314 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 324 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 53 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 53 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 57 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 319 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 215 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 329 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 265 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 300 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 338 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 451 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 481 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 531 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 586 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 597 to 598 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 114 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 134 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 165 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 166 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 248 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 250 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 239 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 436 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 169 to 174 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 105 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 174 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 37 to 41 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 211 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 331 to 334 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 199 to 204 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 529 to 541 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 567 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 576 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 89 to 94 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 187 forms a bond with heme, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 223 forms a bond with heme, indicating a strong binding affinity.
The residue at position 542 to 546 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 543 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 712 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 741 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 39 to 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 165 to 173 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 148 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 337 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 457 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 473 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 788 to 793 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 213 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 703 to 709 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 125 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 126 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 176 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 213 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 263 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 394 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 530 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 533 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 1179 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1182 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1213 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1216 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1233 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1243 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 56 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 193 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 197 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 219 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 89 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 98 to 102 forms a bond with heme, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 552 to 560 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 49 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 148 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 183 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 277 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 280 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 213 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 471 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 169 to 175 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 153 to 159 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 183 to 187 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 664 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 666 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 690 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 719 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 721 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 189 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 345 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 413 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 1 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 21 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 143 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 172 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 36 to 47 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1830 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1832 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1872 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 246 forms a bond with O2, indicating a strong binding affinity.
The residue at position 50 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 205 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 213 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 408 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 432 to 435 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 490 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 494 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 365 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 15 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 14 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 74 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 125 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 508 to 515 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 558 to 562 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 612 to 615 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 128 to 133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 to 159 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 172 to 179 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 105 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 164 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 168 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 420 to 423 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 520 to 521 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 526 to 530 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 562 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 600 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 348 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 216 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 175 to 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 58 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 138 to 145 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 205 to 209 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 307 to 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 349 to 351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 996 to 998 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1003 to 1007 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1043 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 29 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 43 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 98 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 345 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 453 to 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 16 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 383 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 148 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 to 188 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 311 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 356 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 329 to 339 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 456 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 497 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 554 to 556 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 578 to 579 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 625 to 630 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 256 to 259 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 599 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 656 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 667 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 669 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 719 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 729 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 136 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 503 to 511 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 to 127 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 727 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 756 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 760 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 335 to 338 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 954 to 961 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1215 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1218 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1235 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1244 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1274 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1289 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 78 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 121 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 816 to 817 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1098 to 1101 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1213 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1278 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 69 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 73 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 222 to 226 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 1109 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1116 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 78 to 102 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 411 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 419 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 448 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 460 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 473 to 474 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 9 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 435 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 544 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 560 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 561 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 562 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 648 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 649 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 696 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 96 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 148 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 649 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 652 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 653 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 692 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 294 to 295 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 300 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 331 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 181 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 357 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 310 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 308 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 341 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 553 to 561 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 503 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 96 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 526 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 568 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 628 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 628 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 630 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 636 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 413 to 419 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1123 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1126 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1139 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1142 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1150 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1169 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1172 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 610 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 29 to 33 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 65 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 380 to 384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 580 to 584 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 904 to 911 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 229 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with sphing-4-enine 1-phosphate, indicating a strong binding affinity.
The residue at position 265 to 269 forms a bond with sphing-4-enine 1-phosphate, indicating a strong binding affinity.
The residue at position 324 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 565 to 569 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 566 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 734 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 764 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 898 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 72 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 491 to 499 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 376 to 382 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 471 to 474 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 526 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 106 to 112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 347 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 133 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1492 to 1500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1515 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 280 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 847 to 853 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 907 to 909 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 934 to 942 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1001 to 1003 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1145 to 1146 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1150 to 1151 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 172 to 225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 404 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 621 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 625 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 625 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 269 to 274 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 23 to 29 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 490 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 500 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 22 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 213 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 228 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 254 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 267 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 438 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 442 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 615 to 618 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 392 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 498 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 524 to 525 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 547 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 574 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 741 to 750 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 817 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 842 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 256 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 160 to 166 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 722 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 836 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 212 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 262 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 283 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 312 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 339 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 134 to 149 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 to 192 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 171 to 177 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 230 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 355 to 359 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 146 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 450 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 145 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 147 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 148 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 151 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 173 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 213 to 219 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 to 242 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 95 to 100 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 492 to 497 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 539 to 542 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 573 to 575 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 581 to 583 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 15 to 22 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 forms a bond with (1S,3R,6R,8R,9R,11R,14S,15S,19R,20R)-8-ethyl-9,15-dihydroxy-3,4,6,20-tetramethyl-21,23-dioxo-24-azapentacyclo[20.2.1.0(1,6).0(11,20).0(14,19)]pentacosa-4,12,22(25)-trien-25-olate, indicating a strong binding affinity.
The residue at position 183 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 345 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 119 to 123 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 317 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 341 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 355 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 420 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 427 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 703 to 704 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 729 to 731 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 730 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 830 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 852 to 854 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 682 to 689 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1010 to 1017 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 640 to 645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 401 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 403 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 109 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 4 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 1, indicating a strong binding affinity.
The residue at position 6 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 1, indicating a strong binding affinity.
The residue at position 6 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 2, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 215 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 1, indicating a strong binding affinity.
The residue at position 240 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 2, indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 13 to 20 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1071 to 1073 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1090 to 1091 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1270 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1273 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1285 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1294 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1297 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1310 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1318 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 93 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 47 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 301 to 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 93 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 148 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 162 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 191 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 360 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 245 to 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 to 259 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 11 to 13 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 127 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 131 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 152 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 315 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 699 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 762 to 766 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 765 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 810 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 814 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 867 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 1142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1197 to 1198 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 428 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 456 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 460 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 462 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 488 to 490 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 531 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 560 to 561 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 563 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 625 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 630 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 131 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 205 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 231 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 262 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 386 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 122 to 239 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 240 to 366 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 559 to 566 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 606 to 610 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 660 to 663 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 225 to 235 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 269 to 276 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 304 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 396 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 217 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 267 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 288 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 317 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 344 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 309 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 490 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 490 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 30 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 161 to 165 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 223 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 311 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 317 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 419 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 299 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 299 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 299 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 299 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 314 to 319 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 314 to 319 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 314 to 319 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 381 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 429 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 434 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 455 to 456 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 471 to 474 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 471 to 474 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 471 to 474 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 498 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 498 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 498 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 527 to 528 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 527 to 528 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 527 to 528 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 527 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 543 to 546 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 338 forms a bond with sulfur of a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 420 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 470 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 519 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 535 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 539 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 543 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 581 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 47 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 50 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe of heme d1, indicating a strong binding affinity.
The residue at position 236 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 237 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 256 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 382 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 500 forms a bond with heme d1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 56 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 72 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 60 to 64 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 123 to 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 to 473 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 526 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 69 forms a bond with 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate, indicating a strong binding affinity.
The residue at position 244 forms a bond with urate, indicating a strong binding affinity.
The residue at position 354 forms a bond with urate, indicating a strong binding affinity.
The residue at position 371 forms a bond with urate, indicating a strong binding affinity.
The residue at position 419 forms a bond with urate, indicating a strong binding affinity.
The residue at position 420 forms a bond with urate, indicating a strong binding affinity.
The residue at position 446 forms a bond with urate, indicating a strong binding affinity.
The residue at position 469 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 36 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1488 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1531 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 13 to 16 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 128 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 451 to 453 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 451 to 453 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 504 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 504 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 535 to 536 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 581 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 619 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 619 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 625 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 87 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 237 to 244 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 284 to 288 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 349 to 352 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 9 to 15 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 278 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 377 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 98 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 410 to 414 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 430 to 439 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 440 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 422 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 842 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 848 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 904 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 906 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1372 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1372 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1378 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1427 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1427 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1429 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1429 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1435 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 118 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 26 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 146 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 150 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 153 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 883 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 883 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 884 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 927 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 927 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 206 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 36 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 63 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 149 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 176 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 194 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 431 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 317 to 321 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 to 82 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 218 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 825 to 832 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 95 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 24 to 140 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 72 to 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 2290 to 2297 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 441 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 283 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 296 to 297 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 319 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 230 to 234 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 143 to 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 to 23 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 219 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 628 to 636 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 to 83 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 94 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 136 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 266 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 83 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 1097 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1099 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 7 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 33 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 33 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 36 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 43 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 45 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 45 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 49 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 49 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 57 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 63 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 302 to 305 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 330 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 173 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 504 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 486 to 608 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 545 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 560 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 481 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 515 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 516 to 518 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 to 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 160 to 164 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 to 218 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 440 to 448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 770 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 773 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 774 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 266 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 150 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 182 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 70 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 247 to 253 forms a bond with strychnine, indicating a strong binding affinity.
The residue at position 254 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 258 forms a bond with [4Fe-4S] cluster 5, indicating a strong binding affinity.
The residue at position 129 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 268 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 255 to 261 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 116 to 124 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 289 to 295 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 313 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 350 to 355 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 356 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 431 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 435 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 502 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 318 to 324 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 348 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 103 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 3 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 439 to 446 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 854 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 940 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 953 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 54 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 129 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 279 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 506 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 542 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 543 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 543 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 656 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 38 to 43 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 297 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 382 to 386 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 409 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 463 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 464 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 465 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 296 to 310 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 429 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 584 to 587 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 594 to 595 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 699 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 708 to 711 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 718 to 719 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 446 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 to 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 530 to 532 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 746 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 861 to 865 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 to 424 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 472 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 474 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 531 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 533 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 367 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 443 to 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 467 to 472 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 650 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 80 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 83 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 101 to 109 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 276 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 309 to 314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 315 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 168 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 182 to 186 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 407 to 415 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 323 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 231 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 364 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 470 to 471 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 289 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 297 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 302 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 308 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 368 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 386 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 388 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 393 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 396 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 408 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 416 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 26 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 41 forms a bond with mesobiliverdin, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 1135 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1155 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1158 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 245 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 358 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 453 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 261 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 327 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 354 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 362 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 399 to 402 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 563 to 565 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 385 to 388 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 842 to 849 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 440 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 489 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 496 to 497 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 505 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 208 to 215 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 255 to 259 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 320 to 323 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 78 to 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 227 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 270 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 40 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 14 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 121 to 127 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 281 to 289 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 304 to 315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 206 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 534 to 539 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 868 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 870 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 872 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 874 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 879 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 904 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 906 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 915 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 404 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 701 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 761 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 299 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 383 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 260 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 281 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 337 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 114 forms a bond with (2R)-2-O-(alpha-D-glucopyranosyl)-3-phospho-glycerate, indicating a strong binding affinity.
The residue at position 184 to 187 forms a bond with (2R)-2-O-(alpha-D-glucopyranosyl)-3-phospho-glycerate, indicating a strong binding affinity.
The residue at position 256 forms a bond with (2R)-2-O-(alpha-D-glucopyranosyl)-3-phospho-glycerate, indicating a strong binding affinity.
The residue at position 60 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 175 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 177 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 157 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 158 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 209 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 213 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 249 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 260 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 317 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 403 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 183 to 236 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 320 to 321 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 170 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 194 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 1007 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1009 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1125 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 6 to 12 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 308 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 378 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 462 to 468 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 514 to 517 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 652 to 653 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 to 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 600 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 514 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 531 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 55 to 60 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 69 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 to 135 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 197 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 216 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 364 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 364 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 501 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 265 to 271 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 423 to 425 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 423 to 425 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 476 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 476 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 507 to 508 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 553 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 591 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 591 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 597 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 34 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 73 to 79 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 154 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 37 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 127 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 232 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 234 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 370 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 373 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 404 to 408 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 427 to 428 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 437 to 442 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 176 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 369 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 371 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 395 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 410 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 181 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 336 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 531 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 175 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 373 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 377 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 463 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 476 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 491 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 623 to 654 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 767 to 778 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 903 to 913 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 978 to 996 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1076 to 1091 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 645 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 647 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 671 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 700 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 701 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 702 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 376 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 381 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 386 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 387 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 423 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 428 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 429 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 forms a bond with glycochenodeoxycholate, indicating a strong binding affinity.
The residue at position 146 forms a bond with glycochenodeoxycholate, indicating a strong binding affinity.
The residue at position 151 forms a bond with glycochenodeoxycholate, indicating a strong binding affinity.
The residue at position 159 forms a bond with glycochenodeoxycholate, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 187 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 223 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 227 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 161 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 174 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 258 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 257 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 495 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 203 to 206 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 291 to 297 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 213 to 275 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 343 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 396 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 441 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 448 to 449 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 375 to 378 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 387 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 452 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 254 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 419 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 1157 to 1164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 371 to 372 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 395 to 399 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 425 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 479 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 480 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 481 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 621 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 640 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 767 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 767 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 767 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 773 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 773 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 773 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 814 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 814 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 814 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 942 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 942 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 942 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 264 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 343 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 453 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 484 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 525 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 978 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 989 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 996 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 609 to 613 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 663 to 666 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 to 167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 302 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 343 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 481 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 27 to 28 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 86 to 104 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 301 to 312 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 31 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 32 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 33 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 34 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 35 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 64 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 72 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 102 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 123 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 146 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 170 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 173 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 176 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 212 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 213 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 221 forms a bond with a 2-deoxystreptamine antibiotic, indicating a strong binding affinity.
The residue at position 226 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 392 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 403 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 429 to 434 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 474 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 533 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1043 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1068 to 1074 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1114 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1174 to 1176 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 509 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 148 to 153 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 162 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 347 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 351 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 375 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 570 to 577 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 644 to 645 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 62 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 260 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 96 to 103 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 to 481 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 712 to 716 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 750 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 757 to 759 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 817 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 843 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 849 to 852 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 918 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 195 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 505 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 586 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 588 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 736 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 9 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 523 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 533 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 103 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 104 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 107 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 110 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 120 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 121 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 124 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 127 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 138 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 26 to 55 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1090 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1143 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 128 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 720 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 548 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 682 to 685 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 699 to 703 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 704 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 716 to 718 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 769 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 466 to 468 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 277 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 142 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 349 to 351 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 189 to 244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 to 367 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 539 to 540 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 591 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 214 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 187 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 157 to 172 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 182 to 214 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 346 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 371 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 11 to 28 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 30 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 394 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 230 to 237 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 312 to 316 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 19 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 345 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 to 435 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 437 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 173 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 378 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 481 to 482 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 103 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 653 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 664 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 683 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1143 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1147 to 1148 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1187 to 1188 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1188 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1574 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1576 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 481 to 486 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 481 to 482 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 to 63 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 404 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 508 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 580 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 582 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 584 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 620 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 622 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 624 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 626 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 125 to 129 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1105 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1108 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1121 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1124 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1129 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1132 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1151 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1154 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 258 to 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 76 to 81 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 108 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 176 to 181 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 221 to 225 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 457 to 460 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 236 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 318 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 58 to 65 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 981 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 992 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 119 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 132 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 323 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 574 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 192 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 284 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 428 to 431 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 445 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 471 to 472 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 510 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 271 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 275 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 276 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 297 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 330 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 557 to 561 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 611 to 614 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 540 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 604 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 604 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1020 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1038 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1089 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1092 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1142 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1149 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1150 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 137 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 139 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 143 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 152 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 154 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 157 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 166 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 167 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 168 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 183 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 183 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 184 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 202 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 207 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 207 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 230 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 325 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 165 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 234 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 173 to 180 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 837 to 844 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 18 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 70 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 74 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 74 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 95 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 111 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-quinate, indicating a strong binding affinity.
The residue at position 259 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 27 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 132 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 167 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 261 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 264 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 24 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 302 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 358 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 430 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 438 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 105 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 957 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1068 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 28 to 31 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 410 to 411 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 338 to 346 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 342 to 346 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 455 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 530 to 541 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 596 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 349 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 356 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 461 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 534 to 538 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 31 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 33 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 544 to 550 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 242 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 362 to 369 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 408 to 412 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 462 to 465 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 31 to 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 172 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 198 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 427 to 436 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 437 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 10 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 59 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 81 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 82 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 86 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 94 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 187 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 191 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 413 to 418 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 413 to 418 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 477 to 480 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 480 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 535 to 536 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 561 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 721 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 725 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 729 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 113 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 3 to 10 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 395 to 396 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 554 to 557 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 567 to 568 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 305 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 168 to 178 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 255 to 263 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 200 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 475 to 477 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 482 to 488 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 338 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 8 to 12 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 51 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 164 to 217 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1252 to 1260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 246 to 253 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 to 296 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 311 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 546 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 551 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 124 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 129 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 144 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 225 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2284 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2286 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2288 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2290 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2295 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2327 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2333 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2338 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 65 to 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 317 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 319 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 406 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 408 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 10 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 15 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 84 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 518 to 525 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 forms a bond with heme, indicating a strong binding affinity.
The residue at position 243 forms a bond with heme, indicating a strong binding affinity.
The residue at position 295 forms a bond with heme, indicating a strong binding affinity.
The residue at position 348 forms a bond with heme, indicating a strong binding affinity.
The residue at position 352 forms a bond with heme, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 403 to 406 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 436 to 439 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 536 to 537 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 542 to 546 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 578 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 616 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 69 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 130 to 137 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 511 to 512 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 550 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 557 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 240 forms a bond with heme, indicating a strong binding affinity.
The residue at position 260 forms a bond with heme, indicating a strong binding affinity.
The residue at position 294 forms a bond with heme, indicating a strong binding affinity.
The residue at position 296 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 330 forms a bond with heme, indicating a strong binding affinity.
The residue at position 408 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 241 to 248 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 352 to 355 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 953 to 961 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 977 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 401 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1263 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1360 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1363 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1420 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1488 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1490 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 318 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 463 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 184 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 227 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 256 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 261 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 293 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 438 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 441 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 455 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 544 to 551 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 131 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 46 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 74 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 134 to 141 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 336 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 372 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 443 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 471 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 474 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 311 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 389 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 73 to 78 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 105 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 173 to 178 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 218 to 222 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 180 to 182 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 225 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 156 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 8 to 12 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 227 to 233 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 604 to 611 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 846 to 853 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 239 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 503 to 505 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 510 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 681 to 682 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 722 to 723 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 257 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 259 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 275 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 331 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 139 to 260 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 261 to 404 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 347 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 13 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 22 to 26 forms a bond with heme, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with heme, indicating a strong binding affinity.
The residue at position 210 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 815 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 817 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 896 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 898 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 900 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 902 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 969 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 1063 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 245 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 176 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 109 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 112 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 327 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 309 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 346 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 348 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 364 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 379 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 778 to 788 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 102 to 116 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 334 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 335 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 605 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 286 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 288 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 290 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 584 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 650 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 703 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 782 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 35 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 237 to 243 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 789 to 796 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 to 279 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 to 320 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 61 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 82 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 121 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 206 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 209 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 235 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 460 to 462 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 352 to 360 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 51 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 181 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 679 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 259 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 263 forms a bond with O2, indicating a strong binding affinity.
The residue at position 699 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 734 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 738 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 742 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 145 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 222 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 238 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 359 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 365 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 391 to 393 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 629 to 630 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 632 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 685 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 687 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 94 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 334 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 336 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 400 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 404 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 733 to 734 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 283 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 350 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 362 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 383 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 303 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 381 to 500 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 123 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 171 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 371 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 166 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 190 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 847 to 851 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 851 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 887 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 888 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 888 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 888 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 1000 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 1000 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 1052 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 293 to 301 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 to 488 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 457 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 135 to 138 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 171 to 176 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 983 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 990 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 209 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 355 to 358 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 232 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 264 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 371 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 397 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 379 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 450 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 477 to 478 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 499 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 508 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 154 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 199 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 203 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 28 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 181 to 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 to 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 210 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 265 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 369 forms a bond with 3,3',5-triiodo-L-thyronine 1, indicating a strong binding affinity.
The residue at position 423 to 427 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 4 to 32 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 58 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 37 to 38 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 190 to 196 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 55 to 58 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 111 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 138 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 619 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 655 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 656 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 781 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 351 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 93 to 124 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 952 to 960 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 973 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 146 to 150 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 129 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 267 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 478 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 482 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 515 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 624 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 667 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 164 to 168 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 333 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 426 to 427 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 442 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 451 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 237 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 294 to 298 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 203 to 210 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 to 299 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 278 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 85 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 151 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 272 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 439 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 317 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 382 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 418 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 424 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 874 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 942 to 943 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 88 to 91 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 413 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 522 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 243 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 267 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 435 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 208 to 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 181 to 187 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 to 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 85 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 124 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 368 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 371 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 373 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 431 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 432 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 1248 to 1256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 620 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 631 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 651 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 721 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 724 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 737 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 740 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 745 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 748 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 79 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 113 to 118 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 140 to 146 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 170 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 10 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 295 to 305 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 to 258 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 261 to 377 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 70 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 57 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 302 to 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 299 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 340 forms a bond with 5-methoxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 346 forms a bond with 5-methoxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with 5-methoxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 433 forms a bond with 5-methoxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 562 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 563 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 566 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 493 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 524 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 565 to 567 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 589 to 590 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 85 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 129 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 219 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 223 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 226 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 245 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 415 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 418 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 447 to 448 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 468 to 469 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 331 to 339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 564 to 572 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1353 to 1360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 444 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 488 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 892 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 135 to 143 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 1326 to 1333 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 514 to 516 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 521 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 686 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 730 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 464 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 492 to 494 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 499 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 668 to 669 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 719 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 244 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 332 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 338 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 440 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 516 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 531 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 534 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 999 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1001 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1008 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 480 to 565 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1166 to 1168 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 1221 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1246 to 1249 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1263 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1297 to 1301 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 1327 to 1330 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 212 to 217 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 668 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 668 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 691 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 692 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 692 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 131 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 284 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 328 to 332 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 465 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 3 to 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 166 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 41 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 285 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 149 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 402 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 404 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1333 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1336 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1375 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1378 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1414 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1419 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1440 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1446 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 292 to 296 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 to 70 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 121 to 126 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 27 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 323 to 326 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 71 to 77 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 187 to 190 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 242 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 53 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 108 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 127 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 65 to 69 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 83 to 90 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 681 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 681 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 683 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 125 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 219 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 371 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 521 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 660 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 721 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 64 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 114 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 117 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 133 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 136 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 259 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 321 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 323 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 266 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 302 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 340 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 519 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 to 100 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 678 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 685 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 688 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 694 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 277 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 25 to 45 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 83 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 97 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 373 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 408 forms a bond with L-kynurenine, indicating a strong binding affinity.
The residue at position 673 to 681 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 353 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 357 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 406 to 411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 153 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 188 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 294 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 345 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 365 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 5 to 8 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 170 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 214 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 293 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 303 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 304 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 332 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 335 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 336 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 46 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 367 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 355 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 505 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 256 to 262 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 217 to 223 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 72 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 413 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 126 forms a bond with lanosterol, indicating a strong binding affinity.
The residue at position 314 forms a bond with itraconazole, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 3 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 272 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 558 to 565 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 772 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 74 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 74 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 217 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 217 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 235 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 235 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 209 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 259 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 280 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 309 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 336 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 188 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 189 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 223 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 224 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 250 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 278 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 309 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 524 to 531 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 572 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 112 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 116 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 44 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 81 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 487 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 488 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 490 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 518 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 521 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 529 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 122 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 150 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 647 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 681 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 685 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 28 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 35 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 121 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 603 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 716 to 724 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 26 forms a bond with (S)-mandelate, indicating a strong binding affinity.
The residue at position 131 forms a bond with (S)-mandelate, indicating a strong binding affinity.
The residue at position 165 forms a bond with (S)-mandelate, indicating a strong binding affinity.
The residue at position 274 forms a bond with (S)-mandelate, indicating a strong binding affinity.
The residue at position 277 forms a bond with (S)-mandelate, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with heme, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 242 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 211 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 1052 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1084 to 1090 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 364 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 371 to 372 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 355 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 376 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 359 to 366 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 405 to 409 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 459 to 462 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 485 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 485 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 667 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 668 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 669 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 909 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 989 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 990 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 991 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1130 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1133 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1134 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1134 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1393 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 187 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 240 to 246 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 300 to 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 310 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 164 to 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 162 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 323 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 1263 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1265 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1266 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1268 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1271 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 530 to 534 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 594 to 601 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 537 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 542 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 545 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 575 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 466 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 452 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 641 to 648 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 687 to 691 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 741 to 744 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 114 forms a bond with 4-(trimethylamino)butanoate 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with (R)-carnitine 1, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with 4-(trimethylamino)butanoate 1, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with (R)-carnitine 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with 4-(trimethylamino)butanoate 2, indicating a strong binding affinity.
The residue at position 327 to 330 forms a bond with (R)-carnitine 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with 4-(trimethylamino)butanoate 2, indicating a strong binding affinity.
The residue at position 5 to 10 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 469 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 488 to 495 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 513 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 155 to 162 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 661 to 668 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1323 to 1330 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 89 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 195 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 412 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 431 to 434 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 507 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 153 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 435 to 440 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 to 295 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 334 to 338 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 14 forms a bond with heme, indicating a strong binding affinity.
The residue at position 17 forms a bond with heme, indicating a strong binding affinity.
The residue at position 302 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 11 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1780 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1804 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1876 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1909 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1925 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1933 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1950 to 1956 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1966 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1968 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 313 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 8 forms a bond with O(6)-methyl-dGMP, indicating a strong binding affinity.
The residue at position 23 forms a bond with O(6)-methyl-dGMP, indicating a strong binding affinity.
The residue at position 33 forms a bond with O(6)-methyl-dGMP, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with O(6)-methyl-dGMP, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with O(6)-methyl-dGMP, indicating a strong binding affinity.
The residue at position 1621 to 1628 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 870 to 877 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 23 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 125 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 253 to 281 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 133 to 138 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 15 to 19 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 362 to 365 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 286 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 288 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 327 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 510 to 518 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 656 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 56 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 611 to 612 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 274 to 281 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 409 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 483 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 485 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 493 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 501 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 135 to 254 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 9 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 645 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 653 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 396 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 399 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 404 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 276 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 88 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 121 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 139 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 167 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 171 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 936 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 290 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 to 51 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 528 to 533 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 528 to 532 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 576 to 579 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 607 to 639 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 618 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 372 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 482 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 751 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 755 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 757 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 343 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 553 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 8 to 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 211 to 217 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 442 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 9 to 12 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 224 to 234 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 268 to 275 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 302 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 380 to 382 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 451 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 583 to 586 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 27 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 441 to 446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 619 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 85 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1309 to 1311 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 1325 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 1375 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 119 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 328 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 217 to 226 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 to 283 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 53 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 344 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 363 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 241 to 244 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 400 to 405 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 272 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 399 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 393 to 394 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 412 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 85 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 1138 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1141 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1157 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1162 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1165 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1185 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 846 to 853 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 635 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 399 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 278 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 340 to 341 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 388 to 394 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 544 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 to 302 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 408 to 414 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1003 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1019 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1030 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 880 to 888 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 447 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 450 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 486 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 490 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 495 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 574 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 610 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 627 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 637 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 577 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 585 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 156 to 163 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 940 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 946 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1004 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1012 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 187 to 191 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 586 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 689 to 697 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 392 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 413 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 416 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 446 to 447 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 467 to 468 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 76 to 78 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 240 to 246 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 5 to 6 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 193 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 229 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 186 to 197 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 113 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 698 to 706 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 439 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 447 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 360 to 368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 603 to 606 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 107 forms a bond with (9Z,12Z)-octadecadienoate, indicating a strong binding affinity.
The residue at position 127 forms a bond with (9Z,12Z)-octadecadienoate, indicating a strong binding affinity.
The residue at position 258 to 259 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 77 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 100 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 94 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 223 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 224 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 225 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 226 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 232 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 234 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 235 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 236 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 5 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 6 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 10 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 18 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 18 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 29 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 69 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 102 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 119 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 261 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 92 to 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 441 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 457 to 458 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 4 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 223 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 226 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 229 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 229 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 304 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 31 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 189 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 238 to 242 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 460 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 25 forms a bond with E64, indicating a strong binding affinity.
The residue at position 185 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 746 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 750 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 896 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 46 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 49 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 58 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 77 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 80 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 83 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 87 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 242 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 279 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 283 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 414 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 417 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 417 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 421 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 425 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 59 to 66 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 106 to 110 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 234 to 241 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 281 to 285 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 83 to 88 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 115 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 183 to 188 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 778 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 852 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 4 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 8 forms a bond with O2, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 88 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 393 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 402 to 403 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 436 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 478 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 543 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 545 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 552 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1589 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1591 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1592 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1594 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1597 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 35 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 18 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 229 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 255 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 278 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 160 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 151 to 159 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 390 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 498 to 628 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 569 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 36 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 166 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 18 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 60 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 290 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 387 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 390 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 489 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 492 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 565 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 568 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 169 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 172 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 1385 to 1392 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 693 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 695 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 698 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 81 to 86 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 298 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 220 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 226 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 365 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 369 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 405 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 39 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 216 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 310 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 353 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 367 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 426 to 430 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 420 to 425 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 79 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 927 to 934 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1143 to 1150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 to 163 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 to 208 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 67 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 88 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 285 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1174 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1217 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1217 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 197 forms a bond with a rhodoquinol, indicating a strong binding affinity.
The residue at position 239 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 86 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 153 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 182 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 215 to 222 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 334 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 706 to 763 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 47 forms a bond with guanosine, indicating a strong binding affinity.
The residue at position 47 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 56 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 57 forms a bond with guanosine, indicating a strong binding affinity.
The residue at position 57 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 128 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 128 forms a bond with guanosine, indicating a strong binding affinity.
The residue at position 128 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 206 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 206 forms a bond with guanosine, indicating a strong binding affinity.
The residue at position 232 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 232 forms a bond with guanosine, indicating a strong binding affinity.
The residue at position 232 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 258 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 258 forms a bond with guanosine, indicating a strong binding affinity.
The residue at position 258 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 280 forms a bond with guanosine, indicating a strong binding affinity.
The residue at position 280 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 2 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 285 to 294 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 193 to 199 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 240 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 483 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 482 to 489 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 380 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 392 to 393 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 432 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 436 to 440 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 447 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 106 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 1173 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1179 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1184 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 45 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 109 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 354 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 426 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 509 to 511 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 534 to 535 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 363 to 367 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 384 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 113 to 223 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 306 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 159 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 533 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 140 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 384 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 306 to 312 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 336 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 151 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 238 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 8 to 35 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 191 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 304 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 26 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 28 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 74 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 148 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 181 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 211 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 294 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 907 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 202 to 208 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 385 to 387 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 418 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 465 to 469 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 505 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 509 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 51 to 61 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 437 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 470 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 147 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 186 to 192 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 332 to 335 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 76 to 82 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 367 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 478 to 480 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 33 to 37 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 356 to 359 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 406 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 482 to 493 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 327 to 330 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 59 to 60 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with trans-zeatin 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with trans-zeatin 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with trans-zeatin 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with trans-zeatin 3, indicating a strong binding affinity.
The residue at position 506 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 509 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 509 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 511 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 580 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 582 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 586 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 245 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 248 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 249 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 218 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 125 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 138 forms a bond with histamine 1, indicating a strong binding affinity.
The residue at position 138 forms a bond with histamine 2, indicating a strong binding affinity.
The residue at position 416 to 423 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 137 to 143 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 300 to 305 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 402 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 404 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 41 to 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 124 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 426 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 119 to 124 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 316 forms a bond with 20-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 316 forms a bond with 25-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 316 forms a bond with 7beta-hydroxycholesterol, indicating a strong binding affinity.
The residue at position 316 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 316 forms a bond with ergosterol, indicating a strong binding affinity.
The residue at position 495 to 498 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 524 to 525 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 106 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 419 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 422 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 400 to 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 468 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 475 to 480 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 475 to 476 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 476 to 480 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 149 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 105 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 175 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 181 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 406 to 409 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 454 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 119 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 504 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 506 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 137 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 286 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 322 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 32 forms a bond with Co of cob(II)alamin, indicating a strong binding affinity.
The residue at position 44 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with ethanolamine 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with ethanolamine 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with ethanolamine 2, indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with ethanolamine 1, indicating a strong binding affinity.
The residue at position 285 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 393 to 394 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 413 to 416 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 352 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 375 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 388 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1 to 4 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 456 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 559 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 618 to 620 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 725 to 728 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 372 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 32 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 37 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 50 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 77 to 79 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 138 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 213 to 223 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 157 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 91 forms a bond with heme, indicating a strong binding affinity.
The residue at position 95 forms a bond with heme, indicating a strong binding affinity.
The residue at position 288 forms a bond with heme, indicating a strong binding affinity.
The residue at position 571 to 575 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 572 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 741 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 771 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 773 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 908 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 124 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 312 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 29 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 152 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 320 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 334 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 235 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 28 to 48 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 to 91 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 531 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 75 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 149 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 267 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 433 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 133 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 424 to 431 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 1125 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1128 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1008 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1036 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1048 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1051 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1061 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1076 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1079 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1090 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1091 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1094 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1113 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1124 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 146 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 171 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 208 to 215 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 416 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 420 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 526 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 551 to 552 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 601 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 813 to 822 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 889 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 897 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 914 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 181 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 211 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 242 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 396 to 397 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 530 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 531 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 854 to 987 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 983 to 1121 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 204 to 210 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 8 to 14 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 82 forms a bond with leukotriene E4, indicating a strong binding affinity.
The residue at position 153 forms a bond with leukotriene E4, indicating a strong binding affinity.
The residue at position 156 forms a bond with leukotriene E4, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 382 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 383 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 476 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 293 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 313 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 316 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 321 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 324 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 334 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 391 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 406 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 417 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 429 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 437 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 12 to 16 forms a bond with a carbohydrate 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with a carbohydrate 1, indicating a strong binding affinity.
The residue at position 36 to 44 forms a bond with a carbohydrate 1, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with a carbohydrate 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with a carbohydrate 2, indicating a strong binding affinity.
The residue at position 95 to 103 forms a bond with a carbohydrate 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 53 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 505 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 177 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 241 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 267 to 274 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 805 to 806 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 805 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1046 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1087 to 1090 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1202 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1266 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 97 to 128 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 375 to 383 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 478 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 319 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 323 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 260 to 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 908 to 909 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 112 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 200 to 206 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 287 to 288 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 140 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 264 to 267 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 96 to 103 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 4 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 23 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 306 to 308 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 11 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 366 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 408 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 409 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 410 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 511 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 536 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 51 to 56 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 54 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 109 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 144 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 254 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 415 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 442 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 272 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 499 to 501 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 294 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 390 forms a bond with matrix attachment region (MAR) of DNA of DNA, indicating a strong binding affinity.
The residue at position 400 to 410 forms a bond with matrix attachment region (MAR) of DNA of DNA, indicating a strong binding affinity.
The residue at position 425 forms a bond with matrix attachment region (MAR) of DNA of DNA, indicating a strong binding affinity.
The residue at position 177 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 212 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 318 to 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 197 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 18 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 35 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with (2R,3E)-phycocyanobilin 3, indicating a strong binding affinity.
The residue at position 82 forms a bond with (2R,3E)-phycocyanobilin 3, indicating a strong binding affinity.
The residue at position 84 forms a bond with (2R,3E)-phycocyanobilin 3, indicating a strong binding affinity.
The residue at position 85 forms a bond with (2R,3E)-phycocyanobilin 3, indicating a strong binding affinity.
The residue at position 156 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 119 to 124 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 20 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 22 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 24 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 31 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 43 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 61 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 63 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 72 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 1087 to 1094 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 615 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 698 forms a bond with Mg of divinylchlorophyll a' A1, indicating a strong binding affinity.
The residue at position 706 forms a bond with Mg of divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 714 forms a bond with divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 715 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 102 to 110 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 221 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 355 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 367 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 227 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 229 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 296 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 9 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 25 to 26 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 89 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 276 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 281 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 314 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 379 to 383 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 503 to 505 forms a bond with alpha,alpha-trehalose 6-phosphate, indicating a strong binding affinity.
The residue at position 233 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 344 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 660 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 662 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 686 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 715 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 716 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 717 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 56 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 112 to 118 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 137 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 121 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 228 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 240 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 298 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 321 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 514 to 521 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 508 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 511 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 513 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 585 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 587 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with heme, indicating a strong binding affinity.
The residue at position 302 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 410 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 789 to 794 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 161 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 391 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 340 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 364 to 367 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 415 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 419 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 26 to 29 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 56 to 63 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 398 to 399 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 131 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 to 291 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 190 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 194 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 196 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 241 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 178 to 185 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 418 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 801 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 263 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 289 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 318 to 334 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 266 to 273 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 310 to 313 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 260 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 262 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 372 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 577 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 337 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 330 to 337 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 652 to 659 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 838 to 845 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 102 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 43 to 47 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 328 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 386 to 389 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 391 to 397 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 67 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 446 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 452 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 139 to 154 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 165 to 197 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 433 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 433 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 437 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 437 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 473 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 474 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 474 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 591 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 642 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 642 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 645 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 645 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 35 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 767 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 771 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 917 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 220 to 224 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 314 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 71 to 77 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 224 to 232 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 21 to 50 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 351 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 109 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 113 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 323 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 325 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 661 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 661 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 665 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 665 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 114 to 144 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 275 to 311 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 to 104 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 95 to 102 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 273 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 542 to 547 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 542 to 546 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 609 to 610 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 626 to 627 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 662 to 663 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 663 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 686 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 686 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 688 to 689 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 714 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 748 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 753 to 754 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 790 to 794 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 867 to 869 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 869 to 873 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 903 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 143 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 453 to 459 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 63 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 138 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 400 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 402 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 483 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 483 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 512 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 538 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 626 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 393 to 396 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 432 to 434 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 319 to 326 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 245 to 250 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 580 to 588 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 764 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1160 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 74 to 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 284 to 295 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 469 to 470 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 557 to 565 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 794 to 801 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 289 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 164 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 327 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 340 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with dopamine, indicating a strong binding affinity.
The residue at position 137 forms a bond with (4-hydroxyphenyl)acetaldehyde, indicating a strong binding affinity.
The residue at position 229 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 233 to 237 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 407 to 419 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 100 to 107 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 329 to 330 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 197 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 672 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 583 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 647 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 686 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 687 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 688 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 719 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1061 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1079 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1095 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1130 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1133 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1183 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1190 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1191 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1316 to 1323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 311 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 239 to 242 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 434 to 436 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 458 to 463 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 573 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 641 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 213 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 308 to 309 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 158 forms a bond with E64, indicating a strong binding affinity.
The residue at position 158 forms a bond with leupeptin, indicating a strong binding affinity.
The residue at position 504 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 476 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 477 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 425 to 428 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 612 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 324 to 327 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 39 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 102 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 217 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 181 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 229 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 270 to 276 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 83 to 86 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 332 to 336 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 101 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 240 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 179 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 383 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 434 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 455 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 495 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 584 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 619 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 623 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 623 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 627 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 to 303 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 355 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 425 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 455 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 487 to 489 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1113 to 1120 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 287 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 310 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 315 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 318 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 326 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 333 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 207 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 231 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 258 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 434 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 453 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 476 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 487 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 685 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 663 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 671 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 679 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 680 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 251 to 261 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 295 to 302 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 329 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 421 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 367 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 373 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 431 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 435 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 437 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 439 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 533 to 535 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 864 to 868 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 864 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 513 to 524 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 124 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 183 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 210 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 241 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 379 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 242 to 249 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 203 to 238 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 319 to 321 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 172 to 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 320 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 285 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 357 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 374 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 375 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 265 to 270 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 220 to 227 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 1 to 9 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 189 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 218 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 308 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 345 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 349 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 486 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 489 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 810 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 300 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 355 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 499 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 503 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 503 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 12 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 12 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 78 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 105 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 108 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 109 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 413 to 415 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 529 to 530 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 439 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 520 to 523 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 762 to 769 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 442 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 446 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 43 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 76 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 311 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 208 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 226 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 249 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 272 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 284 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 37 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 82 to 86 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 29 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 123 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 286 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 289 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 333 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 73 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 373 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 298 to 302 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 26 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 79 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 157 to 162 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 213 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 205 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 421 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 162 to 171 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 377 to 381 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 891 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1005 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1011 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 676 to 680 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 700 to 704 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1044 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1063 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1071 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1074 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 618 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 621 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 49 forms a bond with tridecanoate, indicating a strong binding affinity.
The residue at position 65 forms a bond with tridecanoate, indicating a strong binding affinity.
The residue at position 433 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 435 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 447 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 1138 to 1145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 96 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 667 to 675 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 467 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 243 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 45 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 65 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 74 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 186 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 217 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 463 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 481 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 490 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 599 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 603 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 630 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 880 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 899 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 908 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 1012 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 313 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 433 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 481 to 482 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 506 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 548 to 556 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 to 24 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 379 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 250 to 255 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 78 to 81 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 280 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 281 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 345 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 57 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 265 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 251 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 28 to 36 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 to 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 428 to 432 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 177 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 145 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 160 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 477 to 484 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 827 to 834 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1097 to 1104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 594 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 657 to 658 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 401 to 408 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 to 271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 389 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 391 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1772 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2074 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2076 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 284 to 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 438 to 440 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 348 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 1561 to 1569 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1584 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 408 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 428 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 123 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 455 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 10 to 33 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 762 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 766 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 766 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 983 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1297 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 1328 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 253 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 294 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 298 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 302 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 134 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 to 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 245 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 251 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 290 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 292 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 326 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 328 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 330 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 332 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 337 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 112 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 157 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 160 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 170 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 171 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 174 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 177 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 186 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 188 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 264 to 266 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 230 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 to 308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 71 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 90 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 154 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 211 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 36 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 7 to 9 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 136 to 257 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 205 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 258 to 401 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 57 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 379 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 426 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 327 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 205 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 315 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 375 to 381 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 490 to 492 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 254 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 269 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 329 to 335 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 239 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 239 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 239 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 243 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 243 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 243 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 309 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 309 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 309 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 332 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 332 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 332 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 336 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 336 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 336 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 336 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 344 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 344 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 344 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 420 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 420 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 420 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 420 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 435 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 435 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 435 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 437 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 437 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 437 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with (E)-caffeoyl-AMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with (E)-feruloyl-AMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 446 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 492 to 624 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 613 to 740 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 779 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 73 to 103 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 240 to 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 168 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 294 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 392 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 415 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 to 97 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1301 to 1308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 282 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 501 forms a bond with kainate, indicating a strong binding affinity.
The residue at position 506 forms a bond with kainate, indicating a strong binding affinity.
The residue at position 675 forms a bond with kainate, indicating a strong binding affinity.
The residue at position 676 forms a bond with kainate, indicating a strong binding affinity.
The residue at position 726 forms a bond with kainate, indicating a strong binding affinity.
The residue at position 1213 to 1220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1240 to 1247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 to 241 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 to 379 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 469 to 479 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 to 113 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 621 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 247 to 252 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 529 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 218 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 507 to 511 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 561 to 564 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 327 to 329 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 332 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 367 to 369 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 390 to 391 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 414 to 418 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 126 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 145 forms a bond with a carboxymycobactin, indicating a strong binding affinity.
The residue at position 154 forms a bond with a carboxymycobactin, indicating a strong binding affinity.
The residue at position 154 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 158 forms a bond with a carboxymycobactin, indicating a strong binding affinity.
The residue at position 52 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 110 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 136 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 148 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 136 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 136 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 169 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 169 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 391 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 391 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 182 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 334 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 353 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 390 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 42 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 96 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 184 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 352 to 353 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 440 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 451 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 372 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 413 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 481 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 341 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 994 to 999 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 to 98 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 410 to 417 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 625 to 632 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 964 to 971 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 1509 to 1516 forms a bond with ATP 4, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 703 to 706 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 720 to 724 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 732 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 737 to 739 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 788 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 791 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 57 to 64 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 58 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 146 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 232 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 422 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 480 to 481 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 170 to 176 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 259 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 176 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 106 to 109 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 150 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 361 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 382 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 39 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 78 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 872 to 880 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 900 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 367 to 373 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 418 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 437 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 558 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 596 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 615 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 715 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 767 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 802 to 804 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 476 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 241 to 247 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 480 to 485 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 43 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 388 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 422 to 424 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 126 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 174 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 322 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 378 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 490 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 579 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 614 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 614 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 625 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 498 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 618 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 654 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 116 to 121 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 385 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 509 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 598 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 610 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 615 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 651 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 654 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 669 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 672 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 343 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 61 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 146 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 106 forms a bond with D-sorbitol, indicating a strong binding affinity.
The residue at position 106 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 320 forms a bond with D-sorbitol, indicating a strong binding affinity.
The residue at position 320 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 322 forms a bond with D-sorbitol, indicating a strong binding affinity.
The residue at position 322 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 345 forms a bond with D-sorbitol, indicating a strong binding affinity.
The residue at position 345 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 375 forms a bond with D-sorbitol, indicating a strong binding affinity.
The residue at position 375 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 19 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 122 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 163 to 172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 to 413 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 418 to 424 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 262 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 614 to 625 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 328 to 329 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 384 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 479 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 209 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 144 to 149 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 196 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 247 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 335 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 341 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 371 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 110 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 170 to 174 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 202 to 208 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 223 to 246 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 379 to 381 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 27 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 38 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 85 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 114 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 164 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 212 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 457 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 479 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 483 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 570 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 688 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 713 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 301 to 308 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 77 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 148 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 151 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 548 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 79 to 84 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 235 to 241 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 340 to 341 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 to 375 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 424 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 623 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 625 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 627 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 634 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 655 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 657 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 659 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 664 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 103 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 184 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 186 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 232 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 345 to 355 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 136 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 140 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 306 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 94 to 102 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 227 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 54 forms a bond with (12R)-hydroxy-(9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 54 forms a bond with (9Z)-hexadecenoate, indicating a strong binding affinity.
The residue at position 54 forms a bond with leukotriene B4, indicating a strong binding affinity.
The residue at position 85 forms a bond with (12R)-hydroxy-(9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 85 forms a bond with (9Z)-hexadecenoate, indicating a strong binding affinity.
The residue at position 87 forms a bond with (9Z)-hexadecenoate, indicating a strong binding affinity.
The residue at position 87 forms a bond with leukotriene B4, indicating a strong binding affinity.
The residue at position 107 forms a bond with (12R)-hydroxy-(9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 107 forms a bond with leukotriene B4, indicating a strong binding affinity.
The residue at position 119 forms a bond with (12R)-hydroxy-(9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 119 forms a bond with leukotriene B4, indicating a strong binding affinity.
The residue at position 121 forms a bond with (12R)-hydroxy-(9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 121 forms a bond with leukotriene B4, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with 2',3',3'-c-tri-AMP, indicating a strong binding affinity.
The residue at position 449 forms a bond with 2',3',3'-c-tri-AMP, indicating a strong binding affinity.
The residue at position 454 forms a bond with 2',3',3'-c-tri-AMP, indicating a strong binding affinity.
The residue at position 28 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1506 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1508 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1511 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1514 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 294 to 301 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 587 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 280 forms a bond with indeglitazar, indicating a strong binding affinity.
The residue at position 314 forms a bond with indeglitazar, indicating a strong binding affinity.
The residue at position 464 forms a bond with indeglitazar, indicating a strong binding affinity.
The residue at position 1117 forms a bond with ganglioside GT1b (d18:1(4E)), indicating a strong binding affinity.
The residue at position 1203 forms a bond with ganglioside GT1b (d18:1(4E)), indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 87 to 92 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 388 to 390 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 412 to 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 372 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 374 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 2174 to 2181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 965 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1037 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1173 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1211 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1213 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 975 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 975 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 981 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1037 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1037 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 15 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 71 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 92 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 286 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 210 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 295 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 36 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 36 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 244 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 369 to 371 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 466 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 114 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 202 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 208 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 238 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 777 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 779 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 798 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 800 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 849 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 262 to 270 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 277 to 285 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 164 to 172 forms a bond with folate, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 225 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 319 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 763 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 763 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 763 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 769 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 769 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 769 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 810 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 810 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 810 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 938 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 938 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 938 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 53 to 57 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 119 to 125 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 151 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 333 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 362 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 364 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 366 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 368 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 408 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 411 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 451 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 455 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 286 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 397 to 399 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 632 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 635 to 636 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 638 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 691 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 698 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 269 to 275 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 201 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 128 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 163 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 255 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 494 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1296 to 1303 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 189 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 213 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 127 to 134 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 474 to 475 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 279 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 65 to 71 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 298 to 302 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 107 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 121 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 321 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 9 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 270 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 35 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 163 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 164 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 165 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 166 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 174 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 175 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 176 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 449 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 543 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 611 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 183 to 203 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 403 to 405 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 445 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 372 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 475 to 480 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 79 to 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 to 370 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 117 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 177 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 108 to 114 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 276 to 284 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 66 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 184 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 263 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 270 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 159 to 163 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 385 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 391 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 424 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 427 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 1469 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 4 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1557 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1589 to 1595 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1633 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 forms a bond with N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 254 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 258 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 319 forms a bond with N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 346 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 320 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 458 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 461 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 465 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 12 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 85 to 92 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 399 to 406 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 105 to 109 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 105 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 105 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 148 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 134 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 580 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 377 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 90 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 120 to 125 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 147 to 153 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 174 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 69 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 217 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 218 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 152 to 156 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 193 forms a bond with Co of cob(II)alamin, indicating a strong binding affinity.
The residue at position 245 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 248 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 292 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 130 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 294 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 404 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 466 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 471 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 498 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 504 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 508 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 529 to 531 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 562 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 614 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 617 to 618 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 620 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 688 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 175 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 255 to 265 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 299 to 306 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 333 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 423 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 14 to 43 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 420 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 459 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 515 to 523 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with a tetrapyrrole, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 415 to 424 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 674 to 681 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 1139 to 1191 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1192 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1198 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1203 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 102 forms a bond with folate, indicating a strong binding affinity.
The residue at position 106 forms a bond with folate, indicating a strong binding affinity.
The residue at position 123 to 127 forms a bond with folate, indicating a strong binding affinity.
The residue at position 156 to 161 forms a bond with folate, indicating a strong binding affinity.
The residue at position 195 forms a bond with folate, indicating a strong binding affinity.
The residue at position 160 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 161 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 173 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 246 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 252 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 273 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 279 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 267 to 272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 343 to 344 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1077 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1077 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1079 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1083 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1083 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1089 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1091 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1129 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1135 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1140 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1161 to 1163 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1201 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1365 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1368 to 1369 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1371 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1424 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1426 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1431 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 566 to 573 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1416 to 1423 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 153 to 172 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 370 to 371 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 318 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 611 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 632 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 634 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 111 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 197 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 218 to 222 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 181 to 216 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 412 to 419 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 373 to 379 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 210 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 264 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 267 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 317 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 110 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 288 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 318 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 444 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 552 to 553 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 189 to 197 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 2239 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 192 to 197 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 188 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 328 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 711 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 713 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 745 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 777 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 830 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 909 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 591 to 592 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 27 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 294 to 304 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 628 to 629 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 84 to 91 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 315 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 147 to 151 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 239 to 243 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 169 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 222 to 228 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 291 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 110 to 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 to 160 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 53 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 212 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 223 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 92 to 123 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 383 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 385 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1050 to 1057 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 348 to 356 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 87 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 116 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 260 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 607 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 609 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 613 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 691 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 404 to 406 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 446 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 to 77 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 128 to 134 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 145 to 149 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 217 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 301 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 139 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 790 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 864 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 665 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 673 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 681 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 682 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 495 to 500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 29 forms a bond with UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate, indicating a strong binding affinity.
The residue at position 31 forms a bond with UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate, indicating a strong binding affinity.
The residue at position 184 forms a bond with UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate, indicating a strong binding affinity.
The residue at position 229 forms a bond with UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate, indicating a strong binding affinity.
The residue at position 308 forms a bond with UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate, indicating a strong binding affinity.
The residue at position 309 forms a bond with UDP-2-acetamido-2-deoxy-alpha-D-ribo-hex-3-uluronate, indicating a strong binding affinity.
The residue at position 104 to 107 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 185 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 431 to 436 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 481 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 488 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 515 to 520 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 105 to 112 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 848 to 855 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 540 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 294 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 331 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 335 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 472 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 479 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 788 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 37 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 878 to 886 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 905 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1028 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1060 to 1066 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 517 to 519 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1198 to 1200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1205 to 1209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 215 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 278 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 280 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 282 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 324 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 328 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 52 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 54 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 88 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 1231 to 1238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1025 to 1032 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 241 forms a bond with heme, indicating a strong binding affinity.
The residue at position 261 forms a bond with heme, indicating a strong binding affinity.
The residue at position 296 forms a bond with heme, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 332 forms a bond with heme, indicating a strong binding affinity.
The residue at position 55 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 63 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 67 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 86 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 96 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 41 to 43 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 631 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 656 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 383 to 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 519 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 521 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 528 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 662 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 683 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 123 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 488 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 177 to 182 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 265 to 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 112 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 112 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 155 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 98 to 103 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 93 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 332 to 336 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 336 to 339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 212 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with Co(2+) 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Co(2+) 2, indicating a strong binding affinity.
The residue at position 323 to 346 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 380 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 250 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 192 to 198 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 249 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 259 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 62 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 66 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 67 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 181 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 185 to 188 forms a bond with beta-D-mannose, indicating a strong binding affinity.
The residue at position 262 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 364 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 459 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 714 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 716 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 135 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 163 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 284 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 218 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 to 413 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 286 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 147 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 277 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 369 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 588 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 656 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 657 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 696 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 15 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 775 to 779 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 778 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 823 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 827 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 879 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 966 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1163 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1218 to 1219 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 481 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 68 to 74 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 56 to 61 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 88 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 411 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 483 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 525 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 582 to 584 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 606 to 607 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 525 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 591 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 595 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 40 to 64 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 176 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 339 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 51 to 78 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 79 to 167 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 211 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 240 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 267 forms a bond with UDP-alpha-D-galactofuranose, indicating a strong binding affinity.
The residue at position 408 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 281 to 287 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 174 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 257 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 201 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 241 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 241 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 362 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 512 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 517 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 520 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 548 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 529 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 864 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 502 to 509 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 552 to 556 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 606 to 609 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 222 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 241 to 247 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 510 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 549 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 567 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 904 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 909 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 922 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 928 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 953 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 958 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 971 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 977 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1011 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1030 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 61 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 30 to 32 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 590 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 648 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 661 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 721 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 75 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 163 to 172 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 378 to 382 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 405 to 406 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1703 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1705 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1711 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 472 to 478 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 519 to 522 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 685 to 686 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 386 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 386 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 386 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 390 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 390 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 401 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 401 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 443 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 476 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 476 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 476 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 41 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 142 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 91 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 142 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 244 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 299 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 2336 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2338 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2340 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2342 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2379 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2381 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2383 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2385 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 3 to 7 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 239 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 294 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 337 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 351 to 358 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 351 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 216 to 220 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 263 to 269 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1058 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1080 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1083 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 275 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 412 to 413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 291 to 297 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 323 to 326 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 205 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 320 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 350 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 319 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 336 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 344 to 351 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 283 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 317 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 355 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 470 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 500 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 550 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1286 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 317 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 321 to 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 848 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 861 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 169 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 208 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 262 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 336 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 476 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 547 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 552 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 553 forms a bond with XMP, indicating a strong binding affinity.
The residue at position 69 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 198 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 223 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 257 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 343 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 5 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 410 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 482 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 112 to 116 forms a bond with pyridine, indicating a strong binding affinity.
The residue at position 1171 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1173 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1174 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1176 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1179 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 115 to 122 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 12 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 12 forms a bond with tobramycin, indicating a strong binding affinity.
The residue at position 139 forms a bond with carbamoyl adenylate, indicating a strong binding affinity.
The residue at position 168 forms a bond with carbamoyl adenylate, indicating a strong binding affinity.
The residue at position 172 forms a bond with carbamoyl adenylate, indicating a strong binding affinity.
The residue at position 172 forms a bond with tobramycin, indicating a strong binding affinity.
The residue at position 228 forms a bond with tobramycin, indicating a strong binding affinity.
The residue at position 310 forms a bond with carbamoyl adenylate, indicating a strong binding affinity.
The residue at position 314 forms a bond with carbamoyl adenylate, indicating a strong binding affinity.
The residue at position 418 to 419 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 498 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 528 to 530 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 941 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 943 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 856 to 860 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 865 to 871 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 895 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 198 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 204 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 392 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 404 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 445 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 448 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 463 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 466 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 524 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 545 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 152 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 242 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 243 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 312 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 315 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 331 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 347 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 348 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 423 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 399 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 427 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 452 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 141 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 349 to 370 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 392 to 411 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 234 to 241 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 500 to 507 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 288 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 83 to 87 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 301 to 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 593 to 598 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 953 to 960 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 377 to 385 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 399 to 402 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 167 to 172 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 21 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 23 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 69 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 142 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 175 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 205 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 283 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 284 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 708 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 712 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 717 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 736 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 738 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 742 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 747 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 801 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 803 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 805 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 807 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 217 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 322 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 96 to 100 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 267 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 395 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 350 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 377 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 401 to 404 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 407 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 412 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 419 to 420 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 484 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 488 to 492 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 499 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 210 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 308 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 356 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 478 to 486 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 158 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 167 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 189 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 340 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 342 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 792 to 799 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 840 to 844 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 898 to 901 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 137 to 143 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 297 to 305 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 159 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 167 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 167 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 175 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 178 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 184 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 69 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 262 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 266 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 304 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 305 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 306 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 218 to 279 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 418 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 84 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 124 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 233 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 215 to 221 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 480 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 708 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 714 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 51 to 59 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 188 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 190 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 202 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 344 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 346 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 372 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 88 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 34 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 51 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 139 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 225 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 242 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 242 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 434 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 434 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 192 to 200 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 7 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 58 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 60 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with rosiglitazone, indicating a strong binding affinity.
The residue at position 351 forms a bond with rosiglitazone, indicating a strong binding affinity.
The residue at position 477 forms a bond with rosiglitazone, indicating a strong binding affinity.
The residue at position 501 forms a bond with rosiglitazone, indicating a strong binding affinity.
The residue at position 159 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 297 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 385 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 458 to 559 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 491 to 498 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 72 forms a bond with a rhodoquinol, indicating a strong binding affinity.
The residue at position 72 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 76 forms a bond with a rhodoquinol, indicating a strong binding affinity.
The residue at position 76 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 612 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 106 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 170 to 174 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 337 to 342 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 370 to 371 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 571 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 241 to 250 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 531 to 533 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 538 to 544 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 115 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 115 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 158 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 158 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 89 to 95 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 122 to 131 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 23 to 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 843 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 207 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 209 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 305 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 106 forms a bond with (5Z,8Z,11Z,14Z)-eicosatetraenoate, indicating a strong binding affinity.
The residue at position 106 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with (5Z,8Z,11Z,14Z)-eicosatetraenoate, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 298 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 390 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 201 to 208 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 315 to 319 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 380 to 383 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 240 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 769 to 779 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 158 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 158 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 499 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 501 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 164 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 592 to 594 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 618 to 621 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 651 to 656 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 671 to 672 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 694 to 695 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 778 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 825 to 827 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 240 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 244 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 69 to 73 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 37 to 42 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 127 to 134 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 255 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 1039 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1148 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1200 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 82 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 217 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 383 to 399 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 104 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 132 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 976 to 983 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 587 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 596 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 669 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 680 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 709 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 711 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 713 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 715 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 720 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 331 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 377 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 403 to 405 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 412 to 418 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 103 to 107 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 103 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 103 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 146 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 146 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 1011 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 46 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 185 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 189 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 71 to 79 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 377 to 383 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 431 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 93 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 307 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 265 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1110 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1119 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 423 to 434 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 506 to 511 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 559 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 561 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 714 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 715 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 725 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 531 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 531 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 121 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 158 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 212 forms a bond with ADP-D-ribose, indicating a strong binding affinity.
The residue at position 277 to 313 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 39 to 46 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 264 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 309 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 597 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 428 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 454 to 455 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 388 to 390 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 394 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 459 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 464 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 208 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 224 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 349 to 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 453 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 455 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 459 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 512 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 29 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 234 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 704 to 707 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 721 to 725 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 733 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 738 to 740 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 430 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 476 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 577 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 602 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 692 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 695 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 774 to 782 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 277 to 281 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 462 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 462 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 503 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 503 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 620 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 623 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 671 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 671 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 674 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 674 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 510 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 510 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 541 to 542 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 587 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 625 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 625 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 631 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 333 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 138 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 139 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 187 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 341 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 397 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 449 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 510 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 589 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 635 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 171 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 298 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 313 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 337 to 341 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 442 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 88 to 96 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 126 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 200 to 204 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 111 to 119 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 223 to 227 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 434 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 503 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 513 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 202 to 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 515 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 516 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 517 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 459 to 466 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 244 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 300 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 320 to 321 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 326 to 328 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 335 to 341 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 347 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 199 to 204 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 73 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 76 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 456 to 464 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 436 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 439 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 468 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 475 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 479 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 563 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 601 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 608 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 618 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 628 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 723 to 730 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 143 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 156 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 188 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 215 forms a bond with (S)-2-hydroxypropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 276 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 272 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 331 to 333 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 343 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 347 forms a bond with O2, indicating a strong binding affinity.
The residue at position 478 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 480 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 232 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 325 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 358 to 360 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 381 to 382 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 405 to 409 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 435 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 494 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 495 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 529 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 144 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 353 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 195 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 695 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 823 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 823 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 838 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 839 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 843 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 844 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 582 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 624 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with (-)-pinoresinol, indicating a strong binding affinity.
The residue at position 177 forms a bond with (-)-pinoresinol, indicating a strong binding affinity.
The residue at position 178 forms a bond with (-)-pinoresinol, indicating a strong binding affinity.
The residue at position 7 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 62 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 155 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 185 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 188 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 350 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 369 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 432 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 433 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 501 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 12 to 16 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 114 to 167 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 114 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 255 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 358 to 360 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 406 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 521 to 523 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 528 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 694 to 695 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 743 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 138 to 141 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 219 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 71 to 76 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 209 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 113 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 421 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 423 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 442 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 445 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 98 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 98 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 662 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 670 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 678 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 679 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 234 to 239 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 466 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 468 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 470 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 344 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 303 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 423 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 440 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 136 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 132 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 132 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 263 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 320 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 340 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 89 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 91 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 328 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 360 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 425 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 1073 to 1079 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 16 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 386 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 21 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 292 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 395 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 147 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 149 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 168 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 175 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 404 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 159 to 168 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 372 to 376 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 282 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 863 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 28 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 108 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 104 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 168 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 747 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 333 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 412 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 414 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 487 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 47 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 287 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 344 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 383 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 388 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 399 to 401 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 49 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 104 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 108 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 145 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 12 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 35 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 903 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 903 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 904 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 947 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 947 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 154 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 189 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 292 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 286 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 466 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 156 to 191 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 19 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 114 to 122 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 63 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 118 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 154 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 24 to 28 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 215 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 520 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 525 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 690 to 692 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 739 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 6 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 10 forms a bond with O2, indicating a strong binding affinity.
The residue at position 57 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 283 to 290 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 373 to 377 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 430 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 796 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 827 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 831 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 909 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 941 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 943 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1039 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1108 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 55 to 60 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 234 to 239 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 529 to 536 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 178 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 272 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 218 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 620 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 621 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 628 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 628 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 337 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 59 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 307 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 308 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 309 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 166 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 265 to 277 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1521 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1553 to 1559 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1597 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 521 to 528 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 128 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 390 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 234 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 245 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 272 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 478 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 501 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 504 to 505 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 237 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 298 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 433 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 460 to 464 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 464 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 684 to 692 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 75 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 666 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 669 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 945 to 952 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 191 to 197 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 449 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 452 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 453 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 487 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 490 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 491 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 496 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with folate, indicating a strong binding affinity.
The residue at position 540 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 12 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 80 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 152 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 181 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 212 to 213 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 278 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 346 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 347 to 352 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 695 to 702 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 696 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 758 to 762 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 761 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 806 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 862 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 949 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 214 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 225 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 178 to 184 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 1117 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 261 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 356 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 394 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 533 to 534 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 84 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 150 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 270 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 437 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 226 to 233 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 273 to 277 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 293 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 348 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 366 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 367 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 368 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 370 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 370 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 388 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 245 to 250 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 343 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 423 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 478 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 26 forms a bond with glutathione 2, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with glutathione 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with glutathione 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with glutathione 1, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with glutathione 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with glutathione 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with glutathione 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 134 to 142 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 176 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 307 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 281 to 288 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 209 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 236 to 241 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 108 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 111 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 115 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 145 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 154 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 164 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 176 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 402 to 403 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 463 to 469 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 509 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 824 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 827 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 82 to 87 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 156 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1124 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1251 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 279 to 280 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 571 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 584 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 798 to 804 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 859 to 861 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 886 to 894 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 955 to 957 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1097 to 1098 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1102 to 1103 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 301 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 375 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 376 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 380 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 476 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 480 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 482 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 483 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 99 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 128 to 135 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 27 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 46 forms a bond with heme, indicating a strong binding affinity.
The residue at position 517 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 552 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 571 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 643 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 683 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 718 to 720 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 324 to 328 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 167 to 174 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 193 to 201 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 728 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 348 to 352 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 661 to 782 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 778 to 918 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 891 to 898 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 99 to 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 83 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 224 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 268 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 353 to 356 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 327 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 to 335 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 47 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 214 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 253 to 255 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 258 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 376 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 115 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 432 to 433 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 42 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 101 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 137 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 139 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 1271 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 380 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 512 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 575 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 155 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 163 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 245 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 252 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 772 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 772 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 774 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 281 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 439 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 31 to 32 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 70 to 73 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 144 to 157 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 149 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 768 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 804 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 805 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 805 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 1023 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 48 to 77 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 348 to 353 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 301 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 325 to 331 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 327 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 555 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 581 to 582 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 603 to 604 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 253 to 256 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 426 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 464 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 489 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 516 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 521 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 537 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 626 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 76 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 77 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 78 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 165 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 166 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 200 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 201 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 224 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 227 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 255 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 410 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 40 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 210 to 272 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 92 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 193 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 308 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 338 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 53 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 287 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 460 to 461 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 471 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 810 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 826 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 831 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 834 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 854 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 418 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 420 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 537 to 538 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 53 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 55 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 57 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 90 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 180 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 263 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 298 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 304 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 305 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 348 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 362 forms a bond with alpha-L-iduronate, indicating a strong binding affinity.
The residue at position 504 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 700 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 718 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 721 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 724 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 747 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 750 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 379 to 383 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 47 to 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 915 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 918 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 931 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 934 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 939 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 942 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 258 to 263 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 46 to 65 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 328 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 448 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 263 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 236 to 240 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 412 to 415 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 419 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 438 to 441 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 514 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 234 to 240 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 269 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 92 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 459 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 609 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 401 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 401 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 442 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 442 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 442 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 559 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 562 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 610 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 610 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 613 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 613 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 98 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 266 to 271 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with L-cysteine residue of a protein, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 300 to 306 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 332 to 335 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 89 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 154 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 183 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 216 to 223 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 247 to 251 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 266 to 268 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 487 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 513 to 514 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 536 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 563 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 723 to 732 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 799 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 807 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 824 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 330 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 1281 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1378 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1381 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1438 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1465 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1506 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1508 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 434 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 468 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 472 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 495 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 498 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 501 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 505 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 524 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 527 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 530 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 534 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 94 to 123 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 53 to 67 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 285 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 286 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 252 to 257 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 168 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 237 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 271 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 273 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 279 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 286 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 129 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 58 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 23 forms a bond with 2,6-dihydroxybenzoate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 2,6-dihydroxybenzoate, indicating a strong binding affinity.
The residue at position 287 forms a bond with 2,6-dihydroxybenzoate, indicating a strong binding affinity.
The residue at position 709 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 734 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 153 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 158 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 688 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 39 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 359 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 389 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 223 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 373 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 466 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 719 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 722 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 725 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 729 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 776 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 779 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 782 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 786 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 1542 to 1553 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1685 to 1695 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 37 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 514 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 180 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 619 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 622 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 2126 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2129 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2160 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2163 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2175 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2177 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 355 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 290 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 359 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 398 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 727 to 728 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 741 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 870 to 875 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 316 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 347 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 398 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 1280 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1375 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 314 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 387 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 411 to 414 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 315 to 322 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 416 to 419 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 263 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 267 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 355 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 356 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 368 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 461 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 465 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 467 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 468 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 56 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 160 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 314 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 770 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 771 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 814 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 814 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 37 to 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 471 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 472 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 241 to 243 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 132 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 30 to 33 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 17 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 95 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 123 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 207 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 263 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 98 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 159 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 162 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 98 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 216 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 295 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 377 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 141 to 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 452 to 456 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 3 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 4 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 5 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 5 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 29 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 65 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 70 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 74 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 178 to 185 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 235 to 238 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 457 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 629 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 24 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 252 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 258 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1094 to 1101 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 425 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 296 to 317 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 339 to 358 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 144 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 26 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 132 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 167 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 236 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 260 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 263 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 1077 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1112 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1113 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1133 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1134 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1136 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1186 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1188 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1308 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1309 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1311 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1354 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1355 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 249 to 255 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 905 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 948 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 91 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 95 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 154 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 312 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 369 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 142 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 573 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 575 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 577 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 783 to 930 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 946 to 1070 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 468 to 475 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 427 to 431 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 170 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 321 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 568 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 47 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 48 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 168 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 182 forms a bond with validamine 7-phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 295 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 321 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 366 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 383 to 386 forms a bond with validamine 7-phosphate, indicating a strong binding affinity.
The residue at position 387 to 388 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 391 forms a bond with GDP-valienol, indicating a strong binding affinity.
The residue at position 29 forms a bond with D-galactonate, indicating a strong binding affinity.
The residue at position 32 forms a bond with D-galactonate, indicating a strong binding affinity.
The residue at position 64 forms a bond with D-galactonate, indicating a strong binding affinity.
The residue at position 358 forms a bond with D-galactonate, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 93 to 123 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 18 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 427 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 436 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 24 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 119 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 120 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 139 to 143 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 120 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 190 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 293 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 296 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 339 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 339 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 537 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 539 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 84 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 40 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 18 to 25 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 56 to 61 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 60 to 63 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 98 to 107 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 380 to 383 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 412 to 415 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 452 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 507 to 508 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 589 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 139 to 194 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 918 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 920 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 922 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 231 to 249 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 8 to 36 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 226 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 249 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 174 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 305 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 473 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 491 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 494 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 821 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 229 to 234 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 762 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 766 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 766 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 983 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 227 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 231 to 232 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 245 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 257 to 271 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 687 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 695 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 568 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 565 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 166 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 205 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 214 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 129 to 260 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 261 to 378 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 285 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 345 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 845 to 853 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 870 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 556 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 758 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 758 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 760 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 561 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 126 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 69 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 175 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 260 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 342 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 342 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 353 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 353 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 65 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 160 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 405 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 356 forms a bond with heme, indicating a strong binding affinity.
The residue at position 77 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 1349 to 1356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with glycochenodeoxycholate, indicating a strong binding affinity.
The residue at position 158 forms a bond with glycochenodeoxycholate, indicating a strong binding affinity.
The residue at position 42 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 80 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 156 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 177 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 200 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 244 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 177 to 180 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 301 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 356 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 371 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 372 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 383 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 394 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 401 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 411 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 560 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 596 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 597 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 726 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 118 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 533 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 197 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 201 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 205 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 208 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 671 to 679 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 73 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 114 to 123 forms a bond with monodehydro-L-ascorbate radical, indicating a strong binding affinity.
The residue at position 92 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 123 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 159 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 419 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 1284 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1299 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1308 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1311 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1321 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1325 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 202 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 242 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 254 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 183 to 238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 170 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 223 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 226 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 227 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 264 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 267 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 266 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 286 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 103 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 167 to 171 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 329 to 332 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 534 to 538 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 29 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with bilirubin IXalpha, indicating a strong binding affinity.
The residue at position 351 to 353 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 176 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 299 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 70 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 141 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 312 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 321 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 325 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 343 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 249 to 252 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 325 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 900 to 908 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 to 25 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 147 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 157 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 584 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 100 to 119 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1411 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 134 to 141 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 281 to 285 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 954 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 318 to 323 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 14 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 16 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 16 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 196 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 152 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 156 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 477 to 480 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 497 to 501 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 578 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 21 to 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 47 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 210 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 258 to 263 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 918 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 174 to 181 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 845 to 852 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 321 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 352 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 427 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 116 to 117 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 161 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with (5Z,8Z,11Z,14Z)-eicosatetraenoate, indicating a strong binding affinity.
The residue at position 105 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with (5Z,8Z,11Z,14Z)-eicosatetraenoate, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 236 to 248 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with 3'cADPR, indicating a strong binding affinity.
The residue at position 289 forms a bond with 3'cADPR, indicating a strong binding affinity.
The residue at position 355 forms a bond with 3'cADPR, indicating a strong binding affinity.
The residue at position 373 forms a bond with 3'cADPR, indicating a strong binding affinity.
The residue at position 390 forms a bond with 3'cADPR, indicating a strong binding affinity.
The residue at position 398 forms a bond with 3'cADPR, indicating a strong binding affinity.
The residue at position 402 forms a bond with 3'cADPR, indicating a strong binding affinity.
The residue at position 682 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 810 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 810 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 825 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 826 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 451 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 520 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 238 to 245 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 265 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 203 to 209 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 83 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 309 to 316 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 60 to 67 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 107 to 111 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 235 to 242 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 282 to 286 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 347 to 350 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 296 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 498 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1217 to 1219 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1236 to 1237 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1292 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1417 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1420 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1432 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1435 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1441 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1444 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1457 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1465 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 418 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 88 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 140 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 401 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 576 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 414 to 416 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 710 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 769 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 772 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 791 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 to 93 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 180 to 212 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 229 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 295 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 5 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 181 to 187 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 356 to 359 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 365 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 389 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 399 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 430 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 698 to 705 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 657 to 660 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 717 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 745 to 746 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 945 to 949 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 287 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 37 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 91 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 179 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 295 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 432 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 443 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 253 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 155 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 164 forms a bond with (2R)-2-phosphoglycerate, indicating a strong binding affinity.
The residue at position 208 forms a bond with (2R)-2-phosphoglycerate, indicating a strong binding affinity.
The residue at position 322 forms a bond with (2R)-2-phosphoglycerate, indicating a strong binding affinity.
The residue at position 376 forms a bond with (2R)-2-phosphoglycerate, indicating a strong binding affinity.
The residue at position 377 forms a bond with (2R)-2-phosphoglycerate, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 219 to 224 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 64 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 116 to 117 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 207 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 198 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 265 to 271 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 297 to 302 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 141 to 147 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 301 to 309 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 303 to 304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 159 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 11 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 15 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 254 to 262 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1040 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 308 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 339 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 371 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 443 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 510 to 517 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1135 to 1142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 to 153 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 51 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 287 to 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 592 to 718 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 707 to 836 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 108 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 226 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 369 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 375 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 1 to 64 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 236 to 241 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 402 to 405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 412 to 414 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 492 to 495 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 148 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 to 136 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 144 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 191 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 311 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 494 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 570 to 571 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 607 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 609 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 611 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 737 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 741 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 821 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 822 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 822 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 937 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 937 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 988 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 507 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 509 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 561 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 238 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 283 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 303 to 304 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 318 to 324 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 259 to 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 154 to 210 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 355 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 444 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 492 to 493 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 517 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 462 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 49 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 173 to 178 forms a bond with streptomycin, indicating a strong binding affinity.
The residue at position 185 forms a bond with streptomycin, indicating a strong binding affinity.
The residue at position 19 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 20 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 21 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 31 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 46 to 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 493 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 323 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 270 to 273 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 18 to 25 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 260 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 405 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 450 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 148 to 180 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 169 to 199 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 272 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 38 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 625 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 26 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 51 to 53 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 84 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 663 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 397 to 398 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1125 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1134 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 174 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 231 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 306 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 46 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 206 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 293 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 398 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 391 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 22 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 209 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 316 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 378 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 319 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 401 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 427 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 478 to 480 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 256 to 259 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 263 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 507 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 509 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 547 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 1821 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1824 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1838 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1841 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1846 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1849 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1867 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1870 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 769 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 780 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 336 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 367 to 370 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 376 to 379 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 377 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 444 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 238 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 332 to 336 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 124 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 174 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 522 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 522 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 666 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 674 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 548 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 552 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 555 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 496 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 500 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 1037 to 1043 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1081 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 732 to 736 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 736 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 773 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 773 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 773 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 890 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 890 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 941 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 199 to 203 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 715 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 186 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 240 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 289 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 402 to 404 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 411 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 433 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 81 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 103 forms a bond with heme, indicating a strong binding affinity.
The residue at position 107 forms a bond with heme, indicating a strong binding affinity.
The residue at position 193 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 236 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 293 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 297 forms a bond with heme, indicating a strong binding affinity.
The residue at position 353 forms a bond with heme, indicating a strong binding affinity.
The residue at position 115 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 120 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 187 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 755 to 762 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 98 to 104 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 118 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 122 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 122 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 147 forms a bond with cyclosporin A, indicating a strong binding affinity.
The residue at position 340 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 347 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 382 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 386 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 196 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 197 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 232 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 255 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 258 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 529 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 538 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 541 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 543 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 591 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 591 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 593 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 598 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 605 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 612 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 612 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 616 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 618 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 621 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 45 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 146 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 331 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 400 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 53 to 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 78 to 93 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 429 to 430 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 257 to 264 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 766 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 797 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 879 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 911 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1009 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1078 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 412 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 415 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 419 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 459 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 517 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 546 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 581 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 969 to 976 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 1943 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 278 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 291 to 292 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 360 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 369 to 370 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 158 to 162 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 120 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 434 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 465 to 466 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 387 to 392 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 663 to 666 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 39 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 361 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 409 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 196 to 251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 to 234 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 528 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 460 to 466 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 448 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 147 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 324 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 328 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 352 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 453 to 456 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 499 to 500 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 753 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 726 to 727 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 740 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 869 to 874 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 468 to 476 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 973 to 978 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 694 to 702 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 246 to 258 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 259 forms a bond with a tetrapyrrole, indicating a strong binding affinity.
The residue at position 69 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 82 to 110 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 360 to 373 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 200 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 202 to 208 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 204 to 208 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 212 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 255 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 155 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 199 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 314 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 339 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 373 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 375 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 692 to 700 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 381 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 475 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 508 to 509 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 132 to 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 36 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 211 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 215 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 236 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 83 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 540 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 224 to 229 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 253 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 to 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 49 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 121 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 171 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 125 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 172 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 323 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 414 forms a bond with tRNA discriminator base of tRNA, indicating a strong binding affinity.
The residue at position 702 to 758 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 290 to 298 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 167 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 215 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 242 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 358 to 362 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 398 to 519 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 168 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 191 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 160 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 348 to 354 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 404 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 21 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 108 to 112 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 575 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 210 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 249 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 310 to 312 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 310 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with 16-epivellosimine, indicating a strong binding affinity.
The residue at position 100 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 129 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 153 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 115 to 121 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 142 to 148 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 357 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 361 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 113 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 114 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 115 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 203 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 204 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 238 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 239 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 262 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 265 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 293 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 324 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 452 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1432 to 1439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 151 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 246 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 254 to 283 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 388 to 421 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 552 to 562 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 555 to 562 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 601 to 605 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 655 to 658 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 7 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 68 to 69 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 212 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 226 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 to 236 forms a bond with (R)-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1192 to 1249 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1245 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1256 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1956 to 1970 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 861 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 117 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 321 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1083 to 1091 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 175 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 398 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 470 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 512 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 569 to 571 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 593 to 594 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 46 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 47 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 99 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 133 to 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 163 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 75 forms a bond with (6R)-5,10-methylenetetrahydrofolyl-(gamma-L-Glu)n, indicating a strong binding affinity.
The residue at position 82 forms a bond with (6R)-5,10-methylenetetrahydrofolyl-(gamma-L-Glu)n, indicating a strong binding affinity.
The residue at position 417 forms a bond with (6R)-5,10-methylenetetrahydrofolyl-(gamma-L-Glu)n, indicating a strong binding affinity.
The residue at position 9 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 to 179 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 663 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 671 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 679 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 680 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 394 to 398 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 460 to 463 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 331 to 341 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 345 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 416 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 118 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 271 to 284 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 201 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 208 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 15 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 15 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 18 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 49 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 166 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 55 to 62 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 335 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 383 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 251 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 471 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 509 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 256 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 147 to 157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 289 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 292 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 625 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 179 to 186 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 866 to 873 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 367 to 368 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 528 to 529 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 528 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 366 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 367 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 59 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 85 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 161 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 223 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 469 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 572 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 631 to 633 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 738 to 741 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 402 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 94 to 100 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 358 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 382 to 385 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 433 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 437 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 63 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 65 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 56 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 95 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 175 to 179 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 466 to 468 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 502 to 508 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 529 to 536 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 28 to 35 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 272 to 281 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 583 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 583 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 699 to 703 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 700 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 732 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 833 to 834 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 833 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 885 to 888 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 892 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 911 to 914 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 987 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 147 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with glycine betaine, indicating a strong binding affinity.
The residue at position 253 forms a bond with glycine betaine, indicating a strong binding affinity.
The residue at position 373 to 377 forms a bond with glycine betaine, indicating a strong binding affinity.
The residue at position 200 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 39 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 68 to 73 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 95 to 101 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 118 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 860 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1818 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1835 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1843 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1864 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 12 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 12 forms a bond with pyridoxamine, indicating a strong binding affinity.
The residue at position 47 forms a bond with pyridoxamine, indicating a strong binding affinity.
The residue at position 148 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 235 forms a bond with pyridoxamine, indicating a strong binding affinity.
The residue at position 48 to 54 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 198 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 248 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 560 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 604 to 607 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 325 to 341 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 437 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 262 to 281 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 471 to 473 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 496 to 498 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 513 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 530 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 19 forms a bond with heme, indicating a strong binding affinity.
The residue at position 22 forms a bond with heme, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 450 to 457 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 349 to 354 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 164 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 389 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 391 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 758 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 762 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 766 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 50 to 54 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 496 to 501 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 to 300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 339 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 660 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 805 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 90 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 619 to 627 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 325 to 337 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 450 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 356 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 411 to 414 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 418 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 437 to 440 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 513 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 592 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 75 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 101 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 108 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 73 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 173 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 188 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 258 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 366 forms a bond with 2-methylbutanoate, indicating a strong binding affinity.
The residue at position 388 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 390 forms a bond with monacolin J, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 196 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1761 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2068 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2070 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 90 to 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 130 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 204 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 244 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 419 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 421 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 428 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 75 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 109 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 128 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 235 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 270 to 272 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 276 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 322 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 40 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 320 to 329 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 50 to 74 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 882 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 to 299 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 15 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 17 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 65 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 160 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 190 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 220 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 295 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 296 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 327 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 362 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 362 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 364 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 366 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 366 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 370 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 373 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 117 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1096 to 1103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 942 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 945 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 948 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 950 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 64 to 69 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 64 to 69 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 129 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 183 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 351 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 355 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 359 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 50 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 88 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 233 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 341 to 344 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 398 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 652 to 654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 213 to 219 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 209 to 219 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 112 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 356 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 356 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 392 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 392 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 397 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 397 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 419 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 419 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 502 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 502 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 508 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 508 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 307 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 693 to 694 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 231 to 235 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 358 to 359 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 407 to 410 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 414 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 433 to 436 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 509 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 336 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 469 to 475 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 289 to 294 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 335 to 340 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 241 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 185 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1803 to 1848 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 220 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 243 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 91 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 95 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 116 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 196 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 336 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 342 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 399 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 454 to 455 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 483 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 493 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 583 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 201 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 206 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 132 to 138 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 60 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 105 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 175 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 218 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 449 to 452 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 550 to 554 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 592 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 124 to 133 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 554 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 555 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 36 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 253 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 158 to 162 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 107 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 156 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 377 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 380 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 382 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 614 to 618 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 712 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 817 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 833 to 837 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 300 to 308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 417 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 446 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 482 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 42 to 46 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1606 to 1613 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 214 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 49 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 54 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 122 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 92 to 100 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 89 to 122 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 219 to 285 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 351 to 358 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 273 forms a bond with alphaxolone, indicating a strong binding affinity.
The residue at position 326 to 330 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 420 to 427 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 374 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 72 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 to 228 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 723 to 727 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 727 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 727 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 789 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 873 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1050 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with heme, indicating a strong binding affinity.
The residue at position 483 to 488 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 512 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 521 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 404 to 408 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 295 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 397 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 402 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 464 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 495 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 529 to 538 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 616 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 201 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 456 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 393 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 397 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 43 to 47 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 233 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 15 to 70 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 24 to 30 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 546 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 766 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 73 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 131 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 131 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 222 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 161 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 380 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 388 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 201 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 204 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 258 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 660 to 667 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1319 to 1326 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 112 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 170 to 171 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 528 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 168 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 184 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 193 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 195 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 1192 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1377 to 1385 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 820 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 852 to 858 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 772 to 774 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 780 to 785 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 812 to 814 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 111 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 62 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 137 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 246 to 252 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 70 to 84 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 304 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 42 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 139 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 439 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 130 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 to 309 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 191 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 384 to 388 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 308 to 311 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 327 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 341 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 345 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 286 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 62 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 169 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 360 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 367 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 420 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 435 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 440 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 448 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 456 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 460 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 352 to 407 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 579 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 796 to 798 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 369 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 375 to 376 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 394 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 251 to 255 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 292 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 401 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 423 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 451 to 452 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 554 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 179 to 214 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 478 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 496 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 511 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 525 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 531 to 532 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 568 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 444 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 480 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 512 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 640 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 778 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 841 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 407 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 438 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 511 to 512 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 618 to 620 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 626 to 631 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 650 to 652 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 115 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 460 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 367 to 370 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 374 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 377 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 31 forms a bond with beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-D-Manp, indicating a strong binding affinity.
The residue at position 46 forms a bond with beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-D-Manp, indicating a strong binding affinity.
The residue at position 89 forms a bond with beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-D-Manp, indicating a strong binding affinity.
The residue at position 140 to 141 forms a bond with beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-D-Manp, indicating a strong binding affinity.
The residue at position 188 forms a bond with beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-D-Manp, indicating a strong binding affinity.
The residue at position 273 forms a bond with beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-D-Manp, indicating a strong binding affinity.
The residue at position 333 forms a bond with beta-D-Manp-(1->2)-beta-D-Manp-(1->2)-D-Manp, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 95 to 100 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 155 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 255 to 263 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 455 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 675 to 682 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 193 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 385 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 264 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 308 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 462 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 465 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 495 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 498 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 1012 to 1017 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 295 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 358 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 24 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 465 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 468 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 519 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 522 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 537 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 540 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 545 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 548 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 555 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 565 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 558 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 562 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 565 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 506 to 513 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 567 to 571 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 641 to 644 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 129 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 to 480 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 485 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 651 to 652 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 699 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 627 to 632 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1657 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 667 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 671 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 722 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 743 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 745 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 831 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 875 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 223 to 233 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 267 to 274 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 301 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 393 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 364 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 383 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 515 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 515 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 519 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 553 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 554 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 554 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 664 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 716 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 716 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 349 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 301 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 381 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 383 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 456 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 11 to 15 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 241 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 265 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 309 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 396 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 424 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 147 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 296 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 344 to 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 593 to 597 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 687 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 810 to 814 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 597 to 598 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 to 77 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 168 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 226 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 223 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 252 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 383 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 419 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 816 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 841 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 937 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 941 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 321 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 422 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 410 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 62 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 416 to 417 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 433 to 437 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 848 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 877 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 878 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 436 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 74 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 454 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 474 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 488 to 490 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 490 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 320 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 388 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 435 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 40 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 80 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 177 to 181 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 41 forms a bond with (S)-3-amino-3-phenylpropanoate, indicating a strong binding affinity.
The residue at position 40 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 237 to 243 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 101 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 107 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 111 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 380 to 382 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 642 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 645 to 646 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 648 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 701 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 703 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 708 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 302 forms a bond with tetradecanoyl-AMP, indicating a strong binding affinity.
The residue at position 322 forms a bond with tetradecanoyl-AMP, indicating a strong binding affinity.
The residue at position 323 forms a bond with tetradecanoyl-AMP, indicating a strong binding affinity.
The residue at position 327 forms a bond with tetradecanoyl-AMP, indicating a strong binding affinity.
The residue at position 418 forms a bond with tetradecanoyl-AMP, indicating a strong binding affinity.
The residue at position 435 forms a bond with tetradecanoyl-AMP, indicating a strong binding affinity.
The residue at position 439 forms a bond with tetradecanoyl-AMP, indicating a strong binding affinity.
The residue at position 135 to 150 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 156 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 210 to 218 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 276 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 325 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 326 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 413 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 158 to 162 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1306 to 1313 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 554 to 561 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 604 to 608 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 658 to 661 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 891 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 896 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 910 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 340 to 347 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 387 to 391 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 441 to 444 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 564 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 600 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 693 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 716 to 717 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 727 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 67 to 70 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 82 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 247 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 303 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 217 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 269 to 281 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 46 to 53 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 79 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1116 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 63 to 65 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 70 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 87 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 128 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 135 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 181 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 183 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 270 to 274 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 282 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 718 to 720 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 781 to 788 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 805 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 888 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 8 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 859 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 292 forms a bond with cannabigerolate, indicating a strong binding affinity.
The residue at position 417 forms a bond with cannabigerolate, indicating a strong binding affinity.
The residue at position 442 forms a bond with cannabigerolate, indicating a strong binding affinity.
The residue at position 481 to 483 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 286 forms a bond with heme, indicating a strong binding affinity.
The residue at position 343 forms a bond with heme, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 215 to 223 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 501 to 508 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 547 to 551 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 601 to 604 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 257 to 260 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 112 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1283 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1392 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1395 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1485 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1526 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1528 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with hexadecanoyl-CoA, indicating a strong binding affinity.
The residue at position 164 forms a bond with hexadecanoyl-CoA, indicating a strong binding affinity.
The residue at position 206 forms a bond with hexadecanoyl-CoA, indicating a strong binding affinity.
The residue at position 229 forms a bond with hexadecanoyl-CoA, indicating a strong binding affinity.
The residue at position 413 to 415 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 428 to 431 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 527 to 528 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 533 to 537 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 569 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 607 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 471 to 595 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 542 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 155 to 216 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 100 to 108 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 3 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 7 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 93 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 106 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 253 to 284 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 398 to 409 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 749 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 753 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 780 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 428 to 437 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 526 to 527 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 323 to 326 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 439 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 484 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 444 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 840 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 843 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 866 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1070 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 147 to 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 415 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 489 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 489 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 498 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 523 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 523 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 97 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 178 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 181 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 1378 to 1385 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 2290 to 2297 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 158 to 173 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 to 215 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 261 to 266 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 178 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 213 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 213 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 215 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 416 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 110 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 51 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 53 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 143 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 151 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 321 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 323 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 870 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 991 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 993 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 999 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1303 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1306 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1313 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1314 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1316 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1373 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1374 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 96 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 92 to 98 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 974 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 976 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 980 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 980 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1017 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1017 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1021 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1027 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1048 to 1050 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1085 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1112 to 1113 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1169 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1170 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1175 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 6 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 6 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 6 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 134 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 134 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 134 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 344 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 201 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 264 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 361 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 31 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 231 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 244 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 301 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 340 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 155 to 157 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 218 to 223 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 12 to 37 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 92 to 97 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 586 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 601 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 308 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 366 to 371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1069 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1110 to 1116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1154 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 117 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 393 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 475 to 480 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 481 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 412 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 148 to 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 289 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 87 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 879 to 883 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 879 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 287 to 290 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 34 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 56 to 68 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 311 to 320 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 318 to 320 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 95 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 696 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 785 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 788 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 789 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 789 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 894 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 166 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 253 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 16 to 23 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 20 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 22 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 314 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 316 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 319 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 431 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 485 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 486 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 116 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 252 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 to 128 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 116 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 200 to 202 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 217 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 292 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 216 to 224 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 to 107 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 20 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 207 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 82 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 36 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 92 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 166 to 167 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 567 to 575 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 465 to 472 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 335 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 339 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 410 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 414 to 418 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 425 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 375 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 216 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 492 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 352 to 356 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 to 282 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 352 to 353 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 318 forms a bond with suvorexant, indicating a strong binding affinity.
The residue at position 414 to 415 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 589 to 590 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 357 to 361 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 887 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 to 70 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 88 to 103 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 36 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 85 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 164 forms a bond with catechol, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with catechol, indicating a strong binding affinity.
The residue at position 83 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 164 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 43 forms a bond with heme, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 50 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 158 to 162 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 146 to 155 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 508 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 526 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 532 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 146 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 154 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 275 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 442 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 26 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 485 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 733 to 740 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 30 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 32 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 352 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 6 to 11 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 416 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 445 to 447 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 472 to 476 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 526 to 531 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 526 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 200 to 207 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 42 forms a bond with D-threitol, indicating a strong binding affinity.
The residue at position 121 forms a bond with D-threitol, indicating a strong binding affinity.
The residue at position 173 forms a bond with D-threitol, indicating a strong binding affinity.
The residue at position 224 forms a bond with D-threitol, indicating a strong binding affinity.
The residue at position 249 forms a bond with D-threitol, indicating a strong binding affinity.
The residue at position 269 forms a bond with D-threitol, indicating a strong binding affinity.
The residue at position 111 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 452 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 455 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 485 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 488 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 794 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 821 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 829 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 63 forms a bond with taurodeoxycholate, indicating a strong binding affinity.
The residue at position 372 to 380 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 17 to 22 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 378 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1106 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1174 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1184 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1186 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1202 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1211 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1271 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1287 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1293 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1295 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1297 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1300 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1329 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1795 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1810 to 1812 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1816 to 1818 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1826 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 198 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 200 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 233 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 235 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 250 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 267 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 267 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 271 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 306 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 308 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 308 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 339 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 341 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 361 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 382 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 413 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 415 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 415 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 428 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 447 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 450 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+) 13, indicating a strong binding affinity.
The residue at position 465 forms a bond with Ca(2+) 14, indicating a strong binding affinity.
The residue at position 480 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 482 forms a bond with Ca(2+) 11, indicating a strong binding affinity.
The residue at position 482 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 486 forms a bond with Ca(2+) 12, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 484 to 491 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 120 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 655 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 707 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 41 to 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 199 to 236 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 256 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 325 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 201 to 206 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 237 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 237 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 483 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 314 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 436 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1822 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2126 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2128 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 226 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 595 to 598 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 20 to 21 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 220 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 667 to 674 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 593 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 656 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 122 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 138 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 545 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 337 to 341 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 346 to 352 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 302 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 304 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 342 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 652 to 653 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 728 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 813 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 816 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 817 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 871 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 881 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 954 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 974 to 976 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 977 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 661 to 667 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 258 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 280 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 313 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 320 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 371 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 179 to 186 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 202 to 208 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 168 to 200 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 49 to 55 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 106 forms a bond with dihydroxyacetone, indicating a strong binding affinity.
The residue at position 285 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 413 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 413 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 286 to 289 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 418 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 109 forms a bond with substrate 1, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 31 to 36 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 262 to 268 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 257 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 257 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 259 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 281 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 317 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 317 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 321 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 372 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 372 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 2067 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2070 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2089 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2092 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2123 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2126 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2140 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 431 to 440 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 46 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 169 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 346 to 347 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 368 to 369 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 22 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 33 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 314 to 322 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 398 to 406 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 133 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 155 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 145 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1105 to 1162 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1158 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1164 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1169 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1126 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 383 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 449 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 451 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 35 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 35 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 128 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 to 65 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 96 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 345 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 375 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 383 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 461 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 170 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 94 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 97 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 212 forms a bond with heme 6, indicating a strong binding affinity.
The residue at position 215 forms a bond with heme 6, indicating a strong binding affinity.
The residue at position 216 forms a bond with Fe of heme 6, indicating a strong binding affinity.
The residue at position 255 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 258 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 262 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 327 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 328 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe of heme 7, indicating a strong binding affinity.
The residue at position 407 forms a bond with heme 8, indicating a strong binding affinity.
The residue at position 410 forms a bond with heme 8, indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe of heme 8, indicating a strong binding affinity.
The residue at position 426 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 439 forms a bond with heme 7, indicating a strong binding affinity.
The residue at position 442 forms a bond with heme 7, indicating a strong binding affinity.
The residue at position 443 forms a bond with Fe of heme 7, indicating a strong binding affinity.
The residue at position 519 forms a bond with Fe of heme 8, indicating a strong binding affinity.
The residue at position 395 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 428 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 27 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 48 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 59 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 134 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 160 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 190 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 194 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 174 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 330 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 901 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 904 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 570 to 576 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 141 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 142 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 82 to 111 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 forms a bond with 1-propanol, indicating a strong binding affinity.
The residue at position 81 forms a bond with butan-1-ol, indicating a strong binding affinity.
The residue at position 81 forms a bond with ethanol, indicating a strong binding affinity.
The residue at position 86 forms a bond with 1-propanol, indicating a strong binding affinity.
The residue at position 86 forms a bond with butan-1-ol, indicating a strong binding affinity.
The residue at position 86 forms a bond with ethanol, indicating a strong binding affinity.
The residue at position 261 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 582 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 442 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 445 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 474 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 481 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 485 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 490 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 491 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 569 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 604 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 611 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 621 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 631 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 440 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 516 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 524 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 532 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 59 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 62 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 207 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 415 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 429 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 93 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 96 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 99 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 110 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 195 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 195 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 386 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 390 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 403 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 403 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 529 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 529 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 177 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 301 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 335 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 517 to 524 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1325 to 1332 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 294 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 379 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 539 to 545 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 55 to 62 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 298 to 307 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 608 to 609 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 622 to 624 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 657 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 695 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 696 to 703 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 60 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 99 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 128 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 157 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 270 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 to 339 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 to 63 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 240 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 287 to 296 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 302 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 130 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 24 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 73 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 131 to 137 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 652 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 38 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 115 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 115 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 176 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 178 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 182 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 182 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 235 forms a bond with beta-D-galactose, indicating a strong binding affinity.
The residue at position 235 forms a bond with beta-D-glucose, indicating a strong binding affinity.
The residue at position 60 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 66 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 25 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 56 to 85 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 123 to 126 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 502 to 507 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 286 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 287 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 17 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 47 to 51 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 752 to 761 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 806 to 808 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 196 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 217 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 247 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 241 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 244 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 321 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 63 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 118 to 124 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 143 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 376 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 669 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 669 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 671 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 704 to 710 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 759 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 776 to 778 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 to 208 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 141 to 147 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1014 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 140 to 145 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 300 to 357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 29 to 61 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 to 222 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 75 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 103 to 111 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 461 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 11 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 12 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 27 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 147 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 25 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 45 to 46 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 101 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 335 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 400 to 404 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 129 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 to 346 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 393 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 397 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 693 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 694 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 723 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 853 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 128 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 195 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 245 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 1269 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1272 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1333 to 1336 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1351 to 1353 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1357 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 266 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 270 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 293 to 307 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 810 to 818 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 365 to 368 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 377 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 442 forms a bond with L-leucine, indicating a strong binding affinity.
The residue at position 272 to 280 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 199 to 204 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 754 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 845 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 913 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 53 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 256 to 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 3 to 5 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 3 to 5 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 30 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 30 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 187 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 222 forms a bond with beta-D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 225 forms a bond with beta-D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 364 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 364 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 368 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 5 to 34 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 94 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 113 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 to 238 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 239 to 365 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 322 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 172 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 59 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 59 forms a bond with Cd(2+) 5, indicating a strong binding affinity.
The residue at position 67 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cd(2+) 4, indicating a strong binding affinity.
The residue at position 73 forms a bond with Cd(2+) 6, indicating a strong binding affinity.
The residue at position 33 forms a bond with folate, indicating a strong binding affinity.
The residue at position 587 to 593 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 384 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 162 to 166 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 257 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 289 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 322 to 323 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 333 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 341 to 345 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 131 to 136 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 121 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 163 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 192 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 5 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 152 to 161 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 687 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 687 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1082 to 1090 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1061 to 1068 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 891 to 899 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 630 to 637 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 46 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 180 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 222 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 28 to 31 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 102 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 137 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 197 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 44 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 144 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 403 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 445 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 244 to 248 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 302 to 306 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 380 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 109 to 113 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 397 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 48 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 48 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 101 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 101 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 176 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 176 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 216 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 216 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 220 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 220 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 243 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 243 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 45 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 378 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 418 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 528 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 553 to 554 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 576 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 603 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 815 to 824 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 899 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 916 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 552 to 564 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 586 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 588 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 599 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 106 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 405 to 409 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 307 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 322 to 326 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 4 to 9 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 to 36 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 403 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 407 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1397 to 1399 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1409 to 1410 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1456 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1461 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1465 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1669 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1672 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1682 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1685 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1691 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1694 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1700 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1702 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 606 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 608 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 628 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 629 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 632 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 73 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 100 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 107 forms a bond with alpha-L-fucose, indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 84 to 99 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1168 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1170 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 742 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 345 to 351 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 37 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 388 to 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1090 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1167 to 1169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1174 to 1178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1214 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 347 to 351 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 768 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 799 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 913 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 915 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1080 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 395 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 399 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 421 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 439 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 479 to 482 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 497 to 500 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 198 to 204 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 159 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 398 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 536 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 175 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 820 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 820 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 821 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 985 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 554 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 557 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 177 to 182 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 626 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 633 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 634 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 268 to 276 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 280 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 291 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 301 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1070 to 1077 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 45 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 191 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 245 to 252 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 922 to 929 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 448 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 500 to 501 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 540 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 544 to 548 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 555 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 147 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 803 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 to 159 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 354 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 104 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 359 to 363 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 895 to 901 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Fe of heme b562, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme b566, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme b562, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe of heme b566, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 413 to 425 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 451 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 552 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 396 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 139 to 196 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 761 to 767 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 857 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1126 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1253 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 289 to 291 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 414 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 77 to 83 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 179 to 186 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 302 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 448 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 466 to 470 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 478 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 508 to 510 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 396 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 482 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 210 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 256 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 350 to 351 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 355 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 429 to 432 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 689 to 692 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 777 to 779 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 855 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 859 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 544 to 551 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1175 to 1182 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 266 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 38 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 102 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 241 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 439 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 439 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 48 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 1269 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1274 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 230 to 234 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 311 to 314 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 357 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1355 to 1363 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 65 to 71 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 139 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 145 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 94 to 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 573 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 575 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 601 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 602 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 645 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 661 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 663 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 690 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 691 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 734 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 488 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 490 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 509 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 512 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 540 to 541 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 562 to 563 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 175 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 373 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 402 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 521 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 206 to 329 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 1372 to 1379 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 257 to 263 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 212 to 219 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 131 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 477 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 784 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 787 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 883 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 885 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 885 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 887 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 888 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 472 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 537 to 544 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 470 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 552 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 20 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 31 to 36 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 34 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 89 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 1031 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1031 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 152 to 175 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 248 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 298 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 589 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 592 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 596 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 619 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 622 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 625 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 629 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 333 to 341 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 355 to 358 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 1085 to 1142 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1086 to 1142 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1138 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1144 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1149 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 294 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 137 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 256 forms a bond with [7Fe-V-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 422 forms a bond with [7Fe-V-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 248 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 298 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 319 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 348 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 375 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 47 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 169 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 294 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 316 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 378 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 355 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 377 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 385 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 390 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 276 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 47 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 128 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 178 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 184 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 206 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 100 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 104 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 600 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 600 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 112 to 117 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 162 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 311 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 382 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 479 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 483 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 599 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 43 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 72 forms a bond with 1-tetradecanoyl-sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with 1-tetradecanoyl-sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 123 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with 1-tetradecanoyl-sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with enterobactin, indicating a strong binding affinity.
The residue at position 42 to 50 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 310 to 314 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 267 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 345 to 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 930 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 932 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 644 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 473 to 477 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 540 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 573 to 574 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 610 to 612 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 652 to 653 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 657 forms a bond with CDP-glycerol, indicating a strong binding affinity.
The residue at position 297 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 413 to 414 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 418 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 491 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 503 to 506 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 512 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 612 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 787 to 791 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 824 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 854 to 855 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 880 to 882 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 919 to 920 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 956 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 960 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 348 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 350 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 90 to 99 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 124 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 149 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 207 to 211 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 231 to 239 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 354 to 357 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 378 to 379 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 451 to 453 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 494 to 503 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 495 to 501 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 564 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 588 to 589 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 623 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 682 to 684 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 723 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 750 to 751 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 781 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 807 to 809 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 830 to 831 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 964 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 967 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 970 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 974 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 998 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 1001 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 1004 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 1008 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 865 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 984 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 990 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1046 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1048 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1503 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1503 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1509 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1558 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1558 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1560 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1560 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1566 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1831 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1834 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1837 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 259 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 299 to 302 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 93 forms a bond with 15,16-dihydrobiliverdin, indicating a strong binding affinity.
The residue at position 1485 to 1492 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 287 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 379 to 429 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 898 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 917 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 7 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 266 to 271 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 150 to 152 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 342 to 347 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 388 to 389 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 152 to 159 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 3 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 299 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 303 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 566 to 568 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 398 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 282 to 291 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 425 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 545 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with (S)-warfarin, indicating a strong binding affinity.
The residue at position 141 forms a bond with phylloquinone, indicating a strong binding affinity.
The residue at position 145 forms a bond with (S)-warfarin, indicating a strong binding affinity.
The residue at position 145 forms a bond with phylloquinone, indicating a strong binding affinity.
The residue at position 506 to 510 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 560 to 563 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 205 to 211 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 46 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 365 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 367 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 373 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 240 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 923 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 923 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 924 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 967 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 967 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 424 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1107 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1111 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 392 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 to 19 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 272 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 279 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 483 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 487 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 682 to 684 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 579 to 586 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 625 to 629 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 679 to 682 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 214 to 219 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 393 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 515 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1539 to 1546 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 113 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 319 to 324 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 243 to 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 492 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 591 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 331 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 371 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 680 to 684 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 721 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 832 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 884 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 102 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 293 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 84 to 92 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 296 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 401 forms a bond with thyroxine, indicating a strong binding affinity.
The residue at position 382 to 390 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 143 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 173 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 175 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 184 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 238 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 399 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 494 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 59 to 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 1277 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1650 to 1652 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1650 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1651 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1652 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1676 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1686 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1695 to 1705 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1719 to 1722 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1753 to 1755 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1754 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1755 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 320 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 859 to 861 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 868 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 875 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 901 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 118 to 125 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 794 to 801 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 242 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 182 to 187 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 720 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 37 to 66 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 319 to 329 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 37 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 210 to 217 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 987 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 989 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1000 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1002 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1004 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1021 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1042 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1145 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 268 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 317 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 340 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 432 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 452 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 453 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 542 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 547 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 566 to 567 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 589 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 28 to 30 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 61 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 279 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 282 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 287 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 292 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 339 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 346 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 349 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 358 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 38 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 109 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 110 to 118 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1824 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1827 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1830 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 19 to 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 100 to 105 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 390 to 391 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 537 to 538 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 565 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 347 to 356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 498 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 503 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1225 to 1227 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1237 to 1238 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1284 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1289 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1293 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1502 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1513 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1519 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1522 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1528 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1530 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 279 to 291 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 208 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 37 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 61 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 109 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 277 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 332 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 352 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 386 to 387 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 227 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 97 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1060 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1071 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1073 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1103 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1103 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1109 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1134 to 1136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1171 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1198 to 1199 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1201 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1254 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1255 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1261 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 539 to 541 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 762 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 766 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 771 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 208 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 545 to 548 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 605 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 609 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 100 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 993 to 1001 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1016 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 226 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 253 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 263 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 625 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 396 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 220 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 221 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 671 to 678 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1334 to 1341 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 579 to 587 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 322 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 53 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 795 to 803 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 3 to 27 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 39 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 43 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 66 to 71 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 132 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with guanidinoacetate, indicating a strong binding affinity.
The residue at position 19 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 708 to 716 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 828 to 835 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 19 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 165 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 289 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 310 to 311 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 314 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 319 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 500 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 579 to 583 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 362 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 369 to 371 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 426 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 460 to 463 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 637 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 695 to 699 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 733 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 740 to 742 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 826 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 832 to 835 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 915 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 731 to 738 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 to 273 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 812 to 813 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1094 to 1097 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1209 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1274 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 439 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1045 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1048 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1054 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1341 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1344 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1380 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1393 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1398 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 800 to 807 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 296 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 210 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 370 to 372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 320 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 122 to 137 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 543 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 568 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 68 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 224 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 424 to 429 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 553 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 299 to 302 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 384 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 388 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 409 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 419 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 142 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 172 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 174 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 183 forms a bond with N-[(R)-4-phosphopantothenoyl]-L-cysteine, indicating a strong binding affinity.
The residue at position 629 to 634 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 701 to 707 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 751 to 752 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 244 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 65 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 77 to 84 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 7 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 347 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 354 to 355 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 117 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 283 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 202 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 300 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 357 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 184 to 193 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 491 to 493 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 507 to 510 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 615 to 616 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 621 to 625 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 520 to 532 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 558 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 659 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 195 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 298 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 337 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 110 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 328 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 75 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 127 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 253 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 260 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 334 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 348 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 389 to 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 389 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 365 to 366 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 459 to 460 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 582 to 583 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 596 to 598 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 437 to 440 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 693 to 696 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 719 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 785 to 787 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 863 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 867 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 to 291 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 518 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 610 to 611 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 627 to 628 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 663 to 664 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 664 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 687 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 689 to 690 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 715 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 749 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 754 to 755 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 791 to 795 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 868 to 870 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 870 to 874 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 904 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 55 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 447 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 485 to 487 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 487 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 184 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 301 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 303 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 165 forms a bond with staphylopine, indicating a strong binding affinity.
The residue at position 418 forms a bond with staphylopine, indicating a strong binding affinity.
The residue at position 448 forms a bond with staphylopine, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 212 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 222 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 239 to 241 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 775 to 777 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 783 to 788 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 815 to 817 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 13 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 206 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 245 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 247 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 274 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 59 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 487 to 489 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 489 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 154 to 275 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 276 to 418 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 575 to 576 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 103 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 205 to 208 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 269 to 276 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 316 to 320 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 1773 to 1776 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1796 to 1799 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1824 to 1825 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1897 to 1898 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 178 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 271 to 279 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 219 to 224 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 357 to 360 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 622 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 856 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 861 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 973 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1092 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 612 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 615 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 242 to 248 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 18 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 192 to 196 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1543 to 1545 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1566 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1586 to 1595 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1600 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 687 to 695 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 379 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 653 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 656 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 687 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 205 to 209 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 283 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 204 to 211 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 231 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 229 to 248 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 427 to 429 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 452 to 454 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 469 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 191 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 335 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 364 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 390 to 394 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 390 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 159 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 652 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 660 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 668 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 669 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 129 to 134 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 159 to 163 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 369 to 370 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 391 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 257 to 261 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 337 to 364 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 692 to 811 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 856 to 976 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 414 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 442 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 453 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 334 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1337 to 1344 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 613 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 30 to 33 forms a bond with GDP-4-dehydro-alpha-D-rhamnose, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 223 forms a bond with GDP-4-dehydro-alpha-D-rhamnose, indicating a strong binding affinity.
The residue at position 333 forms a bond with GDP-4-dehydro-alpha-D-rhamnose, indicating a strong binding affinity.
The residue at position 339 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 374 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 652 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1100 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 45 to 53 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 292 to 293 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 145 to 149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 299 to 305 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 36 to 39 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 65 to 72 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 344 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 34 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 to 77 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 166 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 397 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 173 to 179 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 246 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 738 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 752 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 760 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 763 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 505 to 509 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 559 to 562 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 to 335 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 285 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 294 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 338 to 454 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 413 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 793 to 801 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 821 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 361 to 367 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 373 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 421 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 428 to 435 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 474 to 478 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 528 to 531 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 237 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 62 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 80 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 to 151 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 311 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 105 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 185 to 186 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 666 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 189 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 275 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 475 to 482 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 184 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 212 to 220 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 386 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 301 to 309 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 599 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 747 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 246 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 257 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 295 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 302 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 327 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 329 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 331 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 333 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 338 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 193 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 274 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 4 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 174 to 180 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 229 to 236 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 953 to 960 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 612 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 614 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 639 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 653 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 58 forms a bond with (S)-allantoin, indicating a strong binding affinity.
The residue at position 59 forms a bond with (S)-allantoin, indicating a strong binding affinity.
The residue at position 80 forms a bond with (S)-allantoin, indicating a strong binding affinity.
The residue at position 111 forms a bond with (S)-allantoin, indicating a strong binding affinity.
The residue at position 113 forms a bond with (S)-allantoin, indicating a strong binding affinity.
The residue at position 115 forms a bond with (S)-allantoin, indicating a strong binding affinity.
The residue at position 265 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 285 to 291 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 346 to 358 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 394 to 400 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 463 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 390 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 174 to 179 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 240 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 405 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 923 to 931 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 945 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 566 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 57 to 63 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 113 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 190 to 195 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 213 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 243 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 161 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 1251 to 1254 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1274 to 1283 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1300 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 46 to 50 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 555 to 557 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 562 to 568 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 593 to 596 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 344 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 503 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 536 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 637 forms a bond with 4-hydroxyphenylacetate, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 230 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 259 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 273 to 280 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 284 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 295 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 305 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 59 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 327 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 400 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 409 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 430 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 278 to 281 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 355 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 445 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 459 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 474 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 648 to 679 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 792 to 803 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1009 to 1027 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1107 to 1122 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 284 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 379 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 415 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 553 to 554 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 356 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 385 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 552 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 575 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 686 to 689 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 703 to 707 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 708 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 715 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 720 to 722 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 15 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 to 173 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 547 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 480 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 508 to 510 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 515 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 686 to 687 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 737 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 551 to 668 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 218 to 223 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 594 to 598 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 701 to 756 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 431 to 436 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1934 to 1942 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1963 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1637 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1639 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1642 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1645 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 114 forms a bond with ferrichrome, indicating a strong binding affinity.
The residue at position 133 forms a bond with ferrichrome, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with ferrichrome, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with ferrichrome, indicating a strong binding affinity.
The residue at position 346 to 348 forms a bond with ferrichrome, indicating a strong binding affinity.
The residue at position 424 forms a bond with ferrichrome, indicating a strong binding affinity.
The residue at position 735 forms a bond with ferrichrome, indicating a strong binding affinity.
The residue at position 91 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 152 to 159 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 1045 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1070 to 1076 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1116 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1176 to 1178 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 162 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 187 to 190 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 204 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 247 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 276 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 401 to 405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 544 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 94 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 134 to 137 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with heme b 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 220 to 224 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 343 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 370 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 98 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 192 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 200 to 206 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with a (3R)-3-hydroxyacyl-CoA, indicating a strong binding affinity.
The residue at position 55 forms a bond with a (3R)-3-hydroxyacyl-CoA, indicating a strong binding affinity.
The residue at position 84 forms a bond with a (3R)-3-hydroxyacyl-CoA, indicating a strong binding affinity.
The residue at position 93 to 106 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 270 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 144 to 159 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 to 207 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 3 to 29 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 156 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 363 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 433 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 489 to 490 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 498 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 68 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 5 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 88 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 194 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 273 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 131 to 138 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 459 to 463 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 499 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 500 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 500 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 616 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 616 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 715 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 615 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 463 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 505 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 562 to 564 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 586 to 587 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 1641 to 1648 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1944 to 1952 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1973 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 52 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 91 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 212 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 218 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 278 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 384 forms a bond with cortisol, indicating a strong binding affinity.
The residue at position 595 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 603 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 611 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 612 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 681 to 683 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 688 to 694 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 718 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 798 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 166 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 167 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 216 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 220 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 257 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 582 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 629 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 90 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 151 to 155 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 263 to 273 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 289 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 296 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 341 to 345 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 236 to 246 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 433 to 435 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 576 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 208 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 64 to 70 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 178 to 188 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 310 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 315 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 97 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 170 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 173 forms a bond with a D-galactosylceramide, indicating a strong binding affinity.
The residue at position 31 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 153 to 198 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 240 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 84 forms a bond with (15Z)-phycoviolobilin, indicating a strong binding affinity.
The residue at position 41 to 44 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 126 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 135 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 182 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 137 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 254 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 549 to 551 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 556 to 562 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 588 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 273 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 259 to 264 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 527 to 530 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 to 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 to 426 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1077 to 1084 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 36 to 39 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 62 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 298 to 303 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 422 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 235 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 259 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 303 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 11 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 32 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 400 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 424 to 427 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 128 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 184 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 357 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 20 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 62 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 317 to 319 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 444 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 475 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 516 to 518 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 540 to 541 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 394 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 398 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 281 to 289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 539 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 554 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 566 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 658 to 660 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 707 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 836 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 836 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 857 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 858 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 859 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 860 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 794 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 240 to 243 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 629 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 61 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 215 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 417 to 420 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 24 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 174 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 116 forms a bond with substrate 1, indicating a strong binding affinity.
The residue at position 426 to 427 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 460 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 401 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 98 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 162 to 164 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 193 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 72 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 116 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 216 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 220 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 242 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 365 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 461 to 465 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 480 to 489 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 490 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 220 to 226 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 4 forms a bond with O2, indicating a strong binding affinity.
The residue at position 50 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 51 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 971 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1459 to 1467 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1482 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 to 167 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 378 to 379 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 504 to 505 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 693 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 699 to 701 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 780 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 100 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 180 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 44 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 244 to 249 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 413 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 521 to 525 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 612 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 541 to 548 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 164 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 165 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 61 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 132 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 156 forms a bond with poly(ethylene terephthalate), indicating a strong binding affinity.
The residue at position 387 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 379 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 496 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 30 to 37 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 211 to 221 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1008 to 1016 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1030 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 165 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 171 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 28 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 35 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 39 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 54 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 129 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 154 to 158 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 158 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 130 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 86 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 387 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 88 to 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 129 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 32 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 46 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 209 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 494 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 229 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 286 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 324 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 331 to 336 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 68 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 62 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 194 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 497 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 508 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 513 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 514 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 591 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 592 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 635 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 94 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 578 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 617 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 642 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 642 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 644 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 681 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 683 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 714 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1056 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1125 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1128 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1178 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1185 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1186 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 504 to 508 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 558 to 561 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 272 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 257 to 263 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 162 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 119 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 152 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 159 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 48 to 54 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 304 to 309 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 20 to 22 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 79 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 157 to 162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 91 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 240 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 237 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 226 to 231 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 265 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 429 to 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 571 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 455 to 577 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 514 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 529 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 1 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 265 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 299 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 452 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 483 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 524 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 166 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 377 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 2230 to 2238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 188 to 191 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 80 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 240 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 847 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1112 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1146 to 1152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1190 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 51 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 309 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 313 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 73 forms a bond with heme, indicating a strong binding affinity.
The residue at position 98 forms a bond with heme, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 581 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 604 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 702 to 705 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 719 to 723 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 875 to 884 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 175 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 267 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 125 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 125 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 158 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 158 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 401 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 401 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 197 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 1939 to 1946 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 181 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 555 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 766 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 104 to 113 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 to 161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 410 to 413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 570 to 572 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 112 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 150 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 152 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 847 to 855 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 464 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 505 to 508 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 843 to 851 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 868 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 120 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 124 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 44 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 237 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with (2R,3E)-phycoerythrobilin 3, indicating a strong binding affinity.
The residue at position 280 to 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 88 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 100 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 244 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 343 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 409 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 413 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 158 to 164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 496 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 515 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 617 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 642 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 731 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 734 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 35 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 12 to 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 8 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 14 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 18 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 71 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 74 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 85 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 91 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 94 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 365 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 377 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 377 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 378 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 378 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 431 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 504 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 504 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 505 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 534 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 544 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 544 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 547 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 547 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 549 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 550 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 53 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 353 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 256 to 259 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 324 to 329 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 333 to 336 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 441 to 442 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 350 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 379 to 381 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 483 to 484 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 564 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 587 to 588 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 451 to 455 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 505 to 508 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 427 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 34 to 35 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 867 to 874 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 520 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 588 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 to 200 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 491 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 493 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 195 to 201 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 296 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 331 to 337 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 350 to 351 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 376 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 9 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1778 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1780 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1782 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 823 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 904 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 906 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 908 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 910 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 977 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 1071 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 172 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 359 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 392 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 331 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 335 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 419 to 420 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 316 to 327 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 462 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 611 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 112 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 115 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 148 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 151 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 193 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 196 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 197 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 238 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 241 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 242 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 320 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 323 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 405 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 408 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 409 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 454 forms a bond with heme c 9, indicating a strong binding affinity.
The residue at position 457 forms a bond with heme c 9, indicating a strong binding affinity.
The residue at position 458 forms a bond with Fe of heme c 9, indicating a strong binding affinity.
The residue at position 504 forms a bond with heme c 10, indicating a strong binding affinity.
The residue at position 507 forms a bond with heme c 10, indicating a strong binding affinity.
The residue at position 508 forms a bond with Fe of heme c 10, indicating a strong binding affinity.
The residue at position 579 forms a bond with heme c 11, indicating a strong binding affinity.
The residue at position 582 forms a bond with heme c 11, indicating a strong binding affinity.
The residue at position 583 forms a bond with Fe of heme c 11, indicating a strong binding affinity.
The residue at position 611 forms a bond with heme c 12, indicating a strong binding affinity.
The residue at position 614 forms a bond with heme c 12, indicating a strong binding affinity.
The residue at position 615 forms a bond with Fe of heme c 12, indicating a strong binding affinity.
The residue at position 12 to 13 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 340 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 342 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 344 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 344 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 353 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 368 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 472 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 474 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 476 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 478 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 527 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 529 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 529 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 531 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 531 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 533 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 533 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 535 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 535 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 576 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 742 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 748 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 778 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 780 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 782 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1312 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1315 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1320 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 335 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 490 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 533 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 590 to 592 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 614 to 615 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 364 to 370 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 601 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 603 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 628 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 642 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 39 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 57 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 158 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 461 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 468 to 469 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 172 to 177 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 275 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 1381 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1384 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1400 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1403 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1432 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1435 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1451 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 171 to 177 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 335 forms a bond with heme, indicating a strong binding affinity.
The residue at position 281 to 285 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 32 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 544 to 549 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 360 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 371 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 826 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 907 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 909 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 911 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 980 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 1074 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 340 to 343 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 450 to 453 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 590 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 481 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 488 to 493 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 488 to 489 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 221 to 227 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 290 to 296 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 303 to 306 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 355 to 361 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 204 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 473 to 480 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 519 to 523 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 573 to 576 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 230 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 199 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 457 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 484 to 491 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 48 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with a beta-D-galactoside 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 281 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 287 to 293 forms a bond with a beta-D-galactoside 2, indicating a strong binding affinity.
The residue at position 498 to 505 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 544 to 548 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 598 to 601 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1166 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1166 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1167 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1330 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1369 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 74 to 76 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 113 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 881 to 882 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 248 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 297 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 310 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 336 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 341 to 345 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 217 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 1, indicating a strong binding affinity.
The residue at position 242 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate 2, indicating a strong binding affinity.
The residue at position 72 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 543 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 742 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 33 to 34 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 38 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 407 to 411 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 437 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 496 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 497 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 498 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 753 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 789 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 790 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 790 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 900 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 830 to 837 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 763 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 767 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 286 to 295 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 638 to 640 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 645 to 651 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 739 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 310 forms a bond with heme, indicating a strong binding affinity.
The residue at position 608 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 610 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 612 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 55 to 82 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 229 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 652 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 810 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 811 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 811 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 11 to 16 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 178 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 836 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 838 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 843 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 870 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 872 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 879 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 674 to 678 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 683 to 689 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 713 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 116 to 239 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 404 to 406 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 575 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 237 to 252 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 685 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 688 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 701 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 706 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 819 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 822 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 835 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 840 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 976 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 979 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 992 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 997 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 63 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 159 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 161 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 246 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 282 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 288 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 148 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 174 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 178 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 60 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 402 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 405 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 405 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 601 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 610 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 693 forms a bond with Mg of divinylchlorophyll a' A1, indicating a strong binding affinity.
The residue at position 701 forms a bond with Mg of divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 709 forms a bond with divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 710 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 172 to 177 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 802 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 505 to 512 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 551 to 555 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 605 to 608 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 325 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 419 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 903 to 910 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 73 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 14 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 221 to 235 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 324 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 608 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 613 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 642 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 647 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 318 to 320 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 325 to 331 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 132 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 423 to 546 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 490 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 505 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 149 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 235 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 2 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 481 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 54 to 56 forms a bond with cholate 1, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with cholate 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with cholate 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 196 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 197 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 202 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 248 to 252 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 29 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 131 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 310 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 380 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 429 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 160 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 196 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 487 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 516 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 545 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 581 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 601 to 603 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 642 to 645 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 681 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 708 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 829 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 832 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 837 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 153 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 72 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 125 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 225 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 82 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 140 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 397 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 496 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 499 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 24 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 24 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 33 to 38 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 116 to 125 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 395 to 399 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 982 to 989 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1040 to 1044 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1098 to 1101 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1700 to 1708 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1726 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 to 416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 511 to 512 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 572 to 574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 240 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 266 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 294 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 398 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 437 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 452 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 455 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 302 to 308 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 332 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 559 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 602 to 605 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 511 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 270 to 278 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 885 to 892 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 113 to 121 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 145 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 139 to 146 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 274 to 280 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 299 to 303 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 369 to 372 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 629 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 237 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 16 to 23 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 433 to 440 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 470 to 474 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 1184 to 1186 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1203 to 1204 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1259 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1384 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1387 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1399 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1408 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1411 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1424 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1504 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1507 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1519 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1522 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1528 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1531 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1538 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1540 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 52 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 193 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 279 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 282 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 1273 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1275 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 45 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 49 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 153 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 285 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 285 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 163 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 222 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 285 to 288 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 213 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 215 to 221 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 217 to 221 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 525 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 162 to 166 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 246 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 39 to 54 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 405 to 406 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1063 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1095 to 1101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1286 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1310 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1315 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 894 to 901 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 324 to 332 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 346 to 349 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 409 to 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 576 to 577 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 124 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 144 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 227 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 231 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 346 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 143 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 146 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 147 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 403 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 502 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 503 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 505 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 81 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 374 to 379 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 575 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 650 to 653 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 forms a bond with biuret, indicating a strong binding affinity.
The residue at position 145 forms a bond with biuret, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with biuret, indicating a strong binding affinity.
The residue at position 215 forms a bond with biuret, indicating a strong binding affinity.
The residue at position 57 to 81 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 78 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1419 to 1424 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 468 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 152 to 156 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 570 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 74 to 80 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 75 to 78 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 459 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 461 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 589 to 591 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 842 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 968 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 968 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 983 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 984 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 to 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 839 to 846 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 295 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 862 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 864 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 941 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 943 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 947 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1015 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 1109 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 1137 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1270 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 822 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1144 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1147 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1153 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 86 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 267 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 554 to 559 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1162 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1242 to 1244 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1249 to 1253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1289 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 206 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 208 to 214 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 74 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 84 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 257 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 272 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 788 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1114 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1132 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 26 to 30 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 60 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 69 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 105 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 212 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 224 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 282 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 305 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 1425 to 1432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 481 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 516 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 572 to 576 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 86 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 1086 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1093 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1093 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 585 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 586 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 54 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1068 to 1075 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 697 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 697 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 699 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 392 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 464 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 492 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 495 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 298 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 351 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 372 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 409 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 412 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 214 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 214 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 217 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 220 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 220 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 226 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 296 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 116 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 144 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 404 to 408 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 408 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 380 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 431 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 479 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 48 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 207 to 218 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 218 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 315 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 22 to 141 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 350 to 353 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 360 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 174 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 268 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 260 to 266 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 600 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 656 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 673 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 674 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 694 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 700 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 128 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 502 to 504 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 60 to 65 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 183 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 187 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 236 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 254 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 254 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 258 forms a bond with (S)-malate, indicating a strong binding affinity.
The residue at position 446 to 449 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 297 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 1664 to 1681 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 1879 to 1894 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 529 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 477 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 298 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 329 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 343 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 415 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 346 to 350 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 476 to 479 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 499 to 501 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 532 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 104 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 294 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 377 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 41 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 171 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 175 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 202 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 14 to 18 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 156 to 165 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 441 to 444 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 459 to 461 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 602 to 603 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 608 to 612 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 644 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 341 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 349 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 416 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 417 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 418 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 480 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 112 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 26 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 96 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 233 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 600 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 74 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 75 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 891 to 898 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 to 99 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 54 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 184 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 208 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 260 to 263 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 315 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 408 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 432 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 435 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 468 to 472 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 491 to 492 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 448 to 455 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 23 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 708 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 711 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1 to 6 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 213 to 215 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 255 to 258 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 264 to 267 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 107 to 113 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 37 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 87 to 96 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 128 to 133 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 355 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 549 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 588 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 613 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 613 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 615 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 656 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 657 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 658 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 689 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1031 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1049 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1065 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1100 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1103 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1160 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1161 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 37 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 398 to 427 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1 to 120 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 1781 to 1789 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1802 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1244 to 1251 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 391 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 29 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 55 to 61 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 319 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 321 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 393 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 455 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 611 to 619 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 598 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 638 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 185 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 135 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 347 to 348 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 265 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 314 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 448 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 449 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 391 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 197 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 30 to 38 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 34 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 34 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 129 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 84 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 93 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 355 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 810 to 819 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 894 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 386 to 388 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1774 to 1776 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1775 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1776 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1800 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1810 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1819 to 1829 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1843 to 1846 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1873 to 1875 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1874 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1875 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 34 to 64 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 313 to 318 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 462 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 239 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 973 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 975 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1082 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1134 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 405 to 411 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 39 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 208 forms a bond with imipenem, indicating a strong binding affinity.
The residue at position 224 forms a bond with imipenem, indicating a strong binding affinity.
The residue at position 226 forms a bond with imipenem, indicating a strong binding affinity.
The residue at position 228 forms a bond with imipenem, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 215 to 222 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 262 to 266 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 327 to 330 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 173 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 449 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 24 to 31 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 438 to 445 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 476 to 480 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 540 to 543 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 279 to 283 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 468 to 479 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 999 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 167 to 171 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 37 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 62 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 253 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 265 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 267 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 274 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 274 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 280 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 283 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 219 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 148 to 154 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 47 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 68 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 73 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 101 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 104 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 122 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 421 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 341 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 371 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 379 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 457 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 163 to 165 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 184 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 297 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 160 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 313 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 189 to 192 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 201 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 797 to 805 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 804 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 947 to 954 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 973 to 977 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1042 to 1045 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1116 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1430 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1432 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1444 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1480 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1495 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1585 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 504 to 511 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 554 to 558 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 608 to 611 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 232 to 240 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 215 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 11 to 15 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 14 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 90 to 94 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 191 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 347 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 410 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 418 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 608 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 965 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 210 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 244 to 249 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 218 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 269 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 274 to 276 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 282 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 313 to 317 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 408 to 415 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 351 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 31 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 39 to 40 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 415 to 420 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 415 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 415 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 437 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 599 to 600 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 390 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 394 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1174 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1337 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1376 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 746 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 746 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 748 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 752 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 752 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 798 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 804 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 830 to 832 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 868 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 870 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1236 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1239 to 1240 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1295 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1302 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 146 to 150 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 152 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 175 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 53 to 58 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 675 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 122 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 123 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 124 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 127 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 142 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 230 to 233 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 407 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 75 to 79 forms a bond with pyridine, indicating a strong binding affinity.
The residue at position 187 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 466 to 468 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 676 forms a bond with 2-hydroxyethane-1-sulfonate, indicating a strong binding affinity.
The residue at position 1518 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1518 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1524 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1524 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1531 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1567 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1567 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1571 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1573 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1577 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1600 to 1602 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1643 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1704 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1707 to 1708 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1710 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1804 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1806 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1811 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 53 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 54 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 61 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 137 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 138 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 542 to 597 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 679 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 679 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1080 to 1137 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1216 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1216 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 1218 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 1483 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1483 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1485 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1487 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1517 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1568 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1568 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1602 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1626 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1649 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1670 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1695 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1695 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1699 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 374 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 341 to 344 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 105 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 105 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 355 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 355 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 481 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 333 to 334 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 670 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 682 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 689 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 692 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 698 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 763 to 770 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 355 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 498 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 113 to 118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 623 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 717 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 75 forms a bond with phycourobilin, indicating a strong binding affinity.
The residue at position 83 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 89 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 172 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 651 to 656 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1 to 7 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 65 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 115 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 80 to 91 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 10 to 29 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 944 to 952 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 971 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 285 to 289 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 69 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 88 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 155 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 220 to 274 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 63 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 106 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 109 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 123 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 44 to 68 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 279 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 135 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 613 to 617 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 711 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 832 to 836 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 35 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 49 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 104 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 181 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 396 to 397 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 to 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 395 to 402 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1033 to 1040 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 485 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 236 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 239 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 240 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 165 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 214 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 199 to 205 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 251 to 260 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 261 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 655 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1077 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 409 to 411 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 572 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 634 to 635 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 760 to 766 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 804 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 317 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 319 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 342 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 372 forms a bond with xylitol, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 61 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 64 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 310 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1162 to 1169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 434 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 435 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 529 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 495 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 459 to 461 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1032 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1107 to 1109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1114 to 1118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 173 forms a bond with heme, indicating a strong binding affinity.
The residue at position 193 forms a bond with heme, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 265 forms a bond with heme, indicating a strong binding affinity.
The residue at position 563 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 77 to 92 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 444 to 445 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 212 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 228 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 236 to 240 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 36 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 105 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 107 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 109 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 111 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 116 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 178 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 273 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 276 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 277 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 331 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 165 to 175 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 to 136 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 643 to 651 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 818 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 821 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 822 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 964 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 967 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 968 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 1088 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 1091 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 1092 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 386 to 390 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 588 to 592 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 17 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 177 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 206 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 118 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 155 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 160 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 76 to 81 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 164 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 222 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with sphing-4-enine 1-phosphate, indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with sphing-4-enine 1-phosphate, indicating a strong binding affinity.
The residue at position 155 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 295 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 376 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 386 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 220 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 395 to 398 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 113 to 144 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 152 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 164 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 309 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 250 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 233 to 237 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 166 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 239 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 396 to 409 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 215 to 218 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 243 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 321 to 325 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 216 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 428 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 84 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 136 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 181 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 349 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 408 to 409 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 558 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 618 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 621 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 622 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 661 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 293 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 58 to 63 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 to 90 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 109 to 114 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 515 to 516 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 658 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 348 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 394 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 481 to 485 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 550 to 553 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 157 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 446 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 449 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 462 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 529 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 535 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 539 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 678 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 696 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 263 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 495 to 502 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 542 to 546 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 596 to 599 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 191 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 319 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 150 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 150 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 154 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 154 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 158 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 214 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 242 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 305 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 312 forms a bond with N-terminal L-methionine residue of a protein, indicating a strong binding affinity.
The residue at position 204 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 245 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 268 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 280 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 187 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 204 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 278 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 1155 to 1159 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 to 77 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 147 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 370 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 396 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 420 to 423 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 579 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 68 to 77 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 366 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 373 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 414 to 417 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 999 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1000 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 43 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 211 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 170 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 204 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 363 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 371 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 333 to 349 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 134 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 4 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 474 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 502 to 504 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 680 to 681 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 731 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 136 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 164 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 451 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 460 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 601 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 348 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 399 to 401 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 423 to 428 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 226 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 208 to 214 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 430 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 299 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 412 to 417 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 445 to 448 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 538 to 539 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 623 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 467 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 553 to 556 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 to 150 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 481 to 483 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 547 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 555 to 557 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 189 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 573 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 596 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 794 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 116 to 120 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 430 to 431 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 471 to 476 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 528 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 71 forms a bond with ubiquinone-8, indicating a strong binding affinity.
The residue at position 75 forms a bond with ubiquinone-8, indicating a strong binding affinity.
The residue at position 98 forms a bond with ubiquinone-8, indicating a strong binding affinity.
The residue at position 176 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 215 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 178 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 375 to 379 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 400 to 404 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 351 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 411 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 414 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1398 to 1400 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1410 to 1411 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1457 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1462 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1466 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1670 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1673 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1683 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1686 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1692 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1695 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1701 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1703 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 205 to 210 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 198 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 213 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 239 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 262 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 287 to 290 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 1200 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 129 to 137 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 61 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 89 to 94 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 116 to 122 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 141 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 349 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 264 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1753 to 1756 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1776 to 1779 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1804 to 1805 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1877 to 1878 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 426 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 124 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 283 to 286 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 397 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 677 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 764 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 909 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 914 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 250 to 257 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 350 to 353 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 565 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 668 to 675 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 to 303 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 90 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 171 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 174 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 324 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 228 to 240 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 383 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 111 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 304 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 17 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 403 to 411 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 493 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 148 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 290 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 353 to 357 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 374 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 459 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 413 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 415 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 431 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 437 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 452 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 453 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 592 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 427 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 452 to 455 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 536 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 562 to 570 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 439 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 298 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 358 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 480 to 484 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 505 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 509 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 523 to 524 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 484 to 492 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 384 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 512 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 147 to 162 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 173 to 205 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 534 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 149 to 156 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 386 to 390 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 414 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 727 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 363 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 245 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 248 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 274 forms a bond with adenosine 3',5'-bisphosphate, indicating a strong binding affinity.
The residue at position 253 to 258 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 397 to 399 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 625 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 628 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 633 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 261 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 329 to 331 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 338 to 344 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 357 to 358 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 308 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 296 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 424 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 424 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 130 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 133 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 221 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 293 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 308 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 197 to 203 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 5 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 784 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 788 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1011 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 150 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 154 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 333 to 335 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 380 to 384 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 410 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 103 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 202 to 205 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 350 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 531 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 147 to 151 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 275 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 320 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 98 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 164 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 193 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 193 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 289 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 323 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 407 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 411 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 90 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 74 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 110 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 173 to 174 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 124 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 323 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 411 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 414 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 540 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 543 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 616 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 619 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 1307 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1311 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 268 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 24 to 28 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 113 to 116 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 97 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 503 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 31 to 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 74 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 319 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 460 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 461 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 463 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 182 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 402 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 455 to 456 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 427 to 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 48 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 140 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 120 to 125 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 145 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 180 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 263 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 266 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with substrate 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 340 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 566 to 568 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 600 to 611 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 34 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 37 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 74 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 209 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 275 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 278 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 436 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 442 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 443 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 444 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 446 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 230 to 231 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 617 to 619 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 624 to 630 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 717 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 199 to 203 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 to 256 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 587 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 587 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 691 to 695 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 692 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 818 to 819 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 818 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 867 to 870 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 874 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 893 to 896 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 969 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 79 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 211 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 341 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 373 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 378 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 381 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 63 to 69 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 89 to 92 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 181 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 275 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 350 to 356 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 465 to 467 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 215 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 476 to 483 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 238 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 1296 to 1304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 361 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 576 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 644 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 47 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 510 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 244 to 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 767 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 769 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 773 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 314 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 887 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 933 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 30 to 34 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 31 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 34 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 65 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 167 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 1125 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1128 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1141 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1144 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1152 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1171 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1174 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 299 to 300 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 198 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 313 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 350 to 352 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 171 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 269 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 273 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 290 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 366 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 374 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 467 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 471 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 473 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 474 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 259 to 265 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 33 to 37 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 65 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 388 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 381 to 385 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 473 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 137 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 441 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 513 to 515 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 to 473 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 488 to 490 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 504 to 507 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 551 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 612 to 613 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 618 to 622 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 654 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 692 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 326 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 33 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 72 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 182 to 185 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 12 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 72 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 274 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 441 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 25 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 89 forms a bond with myricetin, indicating a strong binding affinity.
The residue at position 155 forms a bond with myricetin, indicating a strong binding affinity.
The residue at position 192 forms a bond with myricetin, indicating a strong binding affinity.
The residue at position 202 forms a bond with myricetin, indicating a strong binding affinity.
The residue at position 282 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 308 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 334 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 335 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 352 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 356 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 360 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 375 forms a bond with myricetin, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 1388 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1468 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1573 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1576 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1600 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1603 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 407 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 505 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 812 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 288 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 161 to 165 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 133 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 197 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 72 to 103 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 378 forms a bond with saxitoxin, indicating a strong binding affinity.
The residue at position 701 forms a bond with tetrodotoxin, indicating a strong binding affinity.
The residue at position 704 forms a bond with saxitoxin, indicating a strong binding affinity.
The residue at position 704 forms a bond with tetrodotoxin, indicating a strong binding affinity.
The residue at position 1062 forms a bond with tetrodotoxin, indicating a strong binding affinity.
The residue at position 1063 forms a bond with saxitoxin, indicating a strong binding affinity.
The residue at position 1354 forms a bond with tetrodotoxin, indicating a strong binding affinity.
The residue at position 1356 forms a bond with saxitoxin, indicating a strong binding affinity.
The residue at position 1356 forms a bond with tetrodotoxin, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 383 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 595 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 373 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 2015 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2018 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2040 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2045 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2076 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2079 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2091 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2093 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 13 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 772 to 776 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 775 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 820 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 824 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 876 forms a bond with methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 977 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1225 to 1226 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 27 forms a bond with heme, indicating a strong binding affinity.
The residue at position 30 forms a bond with heme, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 405 to 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 543 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 605 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 224 to 239 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 404 to 405 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 663 to 671 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 529 to 530 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 213 to 216 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 9 to 131 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 126 to 131 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 844 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 867 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1071 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 183 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 191 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 226 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1651 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1654 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 265 to 269 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 91 to 94 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 513 to 518 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 534 to 541 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1153 to 1160 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 24 to 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 349 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 385 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 292 to 306 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 351 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 396 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 402 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 407 to 410 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 472 to 474 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 473 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 784 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 784 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 785 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 956 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 996 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 12 forms a bond with (S)-lactate, indicating a strong binding affinity.
The residue at position 67 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 387 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 35 to 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 273 to 275 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 90 to 92 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 98 to 103 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 247 to 251 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 426 to 427 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 240 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 191 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 575 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 578 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 409 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 72 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 76 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 97 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 326 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 392 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 269 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 363 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 393 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 465 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 255 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 299 to 327 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 187 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 347 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 117 to 120 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 269 to 275 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 977 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1059 to 1066 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 289 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 201 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 864 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 901 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 901 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 1011 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 173 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 402 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 401 to 406 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 478 to 479 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 525 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 124 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 150 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 176 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 548 to 555 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 235 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 305 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 328 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 433 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 439 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 440 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 42 to 46 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 781 to 788 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 461 to 465 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 526 to 529 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 240 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 243 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 246 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 246 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 252 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 252 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 320 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 678 to 685 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 201 forms a bond with 3-hydroxypyruvate, indicating a strong binding affinity.
The residue at position 347 forms a bond with 3-hydroxypyruvate, indicating a strong binding affinity.
The residue at position 148 to 150 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 25 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 182 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 38 to 42 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 128 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 131 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 255 to 260 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 579 to 586 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 43 to 50 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 342 to 349 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 162 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 61 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 343 to 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 494 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 499 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 107 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 183 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 213 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 234 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 282 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 1095 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1236 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1239 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 443 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 156 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 32 to 34 forms a bond with beta-D-galactose 1, indicating a strong binding affinity.
The residue at position 312 forms a bond with beta-D-galactose 3, indicating a strong binding affinity.
The residue at position 324 to 328 forms a bond with beta-D-galactose 2, indicating a strong binding affinity.
The residue at position 337 forms a bond with beta-D-galactose 2, indicating a strong binding affinity.
The residue at position 342 forms a bond with beta-D-galactose 2, indicating a strong binding affinity.
The residue at position 348 forms a bond with beta-D-galactose 2, indicating a strong binding affinity.
The residue at position 437 forms a bond with beta-D-galactose 3, indicating a strong binding affinity.
The residue at position 458 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 498 to 501 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 561 to 562 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 663 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 429 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 432 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 461 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 468 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 472 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 472 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 477 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 478 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 555 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 556 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 594 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 544 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 544 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 546 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 552 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 228 to 234 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 107 to 112 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 413 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 110 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 289 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 289 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 341 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 342 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 567 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 569 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 264 to 270 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 271 to 278 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 196 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 375 to 376 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 405 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 439 to 440 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 467 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 499 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 533 to 542 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 620 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 377 to 382 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 432 to 455 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 482 to 485 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 489 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 555 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 79 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 83 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 126 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 165 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 625 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 629 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 723 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 159 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 188 to 189 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 871 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 894 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 56 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 118 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 133 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 182 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 188 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 379 to 389 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 463 to 468 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 517 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 526 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 527 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 569 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 575 to 582 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 660 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 671 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 681 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 51 to 55 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 288 to 290 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 366 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 1316 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1350 to 1356 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 156 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 221 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 79 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 103 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 109 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 20 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 23 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 34 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 386 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 397 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 460 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 606 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 444 to 451 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 to 302 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 344 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 403 forms a bond with (indol-3-yl)acetate, indicating a strong binding affinity.
The residue at position 436 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with (indol-3-yl)acetate, indicating a strong binding affinity.
The residue at position 484 to 485 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 509 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 463 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 306 to 309 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 423 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 468 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 32 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 60 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 71 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 157 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 183 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 219 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 223 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 92 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 231 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 78 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 80 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 123 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 261 to 266 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 343 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 438 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 442 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 359 to 365 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 120 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 136 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 423 to 425 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 256 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 260 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 321 forms a bond with N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 348 forms a bond with deoxycholate, indicating a strong binding affinity.
The residue at position 141 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 297 to 301 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 158 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 127 to 142 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 153 to 185 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 401 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 429 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 461 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 462 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 174 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 414 to 417 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 446 to 449 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 539 to 540 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 548 to 552 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 624 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 479 to 480 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 497 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 637 to 640 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 650 to 651 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 459 to 470 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 433 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 71 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 173 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 316 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 386 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 231 to 242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 401 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 436 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 439 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 469 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 532 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 600 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 666 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 111 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 304 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 98 to 129 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 6 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 171 to 177 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 200 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 286 to 292 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 309 to 310 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 166 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 709 to 766 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 95 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 144 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 869 to 877 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 to 209 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 209 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 272 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 214 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 36 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 213 to 274 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 302 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 357 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 360 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 403 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 403 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 683 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 686 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 704 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 707 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 713 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 733 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 736 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 346 to 350 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1037 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1060 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1092 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1207 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1225 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1 to 103 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 96 to 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 140 to 170 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1704 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1710 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1715 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 108 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 407 to 411 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 139 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 558 to 563 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 579 to 581 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 581 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 665 to 669 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 23 to 25 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 45 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 159 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 182 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 207 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 200 to 205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 415 to 421 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 144 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 144 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 177 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 177 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 404 forms a bond with piceatannol, indicating a strong binding affinity.
The residue at position 404 forms a bond with trans-resveratrol, indicating a strong binding affinity.
The residue at position 62 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 268 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 392 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 1237 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 97 to 102 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 374 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 375 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 400 to 408 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 573 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 636 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 144 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 264 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 356 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 419 to 420 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 571 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 635 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 638 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 639 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 676 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 36 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 498 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 546 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 660 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 685 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 85 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 99 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 190 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 324 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 403 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 440 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 415 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 357 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 463 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 465 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 466 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 345 forms a bond with CDP-L-ribitol, indicating a strong binding affinity.
The residue at position 352 forms a bond with CDP-L-ribitol, indicating a strong binding affinity.
The residue at position 359 to 364 forms a bond with CDP-L-ribitol, indicating a strong binding affinity.
The residue at position 437 to 438 forms a bond with CDP-L-ribitol, indicating a strong binding affinity.
The residue at position 480 to 482 forms a bond with CDP-L-ribitol, indicating a strong binding affinity.
The residue at position 682 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 407 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 495 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 631 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 633 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1673 to 1690 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 1888 to 1903 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 308 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 29 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 594 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 594 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 600 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 646 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 646 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 648 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 654 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 529 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 651 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 651 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 666 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 667 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 424 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 138 to 255 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 256 to 382 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 1562 to 1579 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 1766 to 1781 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 344 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 346 to 351 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 393 to 394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 to 72 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 119 to 120 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 227 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 300 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 302 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 303 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 70 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 70 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 28 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 84 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with (2R,3E)-phycocyanobilin 1, indicating a strong binding affinity.
The residue at position 385 to 388 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 431 to 432 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 476 to 477 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 452 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 245 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 101 to 109 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 444 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 472 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 205 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 369 to 370 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 89 forms a bond with Cu(2+) 4, indicating a strong binding affinity.
The residue at position 456 to 458 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 127 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 278 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 309 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 385 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 880 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 881 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 992 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1012 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1016 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1275 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 75 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 76 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 210 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 212 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 334 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 361 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 366 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 620 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 730 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 984 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 138 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 306 to 309 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 393 to 399 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 79 to 87 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 116 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 5 forms a bond with 3,5,7-trioxododecanoyl-CoA, indicating a strong binding affinity.
The residue at position 72 forms a bond with 3,5,7-trioxododecanoyl-CoA, indicating a strong binding affinity.
The residue at position 572 to 574 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 572 to 574 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 579 to 585 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 579 to 585 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 610 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 610 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 164 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 227 to 231 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 434 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 437 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 466 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 473 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 482 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 483 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 560 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 596 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 613 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 623 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 632 to 633 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 296 to 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 95 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 201 forms a bond with 2-succinylbenzoate, indicating a strong binding affinity.
The residue at position 1897 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1940 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 70 to 76 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 396 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 396 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 609 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 345 to 349 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 377 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 416 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 445 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 472 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 495 to 496 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 116 to 123 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 469 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 472 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 502 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 505 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 328 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 338 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 414 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 597 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 52 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 216 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 410 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 434 to 437 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 488 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 492 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 158 to 159 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 70 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 287 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 358 to 361 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 312 to 316 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 353 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 462 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 484 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 148 forms a bond with heme, indicating a strong binding affinity.
The residue at position 209 forms a bond with heme, indicating a strong binding affinity.
The residue at position 48 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 54 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 84 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 156 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 184 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 187 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 262 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 317 to 321 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 427 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 95 to 103 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 397 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 221 to 226 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 112 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 256 to 263 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 346 to 350 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 767 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 798 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 802 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 880 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 912 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1010 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1079 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 220 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 212 to 219 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 137 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 172 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 117 forms a bond with galanthamine, indicating a strong binding affinity.
The residue at position 117 forms a bond with huperzine A, indicating a strong binding affinity.
The residue at position 153 forms a bond with huprine W, indicating a strong binding affinity.
The residue at position 164 forms a bond with huperzine A, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with galanthamine, indicating a strong binding affinity.
The residue at position 234 forms a bond with huprine W, indicating a strong binding affinity.
The residue at position 368 forms a bond with galanthamine, indicating a strong binding affinity.
The residue at position 368 forms a bond with huperzine A, indicating a strong binding affinity.
The residue at position 470 forms a bond with huprine W, indicating a strong binding affinity.
The residue at position 478 forms a bond with huprine W, indicating a strong binding affinity.
The residue at position 91 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 130 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 188 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 61 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 503 to 505 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 505 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 173 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 55 to 56 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 126 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 224 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 249 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 231 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 529 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 791 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 829 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 1016 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1090 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1094 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1127 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 201 to 204 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 740 to 744 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 781 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 890 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 137 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 199 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 202 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 241 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 243 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 255 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 163 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 61 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 105 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 209 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 213 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 640 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 125 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 171 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 73 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 412 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 354 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 239 to 243 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 368 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 227 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 405 to 413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1050 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1082 to 1088 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 124 to 239 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 198 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 242 to 362 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 397 to 401 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 451 to 454 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 114 to 120 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 142 to 149 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 110 to 116 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 327 to 332 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 136 to 139 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 180 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 394 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 91 to 95 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 169 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 264 to 268 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 303 to 306 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 331 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 411 to 414 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 244 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 642 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with D-alanylgriseoluteate, indicating a strong binding affinity.
The residue at position 57 forms a bond with D-alanylgriseoluteate, indicating a strong binding affinity.
The residue at position 1111 forms a bond with ganglioside GD1a (d18:1(4E)), indicating a strong binding affinity.
The residue at position 1195 forms a bond with ganglioside GD1a (d18:1(4E)), indicating a strong binding affinity.
The residue at position 1256 forms a bond with ganglioside GD1a (d18:1(4E)), indicating a strong binding affinity.
The residue at position 382 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 463 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 536 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 450 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 457 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 115 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 180 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 137 to 145 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 165 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 1274 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1308 to 1314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1352 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 125 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 380 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 242 to 246 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 102 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 115 to 117 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 196 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 1165 to 1172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 539 to 542 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 549 to 550 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 590 to 593 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 704 to 764 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 to 240 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 279 to 283 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 154 to 157 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 474 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 493 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 413 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 493 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 159 to 166 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 66 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 434 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 464 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 69 to 75 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 234 to 242 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 387 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 318 to 323 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 191 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 194 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 264 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 281 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 355 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 359 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 456 to 457 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 123 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 273 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 280 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 283 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 299 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 315 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 391 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 510 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 32 to 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 10 to 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 510 to 514 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 588 to 620 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 518 to 520 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 525 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 691 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 735 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 456 to 457 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 30 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 135 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 220 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 51 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 83 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 104 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 36 to 67 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 36 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 468 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 498 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 66 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 118 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 179 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 236 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 118 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 418 to 422 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 480 to 484 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 106 to 111 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 430 to 441 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 285 forms a bond with dihydrozeatin, indicating a strong binding affinity.
The residue at position 285 forms a bond with kinetin, indicating a strong binding affinity.
The residue at position 285 forms a bond with N(6)-dimethylallyladenine, indicating a strong binding affinity.
The residue at position 285 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 307 forms a bond with dihydrozeatin, indicating a strong binding affinity.
The residue at position 307 forms a bond with kinetin, indicating a strong binding affinity.
The residue at position 307 forms a bond with N(6)-dimethylallyladenine, indicating a strong binding affinity.
The residue at position 307 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 317 forms a bond with dihydrozeatin, indicating a strong binding affinity.
The residue at position 317 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 39 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 70 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 94 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 114 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 170 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 145 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 254 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 264 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 358 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 556 to 587 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 697 to 708 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 836 to 846 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 911 to 929 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1089 to 1104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 233 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 263 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 287 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 306 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 340 to 341 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 123 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 401 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 403 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 334 to 339 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 250 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 408 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 503 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 569 to 574 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 151 to 156 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 1138 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1268 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 298 to 326 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 120 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 211 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 606 to 661 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 751 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 751 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 753 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 225 to 344 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 525 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 550 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 to 208 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 703 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 483 to 487 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 317 forms a bond with aklavinone, indicating a strong binding affinity.
The residue at position 263 to 265 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1770 to 1772 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1770 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1796 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1806 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1815 to 1825 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1839 to 1842 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1869 to 1871 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1870 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1178 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 4 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 6 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 6 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 12 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 12 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 14 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 18 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 18 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 23 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 23 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 726 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 745 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 778 to 779 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 795 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 70 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 70 forms a bond with anthranilate 1, indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 156 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 859 to 867 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 566 to 573 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1416 to 1423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 601 to 608 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 651 to 655 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 705 to 708 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 68 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 77 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 417 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 92 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 143 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 237 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 70 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 81 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 896 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 969 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 973 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 1054 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 93 to 94 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 148 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 236 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 216 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 219 to 225 forms a bond with (S)-malate 2, indicating a strong binding affinity.
The residue at position 421 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 467 to 471 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 491 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with heme, indicating a strong binding affinity.
The residue at position 517 to 522 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 634 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 682 to 683 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 89 to 90 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 134 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 162 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 189 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 150 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 547 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 672 to 675 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 689 to 693 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 703 to 705 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 756 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 843 to 852 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 47 to 50 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 277 to 281 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 346 to 347 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 822 to 829 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1964 to 1971 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 115 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 215 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 241 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 330 to 332 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 480 to 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 325 to 328 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 90 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1122 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 187 forms a bond with [2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 200 forms a bond with [2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 201 forms a bond with [2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 203 forms a bond with [2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 286 forms a bond with [2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 288 forms a bond with [2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 341 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 343 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 409 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 135 to 139 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 283 forms a bond with heme, indicating a strong binding affinity.
The residue at position 285 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 394 to 400 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 450 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 341 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 344 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 362 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 384 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 331 to 338 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 119 to 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 478 to 484 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 226 to 232 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 613 to 614 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 619 to 623 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 655 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 693 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 428 to 429 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 293 to 296 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 669 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 676 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 368 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 137 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 139 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 142 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 147 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 187 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 204 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 208 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 211 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 266 forms a bond with 3-oxoeicosanoyl-CoA, indicating a strong binding affinity.
The residue at position 390 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 583 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 586 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 591 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 685 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 688 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 689 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 772 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 294 to 306 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with CP-96345, indicating a strong binding affinity.
The residue at position 32 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 111 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 83 to 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 254 to 257 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 392 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 412 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 427 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 447 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 158 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 170 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 171 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 183 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 257 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 263 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 284 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 290 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 1604 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1608 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1628 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 314 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 711 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 40 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 69 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 136 to 140 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 244 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 283 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 186 to 194 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 459 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 462 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 464 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 521 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 523 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 437 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 437 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 288 to 289 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 317 to 320 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 35 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 73 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 164 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 189 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 238 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 242 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 41 to 44 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 94 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 173 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 188 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 321 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 461 to 463 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 463 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 457 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 465 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 61 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 339 to 347 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 361 to 364 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1232 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1238 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1284 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1286 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1286 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1303 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with phycourobilin 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with phycourobilin 2, indicating a strong binding affinity.
The residue at position 212 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 299 forms a bond with phycourobilin 3, indicating a strong binding affinity.
The residue at position 38 to 44 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 84 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 34 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 71 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 72 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 98 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 593 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 597 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 689 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 691 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 694 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 137 to 143 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 354 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 376 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 398 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 516 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 198 to 202 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 508 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 25 forms a bond with Mg of a bacteriochlorophyll e, indicating a strong binding affinity.
The residue at position 280 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 489 to 496 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 238 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1295 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1520 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1522 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 70 to 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 866 to 874 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 479 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 552 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 967 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 970 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 972 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 204 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 26 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 53 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 64 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 148 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 174 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 210 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 214 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 232 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 256 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 300 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 392 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 420 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 445 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 248 to 252 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 361 to 365 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 427 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 467 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 235 to 239 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 275 to 282 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 373 to 375 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 405 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 343 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 710 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 722 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 3 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 6 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 547 to 550 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 607 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 611 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 614 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 1017 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 263 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 289 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 372 to 374 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 394 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 493 to 495 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 518 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 631 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 326 to 337 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 406 to 408 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 911 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 674 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 210 to 216 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1153 to 1196 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 178 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 403 to 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 to 23 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 29 to 30 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 311 forms a bond with heme, indicating a strong binding affinity.
The residue at position 367 forms a bond with heme, indicating a strong binding affinity.
The residue at position 190 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 216 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 259 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 320 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 321 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 419 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 467 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 21 to 22 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 74 to 75 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 215 forms a bond with allantoate, indicating a strong binding affinity.
The residue at position 275 forms a bond with allantoate, indicating a strong binding affinity.
The residue at position 288 forms a bond with allantoate, indicating a strong binding affinity.
The residue at position 602 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 57 to 61 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 98 forms a bond with O-phospho-L-serine, indicating a strong binding affinity.
The residue at position 245 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 248 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 252 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 280 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 5 to 6 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 5 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 36 to 40 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 229 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 261 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 294 to 296 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 306 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 35 to 43 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 277 to 279 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 380 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 336 to 343 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 658 to 665 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 705 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 705 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 707 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 646 to 651 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 65 to 68 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 473 to 475 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1871 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1905 to 1911 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1949 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 to 227 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 266 to 271 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 141 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 526 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 549 to 552 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 562 to 563 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 82 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 246 to 248 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 550 to 557 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 272 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 474 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1382 to 1390 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 175 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 269 to 274 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 1 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 323 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 448 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 11 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 145 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 200 to 208 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 3 to 8 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 132 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 355 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 63 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 93 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 94 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 118 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 169 to 170 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 188 to 191 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 188 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 257 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 378 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 385 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 392 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 399 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 399 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 403 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 405 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 95 to 101 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 276 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 309 to 314 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 405 to 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 to 275 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 322 to 330 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 194 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 248 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 239 forms a bond with O2, indicating a strong binding affinity.
The residue at position 370 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 372 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 62 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 71 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 152 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 155 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 645 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 771 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 148 to 152 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 403 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 477 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 327 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 95 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 189 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 102 to 108 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 128 to 131 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 388 to 394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 394 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 5 to 7 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 187 to 191 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 205 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 600 to 655 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 745 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 745 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 182 to 191 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 468 to 471 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 486 to 488 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 502 to 505 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 549 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 616 to 620 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 652 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 690 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 424 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 449 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 72 to 81 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1109 to 1166 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1162 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1168 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 130 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 766 to 774 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 to 414 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 443 to 446 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 545 to 549 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 621 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 534 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 691 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 730 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 21 to 23 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 32 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 56 to 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 323 to 327 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 382 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 406 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 433 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 439 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 496 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 500 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 557 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 564 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 570 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 641 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 652 to 655 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 659 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 670 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 697 to 701 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 697 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 701 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 371 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 414 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 409 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 519 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 545 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 633 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 992 to 1000 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1061 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1822 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1839 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1889 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1891 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 30 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 68 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 86 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 109 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 113 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 131 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 134 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 163 forms a bond with [(1R)-1-hydroxy-2-(trimethylamino)ethyl]phosphonate, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 386 to 390 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 441 to 445 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1374 to 1381 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 341 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 186 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 forms a bond with D-glucosamine, indicating a strong binding affinity.
The residue at position 409 forms a bond with D-glucosamine, indicating a strong binding affinity.
The residue at position 161 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 253 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 289 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 354 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 385 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 399 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 403 to 405 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 471 forms a bond with N-methylethanolamine phosphate, indicating a strong binding affinity.
The residue at position 1127 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1145 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 306 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 317 to 325 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 385 to 391 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 524 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 586 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 588 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 594 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 654 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 656 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 658 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 662 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 857 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 106 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 54 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 119 to 122 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 212 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 285 to 290 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 666 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 693 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 707 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 165 to 167 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 302 to 308 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 757 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 778 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 780 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 781 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 898 to 906 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 926 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 501 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 509 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 49 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 53 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 150 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 177 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 211 to 212 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 222 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 292 to 295 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 331 to 334 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 344 to 348 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 358 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 362 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 225 to 230 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 192 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 299 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 306 to 307 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 347 to 349 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 35 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 290 to 291 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 368 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 387 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 519 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 519 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 523 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 557 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 558 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 558 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 720 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 720 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 24 to 26 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1204 to 1206 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1223 to 1224 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1279 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1404 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1407 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1422 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1428 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1431 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1444 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1452 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1527 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1539 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1548 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1551 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1560 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1562 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 760 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 209 to 212 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 327 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 601 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 119 to 121 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 166 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 195 to 201 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 197 to 201 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 534 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 431 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 470 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 479 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 480 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 557 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 558 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 207 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 8 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 10 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 120 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 122 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 2 to 30 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 509 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 427 to 430 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 to 186 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 563 to 569 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 567 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 569 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 697 to 699 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with (indol-3-yl)acetate, indicating a strong binding affinity.
The residue at position 172 forms a bond with (indol-3-yl)acetate, indicating a strong binding affinity.
The residue at position 210 to 213 forms a bond with (indol-3-yl)acetate, indicating a strong binding affinity.
The residue at position 235 forms a bond with (indol-3-yl)acetate, indicating a strong binding affinity.
The residue at position 430 to 437 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 466 to 470 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 535 to 538 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 165 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 278 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 121 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with all-trans-hexaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 146 to 153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 35 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 38 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 112 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 115 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 158 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 203 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 616 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 324 to 327 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 359 to 364 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 233 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 233 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 244 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 244 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 543 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 544 to 547 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 555 to 556 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 605 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 648 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 426 to 433 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 464 to 468 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 619 to 621 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 626 to 632 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 719 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 61 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 840 to 848 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 19 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 20 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 27 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 61 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 180 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 217 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 15 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 85 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 173 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 222 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 224 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 229 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 607 to 611 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 661 to 664 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 152 to 157 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1230 to 1238 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1253 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 502 to 505 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 70 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 148 to 153 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 346 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 70 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 121 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 231 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 484 to 488 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 602 to 604 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 756 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 772 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 780 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 226 to 231 forms a bond with strychnine, indicating a strong binding affinity.
The residue at position 241 to 245 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 278 to 285 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 68 forms a bond with kinetin, indicating a strong binding affinity.
The residue at position 68 forms a bond with N(6)-dimethylallyladenine, indicating a strong binding affinity.
The residue at position 68 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 82 forms a bond with kinetin, indicating a strong binding affinity.
The residue at position 82 forms a bond with N(6)-dimethylallyladenine, indicating a strong binding affinity.
The residue at position 82 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 133 forms a bond with trans-zeatin, indicating a strong binding affinity.
The residue at position 399 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 91 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 237 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 646 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 903 to 905 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 922 to 923 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 978 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1099 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1102 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1225 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1240 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1243 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1252 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1261 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1263 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 501 to 507 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 576 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 579 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 1760 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1764 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 952 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 955 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 958 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 962 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 985 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 988 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 991 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 995 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 912 to 919 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 174 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 235 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 277 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 356 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 371 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 30 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 238 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 237 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 386 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 437 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 526 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 990 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 87 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 105 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 105 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 113 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 116 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 122 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 154 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 157 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 159 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 195 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 202 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 351 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 110 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 1673 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1716 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 418 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 928 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 934 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 936 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 511 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 519 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 525 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 525 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 526 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 633 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 719 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 731 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 731 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 732 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 732 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 859 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 859 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 860 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 889 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 899 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 899 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 902 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 902 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 904 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 905 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 to 266 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 308 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 375 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 607 to 662 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 739 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 752 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 752 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 754 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 541 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 547 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 550 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 587 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 456 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 to 55 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 843 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 859 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 113 to 117 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 to 65 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 143 to 154 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 211 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 118 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 121 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 125 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 174 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 186 forms a bond with poly[(1''->2')-ADP-alpha-D-ribose] group of a glycoprotein, indicating a strong binding affinity.
The residue at position 60 to 79 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 187 to 191 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 189 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 224 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 228 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 226 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 284 forms a bond with O2, indicating a strong binding affinity.
The residue at position 167 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 474 to 476 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 481 to 487 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 510 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 4 to 9 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 779 to 789 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 179 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 197 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 182 to 188 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 240 to 249 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 250 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 99 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 312 to 320 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 to 201 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 85 to 86 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 124 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 154 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 53 to 60 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 227 to 234 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 339 to 342 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 667 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 671 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 872 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 876 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 880 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 291 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 157 to 161 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 53 to 60 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 162 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 372 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 381 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 385 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 408 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 416 to 418 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 436 to 438 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 502 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 518 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 36 forms a bond with adenine, indicating a strong binding affinity.
The residue at position 185 forms a bond with adenine, indicating a strong binding affinity.
The residue at position 211 forms a bond with adenine, indicating a strong binding affinity.
The residue at position 9 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 20 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 150 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 316 to 330 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 136 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 248 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 258 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 460 to 463 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 589 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 569 to 573 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 570 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 738 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 770 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 55 to 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 to 114 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 to 323 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 328 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 416 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 399 to 401 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 428 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 452 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1316 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1395 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1398 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1700 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1805 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1808 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 578 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 419 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 421 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 351 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 211 to 217 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 611 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 193 to 195 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 296 to 297 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1205 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1239 to 1245 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1283 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 to 194 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 261 to 264 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 286 to 288 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 349 to 353 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 413 to 416 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 208 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 209 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 333 to 336 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 93 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 448 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 451 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 453 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 510 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 511 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 512 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 213 to 214 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1094 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 413 to 416 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 518 to 519 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 535 to 537 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 553 to 554 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 700 to 701 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 144 to 163 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 147 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 177 to 182 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 330 to 341 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 334 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 269 to 276 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 408 to 411 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 447 to 449 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 691 to 698 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 938 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 261 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 412 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 415 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 477 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 108 to 111 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 248 to 249 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 422 to 426 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 431 to 437 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 461 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 233 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 233 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 391 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 455 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 482 forms a bond with beta-D-fructose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 488 to 491 forms a bond with beta-D-fructose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 665 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 722 to 726 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 760 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 767 to 769 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 827 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 853 forms a bond with beta-D-fructose 2,6-bisphosphate 2, indicating a strong binding affinity.
The residue at position 859 to 862 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 952 forms a bond with beta-D-fructose 2,6-bisphosphate 1, indicating a strong binding affinity.
The residue at position 689 to 809 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 849 to 969 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 245 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 256 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1627 to 1629 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1731 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1998 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 2034 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2036 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 149 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 198 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 579 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 581 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 585 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 590 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 319 to 322 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1002 to 1004 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1079 to 1081 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 to 53 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 453 to 458 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 166 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 184 to 190 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 251 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 255 to 259 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 368 to 372 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 706 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 753 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 878 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 23 to 28 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 240 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 220 to 229 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 276 to 286 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 192 to 198 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 150 to 153 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 162 to 163 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 310 to 316 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 6 to 29 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 65 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 228 to 232 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 57 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 112 to 115 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 240 to 245 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 834 to 845 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 to 334 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 479 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 520 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 577 to 579 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 601 to 602 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 758 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 782 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 721 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 807 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 947 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 228 to 231 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 388 forms a bond with Cu(+), indicating a strong binding affinity.
The residue at position 763 forms a bond with Mo of Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 505 to 509 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 534 to 536 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 254 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 283 to 284 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 220 to 229 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 to 286 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 155 to 161 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 213 to 221 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 246 to 252 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 243 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 277 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 122 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 151 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 379 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 308 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 331 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 423 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 443 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 444 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 534 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 539 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 558 to 559 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 581 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 91 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 124 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 144 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 170 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 574 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 765 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 769 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 914 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 347 to 351 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 250 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 44 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 317 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 1105 to 1112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 to 85 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 286 to 290 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 398 to 399 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 59 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 180 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 362 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 343 to 350 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 387 to 390 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 271 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 290 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 293 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 70 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 254 to 282 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 224 to 230 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 120 to 123 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 266 to 272 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 405 to 406 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 257 to 269 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 278 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 81 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 149 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 153 to 159 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 182 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 88 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 88 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 106 to 111 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 208 to 212 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 74 to 79 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 95 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 226 to 253 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 1170 to 1177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 648 to 656 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 282 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 319 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 438 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 463 to 466 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 547 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 229 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 303 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 304 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 274 to 275 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 286 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 155 to 167 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 252 to 263 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 forms a bond with tRNA variable arm of tRNA, indicating a strong binding affinity.
The residue at position 79 to 90 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1022 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1103 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1181 to 1188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1243 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 156 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 467 to 470 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 491 to 493 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 524 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 289 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 146 to 161 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 341 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 96 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 182 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 231 to 234 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 211 to 222 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 733 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 11 to 18 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 77 to 80 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 399 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 274 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 440 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 488 to 489 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 496 to 498 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 230 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 8 to 11 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 126 forms a bond with (9Z)-hexadecenoate, indicating a strong binding affinity.
The residue at position 128 forms a bond with (9Z)-hexadecenoate, indicating a strong binding affinity.
The residue at position 159 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 179 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 222 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 472 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 115 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 135 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 159 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 165 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 1008 to 1013 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 21 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 24 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 42 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 46 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 68 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 70 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 76 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 110 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 112 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 148 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 455 to 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 377 to 379 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 442 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 102 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 107 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 175 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 126 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 233 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 245 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 303 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 326 forms a bond with an alpha-L-fucosyl-(1->2)-beta-D-galactosyl derivative, indicating a strong binding affinity.
The residue at position 839 to 846 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1852 to 1859 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 56 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 340 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 344 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 706 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1115 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 871 to 875 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 875 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 911 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 912 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 912 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 912 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 1029 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 1029 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 1080 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 362 to 369 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 168 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 179 to 182 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 108 to 112 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 98 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 112 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 257 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 323 to 326 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 486 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 202 to 212 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 130 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 161 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 182 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 132 to 136 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 164 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 182 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 to 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 6 to 33 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 561 to 568 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 to 187 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 310 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 312 to 315 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 343 to 346 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 355 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 592 to 596 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 593 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 719 to 720 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 768 to 771 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 775 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 794 to 797 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 870 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 652 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 654 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 698 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 597 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 198 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 256 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 566 forms a bond with 4-aminobutanoate, indicating a strong binding affinity.
The residue at position 270 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 285 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 288 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 311 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 334 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 361 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 374 to 377 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 81 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 302 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 1083 to 1090 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 148 to 155 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 57 to 62 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 100 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1567 to 1574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 31 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 433 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 461 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 162 to 170 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 114 to 119 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 363 to 364 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 570 to 574 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 624 to 627 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 29 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 68 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 70 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 72 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 75 forms a bond with vanillin, indicating a strong binding affinity.
The residue at position 151 forms a bond with vanillin, indicating a strong binding affinity.
The residue at position 239 forms a bond with vanillin, indicating a strong binding affinity.
The residue at position 1154 to 1161 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 220 to 228 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 4 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate 2, indicating a strong binding affinity.
The residue at position 33 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate 2, indicating a strong binding affinity.
The residue at position 36 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate 1, indicating a strong binding affinity.
The residue at position 14 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 15 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 386 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 406 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 422 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 335 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 355 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 475 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 563 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 341 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 410 to 412 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 to 439 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 549 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 410 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 413 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 415 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 428 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 317 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 483 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 658 to 777 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 821 to 941 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 564 to 568 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 618 to 621 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 384 forms a bond with heme, indicating a strong binding affinity.
The residue at position 568 forms a bond with heme, indicating a strong binding affinity.
The residue at position 140 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 211 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 223 to 229 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 528 to 529 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 206 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 261 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 298 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 1145 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 232 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 291 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 503 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 544 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 548 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 11 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 197 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 200 to 206 forms a bond with (S)-malate 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 450 to 454 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 474 forms a bond with (S)-malate 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 269 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 290 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 346 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 1234 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1326 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1329 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 187 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 226 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 196 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 214 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 525 to 532 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 675 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 58 to 63 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 115 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 85 to 88 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 462 to 467 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 462 to 463 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 27 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 429 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 470 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 874 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 241 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 244 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 261 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 264 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 274 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 1556 to 1563 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 50 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 73 to 75 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 275 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 159 to 168 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 567 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 605 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 82 to 83 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 152 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 185 to 191 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 17 to 26 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 397 to 418 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 449 to 468 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 19 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 233 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 330 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 57 to 88 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 261 to 268 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 345 to 349 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 11 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 22 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 65 forms a bond with taurodeoxycholate, indicating a strong binding affinity.
The residue at position 143 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 333 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 455 to 458 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 536 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 63 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 172 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 332 to 335 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 882 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 884 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 886 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 299 to 313 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 26 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 277 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 353 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 404 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 804 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 132 to 261 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 264 to 381 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 331 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 340 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 439 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 400 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 286 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 286 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 1123 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1219 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1222 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1275 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1312 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1350 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1352 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 472 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 505 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 519 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 525 to 526 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 321 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 321 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 332 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 332 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 55 to 57 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 365 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 644 to 651 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 941 to 949 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 70 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 163 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 278 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1396 to 1403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 to 439 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 803 to 805 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 306 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 306 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 312 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 202 to 203 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 257 to 267 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 329 to 337 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 147 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 505 to 509 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1699 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1804 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1807 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 214 to 217 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 677 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 680 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 to 129 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 243 to 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 360 to 362 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 338 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 339 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 512 to 516 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 206 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 283 to 291 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 356 to 357 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 83 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 335 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 339 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 344 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 425 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 438 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 453 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 639 to 670 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 780 to 791 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 923 to 933 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 998 to 1016 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1095 to 1110 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 831 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 38 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 75 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 111 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 20 to 44 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 134 to 184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 265 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 148 to 157 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 364 to 368 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 393 to 395 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 393 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 247 to 248 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 341 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 458 to 459 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 317 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 1214 to 1221 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 to 147 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 171 to 180 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 250 to 253 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 121 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 130 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 178 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 191 to 193 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 77 to 81 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 504 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 508 to 510 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 517 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 569 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 800 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 152 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 308 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 741 to 748 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1406 to 1413 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 326 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 428 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 91 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 33 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 63 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 135 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 91 to 96 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 283 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 288 to 293 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 91 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 233 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 358 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 1083 to 1089 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 363 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 392 to 408 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 504 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 218 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 209 to 215 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 282 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 615 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 110 to 119 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 222 to 270 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 6 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 2 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 972 to 979 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 772 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 776 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 778 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 783 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 810 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 398 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 768 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 772 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 342 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 817 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 817 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 818 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 982 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1021 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 20 to 25 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 to 122 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 78 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 103 to 105 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 204 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 246 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 147 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 150 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 181 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 192 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 217 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 225 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 228 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 297 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 300 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 335 forms a bond with L-glutamyl-L-arginyl-glycyl-L-methionyl-L-threonine, indicating a strong binding affinity.
The residue at position 1152 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 184 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1182 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 100 forms a bond with CO, indicating a strong binding affinity.
The residue at position 231 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 259 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 298 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 390 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 393 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 396 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 400 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 428 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 431 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 434 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 438 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 496 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 525 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 560 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 314 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 124 to 130 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 154 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 152 to 167 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 to 281 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 165 to 169 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 542 to 543 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 to 285 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 235 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 244 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 288 to 404 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 354 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 363 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 398 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 326 to 347 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 369 to 388 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 86 to 90 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 164 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 259 to 263 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 298 to 301 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 326 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 43 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 59 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 63 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 72 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 74 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 80 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 83 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 20 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 79 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 103 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 133 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 137 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with L-saccharopine, indicating a strong binding affinity.
The residue at position 222 forms a bond with dodecanoate, indicating a strong binding affinity.
The residue at position 235 forms a bond with dodecanoate, indicating a strong binding affinity.
The residue at position 302 forms a bond with dodecanoate, indicating a strong binding affinity.
The residue at position 121 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 275 to 279 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 299 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 453 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 488 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 493 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 117 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 485 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 473 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 475 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 479 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 484 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 737 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 767 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 769 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 904 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 137 to 142 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 147 to 202 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 87 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 195 to 197 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 399 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 179 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 206 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 383 to 386 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 106 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 175 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 205 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 226 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 274 forms a bond with quinolinate, indicating a strong binding affinity.
The residue at position 1 to 84 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 366 to 370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 425 to 433 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 193 to 199 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 222 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 548 to 552 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 602 to 605 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 291 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 364 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 368 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 369 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 372 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 335 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 8 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 24 to 28 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 64 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 76 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 85 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 93 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 8 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 23 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 34 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 80 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 97 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 495 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 518 to 520 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 637 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 666 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 700 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 701 to 702 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 797 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 230 to 235 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 253 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 299 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 562 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 569 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 614 to 617 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 14 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 223 to 227 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 168 to 173 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 233 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 391 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 104 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 1012 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 28 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 788 to 907 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 951 to 1070 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 467 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 611 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 615 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 619 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 336 to 343 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 514 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 516 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 711 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 748 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 748 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 858 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 312 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 314 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 352 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 174 to 231 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 63 to 67 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 170 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 467 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 561 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 247 to 251 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 278 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 290 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 296 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 299 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 10 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 330 to 335 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 143 to 150 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 113 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 187 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 276 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 8 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 19 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 19 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 164 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 211 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 214 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 347 to 352 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 505 to 515 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 513 to 515 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 539 to 541 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 630 to 633 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 658 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 728 to 732 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 756 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 757 to 759 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 759 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 402 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 430 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 455 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 146 to 150 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 226 to 231 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 481 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 483 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 918 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 267 to 271 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 496 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 129 forms a bond with (E)-ferulate, indicating a strong binding affinity.
The residue at position 229 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 268 forms a bond with (E)-5-hydroxyferulate, indicating a strong binding affinity.
The residue at position 305 to 309 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with (2R,3E)-phycoerythrobilin 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with (2R,3E)-phycoerythrobilin 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 1303 to 1310 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 176 to 182 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 324 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 470 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 488 to 492 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 500 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 530 to 532 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 1029 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1032 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1107 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 658 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 727 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 729 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 733 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 811 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 205 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 242 to 250 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 307 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 313 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 317 to 374 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 454 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1841 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2142 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2144 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 708 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 61 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 139 to 142 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 143 to 144 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with uridine, indicating a strong binding affinity.
The residue at position 382 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 386 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 457 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 532 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 534 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 538 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 140 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 189 forms a bond with Cu cation Z2, indicating a strong binding affinity.
The residue at position 344 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 400 forms a bond with Cu cation Z1, indicating a strong binding affinity.
The residue at position 452 forms a bond with Cu cation Z3, indicating a strong binding affinity.
The residue at position 513 forms a bond with Cu cation Z4, indicating a strong binding affinity.
The residue at position 592 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 629 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 631 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 635 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 638 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 200 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 539 to 541 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 541 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 546 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 717 to 718 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 759 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 123 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 186 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 220 to 225 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 589 to 594 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 632 to 637 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 670 to 672 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 216 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 233 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 244 to 250 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 276 to 281 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 515 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 773 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 709 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 735 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 126 to 131 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 486 to 488 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 488 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 67 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 86 forms a bond with a 1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 584 to 589 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 603 to 608 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 701 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 749 to 750 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1473 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1490 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1490 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1494 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1503 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1507 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1534 to 1536 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1577 to 1579 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1602 to 1603 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1605 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1650 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1652 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1653 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1654 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1659 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 457 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 458 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 373 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 382 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 453 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 455 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 1042 to 1050 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 340 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 345 to 347 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 358 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 244 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 310 to 319 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 243 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 113 to 119 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 174 to 182 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 158 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 159 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 242 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 248 forms a bond with a mannooligosaccharide derivative, indicating a strong binding affinity.
The residue at position 103 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 142 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 294 to 301 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 384 to 388 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 829 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 833 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 911 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 943 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 945 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1110 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 208 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 244 to 247 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 161 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 142 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 145 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 146 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 107 forms a bond with a rhodoquinol, indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 124 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 140 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 176 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 208 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 255 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 1120 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 185 to 213 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1186 to 1243 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1250 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 216 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 292 to 296 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 668 to 672 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 692 to 696 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 982 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1036 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1066 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 176 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1574 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1582 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1647 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 312 to 319 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 to 126 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 16 forms a bond with 5-amino-1-(beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 31 forms a bond with 5-amino-1-(beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 101 forms a bond with 5-amino-1-(beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 162 forms a bond with 5-amino-1-(beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 181 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with 5-amino-1-(beta-D-ribosyl)imidazole, indicating a strong binding affinity.
The residue at position 287 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 47 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 216 to 274 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 95 to 100 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 67 to 71 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 312 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 737 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with monodehydro-L-ascorbate radical, indicating a strong binding affinity.
The residue at position 106 forms a bond with monodehydro-L-ascorbate radical, indicating a strong binding affinity.
The residue at position 115 forms a bond with monodehydro-L-ascorbate radical, indicating a strong binding affinity.
The residue at position 140 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 151 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 182 forms a bond with monodehydro-L-ascorbate radical, indicating a strong binding affinity.
The residue at position 186 forms a bond with monodehydro-L-ascorbate radical, indicating a strong binding affinity.
The residue at position 326 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 407 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 480 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 215 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 30 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 195 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 251 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 507 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 556 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 906 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 911 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 924 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 930 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 955 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 960 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 973 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1013 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1026 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 1032 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 221 forms a bond with heme, indicating a strong binding affinity.
The residue at position 275 forms a bond with heme, indicating a strong binding affinity.
The residue at position 109 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 180 to 184 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 956 to 964 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2 forms a bond with (2R)-2,3-bisphosphoglycerate, indicating a strong binding affinity.
The residue at position 3 forms a bond with (2R)-2,3-bisphosphoglycerate, indicating a strong binding affinity.
The residue at position 83 forms a bond with (2R)-2,3-bisphosphoglycerate, indicating a strong binding affinity.
The residue at position 87 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 174 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 290 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 426 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 436 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 437 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 2078 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2113 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2116 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2147 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2150 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2162 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 283 to 286 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 384 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 479 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 332 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 215 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 193 to 200 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 871 to 878 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 65 to 67 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 168 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 214 to 223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 313 to 319 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 261 to 266 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 39 to 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 248 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 331 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 382 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 609 to 611 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 120 to 127 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 432 to 439 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 133 to 142 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 151 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 341 to 347 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 365 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 401 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 413 to 418 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 419 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 420 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 494 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 498 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 565 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 77 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 607 to 609 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 643 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 681 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 54 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 564 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 568 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 506 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 506 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 161 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 138 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 260 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 362 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 385 forms a bond with beta-D-xylose, indicating a strong binding affinity.
The residue at position 218 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 219 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 454 to 466 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 490 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 501 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 120 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 1530 to 1547 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1719 to 1734 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 17 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 98 forms a bond with D-xylono-1,5-lactone, indicating a strong binding affinity.
The residue at position 100 forms a bond with D-xylono-1,5-lactone, indicating a strong binding affinity.
The residue at position 119 forms a bond with D-xylono-1,5-lactone, indicating a strong binding affinity.
The residue at position 145 forms a bond with D-xylono-1,5-lactone, indicating a strong binding affinity.
The residue at position 94 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 252 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 283 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 286 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 287 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 139 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 57 forms a bond with cholate, indicating a strong binding affinity.
The residue at position 279 to 281 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 429 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 463 to 465 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 818 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 947 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 969 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 122 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 124 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 982 to 990 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 381 to 388 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 89 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 154 to 156 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 185 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 39 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 69 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 196 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 387 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 511 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 518 to 519 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 527 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 155 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 189 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 324 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 413 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 414 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 434 to 438 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 456 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 157 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 249 to 253 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 382 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 403 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 435 to 436 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 456 to 457 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 223 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 30 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 33 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 62 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 189 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 255 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 457 to 458 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 77 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 77 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 163 to 166 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 81 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 231 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 956 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 63 to 68 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 426 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 132 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 277 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 268 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 551 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 615 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 617 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 657 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 659 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 690 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1032 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1050 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1066 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1101 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1104 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 79 to 80 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 88 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 256 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 2154 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2156 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2158 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2160 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 2165 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 105 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 206 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 36 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 39 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 44 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 47 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 92 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 111 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 114 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 497 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 299 to 300 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 917 to 925 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 940 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 600 to 607 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 647 to 651 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 701 to 704 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 396 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 413 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 420 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 427 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 434 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 439 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 441 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 168 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 216 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 222 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 249 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 258 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 265 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 170 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 37 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 to 288 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 243 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 514 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 559 to 562 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 378 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 386 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1370 to 1377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 406 to 413 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1039 to 1046 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 97 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 158 to 162 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 270 to 280 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 303 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 389 to 391 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 340 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 343 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 349 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 371 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 35 to 37 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 155 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 628 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 63 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 180 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 565 to 571 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 653 to 661 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 720 to 722 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 865 to 866 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 870 to 871 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with (indol-3-yl)acetate, indicating a strong binding affinity.
The residue at position 211 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 188 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 192 forms a bond with beta-nicotinamide D-riboside, indicating a strong binding affinity.
The residue at position 215 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 241 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 425 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 429 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 198 to 200 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 305 to 319 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 88 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 151 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 151 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 482 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 484 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 486 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 to 284 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 327 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 328 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 380 to 396 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 595 to 602 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 950 to 957 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 44 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 841 to 848 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1827 to 1834 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 232 to 237 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 198 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 106 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 367 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 95 forms a bond with nogalaviketone, indicating a strong binding affinity.
The residue at position 406 to 409 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 786 to 791 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 78 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 78 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 90 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 204 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 227 forms a bond with beta-L-fucose 4, indicating a strong binding affinity.
The residue at position 239 forms a bond with beta-L-fucose 4, indicating a strong binding affinity.
The residue at position 246 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 299 forms a bond with beta-L-fucose 4, indicating a strong binding affinity.
The residue at position 164 to 167 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 441 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 79 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 346 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 443 to 444 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 450 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 454 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 96 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 130 to 133 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 342 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 437 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 441 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 353 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 360 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 402 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 403 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 404 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 490 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 496 forms a bond with vanadate, indicating a strong binding affinity.
The residue at position 290 to 293 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 27 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 29 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 36 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 63 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 65 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 67 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 72 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 393 to 401 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 465 to 467 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1252 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 61 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 350 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 421 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 391 to 511 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 826 to 836 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 574 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 785 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 179 to 184 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 317 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 271 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1752 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1758 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1763 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 157 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 114 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 430 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 433 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 462 to 463 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 483 to 484 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 2032 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 2136 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 2139 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 328 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 90 to 93 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 139 to 145 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 168 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 104 to 109 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 197 to 206 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 149 to 152 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 130 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 427 to 435 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 115 to 128 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 343 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 403 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 438 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 474 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 612 to 613 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 19 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 430 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 461 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 533 to 534 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 to 306 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 38 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 91 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 286 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 1561 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1564 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1577 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1579 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1582 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1585 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1604 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1609 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1649 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1672 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1675 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1680 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1683 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1688 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1693 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1719 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1722 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1737 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 56 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 163 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 91 to 99 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 95 to 99 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 95 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 95 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 138 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 138 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 45 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 13 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 205 to 214 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 289 to 293 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 181 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1902 to 1903 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 118 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 138 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 141 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 144 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 59 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 280 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 295 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 306 to 312 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 338 to 343 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 660 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 662 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 136 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 169 to 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 108 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 55 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 222 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 413 to 417 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 447 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 507 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 176 to 185 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 543 to 544 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 549 to 553 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 798 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 801 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 93 to 100 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 542 to 549 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 592 to 596 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 646 to 649 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 317 to 324 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 493 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 151 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 238 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 249 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 252 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 309 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 312 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 183 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 224 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 247 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 258 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 817 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 559 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 607 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 290 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 236 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 258 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 266 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 337 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 367 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 165 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 219 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 256 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 288 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 27 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 96 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 150 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 195 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 239 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 268 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 326 to 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 46 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 319 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 430 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 109 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 110 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 169 to 174 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 264 forms a bond with urate, indicating a strong binding affinity.
The residue at position 1203 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1206 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1223 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1226 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 492 to 500 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 to 279 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 240 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 282 to 283 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 283 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 264 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 137 to 143 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 621 to 628 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 827 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 861 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 133 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 414 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 417 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 429 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 441 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 452 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 164 to 219 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 95 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 247 to 251 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 forms a bond with D-glucosamine, indicating a strong binding affinity.
The residue at position 370 forms a bond with D-glucosamine, indicating a strong binding affinity.
The residue at position 299 to 300 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 43 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 160 to 168 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 156 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 195 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 841 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 844 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 865 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 190 to 242 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 8 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 113 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 201 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 357 to 361 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 366 to 372 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 360 to 361 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 95 to 104 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1640 to 1647 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 324 to 331 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 161 to 163 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 300 to 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 37 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 202 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 406 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 430 to 433 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 485 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 96 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 145 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 148 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 196 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 205 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 261 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 307 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 405 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 429 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 470 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 158 forms a bond with D-glucosamine 6-phosphate, indicating a strong binding affinity.
The residue at position 708 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 711 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 714 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 718 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 764 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 767 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 770 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 774 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 841 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 866 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1103 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 53 to 57 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 14 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 348 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 1359 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1362 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1421 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1449 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1492 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 36 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 36 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 43 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 117 forms a bond with K(+) 3, indicating a strong binding affinity.
The residue at position 125 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 52 to 57 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 946 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 948 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 969 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1018 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 471 to 477 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 549 to 551 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 395 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 417 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 435 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 552 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 94 to 99 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 243 to 245 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 313 to 316 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 392 to 398 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 443 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 288 to 294 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 30 to 74 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 239 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 243 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 405 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 425 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 841 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1176 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1193 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1245 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1247 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 98 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 187 forms a bond with farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 369 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 565 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 709 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 375 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 207 to 210 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 210 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 218 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 248 to 250 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 304 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 209 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 218 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 238 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 50 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 2 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 4 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 932 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 932 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 933 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 976 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 976 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 447 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 449 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 473 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 492 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 859 to 866 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 to 140 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 375 to 492 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 200 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 212 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 225 to 226 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 599 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 610 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 664 to 665 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 409 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 437 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 462 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 499 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 323 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 370 to 373 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 165 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 166 forms a bond with arsenate, indicating a strong binding affinity.
The residue at position 189 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 190 forms a bond with arsenate, indicating a strong binding affinity.
The residue at position 193 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 198 forms a bond with arsenate, indicating a strong binding affinity.
The residue at position 210 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 69 to 71 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 77 to 82 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 111 to 117 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 290 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 322 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 335 to 347 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 535 to 536 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 569 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 958 to 965 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 194 to 197 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 438 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 518 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 147 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 905 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 908 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 929 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 932 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 158 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 200 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 300 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 36 to 52 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 44 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 83 to 88 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 178 to 182 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 401 to 404 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 853 to 860 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 133 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 199 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 275 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 276 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 313 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 330 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 154 to 159 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 602 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 604 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 606 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 611 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 632 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 17 to 19 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 188 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 495 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 627 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 657 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 674 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 677 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 716 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 733 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 736 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 762 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 779 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 782 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 1221 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1223 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1232 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1233 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1439 to 1446 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 39 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 59 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 61 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 61 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 69 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 134 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 190 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 218 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 218 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 244 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 290 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 373 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 389 forms a bond with pemetrexed, indicating a strong binding affinity.
The residue at position 250 forms a bond with beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl group of a glycoprotein, indicating a strong binding affinity.
The residue at position 401 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 846 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 952 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 953 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1147 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1177 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1436 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 384 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 210 to 212 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 278 to 279 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 670 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 717 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 842 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 102 to 105 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 104 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 146 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 213 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 168 to 174 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 201 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 572 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 390 to 393 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 426 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 95 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 159 to 163 forms a bond with an L-alpha-amino acid, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 326 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 838 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 896 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 922 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 924 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 964 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 974 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 976 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 992 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1001 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1077 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1083 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1085 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1087 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1090 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1119 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1681 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1696 to 1698 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1702 to 1704 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1712 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 289 to 297 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 43 forms a bond with rifampicin, indicating a strong binding affinity.
The residue at position 285 forms a bond with rifampicin, indicating a strong binding affinity.
The residue at position 373 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 639 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 to 67 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 105 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 135 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 1094 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1144 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1195 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 589 to 593 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 372 to 375 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 395 to 404 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 422 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 376 to 377 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 93 to 102 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 93 to 100 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 183 to 184 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 219 to 220 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 220 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 243 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 271 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 302 to 305 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 424 to 426 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 540 to 545 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 540 to 544 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 608 to 609 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 625 to 626 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 661 to 662 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 662 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 685 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 685 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 687 to 688 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 713 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 747 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 752 to 753 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 789 to 793 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 866 to 868 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 868 to 872 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 902 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 39 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 39 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 78 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 78 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 94 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 94 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 154 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 154 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 197 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 197 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 214 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 214 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 218 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 218 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 241 forms a bond with D-galacturonate, indicating a strong binding affinity.
The residue at position 241 forms a bond with D-glucuronate, indicating a strong binding affinity.
The residue at position 439 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 176 to 178 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 333 to 344 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 420 to 425 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 480 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 491 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 632 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 633 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 643 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 700 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 701 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 46 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 58 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 320 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 14 to 16 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 117 to 125 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 171 forms a bond with a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 171 forms a bond with a 1-acyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 1661 to 1663 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1661 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1706 to 1716 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1730 to 1734 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1760 to 1762 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 360 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 58 to 62 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 308 to 313 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 30 forms a bond with beta-D-Gal-(1->3)-alpha-D-GalNAc, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with beta-D-Gal-(1->3)-alpha-D-GalNAc, indicating a strong binding affinity.
The residue at position 49 to 50 forms a bond with N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with beta-D-Gal-(1->3)-alpha-D-GalNAc, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with N,N'-diacetylchitobiose, indicating a strong binding affinity.
The residue at position 79 to 82 forms a bond with N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 103 forms a bond with N,N'-diacetylchitobiose, indicating a strong binding affinity.
The residue at position 103 forms a bond with N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 114 forms a bond with N,N'-diacetylchitobiose, indicating a strong binding affinity.
The residue at position 114 forms a bond with N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 2 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 16 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 71 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 103 to 110 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 225 to 229 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 180 to 187 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 859 to 866 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 550 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 29 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 67 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 560 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 675 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 968 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1041 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1044 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1146 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1218 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1221 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 712 to 719 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 364 to 367 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 387 to 396 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 55 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 744 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 84 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 177 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 292 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 172 to 175 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 210 to 219 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 336 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 497 to 500 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 515 to 517 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 531 to 534 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 639 to 640 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 645 to 649 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 681 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 719 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 136 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 424 to 431 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 455 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 466 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 117 to 127 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 105 to 108 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 383 to 391 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 68 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 71 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 93 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 100 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 268 forms a bond with taurine, indicating a strong binding affinity.
The residue at position 240 to 246 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 to 130 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 269 to 274 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 124 forms a bond with bortezomib, indicating a strong binding affinity.
The residue at position 16 to 21 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 102 to 111 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 465 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 36 to 56 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 123 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 828 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 896 to 897 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 489 to 491 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 513 to 514 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 67 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 93 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 338 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 678 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 831 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 79 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 275 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 297 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 348 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 453 to 454 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 572 to 574 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 188 to 223 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 405 to 406 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 434 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 509 to 514 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 532 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 562 forms a bond with (3R)-3-hydroxydecanoyl-CoA, indicating a strong binding affinity.
The residue at position 705 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 557 to 672 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 742 to 743 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 27 to 30 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 100 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 137 to 146 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 387 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 420 to 423 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 413 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 431 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 548 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 482 to 609 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 598 to 727 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 64 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 70 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 99 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 145 to 153 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 561 to 562 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 591 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 19 to 23 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 170 to 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 537 to 538 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 226 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 545 to 600 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 682 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 682 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 684 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1078 to 1135 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1202 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1214 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1214 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 1471 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1471 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1475 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1505 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1556 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1556 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1590 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1613 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1614 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1637 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1661 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1686 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1686 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1690 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 96 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 1462 to 1470 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 605 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 251 to 259 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 99 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 389 to 397 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 393 to 397 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 160 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 to 22 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 227 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 266 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 626 to 629 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 204 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 266 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 268 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 287 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 315 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 319 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 95 to 104 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 127 to 132 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 418 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 422 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 427 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 430 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1434 to 1436 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1446 to 1447 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1493 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1498 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1502 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1707 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1720 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1723 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1729 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1732 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1738 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1740 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 162 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 459 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 553 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 49 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 79 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 104 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 124 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 241 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 107 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 108 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 138 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 150 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 155 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 157 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 187 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 227 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 228 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 332 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 354 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 12 to 25 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 719 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 723 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 803 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 804 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 804 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 804 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 919 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 919 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 970 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 457 to 460 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 41 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 2146 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 2148 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 2276 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 27 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 411 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 447 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 565 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 54 to 65 forms a bond with cyclosporin A, indicating a strong binding affinity.
The residue at position 70 to 71 forms a bond with cyclosporin A, indicating a strong binding affinity.
The residue at position 99 to 104 forms a bond with cyclosporin A, indicating a strong binding affinity.
The residue at position 109 to 113 forms a bond with cyclosporin A, indicating a strong binding affinity.
The residue at position 119 forms a bond with cyclosporin A, indicating a strong binding affinity.
The residue at position 125 forms a bond with cyclosporin A, indicating a strong binding affinity.
The residue at position 98 to 107 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 214 to 261 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 55 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 138 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 150 forms a bond with 3-hydroxy-L-kynurenine, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 305 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 627 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 646 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 779 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 564 to 568 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 573 to 579 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 603 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 57 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 270 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 165 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 367 to 371 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 277 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 333 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 406 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 451 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 486 to 488 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 475 to 478 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 526 to 529 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 552 to 555 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 587 to 591 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 613 to 615 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 368 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 375 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 405 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 415 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 169 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 256 to 258 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 341 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 345 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 451 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 497 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 524 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 642 to 651 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 728 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 745 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 30 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 205 to 210 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 404 to 406 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 416 to 422 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 395 to 397 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 526 to 530 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 216 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 242 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 255 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 603 to 606 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 93 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 323 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 384 to 392 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 388 to 392 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 101 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 153 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 198 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 274 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 366 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 425 to 426 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 575 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 678 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 252 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 253 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 362 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 332 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 118 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 256 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 263 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 178 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 226 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 38 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 41 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 89 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 90 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 105 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 108 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 109 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 170 to 183 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1972 to 1980 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2073 to 2074 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 183 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 151 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 214 to 273 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 119 to 132 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 155 to 164 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 975 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 989 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 467 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 492 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 513 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 57 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 93 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 165 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 215 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 160 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 140 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 264 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 399 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 143 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 414 forms a bond with 15-deacetylcalonectrin, indicating a strong binding affinity.
The residue at position 123 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 163 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 254 to 255 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 458 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 320 to 329 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 476 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 176 to 181 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 884 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 886 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 993 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1046 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 135 to 137 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 162 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 182 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 331 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 214 to 215 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 40 to 67 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 559 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 562 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 669 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 702 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 712 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 730 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 196 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1193 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1339 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1342 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 87 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 18 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 21 forms a bond with quercetin, indicating a strong binding affinity.
The residue at position 250 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 250 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 315 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 315 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 332 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 332 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 336 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 336 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 337 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 337 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 340 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 340 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 233 to 234 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 480 to 484 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 530 to 533 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 to 188 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 348 to 350 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1110 to 1113 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1133 to 1142 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 89 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 102 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 170 to 175 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 215 to 219 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 118 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 94 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 283 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 448 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 104 to 108 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 93 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 204 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 293 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 379 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 381 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 445 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 161 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 424 to 426 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 133 to 137 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 456 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 338 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 101 to 106 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 700 to 708 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 348 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 99 to 106 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 285 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 289 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 292 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 310 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 43 to 49 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 441 to 443 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 337 to 344 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 43 to 47 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 130 to 162 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 422 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 494 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 498 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 62 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 26 to 32 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1233 to 1240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 478 to 485 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 441 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 346 to 354 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 149 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 153 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 157 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 802 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 537 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 778 to 786 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 106 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 148 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 150 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 519 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 522 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 524 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 595 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 597 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 197 to 202 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 235 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 255 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 49 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 135 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 262 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 683 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 691 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 699 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 700 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 175 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 327 to 329 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 177 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 215 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 232 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 89 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 90 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 103 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 104 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 316 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 320 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 321 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 334 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 335 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 58 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 103 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 280 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 317 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 344 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 436 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 461 to 464 forms a bond with glyoxylate, indicating a strong binding affinity.
The residue at position 545 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 232 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 399 forms a bond with sucrose, indicating a strong binding affinity.
The residue at position 824 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 1, indicating a strong binding affinity.
The residue at position 833 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 1, indicating a strong binding affinity.
The residue at position 922 to 926 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 1, indicating a strong binding affinity.
The residue at position 961 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 1, indicating a strong binding affinity.
The residue at position 1023 to 1024 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1034 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1046 to 1049 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1133 to 1137 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1175 to 1178 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1235 to 1236 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 1247 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 1258 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 1332 to 1336 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 1371 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 554 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 591 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 602 to 604 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 651 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 190 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 1632 to 1640 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1654 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 405 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 20 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 20 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 105 to 106 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 134 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 287 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 348 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 188 to 199 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 26 to 28 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 184 to 301 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 258 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 302 to 416 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 274 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 291 to 299 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with dodecanoyl-CoA, indicating a strong binding affinity.
The residue at position 122 forms a bond with dodecanoyl-CoA, indicating a strong binding affinity.
The residue at position 289 forms a bond with dodecanoyl-CoA, indicating a strong binding affinity.
The residue at position 319 forms a bond with dodecanoyl-CoA, indicating a strong binding affinity.
The residue at position 321 forms a bond with dodecanoyl-CoA, indicating a strong binding affinity.
The residue at position 151 to 160 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 52 to 53 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 163 to 169 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 541 to 545 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 542 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 712 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 743 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 231 forms a bond with beta-D-glucuronate, indicating a strong binding affinity.
The residue at position 195 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 235 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 426 to 434 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 287 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 419 to 420 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 502 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 526 to 527 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 809 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 811 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 813 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 815 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 820 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 839 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 843 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 845 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 850 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with AMP 3'-end residue of tRNA, indicating a strong binding affinity.
The residue at position 89 forms a bond with AMP 3'-end residue of tRNA, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 179 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 623 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 627 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 56 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 341 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 45 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 117 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 190 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 195 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 246 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 266 to 274 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 2 to 8 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 104 to 111 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 377 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 395 to 399 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 407 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 437 to 439 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 587 to 595 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 850 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 67 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 877 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 881 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with substrate 1, indicating a strong binding affinity.
The residue at position 293 to 321 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 389 to 395 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 52 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 95 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 47 to 48 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 264 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 300 to 301 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 710 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 96 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 471 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 474 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 475 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 559 to 564 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 525 to 526 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 137 forms a bond with methotrexate, indicating a strong binding affinity.
The residue at position 84 to 93 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 146 to 150 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 695 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 731 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 734 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 360 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 823 to 830 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 158 to 160 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 164 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 214 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 239 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 260 forms a bond with D-apiofuranose, indicating a strong binding affinity.
The residue at position 730 to 738 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 805 to 807 forms a bond with semaxanib, indicating a strong binding affinity.
The residue at position 244 to 250 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 280 to 284 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 343 to 346 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 393 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 469 to 480 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 577 to 582 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 598 to 600 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 600 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 155 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 686 to 743 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 809 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 159 to 160 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 124 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 193 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 239 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 336 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 194 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 197 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 265 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 268 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 272 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 72 forms a bond with triuret, indicating a strong binding affinity.
The residue at position 132 forms a bond with triuret, indicating a strong binding affinity.
The residue at position 157 forms a bond with triuret, indicating a strong binding affinity.
The residue at position 158 forms a bond with triuret, indicating a strong binding affinity.
The residue at position 162 forms a bond with triuret, indicating a strong binding affinity.
The residue at position 202 forms a bond with triuret, indicating a strong binding affinity.
The residue at position 710 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 711 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 821 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 340 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 484 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 594 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 598 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 684 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 697 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 712 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 887 to 918 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1033 to 1044 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1176 to 1186 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1251 to 1269 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1349 to 1364 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 394 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 994 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 224 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 320 to 324 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 18 to 19 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 20 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 187 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 187 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 268 to 272 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 52 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 8 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 99 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 99 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 102 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 327 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1567 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1580 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1582 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1588 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1607 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1612 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1657 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1686 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1696 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1725 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1742 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 844 to 852 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 374 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 377 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 333 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 361 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 494 to 495 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 575 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 598 to 599 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 284 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 56 to 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 553 to 558 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 121 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 125 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 201 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 204 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 270 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 277 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 281 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 296 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 309 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 388 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 250 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 268 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 298 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 313 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 342 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 10 to 16 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 to 92 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 90 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 163 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 471 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 482 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 565 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 566 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 61 to 63 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 to 80 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 394 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 437 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 440 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 488 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 491 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 492 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 281 to 284 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 197 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 202 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 208 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 572 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 576 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 11 to 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 934 to 941 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 46 to 49 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 157 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 160 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 195 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 199 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 244 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 247 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 312 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 319 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 322 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 338 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 353 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 356 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 357 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 432 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 469 to 476 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1135 to 1142 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 461 to 464 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 485 to 487 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 455 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 15 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 17 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 19 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 28 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 32 forms a bond with Cu cation 7, indicating a strong binding affinity.
The residue at position 34 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 34 forms a bond with Cu cation 7, indicating a strong binding affinity.
The residue at position 34 forms a bond with Cu cation 8, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cu cation 8, indicating a strong binding affinity.
The residue at position 44 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 44 forms a bond with Cu cation 8, indicating a strong binding affinity.
The residue at position 46 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 46 forms a bond with Cu cation 7, indicating a strong binding affinity.
The residue at position 25 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 15 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 159 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 156 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 178 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 251 to 253 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 300 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 310 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 556 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 651 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 659 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 667 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 668 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 202 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 399 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 444 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 407 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 552 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 33 to 37 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 345 to 349 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 5 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 230 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 7 to 13 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 41 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 71 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 43 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 401 to 404 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 121 to 123 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 129 to 134 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 19 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 476 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 21 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 23 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 40 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 40 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 42 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 45 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 104 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 39 to 65 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 to 220 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 948 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 948 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 950 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 954 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 954 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 960 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1000 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1000 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1010 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1031 to 1033 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1069 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1071 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1191 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1194 to 1195 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1197 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1250 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1252 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 362 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 365 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 126 to 130 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 136 to 138 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 103 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 244 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 353 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 354 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 444 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 457 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 472 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 527 to 531 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 669 to 700 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 811 to 822 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 954 to 964 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1028 to 1147 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1128 to 1143 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 228 to 235 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 52 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 61 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 90 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 119 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 483 to 485 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 141 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 329 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 966 to 973 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 1536 to 1543 forms a bond with ATP 4, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1067 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 547 to 554 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 654 to 657 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 354 to 357 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 43 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 138 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 149 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 364 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 384 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 388 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 408 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 118 to 127 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 369 to 373 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 433 to 436 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 136 to 141 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1645 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1649 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1669 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 216 to 221 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 258 forms a bond with O2, indicating a strong binding affinity.
The residue at position 303 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 304 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 389 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 391 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 801 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 836 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 840 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 844 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 610 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 289 to 290 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 188 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 284 to 290 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 310 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 450 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 498 to 499 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 506 to 508 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 273 to 283 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 246 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 180 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 61 to 66 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 500 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 5 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 13 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 466 to 469 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 645 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 702 to 706 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 740 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 747 to 749 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 807 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 833 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 839 to 842 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 906 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 169 to 171 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 396 to 397 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 219 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 263 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 315 to 316 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 434 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 468 to 470 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 841 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 112 to 119 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 281 to 286 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 400 to 403 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1653 to 1660 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 360 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 477 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 60 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 63 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 72 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 229 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 276 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 302 to 304 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 311 to 317 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 111 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 247 to 254 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 716 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 719 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 732 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 744 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 747 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 760 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 764 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 772 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 775 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 788 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 792 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 670 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 204 to 210 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 367 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 472 to 475 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 495 to 497 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 528 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 521 to 580 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 702 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 702 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 725 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 725 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 491 to 495 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 545 to 548 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 339 to 340 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 344 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 425 to 428 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 720 to 723 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 807 to 809 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 880 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 884 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 152 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 277 to 278 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 185 to 190 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 102 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 225 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 321 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 330 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 336 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 338 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 486 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 616 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 33 to 36 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 150 to 159 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 190 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 18 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 280 to 285 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 1294 to 1301 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 391 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 301 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 130 to 134 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 76 to 82 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 1705 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1810 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1813 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 132 forms a bond with bergaptol, indicating a strong binding affinity.
The residue at position 270 forms a bond with bergaptol, indicating a strong binding affinity.
The residue at position 246 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 16 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with anthranilate 2, indicating a strong binding affinity.
The residue at position 38 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 247 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 278 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 174 forms a bond with D-hexose, indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with D-hexose, indicating a strong binding affinity.
The residue at position 418 forms a bond with D-hexose, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 757 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 762 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 943 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 947 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 597 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 876 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 880 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 880 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1162 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1556 forms a bond with PAM RNA of RNA, indicating a strong binding affinity.
The residue at position 1585 forms a bond with PAM RNA of RNA, indicating a strong binding affinity.
The residue at position 176 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 325 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 394 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 37 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 878 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 880 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 929 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 382 to 389 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1015 to 1022 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 81 to 85 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 476 to 483 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 672 to 679 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1004 to 1009 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1036 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1105 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1197 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1206 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1287 to 1291 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 1475 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 167 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 154 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 366 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 172 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 217 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 295 to 300 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 939 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1019 to 1021 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1026 to 1030 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 191 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 544 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 563 to 564 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 978 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 987 to 990 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 471 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 131 to 135 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 222 to 227 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 366 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 401 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 525 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 180 to 190 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 448 to 451 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 185 to 191 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 679 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 682 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 694 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 701 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 712 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 588 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 620 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 620 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 652 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 705 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 164 to 183 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 246 to 249 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 373 to 375 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 167 to 171 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 161 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 299 to 303 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 236 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 399 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 534 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 796 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 834 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 1095 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1099 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1132 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 1043 to 1046 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1053 to 1056 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1054 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1056 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1126 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1148 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1166 to 1170 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1282 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 161 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 299 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 9 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 13 forms a bond with O2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 147 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 40 to 45 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 87 to 89 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 229 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 1001 to 1006 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1050 to 1052 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 1079 to 1082 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 1421 to 1426 forms a bond with ATP 3, indicating a strong binding affinity.
The residue at position 1447 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 1470 to 1472 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 1499 to 1502 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 1506 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 1543 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 750 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with xanthan, indicating a strong binding affinity.
The residue at position 246 forms a bond with xanthan, indicating a strong binding affinity.
The residue at position 255 forms a bond with xanthan, indicating a strong binding affinity.
The residue at position 309 forms a bond with xanthan, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with xanthan, indicating a strong binding affinity.
The residue at position 424 forms a bond with xanthan, indicating a strong binding affinity.
The residue at position 515 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 612 forms a bond with xanthan, indicating a strong binding affinity.
The residue at position 1340 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1343 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1383 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1386 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1448 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 419 to 421 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 426 to 432 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 182 to 217 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 410 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 479 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 621 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 301 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 28 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 221 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 124 to 125 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 44 to 49 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 623 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 545 to 546 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 171 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 175 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 200 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 297 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 306 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 345 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 380 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 381 to 386 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 forms a bond with (9Z)-hexadecenoate, indicating a strong binding affinity.
The residue at position 401 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 489 to 494 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 536 to 539 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 570 to 572 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 578 to 580 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 62 to 69 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 727 to 734 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 787 to 795 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 810 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 387 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 526 to 527 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 712 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 95 to 97 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 274 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 276 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 305 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 308 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 310 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 381 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 442 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 444 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 446 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 449 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 513 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 515 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 549 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 551 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 553 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 559 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 622 forms a bond with deinoxanthin, indicating a strong binding affinity.
The residue at position 716 forms a bond with Cu(2+) 3, indicating a strong binding affinity.
The residue at position 389 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 398 to 399 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 197 to 198 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 345 to 347 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 500 to 502 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 502 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 311 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 323 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 380 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 419 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 685 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 732 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 857 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 318 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 448 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 541 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 610 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 777 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 781 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 936 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 593 to 710 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 658 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 169 to 176 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 7 to 8 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 196 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 211 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 237 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 250 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 420 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 194 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 270 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 221 to 227 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 238 to 253 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 281 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 325 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 333 to 335 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 178 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 303 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 335 forms a bond with CMP-N-acetyl-beta-neuraminate, indicating a strong binding affinity.
The residue at position 338 to 342 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 202 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 203 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 323 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 378 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 77 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 132 forms a bond with (R)-glycerate, indicating a strong binding affinity.
The residue at position 137 to 140 forms a bond with (R)-glycerate, indicating a strong binding affinity.
The residue at position 164 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 193 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 69 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 54 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 65 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 65 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 119 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 205 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 252 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 255 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 697 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 721 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 750 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 751 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 37 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 119 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 130 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 239 to 249 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 311 to 319 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 284 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 21 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 31 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 37 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 41 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 49 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 49 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 57 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 60 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 97 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 101 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 103 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 130 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 139 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 146 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 604 to 605 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 532 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 865 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 493 to 501 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate), indicating a strong binding affinity.
The residue at position 187 forms a bond with (+)-alpha-tocopherol, indicating a strong binding affinity.
The residue at position 190 to 192 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate), indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 217 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate), indicating a strong binding affinity.
The residue at position 221 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate), indicating a strong binding affinity.
The residue at position 198 to 205 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 310 to 313 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 15 to 19 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 211 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 174 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 653 forms a bond with Mo of Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 869 forms a bond with Mo of Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 606 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 46 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 65 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 133 to 134 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 153 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 268 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 565 to 567 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 224 to 227 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 341 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 417 to 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 169 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 609 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 681 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 819 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 90 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 431 to 435 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 291 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 350 to 357 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 423 to 425 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 505 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 559 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 565 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 566 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 473 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 86 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 464 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 523 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 505 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 173 to 179 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 378 to 386 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 436 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 109 to 114 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 57 to 62 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 297 to 300 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with heme, indicating a strong binding affinity.
The residue at position 279 forms a bond with heme, indicating a strong binding affinity.
The residue at position 712 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 714 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 716 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 718 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 748 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 407 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 184 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 1151 to 1158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 67 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 102 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 113 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 296 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 380 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 382 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 450 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 2 to 32 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 86 to 87 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 160 to 163 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 216 to 223 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 310 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 175 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 178 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 895 to 902 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 943 to 949 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 988 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 116 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 17 to 42 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 4 to 7 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 261 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 295 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 333 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 446 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 476 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 526 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 155 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 190 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 190 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 6 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 159 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 434 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1607 to 1614 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 250 to 256 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 372 to 377 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 648 to 651 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 268 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 328 to 334 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 458 to 461 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 884 to 892 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2014 to 2133 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 2490 to 2616 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 297 to 299 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 424 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 507 to 509 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 532 to 533 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 165 to 170 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 195 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 119 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 128 to 143 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 154 to 191 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 109 to 120 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 287 to 290 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 869 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 85 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 129 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 59 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 39 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 42 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 353 to 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 267 to 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 335 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 390 to 392 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 425 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 473 to 474 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 498 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 41 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 394 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 538 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 563 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 61 to 64 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 87 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 391 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1119 to 1126 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 172 to 177 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 449 to 454 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 513 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 600 to 608 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 392 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 304 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 186 to 193 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 728 to 736 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 665 to 672 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 59 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 67 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 88 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 92 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 93 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 504 to 511 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 176 forms a bond with folate, indicating a strong binding affinity.
The residue at position 500 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 523 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 47 to 71 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 131 to 137 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 157 to 160 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 135 to 141 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 295 to 303 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 55 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 114 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 126 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 158 to 163 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 803 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 807 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 212 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 215 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 301 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 303 forms a bond with [Ni-Fe-S] cluster, indicating a strong binding affinity.
The residue at position 205 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 118 to 126 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 228 to 231 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 471 to 482 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 23 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 143 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 320 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 1808 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1811 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1825 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1828 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1833 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1836 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1854 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1857 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 157 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 296 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 7 to 9 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 30 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 102 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 161 forms a bond with a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 197 forms a bond with a 1-acyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 197 forms a bond with a 1-acyl-sn-glycero-3-phospho-L-serine, indicating a strong binding affinity.
The residue at position 42 to 44 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 77 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 250 to 260 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 276 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 283 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 328 to 330 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 369 to 371 forms a bond with heparan sulfate group, indicating a strong binding affinity.
The residue at position 125 to 131 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 154 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 186 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 207 to 208 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 76 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 119 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 300 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 284 to 287 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 344 to 354 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 115 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 245 to 246 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 228 forms a bond with heme b 2, indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 184 to 189 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 184 to 189 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 220 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 719 to 726 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 to 200 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 333 to 335 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 373 to 375 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 396 to 397 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 463 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 522 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 142 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 156 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 158 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 28 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 451 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 574 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 73 to 78 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 600 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 702 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 703 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 584 to 591 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 659 to 665 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 434 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 110 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 113 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 202 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 205 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 489 to 496 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 535 to 539 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 716 to 722 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 804 to 812 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 873 to 875 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1015 to 1016 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1020 to 1021 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 397 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 397 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 397 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 412 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 412 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 454 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 487 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 487 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 487 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 773 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 866 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 868 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 868 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 870 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 894 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 897 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 897 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 993 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 995 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 995 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 997 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1016 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1020 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1020 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 223 to 224 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 200 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 392 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 142 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 169 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 364 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 328 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 490 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 89 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 108 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 208 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 343 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 396 to 403 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1017 to 1024 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 428 to 432 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1032 to 1040 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1055 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 to 277 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 forms a bond with 5-hydroxybenzimidazolylcob(I)amide, indicating a strong binding affinity.
The residue at position 121 to 126 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 399 to 401 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 451 to 452 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 299 to 310 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 45 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 105 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 123 to 130 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 470 to 471 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 92 forms a bond with dibenzothiophene, indicating a strong binding affinity.
The residue at position 129 forms a bond with dibenzothiophene, indicating a strong binding affinity.
The residue at position 205 forms a bond with dibenzothiophene, indicating a strong binding affinity.
The residue at position 391 to 392 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 300 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 416 to 417 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 495 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 507 to 510 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 616 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 787 to 790 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 920 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 983 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 830 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 888 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 916 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 956 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 966 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 968 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 984 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1053 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1069 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1077 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1079 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1082 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1111 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1673 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1688 to 1690 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1694 to 1696 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1704 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 124 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 215 to 222 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 939 to 946 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 8 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 27 to 29 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 56 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 157 to 159 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 836 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1559 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 417 to 419 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 713 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 775 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 285 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 348 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 387 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 543 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 219 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 224 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 266 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 67 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 456 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 459 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 489 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 492 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 162 to 169 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 18 forms a bond with kaempferol, indicating a strong binding affinity.
The residue at position 18 forms a bond with quercetin, indicating a strong binding affinity.
The residue at position 19 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 20 forms a bond with kaempferol, indicating a strong binding affinity.
The residue at position 84 forms a bond with kaempferol, indicating a strong binding affinity.
The residue at position 84 forms a bond with quercetin, indicating a strong binding affinity.
The residue at position 150 forms a bond with kaempferol, indicating a strong binding affinity.
The residue at position 150 forms a bond with quercetin, indicating a strong binding affinity.
The residue at position 188 forms a bond with kaempferol, indicating a strong binding affinity.
The residue at position 188 forms a bond with quercetin, indicating a strong binding affinity.
The residue at position 280 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 306 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 373 forms a bond with quercetin, indicating a strong binding affinity.
The residue at position 500 to 503 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 1502 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 261 to 281 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 312 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 339 to 349 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 481 to 489 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 202 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 237 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 264 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 292 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 323 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 451 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 43 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 103 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 638 to 646 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 419 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 423 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 460 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 577 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 628 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 628 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 631 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 631 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 358 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 345 to 351 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 178 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 2045 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 2249 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 2259 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 353 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 1035 to 1042 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 to 293 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 797 to 802 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 166 forms a bond with 3',3'-cGAMP, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 237 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 237 forms a bond with 3',3'-cGAMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 194 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 226 to 229 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 266 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 784 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 69 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 112 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 294 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 547 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 277 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 342 to 344 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 159 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 160 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 305 to 306 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1034 to 1041 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 9 to 15 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 505 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 509 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 159 to 162 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 237 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 49 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 78 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 220 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 271 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 293 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 333 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 333 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 387 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 387 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 466 to 467 forms a bond with orotidine 5'-phosphate, indicating a strong binding affinity.
The residue at position 466 to 467 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 35 to 39 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 1655 to 1662 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 293 to 297 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 29 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 116 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 161 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 291 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 323 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 331 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 95 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 96 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 375 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 399 to 402 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 14 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 118 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 93 to 99 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 528 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 316 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 212 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 227 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 253 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 276 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 395 to 404 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 58 to 82 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 to 176 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 466 to 468 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 490 to 491 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 308 to 314 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 431 to 439 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 121 to 136 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 147 to 181 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 303 to 306 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 268 forms a bond with O2, indicating a strong binding affinity.
The residue at position 709 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 744 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 748 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 752 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 1433 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1436 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1493 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1527 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1568 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1570 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 124 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 293 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 3 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 309 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 391 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 19 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 52 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 97 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 159 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 286 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 476 to 478 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 399 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 401 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 403 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 607 to 721 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 734 to 851 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 32 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 251 to 257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 432 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 to 337 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 425 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 45 to 47 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 98 to 100 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 156 to 161 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 474 to 475 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 97 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 163 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 284 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 722 to 723 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 722 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 744 to 747 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 757 to 759 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 783 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 804 to 805 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 806 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 807 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 828 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 888 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 901 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 901 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 919 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 763 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1087 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1090 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 942 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 774 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 156 to 213 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 to 58 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 92 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 123 to 124 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 162 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with adenosine 5'-phosphosulfate, indicating a strong binding affinity.
The residue at position 415 to 418 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 517 to 521 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 559 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 627 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 633 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 637 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 660 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 663 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 666 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 670 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 487 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 142 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 13 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 145 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 145 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 151 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 151 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 151 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 192 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 192 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 192 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 320 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 320 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 320 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 47 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 490 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 524 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 560 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 565 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 55 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 42 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 76 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 116 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 462 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 86 to 89 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 100 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 163 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 361 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 508 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 696 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1032 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1032 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1033 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1076 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1076 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 170 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 35 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 94 to 97 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 137 to 144 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 264 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 410 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 428 to 432 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 440 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 470 to 472 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 441 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 466 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 493 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 515 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 536 to 537 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 171 to 175 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 350 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 311 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 519 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 468 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 489 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 526 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 575 forms a bond with an N-acylsphing-4-enine, indicating a strong binding affinity.
The residue at position 259 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 280 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 329 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 457 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 463 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 464 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1086 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1101 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 118 to 124 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 40 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with staurosporine, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 180 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 153 to 155 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 74 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 74 forms a bond with beta-alanine, indicating a strong binding affinity.
The residue at position 168 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 805 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1095 to 1102 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 169 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 233 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 272 to 277 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 184 to 189 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 224 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 202 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 317 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 10 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 45 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 132 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 394 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 88 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 406 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 410 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 447 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 564 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 564 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 615 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 618 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 16 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 18 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 68 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 173 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 203 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 278 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 279 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 740 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 746 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 784 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 790 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 814 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 832 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 838 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 867 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 885 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 891 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 111 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 268 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 202 to 206 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 222 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 234 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 329 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 366 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 504 to 505 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 186 to 194 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 118 to 121 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 14 to 18 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 90 to 158 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 121 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-isoleucine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1089 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 518 to 519 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 524 to 528 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 261 to 268 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 409 to 412 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 281 forms a bond with 5-(2-hydroxyethyl)-4-methylthiazole, indicating a strong binding affinity.
The residue at position 430 forms a bond with 5-(2-hydroxyethyl)-4-methylthiazole, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 645 to 646 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 679 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 684 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 685 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 690 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 717 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 722 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 722 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 212 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 217 to 222 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 353 to 356 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 991 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1097 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1150 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 201 to 256 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 to 191 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 199 to 203 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 430 to 431 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 59 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 79 to 81 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 111 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 438 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 204 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 206 to 212 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 208 to 212 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 598 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 605 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 331 to 336 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 388 to 394 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 415 to 417 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 467 to 470 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 241 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 620 to 621 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 59 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 309 to 315 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 126 to 134 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 556 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 557 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 32 to 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 70 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 71 to 72 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 130 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 321 to 328 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 438 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 463 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 500 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 200 to 201 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 531 to 532 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1256 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1259 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1285 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1316 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1335 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1340 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 496 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 498 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 318 to 321 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 78 to 82 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 79 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 390 to 394 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 212 to 214 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 79 to 86 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 13 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 2038 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2041 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2063 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2068 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2099 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2102 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2114 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2116 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 524 to 668 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 584 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 596 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 52 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 616 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 619 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 624 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 435 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1179 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1225 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1225 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1227 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1227 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1244 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 557 to 564 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 34 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 297 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 334 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 249 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 277 to 281 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 597 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 669 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 60 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 271 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 65 to 79 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 136 to 145 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 665 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 368 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 404 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 409 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 432 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 515 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 154 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 237 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 292 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 34 to 51 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 256 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 11 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 111 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 116 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 244 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 246 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 254 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 255 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 490 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 493 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 566 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 569 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 1292 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1296 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 255 to 262 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 302 to 306 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 170 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 178 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 208 to 210 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 264 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 563 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 710 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 714 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 718 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 496 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 498 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 662 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1164 to 1169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 169 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 232 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 235 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 306 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 308 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 311 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 759 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 766 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 811 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 814 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 817 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 821 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 1458 to 1469 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1585 to 1595 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 424 to 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 580 to 587 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1411 to 1418 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 16 to 18 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 107 to 108 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 25 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 100 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 103 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 99 to 100 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 104 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 207 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 282 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 434 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 438 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 480 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 505 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 85 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 386 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 255 to 261 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with dopamine, indicating a strong binding affinity.
The residue at position 141 forms a bond with (4-hydroxyphenyl)acetaldehyde, indicating a strong binding affinity.
The residue at position 1275 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1278 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 209 to 216 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 291 to 295 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 278 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 357 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 362 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 365 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 446 to 447 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 504 to 506 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 629 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 334 to 336 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 351 to 359 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 122 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 428 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 215 to 227 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 160 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 146 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 720 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 726 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 760 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 764 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 764 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 976 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 978 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 1001 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 1004 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 672 to 673 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 171 to 175 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 203 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 242 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 268 to 270 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 298 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 767 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 768 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 769 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 769 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 220 to 222 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 286 to 287 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 287 to 291 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 15 to 19 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 113 to 115 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 363 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 411 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 585 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 84 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 91 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 250 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 310 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 518 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 417 forms a bond with heme, indicating a strong binding affinity.
The residue at position 601 forms a bond with heme, indicating a strong binding affinity.
The residue at position 160 to 195 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 206 to 210 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 269 to 272 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 316 to 319 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 394 to 405 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1161 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1180 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1183 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 126 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 148 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with N-acetyl-L-glutamate, indicating a strong binding affinity.
The residue at position 282 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 334 to 337 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 342 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 866 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 57 to 58 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 27 to 28 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 287 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 291 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 298 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 86 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 66 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 154 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 239 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 674 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 682 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 690 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 691 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 41 to 48 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 66 to 70 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with GTP 3, indicating a strong binding affinity.
The residue at position 903 to 910 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 271 to 274 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 370 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1015 to 1022 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 284 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 340 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 342 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 231 to 233 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 156 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 101 to 102 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 35 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 114 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 125 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 45 to 50 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 55 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 145 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 559 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 559 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 561 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 498 to 502 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1958 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1962 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1962 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1982 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1984 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1985 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1991 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1991 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1992 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1992 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2005 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2006 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 40 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 259 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 211 to 268 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 774 to 852 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 919 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 931 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 931 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 933 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 38 to 43 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 63 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 32 to 35 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 47 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 216 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 272 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 202 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 317 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 152 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 323 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 354 to 358 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 781 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 812 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 816 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 926 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 928 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1093 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 138 to 144 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 319 to 322 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 367 to 370 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 376 to 379 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 157 to 163 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 193 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 200 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 275 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 319 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 343 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 380 to 385 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 154 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 208 to 216 forms a bond with dolichyl phosphate, indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 809 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 32 to 36 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 379 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 464 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 513 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with Ni of coenzyme F430, indicating a strong binding affinity.
The residue at position 230 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 261 to 262 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 275 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 337 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 448 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 72 to 73 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 224 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 236 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 238 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 240 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 242 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 247 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 365 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 435 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 465 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 497 to 499 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 520 to 521 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 319 to 323 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 80 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 443 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 468 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 539 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 607 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 79 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 211 to 214 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 249 to 250 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 308 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 345 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 288 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 433 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 451 to 453 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 474 to 475 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 559 to 560 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 581 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 197 to 204 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 244 to 248 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 813 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 838 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 843 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1131 to 1138 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 to 17 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 77 to 81 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 120 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 25 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 26 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 36 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 56 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 970 to 1109 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 1030 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 1042 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 13 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 105 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 403 to 405 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 195 to 322 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 511 to 633 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 629 to 749 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 87 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 482 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 626 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 655 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 689 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 691 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 787 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 165 to 169 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 31 to 39 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 347 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 352 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 165 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 369 to 371 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 369 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 403 to 407 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 435 to 437 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 53 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 86 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 106 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 132 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 139 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 41 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 78 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 114 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 311 to 317 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 231 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 54 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 204 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 416 to 425 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 47 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 137 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 270 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 346 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 568 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 73 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 263 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 418 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 113 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 388 to 393 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 664 to 667 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 199 to 200 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 254 to 258 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 173 to 176 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 176 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 269 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 630 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1383 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1462 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1463 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1644 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1720 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 13 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 81 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 159 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 238 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 253 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 257 forms a bond with salicylate, indicating a strong binding affinity.
The residue at position 20 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 177 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 148 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 103 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 106 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 913 to 920 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 500 to 507 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 546 to 550 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 600 to 603 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 114 to 119 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 476 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 476 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 690 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 177 to 187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 128 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 131 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 132 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 133 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 345 forms a bond with Fe of heme b 2; high-spin, indicating a strong binding affinity.
The residue at position 347 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 101 forms a bond with folate, indicating a strong binding affinity.
The residue at position 105 forms a bond with folate, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with folate, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with folate, indicating a strong binding affinity.
The residue at position 194 forms a bond with folate, indicating a strong binding affinity.
The residue at position 282 to 291 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 601 to 603 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 608 to 614 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 700 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 236 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 to 270 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 330 to 333 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 31 to 35 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 221 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 249 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 304 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 187 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 191 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 910 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 912 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1020 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 300 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 573 to 574 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 383 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 166 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 175 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 442 to 444 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 13 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 194 to 201 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 374 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 379 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 386 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 399 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 399 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 459 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 246 to 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 328 to 331 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 430 to 432 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 455 to 457 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 451 to 455 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 504 to 509 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 504 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 94 forms a bond with heme, indicating a strong binding affinity.
The residue at position 71 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 334 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 335 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 408 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 432 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 446 forms a bond with alpha-D-glucose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 224 to 226 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 161 to 172 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 20 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 32 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 191 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 80 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 99 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 173 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 to 28 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 47 to 52 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 62 to 63 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1099 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 17 to 18 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 77 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 to 270 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 288 to 293 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 381 forms a bond with heme, indicating a strong binding affinity.
The residue at position 565 forms a bond with heme, indicating a strong binding affinity.
The residue at position 817 to 824 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 161 to 193 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 125 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 175 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 224 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 240 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 285 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 83 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 132 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 220 to 226 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 280 to 288 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 212 to 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 419 to 421 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 11 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 10 to 13 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 118 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 143 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 206 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 466 to 471 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 316 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 190 to 197 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 to 240 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 266 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 281 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 372 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 501 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 504 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 577 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 580 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 929 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1008 to 1010 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1015 to 1019 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 51 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 171 to 173 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1462 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1484 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 297 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 387 to 394 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 418 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 516 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 72 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 155 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 302 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 200 to 215 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 328 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 423 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 101 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe(3+) 3, indicating a strong binding affinity.
The residue at position 218 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 320 to 327 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 589 to 596 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 447 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 698 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 157 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 178 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 213 to 330 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 278 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 287 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 333 to 451 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 408 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 609 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 722 to 725 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 739 to 743 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 751 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 809 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 742 to 799 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 878 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 878 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 880 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 218 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 964 to 971 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1516 to 1523 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 423 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 426 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 462 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 466 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 471 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 472 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 548 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 549 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 584 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 630 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 281 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 311 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 407 forms a bond with Fe(2+) 3, indicating a strong binding affinity.
The residue at position 409 forms a bond with Fe(2+) 3, indicating a strong binding affinity.
The residue at position 448 forms a bond with Fe(2+) 3, indicating a strong binding affinity.
The residue at position 104 to 110 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 500 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 462 to 467 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 737 to 740 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 207 to 211 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 288 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 296 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 413 to 417 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 28 to 32 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 209 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 29 to 35 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 346 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 385 to 387 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 451 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 40 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 41 to 160 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 11 to 34 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 161 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 163 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1024 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1053 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1056 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 261 to 266 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 495 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 49 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 51 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 60 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 61 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 64 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 65 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 67 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 80 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 82 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 84 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 88 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 95 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 96 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 99 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 106 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 120 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 82 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 261 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 26 to 32 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 235 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 261 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 274 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with dTTP, indicating a strong binding affinity.
The residue at position 446 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 450 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 632 to 635 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 110 to 113 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 34 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 41 to 44 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 414 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 545 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 614 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 104 to 109 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 131 to 137 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 199 to 207 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 292 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 97 to 103 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 108 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 151 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 156 to 157 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 1349 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1351 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1374 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1382 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 90 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 172 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 64 to 72 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 186 to 194 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 190 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 418 to 420 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 28 forms a bond with Zn(2+) 201, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 187 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 287 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 376 to 377 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 393 to 395 forms a bond with cyanocob(III)alamin, indicating a strong binding affinity.
The residue at position 189 forms a bond with alpha-maltose, indicating a strong binding affinity.
The residue at position 229 forms a bond with alpha-maltose, indicating a strong binding affinity.
The residue at position 305 forms a bond with alpha-maltose, indicating a strong binding affinity.
The residue at position 320 to 326 forms a bond with alpha-maltose, indicating a strong binding affinity.
The residue at position 1 to 101 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 187 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 466 to 468 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 78 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 92 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 266 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 124 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 428 to 431 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 71 to 75 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 150 to 157 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 188 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 191 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 255 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 173 forms a bond with (R)-pantoate, indicating a strong binding affinity.
The residue at position 363 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 603 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 711 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 90 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 187 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 41 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 858 to 865 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 164 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 167 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 177 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 180 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 180 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 192 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 85 to 113 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 450 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 766 to 772 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 862 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 174 forms a bond with Cu(2+) 1, indicating a strong binding affinity.
The residue at position 561 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 303 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 315 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 372 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 411 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 261 to 266 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 327 to 333 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 333 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 39 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 126 to 132 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 188 to 196 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 218 to 222 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 394 to 397 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 401 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 420 to 423 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 496 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 28 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 157 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 1014 to 1016 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1021 to 1025 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 to 311 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 53 to 72 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 208 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 375 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 452 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 267 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 282 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 337 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 345 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 352 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 359 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 356 to 358 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 396 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 421 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 577 to 701 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 697 to 821 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 149 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 306 forms a bond with (9Z)-octadecenoate, indicating a strong binding affinity.
The residue at position 91 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 236 to 238 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 64 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 78 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 124 to 126 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 171 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 286 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 203 to 214 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 2215 to 2223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2242 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1831 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1848 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1898 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1900 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 56 to 61 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 79 to 94 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 446 to 447 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 477 to 600 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 548 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 190 to 194 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 190 forms a bond with Co of cob(II)alamin, indicating a strong binding affinity.
The residue at position 242 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 291 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 161 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 164 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 169 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 208 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 231 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 236 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 239 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 246 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 252 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 194 to 201 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 882 to 889 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 167 to 170 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 35 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 36 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 55 forms a bond with riboflavin, indicating a strong binding affinity.
The residue at position 4 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 150 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 56 to 80 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 597 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 608 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 161 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 175 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 345 to 350 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 588 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 756 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 786 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 921 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 299 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 439 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 521 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 523 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 531 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 601 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 335 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 339 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 343 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate), indicating a strong binding affinity.
The residue at position 565 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 49 forms a bond with thiamine, indicating a strong binding affinity.
The residue at position 310 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 488 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 491 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 464 to 469 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 to 208 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 190 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 233 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 464 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 347 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 454 to 455 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 575 to 577 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 920 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 922 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1030 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1083 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 88 to 95 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 159 to 171 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 89 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 126 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 130 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 138 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 151 to 152 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 34 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 295 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 350 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 482 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 486 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 486 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 575 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 580 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 612 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 616 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 39 to 49 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 to 29 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 128 to 132 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 8 to 9 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 44 to 47 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 57 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 83 to 85 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 523 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 591 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 681 to 688 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 214 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 257 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 258 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 271 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 260 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 455 to 462 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 236 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 233 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 111 to 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 30 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 31 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 162 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 171 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 173 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 1952 to 1954 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1994 to 1997 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 2020 to 2021 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 2065 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 2071 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 94 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 119 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 360 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 421 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 423 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 49 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 208 to 214 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 267 to 276 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 277 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 254 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 657 to 663 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 379 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 59 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 to 291 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 402 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 214 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 125 to 134 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 328 forms a bond with 3beta,7beta-dihydroxy-5beta-cholan-24-oate, indicating a strong binding affinity.
The residue at position 328 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 358 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 366 forms a bond with 3beta,7beta-dihydroxy-5beta-cholan-24-oate, indicating a strong binding affinity.
The residue at position 366 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 444 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 29 forms a bond with beta-D-Gal-(1->3)-alpha-D-GalNAc, indicating a strong binding affinity.
The residue at position 48 forms a bond with beta-D-Gal-(1->3)-alpha-D-GalNAc, indicating a strong binding affinity.
The residue at position 49 forms a bond with beta-D-Gal-(1->3)-alpha-D-GalNAc, indicating a strong binding affinity.
The residue at position 73 forms a bond with beta-D-Gal-(1->3)-alpha-D-GalNAc, indicating a strong binding affinity.
The residue at position 82 forms a bond with N-acetyl-beta-D-glucosamine, indicating a strong binding affinity.
The residue at position 103 forms a bond with N-acetyl-beta-D-glucosamine, indicating a strong binding affinity.
The residue at position 114 forms a bond with N-acetyl-beta-D-glucosamine, indicating a strong binding affinity.
The residue at position 314 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 397 to 401 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 417 to 426 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 427 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 5 to 33 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 140 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 250 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 353 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 368 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 426 to 430 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 561 to 592 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 704 to 715 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 847 to 857 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 922 to 940 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1019 to 1034 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 180 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 183 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 320 to 331 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 407 to 412 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 608 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 307 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 432 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 136 to 137 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 244 to 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 158 to 165 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 374 to 384 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 461 to 466 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 513 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 515 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 523 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 571 to 578 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 661 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 678 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 147 to 179 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 174 to 177 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 218 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 406 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 43 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 82 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 168 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 230 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 234 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 584 to 586 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 to 246 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 284 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 284 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 295 forms a bond with 9-cis-retinoate, indicating a strong binding affinity.
The residue at position 295 forms a bond with all-trans-retinoate, indicating a strong binding affinity.
The residue at position 335 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 379 to 383 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 416 to 422 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 476 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 477 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 203 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 551 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 562 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 660 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 674 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 674 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 18 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 430 to 433 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 440 to 441 forms a bond with 3',5'-cyclic GMP 1, indicating a strong binding affinity.
The residue at position 545 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 554 to 557 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 564 to 565 forms a bond with 3',5'-cyclic GMP 2, indicating a strong binding affinity.
The residue at position 337 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 433 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with a menaquinone, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 532 to 539 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 204 to 206 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 215 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 390 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 394 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 418 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 378 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 164 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 135 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 666 to 674 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 55 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 21 to 149 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 169 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 173 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 289 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 175 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 336 to 338 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 383 to 387 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 327 to 329 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 344 to 352 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 366 to 369 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1164 to 1172 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1184 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 979 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 102 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 378 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 622 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 658 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 659 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 659 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 456 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 606 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 216 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1752 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2053 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2055 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 99 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 185 to 191 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 214 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 606 to 614 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 253 to 259 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 354 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 390 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 527 to 532 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 191 to 192 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 486 to 490 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 105 forms a bond with lanosterol, indicating a strong binding affinity.
The residue at position 22 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 98 to 99 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 206 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 593 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 601 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with folate, indicating a strong binding affinity.
The residue at position 73 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 154 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 228 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 302 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 437 to 440 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 419 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 281 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 283 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 289 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 291 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 292 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 293 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 439 to 441 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 582 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 to 77 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1298 to 1305 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 395 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 438 to 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1322 to 1324 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1353 to 1355 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1353 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1364 to 1365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1438 to 1441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1443 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 1476 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1648 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1653 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1695 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 486 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 491 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 510 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 800 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 805 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 818 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 824 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 844 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 849 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 862 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 868 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 893 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 898 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 911 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 917 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 946 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 951 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 964 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 970 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 371 to 375 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 29 forms a bond with anthraniloyl-CoA, indicating a strong binding affinity.
The residue at position 33 forms a bond with anthraniloyl-CoA, indicating a strong binding affinity.
The residue at position 154 to 155 forms a bond with anthraniloyl-CoA, indicating a strong binding affinity.
The residue at position 221 to 224 forms a bond with anthraniloyl-CoA, indicating a strong binding affinity.
The residue at position 258 forms a bond with anthraniloyl-CoA, indicating a strong binding affinity.
The residue at position 433 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 497 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 523 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 113 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 114 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 235 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 258 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 261 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 290 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 446 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 407 to 418 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 461 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 834 to 842 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 103 to 109 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 118 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 141 forms a bond with D-threo-isocitrate, indicating a strong binding affinity.
The residue at position 318 to 323 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 369 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 377 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 753 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 254 to 258 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 355 to 357 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 297 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 7 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 268 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 237 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 292 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 115 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 33 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 168 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 284 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 292 to 294 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 379 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 407 to 408 forms a bond with D-fructose, indicating a strong binding affinity.
The residue at position 183 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 98 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 210 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 134 to 136 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 165 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 150 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 170 forms a bond with heme, indicating a strong binding affinity.
The residue at position 288 to 291 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 39 to 42 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 348 to 349 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 113 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 20 to 34 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 155 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 157 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 176 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 183 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 416 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 504 to 510 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 177 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 203 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 239 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 244 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 446 to 459 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 481 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 494 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 195 to 199 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 144 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 220 forms a bond with (R)-imazaquin, indicating a strong binding affinity.
The residue at position 246 forms a bond with (R)-imazaquin, indicating a strong binding affinity.
The residue at position 256 forms a bond with chlorimuron-ethyl, indicating a strong binding affinity.
The residue at position 331 to 332 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 to 352 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 376 to 377 forms a bond with chlorimuron-ethyl, indicating a strong binding affinity.
The residue at position 395 to 396 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 414 to 415 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 487 to 488 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 508 to 509 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 511 to 513 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 538 to 540 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 565 to 570 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 574 forms a bond with chlorimuron-ethyl, indicating a strong binding affinity.
The residue at position 653 forms a bond with chlorimuron-ethyl, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 489 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 490 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 573 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 642 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 320 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 392 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 398 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 231 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 235 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 242 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 106 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 119 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 123 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 126 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 136 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 137 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 140 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 143 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 152 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 154 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 381 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 233 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 280 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 306 to 308 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 315 to 321 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 385 to 393 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 488 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 127 to 140 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 163 to 172 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 359 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 268 to 273 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 564 to 566 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 1692 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1698 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1703 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 142 to 145 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 165 to 174 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 301 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 88 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 106 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 217 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 218 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 89 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 131 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 234 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 243 to 244 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 267 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 234 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 281 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 307 to 309 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 316 to 322 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 449 to 453 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 709 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 743 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 743 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 775 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 828 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 521 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 275 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 160 to 165 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 to 391 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 63 to 83 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 37 to 42 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 784 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 785 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 659 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 159 to 169 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 895 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 939 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 939 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 941 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 250 to 255 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 132 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 217 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 146 to 151 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 387 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 6 to 7 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 30 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 159 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 323 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 337 forms a bond with O-phospho-L-threonine, indicating a strong binding affinity.
The residue at position 209 to 221 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 175 forms a bond with melatonin, indicating a strong binding affinity.
The residue at position 194 forms a bond with melatonin, indicating a strong binding affinity.
The residue at position 58 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 340 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 429 to 430 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 911 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 955 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 978 to 979 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1031 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1038 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 38 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 43 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 168 to 173 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1441 to 1448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 to 27 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 195 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 741 to 744 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 437 to 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 110 to 117 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 379 to 386 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 257 to 263 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 358 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 394 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 531 to 536 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 46 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 386 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 492 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 518 to 519 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 541 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 568 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 728 to 737 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 812 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 829 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 472 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 148 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 265 to 286 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 107 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 125 to 133 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 322 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 341 to 343 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 347 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 359 to 364 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 366 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 440 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 512 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 195 to 200 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 233 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 2 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 103 to 112 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 216 to 264 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 273 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 200 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 614 to 615 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 268 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with 1D-myo-inositol 1,4-bisphosphate, indicating a strong binding affinity.
The residue at position 1387 to 1394 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 330 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 386 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 479 to 485 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 526 to 529 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 677 to 678 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 368 forms a bond with coenzyme M, indicating a strong binding affinity.
The residue at position 370 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 307 to 318 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 391 to 396 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 445 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 447 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 593 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 594 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 604 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 393 to 398 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 393 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1099 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1176 to 1178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1183 to 1187 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1223 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 276 to 278 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 426 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 460 to 462 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 462 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 486 to 490 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 540 to 543 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 184 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 212 to 216 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 287 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 291 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 291 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 295 forms a bond with Cu cation A2, indicating a strong binding affinity.
The residue at position 298 forms a bond with Cu cation A1, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 277 to 280 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 77 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with S-adenosyl-L-methionine 2, indicating a strong binding affinity.
The residue at position 197 forms a bond with S-adenosyl-L-methionine 1, indicating a strong binding affinity.
The residue at position 256 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 334 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 442 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 473 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 514 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 486 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 431 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 203 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 348 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 98 to 103 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 250 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 316 to 318 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 500 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 504 to 506 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 513 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 565 forms a bond with alpha-L-rhamnose, indicating a strong binding affinity.
The residue at position 73 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 77 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 327 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 393 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 188 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 467 to 468 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 183 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 582 to 586 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 627 to 629 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 832 to 834 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 641 to 645 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 686 to 688 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 891 to 893 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 734 to 741 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 188 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 146 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 287 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 396 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 397 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 401 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 406 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 487 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 500 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 515 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 712 to 743 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 855 to 866 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 998 to 1008 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1073 to 1091 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1170 to 1185 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 684 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 705 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 708 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 734 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 287 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 377 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 413 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 512 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 235 to 241 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 495 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 503 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 164 to 165 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 194 to 199 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 118 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 141 to 148 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 70 to 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 to 150 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 644 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 360 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 390 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 399 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 343 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 614 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 616 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 53 to 54 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 128 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 347 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 53 to 56 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 558 to 561 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 593 to 597 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 619 to 621 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 228 to 238 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 302 to 310 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 873 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 477 to 478 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 524 to 527 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 527 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 535 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 565 to 567 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 52 to 57 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 75 to 90 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 442 to 443 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 906 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 949 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 180 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 643 to 650 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 229 to 231 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 147 to 148 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 867 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 942 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 946 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 1024 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 31 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 494 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 517 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 277 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 237 to 241 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 390 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 475 to 477 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 480 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 512 to 514 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 249 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 245 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 1341 to 1348 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1885 to 1893 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1906 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2098 to 2121 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 2295 to 2298 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 267 to 272 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 134 to 135 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 139 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 249 to 253 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 273 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 428 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 463 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 468 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 380 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 474 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 915 to 922 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 50 to 56 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 264 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 398 to 399 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 479 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 505 to 506 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 158 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 185 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 108 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 8 to 21 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 to 66 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 20 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 126 to 127 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 180 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 268 to 271 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 311 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 360 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 361 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 692 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 695 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 81 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 111 to 116 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 138 to 144 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 160 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mg of (7R,8Z)-bacteriochlorophyll b, indicating a strong binding affinity.
The residue at position 540 to 547 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 81 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 117 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 332 forms a bond with dTDP, indicating a strong binding affinity.
The residue at position 137 forms a bond with cytochalasin B, indicating a strong binding affinity.
The residue at position 282 forms a bond with cytochalasin B, indicating a strong binding affinity.
The residue at position 388 forms a bond with cytochalasin B, indicating a strong binding affinity.
The residue at position 411 forms a bond with cytochalasin B, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 182 to 187 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 494 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 105 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 462 to 464 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 532 to 537 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 162 to 167 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 270 to 275 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 149 to 177 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 315 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 44 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 82 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 108 forms a bond with hyaluronan, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 336 to 340 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 363 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 38 to 41 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 102 to 110 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 114 to 119 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 1019 to 1020 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1024 to 1025 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 71 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 72 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 74 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 90 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 92 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 103 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 104 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 107 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 122 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 124 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 128 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 133 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 99 forms a bond with (R)-haloxyfop, indicating a strong binding affinity.
The residue at position 138 forms a bond with (R)-haloxyfop, indicating a strong binding affinity.
The residue at position 185 forms a bond with (R)-haloxyfop, indicating a strong binding affinity.
The residue at position 334 forms a bond with (R)-haloxyfop, indicating a strong binding affinity.
The residue at position 857 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1192 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1209 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1291 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1293 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 249 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 168 to 176 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 69 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 79 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 249 to 255 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 181 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 358 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 445 to 449 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 465 to 474 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 475 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 94 to 98 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 42 to 45 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 87 to 91 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 113 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 132 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 58 forms a bond with Co of methylcob(III)alamin, indicating a strong binding affinity.
The residue at position 330 to 335 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 340 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 428 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 189 to 196 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 852 to 859 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 185 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 265 to 266 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 420 to 421 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 135 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 135 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 156 forms a bond with N(7)-methyl-GMP, indicating a strong binding affinity.
The residue at position 313 to 370 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1818 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2119 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2121 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 411 to 422 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 554 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 556 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 563 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 564 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 565 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 603 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 702 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 708 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 719 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 526 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 45 to 49 forms a bond with Se-Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 85 to 90 forms a bond with Se-Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 211 to 223 forms a bond with Se-Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 284 to 289 forms a bond with Se-Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 300 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 374 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 381 to 382 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 661 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 726 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 740 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 796 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 810 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 848 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 851 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 862 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 26 forms a bond with 2-(N(omega)-L-arginino)succinate, indicating a strong binding affinity.
The residue at position 262 to 265 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 198 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 302 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 495 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 204 to 209 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 58 to 67 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 116 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 134 to 142 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 314 to 320 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 357 to 359 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 363 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 375 to 380 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 381 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 382 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 456 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 460 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 529 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 262 forms a bond with inosine, indicating a strong binding affinity.
The residue at position 301 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 370 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 45 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 184 to 186 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 126 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 128 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 166 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 183 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 184 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 187 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 417 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 498 to 499 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 294 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 296 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 141 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 151 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 175 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 216 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 219 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 227 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 230 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 247 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 250 forms a bond with heme c 6, indicating a strong binding affinity.
The residue at position 251 forms a bond with Fe of heme c 6, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 297 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 300 forms a bond with heme c 7, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 306 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 342 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 345 forms a bond with heme c 8, indicating a strong binding affinity.
The residue at position 346 forms a bond with Fe of heme c 8, indicating a strong binding affinity.
The residue at position 454 forms a bond with Fe of heme c 7, indicating a strong binding affinity.
The residue at position 34 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 254 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 266 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 296 to 299 forms a bond with an L-amino acid tripeptide, indicating a strong binding affinity.
The residue at position 357 forms a bond with an L-amino acid tripeptide, indicating a strong binding affinity.
The residue at position 539 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 84 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 111 to 115 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 111 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 111 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 153 to 154 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 154 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 194 to 195 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 113 to 118 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 488 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 505 to 512 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1296 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1299 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1324 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1329 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1362 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1385 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1388 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 39 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with an (S)-2-haloacid, indicating a strong binding affinity.
The residue at position 479 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 311 to 316 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 388 to 390 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 435 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 515 to 519 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 515 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 519 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 59 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 278 to 283 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 74 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 88 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 975 to 982 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 119 to 126 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 119 to 126 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 331 to 339 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 353 to 356 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 365 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 166 to 190 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 80 forms a bond with urate, indicating a strong binding affinity.
The residue at position 81 forms a bond with urate, indicating a strong binding affinity.
The residue at position 204 forms a bond with urate, indicating a strong binding affinity.
The residue at position 221 forms a bond with urate, indicating a strong binding affinity.
The residue at position 270 forms a bond with urate, indicating a strong binding affinity.
The residue at position 296 forms a bond with urate, indicating a strong binding affinity.
The residue at position 485 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 279 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 813 to 821 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 450 to 451 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 654 to 655 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 55 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 102 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 131 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 177 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 222 forms a bond with trimethylamine N-oxide, indicating a strong binding affinity.
The residue at position 212 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 244 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with (R)-5-diphosphomevalonate, indicating a strong binding affinity.
The residue at position 443 to 450 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 197 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 250 to 256 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 309 to 318 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 319 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 848 to 856 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 869 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 303 to 331 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 101 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 102 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 226 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 250 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 281 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 312 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 437 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 556 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 581 to 584 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 256 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 291 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 255 to 259 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 331 to 334 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 231 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 234 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 104 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 117 to 119 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 127 to 129 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 198 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 274 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 688 to 691 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 512 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 516 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 3 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 13 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 22 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 24 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 32 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 56 forms a bond with a divalent metal cation 7, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 43 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 45 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 477 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 70 to 72 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 136 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 174 to 175 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 13 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 16 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 92 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 199 to 207 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 628 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 629 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 38 to 40 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 226 to 230 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 282 to 286 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 388 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 388 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 429 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 546 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 597 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 597 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 600 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 514 to 521 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 27 to 29 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 340 to 341 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 45 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 84 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 157 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 381 to 382 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 540 to 543 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 553 to 554 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 206 to 215 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 366 to 369 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 77 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 240 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 206 to 207 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 315 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 338 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 430 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 450 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 451 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 107 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 160 to 166 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 213 to 222 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 223 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 30 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 83 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 712 to 713 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 to 297 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 513 to 520 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 22 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 287 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 288 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 306 to 312 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 77 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with Fe(2+) 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with Fe(2+) 2, indicating a strong binding affinity.
The residue at position 315 to 318 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 452 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 336 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 444 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 475 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 516 forms a bond with [Ni-4Fe-5S] cluster, indicating a strong binding affinity.
The residue at position 110 to 115 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 493 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 10 to 11 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 140 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 349 forms a bond with urate, indicating a strong binding affinity.
The residue at position 366 forms a bond with urate, indicating a strong binding affinity.
The residue at position 414 forms a bond with urate, indicating a strong binding affinity.
The residue at position 415 forms a bond with urate, indicating a strong binding affinity.
The residue at position 441 forms a bond with urate, indicating a strong binding affinity.
The residue at position 69 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 98 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 126 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 252 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 349 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 180 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 208 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 216 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 219 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 222 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 223 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 276 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 9 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 117 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 120 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 972 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 311 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 314 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 154 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 341 to 349 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 363 to 366 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 8 to 27 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 139 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 110 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 422 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 462 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 485 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 592 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 698 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 838 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 854 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 965 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 968 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 981 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 986 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 19 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 710 forms a bond with (8S)-8-amino-7-oxononanoate, indicating a strong binding affinity.
The residue at position 121 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 549 to 555 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 307 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 376 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 110 to 114 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 140 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 140 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 167 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 171 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 171 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 192 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 192 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 333 to 337 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 342 to 348 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 372 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 4 to 24 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1283 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 160 to 166 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 998 to 1001 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1008 to 1011 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1009 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1011 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1081 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1103 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1121 to 1125 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 1237 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 441 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 530 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 15 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 175 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 834 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 966 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 976 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 310 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 899 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 573 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 576 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 579 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 585 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 602 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 605 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 608 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 612 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 335 to 337 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 397 to 399 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 298 to 300 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1170 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1176 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1232 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1234 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1621 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1627 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1676 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1678 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1941 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1944 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 1947 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 195 to 198 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 528 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 109 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 143 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 251 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 782 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 821 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 783 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 31 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 91 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 185 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 190 forms a bond with sulfur of a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 272 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 322 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 371 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 387 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 391 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 395 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 433 forms a bond with a (Z)-N-(sulfonatooxy)alkanimidothioate, indicating a strong binding affinity.
The residue at position 434 to 491 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 557 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 572 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1924 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2228 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2230 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 26 forms a bond with a 1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 150 forms a bond with a 1,2-diacyl-sn-glycerol, indicating a strong binding affinity.
The residue at position 283 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 113 to 122 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 279 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 26 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 34 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 138 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 173 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 262 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 35 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 306 forms a bond with adenosine, indicating a strong binding affinity.
The residue at position 287 to 301 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 112 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 257 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 367 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 470 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 617 to 648 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 761 to 772 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 897 to 907 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 972 to 990 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1070 to 1085 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 808 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 828 to 830 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 851 to 852 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 988 to 989 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1010 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 529 to 531 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 536 to 542 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 89 to 95 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 144 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 177 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 178 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 181 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 207 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 211 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 275 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 1088 to 1095 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 204 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 39 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 222 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 282 to 285 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 713 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 797 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 798 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 798 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 913 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 913 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 964 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 371 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 402 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 450 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 24 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 49 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 129 to 133 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 1109 to 1115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1153 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 217 to 230 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 31 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 108 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 183 forms a bond with a peptide antigen 2, indicating a strong binding affinity.
The residue at position 195 forms a bond with a peptide antigen 1, indicating a strong binding affinity.
The residue at position 681 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 828 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 427 to 431 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 346 to 350 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 378 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 417 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 443 to 445 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 446 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 473 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 496 to 497 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 50 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 138 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 144 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 174 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 246 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 274 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 277 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 273 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 122 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 769 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 285 to 286 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 309 to 313 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 394 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 395 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 396 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 397 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 102 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 105 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 307 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 344 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 485 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 48 to 53 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 637 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 645 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 653 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 654 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 132 to 135 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 140 to 142 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 397 to 401 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 867 to 999 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 33 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 41 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 41 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 49 to 52 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with spermine, indicating a strong binding affinity.
The residue at position 94 to 100 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 127 to 136 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 144 to 148 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 543 to 546 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 372 to 493 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 39 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 321 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 447 to 448 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 670 to 674 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 857 to 861 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 116 forms a bond with (2R,3E)-phycocyanobilin 2, indicating a strong binding affinity.
The residue at position 906 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1025 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1045 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1048 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1049 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1049 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 66 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 171 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 201 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 276 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 277 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 130 forms a bond with 3,4-dihydroxybenzoate, indicating a strong binding affinity.
The residue at position 577 to 584 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 279 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 371 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 585 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 651 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 654 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 694 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 286 to 297 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 95 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 139 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 937 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 328 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 151 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 178 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 193 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 250 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 409 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 516 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 716 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 137 forms a bond with fumarate 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with fumarate 1, indicating a strong binding affinity.
The residue at position 201 forms a bond with fumarate 1, indicating a strong binding affinity.
The residue at position 308 forms a bond with fumarate 2, indicating a strong binding affinity.
The residue at position 310 forms a bond with fumarate 2, indicating a strong binding affinity.
The residue at position 268 to 278 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 169 to 172 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 416 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 525 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 539 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 539 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 268 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 289 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 338 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 365 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 469 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 471 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 472 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 66 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 69 forms a bond with a metal cation 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with a metal cation 2, indicating a strong binding affinity.
The residue at position 339 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 343 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 480 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 483 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 185 to 240 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 310 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 409 to 410 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 398 to 399 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 781 to 782 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 269 to 274 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 321 to 324 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 356 to 361 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 160 to 167 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 189 to 190 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 356 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 235 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 285 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 306 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 335 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 362 forms a bond with D-arabinonate, indicating a strong binding affinity.
The residue at position 613 to 620 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 271 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 381 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 388 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 390 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 390 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 399 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 406 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 416 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 632 to 640 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 165 to 166 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 193 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 302 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 388 to 395 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1020 to 1027 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 269 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 273 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 299 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 288 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 756 to 763 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 177 to 182 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 18 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 48 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 221 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 811 to 819 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 54 to 58 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 121 to 127 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 150 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 153 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 217 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 275 to 276 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 299 to 303 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 383 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 384 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 385 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 30 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 34 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with D-ribulose 5-phosphate, indicating a strong binding affinity.
The residue at position 36 to 37 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 41 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 42 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 73 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 97 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 117 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 149 to 150 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 177 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 46 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 116 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 117 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 161 to 162 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 244 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 259 to 260 forms a bond with succinate, indicating a strong binding affinity.
The residue at position 135 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 139 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 395 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 494 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 352 to 363 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 439 to 444 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 499 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 501 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 508 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 510 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 651 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 652 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 10 to 39 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 14 forms a bond with E64, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 145 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 192 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 194 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 455 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 458 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 460 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 513 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 514 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 312 to 315 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1230 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1235 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1248 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1253 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1258 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1265 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1283 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1288 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1301 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1305 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1313 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1331 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 152 to 155 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 549 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 227 to 233 forms a bond with a beta-D-galactoside, indicating a strong binding affinity.
The residue at position 580 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 852 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 898 to 900 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 904 to 907 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 952 to 957 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 970 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1536 to 1553 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1725 to 1740 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 39 to 68 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 14 to 47 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 102 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 141 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 247 to 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 266 to 272 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 to 77 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 142 to 143 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 150 to 151 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 185 to 195 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 130 to 136 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 133 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 185 to 192 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 219 to 223 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 239 to 244 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 163 to 173 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 133 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 359 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 454 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 454 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 769 to 770 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 567 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 603 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 720 to 721 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 731 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 186 to 194 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 516 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 59 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 117 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 200 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 392 to 421 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 136 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 143 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 232 to 236 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 415 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 418 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 454 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 458 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 463 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 464 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 586 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 595 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 267 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 283 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 157 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 171 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 239 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 317 to 323 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 138 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 204 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 205 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 208 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 210 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 129 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 186 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 204 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 224 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 227 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 21 to 28 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 2, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 2, indicating a strong binding affinity.
The residue at position 46 to 48 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 1, indicating a strong binding affinity.
The residue at position 59 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 1, indicating a strong binding affinity.
The residue at position 105 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 1, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 1, indicating a strong binding affinity.
The residue at position 148 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 2, indicating a strong binding affinity.
The residue at position 151 to 155 forms a bond with guanosine 3'-diphosphate 5'-triphosphate 1, indicating a strong binding affinity.
The residue at position 186 to 190 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 916 to 923 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 504 to 508 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 508 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 544 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 545 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 545 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 654 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 654 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 706 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 212 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 88 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 202 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 242 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 315 to 317 forms a bond with L-histidine, indicating a strong binding affinity.
The residue at position 684 to 695 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 814 to 824 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 517 to 520 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 628 to 629 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 673 to 682 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 to 204 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 17 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 17 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 325 to 329 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 325 to 329 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 421 to 425 forms a bond with alpha-D-mannose 1-phosphate, indicating a strong binding affinity.
The residue at position 902 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 945 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 945 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 71 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1058 to 1061 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1079 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1081 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 38 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 49 to 54 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 164 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 583 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 698 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 592 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 594 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 285 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 310 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 133 to 135 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 223 to 233 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 229 to 233 forms a bond with UMP, indicating a strong binding affinity.
The residue at position 129 to 131 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 436 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 440 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 541 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 586 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 588 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 592 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 597 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 497 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 406 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 487 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 516 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 542 forms a bond with Ni(2+) 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with Ni(2+) 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 54 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 115 to 119 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 336 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 387 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 392 to 395 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 457 to 459 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 458 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 27 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 185 to 187 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 187 to 189 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 224 to 229 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 248 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 284 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 476 to 478 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 484 to 489 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 513 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 522 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 479 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 283 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 27 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 310 to 311 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 369 to 373 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 141 to 143 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 149 to 154 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 720 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 834 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 115 forms a bond with (2R,3R)-nemonapride, indicating a strong binding affinity.
The residue at position 122 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 196 forms a bond with (2R,3R)-nemonapride, indicating a strong binding affinity.
The residue at position 21 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 137 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 186 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 111 to 120 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 460 to 466 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 106 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 130 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 150 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 181 to 182 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 200 to 203 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 200 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 269 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 181 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 147 to 152 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 112 to 119 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1383 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1440 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1467 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1510 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 343 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 797 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 822 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 54 to 57 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 65 to 71 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 104 to 109 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 485 to 492 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 566 to 570 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 567 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 735 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 765 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 899 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 48 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 54 to 55 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 62 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 150 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 174 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 49 to 56 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 386 to 391 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 662 to 665 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 75 to 76 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 92 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 151 to 154 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 174 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 408 to 419 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 490 to 495 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 551 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 553 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 560 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 560 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 561 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 705 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 716 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 50 to 56 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 204 to 212 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 247 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 280 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 316 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 438 forms a bond with D-galactose 6-phosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 192 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 332 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 404 to 408 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 423 to 432 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 433 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 432 to 437 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1046 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1071 to 1077 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1124 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1184 to 1186 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 465 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 412 to 414 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 528 to 529 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 108 to 116 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 198 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 286 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 399 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 420 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 1144 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1166 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 136 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 267 to 271 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 523 to 525 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 557 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 607 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 651 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 758 to 759 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 782 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 247 to 251 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 143 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 652 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 655 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 676 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 699 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 325 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 114 to 129 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 318 to 334 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 170 to 177 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 134 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 190 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 113 to 120 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 371 to 374 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 47 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 31 to 38 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 52 to 57 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 451 to 458 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1112 to 1119 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 149 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 698 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 745 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 870 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 459 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 873 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 69 to 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 437 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 444 to 445 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 453 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 76 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 251 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 255 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 386 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 388 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 286 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 317 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 368 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 207 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 209 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 211 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 293 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 332 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 336 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 87 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 203 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 263 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 132 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 413 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 416 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 420 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 428 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 451 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 159 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 208 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 321 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 326 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 242 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 382 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 283 forms a bond with L-citrulline, indicating a strong binding affinity.
The residue at position 252 to 266 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 146 to 148 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 60 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 312 to 318 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 342 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 298 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 479 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 677 to 685 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 728 to 736 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 458 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 465 to 466 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 474 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 54 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 57 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 322 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 709 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 710 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 45 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 59 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 90 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 91 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 134 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 156 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 201 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 205 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 230 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 231 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 232 forms a bond with RNA, indicating a strong binding affinity.
The residue at position 462 to 465 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 506 to 507 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 562 to 563 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 to 154 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 189 to 191 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 280 to 283 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 323 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 490 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 577 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 850 to 853 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 460 to 469 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 152 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 153 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 204 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 208 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 242 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 244 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 255 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 398 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 259 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 273 to 277 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 296 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 365 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 206 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 172 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 247 to 255 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 15 to 16 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 122 to 123 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 247 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 247 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 296 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 335 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 340 to 344 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 807 to 808 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1048 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1089 to 1092 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1269 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 554 to 562 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 8 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 31 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 100 to 104 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 33 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 35 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 39 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 679 to 686 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1328 to 1335 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 161 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 544 to 545 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1360 to 1364 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1619 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1655 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1787 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 233 forms a bond with heme, indicating a strong binding affinity.
The residue at position 303 forms a bond with heme, indicating a strong binding affinity.
The residue at position 59 to 63 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 283 to 285 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 379 to 380 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 94 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 190 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 256 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 317 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 449 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 290 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 264 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 266 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 290 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 309 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 351 to 352 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 77 to 83 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 242 to 250 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 27 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 229 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 252 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 341 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 240 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 295 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 486 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 482 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 104 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 53 to 64 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 248 to 251 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 304 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 64 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 99 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 217 to 224 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 257 to 270 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 273 to 276 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 73 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 317 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 332 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 82 to 87 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 132 to 139 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 584 to 585 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 589 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 600 to 602 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 649 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 643 to 647 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 652 to 658 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 682 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 229 forms a bond with 3,6-dichloro-2-methoxybenzoate, indicating a strong binding affinity.
The residue at position 250 forms a bond with 3,6-dichloro-2-methoxybenzoate, indicating a strong binding affinity.
The residue at position 284 forms a bond with 3,6-dichloro-2-methoxybenzoate, indicating a strong binding affinity.
The residue at position 11 to 40 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 510 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 445 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 101 to 108 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 112 to 117 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 182 to 186 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 44 to 58 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 276 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 277 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 238 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 128 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 132 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 166 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 290 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 293 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 14 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 45 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 264 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 269 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 274 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 307 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 311 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 337 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 339 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 348 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 313 to 317 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 336 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 747 to 754 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 167 to 214 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 606 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 608 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 671 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 207 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 302 to 308 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 140 to 143 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 221 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 378 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 325 to 332 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 464 to 467 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 750 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 421 to 424 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 213 to 222 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 239 to 242 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 461 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 520 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 521 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 152 to 160 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 206 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 229 to 240 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 254 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 261 to 267 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 314 to 322 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 314 to 321 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 289 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 326 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 330 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 468 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 471 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 484 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 487 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 100 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 224 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 401 to 403 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 528 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 558 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 609 to 611 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 633 to 634 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 485 to 607 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 544 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 559 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 310 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 324 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 380 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 394 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 473 to 479 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 520 to 523 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 660 to 661 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 1602 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1605 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1608 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 473 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 568 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 631 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 657 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 663 to 666 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 737 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 1060 to 1112 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1119 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1124 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 82 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 90 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 140 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 184 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 374 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 592 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 320 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 1010 to 1018 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 94 to 99 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 173 to 179 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 33 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 48 to 52 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 334 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 507 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1345 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1373 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1376 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 95 to 101 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 247 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 271 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 315 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 163 to 169 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 232 to 238 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 245 to 248 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 201 to 208 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 117 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 134 to 140 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 27 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 203 to 205 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 350 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 369 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 382 to 384 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 419 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 109 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 438 to 443 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 713 to 716 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 7 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 483 to 490 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 529 to 533 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1693 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1695 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1698 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1701 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 134 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 183 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 246 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 38 to 62 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1518 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1550 to 1556 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1594 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 191 to 198 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 237 to 241 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 672 to 680 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 92 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 240 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 271 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 272 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 273 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 317 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 45 to 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 166 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 338 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 57 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 118 to 119 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 148 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 317 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 346 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 370 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 399 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 128 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 384 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 494 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 520 to 521 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 543 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 570 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 737 to 746 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 813 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 838 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 141 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 334 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 338 to 344 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 9 to 15 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 35 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 669 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 172 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 188 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 265 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 320 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 157 to 192 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 134 to 188 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 187 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 239 to 247 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 259 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 278 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 314 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 353 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 394 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 436 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 439 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 454 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 459 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 464 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 467 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 475 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 479 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 582 to 697 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 38 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 164 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 287 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 515 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 61 to 70 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 160 to 167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 20 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 22 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 24 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 49 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 51 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 105 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 106 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 133 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 226 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 258 to 261 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 310 to 313 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 437 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 440 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 442 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 487 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 491 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 1227 to 1234 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 2336 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 2338 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 2466 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 139 to 189 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 926 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 347 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 393 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 415 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 433 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 550 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 248 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 357 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 72 to 87 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 151 to 176 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 322 to 329 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 193 to 200 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 27 to 31 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 415 to 418 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 179 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 88 to 119 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 234 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 90 to 97 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 73 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 175 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 426 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 486 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 649 to 657 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 418 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 68 to 71 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 527 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 534 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 187 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 933 to 940 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1946 to 1953 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 282 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 308 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 323 to 324 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 331 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 360 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 32 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 32 forms a bond with 5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate, indicating a strong binding affinity.
The residue at position 32 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with 5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate, indicating a strong binding affinity.
The residue at position 52 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 53 forms a bond with 5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate, indicating a strong binding affinity.
The residue at position 53 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with 5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate, indicating a strong binding affinity.
The residue at position 63 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 100 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 102 forms a bond with 5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with 5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with 5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 173 forms a bond with P(1),P(5)-bis(5'-adenosyl) pentaphosphate, indicating a strong binding affinity.
The residue at position 863 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 255 to 259 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 139 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 205 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 169 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 394 forms a bond with cholesterol, indicating a strong binding affinity.
The residue at position 12 to 17 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 247 to 253 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 430 to 438 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 491 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 637 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 640 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 28 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 186 forms a bond with K(+) 1, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 forms a bond with K(+) 2, indicating a strong binding affinity.
The residue at position 387 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 389 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 413 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 426 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 22 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 68 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 141 forms a bond with gibberellin A3, indicating a strong binding affinity.
The residue at position 96 to 105 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 212 to 259 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 709 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 988 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 991 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 993 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 185 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 188 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 202 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 207 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 544 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 558 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 577 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 114 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 24 to 28 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 60 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 45 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 49 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 249 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 310 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 335 to 336 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 337 forms a bond with sn-glycerol 3-phosphate, indicating a strong binding affinity.
The residue at position 402 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 437 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 442 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 91 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 213 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 240 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 970 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 977 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 980 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 986 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 453 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 371 to 376 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 311 to 314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 119 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 210 to 211 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 215 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 291 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 131 to 132 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 144 to 145 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 128 to 136 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 170 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 496 to 508 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 656 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 479 to 485 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 578 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 479 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 925 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1005 to 1007 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1012 to 1016 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1052 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 174 to 203 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 126 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 179 to 185 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 472 to 478 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 89 to 93 forms a bond with heme, indicating a strong binding affinity.
The residue at position 285 to 287 forms a bond with heme, indicating a strong binding affinity.
The residue at position 343 to 345 forms a bond with heme, indicating a strong binding affinity.
The residue at position 5 to 6 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 144 to 146 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 204 to 205 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 227 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 21 to 24 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 201 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 37 to 39 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 73 to 76 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 154 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 266 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 248 to 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 to 188 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 189 to 327 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 262 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 282 to 287 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 12 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 16 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 7 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 18 to 23 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 76 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 75 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 5 to 8 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 58 to 63 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 73 to 74 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 153 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 156 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 157 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 512 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 513 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 515 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 2001 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 111 to 114 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 170 to 185 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1250 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 1352 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 1391 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 35 to 46 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 to 136 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 129 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 345 to 349 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 356 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 378 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 489 to 491 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 75 forms a bond with D-mannonate, indicating a strong binding affinity.
The residue at position 75 forms a bond with L-galactonate, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with D-mannonate, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with L-galactonate, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with D-mannonate, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with L-galactonate, indicating a strong binding affinity.
The residue at position 171 forms a bond with D-mannonate, indicating a strong binding affinity.
The residue at position 171 forms a bond with L-galactonate, indicating a strong binding affinity.
The residue at position 211 forms a bond with D-mannonate, indicating a strong binding affinity.
The residue at position 211 forms a bond with L-galactonate, indicating a strong binding affinity.
The residue at position 35 to 46 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 273 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 446 to 448 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 913 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1022 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1075 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 182 to 183 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 209 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 257 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 259 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 618 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 619 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 620 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 624 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 629 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 12 to 15 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 839 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 842 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 847 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1276 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1279 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 271 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 389 to 397 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 to 15 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 142 to 146 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 175 to 177 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 236 to 243 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 283 to 287 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 348 to 351 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 186 to 189 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 304 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 380 to 382 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 404 to 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 516 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 59 to 61 forms a bond with L-asparagine 1, indicating a strong binding affinity.
The residue at position 91 to 92 forms a bond with L-asparagine 1, indicating a strong binding affinity.
The residue at position 162 forms a bond with L-asparagine 2, indicating a strong binding affinity.
The residue at position 240 forms a bond with L-asparagine 2, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with L-asparagine 2, indicating a strong binding affinity.
The residue at position 352 to 355 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 375 to 384 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 437 to 438 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 311 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 202 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 155 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 1492 to 1551 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 129 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 166 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cd(2+) 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with Cd(2+) 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 34 forms a bond with Cd(2+) 3, indicating a strong binding affinity.
The residue at position 450 to 456 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 182 to 205 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 335 to 352 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 327 to 331 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 418 to 421 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 130 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 161 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 182 forms a bond with 3,5-diiodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 484 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 624 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 891 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 893 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 1000 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 376 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 572 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 717 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 183 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 304 to 305 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 310 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 339 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 402 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 885 to 892 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 182 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 595 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 689 to 692 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 708 to 712 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 713 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 725 to 727 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 778 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 872 to 879 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 654 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 31 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 32 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 83 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 97 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 184 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 221 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 314 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 378 to 381 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 413 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 348 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 60 to 73 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 234 to 243 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 153 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 171 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 312 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 648 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 776 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 356 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 377 to 379 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 648 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 651 to 652 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 654 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 707 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 709 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 714 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 344 to 346 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 498 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 531 to 533 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 556 to 557 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 534 to 535 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 568 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 35 to 36 forms a bond with orotate, indicating a strong binding affinity.
The residue at position 188 to 193 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 125 to 142 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 140 to 147 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 140 to 145 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 211 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 228 to 229 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 264 to 265 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 265 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 288 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 316 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 347 to 350 forms a bond with D-glucose 1, indicating a strong binding affinity.
The residue at position 469 to 471 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 481 to 482 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 505 forms a bond with D-glucose 6-phosphate 1, indicating a strong binding affinity.
The residue at position 588 to 593 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 588 to 592 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 659 to 660 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 676 to 677 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 712 to 713 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 713 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 736 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 736 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 738 to 739 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 764 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 798 forms a bond with D-glucose 2, indicating a strong binding affinity.
The residue at position 803 to 804 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 840 to 844 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 917 to 919 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 919 to 923 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 953 forms a bond with D-glucose 6-phosphate 2, indicating a strong binding affinity.
The residue at position 132 forms a bond with 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol), indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with molybdate, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with tungstate, indicating a strong binding affinity.
The residue at position 402 to 404 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 362 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 242 to 249 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 288 to 292 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 252 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 352 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 488 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 289 to 292 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 359 to 361 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 569 to 571 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 161 to 168 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 680 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 40 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 101 to 104 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 182 forms a bond with dimethylallyl phosphate, indicating a strong binding affinity.
The residue at position 421 to 422 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 to 162 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 871 to 879 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 924 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 528 to 535 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 575 to 579 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 629 to 632 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1249 to 1257 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 89 to 91 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 183 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 86 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 287 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 405 to 410 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 644 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 421 to 423 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 474 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 474 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 505 to 506 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 551 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 589 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 589 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 595 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 55 to 85 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 229 to 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 467 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 470 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 529 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 530 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 531 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 535 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 792 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 813 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 815 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 864 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 24 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 27 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 237 to 239 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 244 to 250 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 276 to 279 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 160 to 170 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 420 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 518 forms a bond with a glycophospholipid, indicating a strong binding affinity.
The residue at position 106 to 108 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 146 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 98 to 111 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 114 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 118 to 120 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 100 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 148 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 193 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 237 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 266 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 170 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 865 to 870 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 884 to 889 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 982 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1035 to 1036 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 142 to 157 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 to 199 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 forms a bond with allantoate, indicating a strong binding affinity.
The residue at position 278 forms a bond with allantoate, indicating a strong binding affinity.
The residue at position 291 forms a bond with allantoate, indicating a strong binding affinity.
The residue at position 1228 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1231 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1247 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1252 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1255 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 80 to 100 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 588 to 592 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 611 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 633 to 635 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 838 to 840 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 35 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 141 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 142 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 162 to 165 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 191 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 196 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 217 to 218 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 305 to 308 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 67 to 75 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 364 to 369 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 333 to 335 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 731 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 744 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 749 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 799 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 802 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 815 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 820 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 614 to 615 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 135 to 141 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 697 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 777 to 778 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 82 to 97 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 449 to 450 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 22 to 26 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 50 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 42 to 48 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 245 to 251 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 40 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 258 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 273 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 333 to 339 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 337 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 365 to 367 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 339 forms a bond with Cu(2+), indicating a strong binding affinity.
The residue at position 50 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 61 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 77 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 176 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 180 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 223 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 200 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 228 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 252 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 309 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 541 to 545 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 595 to 598 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 105 to 107 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 140 forms a bond with 2,4-dihydroxypteridine 2, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 163 to 168 forms a bond with 2,4-dihydroxypteridine 1, indicating a strong binding affinity.
The residue at position 375 to 377 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 415 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 76 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 1048 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1073 to 1079 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1119 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1179 to 1181 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 3 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 145 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 185 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 209 to 215 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 65 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 117 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 197 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 239 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 74 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 226 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 226 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 402 forms a bond with 2-oxoadipate, indicating a strong binding affinity.
The residue at position 228 to 230 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 404 to 408 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 1059 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1062 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 246 to 261 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 127 to 132 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 330 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 437 to 445 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 608 to 616 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 732 to 735 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 71 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 72 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 75 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 110 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 245 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 246 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 249 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 251 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 261 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 311 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 312 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 352 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 472 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 478 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 479 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 480 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 482 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 484 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 248 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 282 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 121 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 186 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 27 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 564 forms a bond with oxalate, indicating a strong binding affinity.
The residue at position 425 to 429 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 434 to 440 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 464 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 131 to 150 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with GDP, indicating a strong binding affinity.
The residue at position 310 to 314 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 642 to 647 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 185 to 193 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 283 to 292 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 298 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 323 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 402 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 492 to 499 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 to 302 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 509 to 510 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 704 to 768 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 391 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 701 to 721 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 752 to 778 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 532 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 675 to 679 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 687 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 692 to 694 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 412 to 414 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 482 to 484 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 168 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 970 to 977 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 56 forms a bond with 2-oxopropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 82 forms a bond with 2-oxopropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 222 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 365 forms a bond with 2-oxopropyl-coenzyme M, indicating a strong binding affinity.
The residue at position 207 to 259 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 546 to 547 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 744 to 745 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1425 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 198 to 206 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 362 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 427 to 431 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 521 to 527 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 533 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 581 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 581 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 176 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 179 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 485 to 488 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 508 to 510 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1489 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1491 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1493 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1495 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1500 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 468 to 473 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 to 312 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 353 to 354 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 22 to 79 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 458 to 587 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 576 to 703 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 167 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 97 to 101 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 221 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 151 to 153 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 251 to 254 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 346 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 261 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 363 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 458 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 458 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 45 to 48 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 59 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 120 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 145 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 170 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 278 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 176 to 180 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 28 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 543 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 230 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 236 to 237 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 909 to 917 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 351 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 151 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 192 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 120 to 121 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 245 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 294 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 307 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 333 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 338 to 342 forms a bond with N(6)-(1,2-dicarboxyethyl)-AMP, indicating a strong binding affinity.
The residue at position 239 to 244 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 53 to 61 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 567 to 569 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 58 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 241 to 248 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 356 to 359 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 110 to 116 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 278 to 286 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 114 to 118 forms a bond with pyridine, indicating a strong binding affinity.
The residue at position 311 to 312 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 352 to 354 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 377 to 380 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 1628 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1631 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1647 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1650 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1655 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1658 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1677 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1680 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 110 to 111 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 155 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 365 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with GDP-beta-L-fucose, indicating a strong binding affinity.
The residue at position 639 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 655 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 776 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 776 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 776 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 817 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 817 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 817 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 945 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 945 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 945 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 49 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 243 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 245 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 310 forms a bond with queuine, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 254 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 282 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 313 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 447 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 21 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 62 forms a bond with heptadecanoate, indicating a strong binding affinity.
The residue at position 95 forms a bond with heptadecanoate, indicating a strong binding affinity.
The residue at position 269 to 275 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 62 to 67 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 94 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 122 to 125 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 199 to 207 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 122 to 126 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 264 to 269 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 227 to 237 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 271 to 278 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 305 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 397 forms a bond with calciol, indicating a strong binding affinity.
The residue at position 1213 to 1215 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1232 to 1233 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1288 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1413 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1416 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1428 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1431 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1437 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1440 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1453 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1461 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1533 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1536 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1548 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1551 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1557 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1560 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1569 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1571 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 2121 to 2129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2142 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 307 forms a bond with (3R)-hydroxybutanoate trimer, indicating a strong binding affinity.
The residue at position 337 to 338 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 458 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 36 to 44 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 166 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 396 to 401 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 728 to 735 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 660 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 664 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 97 forms a bond with folate, indicating a strong binding affinity.
The residue at position 118 to 122 forms a bond with folate, indicating a strong binding affinity.
The residue at position 151 to 156 forms a bond with folate, indicating a strong binding affinity.
The residue at position 437 to 559 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 496 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 511 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 27 to 149 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 301 to 304 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1431 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1433 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1435 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1437 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1442 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 207 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 281 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 551 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 91 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 103 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 178 to 179 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 80 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 81 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 223 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 385 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 61 to 62 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 93 to 99 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 to 140 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 166 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 441 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 445 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 270 to 271 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 311 to 313 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 337 to 340 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 449 to 456 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1194 to 1201 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 37 forms a bond with 3'-hydroxyechinenone, indicating a strong binding affinity.
The residue at position 203 forms a bond with 3'-hydroxyechinenone, indicating a strong binding affinity.
The residue at position 290 forms a bond with 3'-hydroxyechinenone, indicating a strong binding affinity.
The residue at position 136 to 185 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 154 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 174 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 205 to 206 forms a bond with S-adenosyl 3-(methylsulfanyl)propylamine, indicating a strong binding affinity.
The residue at position 292 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 256 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 321 to 323 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 396 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 510 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 567 to 569 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 591 to 592 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 109 to 111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 433 to 438 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 232 to 234 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 126 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 273 to 280 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 790 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 821 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 825 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 935 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 937 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1102 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 722 to 723 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 736 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 865 to 870 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 180 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 205 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 302 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 350 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 385 forms a bond with UDP-alpha-D-galactose, indicating a strong binding affinity.
The residue at position 386 to 391 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 166 to 169 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 377 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 77 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 80 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 111 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 130 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 145 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 157 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 160 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 227 forms a bond with Fe of heme 6, indicating a strong binding affinity.
The residue at position 230 forms a bond with Fe of heme 8, indicating a strong binding affinity.
The residue at position 248 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 255 forms a bond with heme 6, indicating a strong binding affinity.
The residue at position 258 forms a bond with heme 6, indicating a strong binding affinity.
The residue at position 259 forms a bond with Fe of heme 6, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe of heme 7, indicating a strong binding affinity.
The residue at position 271 forms a bond with heme 7, indicating a strong binding affinity.
The residue at position 274 forms a bond with heme 7, indicating a strong binding affinity.
The residue at position 275 forms a bond with Fe of heme 7, indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe of heme 9, indicating a strong binding affinity.
The residue at position 297 forms a bond with heme 8, indicating a strong binding affinity.
The residue at position 300 forms a bond with heme 8, indicating a strong binding affinity.
The residue at position 301 forms a bond with Fe of heme 8, indicating a strong binding affinity.
The residue at position 314 forms a bond with heme 9, indicating a strong binding affinity.
The residue at position 317 forms a bond with heme 9, indicating a strong binding affinity.
The residue at position 318 forms a bond with Fe of heme 9, indicating a strong binding affinity.
The residue at position 1088 to 1096 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1161 to 1164 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 222 to 223 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 352 to 355 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 15 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 47 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 80 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 168 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 547 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 10 to 35 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 405 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 420 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 428 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 431 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 443 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 451 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 104 to 120 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 27 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 132 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 167 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 258 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 25 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 52 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 63 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 147 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 173 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 209 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 213 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 18 to 20 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 166 to 201 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 207 to 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 421 to 427 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 31 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 187 to 193 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 256 to 262 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 269 to 272 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 321 to 327 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 88 to 93 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1821 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1033 to 1041 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 220 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 224 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 40 to 43 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 57 to 63 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 37 to 40 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 124 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 374 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 397 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 404 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 414 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 276 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 327 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 127 to 130 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 303 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 325 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 107 to 109 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 395 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 520 to 523 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 77 to 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 178 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 321 to 322 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 436 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 456 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 470 to 472 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 472 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 219 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 441 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 489 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 759 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 865 forms a bond with crRNA, indicating a strong binding affinity.
The residue at position 1533 to 1541 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1556 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 469 to 476 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 319 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 113 forms a bond with CO, indicating a strong binding affinity.
The residue at position 319 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 413 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 423 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 451 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 461 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 519 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 548 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 583 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 219 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 326 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 329 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 342 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 345 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 360 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 365 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 370 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 373 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 380 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 387 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 430 to 431 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 478 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 251 to 252 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 639 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 713 to 720 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1379 to 1386 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 608 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 611 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 88 to 96 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 180 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 188 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 557 to 559 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 109 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 183 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 216 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 223 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 182 to 184 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 238 to 240 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 768 to 772 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 877 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 998 to 1002 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 180 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 95 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 91 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1058 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1080 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 340 to 341 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 422 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 768 to 775 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 18 to 47 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 594 to 711 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 124 to 131 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 402 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 405 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 441 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 451 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 529 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 530 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 572 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 877 to 884 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 397 to 403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 442 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 277 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 347 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 368 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 386 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 203 forms a bond with alpha-D-mannopyranose, indicating a strong binding affinity.
The residue at position 209 to 211 forms a bond with N-acetyl-D-glucosamine, indicating a strong binding affinity.
The residue at position 173 to 180 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 46 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 240 to 242 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 66 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 571 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 35 to 38 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 258 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 301 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 302 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 303 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 215 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 254 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 283 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 315 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 55 to 60 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 319 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 347 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 561 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 584 to 585 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 309 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 364 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 367 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 410 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 410 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 480 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 525 to 528 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 118 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 539 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 306 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 388 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 73 to 78 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 426 to 429 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 507 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 566 to 570 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 603 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 610 to 612 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 666 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 692 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 698 to 701 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 764 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 175 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 232 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 270 forms a bond with acetate, indicating a strong binding affinity.
The residue at position 288 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 339 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 565 to 567 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 830 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 853 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 854 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 120 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 160 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 787 to 794 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 83 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 262 to 290 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 546 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 681 to 800 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 841 to 961 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 394 to 395 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 434 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 438 to 442 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 449 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 172 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 186 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 34 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 176 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 195 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 292 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 342 to 343 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 429 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 439 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 440 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 143 to 147 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 719 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 803 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 805 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 807 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 809 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 877 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 973 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 105 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 108 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 149 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 150 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 212 forms a bond with fluoroacetate, indicating a strong binding affinity.
The residue at position 278 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 310 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 310 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 400 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 417 forms a bond with a dipeptide, indicating a strong binding affinity.
The residue at position 50 to 53 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 106 to 107 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 291 to 293 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 228 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 252 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 260 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 261 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 419 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 433 forms a bond with Mg(2+) 6, indicating a strong binding affinity.
The residue at position 203 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 290 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 344 to 347 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 240 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 652 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 675 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 776 to 779 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 794 to 798 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 810 to 812 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 863 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 477 to 479 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 485 to 490 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 514 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 523 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 693 to 750 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 817 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 552 to 559 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 600 to 604 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 211 to 213 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 304 to 305 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 29 to 31 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 76 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with 3-hydroxybenzoate, indicating a strong binding affinity.
The residue at position 150 forms a bond with 3-hydroxybenzoate, indicating a strong binding affinity.
The residue at position 170 to 172 forms a bond with 3-hydroxybenzoate, indicating a strong binding affinity.
The residue at position 211 forms a bond with 3-hydroxybenzoate, indicating a strong binding affinity.
The residue at position 782 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 812 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 814 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 818 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 216 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 218 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 342 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 346 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 681 to 811 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 807 to 960 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 231 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 236 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 285 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 153 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 294 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 413 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 441 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 466 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 501 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 503 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 39 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 47 to 49 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 120 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 1035 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1061 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1067 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1152 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1177 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 107 to 115 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 141 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 204 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 207 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 952 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 954 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 956 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 293 to 295 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 330 to 331 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 471 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 105 forms a bond with Fe of heme b 1; low-spin, indicating a strong binding affinity.
The residue at position 632 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 746 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 683 to 690 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 to 38 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 80 to 84 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 518 to 521 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 748 to 752 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 143 forms a bond with heme, indicating a strong binding affinity.
The residue at position 491 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1297 to 1304 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 48 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 123 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 53 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 443 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 476 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 84 to 89 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 259 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 367 to 368 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 493 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 493 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 542 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 357 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 361 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 10 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 109 to 115 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 277 to 285 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 54 to 63 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 291 to 294 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 448 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 795 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 820 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 17 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 17 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 136 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 141 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 141 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 142 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 168 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 179 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 194 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 288 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 289 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 291 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with 1D-myo-inositol 1,3,4,6-tetrakisphosphate, indicating a strong binding affinity.
The residue at position 295 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 852 to 860 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 157 to 167 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 239 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 261 to 263 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 148 to 151 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 557 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 559 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 225 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 227 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 313 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 350 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 354 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 61 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 318 to 319 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 333 to 339 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 352 to 353 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 252 to 280 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 371 to 373 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 98 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 203 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 981 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 200 to 206 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 96 to 98 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 114 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 124 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 143 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 150 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 206 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with (2R,3S)-homoisocitrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 300 to 304 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 312 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 246 to 250 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 268 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 317 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 407 to 410 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 412 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 477 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 479 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 484 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 38 to 39 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 41 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 68 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 68 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 72 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 92 forms a bond with 3-iodo-L-tyrosine, indicating a strong binding affinity.
The residue at position 92 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 161 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 163 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 5 to 36 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 680 to 800 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 840 to 960 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 47 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 267 to 269 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 302 to 303 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 417 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 437 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 451 to 453 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 453 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 734 to 736 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 486 to 494 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 332 to 335 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 to 228 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 253 to 258 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 730 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 762 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 764 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 295 to 305 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 83 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 1217 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1242 to 1249 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 26 to 29 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 136 to 145 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 474 to 479 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 214 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 542 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 546 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 549 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 150 to 156 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 202 to 204 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 233 forms a bond with putrescine, indicating a strong binding affinity.
The residue at position 118 to 128 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 130 to 132 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 166 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 359 to 363 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 396 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 403 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 434 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 1105 to 1111 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1164 to 1165 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 200 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 226 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 263 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 379 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 408 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 438 forms a bond with [Ni-4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 688 to 695 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 264 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 458 forms a bond with (E)-4-coumaroyl-AMP, indicating a strong binding affinity.
The residue at position 428 to 430 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 101 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 114 to 116 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 190 to 191 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 195 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 159 to 161 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 186 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 327 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 331 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 373 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 84 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 876 to 877 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 374 to 375 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 537 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 522 to 526 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 987 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 116 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 199 to 202 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 199 forms a bond with adenine, indicating a strong binding affinity.
The residue at position 225 forms a bond with adenine, indicating a strong binding affinity.
The residue at position 225 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 604 to 656 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 151 to 159 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 376 to 378 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 382 to 383 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 82 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 251 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 361 to 365 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 383 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 1459 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 255 to 263 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 81 to 84 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 121 to 125 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 148 to 155 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 171 to 172 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 14 forms a bond with pyridoxal, indicating a strong binding affinity.
The residue at position 115 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 125 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 146 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 220 to 221 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 176 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 234 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 299 to 301 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 178 to 180 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 186 to 191 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 306 to 314 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 336 to 337 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 123 to 132 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 150 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 563 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 564 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 565 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 569 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 574 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 119 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 156 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 156 to 278 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 226 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 279 to 403 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 349 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 358 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 84 forms a bond with urate, indicating a strong binding affinity.
The residue at position 85 forms a bond with urate, indicating a strong binding affinity.
The residue at position 208 forms a bond with urate, indicating a strong binding affinity.
The residue at position 225 forms a bond with urate, indicating a strong binding affinity.
The residue at position 273 forms a bond with urate, indicating a strong binding affinity.
The residue at position 274 forms a bond with urate, indicating a strong binding affinity.
The residue at position 300 forms a bond with urate, indicating a strong binding affinity.
The residue at position 1060 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1078 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 332 to 339 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 206 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 440 to 447 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 144 to 150 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 472 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 50 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 98 to 101 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 105 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 141 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 142 to 195 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 636 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 482 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 484 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 549 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 198 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 702 to 709 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 to 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 282 to 292 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 624 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 632 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 640 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 641 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 1001 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1020 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 590 to 592 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 597 to 603 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 630 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 637 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 62 to 79 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 58 forms a bond with alpha-L-arabinofuranose, indicating a strong binding affinity.
The residue at position 247 forms a bond with alpha-L-arabinofuranose, indicating a strong binding affinity.
The residue at position 379 to 380 forms a bond with alpha-L-arabinofuranose, indicating a strong binding affinity.
The residue at position 590 to 597 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 255 forms a bond with L-threonylcarbamoyladenylate, indicating a strong binding affinity.
The residue at position 463 to 464 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 469 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 88 to 90 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 67 to 68 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 391 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 93 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 93 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 185 forms a bond with isopenicillin N, indicating a strong binding affinity.
The residue at position 185 forms a bond with N-[(5S)-5-amino-5-carboxypentanoyl]-L-cysteinyl-D-valine, indicating a strong binding affinity.
The residue at position 24 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 42 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 238 to 250 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 314 to 318 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1023 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 59 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 971 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 995 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 998 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 402 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 17 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 111 to 112 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 138 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 146 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 326 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 350 to 353 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 597 to 598 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 638 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 89 to 120 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 139 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 159 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 181 to 183 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 237 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 241 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 356 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 31 to 32 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 70 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 725 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1121 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 91 to 95 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 442 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 355 to 358 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 268 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 271 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 1006 to 1013 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 279 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 334 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 359 forms a bond with UDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 5 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1667 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1670 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1673 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 160 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 166 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 346 to 367 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 389 to 408 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 30 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 165 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 209 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 375 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 468 forms a bond with [alpha-D-GalNAc-(1->4)]2-[beta-D-Glc-(1->3)]-[alpha-D-GalNAc-(1->4)]2-alpha-D-GalNAc-(1->3)-alpha-D-diNAcBac-tri-trans,hepta-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 267 to 273 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 215 to 217 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 223 to 228 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 106 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with a fatty acid, indicating a strong binding affinity.
The residue at position 392 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 401 to 402 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 455 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 254 to 259 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 128 to 136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 155 to 160 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 297 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 299 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 137 to 141 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 392 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 431 to 432 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 459 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 491 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 532 to 534 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 612 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 386 to 508 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 361 to 363 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 377 to 378 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 476 forms a bond with N(6)-methyladenosine 5'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 47 to 52 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 79 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 148 to 153 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 544 to 545 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 320 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 734 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 883 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 888 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 107 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 160 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 982 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1042 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1110 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1120 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1122 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1138 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1147 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1207 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1223 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1229 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1231 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1233 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1265 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1804 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1819 to 1821 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 246 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 690 to 698 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 866 to 870 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 935 to 938 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1009 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 17 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 688 to 745 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 812 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 824 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 826 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 207 to 209 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 242 to 243 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 357 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 377 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 391 to 393 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 393 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 406 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 58 forms a bond with fatty acid 16:0, indicating a strong binding affinity.
The residue at position 71 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 138 to 142 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 75 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 79 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 80 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 170 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 170 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 273 to 276 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 273 to 274 forms a bond with D-alanine, indicating a strong binding affinity.
The residue at position 17 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 23 to 24 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 28 to 33 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 86 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 119 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 143 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 163 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 81 to 82 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 170 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 503 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 526 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 513 to 514 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 552 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 559 forms a bond with resiniferatoxin, indicating a strong binding affinity.
The residue at position 163 to 171 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 793 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 99 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 113 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 114 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 332 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 333 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 346 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 347 forms a bond with L-valine, indicating a strong binding affinity.
The residue at position 52 to 56 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 23 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 69 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 127 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 187 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 257 to 259 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 562 to 564 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 105 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 292 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 1464 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1464 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1470 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1519 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1519 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1521 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1521 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1527 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1795 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1798 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1801 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 413 to 420 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 15 forms a bond with Mg of a bacteriochlorophyll, indicating a strong binding affinity.
The residue at position 19 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 94 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 1048 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 1055 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 51 to 54 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 169 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 187 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 153 to 158 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 332 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 339 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 384 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 508 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 515 to 516 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 524 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 123 to 130 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 435 to 442 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 266 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 297 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 356 forms a bond with carnosine, indicating a strong binding affinity.
The residue at position 237 to 241 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 431 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 118 forms a bond with Fe cation 3, indicating a strong binding affinity.
The residue at position 566 forms a bond with Mg of chlorophyll a B1, indicating a strong binding affinity.
The residue at position 574 forms a bond with Mg of chlorophyll a B3, indicating a strong binding affinity.
The residue at position 582 forms a bond with chlorophyll a B3, indicating a strong binding affinity.
The residue at position 583 forms a bond with phylloquinone B, indicating a strong binding affinity.
The residue at position 41 to 49 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 60 to 66 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 166 to 168 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 256 to 257 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 325 to 326 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 177 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 219 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 223 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 275 to 278 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 334 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 360 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 376 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 453 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 456 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 489 to 493 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1000 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1002 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1118 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1062 to 1069 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 416 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 553 forms a bond with dolichyl diphosphooligosaccharide, indicating a strong binding affinity.
The residue at position 283 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 311 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 147 to 156 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 393 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 127 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 1328 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1331 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1355 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1389 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1392 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1406 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1411 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 217 to 219 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 248 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 299 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 205 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 206 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 94 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 653 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 713 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 810 to 811 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 58 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 260 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 261 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 262 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 263 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 267 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 362 to 364 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 385 to 386 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 409 to 413 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 439 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 499 forms a bond with K(+), indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 339 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 419 to 422 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 718 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 774 to 776 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 844 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 848 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 21 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 21 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 24 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 94 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 94 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 95 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 99 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 200 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 203 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 203 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 291 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 163 forms a bond with (2E,6E)-farnesyl diphosphate 2, indicating a strong binding affinity.
The residue at position 169 forms a bond with (2E,6E)-farnesyl diphosphate 1, indicating a strong binding affinity.
The residue at position 247 forms a bond with (2E,6E)-farnesyl diphosphate 1, indicating a strong binding affinity.
The residue at position 76 to 80 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 240 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 290 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 537 to 539 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 537 to 539 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 544 to 550 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 544 to 550 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 575 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 575 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 369 to 371 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 29 to 58 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1328 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1334 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1373 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1377 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1377 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 17 forms a bond with dGMP, indicating a strong binding affinity.
The residue at position 17 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 47 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 74 forms a bond with dGMP, indicating a strong binding affinity.
The residue at position 78 forms a bond with dGMP, indicating a strong binding affinity.
The residue at position 99 forms a bond with dGMP, indicating a strong binding affinity.
The residue at position 99 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 107 forms a bond with dGMP, indicating a strong binding affinity.
The residue at position 107 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 108 forms a bond with dGMP, indicating a strong binding affinity.
The residue at position 153 forms a bond with dGMP, indicating a strong binding affinity.
The residue at position 148 to 158 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1507 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1539 to 1545 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1583 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 70 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 99 to 101 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 130 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 176 to 177 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 934 to 944 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 372 to 377 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 489 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 537 to 538 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 6 to 7 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 203 to 204 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 226 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 92 to 120 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 370 to 383 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 33 to 38 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 130 to 131 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 264 to 270 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 167 to 173 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 261 to 264 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 29 to 32 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 118 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 329 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 445 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1251 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1264 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1267 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1272 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1275 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1296 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 30 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 441 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 262 to 264 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 323 to 333 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 237 to 240 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 345 to 348 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 1097 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1104 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 337 to 343 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 360 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 378 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 380 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 408 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 207 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 219 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 276 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 315 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 162 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 208 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 417 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 499 to 502 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1442 to 1449 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 935 to 942 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 373 to 375 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 491 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 527 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 528 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 639 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 449 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 198 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 5 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 32 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 175 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 248 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 276 to 280 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 121 to 124 forms a bond with 7,8-dihydropteroate, indicating a strong binding affinity.
The residue at position 1 to 25 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 138 to 149 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 274 to 284 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 349 to 367 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 447 to 462 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 293 to 303 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 147 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 151 forms a bond with O2, indicating a strong binding affinity.
The residue at position 198 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 348 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 563 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 631 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 754 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 756 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 54 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 160 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 197 forms a bond with a 2-oxocarboxylate, indicating a strong binding affinity.
The residue at position 380 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 416 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 435 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 547 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 583 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 629 to 631 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 209 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 214 to 216 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 215 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 834 forms a bond with ergosterol, indicating a strong binding affinity.
The residue at position 962 forms a bond with ergosterol, indicating a strong binding affinity.
The residue at position 383 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 413 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 464 to 466 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 488 to 489 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 202 to 237 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 25 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 591 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 130 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 203 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 772 to 780 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 718 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 497 to 504 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 203 forms a bond with alpha-D-glucose 1-phosphate, indicating a strong binding affinity.
The residue at position 200 to 206 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 163 to 176 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 700 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 758 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 178 to 183 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 405 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 258 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 260 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 320 forms a bond with 8-oxoguanine, indicating a strong binding affinity.
The residue at position 540 to 547 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 309 to 315 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 83 forms a bond with hydrogen sulfide, indicating a strong binding affinity.
The residue at position 103 to 111 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 115 to 120 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 1843 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1845 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1365 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1368 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1383 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1387 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 661 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 662 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 663 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 694 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 1036 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1070 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1105 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1108 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1158 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1165 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1166 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 691 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 694 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 697 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 701 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 811 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 814 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 839 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1072 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 590 to 720 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 707 to 856 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 149 to 158 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 570 to 571 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 600 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 800 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1122 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 23 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 28 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 97 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 141 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 376 to 377 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 468 to 472 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 494 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 95 to 96 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 180 to 185 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 567 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 580 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 582 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1934 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2238 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 2240 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 398 to 400 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 406 to 409 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 366 to 373 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 299 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 1529 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1533 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1553 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 267 to 273 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 368 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 404 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 541 to 546 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 183 to 194 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 501 to 624 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 568 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 583 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 76 to 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 443 to 444 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 191 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 280 to 399 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 402 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 500 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 673 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 676 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 80 to 83 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 358 to 360 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 129 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 303 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 346 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 351 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 657 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 700 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 705 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 710 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 1014 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1017 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 1019 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1059 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1060 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1061 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1065 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1070 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 34 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 64 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 76 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 82 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 100 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 108 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 111 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 125 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 128 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 129 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 618 to 624 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 681 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 702 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 9 to 10 forms a bond with 6,7-dimethyl-8-(1-D-ribityl)lumazine, indicating a strong binding affinity.
The residue at position 32 to 40 forms a bond with 6,7-dimethyl-8-(1-D-ribityl)lumazine, indicating a strong binding affinity.
The residue at position 105 forms a bond with 6,7-dimethyl-8-(1-D-ribityl)lumazine, indicating a strong binding affinity.
The residue at position 265 to 269 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 363 to 366 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 288 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 438 to 439 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 449 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 340 to 344 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 592 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 482 to 483 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 491 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 466 to 471 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 485 to 490 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 583 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 631 to 632 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 138 to 140 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 155 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 225 to 227 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 2 to 3 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 225 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 320 to 322 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 337 to 345 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 359 to 362 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 250 to 255 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 385 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 406 to 407 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 648 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 651 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 689 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 167 to 169 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 235 to 236 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 841 to 849 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 198 to 199 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 225 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 90 forms a bond with heme, indicating a strong binding affinity.
The residue at position 482 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 39 to 41 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 357 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 360 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 454 to 455 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 461 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 465 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 290 to 307 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 443 to 449 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 790 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 822 to 828 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 866 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 224 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 41 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 74 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 92 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 94 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 125 forms a bond with phosphocholine, indicating a strong binding affinity.
The residue at position 197 to 199 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 228 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 57 to 62 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 174 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with a ribonucleoside 5'-phosphate, indicating a strong binding affinity.
The residue at position 416 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 281 to 284 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 566 to 571 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 forms a bond with red chlorophyll catabolite, indicating a strong binding affinity.
The residue at position 216 to 218 forms a bond with red chlorophyll catabolite, indicating a strong binding affinity.
The residue at position 299 forms a bond with red chlorophyll catabolite, indicating a strong binding affinity.
The residue at position 160 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 275 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 279 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 388 to 389 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 477 to 482 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 477 to 478 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 478 to 482 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 1743 to 1745 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1743 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1744 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1745 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1769 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1779 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1788 to 1798 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1812 to 1815 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1842 to 1844 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1843 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1844 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 319 to 325 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 340 to 348 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 362 to 365 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 129 to 130 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 450 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 452 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 549 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 21 to 26 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 112 to 113 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 230 to 236 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 460 to 463 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 39 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 73 forms a bond with hexadecanoate, indicating a strong binding affinity.
The residue at position 150 to 157 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 236 to 239 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 25 to 31 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 251 to 256 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 213 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 290 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 307 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 350 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 364 to 371 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 364 to 366 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 420 to 424 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 70 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 133 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 133 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 299 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 322 to 324 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 608 to 611 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 618 to 619 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 86 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 201 to 207 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 13 to 18 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 472 to 474 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 543 to 545 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 244 to 246 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 464 to 468 forms a bond with pepstatin A, indicating a strong binding affinity.
The residue at position 21 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 641 to 649 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 787 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 816 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 9 to 11 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 102 to 104 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 176 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 378 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 443 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 447 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 255 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 375 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 386 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 401 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 407 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 409 forms a bond with Ca(2+) 7, indicating a strong binding affinity.
The residue at position 457 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 459 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 462 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 464 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 466 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 496 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 498 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 500 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 502 forms a bond with Ca(2+) 9, indicating a strong binding affinity.
The residue at position 532 to 534 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 543 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 545 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 547 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 549 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 551 forms a bond with Ca(2+) 10, indicating a strong binding affinity.
The residue at position 177 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 229 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 294 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 355 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 103 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 132 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 221 forms a bond with L-proline, indicating a strong binding affinity.
The residue at position 735 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 736 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 512 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 807 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 826 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 846 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 851 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 864 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 870 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 895 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 900 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 913 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 919 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 948 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 953 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 966 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 972 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 122 to 124 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 183 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 272 to 274 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 297 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 422 to 425 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 556 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 341 to 344 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 466 to 470 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 251 to 255 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 339 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 133 forms a bond with L-ectoine, indicating a strong binding affinity.
The residue at position 646 to 647 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 670 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 772 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 1675 to 1692 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 1889 to 1904 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 34 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 49 to 53 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 115 to 192 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 775 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 779 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 67 to 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 348 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 390 to 394 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 234 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 283 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 302 to 306 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 160 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 189 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 285 forms a bond with H(+), indicating a strong binding affinity.
The residue at position 689 to 694 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 433 to 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1378 to 1385 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 245 to 247 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 460 to 462 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 483 to 484 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 422 to 424 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 422 to 424 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 475 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 475 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 552 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 590 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 590 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 596 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 315 to 323 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 179 to 180 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 222 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 230 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 260 to 262 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 316 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 243 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 538 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 632 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 281 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 13 to 36 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 2141 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2144 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2178 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2192 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 263 to 268 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 284 to 286 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 183 forms a bond with heme c, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 236 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 693 to 703 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 116 forms a bond with Mg of chlorophyll a ChlzD1, indicating a strong binding affinity.
The residue at position 124 forms a bond with pheophytin a D1, indicating a strong binding affinity.
The residue at position 168 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 187 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 196 forms a bond with Mg of chlorophyll a PD1, indicating a strong binding affinity.
The residue at position 213 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 262 to 263 forms a bond with a quinone B, indicating a strong binding affinity.
The residue at position 330 forms a bond with [CaMn4O5] cluster, indicating a strong binding affinity.
The residue at position 88 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 405 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 507 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 533 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 533 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 547 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 547 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 470 to 477 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 171 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 180 to 181 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 480 to 488 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 10 to 14 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 282 forms a bond with 4-amino-5-hydroxymethyl-2-methylpyrimidine, indicating a strong binding affinity.
The residue at position 617 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 436 to 437 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 466 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 477 to 482 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 7 forms a bond with prephenate, indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with prephenate, indicating a strong binding affinity.
The residue at position 90 forms a bond with prephenate, indicating a strong binding affinity.
The residue at position 108 forms a bond with prephenate, indicating a strong binding affinity.
The residue at position 359 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 389 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 461 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 272 to 273 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 25 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 252 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 256 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 323 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 740 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 742 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 744 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 746 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 748 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 58 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 60 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 160 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 207 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 210 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 269 to 270 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 37 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 97 to 99 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 142 to 144 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 386 to 392 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 460 to 461 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 466 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 224 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 248 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 297 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 1001 to 1009 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 316 to 323 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 141 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 142 to 174 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 590 to 591 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 25 forms a bond with rebaudioside A, indicating a strong binding affinity.
The residue at position 25 forms a bond with rubusoside, indicating a strong binding affinity.
The residue at position 27 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 146 to 147 forms a bond with rebaudioside A, indicating a strong binding affinity.
The residue at position 155 forms a bond with rebaudioside A, indicating a strong binding affinity.
The residue at position 338 to 339 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 356 to 364 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 359 forms a bond with rebaudioside A, indicating a strong binding affinity.
The residue at position 380 to 381 forms a bond with rebaudioside A, indicating a strong binding affinity.
The residue at position 175 to 182 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 869 to 876 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 90 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 26 to 30 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 1116 to 1173 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1175 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1180 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 49 to 73 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 269 to 272 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 347 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 306 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 350 to 466 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 425 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 138 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 to 264 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 286 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 305 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 477 to 484 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 726 to 733 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 346 forms a bond with a quinone, indicating a strong binding affinity.
The residue at position 70 to 74 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 314 to 316 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 314 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 369 to 370 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 408 forms a bond with beta-nicotinamide D-ribonucleotide, indicating a strong binding affinity.
The residue at position 1464 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1645 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1687 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1721 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 286 to 293 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 131 to 133 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 182 to 188 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 342 to 345 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 113 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 176 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 209 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 274 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 277 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 349 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 351 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 353 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 354 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 683 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 512 to 513 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 521 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 394 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 143 to 277 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 224 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 233 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 278 to 412 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 732 to 740 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 479 to 486 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 504 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 19 to 21 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 207 to 211 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 263 to 267 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 145 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 175 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 207 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 1849 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1853 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1869 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1872 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 469 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 503 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 504 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 504 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 614 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 156 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 158 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 177 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 184 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 417 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 502 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 525 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 291 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 292 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 533 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 877 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 572 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 588 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 320 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 160 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 183 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 259 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 133 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 458 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 534 to 537 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 598 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 74 to 78 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 78 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 82 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mn(2+) 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mn(2+) 4, indicating a strong binding affinity.
The residue at position 1266 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 44 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 79 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphocholine, indicating a strong binding affinity.
The residue at position 307 to 310 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 330 to 339 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 270 forms a bond with O2, indicating a strong binding affinity.
The residue at position 318 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 321 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 324 to 325 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 338 to 340 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 345 to 346 forms a bond with L-lysine, indicating a strong binding affinity.
The residue at position 400 to 407 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1045 to 1052 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 520 to 578 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 700 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 721 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 721 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 599 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 622 to 625 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 410 to 413 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 436 to 438 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 464 to 465 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 490 to 495 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 561 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 823 to 831 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 138 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 185 to 300 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 250 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 259 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 303 to 422 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 372 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 381 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 324 to 326 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 589 to 591 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 727 to 735 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 24 to 25 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 29 to 34 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 32 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 87 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 114 to 121 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 428 to 435 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 446 to 449 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 480 to 481 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 2280 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2282 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2291 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2323 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2329 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2334 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 104 to 106 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 227 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 290 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 328 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 331 forms a bond with 3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-seryl residue of a glycoprotein, indicating a strong binding affinity.
The residue at position 331 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 360 forms a bond with 3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-seryl residue of a glycoprotein, indicating a strong binding affinity.
The residue at position 383 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 385 forms a bond with 3-O-[alpha-D-xylosyl-(1->3)-beta-D-glucosyl]-L-seryl residue of a glycoprotein, indicating a strong binding affinity.
The residue at position 516 to 523 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 344 to 345 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 362 to 370 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 384 to 387 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 140 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 191 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 269 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with an all-trans-polyprenyl diphosphate, indicating a strong binding affinity.
The residue at position 271 to 275 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 254 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 314 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 527 to 528 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 483 to 490 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 181 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 102 to 108 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 168 to 169 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 366 to 367 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 482 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 541 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 543 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 140 to 155 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 166 to 198 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 23 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 217 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 9 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 9 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 20 forms a bond with Cu(+) 6, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 25 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 337 to 343 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 95 forms a bond with L-rhamnose, indicating a strong binding affinity.
The residue at position 226 to 228 forms a bond with L-rhamnose, indicating a strong binding affinity.
The residue at position 262 forms a bond with L-rhamnose, indicating a strong binding affinity.
The residue at position 326 forms a bond with L-rhamnose, indicating a strong binding affinity.
The residue at position 278 to 280 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 332 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 432 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 227 to 230 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 685 forms a bond with Mg of divinylchlorophyll a' A1, indicating a strong binding affinity.
The residue at position 693 forms a bond with Mg of divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 701 forms a bond with divinyl chlorophyll a A3, indicating a strong binding affinity.
The residue at position 702 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 1093 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1095 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1173 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1278 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1281 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1305 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1308 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 120 to 122 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 128 to 133 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 64 to 91 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 838 to 846 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 139 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 148 to 149 forms a bond with (S)-2,3,4,5-tetrahydrodipicolinate, indicating a strong binding affinity.
The residue at position 267 to 270 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 19 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 135 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 184 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 276 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 963 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1157 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1211 to 1212 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 234 to 238 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 361 to 362 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 410 to 413 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 417 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 436 to 439 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 512 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 127 to 131 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 132 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 467 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 468 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 492 to 497 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 492 to 493 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 445 to 453 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 112 to 119 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 108 to 114 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 181 to 185 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 461 to 465 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 68 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with Cu(+) 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 156 forms a bond with Cu(+) 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 270 forms a bond with Cu(+) 3, indicating a strong binding affinity.
The residue at position 492 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 495 forms a bond with Cu(+) 4, indicating a strong binding affinity.
The residue at position 568 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 571 forms a bond with Cu(+) 5, indicating a strong binding affinity.
The residue at position 1255 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 14 to 43 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 75 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 85 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 87 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 89 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 114 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 117 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 139 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 195 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 197 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 206 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 207 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 207 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 244 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 283 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 285 forms a bond with (R)-methylmalonyl-CoA, indicating a strong binding affinity.
The residue at position 333 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 370 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 609 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 610 forms a bond with Co of cob(II)alamin, indicating a strong binding affinity.
The residue at position 611 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 655 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 657 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 686 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 709 forms a bond with cob(II)alamin, indicating a strong binding affinity.
The residue at position 239 to 245 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 1040 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 275 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 316 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 453 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 456 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 185 to 189 forms a bond with tetradecanoyl-CoA, indicating a strong binding affinity.
The residue at position 267 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 337 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 416 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 418 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 491 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 145 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 289 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 125 to 130 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 65 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 67 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1233 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1235 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1236 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1238 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1241 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1193 to 1250 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 1246 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1252 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 88 to 93 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 115 to 116 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 536 to 538 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 291 to 292 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 297 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 89 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 89 forms a bond with nitrite, indicating a strong binding affinity.
The residue at position 175 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 263 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 263 forms a bond with nitrite, indicating a strong binding affinity.
The residue at position 411 forms a bond with nitrate, indicating a strong binding affinity.
The residue at position 233 to 237 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 471 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 480 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 481 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 559 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 624 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 27 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 44 to 48 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 65 to 66 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 305 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 433 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 482 to 488 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 560 to 562 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 245 to 372 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 444 to 581 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 570 to 692 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 406 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 53 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 106 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 112 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 143 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 231 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 238 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 244 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 313 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 327 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 331 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 372 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 10 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 12 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 232 to 233 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 82 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 95 forms a bond with citrate, indicating a strong binding affinity.
The residue at position 274 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 427 to 430 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 177 to 178 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 217 to 220 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 220 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 228 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 314 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 409 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 409 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 409 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 413 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 413 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 424 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 424 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 466 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 499 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 499 forms a bond with (R)-lactate, indicating a strong binding affinity.
The residue at position 499 forms a bond with (R)-malate, indicating a strong binding affinity.
The residue at position 19 to 20 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 506 to 507 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 483 to 485 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 10 to 18 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 138 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 138 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 175 to 178 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 647 to 654 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 674 to 782 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 280 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 376 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 412 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 550 to 551 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 324 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 326 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 426 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 132 forms a bond with tetradecanoate, indicating a strong binding affinity.
The residue at position 179 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with (6S)-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 67 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 114 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 146 to 149 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 186 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 218 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 248 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 326 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 327 forms a bond with N(6)-methyl-AMP, indicating a strong binding affinity.
The residue at position 22 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 25 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 516 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 735 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 765 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 872 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 874 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 319 to 321 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 429 to 431 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 111 forms a bond with 4-O-phospho-L-tyrosine, indicating a strong binding affinity.
The residue at position 682 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 729 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 854 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 474 to 559 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 446 to 447 forms a bond with a 2'-deoxyribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 631 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 206 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 213 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 477 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 509 forms a bond with Na(+) 2, indicating a strong binding affinity.
The residue at position 574 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 577 forms a bond with Na(+) 1, indicating a strong binding affinity.
The residue at position 129 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 285 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with a purine D-ribonucleoside, indicating a strong binding affinity.
The residue at position 143 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 235 to 237 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 266 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 295 to 296 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 318 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 189 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 236 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 550 to 667 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 16 to 20 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 61 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 317 forms a bond with 6-hydroxy-FAD, indicating a strong binding affinity.
The residue at position 1172 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 105 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 323 to 334 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 410 to 415 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 472 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 621 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 622 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 273 to 276 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with Mg of a bacteriochlorophyll d, indicating a strong binding affinity.
The residue at position 304 to 307 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 323 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 25 to 49 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 96 to 101 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 250 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 261 to 267 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 80 to 82 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 119 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 313 to 314 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 23 to 26 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 192 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 212 forms a bond with levoglucosan, indicating a strong binding affinity.
The residue at position 221 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 328 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 362 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 666 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 693 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 176 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 205 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 362 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 366 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 506 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 514 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 149 to 174 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 320 to 327 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 387 to 391 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 forms a bond with (1,3-beta-D-glucosyl)n 2, indicating a strong binding affinity.
The residue at position 298 forms a bond with (1,3-beta-D-glucosyl)n 1, indicating a strong binding affinity.
The residue at position 147 forms a bond with heme, indicating a strong binding affinity.
The residue at position 435 to 440 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 711 to 714 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 158 to 163 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 188 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 208 to 209 forms a bond with sn-glycerol 1-phosphate, indicating a strong binding affinity.
The residue at position 518 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 89 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 228 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 230 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 240 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 11 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 121 to 127 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 67 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 179 to 226 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 219 to 228 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 332 to 379 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 123 to 128 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 374 to 380 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 785 to 792 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 617 to 625 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 131 to 144 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 167 to 176 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 225 to 236 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 811 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 813 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 891 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 998 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1025 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 424 to 428 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 365 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 365 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 145 to 152 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 194 forms a bond with (1,3-beta-D-glucosyl)n, indicating a strong binding affinity.
The residue at position 323 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 324 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 409 forms a bond with UDP-N-acetyl-alpha-D-mannosaminouronate, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 168 to 171 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 235 to 242 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 108 to 113 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 361 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 424 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 717 to 724 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 to 272 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 41 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 89 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 283 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 293 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 309 to 312 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 328 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 346 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 167 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 677 to 680 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 694 to 698 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 711 to 713 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 764 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 314 to 319 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 381 to 384 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 388 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 483 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 5 to 27 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 to 47 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 25 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 67 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 165 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 186 to 197 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 300 forms a bond with 1D-myo-inositol 1,3,4-trisphosphate, indicating a strong binding affinity.
The residue at position 650 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 702 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 712 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 615 to 623 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 628 to 635 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 519 to 521 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 578 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 601 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 648 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 765 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 776 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 793 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 313 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 441 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 441 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 467 to 468 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 527 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 328 to 332 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 424 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 352 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 373 forms a bond with homogentisate, indicating a strong binding affinity.
The residue at position 25 to 27 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 14 forms a bond with Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 537 to 541 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 591 to 594 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 914 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 243 to 250 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 364 to 367 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 137 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1802 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 1804 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 60 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 84 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 230 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 264 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 305 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 60 to 61 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 129 forms a bond with 3-methyl-2-oxobutanoate, indicating a strong binding affinity.
The residue at position 422 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 425 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 438 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 447 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 75 to 77 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 209 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 41 to 44 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 149 to 153 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 807 to 809 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 884 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 981 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 149 to 172 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 615 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 621 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 624 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 644 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 647 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 650 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 654 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1706 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1811 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1814 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 318 forms a bond with D-glucose 6-phosphate, indicating a strong binding affinity.
The residue at position 379 to 387 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 383 to 387 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 287 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 328 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 467 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 470 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 58 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with L-phenylalanine, indicating a strong binding affinity.
The residue at position 190 to 193 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 504 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 310 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 322 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 379 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 418 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 590 forms a bond with L-isoleucyl-5'-AMP, indicating a strong binding affinity.
The residue at position 1210 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1210 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1211 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1374 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1413 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 899 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1023 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 1051 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 1052 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 63 to 64 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 242 to 244 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 322 to 328 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 326 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 150 to 206 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 61 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 178 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 214 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 249 to 251 forms a bond with (7,8-dihydropterin-6-yl)methyl diphosphate, indicating a strong binding affinity.
The residue at position 480 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 34 to 40 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 60 to 76 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 332 to 333 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 350 to 356 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 420 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 92 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 353 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 391 forms a bond with jasmonate, indicating a strong binding affinity.
The residue at position 280 forms a bond with N(2)-acetyl-L-ornithine, indicating a strong binding affinity.
The residue at position 26 to 27 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 229 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 527 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 789 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 827 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 1014 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1088 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1092 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1125 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 385 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 387 to 388 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 418 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 100 to 108 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 to 138 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 897 to 904 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1040 to 1047 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 25 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 54 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 79 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 85 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 86 forms a bond with hydrogencarbonate 1, indicating a strong binding affinity.
The residue at position 152 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 208 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 344 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 379 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 408 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 411 forms a bond with hydrogencarbonate 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 158 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 281 to 283 forms a bond with uracil, indicating a strong binding affinity.
The residue at position 282 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 216 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 265 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 369 forms a bond with L-thyroxine, indicating a strong binding affinity.
The residue at position 87 to 90 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 103 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 to 87 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 335 to 338 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 358 forms a bond with chitin, indicating a strong binding affinity.
The residue at position 156 to 158 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 274 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 150 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 152 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 242 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 245 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 729 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 768 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 773 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 786 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 792 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 816 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 821 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 834 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 840 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 869 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 874 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 887 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 599 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 608 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 627 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 629 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 638 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 305 forms a bond with ssDNA, indicating a strong binding affinity.
The residue at position 220 to 232 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 66 to 68 forms a bond with glycerol 1, indicating a strong binding affinity.
The residue at position 138 forms a bond with glycerol 2, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with glycerol 3, indicating a strong binding affinity.
The residue at position 203 forms a bond with glycerol 1, indicating a strong binding affinity.
The residue at position 206 forms a bond with glycerol 3, indicating a strong binding affinity.
The residue at position 693 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 740 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 865 forms a bond with 17beta-hydroxy-5alpha-androstan-3-one, indicating a strong binding affinity.
The residue at position 865 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 196 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 563 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 352 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with heme, indicating a strong binding affinity.
The residue at position 420 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 456 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 460 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 465 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 544 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 606 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 236 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 174 to 180 forms a bond with nicotinate beta-D-ribonucleotide, indicating a strong binding affinity.
The residue at position 203 forms a bond with nicotinate beta-D-ribonucleotide, indicating a strong binding affinity.
The residue at position 265 forms a bond with nicotinate beta-D-ribonucleotide, indicating a strong binding affinity.
The residue at position 291 forms a bond with nicotinate beta-D-ribonucleotide, indicating a strong binding affinity.
The residue at position 314 to 315 forms a bond with nicotinate beta-D-ribonucleotide, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with malonyl-CoA, indicating a strong binding affinity.
The residue at position 275 to 285 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 271 forms a bond with platencin, indicating a strong binding affinity.
The residue at position 271 forms a bond with platensimycin, indicating a strong binding affinity.
The residue at position 304 forms a bond with platensimycin, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with platencin, indicating a strong binding affinity.
The residue at position 308 to 310 forms a bond with platensimycin, indicating a strong binding affinity.
The residue at position 341 forms a bond with platencin, indicating a strong binding affinity.
The residue at position 341 forms a bond with platensimycin, indicating a strong binding affinity.
The residue at position 206 to 210 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 95 to 100 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 892 to 899 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 152 to 159 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 344 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 490 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 82 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 91 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 127 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 447 to 449 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 447 to 449 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 500 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 500 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 531 to 532 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 577 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 615 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 615 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 621 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 312 to 319 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 415 to 419 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 37 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 48 to 53 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 51 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 106 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 138 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 182 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 259 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 158 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 162 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 189 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 218 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 224 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 362 to 363 forms a bond with UDP-N-acetyl-alpha-D-galactosamine, indicating a strong binding affinity.
The residue at position 442 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 470 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 518 to 521 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 522 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 582 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 604 to 605 forms a bond with UDP-alpha-D-glucuronate, indicating a strong binding affinity.
The residue at position 632 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 195 to 196 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 200 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 287 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 258 to 265 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 406 to 409 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 671 to 677 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 297 to 298 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 462 to 559 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 181 to 184 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 33 to 39 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 135 to 142 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 256 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 402 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 420 to 424 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 432 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 462 to 464 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 6 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 210 to 214 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 235 to 241 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 230 to 234 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 448 to 450 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 448 to 450 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 501 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 501 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 532 to 533 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 578 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 616 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 616 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 622 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 197 to 203 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 114 to 117 forms a bond with GTP 1, indicating a strong binding affinity.
The residue at position 465 to 469 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 534 to 537 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 108 to 110 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 261 to 267 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 253 to 254 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 368 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 402 to 404 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 404 forms a bond with chorismate, indicating a strong binding affinity.
The residue at position 305 to 307 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 359 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 423 to 426 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 471 forms a bond with L-serine, indicating a strong binding affinity.
The residue at position 454 to 462 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 371 to 378 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 417 to 421 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 486 to 489 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 509 to 511 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 542 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1084 to 1222 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 1144 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 1156 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 328 to 330 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 345 to 353 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 367 to 370 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 117 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 429 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 431 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 56 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 298 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 322 to 328 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 324 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 559 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 585 to 586 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 607 to 608 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 29 to 32 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 78 to 79 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 160 to 162 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 312 to 313 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 317 to 318 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 324 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 138 to 148 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 1728 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1734 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1739 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 555 to 610 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 678 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 692 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 692 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1092 to 1149 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1228 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1228 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 1230 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 1486 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1486 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1488 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1490 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1520 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1571 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1571 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1628 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1629 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1652 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1676 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1701 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 1701 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1705 forms a bond with N-carbamoyl-L-aspartate, indicating a strong binding affinity.
The residue at position 696 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 819 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 822 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 835 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 868 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 884 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 887 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 892 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 910 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 919 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 32 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 85 to 87 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 254 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 254 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 295 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 463 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 463 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 466 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 466 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 4 to 7 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 295 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 374 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 259 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 303 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 48 to 49 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 196 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 286 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 324 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 100 to 103 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 120 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 191 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 424 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 29 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 51 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with Mg of chlorophyll a 1, indicating a strong binding affinity.
The residue at position 73 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 108 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 118 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 124 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 128 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 144 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 147 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 153 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 185 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 188 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 190 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 202 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 217 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 226 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 233 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 163 to 169 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 66 to 69 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 92 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 331 to 338 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 243 to 255 forms a bond with geranylgeranyl diphosphate, indicating a strong binding affinity.
The residue at position 719 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 766 forms a bond with N(7)-methylguanosine, indicating a strong binding affinity.
The residue at position 64 to 67 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 139 to 152 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 172 to 174 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with NAD(+) 1, indicating a strong binding affinity.
The residue at position 254 to 256 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 289 to 292 forms a bond with NAD(+) 2, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 346 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 323 to 325 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 209 to 210 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 369 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 85 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 276 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 288 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 289 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 387 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 432 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 435 forms a bond with fumarate, indicating a strong binding affinity.
The residue at position 360 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 392 to 395 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 7 to 9 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 381 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5-trisphosphate), indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 93 to 98 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 313 to 315 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 382 to 391 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 88 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 114 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 149 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 260 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 409 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 502 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 1 to 10 forms a bond with 1,2-diacylglycero-3-phosphoethanolamine, indicating a strong binding affinity.
The residue at position 325 to 335 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 294 to 298 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 357 to 360 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 407 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 480 to 485 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 767 to 775 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 63 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 232 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 417 forms a bond with sulfate, indicating a strong binding affinity.
The residue at position 51 to 59 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 442 to 447 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 620 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 496 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 111 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 113 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 120 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 177 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 525 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 569 forms a bond with brassinolide, indicating a strong binding affinity.
The residue at position 881 to 883 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 887 to 890 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 933 to 938 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 951 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 330 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 224 to 225 forms a bond with 3-amino-2-oxopropyl phosphate, indicating a strong binding affinity.
The residue at position 6 to 23 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 177 to 182 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 587 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 634 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 99 forms a bond with brevianamide F, indicating a strong binding affinity.
The residue at position 340 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 1301 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1305 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 30 forms a bond with bongkrekate, indicating a strong binding affinity.
The residue at position 62 forms a bond with a cardiolipin, indicating a strong binding affinity.
The residue at position 81 to 83 forms a bond with a cardiolipin, indicating a strong binding affinity.
The residue at position 88 to 89 forms a bond with bongkrekate, indicating a strong binding affinity.
The residue at position 88 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 96 forms a bond with bongkrekate, indicating a strong binding affinity.
The residue at position 166 forms a bond with a cardiolipin, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with a cardiolipin, indicating a strong binding affinity.
The residue at position 196 to 197 forms a bond with bongkrekate, indicating a strong binding affinity.
The residue at position 245 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 260 to 261 forms a bond with a cardiolipin, indicating a strong binding affinity.
The residue at position 280 to 282 forms a bond with a cardiolipin, indicating a strong binding affinity.
The residue at position 234 to 238 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 424 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 427 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 463 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 467 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 472 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 473 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 550 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 551 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 589 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 164 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 166 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 254 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 178 to 183 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 112 forms a bond with nicotinamide, indicating a strong binding affinity.
The residue at position 620 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 623 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 642 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 645 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 650 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 653 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 672 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 186 to 187 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 208 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 323 forms a bond with carboxy-S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 64 to 69 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 96 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 114 to 115 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 164 to 169 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 209 to 213 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 111 to 116 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 to 86 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 47 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 48 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 115 forms a bond with Hg(2+), indicating a strong binding affinity.
The residue at position 431 to 438 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 513 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 610 to 621 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1067 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1108 to 1114 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1152 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 474 to 476 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 106 to 111 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 199 to 208 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 482 to 485 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 500 to 502 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 516 to 519 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 624 to 625 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 630 to 634 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 666 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 165 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 475 to 478 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 498 to 500 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 531 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 698 to 857 forms a bond with a nucleoside 3',5'-cyclic phosphate 1, indicating a strong binding affinity.
The residue at position 1105 to 1218 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 1182 to 1303 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 134 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 154 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 179 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 183 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 283 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 294 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 297 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 298 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 378 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 381 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 382 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 581 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 592 to 593 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 43 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 871 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 269 to 276 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 171 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 102 to 103 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 226 to 232 forms a bond with UDP, indicating a strong binding affinity.
The residue at position 686 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 748 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 749 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 893 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 936 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 961 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1175 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1236 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 100 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 395 to 396 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 57 forms a bond with ADP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 101 to 108 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 133 to 141 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate), indicating a strong binding affinity.
The residue at position 578 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 659 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 660 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 682 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 181 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 191 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 223 to 226 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 301 to 305 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 308 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 324 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 393 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 955 to 962 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 to 133 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 287 to 295 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 338 to 341 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 48 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 53 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 58 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 69 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 74 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 75 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 93 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 102 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 105 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 106 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 123 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 234 to 239 forms a bond with strychnine, indicating a strong binding affinity.
The residue at position 68 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 69 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 82 forms a bond with (6R)-L-erythro-5,6,7,8-tetrahydrobiopterin, indicating a strong binding affinity.
The residue at position 360 to 363 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 448 to 450 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 58 to 61 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 456 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 263 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 539 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 581 to 584 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 86 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 111 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 115 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 259 forms a bond with 7alpha,25-dihydroxycholesterol, indicating a strong binding affinity.
The residue at position 14 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 43 to 44 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 6 to 12 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 42 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 249 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 50 to 52 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 162 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 325 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 240 to 244 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 259 to 261 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 38 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 42 to 46 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 114 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 289 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 325 to 327 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 74 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 162 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 823 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 53 to 55 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 144 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 234 to 236 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 357 to 361 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 408 to 410 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 271 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 62 to 87 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 174 to 178 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 233 to 240 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 183 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 269 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 335 to 341 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 64 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 114 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 121 to 122 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 278 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 112 to 125 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 148 to 157 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 214 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 244 to 245 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 522 to 526 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 650 to 655 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 722 to 725 forms a bond with Mo-molybdopterin cytosine dinucleotide, indicating a strong binding affinity.
The residue at position 234 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 205 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 261 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 640 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 672 to 675 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 57 forms a bond with Fe of Fe-coproporphyrin III, indicating a strong binding affinity.
The residue at position 187 forms a bond with (2R,3E)-phycocyanobilin, indicating a strong binding affinity.
The residue at position 241 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 271 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 315 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 349 to 350 forms a bond with S-methyl-5'-thioadenosine, indicating a strong binding affinity.
The residue at position 213 to 276 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 238 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 266 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 295 to 297 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 503 to 504 forms a bond with UDP-alpha-D-xylose, indicating a strong binding affinity.
The residue at position 39 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 126 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 176 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 370 forms a bond with L-asparagine, indicating a strong binding affinity.
The residue at position 507 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 525 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1399 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1402 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1410 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1411 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1417 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1421 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1429 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1433 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 32 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 40 to 42 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 92 to 95 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 225 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 274 forms a bond with 3,3',5-triiodo-L-thyronine, indicating a strong binding affinity.
The residue at position 6 to 20 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 378 to 388 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 516 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 518 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 525 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 574 to 581 forms a bond with heparin, indicating a strong binding affinity.
The residue at position 680 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 3 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 125 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 325 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 365 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 931 to 937 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 976 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 252 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 312 to 318 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 316 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 318 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 426 to 428 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 301 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 482 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 486 to 488 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 267 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 26 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 233 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 237 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 110 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 110 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 112 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 154 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 154 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 40 forms a bond with 5-(2-hydroxyethyl)-4-methylthiazole, indicating a strong binding affinity.
The residue at position 191 forms a bond with 5-(2-hydroxyethyl)-4-methylthiazole, indicating a strong binding affinity.
The residue at position 303 to 307 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 335 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 374 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 403 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 431 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 451 to 452 forms a bond with 2-[(2R,5Z)-2-carboxy-4-methylthiazol-5(2H)-ylidene]ethyl phosphate, indicating a strong binding affinity.
The residue at position 170 to 173 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 146 to 154 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 220 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 342 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 346 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 372 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 451 to 453 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 475 to 476 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 657 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 660 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 674 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 690 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1151 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1155 to 1156 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1173 to 1174 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1195 to 1196 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1196 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1584 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 161 to 164 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 199 to 201 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 207 to 212 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 245 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 209 to 216 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 260 to 272 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 159 to 182 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 255 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 595 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 598 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 602 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 621 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 627 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 631 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 94 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 128 to 130 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 152 to 154 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 157 to 158 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with 5-amino-6-(D-ribitylamino)uracil, indicating a strong binding affinity.
The residue at position 199 forms a bond with (2S)-2-hydroxy-3-oxobutyl phosphate, indicating a strong binding affinity.
The residue at position 565 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 290 to 294 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 116 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 133 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 136 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 160 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 166 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 253 forms a bond with N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose, indicating a strong binding affinity.
The residue at position 106 to 117 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 244 forms a bond with shikimate, indicating a strong binding affinity.
The residue at position 201 to 205 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 226 to 227 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 20 to 29 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 40 to 44 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 66 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 211 to 215 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 432 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 435 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 174 to 176 forms a bond with 3-phosphoshikimate, indicating a strong binding affinity.
The residue at position 94 to 95 forms a bond with a 3'-terminal ribonucleotide 3'-phosphate residue of RNA, indicating a strong binding affinity.
The residue at position 65 to 84 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 280 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 306 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 389 to 391 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 411 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 510 to 512 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 535 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 640 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 344 to 350 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 194 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 65 forms a bond with 7,8-didemethyl-8-hydroxy-5-deazariboflavin, indicating a strong binding affinity.
The residue at position 138 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 179 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 235 forms a bond with nicotinate, indicating a strong binding affinity.
The residue at position 240 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 272 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 293 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 377 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 456 to 458 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 480 to 481 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 897 to 905 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 15 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 121 forms a bond with Fe of heme b 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with Fe of heme b 1, indicating a strong binding affinity.
The residue at position 814 to 816 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 867 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 892 to 895 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 909 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 943 to 947 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 973 to 976 forms a bond with N(1)-(5-phospho-beta-D-ribosyl)glycinamide, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 105 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 440 to 443 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 134 to 251 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 199 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 252 to 378 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 323 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 332 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 176 forms a bond with heme, indicating a strong binding affinity.
The residue at position 178 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 212 forms a bond with heme, indicating a strong binding affinity.
The residue at position 365 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 468 forms a bond with L-threonine, indicating a strong binding affinity.
The residue at position 485 to 486 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 147 forms a bond with UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamate, indicating a strong binding affinity.
The residue at position 374 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 398 to 401 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 449 forms a bond with meso-2,6-diaminoheptanedioate, indicating a strong binding affinity.
The residue at position 650 to 651 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 696 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 704 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 55 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 194 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 242 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 331 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 432 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 44 to 46 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 78 forms a bond with 3-dehydroquinate, indicating a strong binding affinity.
The residue at position 28 to 34 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 57 to 59 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 245 to 249 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 301 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 to 175 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 187 to 193 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 198 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 241 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with dUTP, indicating a strong binding affinity.
The residue at position 291 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 357 forms a bond with phytochromobilin, indicating a strong binding affinity.
The residue at position 817 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 167 to 178 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 256 to 260 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 187 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 192 forms a bond with a ubiquinone, indicating a strong binding affinity.
The residue at position 159 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 285 to 291 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 500 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 182 to 187 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 247 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 320 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 262 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 322 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 357 forms a bond with alpha-maltose 1-phosphate, indicating a strong binding affinity.
The residue at position 219 to 221 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 226 to 232 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 351 to 352 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 895 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 939 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 962 to 963 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 370 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 475 to 477 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 326 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 335 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 350 to 355 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 121 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 184 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 184 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 220 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 280 forms a bond with (6S)-5-methyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 293 to 300 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 921 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 924 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 424 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 493 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 503 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 430 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 464 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 891 to 896 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1118 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 268 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 82 to 86 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 154 to 160 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 183 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 52 to 76 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 166 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 187 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 216 forms a bond with adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 580 to 582 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 611 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 658 to 659 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 126 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 743 forms a bond with beta-D-fructose 2,6-bisphosphate, indicating a strong binding affinity.
The residue at position 14 to 150 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 54 to 60 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 269 forms a bond with beta-D-fructose 6-phosphate, indicating a strong binding affinity.
The residue at position 367 to 368 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 447 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 308 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 320 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 416 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with urate, indicating a strong binding affinity.
The residue at position 87 forms a bond with urate, indicating a strong binding affinity.
The residue at position 214 forms a bond with urate, indicating a strong binding affinity.
The residue at position 231 forms a bond with urate, indicating a strong binding affinity.
The residue at position 279 forms a bond with urate, indicating a strong binding affinity.
The residue at position 280 forms a bond with urate, indicating a strong binding affinity.
The residue at position 306 forms a bond with urate, indicating a strong binding affinity.
The residue at position 263 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 274 forms a bond with peptidoglycan, indicating a strong binding affinity.
The residue at position 172 to 173 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 9 to 13 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 89 to 120 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 229 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 236 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 109 to 117 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 193 to 194 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 198 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 221 to 225 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 1078 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1084 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 135 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 237 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 260 forms a bond with L-alanine, indicating a strong binding affinity.
The residue at position 1358 to 1365 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 355 to 356 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 374 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 75 to 80 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 290 to 292 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 91 to 147 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 580 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 618 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 841 to 848 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 97 to 100 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 140 to 147 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 267 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 413 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 431 to 435 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 443 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 473 to 475 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 549 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 669 to 672 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 686 to 690 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 700 to 702 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 753 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 837 to 846 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 296 forms a bond with 5-aminolevulinate 1, indicating a strong binding affinity.
The residue at position 365 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 404 forms a bond with 5-aminolevulinate 2, indicating a strong binding affinity.
The residue at position 675 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 683 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 191 to 197 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 469 to 470 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 163 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 288 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 360 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 196 to 202 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 241 to 245 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 260 to 269 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with (6S)-NADPHX, indicating a strong binding affinity.
The residue at position 1015 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1018 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1020 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 155 to 156 forms a bond with mRNA cap of mRNA, indicating a strong binding affinity.
The residue at position 40 to 69 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 to 211 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 241 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 291 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 298 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 341 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 341 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 259 forms a bond with coenzyme B, indicating a strong binding affinity.
The residue at position 537 to 545 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 83 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 84 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 249 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 272 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 278 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 285 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 294 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 281 to 282 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 303 to 305 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 379 to 382 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 386 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 389 forms a bond with 4-CDP-2-C-methyl-D-erythritol 2-phosphate, indicating a strong binding affinity.
The residue at position 553 to 556 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 614 to 616 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 188 to 190 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 271 to 273 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 540 to 543 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 155 to 163 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 99 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 100 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 1629 to 1636 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 49 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 61 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 67 forms a bond with a menaquinol, indicating a strong binding affinity.
The residue at position 82 forms a bond with a menaquinol, indicating a strong binding affinity.
The residue at position 89 forms a bond with a menaquinol, indicating a strong binding affinity.
The residue at position 89 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 119 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 120 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 136 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 139 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 140 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 409 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 630 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 770 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 778 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 50 to 51 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 298 to 302 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 326 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 93 to 95 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 137 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 165 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 183 to 185 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 215 to 216 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 243 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 446 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 816 to 824 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 470 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 513 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 558 to 561 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 217 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 221 to 222 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 257 to 258 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 79 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 201 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 467 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 175 to 176 forms a bond with coenzyme F420-(gamma-Glu)n, indicating a strong binding affinity.
The residue at position 23 forms a bond with pyridoxal, indicating a strong binding affinity.
The residue at position 58 forms a bond with pyridoxal, indicating a strong binding affinity.
The residue at position 58 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 124 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 155 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 193 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 188 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 28 to 60 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 267 forms a bond with pyruvate, indicating a strong binding affinity.
The residue at position 161 to 212 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 forms a bond with urate, indicating a strong binding affinity.
The residue at position 258 forms a bond with urate, indicating a strong binding affinity.
The residue at position 54 forms a bond with Mg of chlorophyll b 1, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mg of chlorophyll a 2, indicating a strong binding affinity.
The residue at position 133 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 143 forms a bond with chlorophyll a 3, indicating a strong binding affinity.
The residue at position 149 forms a bond with Mg of chlorophyll b 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with chlorophyll b 3, indicating a strong binding affinity.
The residue at position 161 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 178 forms a bond with chlorophyll b 2, indicating a strong binding affinity.
The residue at position 209 forms a bond with chlorophyll a 5, indicating a strong binding affinity.
The residue at position 210 forms a bond with Mg of chlorophyll a 3, indicating a strong binding affinity.
The residue at position 213 forms a bond with Mg of chlorophyll a 4, indicating a strong binding affinity.
The residue at position 215 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 227 forms a bond with Mg of chlorophyll a 5, indicating a strong binding affinity.
The residue at position 242 forms a bond with Mg of chlorophyll a 6, indicating a strong binding affinity.
The residue at position 251 forms a bond with chlorophyll a 6, indicating a strong binding affinity.
The residue at position 258 forms a bond with chlorophyll b 5, indicating a strong binding affinity.
The residue at position 102 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 105 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 106 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 107 forms a bond with Co(3+), indicating a strong binding affinity.
The residue at position 82 to 84 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 550 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 613 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 432 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 556 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 557 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 558 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 644 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 645 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 692 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 226 to 235 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 210 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 318 to 322 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 501 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 593 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 593 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 630 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 655 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 707 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 1028 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1090 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1092 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1442 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1448 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1497 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1499 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 1764 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1767 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 1770 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 299 forms a bond with acarbose, indicating a strong binding affinity.
The residue at position 417 forms a bond with acarbose, indicating a strong binding affinity.
The residue at position 463 forms a bond with acarbose, indicating a strong binding affinity.
The residue at position 480 forms a bond with acarbose, indicating a strong binding affinity.
The residue at position 540 forms a bond with acarbose, indicating a strong binding affinity.
The residue at position 569 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 939 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 942 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 518 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 276 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 277 forms a bond with Mo of Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 93 to 96 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 90 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 157 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 186 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 219 to 226 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 250 to 254 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 269 to 271 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 383 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 489 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 515 to 516 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 538 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 565 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 729 to 738 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 813 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 830 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 164 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 333 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 337 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 227 to 229 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 805 to 813 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 827 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 789 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 791 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 810 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 812 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 861 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 398 to 401 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 441 to 442 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 483 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 540 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 553 to 555 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 192 to 200 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 269 forms a bond with Fe(3+) 1, indicating a strong binding affinity.
The residue at position 450 forms a bond with Fe(3+) 2, indicating a strong binding affinity.
The residue at position 119 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 148 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 151 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 189 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 228 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 231 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 232 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 294 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 301 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 304 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 305 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 319 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 15 to 18 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 252 to 258 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 353 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 389 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 526 to 531 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 442 to 471 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 70 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 109 to 110 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 397 to 399 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 432 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 480 to 481 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 505 forms a bond with 1D-myo-inositol hexakisphosphate, indicating a strong binding affinity.
The residue at position 68 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 107 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 144 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 16 to 19 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 42 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 48 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with a ribonucleoside 5'-triphosphate, indicating a strong binding affinity.
The residue at position 125 to 126 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 568 to 573 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 to 260 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 275 forms a bond with iminosuccinate, indicating a strong binding affinity.
The residue at position 808 to 815 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 93 to 107 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1146 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1150 to 1151 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1168 to 1169 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1190 to 1191 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1578 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 1580 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 103 to 104 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 849 to 857 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 242 to 245 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 181 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 184 to 185 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 209 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 438 to 442 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 438 to 440 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 1030 to 1035 forms a bond with dsDNA, indicating a strong binding affinity.
The residue at position 301 to 302 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 18 to 22 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 2 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 4 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 50 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 397 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 63 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 66 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 67 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 363 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 366 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 371 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 78 forms a bond with 4-amino-2-methyl-5-(diphosphooxymethyl)pyrimidine, indicating a strong binding affinity.
The residue at position 708 forms a bond with Mg of chlorophyll a' A1, indicating a strong binding affinity.
The residue at position 716 forms a bond with Mg of chlorophyll a A3, indicating a strong binding affinity.
The residue at position 724 forms a bond with chlorophyll a A3, indicating a strong binding affinity.
The residue at position 725 forms a bond with phylloquinone A, indicating a strong binding affinity.
The residue at position 495 forms a bond with (R)-2-hydroxyglutarate, indicating a strong binding affinity.
The residue at position 665 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 668 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 671 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 26 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 152 forms a bond with a 1,2-diacyl-sn-glycero-3-phosphate, indicating a strong binding affinity.
The residue at position 321 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 822 to 829 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 36 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 42 to 43 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 47 to 52 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 50 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 105 forms a bond with 1D-myo-inositol 3-phosphate, indicating a strong binding affinity.
The residue at position 24 to 27 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 372 to 373 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 8 to 10 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 132 to 138 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 194 to 202 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 449 to 452 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 483 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 996 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 55 to 59 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 86 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 139 to 141 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 234 to 237 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 265 forms a bond with (2R)-3-phosphoglycerate, indicating a strong binding affinity.
The residue at position 13 to 15 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 60 to 62 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 112 to 114 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 248 to 254 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 271 to 272 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 386 to 387 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 271 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 280 forms a bond with D-xylobiose, indicating a strong binding affinity.
The residue at position 280 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with D-xylobiose, indicating a strong binding affinity.
The residue at position 337 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 364 forms a bond with D-xylobiose, indicating a strong binding affinity.
The residue at position 364 forms a bond with D-xylotriose 1, indicating a strong binding affinity.
The residue at position 417 forms a bond with D-xylotriose 2, indicating a strong binding affinity.
The residue at position 474 forms a bond with D-xylotriose 2, indicating a strong binding affinity.
The residue at position 501 forms a bond with D-xylotriose 2, indicating a strong binding affinity.
The residue at position 1347 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1370 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1373 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1404 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1409 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 21 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 28 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 35 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 36 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 37 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 41 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 92 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 94 forms a bond with 3',3'-c-di-AMP, indicating a strong binding affinity.
The residue at position 19 to 22 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 90 to 91 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 95 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 130 to 139 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 175 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 924 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 13 forms a bond with N-methylmesoporphyrin, indicating a strong binding affinity.
The residue at position 31 to 33 forms a bond with N-methylmesoporphyrin, indicating a strong binding affinity.
The residue at position 183 forms a bond with N-methylmesoporphyrin, indicating a strong binding affinity.
The residue at position 188 forms a bond with N-methylmesoporphyrin, indicating a strong binding affinity.
The residue at position 342 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 467 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 469 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 2 to 5 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 103 to 106 forms a bond with CDP, indicating a strong binding affinity.
The residue at position 24 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 30 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 616 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 162 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 164 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 435 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 525 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 528 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 603 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 604 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 605 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 609 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 614 forms a bond with Cu cation 5, indicating a strong binding affinity.
The residue at position 126 forms a bond with N-acetylneuraminate, indicating a strong binding affinity.
The residue at position 32 forms a bond with a metal cation, indicating a strong binding affinity.
The residue at position 84 to 86 forms a bond with acetyl-CoA 1, indicating a strong binding affinity.
The residue at position 2278 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2289 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2321 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2325 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2332 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 174 to 182 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 450 to 457 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 555 to 558 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 335 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 338 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 109 to 112 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 201 to 203 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 198 to 204 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 28 to 31 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 33 to 36 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 468 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 545 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 577 to 579 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 652 to 653 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 655 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 695 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 711 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 713 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 718 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 155 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 156 forms a bond with arsenate, indicating a strong binding affinity.
The residue at position 179 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 180 forms a bond with arsenate, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mo of Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 188 forms a bond with arsenate, indicating a strong binding affinity.
The residue at position 200 forms a bond with arsenite, indicating a strong binding affinity.
The residue at position 141 to 142 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 196 to 200 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 268 to 269 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 409 forms a bond with L-ascorbate, indicating a strong binding affinity.
The residue at position 198 forms a bond with ergotamine, indicating a strong binding affinity.
The residue at position 176 to 181 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 195 to 200 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 28 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 70 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 161 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 166 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 198 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 200 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 280 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 299 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 303 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 306 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 104 forms a bond with agmatine, indicating a strong binding affinity.
The residue at position 869 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1073 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 144 to 151 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1226 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1226 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1278 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1278 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1280 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1280 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1297 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 79 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 262 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 482 forms a bond with [7Fe-Mo-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 219 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 222 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 234 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 240 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 415 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 422 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 622 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 642 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 666 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 712 forms a bond with (E)-cinnamaldehyde, indicating a strong binding affinity.
The residue at position 1048 to 1054 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), indicating a strong binding affinity.
The residue at position 161 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 175 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 261 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 276 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 189 to 193 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 252 to 255 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 302 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 378 to 389 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 69 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 73 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 116 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 155 forms a bond with ganglioside GM3 (d18:1(4E)), indicating a strong binding affinity.
The residue at position 104 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 135 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 136 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 173 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 219 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 222 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 223 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 252 to 254 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 to 262 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 216 to 221 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 544 forms a bond with Fe of siroheme, indicating a strong binding affinity.
The residue at position 1576 to 1583 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 4 to 34 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 337 to 339 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 354 to 362 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 376 to 379 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 38 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 41 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 103 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 116 to 118 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 192 to 193 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 197 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 267 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 141 to 144 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 164 to 173 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 25 forms a bond with Co of adenosylcob(III)alamin, indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 751 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 835 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 952 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1070 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 270 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 326 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 469 to 477 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 624 to 632 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 468 to 469 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 474 forms a bond with 5-methylcytosine group of DNA, indicating a strong binding affinity.
The residue at position 293 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 1682 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1791 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1794 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 200 forms a bond with Fe of heme c, indicating a strong binding affinity.
The residue at position 550 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 589 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 101 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 298 to 299 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1324 to 1331 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 163 to 173 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 118 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 211 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 214 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 215 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 288 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 298 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 299 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 313 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 329 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 405 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 73 to 76 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 130 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 204 to 333 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 282 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 291 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 336 to 453 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 401 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 410 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 650 to 716 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 782 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 782 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 794 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 794 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 796 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 96 forms a bond with thebaine, indicating a strong binding affinity.
The residue at position 127 forms a bond with thebaine, indicating a strong binding affinity.
The residue at position 509 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 202 to 210 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 46 forms a bond with ITP, indicating a strong binding affinity.
The residue at position 91 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 273 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 277 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 406 forms a bond with Fe of heme a3, indicating a strong binding affinity.
The residue at position 408 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 69 to 74 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 74 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 1 to 97 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 107 to 220 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 434 to 437 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 127 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 187 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 189 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1003 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1006 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 1008 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1048 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1049 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1050 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1054 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1059 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 392 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 704 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 715 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 737 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 350 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 378 to 381 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 401 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 456 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 396 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 122 to 127 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 457 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 123 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 127 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 263 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 1133 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1135 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1193 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1219 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1261 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1289 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1358 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1374 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1382 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1384 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1387 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1416 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1881 forms a bond with Fe cation, indicating a strong binding affinity.
The residue at position 1896 to 1898 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 1902 to 1904 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 1912 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 193 to 197 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 94 to 96 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 243 to 247 forms a bond with D-ribose 5-phosphate, indicating a strong binding affinity.
The residue at position 274 to 280 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 59 to 64 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 354 to 356 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 792 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 795 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 100 to 128 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 72 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 86 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 182 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 269 forms a bond with iron-sulfur cluster, indicating a strong binding affinity.
The residue at position 368 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 370 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 376 forms a bond with (S)-thalidomide, indicating a strong binding affinity.
The residue at position 177 to 179 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 184 to 190 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 216 to 219 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 29 to 35 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 67 to 69 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 131 to 138 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 258 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 404 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 422 to 426 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 434 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 464 to 466 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 134 to 153 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 1645 to 1652 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 849 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 897 forms a bond with Mg(2+) 1, indicating a strong binding affinity.
The residue at position 996 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 1014 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1336 to 1343 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1495 to 1502 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1548 to 1551 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1625 to 1628 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 318 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 336 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 373 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 237 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 275 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 52 to 54 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 106 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 56 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 25 forms a bond with phycourobilin 1, indicating a strong binding affinity.
The residue at position 34 forms a bond with phycourobilin 2, indicating a strong binding affinity.
The residue at position 49 forms a bond with (2R,3E)-phycoerythrobilin, indicating a strong binding affinity.
The residue at position 58 forms a bond with phycourobilin 3, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 176 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 208 to 211 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 272 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 286 to 290 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 309 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 378 forms a bond with 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonate, indicating a strong binding affinity.
The residue at position 922 to 929 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 840 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 921 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 922 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 996 to 1003 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1364 to 1371 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 540 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 545 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 564 to 565 forms a bond with (6S)-10-formyltetrahydrofolate, indicating a strong binding affinity.
The residue at position 587 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 135 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 518 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 646 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 648 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 650 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 19 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 64 to 65 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 97 to 98 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 202 forms a bond with phosphate, indicating a strong binding affinity.
The residue at position 78 to 80 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 455 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 558 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 617 to 619 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 724 to 727 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 102 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 105 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 326 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 418 to 419 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 434 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 443 forms a bond with L-arginine residue of a protein, indicating a strong binding affinity.
The residue at position 41 to 42 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 112 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 141 to 145 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 1258 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1261 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1278 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1281 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1292 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 46 to 47 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 211 to 220 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 637 to 644 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1241 to 1248 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 29 to 33 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 163 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 194 to 196 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 222 to 224 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 199 forms a bond with dimethylallyl diphosphate, indicating a strong binding affinity.
The residue at position 176 to 179 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 45 to 69 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 401 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 507 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 107 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 193 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 133 to 136 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 121 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 200 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 316 to 317 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with E64, indicating a strong binding affinity.
The residue at position 192 forms a bond with E64, indicating a strong binding affinity.
The residue at position 282 forms a bond with E64, indicating a strong binding affinity.
The residue at position 340 forms a bond with E64, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 42 to 50 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 81 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 127 to 128 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 132 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 157 to 161 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 312 to 314 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 148 to 183 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 322 to 323 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 291 to 300 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 442 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 69 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 125 to 127 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 218 to 220 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 301 to 303 forms a bond with 2-oxoglutarate, indicating a strong binding affinity.
The residue at position 120 to 124 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 142 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 146 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 165 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 425 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 425 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 554 to 566 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 601 forms a bond with (R)-carnitine, indicating a strong binding affinity.
The residue at position 568 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 570 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 439 to 443 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 463 to 467 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 17 to 20 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 252 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 26 to 37 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 184 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 237 forms a bond with [3Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 72 to 74 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 171 to 174 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 301 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 584 to 589 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 168 to 170 forms a bond with prenyl-FMN, indicating a strong binding affinity.
The residue at position 381 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 215 to 224 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 250 to 252 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 462 to 464 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 465 to 467 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 563 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 235 to 246 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 107 to 110 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 469 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 98 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 166 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 191 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 195 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 228 to 235 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 433 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 437 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 568 to 569 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 591 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 618 forms a bond with Mo-bis(molybdopterin guanine dinucleotide), indicating a strong binding affinity.
The residue at position 170 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 173 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 202 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 191 forms a bond with Fe of heme b b562, indicating a strong binding affinity.
The residue at position 204 forms a bond with Fe of heme b b566, indicating a strong binding affinity.
The residue at position 100 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 167 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 252 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 367 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 372 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 401 forms a bond with pyrroloquinoline quinone, indicating a strong binding affinity.
The residue at position 140 forms a bond with diphosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 508 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 511 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 143 to 145 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 279 to 285 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 420 to 421 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 89 to 94 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 309 to 311 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 62 to 64 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 471 to 476 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 604 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 606 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 276 to 282 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 72 to 75 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 162 to 166 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 616 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 618 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 238 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 848 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1183 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1200 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1282 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 1284 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 276 to 279 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 296 to 298 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 454 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 491 to 494 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 505 to 508 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 512 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 228 to 248 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 279 to 305 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 306 to 316 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 402 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 452 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 459 to 460 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 64 to 66 forms a bond with L-arginine, indicating a strong binding affinity.
The residue at position 1409 to 1416 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 400 to 403 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 16 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 30 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 34 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 101 forms a bond with Cd(2+), indicating a strong binding affinity.
The residue at position 636 to 643 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1253 to 1260 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 361 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 394 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 1165 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1181 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1184 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 574 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 598 to 599 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 692 to 694 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 733 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 760 to 761 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 791 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 817 to 819 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 840 to 841 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 961 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 968 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1002 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 227 to 228 forms a bond with 1-deoxy-D-xylulose 5-phosphate, indicating a strong binding affinity.
The residue at position 509 to 551 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 558 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 572 to 573 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1147 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 1156 to 1157 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 106 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 135 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 136 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 327 to 328 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 2054 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2057 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2086 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2089 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2098 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2103 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 396 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 424 to 427 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 503 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 250 to 251 forms a bond with deamido-NAD(+), indicating a strong binding affinity.
The residue at position 2161 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2190 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 2224 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2236 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 2238 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1 to 107 forms a bond with heme b, indicating a strong binding affinity.
The residue at position 64 to 68 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 115 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 173 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 237 to 241 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 276 to 279 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 304 forms a bond with L-ornithine, indicating a strong binding affinity.
The residue at position 177 to 180 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 776 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 116 to 119 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 126 to 128 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 187 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1129 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1260 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 835 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 1, indicating a strong binding affinity.
The residue at position 844 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 1, indicating a strong binding affinity.
The residue at position 933 to 937 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 1, indicating a strong binding affinity.
The residue at position 1034 to 1035 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1045 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1057 to 1060 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1145 to 1149 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1187 to 1190 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 2, indicating a strong binding affinity.
The residue at position 1246 to 1247 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 1269 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 1343 to 1347 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 1382 forms a bond with 5-O-(ADP-D-ribosyl)-L-glutamate residue of a glycoprotein 3, indicating a strong binding affinity.
The residue at position 92 forms a bond with Co(2+), indicating a strong binding affinity.
The residue at position 142 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 187 to 188 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 480 to 481 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 205 to 207 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 382 to 386 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 437 to 441 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 450 to 452 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 450 to 452 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 503 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 503 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 580 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 618 forms a bond with L-homocysteine, indicating a strong binding affinity.
The residue at position 618 forms a bond with L-methionine, indicating a strong binding affinity.
The residue at position 624 forms a bond with 5-methyltetrahydropteroyltri-L-glutamate, indicating a strong binding affinity.
The residue at position 513 to 637 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 584 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 164 to 169 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 251 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 302 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 410 to 411 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 531 to 533 forms a bond with glycine, indicating a strong binding affinity.
The residue at position 232 to 236 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 480 to 595 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 162 forms a bond with Fe(2+), indicating a strong binding affinity.
The residue at position 399 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 216 to 225 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 430 to 437 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 1234 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1237 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1242 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1245 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 34 to 36 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 48 to 50 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 243 forms a bond with Fe cation 1, indicating a strong binding affinity.
The residue at position 457 forms a bond with Cu cation, indicating a strong binding affinity.
The residue at position 606 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 482 to 483 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 52 to 61 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 72 to 76 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 98 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 117 forms a bond with an acyl-CoA, indicating a strong binding affinity.
The residue at position 123 to 130 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 58 to 60 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 92 to 94 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 129 to 132 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 373 to 376 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 407 to 410 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 503 to 504 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 509 to 513 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 203 to 207 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 533 forms a bond with chloride 1, indicating a strong binding affinity.
The residue at position 795 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 833 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 996 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1098 forms a bond with chloride 2, indicating a strong binding affinity.
The residue at position 1131 forms a bond with chloride 3, indicating a strong binding affinity.
The residue at position 347 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 377 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 385 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 463 forms a bond with chenodeoxycholate, indicating a strong binding affinity.
The residue at position 132 to 134 forms a bond with a peptide, indicating a strong binding affinity.
The residue at position 265 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 291 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 354 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 364 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 369 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 415 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 418 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 433 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 438 forms a bond with Zn(2+) 7, indicating a strong binding affinity.
The residue at position 443 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 446 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 454 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 458 forms a bond with Zn(2+) 8, indicating a strong binding affinity.
The residue at position 215 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 240 forms a bond with Na(+), indicating a strong binding affinity.
The residue at position 114 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 137 to 139 forms a bond with xyloglucan, indicating a strong binding affinity.
The residue at position 387 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 436 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 10 to 15 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 43 to 45 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 44 to 45 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 69 to 70 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 91 to 93 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 132 to 133 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 157 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 157 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 161 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 182 forms a bond with dTDP-beta-L-rhamnose, indicating a strong binding affinity.
The residue at position 89 forms a bond with heme, indicating a strong binding affinity.
The residue at position 178 forms a bond with heme, indicating a strong binding affinity.
The residue at position 375 forms a bond with heme, indicating a strong binding affinity.
The residue at position 386 forms a bond with heme, indicating a strong binding affinity.
The residue at position 1466 to 1473 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 548 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 921 to 928 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1150 to 1157 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 2184 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2188 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2188 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2208 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2210 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2211 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2217 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2217 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2218 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 2218 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 2231 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 2232 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 64 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 230 to 232 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 721 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 284 to 288 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 44 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 44 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 44 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 50 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 50 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 50 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 91 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 91 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 91 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 219 forms a bond with 21-hydroxyprogesterone, indicating a strong binding affinity.
The residue at position 219 forms a bond with aldosterone, indicating a strong binding affinity.
The residue at position 219 forms a bond with progesterone, indicating a strong binding affinity.
The residue at position 33 to 38 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 68 to 70 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 131 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 167 to 168 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 1335 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1746 to 1748 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1746 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1747 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1748 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 1772 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1782 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1791 to 1801 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1815 to 1818 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1843 to 1845 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1845 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 287 forms a bond with Ca(2+) 8, indicating a strong binding affinity.
The residue at position 35 forms a bond with a divalent metal cation 3, indicating a strong binding affinity.
The residue at position 39 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 40 forms a bond with a divalent metal cation 4, indicating a strong binding affinity.
The residue at position 40 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 42 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 43 forms a bond with a divalent metal cation 5, indicating a strong binding affinity.
The residue at position 47 forms a bond with a divalent metal cation 6, indicating a strong binding affinity.
The residue at position 25 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 28 forms a bond with heme c 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with Fe of heme c 1, indicating a strong binding affinity.
The residue at position 120 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 124 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 270 to 277 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 821 to 822 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1103 to 1106 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1218 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 1285 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 538 to 543 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 453 to 456 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 491 to 493 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 274 to 295 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 317 to 336 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 71 to 74 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 92 to 96 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 232 to 236 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 359 to 360 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 408 to 411 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 415 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 434 to 437 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 510 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 220 forms a bond with Fe(3+), indicating a strong binding affinity.
The residue at position 296 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 298 forms a bond with N-formimidoyl-L-glutamate, indicating a strong binding affinity.
The residue at position 299 forms a bond with 4-imidazolone-5-propanoate, indicating a strong binding affinity.
The residue at position 10 to 14 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 192 to 198 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 252 to 253 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 36 to 43 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 169 forms a bond with NADP(+) 1, indicating a strong binding affinity.
The residue at position 356 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 365 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 369 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 392 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 400 to 402 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 420 to 422 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 486 forms a bond with NADP(+) 2, indicating a strong binding affinity.
The residue at position 452 forms a bond with IMP, indicating a strong binding affinity.
The residue at position 418 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 418 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 291 forms a bond with cannabigerolate, indicating a strong binding affinity.
The residue at position 416 forms a bond with cannabigerolate, indicating a strong binding affinity.
The residue at position 441 forms a bond with cannabigerolate, indicating a strong binding affinity.
The residue at position 480 to 482 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 187 to 198 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 1002 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1005 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 1007 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1047 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1048 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1049 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1053 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1058 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 749 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 750 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 920 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 8 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 37 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 89 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 91 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 93 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 93 forms a bond with Mn(2+), indicating a strong binding affinity.
The residue at position 156 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 178 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 202 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 208 forms a bond with GDP-alpha-D-mannose, indicating a strong binding affinity.
The residue at position 994 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 997 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 999 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1041 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 271 to 276 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 425 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 431 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 435 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 456 to 458 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 548 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 551 to 552 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 554 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 614 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 619 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 401 to 402 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 441 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 445 to 449 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 275 to 284 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 888 to 896 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 173 forms a bond with D-hexose, indicating a strong binding affinity.
The residue at position 284 to 285 forms a bond with D-hexose, indicating a strong binding affinity.
The residue at position 408 forms a bond with D-hexose, indicating a strong binding affinity.
The residue at position 470 to 477 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 26 forms a bond with Mg of a bacteriochlorophyll c, indicating a strong binding affinity.
The residue at position 251 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 263 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 276 to 277 forms a bond with glutathione, indicating a strong binding affinity.
The residue at position 302 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 302 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 302 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 317 to 322 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 317 to 322 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 317 to 322 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 362 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with ADP 1, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with AMP 1, indicating a strong binding affinity.
The residue at position 383 to 384 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 384 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 402 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 402 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 402 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 432 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 437 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 458 to 459 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 474 to 477 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 474 to 477 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 474 to 477 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 501 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 501 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 501 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 530 to 531 forms a bond with ADP 2, indicating a strong binding affinity.
The residue at position 530 to 531 forms a bond with AMP 2, indicating a strong binding affinity.
The residue at position 530 to 531 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 530 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 546 to 549 forms a bond with AMP 3, indicating a strong binding affinity.
The residue at position 434 to 442 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 126 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 126 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 163 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 185 forms a bond with alpha-L-fucose 1, indicating a strong binding affinity.
The residue at position 185 forms a bond with beta-L-fucose 1, indicating a strong binding affinity.
The residue at position 222 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 234 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 242 forms a bond with beta-L-fucose 2, indicating a strong binding affinity.
The residue at position 282 forms a bond with beta-L-fucose 3, indicating a strong binding affinity.
The residue at position 289 forms a bond with alpha-L-fucose 2, indicating a strong binding affinity.
The residue at position 150 to 165 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 405 to 407 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 708 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 151 forms a bond with E64, indicating a strong binding affinity.
The residue at position 4 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 33 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 1349 to 1357 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1372 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 163 to 164 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 241 to 242 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 264 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 196 forms a bond with 1D-myo-inositol 2-(L-cysteinylamino)-2-deoxy-alpha-D-glucopyranoside, indicating a strong binding affinity.
The residue at position 296 to 301 forms a bond with acetyl-CoA 2, indicating a strong binding affinity.
The residue at position 86 forms a bond with 5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide, indicating a strong binding affinity.
The residue at position 458 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 513 to 514 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 519 to 523 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 594 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 86 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 90 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 110 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 111 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 122 forms a bond with a peptide antigen, indicating a strong binding affinity.
The residue at position 84 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 81 forms a bond with heme, indicating a strong binding affinity.
The residue at position 1622 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1646 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1718 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1751 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1767 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1775 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1792 to 1798 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1808 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 1814 forms a bond with Zn(2+), indicating a strong binding affinity.
The residue at position 92 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 96 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 1024 to 1031 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1625 to 1632 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 590 to 599 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 391 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 394 forms a bond with Ni(2+), indicating a strong binding affinity.
The residue at position 191 to 196 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 247 to 249 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 307 to 308 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 330 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 412 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 323 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 337 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 393 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 407 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 493 to 499 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 538 to 541 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 678 to 679 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 17 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 20 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 26 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 29 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 30 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 49 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 52 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 53 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 62 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 65 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 66 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 382 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 40 to 59 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 329 to 332 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 334 to 335 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 712 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 833 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 852 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 853 forms a bond with Mn(2+) 1, indicating a strong binding affinity.
The residue at position 340 to 347 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 83 forms a bond with [2Fe-2S] cluster 1, indicating a strong binding affinity.
The residue at position 159 forms a bond with [2Fe-2S] cluster 2, indicating a strong binding affinity.
The residue at position 285 to 292 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 121 to 129 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 270 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 366 forms a bond with (E)-cinnamate, indicating a strong binding affinity.
The residue at position 285 to 290 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 389 to 445 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 807 to 809 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 151 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 404 forms a bond with an anthocyanidin, indicating a strong binding affinity.
The residue at position 405 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 406 forms a bond with UDP-alpha-D-glucose, indicating a strong binding affinity.
The residue at position 16 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 58 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 148 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 153 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 185 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 187 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 271 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 290 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 297 forms a bond with 1D-myo-inositol 6-phosphate, indicating a strong binding affinity.
The residue at position 347 to 351 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 405 to 408 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1348 to 1356 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 125 to 186 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 11 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 51 to 52 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 83 to 84 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 109 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 186 to 192 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 162 to 211 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 572 to 577 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1135 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 144 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 144 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 149 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 149 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 220 to 223 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 220 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 245 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 245 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 92 to 100 forms a bond with 5-phospho-alpha-D-ribose 1-diphosphate, indicating a strong binding affinity.
The residue at position 96 to 100 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 96 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 96 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 138 to 139 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 139 forms a bond with guanine, indicating a strong binding affinity.
The residue at position 139 forms a bond with xanthine, indicating a strong binding affinity.
The residue at position 14 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 700 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 704 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 783 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 490 to 497 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 526 to 530 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 595 to 598 forms a bond with GTP 2, indicating a strong binding affinity.
The residue at position 334 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 343 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 322 to 436 forms a bond with a nucleoside 3',5'-cyclic phosphate, indicating a strong binding affinity.
The residue at position 484 to 611 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 600 to 727 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 64 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 149 forms a bond with (2E)-geranyl diphosphate, indicating a strong binding affinity.
The residue at position 584 to 588 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 42 to 50 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 267 to 268 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 273 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 67 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 70 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 71 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 140 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 144 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 155 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 156 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 186 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 189 forms a bond with heme 5, indicating a strong binding affinity.
The residue at position 190 forms a bond with Fe of heme 5, indicating a strong binding affinity.
The residue at position 205 forms a bond with heme 6, indicating a strong binding affinity.
The residue at position 208 forms a bond with heme 6, indicating a strong binding affinity.
The residue at position 209 forms a bond with Fe of heme 6, indicating a strong binding affinity.
The residue at position 166 forms a bond with (S)-6-hydroxynicotine, indicating a strong binding affinity.
The residue at position 311 forms a bond with (S)-6-hydroxynicotine, indicating a strong binding affinity.
The residue at position 326 forms a bond with (S)-6-hydroxynicotine, indicating a strong binding affinity.
The residue at position 371 forms a bond with (S)-6-hydroxynicotine, indicating a strong binding affinity.
The residue at position 407 forms a bond with (S)-6-hydroxynicotine, indicating a strong binding affinity.
The residue at position 160 to 161 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 160 to 191 forms a bond with FMN, indicating a strong binding affinity.
The residue at position 249 to 299 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 504 to 630 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 54 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 100 to 102 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 122 to 143 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 398 to 419 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 74 forms a bond with chlorophyll a 1, indicating a strong binding affinity.
The residue at position 155 forms a bond with Mg of chlorophyll b 3, indicating a strong binding affinity.
The residue at position 158 forms a bond with chlorophyll b 4, indicating a strong binding affinity.
The residue at position 275 to 277 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 293 to 294 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 332 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 213 forms a bond with [8Fe-9S-C-homocitryl] cluster, indicating a strong binding affinity.
The residue at position 145 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 218 to 219 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 246 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 449 forms a bond with thiamine diphosphate, indicating a strong binding affinity.
The residue at position 179 to 181 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 210 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 239 to 240 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 262 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 200 to 205 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 736 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1163 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 36 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 50 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 398 to 403 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 287 to 289 forms a bond with succinyl-CoA, indicating a strong binding affinity.
The residue at position 87 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 100 to 101 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 129 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 237 to 238 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 261 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 342 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 411 to 414 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 578 to 579 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 59 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 179 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 257 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 258 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 324 to 328 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 328 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 365 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 365 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 365 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 482 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 482 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 533 forms a bond with 3',5'-cyclic AMP, indicating a strong binding affinity.
The residue at position 175 forms a bond with D-glucose, indicating a strong binding affinity.
The residue at position 291 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 341 to 342 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 428 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 438 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 56 forms a bond with Fe of Fe(II)-heme a, indicating a strong binding affinity.
The residue at position 45 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 50 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 54 forms a bond with [4Fe-4S] cluster 4, indicating a strong binding affinity.
The residue at position 83 forms a bond with [4Fe-4S] cluster 3, indicating a strong binding affinity.
The residue at position 1150 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1150 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1156 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1204 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1206 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 1206 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1212 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 1212 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 114 to 124 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 67 to 73 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 82 to 85 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 92 to 93 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 137 to 138 forms a bond with 3',5'-cyclic AMP 1, indicating a strong binding affinity.
The residue at position 145 to 146 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 181 to 191 forms a bond with 3',5'-cyclic AMP 2, indicating a strong binding affinity.
The residue at position 525 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 145 forms a bond with (R)-lipoate, indicating a strong binding affinity.
The residue at position 113 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 118 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 163 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 168 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 22 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 24 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 26 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 28 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 30 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 382 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 383 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 411 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 438 forms a bond with a divalent metal cation 2, indicating a strong binding affinity.
The residue at position 466 forms a bond with a divalent metal cation 1, indicating a strong binding affinity.
The residue at position 111 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 165 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 104 to 105 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 212 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 256 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 282 to 284 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 291 to 297 forms a bond with spermidine, indicating a strong binding affinity.
The residue at position 310 to 311 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 207 to 211 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 69 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 171 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 216 to 217 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 359 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 486 to 487 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 495 forms a bond with a beta-D-glucoside, indicating a strong binding affinity.
The residue at position 802 to 809 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 674 to 675 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 835 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 838 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 889 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 893 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 996 to 998 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 999 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 356 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 387 to 390 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 396 to 399 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 487 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 241 forms a bond with DNA, indicating a strong binding affinity.
The residue at position 34 to 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 473 to 474 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 298 to 307 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 1264 forms a bond with Mo-molybdopterin, indicating a strong binding affinity.
The residue at position 598 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 590 forms a bond with pyridoxal 5'-phosphate, indicating a strong binding affinity.
The residue at position 749 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 765 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 59 to 62 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 91 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 117 to 118 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 178 to 183 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 532 to 676 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 592 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 604 forms a bond with 3',5'-cyclic GMP, indicating a strong binding affinity.
The residue at position 256 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 256 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 256 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 277 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 290 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 295 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 295 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 340 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 376 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 376 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 376 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 380 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 424 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 424 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 424 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 424 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 532 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 535 forms a bond with AMP, indicating a strong binding affinity.
The residue at position 535 forms a bond with CMP, indicating a strong binding affinity.
The residue at position 535 forms a bond with dTMP, indicating a strong binding affinity.
The residue at position 535 forms a bond with GMP, indicating a strong binding affinity.
The residue at position 804 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 806 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 808 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 19 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 33 to 36 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 49 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 117 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 131 to 134 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 144 to 147 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 178 to 181 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 219 to 222 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 232 to 235 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 239 forms a bond with Ca(2+) 4, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 279 to 282 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 286 forms a bond with Ca(2+) 5, indicating a strong binding affinity.
The residue at position 286 forms a bond with D-galactose, indicating a strong binding affinity.
The residue at position 140 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 323 forms a bond with an alpha-D-glucoside, indicating a strong binding affinity.
The residue at position 85 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 117 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 118 forms a bond with chloride, indicating a strong binding affinity.
The residue at position 84 to 85 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 107 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 111 to 113 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 182 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 170 to 177 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 63 forms a bond with heme, indicating a strong binding affinity.
The residue at position 827 to 829 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 846 to 847 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 902 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1021 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1042 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 1058 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1066 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 1133 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1145 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1148 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 1157 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 1177 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 376 forms a bond with Fe of heme, indicating a strong binding affinity.
The residue at position 12 to 14 forms a bond with NADH, indicating a strong binding affinity.
The residue at position 13 to 14 forms a bond with NADPH, indicating a strong binding affinity.
The residue at position 401 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 445 forms a bond with Mg(2+) 2, indicating a strong binding affinity.
The residue at position 509 to 515 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 521 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 569 forms a bond with dCTP, indicating a strong binding affinity.
The residue at position 348 to 353 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 30 to 33 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 76 to 79 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 86 to 88 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 117 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 196 to 198 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 235 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 240 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 245 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 284 forms a bond with (3S)-3-hydroxybutanoyl-CoA, indicating a strong binding affinity.
The residue at position 19 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 22 forms a bond with Zn(2+) 101, indicating a strong binding affinity.
The residue at position 35 to 42 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 85 to 89 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 110 to 117 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 205 to 212 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 208 to 218 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 336 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 415 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 417 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 490 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 577 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 772 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 295 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 296 forms a bond with isopentenyl diphosphate, indicating a strong binding affinity.
The residue at position 117 to 124 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 380 to 387 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 152 to 153 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 192 to 195 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 195 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 289 forms a bond with (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 142 forms a bond with [8Fe-7S] cluster, indicating a strong binding affinity.
The residue at position 13 to 22 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 792 to 800 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 814 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 197 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 269 to 273 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 266 to 269 forms a bond with carbamoyl phosphate, indicating a strong binding affinity.
The residue at position 149 to 151 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 155 to 158 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 59 to 73 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 59 forms a bond with abscisate, indicating a strong binding affinity.
The residue at position 103 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 649 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 670 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 673 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 673 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 675 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 675 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 685 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 685 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 685 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 697 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 697 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 698 forms a bond with a carbohydrate, indicating a strong binding affinity.
The residue at position 698 forms a bond with Ca(2+) 3, indicating a strong binding affinity.
The residue at position 710 forms a bond with Ca(2+) 1, indicating a strong binding affinity.
The residue at position 110 to 112 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 781 to 789 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 802 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 350 to 357 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 311 to 316 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 87 to 88 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 232 to 237 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 39 to 60 forms a bond with NAD(+), indicating a strong binding affinity.
The residue at position 13 forms a bond with [2Fe-2S] cluster, indicating a strong binding affinity.
The residue at position 493 to 500 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 24 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 24 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 95 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 108 to 109 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 137 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 237 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 246 to 247 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 270 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 291 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 352 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 143 to 146 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 292 to 297 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 130 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 136 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 141 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 165 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 194 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 207 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 226 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 257 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 290 forms a bond with (E)-coniferaldehyde, indicating a strong binding affinity.
The residue at position 36 to 48 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 289 to 298 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 480 forms a bond with Ca(2+) 2, indicating a strong binding affinity.
The residue at position 58 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 96 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 221 to 223 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 326 to 327 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 434 forms a bond with sucrose 6(F)-phosphate, indicating a strong binding affinity.
The residue at position 821 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 233 to 235 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with D-glyceraldehyde 3-phosphate, indicating a strong binding affinity.
The residue at position 46 to 51 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 78 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 96 to 97 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 147 to 152 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 191 to 194 forms a bond with N(7)-methylguanosine 5'-triphosphate group of mRNA, indicating a strong binding affinity.
The residue at position 579 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 777 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 779 forms a bond with a divalent metal cation, indicating a strong binding affinity.
The residue at position 912 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 412 to 420 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 393 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 429 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 435 forms a bond with [4Fe-4S] cluster 2, indicating a strong binding affinity.
The residue at position 439 forms a bond with [4Fe-4S] cluster 1, indicating a strong binding affinity.
The residue at position 53 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 147 forms a bond with an N-acylsphingoid base 1-phosphate, indicating a strong binding affinity.
The residue at position 480 to 607 forms a bond with a nucleoside 3',5'-cyclic phosphate 2, indicating a strong binding affinity.
The residue at position 596 to 723 forms a bond with a nucleoside 3',5'-cyclic phosphate 3, indicating a strong binding affinity.
The residue at position 325 forms a bond with Cu cation A, indicating a strong binding affinity.
The residue at position 479 forms a bond with Cu cation B, indicating a strong binding affinity.
The residue at position 111 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 114 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 115 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 149 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 152 forms a bond with heme c 2, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 191 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 194 forms a bond with heme c 3, indicating a strong binding affinity.
The residue at position 195 forms a bond with Fe of heme c 3, indicating a strong binding affinity.
The residue at position 260 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 267 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 270 forms a bond with heme c 4, indicating a strong binding affinity.
The residue at position 271 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 286 forms a bond with Fe of heme c 2, indicating a strong binding affinity.
The residue at position 299 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 302 forms a bond with heme c 5, indicating a strong binding affinity.
The residue at position 303 forms a bond with Fe of heme c 5, indicating a strong binding affinity.
The residue at position 378 forms a bond with Fe of heme c 4, indicating a strong binding affinity.
The residue at position 429 to 433 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 440 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 988 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 991 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 993 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1033 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 1034 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1035 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 1039 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 1044 forms a bond with Cu cation 6, indicating a strong binding affinity.
The residue at position 125 to 128 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 695 to 752 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 818 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 617 to 624 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 690 to 697 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 276 forms a bond with Ca(2+) 6, indicating a strong binding affinity.
The residue at position 34 to 40 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 99 to 102 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 257 forms a bond with dUMP, indicating a strong binding affinity.
The residue at position 565 to 568 forms a bond with GTP, indicating a strong binding affinity.
The residue at position 1022 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 1029 forms a bond with Ca(2+), indicating a strong binding affinity.
The residue at position 177 forms a bond with (6S)-NADPHX 1, indicating a strong binding affinity.
The residue at position 428 to 432 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 447 to 456 forms a bond with ADP, indicating a strong binding affinity.
The residue at position 457 forms a bond with (6S)-NADPHX 2, indicating a strong binding affinity.
The residue at position 145 to 147 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 201 to 202 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 229 to 230 forms a bond with 1-deoxy-D-threo-hexo-2,5-diulose 6-phosphate, indicating a strong binding affinity.
The residue at position 389 to 390 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 16 forms a bond with Fe of heme b, indicating a strong binding affinity.
The residue at position 186 to 190 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 290 to 297 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 252 forms a bond with L-glutamate residue of a protein, indicating a strong binding affinity.
The residue at position 470 forms a bond with L-glutamate, indicating a strong binding affinity.
The residue at position 227 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 295 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 384 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 412 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 472 forms a bond with hybrid [4Fe-2O-2S] cluster, indicating a strong binding affinity.
The residue at position 107 forms a bond with Mg of chlorophyll a ChlzD2, indicating a strong binding affinity.
The residue at position 119 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 132 forms a bond with pheophytin a D2, indicating a strong binding affinity.
The residue at position 187 forms a bond with Mg of chlorophyll a PD2, indicating a strong binding affinity.
The residue at position 204 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 251 forms a bond with a plastoquinone Q(A), indicating a strong binding affinity.
The residue at position 453 to 457 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 686 forms a bond with S-adenosyl-L-methionine, indicating a strong binding affinity.
The residue at position 467 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 518 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 521 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 536 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 539 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 544 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 547 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 554 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 564 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 233 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 255 to 257 forms a bond with L-cysteinyl-5'-AMP, indicating a strong binding affinity.
The residue at position 203 to 208 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 238 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 1600 to 1607 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 40 to 41 forms a bond with phosphoenolpyruvate, indicating a strong binding affinity.
The residue at position 111 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 140 to 144 forms a bond with UDP-N-acetyl-alpha-D-glucosamine, indicating a strong binding affinity.
The residue at position 86 forms a bond with a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate), indicating a strong binding affinity.
The residue at position 550 forms a bond with (6S)-5-formyl-5,6,7,8-tetrahydrofolate, indicating a strong binding affinity.
The residue at position 140 forms a bond with Mg of a chlorophyll, indicating a strong binding affinity.
The residue at position 220 forms a bond with Mg of a chlorophyll, indicating a strong binding affinity.
The residue at position 183 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 186 forms a bond with Mg(2+) 3, indicating a strong binding affinity.
The residue at position 78 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 121 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 174 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 175 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 178 forms a bond with creatine, indicating a strong binding affinity.
The residue at position 389 to 392 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 584 forms a bond with Zn(2+) 1, indicating a strong binding affinity.
The residue at position 51 to 80 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 214 forms a bond with Mg(2+) 5, indicating a strong binding affinity.
The residue at position 54 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 55 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 66 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 91 forms a bond with beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate, indicating a strong binding affinity.
The residue at position 73 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 139 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 140 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 300 to 321 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 343 to 362 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 218 to 221 forms a bond with NADP(+), indicating a strong binding affinity.
The residue at position 518 to 520 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 127 forms a bond with heme 1, indicating a strong binding affinity.
The residue at position 131 forms a bond with Fe of heme 1, indicating a strong binding affinity.
The residue at position 153 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 167 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 178 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 181 forms a bond with heme 2, indicating a strong binding affinity.
The residue at position 182 forms a bond with Fe of heme 2, indicating a strong binding affinity.
The residue at position 267 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 278 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 281 forms a bond with heme 3, indicating a strong binding affinity.
The residue at position 282 forms a bond with Fe of heme 3, indicating a strong binding affinity.
The residue at position 339 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 342 forms a bond with heme 4, indicating a strong binding affinity.
The residue at position 343 forms a bond with Fe of heme 4, indicating a strong binding affinity.
The residue at position 274 to 278 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 389 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 393 forms a bond with CoA, indicating a strong binding affinity.
The residue at position 167 to 172 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 172 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 243 to 246 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 268 forms a bond with 2',3'-cGAMP, indicating a strong binding affinity.
The residue at position 268 forms a bond with 3',3'-c-di-GMP, indicating a strong binding affinity.
The residue at position 76 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 142 forms a bond with L-tryptophan, indicating a strong binding affinity.
The residue at position 142 forms a bond with L-tyrosine, indicating a strong binding affinity.
The residue at position 327 to 338 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 754 forms a bond with Mg(2+), indicating a strong binding affinity.
The residue at position 84 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 107 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 108 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 109 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 141 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 160 forms a bond with S-adenosyl-L-homocysteine, indicating a strong binding affinity.
The residue at position 90 to 95 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 284 to 289 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 316 to 320 forms a bond with 3'-phosphoadenylyl sulfate, indicating a strong binding affinity.
The residue at position 707 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 723 forms a bond with Zn(2+) 3, indicating a strong binding affinity.
The residue at position 735 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 738 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 751 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 755 forms a bond with Zn(2+) 4, indicating a strong binding affinity.
The residue at position 763 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 766 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 779 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 783 forms a bond with Zn(2+) 5, indicating a strong binding affinity.
The residue at position 791 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 794 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 807 forms a bond with Zn(2+) 6, indicating a strong binding affinity.
The residue at position 210 forms a bond with Fe cation 2, indicating a strong binding affinity.
The residue at position 658 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 662 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 665 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 665 forms a bond with Zn(2+) 2, indicating a strong binding affinity.
The residue at position 666 forms a bond with Cu(2+) 2, indicating a strong binding affinity.
The residue at position 164 to 166 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 204 to 209 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 204 to 209 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 240 forms a bond with CTP, indicating a strong binding affinity.
The residue at position 240 forms a bond with UTP, indicating a strong binding affinity.
The residue at position 421 forms a bond with L-glutamine, indicating a strong binding affinity.
The residue at position 1582 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1589 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1592 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 1598 forms a bond with [4Fe-4S] cluster, indicating a strong binding affinity.
The residue at position 204 to 207 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 247 to 250 forms a bond with (2E,6E)-farnesyl diphosphate, indicating a strong binding affinity.
The residue at position 231 forms a bond with Mg(2+) 4, indicating a strong binding affinity.
The residue at position 240 to 241 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 264 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 285 forms a bond with dihydroxyacetone phosphate, indicating a strong binding affinity.
The residue at position 346 forms a bond with beta-D-fructose 1,6-bisphosphate, indicating a strong binding affinity.
The residue at position 48 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 50 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 95 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 440 forms a bond with Cu cation 4, indicating a strong binding affinity.
The residue at position 443 forms a bond with Cu cation 1, indicating a strong binding affinity.
The residue at position 445 forms a bond with Cu cation 3, indicating a strong binding affinity.
The residue at position 504 forms a bond with Cu cation 2, indicating a strong binding affinity.
The residue at position 312 to 317 forms a bond with FAD, indicating a strong binding affinity.
The residue at position 436 to 443 forms a bond with ATP 1, indicating a strong binding affinity.
The residue at position 1065 to 1072 forms a bond with ATP 2, indicating a strong binding affinity.
The residue at position 118 to 123 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 263 to 266 forms a bond with ATP, indicating a strong binding affinity.
The residue at position 300 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 355 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 358 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 401 forms a bond with biotin, indicating a strong binding affinity.
The residue at position 401 forms a bond with hydrogencarbonate, indicating a strong binding affinity.
The residue at position 601 to 602 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 665 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 667 to 669 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 675 to 680 forms a bond with acetyl-CoA, indicating a strong binding affinity.
The residue at position 699 to 701 forms a bond with substrate, indicating a strong binding affinity.
The residue at position 599 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 639 forms a bond with Mn(2+) 2, indicating a strong binding affinity.
The residue at position 184 forms a bond with L-aspartate, indicating a strong binding affinity.
The residue at position 382 forms a bond with L-aspartate, indicating a strong binding affinity.